PSI-HHS-000004592364-65 and PSI-HHS-000004588545-46 attachment

PSI-HHS-000004592364-65-and-000004588545-46

Type: Spreadsheet
Source: hsgac.senate.gov
Download: Original spreadsheet

This spreadsheet is large; only the first 1,000 rows of each sheet are shown. Download the full file for complete data.

Masked

24 rows

Vaccine Type + Manufacturer	Event: HLT	N	ER05	ERAM	ER95	E	EB05	EBGM	EB95	PRR	ROR	ROR05	PRR_B
COVID19_MODERNA	Coronary artery disorders NEC	73	1.38	1.69	2.03	64.3	0.93	1.12	1.35	1.37	1.37	1.09	181
COVID19_PFIZER/BIONTECH	Coronary artery disorders NEC	90	2.01	2.41	2.84	56.4	1.31	1.56	1.85	2.25	2.25	1.81	164
COVID19_JANSSEN	Death and sudden death	303	1.39	1.53	1.68	303.1	0.91	1.00	1.10	0.71	0.71	0.64	6612
COVID19_MODERNA	Death and sudden death	1903	2.08	2.16	2.25	1387.9	1.32	1.37	1.42	1.29	1.29	1.24	5012
COVID19_PFIZER/BIONTECH	Death and sudden death	1984	2.35	2.44	2.53	1278.3	1.49	1.55	1.61	1.65	1.66	1.59	4931
COVID19_MODERNA	Dementia (excl Alzheimer's type)	43	1.94	2.54	3.20	29.8	1.08	1.40	1.77	1.64	1.64	1.21	89
COVID19_PFIZER/BIONTECH	Dementia (excl Alzheimer's type)	52	2.54	3.23	4.00	27.1	1.45	1.83	2.28	2.66	2.66	1.99	80
COVID19_MODERNA	Device issues NEC	123	8.62	10.07	11.60	36.9	2.77	3.22	3.74	4.69	4.70	3.74	89
COVID19_PFIZER/BIONTECH	Exposures to agents or circumstances NEC	244	5.19	5.79	6.41	81.7	2.64	2.94	3.26	6.70	6.72	5.66	149
COVID19_MODERNA	Herpes viral infections	1159	1.05	1.10	1.15	2368.4	0.47	0.49	0.51	0.28	0.28	0.26	13891
COVID19_PFIZER/BIONTECH	Herpes viral infections	1380	1.28	1.34	1.40	2501.7	0.53	0.55	0.58	0.41	0.41	0.39	13670
COVID19_MODERNA	Intentional product use issues	22	3.68	5.41	7.41	7.6	1.72	2.46	3.49	14.94	14.94	6.61	5
COVID19_JANSSEN	Non-site specific embolism and thrombosis	514	7.16	7.71	8.27	111.8	4.25	4.58	4.92	6.92	7.01	6.42	1146
COVID19_MODERNA	Non-site specific embolism and thrombosis	387	1.21	1.32	1.43	460.1	0.77	0.84	0.91	1.03	1.03	0.94	1273
COVID19_PFIZER/BIONTECH	Non-site specific embolism and thrombosis	640	2.45	2.62	2.79	391.9	1.53	1.63	1.74	2.57	2.58	2.37	1020
COVID19_MODERNA	Noninfectious myocarditis	130	1.27	1.48	1.70	133.9	0.84	0.97	1.11	0.97	0.97	0.83	454
COVID19_PFIZER/BIONTECH	Noninfectious myocarditis	268	2.80	3.10	3.42	131.2	1.83	2.02	2.23	3.47	3.48	3.03	316
COVID19_JANSSEN	Off label uses	91	5.30	6.35	7.48	34.9	2.10	2.51	2.97	3.41	3.42	2.82	412
COVID19_PFIZER/BIONTECH	Off label uses	260	6.13	6.81	7.52	98.9	2.34	2.59	2.87	4.38	4.39	3.79	243
COVID19_JANSSEN	Peripheral embolism and thrombosis	390	6.42	6.99	7.58	87.3	4.08	4.44	4.83	7.00	7.07	6.39	860
COVID19_MODERNA	Product distribution and storage issues	614	24.88	26.63	28.42	49.5	11.56	12.36	13.20	11.78	11.83	10.28	177
COVID19_PFIZER/BIONTECH	Product distribution and storage issues	41	1.74	2.29	2.91	41.1	0.76	0.99	1.26	0.22	0.22	0.17	750
COVID19_PFIZER/BIONTECH	Product preparation errors and issues	580	3.91	4.19	4.48	236.3	2.28	2.44	2.61	1.95	1.95	1.80	1220
COVID19_PFIZER/BIONTECH	Sodium imbalance	93	2.56	3.06	3.59	46.1	1.65	1.96	2.31	2.88	2.89	2.31	132

All DECs

5,308 rows (showing first 1,000)

Vaccine Type + Manufacturer	Event: HLT	N	ER05	ERAM	ER95	E	EB05	EBGM	EB95	PRR	ROR	ROR05	PRR_B
COVID19_JANSSEN	Abdominal and gastrointestinal infections	47	0.84	1.09	1.36	62.0	0.60	0.76	0.96	0.68	0.68	0.53	1063
COVID19_MODERNA	Abdominal and gastrointestinal infections	155	1.02	1.18	1.33	179.3	0.76	0.86	0.98	0.55	0.55	0.48	955
COVID19_PFIZER/BIONTECH	Abdominal and gastrointestinal infections	291	2.06	2.28	2.50	180.5	1.45	1.60	1.76	1.45	1.46	1.30	819
COVID19_UNKNOWN MFR	Abdominal and gastrointestinal infections	0	0.01	0.42	1.41	1.0
COVID19_JANSSEN	Abdominal and gastrointestinal injuries NEC	23	0.93	1.34	1.80	19.3	0.82	1.15	1.58	1.32	1.32	0.92	270
COVID19_MODERNA	Abdominal and gastrointestinal injuries NEC	45	0.67	0.87	1.09	58.7	0.60	0.77	0.97	0.62	0.62	0.47	248
COVID19_PFIZER/BIONTECH	Abdominal and gastrointestinal injuries NEC	58	0.95	1.19	1.46	54.8	0.84	1.05	1.29	1.01	1.01	0.79	235
COVID19_UNKNOWN MFR	Abdominal and gastrointestinal injuries NEC	1	0.37	1.23	2.51	0.4	0.35	1.05	2.73	2.36	2.36	0.45	292
COVID19_JANSSEN	Abdominal findings abnormal	10	1.16	2.09	3.24	4.6	1.03	1.72	2.74	1.72	1.72	0.99	90
COVID19_MODERNA	Abdominal findings abnormal	16	0.63	0.99	1.42	17.0	0.62	0.92	1.34	0.65	0.65	0.41	84
COVID19_PFIZER/BIONTECH	Abdominal findings abnormal	13	0.54	0.90	1.33	15.9	0.52	0.81	1.22	0.61	0.61	0.38	87
COVID19_UNKNOWN MFR	Abdominal findings abnormal	0	0.01	0.85	3.03	0.1
COVID19_JANSSEN	Abdominal hernias NEC	1	0.26	1.23	2.77	0.5	0.33	1.00	2.54	1.19	1.19	0.22	13
COVID19_MODERNA	Abdominal hernias NEC	3	0.43	1.20	2.27	2.6	0.44	0.97	1.95	0.93	0.93	0.32	11
COVID19_PFIZER/BIONTECH	Abdominal hernias NEC	3	0.46	1.27	2.40	2.2	0.48	1.07	2.14	1.12	1.12	0.38	11
COVID19_UNKNOWN MFR	Abdominal hernias NEC	0	0.10	0.99	2.67	0.0
COVID19_JANSSEN	Abdominal therapeutic procedures NEC	8	0.78	1.52	2.47	5.7	0.70	1.22	2.00	0.97	0.97	0.53	127
COVID19_MODERNA	Abdominal therapeutic procedures NEC	18	0.66	1.01	1.43	19.3	0.63	0.92	1.31	0.52	0.52	0.34	117
COVID19_PFIZER/BIONTECH	Abdominal therapeutic procedures NEC	24	0.99	1.43	1.94	19.4	0.85	1.19	1.62	0.89	0.89	0.61	111
COVID19_UNKNOWN MFR	Abdominal therapeutic procedures NEC	1	0.29	2.23	5.69	0.1	0.40	1.31	5.13	5.13	5.14	0.99	134
COVID19_JANSSEN	Abdominal wall conditions NEC	0	0.06	0.68	1.86	0.6
COVID19_MODERNA	Abdominal wall conditions NEC	4	0.60	1.49	2.69	2.7	0.57	1.18	2.23	2.26	2.26	0.78	6
COVID19_PFIZER/BIONTECH	Abdominal wall conditions NEC	4	0.66	1.63	2.95	2.1	0.64	1.33	2.55	2.73	2.73	0.94	6
COVID19_UNKNOWN MFR	Abdominal wall conditions NEC	0	0.09	0.99	2.73	0.0
COVID19_JANSSEN	Abnormal behaviour NEC	27	0.55	0.77	1.01	41.8	0.48	0.65	0.88	0.24	0.24	0.18	1712
COVID19_MODERNA	Abnormal behaviour NEC	89	0.77	0.92	1.09	108.7	0.69	0.82	0.97	0.18	0.18	0.15	1650
COVID19_PFIZER/BIONTECH	Abnormal behaviour NEC	112	0.80	0.94	1.09	148.6	0.65	0.75	0.88	0.28	0.28	0.24	1627
COVID19_UNKNOWN MFR	Abnormal behaviour NEC	0	0.21	0.75	1.58	1.0
COVID19_JANSSEN	Abnormal food elimination	0	0.06	0.86	2.48	0.2
COVID19_MODERNA	Abnormal food elimination	0	0.04	0.62	1.79	0.7
COVID19_PFIZER/BIONTECH	Abnormal food elimination	1	0.24	1.24	2.90	0.6	0.32	0.97	2.45	2.05	2.05	0.27	2
COVID19_UNKNOWN MFR	Abnormal food elimination	0	0.07	1.00	2.88	0.0
COVID19_JANSSEN	Abnormal gene carriers	1	0.34	1.87	4.44	0.1	0.43	1.48	8.71	46.31	46.32	3.16	0
COVID19_MODERNA	Abnormal gene carriers	0	0.04	0.82	2.44	0.2
COVID19_PFIZER/BIONTECH	Abnormal gene carriers	0	0.04	0.84	2.50	0.2
COVID19_UNKNOWN MFR	Abnormal gene carriers	0	0.05	1.00	2.98	0.0
COVID19_JANSSEN	Abnormal reflexes	13	0.36	0.60	0.89	29.0	0.30	0.47	0.71	0.42	0.42	0.27	477
COVID19_MODERNA	Abnormal reflexes	29	0.31	0.43	0.57	81.7	0.27	0.37	0.49	0.21	0.21	0.16	461
COVID19_PFIZER/BIONTECH	Abnormal reflexes	35	0.40	0.54	0.70	83.2	0.33	0.43	0.56	0.32	0.32	0.24	455
COVID19_UNKNOWN MFR	Abnormal reflexes	1	0.22	1.31	3.14	0.7	0.31	0.93	2.32	1.41	1.41	0.27	489
COVID19_JANSSEN	Abnormal sleep-related events	1	0.06	0.57	1.56	2.3	0.18	0.58	1.46	0.52	0.52	0.10	30
COVID19_MODERNA	Abnormal sleep-related events	5	0.31	0.77	1.38	6.4	0.40	0.78	1.41	0.65	0.65	0.29	26
COVID19_PFIZER/BIONTECH	Abnormal sleep-related events	8	0.65	1.29	2.10	6.4	0.65	1.13	1.85	1.42	1.42	0.73	23
COVID19_UNKNOWN MFR	Abnormal sleep-related events	0	0.00	0.88	3.87	0.0
COVID19_JANSSEN	Abortion related conditions and complications	0	0.01	0.41	1.40	1.0
COVID19_MODERNA	Abortion related conditions and complications	6	0.66	1.43	2.45	3.7	0.71	1.31	2.30	3.40	3.40	1.31	6
COVID19_PFIZER/BIONTECH	Abortion related conditions and complications	2	0.16	0.66	1.43	3.2	0.27	0.68	1.47	0.82	0.82	0.23	10
COVID19_UNKNOWN MFR	Abortion related conditions and complications	0	0.02	0.97	3.33	0.0
COVID19_JANSSEN	Abortions not specified as induced or spontaneous	0	0.00	0.12	0.53	2.6
COVID19_MODERNA	Abortions not specified as induced or spontaneous	7	0.43	0.89	1.49	11.1	0.37	0.66	1.11	0.68	0.68	0.34	35
COVID19_PFIZER/BIONTECH	Abortions not specified as induced or spontaneous	7	0.43	0.90	1.51	11.1	0.37	0.66	1.11	0.82	0.82	0.41	35
COVID19_UNKNOWN MFR	Abortions not specified as induced or spontaneous	0	0.00	0.86	3.70	0.1
COVID19_JANSSEN	Abortions spontaneous	34	0.47	0.64	0.82	55.4	0.47	0.62	0.81	0.87	0.87	0.65	604
COVID19_MODERNA	Abortions spontaneous	172	0.75	0.85	0.96	206.9	0.73	0.83	0.94	1.25	1.25	1.08	466
COVID19_PFIZER/BIONTECH	Abortions spontaneous	238	1.17	1.31	1.45	186.4	1.14	1.27	1.41	2.44	2.44	2.13	400
COVID19_UNKNOWN MFR	Abortions spontaneous	0	0.02	0.47	1.43	1.1
COVID19_JANSSEN	Absence seizures	5	0.40	0.88	1.52	7.4	0.36	0.70	1.25	0.41	0.41	0.19	190
COVID19_MODERNA	Absence seizures	6	0.25	0.51	0.85	15.1	0.24	0.45	0.78	0.11	0.11	0.05	189
COVID19_PFIZER/BIONTECH	Absence seizures	14	0.54	0.86	1.25	20.9	0.44	0.68	1.01	0.32	0.32	0.20	181
COVID19_UNKNOWN MFR	Absence seizures	1	0.35	1.52	3.35	0.2	0.39	1.24	4.01	3.55	3.55	0.68	194
COVID19_JANSSEN	Accelerated and malignant hypertension	11	0.94	1.58	2.36	8.2	0.76	1.22	1.89	1.45	1.45	0.86	117
COVID19_MODERNA	Accelerated and malignant hypertension	39	1.09	1.44	1.83	35.4	0.83	1.08	1.39	1.49	1.49	1.09	89
COVID19_PFIZER/BIONTECH	Accelerated and malignant hypertension	51	1.73	2.20	2.72	29.6	1.32	1.66	2.07	2.71	2.71	2.02	77
COVID19_UNKNOWN MFR	Accelerated and malignant hypertension	0	0.17	0.93	2.18	0.2
COVID19_JANSSEN	Accidental exposures to product	13	0.58	0.97	1.43	18.4	0.46	0.71	1.07	0.72	0.72	0.45	280
COVID19_MODERNA	Accidental exposures to product	7	0.14	0.28	0.46	34.1	0.13	0.24	0.40	0.08	0.08	0.04	286
COVID19_PFIZER/BIONTECH	Accidental exposures to product	15	0.30	0.47	0.69	43.5	0.24	0.37	0.54	0.22	0.22	0.14	278
COVID19_UNKNOWN MFR	Accidental exposures to product	1	0.23	1.59	3.95	0.5	0.34	1.03	2.63	2.36	2.36	0.45	292
COVID19_JANSSEN	Acnes	22	0.65	0.95	1.29	28.2	0.55	0.78	1.08	0.75	0.75	0.53	451
COVID19_MODERNA	Acnes	69	0.65	0.80	0.97	102.6	0.55	0.68	0.82	0.58	0.58	0.47	404
COVID19_PFIZER/BIONTECH	Acnes	67	0.71	0.88	1.06	92.6	0.59	0.73	0.88	0.68	0.68	0.54	406
COVID19_UNKNOWN MFR	Acnes	0	0.09	0.73	1.89	0.6
COVID19_JANSSEN	Acquired immunodeficiency syndromes	0	0.05	0.94	2.83	0.1
COVID19_MODERNA	Acquired immunodeficiency syndromes	0	0.04	0.81	2.44	0.2
COVID19_PFIZER/BIONTECH	Acquired immunodeficiency syndromes	0	0.04	0.84	2.51	0.2
COVID19_UNKNOWN MFR	Acquired immunodeficiency syndromes	0	0.05	1.00	3.00	0.0
COVID19_JANSSEN	Acute and chronic pancreatitis	11	0.45	0.77	1.16	15.6	0.44	0.72	1.11	0.77	0.77	0.46	220
COVID19_MODERNA	Acute and chronic pancreatitis	65	0.99	1.23	1.48	56.2	0.93	1.14	1.39	1.33	1.33	1.05	166
COVID19_PFIZER/BIONTECH	Acute and chronic pancreatitis	75	1.31	1.60	1.91	49.8	1.22	1.47	1.77	1.97	1.97	1.56	156
COVID19_UNKNOWN MFR	Acute and chronic pancreatitis	0	0.08	0.79	2.11	0.4
COVID19_JANSSEN	Acute and chronic sarcoidosis	1	0.12	0.60	1.40	2.9	0.15	0.51	1.28	0.48	0.48	0.09	32
COVID19_MODERNA	Acute and chronic sarcoidosis	3	0.19	0.55	1.06	6.7	0.23	0.53	1.06	0.34	0.34	0.13	30
COVID19_PFIZER/BIONTECH	Acute and chronic sarcoidosis	7	0.55	1.09	1.78	7.2	0.52	0.93	1.56	1.10	1.10	0.55	26
COVID19_UNKNOWN MFR	Acute and chronic sarcoidosis	0	0.07	0.96	2.74	0.1
COVID19_JANSSEN	Acute and chronic thyroiditis	2	0.05	0.23	0.49	13.6	0.06	0.21	0.50	0.16	0.16	0.05	196
COVID19_MODERNA	Acute and chronic thyroiditis	16	0.37	0.58	0.83	32.1	0.35	0.52	0.75	0.30	0.30	0.19	182
COVID19_PFIZER/BIONTECH	Acute and chronic thyroiditis	32	0.79	1.08	1.41	35.7	0.67	0.89	1.17	0.79	0.79	0.57	166
COVID19_UNKNOWN MFR	Acute and chronic thyroiditis	0	0.01	0.68	2.52	0.3
COVID19_JANSSEN	Acute polyneuropathies	61	0.71	0.88	1.07	118.4	0.42	0.52	0.64	0.55	0.55	0.45	1700
COVID19_MODERNA	Acute polyneuropathies	99	0.37	0.44	0.52	372.1	0.23	0.27	0.32	0.20	0.20	0.17	1662
COVID19_PFIZER/BIONTECH	Acute polyneuropathies	125	0.52	0.61	0.70	346.0	0.31	0.36	0.42	0.31	0.31	0.27	1636
COVID19_UNKNOWN MFR	Acute polyneuropathies	4	0.71	1.91	3.58	3.0	0.53	1.10	2.07	1.57	1.57	0.69	1757
COVID19_JANSSEN	Adenoviral infections	0	0.00	0.28	1.08	1.3
COVID19_MODERNA	Adenoviral infections	2	0.13	0.58	1.28	2.0	0.35	0.88	1.89	0.16	0.16	0.05	43
COVID19_PFIZER/BIONTECH	Adenoviral infections	2	0.12	0.54	1.19	4.0	0.23	0.59	1.29	0.19	0.19	0.06	43
COVID19_UNKNOWN MFR	Adenoviral infections	0	0.00	0.94	3.60	0.0
COVID19_JANSSEN	Adjustment disorders	0	0.00	0.23	1.02	1.1
COVID19_MODERNA	Adjustment disorders	0	0.00	0.08	0.36	3.9
COVID19_PFIZER/BIONTECH	Adjustment disorders	2	0.13	0.61	1.38	2.6	0.31	0.77	1.67	0.59	0.59	0.17	14
COVID19_UNKNOWN MFR	Adjustment disorders	0	0.00	0.94	4.09	0.0
COVID19_JANSSEN	Administration site reactions NEC	2	0.03	0.12	0.26	20.6	0.03	0.13	0.34	0.07	0.07	0.02	433
COVID19_MODERNA	Administration site reactions NEC	29	0.25	0.35	0.46	72.4	0.30	0.41	0.55	0.24	0.24	0.18	406
COVID19_PFIZER/BIONTECH	Administration site reactions NEC	9	0.07	0.13	0.21	67.3	0.08	0.15	0.24	0.09	0.09	0.05	426
COVID19_UNKNOWN MFR	Administration site reactions NEC	0	0.01	0.57	1.92	0.5
COVID19_JANSSEN	Adrenal cortex tests	2	0.15	0.55	1.16	4.9	0.20	0.52	1.14	0.39	0.39	0.12	80
COVID19_MODERNA	Adrenal cortex tests	12	0.47	0.79	1.18	16.6	0.46	0.73	1.11	0.58	0.58	0.35	70
COVID19_PFIZER/BIONTECH	Adrenal cortex tests	12	0.51	0.86	1.29	15.6	0.49	0.77	1.17	0.70	0.70	0.42	70
COVID19_UNKNOWN MFR	Adrenal cortex tests	0	0.05	0.91	2.73	0.1
COVID19_JANSSEN	Adrenal cortical hyperfunctions	1	0.22	1.34	3.26	0.5	0.33	1.00	2.53	1.40	1.40	0.25	11
COVID19_MODERNA	Adrenal cortical hyperfunctions	1	0.12	0.74	1.79	1.5	0.24	0.73	1.80	0.31	0.31	0.06	11
COVID19_PFIZER/BIONTECH	Adrenal cortical hyperfunctions	0	0.01	0.34	1.09	1.6
COVID19_UNKNOWN MFR	Adrenal cortical hyperfunctions	0	0.03	0.98	3.12	0.0
COVID19_JANSSEN	Adrenal cortical hypofunctions	2	0.18	0.70	1.51	3.7	0.24	0.62	1.35	0.62	0.62	0.19	50
COVID19_MODERNA	Adrenal cortical hypofunctions	9	0.48	0.89	1.41	11.3	0.47	0.80	1.28	0.71	0.71	0.39	43
COVID19_PFIZER/BIONTECH	Adrenal cortical hypofunctions	9	0.52	0.97	1.53	10.6	0.50	0.84	1.34	0.86	0.86	0.47	43
COVID19_UNKNOWN MFR	Adrenal cortical hypofunctions	0	0.02	0.91	3.03	0.1
COVID19_JANSSEN	Adrenal gland disorders NEC	3	0.52	1.16	1.99	2.0	0.50	1.11	2.23	1.60	1.60	0.59	29
COVID19_MODERNA	Adrenal gland disorders NEC	10	0.69	1.16	1.72	8.8	0.64	1.06	1.67	1.54	1.54	0.82	22
COVID19_PFIZER/BIONTECH	Adrenal gland disorders NEC	5	0.41	0.80	1.30	7.5	0.35	0.69	1.24	0.76	0.76	0.34	27
COVID19_UNKNOWN MFR	Adrenal gland disorders NEC	0	0.30	0.99	1.99	0.1
COVID19_JANSSEN	Adrenal gland therapeutic procedures	0	0.05	0.94	2.81	0.1
COVID19_MODERNA	Adrenal gland therapeutic procedures	0	0.04	0.82	2.44	0.2
COVID19_PFIZER/BIONTECH	Adrenal gland therapeutic procedures	0	0.04	0.84	2.50	0.2
COVID19_UNKNOWN MFR	Adrenal gland therapeutic procedures	0	0.05	1.00	2.98	0.0
COVID19_JANSSEN	Adrenal medulla tests	4	0.39	0.94	1.70	4.4	0.42	0.86	1.62	1.14	1.14	0.49	54
COVID19_MODERNA	Adrenal medulla tests	26	1.10	1.55	2.07	17.4	1.02	1.41	1.91	2.76	2.76	1.79	32
COVID19_PFIZER/BIONTECH	Adrenal medulla tests	16	0.72	1.12	1.59	14.8	0.69	1.04	1.51	1.56	1.56	0.96	42
COVID19_UNKNOWN MFR	Adrenal medulla tests	0	0.10	0.94	2.52	0.1
COVID19_JANSSEN	Adrenal neoplasms benign	1	0.34	1.64	3.74	0.2	0.39	1.26	4.24	15.44	15.44	1.51	1
COVID19_MODERNA	Adrenal neoplasms benign	1	0.27	1.32	3.01	0.7	0.31	0.93	2.32	3.40	3.40	0.33	1
COVID19_PFIZER/BIONTECH	Adrenal neoplasms benign	0	0.07	0.76	2.11	0.4
COVID19_UNKNOWN MFR	Adrenal neoplasms benign	0	0.09	1.00	2.76	0.0
COVID19_JANSSEN	Adrenal neoplasms malignant	0	0.05	0.94	2.83	0.1
COVID19_MODERNA	Adrenal neoplasms malignant	0	0.04	0.81	2.44	0.2
COVID19_PFIZER/BIONTECH	Adrenal neoplasms malignant	0	0.04	0.84	2.51	0.2
COVID19_UNKNOWN MFR	Adrenal neoplasms malignant	0	0.05	1.00	3.00	0.0
COVID19_JANSSEN	Adverse effect absent	337	0.14	0.15	0.17	2115.8	0.15	0.16	0.18	0.09	0.08	0.07	58963
COVID19_MODERNA	Adverse effect absent	1552	0.35	0.36	0.38	3937.4	0.38	0.39	0.41	0.09	0.08	0.08	57748
COVID19_PFIZER/BIONTECH	Adverse effect absent	958	0.23	0.25	0.26	3584.4	0.25	0.27	0.28	0.07	0.06	0.06	58342
COVID19_UNKNOWN MFR	Adverse effect absent	4	0.04	0.10	0.18	50.3	0.04	0.09	0.19	0.05	0.04	0.02	59296
COVID19_JANSSEN	Aeromonas infections	0	0.03	0.88	2.75	0.1
COVID19_MODERNA	Aeromonas infections	0	0.03	0.66	2.07	0.5
COVID19_PFIZER/BIONTECH	Aeromonas infections	0	0.03	0.69	2.17	0.4
COVID19_UNKNOWN MFR	Aeromonas infections	0	0.04	1.00	3.11	0.0
COVID19_JANSSEN	Affect alterations NEC	17	1.29	1.96	2.74	7.8	1.25	1.86	2.70	2.00	2.00	1.31	131
COVID19_MODERNA	Affect alterations NEC	14	0.45	0.72	1.03	21.4	0.43	0.67	0.99	0.36	0.36	0.22	134
COVID19_PFIZER/BIONTECH	Affect alterations NEC	18	0.56	0.84	1.16	22.6	0.54	0.79	1.13	0.57	0.57	0.38	130
COVID19_UNKNOWN MFR	Affect alterations NEC	0	0.21	0.93	2.07	0.2
COVID19_JANSSEN	Age related issues	10	1.97	3.56	5.54	3.2	1.32	2.24	3.78	4.54	4.54	2.51	34
COVID19_MODERNA	Age related issues	11	0.63	1.11	1.70	13.5	0.50	0.81	1.26	1.13	1.13	0.64	33
COVID19_PFIZER/BIONTECH	Age related issues	14	0.99	1.63	2.39	11.4	0.75	1.15	1.71	1.91	1.91	1.12	30
COVID19_UNKNOWN MFR	Age related issues	0	0.00	0.90	3.40	0.1
COVID19_JANSSEN	Alcohol product use	2	0.43	1.25	2.41	1.3	0.42	1.06	2.32	2.21	2.21	0.64	14
COVID19_MODERNA	Alcohol product use	4	0.44	1.01	1.76	4.6	0.41	0.84	1.58	1.13	1.13	0.44	12
COVID19_PFIZER/BIONTECH	Alcohol product use	5	0.60	1.26	2.14	4.0	0.56	1.09	1.96	1.86	1.86	0.77	11
COVID19_UNKNOWN MFR	Alcohol product use	0	0.18	0.99	2.33	0.0
COVID19_JANSSEN	Allergic conditions NEC	139	0.52	0.60	0.69	274.6	0.44	0.51	0.58	0.47	0.47	0.41	4556
COVID19_MODERNA	Allergic conditions NEC	607	0.69	0.74	0.79	945.3	0.60	0.64	0.69	0.50	0.50	0.47	4088
COVID19_PFIZER/BIONTECH	Allergic conditions NEC	730	0.92	0.98	1.04	872.3	0.79	0.84	0.89	0.75	0.75	0.70	3965
COVID19_UNKNOWN MFR	Allergic conditions NEC	1	0.10	0.39	0.81	6.7	0.05	0.26	0.73	0.15	0.15	0.03	4694
COVID19_JANSSEN	Allergies to foods, food additives, drugs and other chemicals	20	0.23	0.34	0.47	79.3	0.18	0.27	0.37	0.21	0.21	0.15	1459
COVID19_MODERNA	Allergies to foods, food additives, drugs and other chemicals	91	0.46	0.55	0.65	196.0	0.39	0.47	0.55	0.22	0.22	0.19	1388
COVID19_PFIZER/BIONTECH	Allergies to foods, food additives, drugs and other chemicals	160	0.82	0.94	1.07	215.9	0.65	0.74	0.84	0.50	0.50	0.43	1319
COVID19_UNKNOWN MFR	Allergies to foods, food additives, drugs and other chemicals	1	0.11	0.74	1.81	2.1	0.19	0.62	1.53	0.47	0.47	0.09	1478
COVID19_JANSSEN	Alopecias	42	1.05	1.38	1.74	40.8	0.79	1.01	1.29	0.99	0.99	0.76	658
COVID19_MODERNA	Alopecias	79	0.57	0.70	0.83	134.2	0.49	0.59	0.71	0.43	0.43	0.36	621
COVID19_PFIZER/BIONTECH	Alopecias	82	0.68	0.82	0.98	127.2	0.54	0.65	0.77	0.54	0.54	0.45	618
COVID19_UNKNOWN MFR	Alopecias	1	0.18	1.18	2.91	0.9	0.28	0.86	2.11	0.98	0.98	0.19	699
COVID19_JANSSEN	Alphaviral infections	0	0.04	0.94	2.86	0.1
COVID19_MODERNA	Alphaviral infections	0	0.04	0.81	2.46	0.2
COVID19_PFIZER/BIONTECH	Alphaviral infections	0	0.04	0.83	2.52	0.2
COVID19_UNKNOWN MFR	Alphaviral infections	0	0.05	1.00	3.03	0.0
COVID19_JANSSEN	Alzheimer's disease (incl subtypes)	1	0.21	0.86	1.87	1.2	0.26	0.78	1.93	0.74	0.74	0.14	21
COVID19_MODERNA	Alzheimer's disease (incl subtypes)	9	0.76	1.37	2.13	6.4	0.74	1.24	2.00	2.35	2.35	1.15	13
COVID19_PFIZER/BIONTECH	Alzheimer's disease (incl subtypes)	5	0.43	0.94	1.61	5.5	0.45	0.87	1.57	1.20	1.20	0.52	17
COVID19_UNKNOWN MFR	Alzheimer's disease (incl subtypes)	0	0.14	0.98	2.46	0.0
COVID19_JANSSEN	Amblyopic vision impairment	1	0.30	0.95	1.89	1.1	0.27	0.81	1.99	0.81	0.81	0.15	19
COVID19_MODERNA	Amblyopic vision impairment	1	0.16	0.51	1.01	3.9	0.11	0.41	1.07	0.18	0.18	0.03	19
COVID19_PFIZER/BIONTECH	Amblyopic vision impairment	5	0.56	1.15	1.91	3.7	0.58	1.13	2.05	1.36	1.36	0.58	15
COVID19_UNKNOWN MFR	Amblyopic vision impairment	0	0.24	0.99	2.17	0.0
COVID19_JANSSEN	Amniotic fluid and cavity disorders of pregnancy NEC	0	0.00	0.06	0.31	2.7
COVID19_MODERNA	Amniotic fluid and cavity disorders of pregnancy NEC	3	0.10	0.35	0.72	12.1	0.13	0.32	0.66	0.24	0.24	0.09	42
COVID19_PFIZER/BIONTECH	Amniotic fluid and cavity disorders of pregnancy NEC	3	0.11	0.37	0.77	11.3	0.14	0.34	0.70	0.29	0.29	0.11	42
COVID19_UNKNOWN MFR	Amniotic fluid and cavity disorders of pregnancy NEC	0	0.00	0.71	3.84	0.1
COVID19_JANSSEN	Amoebic infections	0	0.00	0.38	2.11	0.2
COVID19_MODERNA	Amoebic infections	0	0.00	0.14	0.78	0.9
COVID19_PFIZER/BIONTECH	Amoebic infections	0	0.00	0.16	0.89	0.8
COVID19_UNKNOWN MFR	Amoebic infections	0	0.00	0.96	5.32	0.0
COVID19_JANSSEN	Amyloidoses	0	0.10	0.89	2.33	0.2
COVID19_MODERNA	Amyloidoses	1	0.26	1.15	2.55	0.6	0.32	0.96	2.40	1.70	1.70	0.23	2
COVID19_PFIZER/BIONTECH	Amyloidoses	1	0.27	1.20	2.67	0.4	0.35	1.05	2.72	2.05	2.05	0.27	2
COVID19_UNKNOWN MFR	Amyloidoses	0	0.11	1.00	2.62	0.0
COVID19_JANSSEN	Anaemia deficiencies	1	0.09	0.59	1.44	2.5	0.17	0.56	1.39	0.36	0.36	0.07	43
COVID19_MODERNA	Anaemia deficiencies	4	0.23	0.61	1.12	8.6	0.25	0.53	1.00	0.34	0.34	0.14	40
COVID19_PFIZER/BIONTECH	Anaemia deficiencies	8	0.58	1.13	1.82	8.2	0.54	0.94	1.54	0.91	0.91	0.48	36
COVID19_UNKNOWN MFR	Anaemia deficiencies	0	0.02	0.93	3.07	0.1
COVID19_JANSSEN	Anaemias NEC	25	0.67	0.96	1.28	30.5	0.59	0.82	1.11	0.68	0.68	0.48	570
COVID19_MODERNA	Anaemias NEC	97	0.74	0.88	1.03	124.0	0.66	0.78	0.92	0.66	0.66	0.55	498
COVID19_PFIZER/BIONTECH	Anaemias NEC	106	0.92	1.08	1.26	112.6	0.80	0.94	1.10	0.89	0.89	0.74	489
COVID19_UNKNOWN MFR	Anaemias NEC	3	0.74	2.06	3.92	0.8	0.70	1.64	3.85	3.49	3.49	1.35	592
COVID19_JANSSEN	Anaemias congenital (excl haemoglobinopathies)	1	0.34	1.87	4.44	0.0	0.44	1.66	12.37	46.31	46.32	3.16	0
COVID19_MODERNA	Anaemias congenital (excl haemoglobinopathies)	0	0.04	0.82	2.44	0.2
COVID19_PFIZER/BIONTECH	Anaemias congenital (excl haemoglobinopathies)	0	0.04	0.84	2.50	0.2
COVID19_UNKNOWN MFR	Anaemias congenital (excl haemoglobinopathies)	0	0.05	1.00	2.98	0.0
COVID19_JANSSEN	Anaemias due to chronic disorders	0	0.09	0.88	2.37	0.2
COVID19_MODERNA	Anaemias due to chronic disorders	2	0.49	1.64	3.34	1.0	0.46	1.16	2.59	6.79	6.79	0.91	1
COVID19_PFIZER/BIONTECH	Anaemias due to chronic disorders	1	0.26	1.21	2.73	0.9	0.29	0.88	2.18	2.05	2.05	0.27	2
COVID19_UNKNOWN MFR	Anaemias due to chronic disorders	0	0.10	1.00	2.68	0.0
COVID19_JANSSEN	Anaemias haemolytic NEC	1	0.15	0.52	1.08	4.1	0.11	0.40	1.05	0.25	0.25	0.05	61
COVID19_MODERNA	Anaemias haemolytic NEC	8	0.41	0.76	1.18	11.8	0.40	0.70	1.14	0.50	0.50	0.27	54
COVID19_PFIZER/BIONTECH	Anaemias haemolytic NEC	20	1.12	1.65	2.26	11.8	1.08	1.55	2.18	1.95	1.95	1.25	42
COVID19_UNKNOWN MFR	Anaemias haemolytic NEC	0	0.19	0.96	2.22	0.1
COVID19_JANSSEN	Anaemias haemolytic immune	1	0.09	0.45	1.02	3.9	0.11	0.42	1.08	0.20	0.20	0.04	79
COVID19_MODERNA	Anaemias haemolytic immune	13	0.65	1.07	1.58	12.9	0.63	0.98	1.47	0.66	0.66	0.40	67
COVID19_PFIZER/BIONTECH	Anaemias haemolytic immune	9	0.42	0.76	1.19	12.9	0.42	0.71	1.14	0.52	0.52	0.29	71
COVID19_UNKNOWN MFR	Anaemias haemolytic immune	0	0.08	0.92	2.53	0.1
COVID19_JANSSEN	Anaemias haemolytic mechanical factor	0	0.00	0.31	1.34	0.8
COVID19_MODERNA	Anaemias haemolytic mechanical factor	0	0.00	0.22	0.96	1.2
COVID19_PFIZER/BIONTECH	Anaemias haemolytic mechanical factor	2	0.23	1.09	2.47	2.5	0.31	0.78	1.69	0.24	0.24	0.07	34
COVID19_UNKNOWN MFR	Anaemias haemolytic mechanical factor	0	0.00	0.94	4.14	0.0
COVID19_JANSSEN	Anaesthesia and allied procedures	2	0.23	0.81	1.67	2.9	0.29	0.72	1.57	0.61	0.61	0.19	51
COVID19_MODERNA	Anaesthesia and allied procedures	12	0.63	1.07	1.59	13.1	0.56	0.89	1.36	0.99	0.99	0.58	41
COVID19_PFIZER/BIONTECH	Anaesthesia and allied procedures	13	0.79	1.30	1.92	11.4	0.69	1.08	1.62	1.33	1.33	0.79	40
COVID19_UNKNOWN MFR	Anaesthesia and allied procedures	0	0.07	0.94	2.67	0.1
COVID19_JANSSEN	Anaesthetic and allied procedural complications	0	0.05	0.94	2.85	0.1
COVID19_MODERNA	Anaesthetic and allied procedural complications	0	0.04	0.81	2.45	0.2
COVID19_PFIZER/BIONTECH	Anaesthetic and allied procedural complications	0	0.04	0.83	2.52	0.2
COVID19_UNKNOWN MFR	Anaesthetic and allied procedural complications	0	0.05	1.00	3.02	0.0
COVID19_JANSSEN	Anal and rectal disorders NEC	0	0.05	0.47	1.28	1.5
COVID19_MODERNA	Anal and rectal disorders NEC	1	0.09	0.43	0.98	3.7	0.12	0.43	1.12	0.10	0.10	0.02	35
COVID19_PFIZER/BIONTECH	Anal and rectal disorders NEC	3	0.27	0.76	1.43	4.6	0.31	0.70	1.39	0.37	0.37	0.14	33
COVID19_UNKNOWN MFR	Anal and rectal disorders NEC	0	0.09	0.97	2.63	0.0
COVID19_JANSSEN	Anal and rectal pains	0	0.03	0.36	0.99	2.3
COVID19_MODERNA	Anal and rectal pains	5	0.27	0.61	1.05	9.4	0.29	0.58	1.04	0.61	0.61	0.27	28
COVID19_PFIZER/BIONTECH	Anal and rectal pains	13	0.96	1.58	2.32	7.9	0.93	1.46	2.19	2.66	2.66	1.48	20
COVID19_UNKNOWN MFR	Anal and rectal pains	0	0.09	0.96	2.61	0.1
COVID19_JANSSEN	Anal and rectal signs and symptoms	1	0.12	0.52	1.16	3.3	0.13	0.47	1.19	0.28	0.28	0.05	56
COVID19_MODERNA	Anal and rectal signs and symptoms	15	0.68	1.08	1.55	13.6	0.70	1.06	1.55	1.21	1.21	0.74	42
COVID19_PFIZER/BIONTECH	Anal and rectal signs and symptoms	17	0.91	1.40	1.98	11.7	0.91	1.34	1.93	1.74	1.74	1.08	40
COVID19_UNKNOWN MFR	Anal and rectal signs and symptoms	0	0.11	0.95	2.48	0.1
COVID19_JANSSEN	Anal and rectal ulcers and perforation	0	0.00	0.71	2.84	0.2
COVID19_MODERNA	Anal and rectal ulcers and perforation	0	0.00	0.40	1.59	0.7
COVID19_PFIZER/BIONTECH	Anal and rectal ulcers and perforation	0	0.00	0.43	1.73	0.6
COVID19_UNKNOWN MFR	Anal and rectal ulcers and perforation	0	0.00	0.99	3.95	0.0
COVID19_JANSSEN	Anal canal neoplasms malignant	0	0.02	0.81	2.65	0.2
COVID19_MODERNA	Anal canal neoplasms malignant	0	0.01	0.54	1.75	0.7
COVID19_PFIZER/BIONTECH	Anal canal neoplasms malignant	0	0.02	0.57	1.87	0.6
COVID19_UNKNOWN MFR	Anal canal neoplasms malignant	0	0.03	1.00	3.24	0.0
COVID19_JANSSEN	Analgesia supportive care	2	0.42	1.19	2.28	1.4	0.41	1.03	2.25	1.72	1.72	0.50	18
COVID19_MODERNA	Analgesia supportive care	2	0.23	0.64	1.22	4.8	0.20	0.53	1.15	0.38	0.38	0.11	18
COVID19_PFIZER/BIONTECH	Analgesia supportive care	3	0.34	0.84	1.52	4.2	0.33	0.73	1.46	0.72	0.72	0.26	17
COVID19_UNKNOWN MFR	Analgesia supportive care	0	0.20	0.99	2.26	0.0
COVID19_JANSSEN	Anaphylactic and anaphylactoid responses	87	0.60	0.72	0.86	164.0	0.45	0.53	0.63	0.56	0.56	0.47	2397
COVID19_MODERNA	Anaphylactic and anaphylactoid responses	492	1.09	1.18	1.27	553.1	0.83	0.89	0.96	0.84	0.84	0.77	1992
COVID19_PFIZER/BIONTECH	Anaphylactic and anaphylactoid responses	748	1.85	1.97	2.09	509.9	1.38	1.46	1.55	1.76	1.77	1.65	1736
COVID19_UNKNOWN MFR	Anaphylactic and anaphylactoid responses	4	0.53	1.25	2.22	3.8	0.46	0.96	1.80	1.11	1.11	0.49	2480
COVID19_JANSSEN	Anaplastic large cell lymphomas T- and null-cell types	0	0.04	0.94	2.86	0.1
COVID19_MODERNA	Anaplastic large cell lymphomas T- and null-cell types	0	0.04	0.81	2.46	0.2
COVID19_PFIZER/BIONTECH	Anaplastic large cell lymphomas T- and null-cell types	0	0.04	0.83	2.52	0.2
COVID19_UNKNOWN MFR	Anaplastic large cell lymphomas T- and null-cell types	0	0.05	1.00	3.04	0.0
COVID19_JANSSEN	Aneurysms and dissections non-site specific	4	0.59	1.44	2.58	2.3	0.61	1.27	2.42	2.06	2.06	0.86	30
COVID19_MODERNA	Aneurysms and dissections non-site specific	12	0.77	1.29	1.92	9.1	0.76	1.21	1.85	1.85	1.85	1.03	22
COVID19_PFIZER/BIONTECH	Aneurysms and dissections non-site specific	11	0.79	1.36	2.05	7.7	0.79	1.28	1.98	1.96	1.96	1.07	23
COVID19_UNKNOWN MFR	Aneurysms and dissections non-site specific	0	0.10	0.96	2.54	0.1
COVID19_JANSSEN	Angioedemas	39	0.54	0.71	0.90	60.4	0.50	0.65	0.84	0.65	0.65	0.50	929
COVID19_MODERNA	Angioedemas	234	1.00	1.12	1.24	223.1	0.94	1.05	1.16	1.08	1.08	0.96	734
COVID19_PFIZER/BIONTECH	Angioedemas	235	1.14	1.27	1.41	199.2	1.06	1.18	1.31	1.31	1.31	1.16	733
COVID19_UNKNOWN MFR	Angioedemas	0	0.14	0.64	1.46	1.3
COVID19_JANSSEN	Anorectal therapeutic procedures	2	0.59	2.05	4.22	0.5	0.56	1.48	4.02	7.72	7.72	1.86	4
COVID19_MODERNA	Anorectal therapeutic procedures	1	0.17	0.86	1.98	1.3	0.25	0.77	1.88	0.68	0.68	0.11	5
COVID19_PFIZER/BIONTECH	Anorectal therapeutic procedures	0	0.04	0.50	1.42	1.2
COVID19_UNKNOWN MFR	Anorectal therapeutic procedures	0	0.08	0.99	2.79	0.0
COVID19_JANSSEN	Anterior pituitary hyperfunction	0	0.00	0.19	1.09	0.4
COVID19_MODERNA	Anterior pituitary hyperfunction	0	0.00	0.06	0.34	1.6
COVID19_PFIZER/BIONTECH	Anterior pituitary hyperfunction	0	0.00	0.07	0.39	1.4
COVID19_UNKNOWN MFR	Anterior pituitary hyperfunction	0	0.00	0.91	5.27	0.0
COVID19_JANSSEN	Anterior pituitary hypofunction	0	0.11	0.80	2.01	0.4
COVID19_MODERNA	Anterior pituitary hypofunction	2	0.36	1.13	2.23	1.1	0.45	1.14	2.52	1.36	1.36	0.34	5
COVID19_PFIZER/BIONTECH	Anterior pituitary hypofunction	1	0.21	0.88	1.91	1.2	0.26	0.80	1.96	0.68	0.68	0.12	6
COVID19_UNKNOWN MFR	Anterior pituitary hypofunction	0	0.14	0.99	2.50	0.0
COVID19_JANSSEN	Antiinfective therapies	1	0.26	0.90	1.84	1.2	0.26	0.80	1.96	0.86	0.86	0.16	18
COVID19_MODERNA	Antiinfective therapies	9	0.82	1.45	2.23	5.9	0.78	1.33	2.13	3.06	3.06	1.44	10
COVID19_PFIZER/BIONTECH	Antiinfective therapies	5	0.50	1.05	1.76	5.0	0.48	0.93	1.68	1.46	1.46	0.62	14
COVID19_UNKNOWN MFR	Antiinfective therapies	0	0.20	0.99	2.26	0.0
COVID19_JANSSEN	Anxiety disorders NEC	3	0.28	0.87	1.72	3.9	0.35	0.78	1.55	0.77	0.77	0.29	60
COVID19_MODERNA	Anxiety disorders NEC	15	0.93	1.48	2.15	9.4	0.95	1.44	2.12	1.06	1.06	0.65	48
COVID19_PFIZER/BIONTECH	Anxiety disorders NEC	5	0.23	0.53	0.94	10.3	0.27	0.54	0.97	0.35	0.35	0.16	58
COVID19_UNKNOWN MFR	Anxiety disorders NEC	0	0.02	0.90	3.00	0.1
COVID19_JANSSEN	Anxiety symptoms	631	1.48	1.58	1.68	516.4	1.14	1.22	1.30	1.45	1.46	1.36	6708
COVID19_MODERNA	Anxiety symptoms	1791	1.17	1.21	1.26	1874.5	0.92	0.96	0.99	1.10	1.10	1.05	5548
COVID19_PFIZER/BIONTECH	Anxiety symptoms	2451	1.86	1.92	1.99	1643.0	1.44	1.49	1.54	2.05	2.08	1.99	4888
COVID19_UNKNOWN MFR	Anxiety symptoms	8	0.50	0.95	1.50	11.3	0.42	0.72	1.18	0.75	0.75	0.42	7331
COVID19_JANSSEN	Aortic aneurysms and dissections	4	0.63	1.66	3.09	2.0	0.65	1.36	2.62	1.72	1.72	0.72	36
COVID19_MODERNA	Aortic aneurysms and dissections	12	0.72	1.23	1.85	10.2	0.70	1.11	1.69	1.46	1.46	0.83	28
COVID19_PFIZER/BIONTECH	Aortic aneurysms and dissections	14	1.01	1.64	2.40	8.7	0.93	1.44	2.14	2.20	2.20	1.28	26
COVID19_UNKNOWN MFR	Aortic aneurysms and dissections	0	0.02	0.91	3.06	0.1
COVID19_JANSSEN	Aortic embolism and thrombosis	2	0.49	1.77	3.70	0.7	0.52	1.31	3.07	3.43	3.43	0.95	9
COVID19_MODERNA	Aortic embolism and thrombosis	2	0.24	0.86	1.79	3.5	0.25	0.64	1.40	0.76	0.76	0.21	9
COVID19_PFIZER/BIONTECH	Aortic embolism and thrombosis	6	1.03	2.19	3.71	2.7	0.84	1.58	2.81	4.91	4.91	1.81	5
COVID19_UNKNOWN MFR	Aortic embolism and thrombosis	1	0.35	1.92	4.51	0.0	0.44	1.71	13.62	68.78	68.86	12.26	10
COVID19_JANSSEN	Aortic infections and inflammations	0	0.07	0.91	2.55	0.1
COVID19_MODERNA	Aortic infections and inflammations	1	0.27	1.33	3.05	0.7	0.31	0.95	2.36	3.40	3.40	0.33	1
COVID19_PFIZER/BIONTECH	Aortic infections and inflammations	0	0.06	0.76	2.12	0.4
COVID19_UNKNOWN MFR	Aortic infections and inflammations	0	0.08	1.00	2.79	0.0
COVID19_JANSSEN	Aortic necrosis and vascular insufficiency	2	0.41	1.57	3.35	1.8	0.37	0.93	2.02	0.74	0.74	0.22	42
COVID19_MODERNA	Aortic necrosis and vascular insufficiency	14	1.11	1.81	2.65	13.3	0.66	1.01	1.50	1.59	1.59	0.93	30
COVID19_PFIZER/BIONTECH	Aortic necrosis and vascular insufficiency	21	2.35	3.47	4.78	10.8	1.22	1.74	2.44	3.74	3.74	2.28	23
COVID19_UNKNOWN MFR	Aortic necrosis and vascular insufficiency	1	0.34	2.09	5.08	0.1	0.42	1.46	8.23	16.00	16.01	3.03	43
COVID19_JANSSEN	Aortic therapeutic procedures	1	0.27	1.44	3.38	0.6	0.33	0.98	2.47	3.09	3.09	0.51	5
COVID19_MODERNA	Aortic therapeutic procedures	0	0.03	0.44	1.29	1.4
COVID19_PFIZER/BIONTECH	Aortic therapeutic procedures	3	0.63	1.81	3.49	1.5	0.57	1.30	2.66	4.09	4.09	1.07	3
COVID19_UNKNOWN MFR	Aortic therapeutic procedures	0	0.06	0.99	2.90	0.0
COVID19_JANSSEN	Aortic valvular disorders	5	0.97	2.19	3.81	1.6	0.91	1.83	3.64	2.34	2.34	1.06	33
COVID19_MODERNA	Aortic valvular disorders	9	0.50	0.91	1.43	10.4	0.51	0.85	1.37	1.05	1.05	0.56	29
COVID19_PFIZER/BIONTECH	Aortic valvular disorders	14	1.05	1.69	2.46	8.3	0.97	1.49	2.22	2.39	2.39	1.37	24
COVID19_UNKNOWN MFR	Aortic valvular disorders	0	0.08	0.95	2.67	0.1
COVID19_JANSSEN	Apocrine and eccrine gland disorders	2897	1.88	1.94	2.00	1607.4	1.75	1.80	1.86	2.74	2.88	2.79	16353
COVID19_MODERNA	Apocrine and eccrine gland disorders	5448	1.03	1.05	1.08	5532.1	0.96	0.99	1.01	1.34	1.35	1.32	13802
COVID19_PFIZER/BIONTECH	Apocrine and eccrine gland disorders	5415	1.18	1.21	1.24	4800.5	1.10	1.13	1.15	1.60	1.63	1.59	13835
COVID19_UNKNOWN MFR	Apocrine and eccrine gland disorders	46	1.13	1.45	1.80	32.8	1.07	1.36	1.72	1.65	1.68	1.31	19204
COVID19_JANSSEN	Appetite disorders	845	1.57	1.66	1.76	552.8	1.44	1.53	1.61	1.34	1.35	1.27	9747
COVID19_MODERNA	Appetite disorders	2759	1.15	1.19	1.23	2442.7	1.09	1.13	1.17	1.20	1.20	1.16	7833
COVID19_PFIZER/BIONTECH	Appetite disorders	1954	0.98	1.02	1.06	2067.2	0.91	0.95	0.98	0.93	0.93	0.89	8638
COVID19_UNKNOWN MFR	Appetite disorders	20	0.98	1.42	1.94	14.2	0.92	1.32	1.86	1.30	1.31	0.90	10572
COVID19_JANSSEN	Application and instillation site reactions	21	2.29	3.40	4.68	6.9	1.76	2.55	3.67	2.72	2.73	1.85	119
COVID19_MODERNA	Application and instillation site reactions	1	0.01	0.10	0.26	16.8	0.01	0.08	0.31	0.02	0.02	0.01	139
COVID19_PFIZER/BIONTECH	Application and instillation site reactions	8	0.25	0.49	0.80	19.9	0.25	0.44	0.72	0.25	0.25	0.14	132
COVID19_UNKNOWN MFR	Application and instillation site reactions	0	0.01	0.81	2.81	0.2
COVID19_JANSSEN	Arboviral infections NEC	0	0.04	0.94	2.85	0.1
COVID19_MODERNA	Arboviral infections NEC	0	0.04	0.81	2.45	0.2
COVID19_PFIZER/BIONTECH	Arboviral infections NEC	0	0.04	0.83	2.52	0.2
COVID19_UNKNOWN MFR	Arboviral infections NEC	0	0.05	1.00	3.03	0.0
COVID19_JANSSEN	Arterial disorders congenital	0	0.00	0.33	1.51	0.6
COVID19_MODERNA	Arterial disorders congenital	0	0.00	0.12	0.53	2.3
COVID19_PFIZER/BIONTECH	Arterial disorders congenital	2	0.21	1.02	2.31	1.3	0.43	1.07	2.35	1.02	1.02	0.28	8
COVID19_UNKNOWN MFR	Arterial disorders congenital	0	0.00	0.95	4.36	0.0
COVID19_JANSSEN	Arterial infections and inflammations	4	0.26	0.63	1.15	10.4	0.21	0.45	0.86	0.20	0.20	0.09	317
COVID19_MODERNA	Arterial infections and inflammations	11	0.47	0.81	1.22	17.6	0.40	0.64	0.99	0.12	0.12	0.07	310
COVID19_PFIZER/BIONTECH	Arterial infections and inflammations	7	0.21	0.42	0.69	27.2	0.16	0.29	0.50	0.09	0.09	0.05	314
COVID19_UNKNOWN MFR	Arterial infections and inflammations	0	0.07	0.85	2.39	0.2
COVID19_JANSSEN	Arterial therapeutic procedures (excl aortic)	28	2.31	3.24	4.30	10.1	1.77	2.44	3.31	3.13	3.13	2.23	138
COVID19_MODERNA	Arterial therapeutic procedures (excl aortic)	49	0.99	1.27	1.58	44.5	0.86	1.09	1.36	1.42	1.42	1.08	117
COVID19_PFIZER/BIONTECH	Arterial therapeutic procedures (excl aortic)	55	1.38	1.75	2.16	36.7	1.17	1.46	1.80	2.03	2.03	1.55	111
COVID19_UNKNOWN MFR	Arterial therapeutic procedures (excl aortic)	0	0.00	0.62	2.57	0.2
COVID19_JANSSEN	Arthropathies NEC	58	0.76	0.96	1.17	72.9	0.64	0.80	0.98	0.76	0.76	0.61	1186
COVID19_MODERNA	Arthropathies NEC	171	0.60	0.68	0.77	280.6	0.54	0.61	0.69	0.54	0.54	0.47	1073
COVID19_PFIZER/BIONTECH	Arthropathies NEC	223	0.93	1.05	1.16	246.4	0.81	0.90	1.01	0.89	0.89	0.79	1021
COVID19_UNKNOWN MFR	Arthropathies NEC	1	0.12	0.75	1.82	1.9	0.21	0.65	1.60	0.55	0.55	0.11	1243
COVID19_JANSSEN	Aspergillus infections	0	0.00	0.19	1.09	0.6
COVID19_MODERNA	Aspergillus infections	0	0.00	0.06	0.34	2.1
COVID19_PFIZER/BIONTECH	Aspergillus infections	0	0.00	0.07	0.39	1.8
COVID19_UNKNOWN MFR	Aspergillus infections	0	0.00	0.91	5.09	0.0
COVID19_JANSSEN	Asthenic conditions	9518	1.56	1.59	1.62	6504.1	1.44	1.46	1.49	1.76	2.03	1.99	83382
COVID19_MODERNA	Asthenic conditions	28056	1.14	1.15	1.16	26272.6	1.06	1.07	1.08	1.47	1.59	1.57	64844
COVID19_PFIZER/BIONTECH	Asthenic conditions	24764	1.20	1.21	1.22	22060.1	1.11	1.12	1.13	1.49	1.62	1.59	68136
COVID19_UNKNOWN MFR	Asthenic conditions	188	1.17	1.32	1.49	151.5	1.09	1.23	1.39	1.40	1.50	1.31	92712
COVID19_JANSSEN	Astroviral infections	0	0.00	0.76	3.20	0.1
COVID19_MODERNA	Astroviral infections	0	0.00	0.46	1.93	0.5
COVID19_PFIZER/BIONTECH	Astroviral infections	0	0.00	0.50	2.09	0.4
COVID19_UNKNOWN MFR	Astroviral infections	0	0.00	0.99	4.17	0.0
COVID19_JANSSEN	Atmospheric pressure injuries	0	0.10	0.78	2.02	0.4
COVID19_MODERNA	Atmospheric pressure injuries	3	0.54	1.45	2.72	1.3	0.61	1.37	2.85	2.55	2.55	0.73	4
COVID19_PFIZER/BIONTECH	Atmospheric pressure injuries	1	0.20	0.87	1.92	1.4	0.24	0.75	1.84	0.68	0.68	0.12	6
COVID19_UNKNOWN MFR	Atmospheric pressure injuries	0	0.12	0.99	2.57	0.0
COVID19_JANSSEN	Atopic disorders	8	0.57	1.11	1.78	8.5	0.52	0.91	1.48	1.04	1.04	0.57	119
COVID19_MODERNA	Atopic disorders	14	0.41	0.66	0.97	23.4	0.40	0.62	0.91	0.42	0.42	0.26	113
COVID19_PFIZER/BIONTECH	Atopic disorders	27	0.89	1.26	1.67	24.4	0.79	1.08	1.45	1.11	1.11	0.77	100
COVID19_UNKNOWN MFR	Atopic disorders	0	0.03	0.83	2.58	0.2
COVID19_JANSSEN	Attention deficit and disruptive behaviour disorders	5	0.62	1.42	2.50	3.7	0.59	1.14	2.06	0.89	0.89	0.42	87
COVID19_MODERNA	Attention deficit and disruptive behaviour disorders	4	0.22	0.56	1.03	7.5	0.28	0.59	1.12	0.15	0.15	0.07	88
COVID19_PFIZER/BIONTECH	Attention deficit and disruptive behaviour disorders	5	0.25	0.58	1.01	9.9	0.28	0.56	1.00	0.24	0.24	0.11	87
COVID19_UNKNOWN MFR	Attention deficit and disruptive behaviour disorders	0	0.04	0.92	2.79	0.1
COVID19_JANSSEN	Atypical mycobacterial infections	0	0.01	0.56	1.84	0.6
COVID19_MODERNA	Atypical mycobacterial infections	1	0.09	0.58	1.43	0.9	0.29	0.87	2.15	0.38	0.38	0.07	9
COVID19_PFIZER/BIONTECH	Atypical mycobacterial infections	1	0.10	0.65	1.60	1.3	0.25	0.77	1.88	0.46	0.46	0.08	9
COVID19_UNKNOWN MFR	Atypical mycobacterial infections	0	0.02	0.98	3.23	0.0
COVID19_JANSSEN	Auditory and vestibular diagnostic procedures	47	0.79	1.01	1.26	59.3	0.62	0.79	1.00	0.93	0.93	0.73	781
COVID19_MODERNA	Auditory and vestibular diagnostic procedures	251	1.19	1.33	1.47	238.2	0.95	1.05	1.16	1.48	1.48	1.31	577
COVID19_PFIZER/BIONTECH	Auditory and vestibular diagnostic procedures	318	1.83	2.01	2.20	199.9	1.44	1.58	1.73	2.55	2.56	2.27	510
COVID19_UNKNOWN MFR	Auditory and vestibular diagnostic procedures	1	0.29	0.97	1.98	1.4	0.24	0.74	1.82	0.83	0.83	0.16	827
COVID19_JANSSEN	Auditory nerve disorders	0	0.03	0.62	1.86	0.6
COVID19_MODERNA	Auditory nerve disorders	0	0.02	0.30	0.91	2.3
COVID19_PFIZER/BIONTECH	Auditory nerve disorders	5	0.88	2.03	3.56	2.1	0.80	1.58	2.95	4.09	4.09	1.45	5
COVID19_UNKNOWN MFR	Auditory nerve disorders	0	0.05	0.99	2.97	0.0
COVID19_JANSSEN	Aural neoplasms malignant and unspecified	0	0.06	0.95	2.73	0.1
COVID19_MODERNA	Aural neoplasms malignant and unspecified	0	0.06	0.83	2.39	0.2
COVID19_PFIZER/BIONTECH	Aural neoplasms malignant and unspecified	1	0.31	1.61	3.76	0.1	0.40	1.30	4.95	12.28	12.28	0.84	0
COVID19_UNKNOWN MFR	Aural neoplasms malignant and unspecified	0	0.07	1.00	2.88	0.0
COVID19_JANSSEN	Autoimmune disorders NEC	11	0.30	0.52	0.79	26.8	0.27	0.44	0.68	0.41	0.41	0.25	410
COVID19_MODERNA	Autoimmune disorders NEC	36	0.41	0.55	0.71	70.6	0.39	0.52	0.67	0.32	0.32	0.24	385
COVID19_PFIZER/BIONTECH	Autoimmune disorders NEC	46	0.56	0.72	0.90	73.9	0.49	0.63	0.79	0.50	0.50	0.39	375
COVID19_UNKNOWN MFR	Autoimmune disorders NEC	0	0.01	0.56	1.94	0.5
COVID19_JANSSEN	Autoimmunity analyses	57	0.61	0.77	0.94	100.9	0.46	0.57	0.70	0.60	0.60	0.48	1463
COVID19_MODERNA	Autoimmunity analyses	193	0.63	0.71	0.80	327.0	0.53	0.59	0.67	0.49	0.49	0.43	1327
COVID19_PFIZER/BIONTECH	Autoimmunity analyses	202	0.75	0.84	0.94	306.9	0.59	0.66	0.74	0.63	0.63	0.55	1318
COVID19_UNKNOWN MFR	Autoimmunity analyses	3	0.48	1.45	2.84	2.4	0.46	1.02	2.04	1.36	1.36	0.53	1517
COVID19_JANSSEN	Autoinflammatory diseases	0	0.07	0.77	2.15	0.4
COVID19_MODERNA	Autoinflammatory diseases	1	0.18	0.86	1.97	0.8	0.30	0.91	2.27	0.68	0.68	0.11	5
COVID19_PFIZER/BIONTECH	Autoinflammatory diseases	0	0.04	0.51	1.43	1.2
COVID19_UNKNOWN MFR	Autoinflammatory diseases	0	0.08	0.99	2.76	0.0
COVID19_JANSSEN	Autonomic nerve therapeutic procedures	0	0.10	0.86	2.25	0.2
COVID19_MODERNA	Autonomic nerve therapeutic procedures	1	0.23	1.04	2.31	0.8	0.30	0.90	2.23	1.13	1.13	0.17	3
COVID19_PFIZER/BIONTECH	Autonomic nerve therapeutic procedures	2	0.47	1.54	3.11	0.8	0.50	1.27	2.91	4.09	4.09	0.79	2
COVID19_UNKNOWN MFR	Autonomic nerve therapeutic procedures	0	0.11	1.00	2.62	0.0
COVID19_JANSSEN	Autonomic nervous system disorders	3	0.07	0.24	0.49	20.4	0.07	0.19	0.41	0.11	0.11	0.04	425
COVID19_MODERNA	Autonomic nervous system disorders	14	0.24	0.40	0.59	43.4	0.22	0.34	0.51	0.12	0.12	0.07	414
COVID19_PFIZER/BIONTECH	Autonomic nervous system disorders	17	0.28	0.44	0.63	55.7	0.22	0.32	0.47	0.17	0.17	0.11	411
COVID19_UNKNOWN MFR	Autonomic nervous system disorders	2	0.79	3.81	8.66	0.5	0.56	1.49	4.08	3.23	3.23	1.01	426
COVID19_JANSSEN	Autosomal chromosomal abnormalities	0	0.06	0.64	1.75	0.7
COVID19_MODERNA	Autosomal chromosomal abnormalities	1	0.15	0.73	1.65	1.1	0.27	0.82	2.01	0.31	0.31	0.06	11
COVID19_PFIZER/BIONTECH	Autosomal chromosomal abnormalities	2	0.31	1.04	2.13	1.4	0.42	1.04	2.28	0.82	0.82	0.23	10
COVID19_UNKNOWN MFR	Autosomal chromosomal abnormalities	0	0.09	0.99	2.70	0.0
COVID19_JANSSEN	B-cell lymphomas NEC	2	0.49	1.28	2.37	1.0	0.46	1.16	2.56	2.57	2.57	0.73	12
COVID19_MODERNA	B-cell lymphomas NEC	2	0.31	0.81	1.50	3.6	0.25	0.64	1.39	0.57	0.57	0.16	12
COVID19_PFIZER/BIONTECH	B-cell lymphomas NEC	3	0.44	1.03	1.82	3.1	0.40	0.89	1.78	1.12	1.12	0.38	11
COVID19_UNKNOWN MFR	B-cell lymphomas NEC	0	0.25	0.99	2.13	0.0
COVID19_JANSSEN	Babesia infections	0	0.02	0.76	2.49	0.2
COVID19_MODERNA	Babesia infections	0	0.01	0.46	1.51	0.9
COVID19_PFIZER/BIONTECH	Babesia infections	1	0.17	1.14	2.80	0.4	0.36	1.08	2.85	1.36	1.36	0.20	3
COVID19_UNKNOWN MFR	Babesia infections	0	0.03	0.99	3.25	0.0
COVID19_JANSSEN	Bacillary infections	0	0.03	0.88	2.74	0.1
COVID19_MODERNA	Bacillary infections	0	0.03	0.67	2.07	0.5
COVID19_PFIZER/BIONTECH	Bacillary infections	0	0.03	0.70	2.17	0.4
COVID19_UNKNOWN MFR	Bacillary infections	0	0.04	1.00	3.10	0.0
COVID19_JANSSEN	Bacteria identification and serology (excl mycobacteria)	98	0.51	0.60	0.70	207.3	0.40	0.48	0.56	0.37	0.36	0.31	4146
COVID19_MODERNA	Bacteria identification and serology (excl mycobacteria)	312	0.57	0.63	0.68	596.7	0.48	0.52	0.57	0.27	0.27	0.24	3932
COVID19_PFIZER/BIONTECH	Bacteria identification and serology (excl mycobacteria)	437	0.81	0.88	0.95	610.8	0.66	0.72	0.77	0.47	0.47	0.43	3807
COVID19_UNKNOWN MFR	Bacteria identification and serology (excl mycobacteria)	2	0.24	0.67	1.29	5.0	0.20	0.51	1.12	0.32	0.32	0.10	4242
COVID19_JANSSEN	Bacterial infections NEC	55	0.15	0.18	0.23	362.0	0.12	0.16	0.19	0.12	0.12	0.10	7048
COVID19_MODERNA	Bacterial infections NEC	1061	0.79	0.83	0.88	1519.2	0.66	0.70	0.73	0.60	0.59	0.56	6042
COVID19_PFIZER/BIONTECH	Bacterial infections NEC	304	0.25	0.28	0.31	1304.7	0.21	0.23	0.26	0.18	0.18	0.16	6799
COVID19_UNKNOWN MFR	Bacterial infections NEC	3	0.19	0.50	0.92	9.4	0.17	0.40	0.81	0.29	0.29	0.11	7100
COVID19_JANSSEN	Bacterial infections congenital	0	0.04	0.84	2.57	0.2
COVID19_MODERNA	Bacterial infections congenital	0	0.03	0.58	1.77	0.7
COVID19_PFIZER/BIONTECH	Bacterial infections congenital	0	0.03	0.61	1.88	0.6
COVID19_UNKNOWN MFR	Bacterial infections congenital	0	0.04	1.00	3.06	0.0
COVID19_JANSSEN	Bartonella infections	0	0.00	0.18	1.05	0.4
COVID19_MODERNA	Bartonella infections	0	0.00	0.06	0.32	1.7
COVID19_PFIZER/BIONTECH	Bartonella infections	0	0.00	0.06	0.37	1.4
COVID19_UNKNOWN MFR	Bartonella infections	0	0.00	0.90	5.24	0.0
COVID19_JANSSEN	Behaviour and socialisation disturbances	18	0.53	0.79	1.11	25.2	0.49	0.72	1.03	0.40	0.40	0.27	688
COVID19_MODERNA	Behaviour and socialisation disturbances	69	0.82	1.01	1.22	73.0	0.77	0.94	1.14	0.37	0.37	0.30	637
COVID19_PFIZER/BIONTECH	Behaviour and socialisation disturbances	62	0.68	0.84	1.02	83.0	0.61	0.75	0.92	0.39	0.39	0.32	644
COVID19_UNKNOWN MFR	Behaviour and socialisation disturbances	2	0.53	1.51	2.91	0.7	0.53	1.35	3.24	1.95	1.96	0.61	704
COVID19_JANSSEN	Benign and malignant breast neoplasms	3	0.74	2.14	4.13	0.8	0.71	1.66	4.00	5.79	5.79	1.90	8
COVID19_MODERNA	Benign and malignant breast neoplasms	4	0.47	1.18	2.16	2.9	0.54	1.11	2.10	1.94	1.94	0.69	7
COVID19_PFIZER/BIONTECH	Benign and malignant breast neoplasms	1	0.10	0.53	1.24	2.6	0.16	0.54	1.36	0.41	0.41	0.07	10
COVID19_UNKNOWN MFR	Benign and malignant breast neoplasms	0	0.06	0.98	2.89	0.0
COVID19_JANSSEN	Benign neoplasms gastrointestinal (excl oral cavity)	0	0.08	0.61	1.58	1.0
COVID19_MODERNA	Benign neoplasms gastrointestinal (excl oral cavity)	2	0.19	0.60	1.21	4.4	0.22	0.56	1.22	0.36	0.36	0.11	19
COVID19_PFIZER/BIONTECH	Benign neoplasms gastrointestinal (excl oral cavity)	4	0.44	1.05	1.87	3.8	0.46	0.96	1.80	0.96	0.96	0.39	17
COVID19_UNKNOWN MFR	Benign neoplasms gastrointestinal (excl oral cavity)	0	0.12	0.98	2.53	0.0
COVID19_JANSSEN	Benign oral cavity neoplasms	0	0.03	0.88	2.76	0.1
COVID19_MODERNA	Benign oral cavity neoplasms	0	0.02	0.66	2.07	0.5
COVID19_PFIZER/BIONTECH	Benign oral cavity neoplasms	0	0.02	0.69	2.17	0.4
COVID19_UNKNOWN MFR	Benign oral cavity neoplasms	0	0.04	1.00	3.14	0.0
COVID19_JANSSEN	Bereavement issues	0	0.07	0.91	2.56	0.1
COVID19_MODERNA	Bereavement issues	1	0.26	1.33	3.07	0.6	0.33	0.99	2.50	3.40	3.40	0.33	1
COVID19_PFIZER/BIONTECH	Bereavement issues	0	0.06	0.75	2.12	0.4
COVID19_UNKNOWN MFR	Bereavement issues	0	0.08	1.00	2.81	0.0
COVID19_JANSSEN	Bile duct infections and inflammations	3	0.43	1.15	2.15	2.6	0.44	0.98	1.96	1.32	1.32	0.49	35
COVID19_MODERNA	Bile duct infections and inflammations	10	0.55	0.97	1.48	10.2	0.57	0.94	1.48	1.21	1.21	0.66	28
COVID19_PFIZER/BIONTECH	Bile duct infections and inflammations	13	0.88	1.43	2.10	8.7	0.86	1.35	2.03	2.13	2.13	1.21	25
COVID19_UNKNOWN MFR	Bile duct infections and inflammations	0	0.13	0.97	2.47	0.1
COVID19_JANSSEN	Bile duct neoplasms malignant	0	0.07	0.87	2.42	0.2
COVID19_MODERNA	Bile duct neoplasms malignant	0	0.05	0.65	1.79	0.7
COVID19_PFIZER/BIONTECH	Bile duct neoplasms malignant	1	0.25	1.22	2.80	0.5	0.34	1.03	2.63	2.05	2.05	0.27	2
COVID19_UNKNOWN MFR	Bile duct neoplasms malignant	0	0.08	1.00	2.77	0.0
COVID19_JANSSEN	Biliary tract and gallbladder therapeutic procedures	3	0.35	0.81	1.44	4.4	0.32	0.71	1.42	0.71	0.71	0.27	65
COVID19_MODERNA	Biliary tract and gallbladder therapeutic procedures	21	0.74	1.08	1.47	19.2	0.74	1.06	1.48	1.52	1.52	0.99	47
COVID19_PFIZER/BIONTECH	Biliary tract and gallbladder therapeutic procedures	17	0.71	1.08	1.50	15.7	0.70	1.04	1.50	1.36	1.36	0.86	51
COVID19_UNKNOWN MFR	Biliary tract and gallbladder therapeutic procedures	1	0.43	1.31	2.59	0.1	0.41	1.37	6.27	10.27	10.28	1.96	67
COVID19_JANSSEN	Bipolar disorders	1	0.18	0.74	1.62	2.1	0.19	0.62	1.53	0.59	0.59	0.11	26
COVID19_MODERNA	Bipolar disorders	2	0.17	0.55	1.09	5.0	0.20	0.51	1.11	0.27	0.27	0.08	25
COVID19_PFIZER/BIONTECH	Bipolar disorders	3	0.26	0.70	1.32	5.2	0.28	0.64	1.27	0.51	0.51	0.19	24
COVID19_UNKNOWN MFR	Bipolar disorders	1	0.38	1.58	3.45	0.0	0.43	1.57	10.47	26.46	26.48	4.95	26
COVID19_JANSSEN	Bladder and urethral symptoms	184	1.31	1.49	1.67	136.1	1.19	1.34	1.51	1.36	1.36	1.20	2094
COVID19_MODERNA	Bladder and urethral symptoms	496	0.88	0.95	1.02	555.2	0.83	0.89	0.96	0.95	0.95	0.87	1782
COVID19_PFIZER/BIONTECH	Bladder and urethral symptoms	437	0.92	1.00	1.08	476.1	0.85	0.92	0.99	0.97	0.97	0.89	1841
COVID19_UNKNOWN MFR	Bladder and urethral symptoms	5	0.64	1.36	2.30	3.4	0.61	1.19	2.15	1.51	1.52	0.72	2273
COVID19_JANSSEN	Bladder disorders NEC	4	0.50	1.30	2.40	3.3	0.50	1.04	1.95	1.21	1.21	0.52	51
COVID19_MODERNA	Bladder disorders NEC	14	0.78	1.27	1.86	13.4	0.66	1.01	1.49	1.16	1.16	0.70	41
COVID19_PFIZER/BIONTECH	Bladder disorders NEC	12	0.73	1.24	1.87	11.4	0.63	1.00	1.53	1.14	1.14	0.67	43
COVID19_UNKNOWN MFR	Bladder disorders NEC	0	0.03	0.92	2.96	0.1
COVID19_JANSSEN	Bladder disorders congenital	0	0.02	0.77	2.48	0.2
COVID19_MODERNA	Bladder disorders congenital	0	0.01	0.47	1.52	0.9
COVID19_PFIZER/BIONTECH	Bladder disorders congenital	0	0.01	0.51	1.64	0.8
COVID19_UNKNOWN MFR	Bladder disorders congenital	0	0.03	0.99	3.21	0.0
COVID19_JANSSEN	Bladder infections and inflammations	0	0.01	0.33	1.15	1.3
COVID19_MODERNA	Bladder infections and inflammations	5	0.41	0.97	1.72	5.5	0.45	0.87	1.57	1.00	1.00	0.43	17
COVID19_PFIZER/BIONTECH	Bladder infections and inflammations	1	0.05	0.33	0.82	4.9	0.09	0.34	0.92	0.20	0.20	0.04	21
COVID19_UNKNOWN MFR	Bladder infections and inflammations	0	0.01	0.96	3.32	0.0
COVID19_JANSSEN	Bladder neoplasms malignant	0	0.16	0.83	1.94	0.4
COVID19_MODERNA	Bladder neoplasms malignant	3	0.49	1.23	2.24	2.2	0.48	1.07	2.14	1.27	1.27	0.42	8
COVID19_PFIZER/BIONTECH	Bladder neoplasms malignant	3	0.52	1.30	2.37	2.1	0.49	1.10	2.21	1.54	1.54	0.50	8
COVID19_UNKNOWN MFR	Bladder neoplasms malignant	0	0.19	0.99	2.32	0.0
COVID19_JANSSEN	Bladder reflux conditions	0	0.00	0.35	1.83	0.4
COVID19_MODERNA	Bladder reflux conditions	0	0.00	0.13	0.66	1.3
COVID19_PFIZER/BIONTECH	Bladder reflux conditions	0	0.00	0.14	0.75	1.2
COVID19_UNKNOWN MFR	Bladder reflux conditions	0	0.00	0.96	4.96	0.0
COVID19_JANSSEN	Bladder therapeutic procedures	0	0.05	0.82	2.37	0.2
COVID19_MODERNA	Bladder therapeutic procedures	0	0.04	0.55	1.59	0.9
COVID19_PFIZER/BIONTECH	Bladder therapeutic procedures	2	0.46	1.64	3.41	0.7	0.52	1.33	3.15	4.09	4.09	0.79	2
COVID19_UNKNOWN MFR	Bladder therapeutic procedures	0	0.07	1.00	2.88	0.0
COVID19_JANSSEN	Blastocystis infections	0	0.04	0.94	2.86	0.1
COVID19_MODERNA	Blastocystis infections	0	0.04	0.81	2.46	0.2
COVID19_PFIZER/BIONTECH	Blastocystis infections	0	0.04	0.83	2.53	0.2
COVID19_UNKNOWN MFR	Blastocystis infections	0	0.05	1.00	3.04	0.0
COVID19_JANSSEN	Blastomyces infections	0	0.07	0.95	2.72	0.1
COVID19_MODERNA	Blastomyces infections	1	0.30	1.57	3.64	0.3	0.38	1.17	3.32	10.19	10.19	0.69	0
COVID19_PFIZER/BIONTECH	Blastomyces infections	0	0.06	0.85	2.44	0.2
COVID19_UNKNOWN MFR	Blastomyces infections	0	0.07	1.00	2.86	0.0
COVID19_JANSSEN	Bleeding tendencies	7	0.74	1.49	2.44	5.0	0.68	1.21	2.05	1.07	1.07	0.56	101
COVID19_MODERNA	Bleeding tendencies	14	0.51	0.83	1.21	18.9	0.49	0.75	1.11	0.51	0.51	0.32	94
COVID19_PFIZER/BIONTECH	Bleeding tendencies	7	0.24	0.49	0.80	17.8	0.24	0.44	0.74	0.28	0.28	0.15	101
COVID19_UNKNOWN MFR	Bleeding tendencies	0	0.05	0.90	2.69	0.1
COVID19_JANSSEN	Blood and blood product treatment	37	0.82	1.10	1.40	38.1	0.73	0.96	1.24	0.94	0.94	0.71	609
COVID19_MODERNA	Blood and blood product treatment	109	0.70	0.83	0.96	144.5	0.64	0.76	0.88	0.69	0.69	0.58	537
COVID19_PFIZER/BIONTECH	Blood and blood product treatment	109	0.80	0.94	1.09	130.6	0.71	0.83	0.97	0.83	0.83	0.70	537
COVID19_UNKNOWN MFR	Blood and blood product treatment	2	0.46	1.45	2.88	1.0	0.47	1.17	2.61	2.14	2.14	0.67	644
COVID19_JANSSEN	Blood counts NEC	612	1.31	1.40	1.49	446.9	1.28	1.37	1.46	1.49	1.50	1.39	6356
COVID19_MODERNA	Blood counts NEC	1699	0.93	0.97	1.01	1791.1	0.91	0.95	0.99	1.10	1.10	1.05	5269
COVID19_PFIZER/BIONTECH	Blood counts NEC	1742	1.12	1.17	1.21	1534.0	1.09	1.14	1.18	1.36	1.37	1.31	5226
COVID19_UNKNOWN MFR	Blood counts NEC	17	1.00	1.48	2.04	10.1	1.02	1.52	2.19	1.68	1.70	1.13	6951
COVID19_JANSSEN	Blood gas and acid base analyses	238	1.32	1.47	1.63	184.0	1.16	1.29	1.43	1.20	1.21	1.08	3053
COVID19_MODERNA	Blood gas and acid base analyses	823	1.17	1.24	1.31	744.3	1.04	1.11	1.17	1.13	1.13	1.06	2468
COVID19_PFIZER/BIONTECH	Blood gas and acid base analyses	1030	1.69	1.78	1.87	659.6	1.48	1.56	1.64	1.87	1.87	1.76	2261
COVID19_UNKNOWN MFR	Blood gas and acid base analyses	5	0.52	1.10	1.85	4.9	0.48	0.94	1.70	1.05	1.05	0.50	3286
COVID19_JANSSEN	Blood grouping and cross-matching analyses	8	0.78	1.50	2.42	5.4	0.74	1.28	2.10	1.45	1.45	0.79	85
COVID19_MODERNA	Blood grouping and cross-matching analyses	13	0.46	0.76	1.12	17.4	0.48	0.75	1.13	0.55	0.55	0.34	80
COVID19_PFIZER/BIONTECH	Blood grouping and cross-matching analyses	13	0.49	0.82	1.20	16.8	0.50	0.78	1.17	0.67	0.67	0.41	80
COVID19_UNKNOWN MFR	Blood grouping and cross-matching analyses	0	0.04	0.88	2.72	0.1
COVID19_JANSSEN	Blood isoimmune reactions	0	0.04	0.89	2.69	0.1
COVID19_MODERNA	Blood isoimmune reactions	0	0.03	0.68	2.06	0.5
COVID19_PFIZER/BIONTECH	Blood isoimmune reactions	0	0.03	0.71	2.16	0.4
COVID19_UNKNOWN MFR	Blood isoimmune reactions	0	0.05	1.00	3.02	0.0
COVID19_JANSSEN	Blood pressure disorders NEC	14	0.57	0.91	1.31	16.3	0.55	0.85	1.26	0.87	0.86	0.55	250
COVID19_MODERNA	Blood pressure disorders NEC	87	1.03	1.24	1.47	72.6	0.99	1.19	1.41	1.67	1.67	1.35	177
COVID19_PFIZER/BIONTECH	Blood pressure disorders NEC	89	1.27	1.52	1.80	60.5	1.21	1.45	1.71	2.08	2.08	1.68	175
COVID19_UNKNOWN MFR	Blood pressure disorders NEC	1	0.34	1.25	2.63	0.4	0.35	1.06	2.73	2.62	2.62	0.50	263
COVID19_JANSSEN	Body temperature altered	10	0.40	0.73	1.13	18.0	0.35	0.58	0.92	0.36	0.36	0.21	428
COVID19_MODERNA	Body temperature altered	33	0.53	0.72	0.94	52.5	0.48	0.64	0.83	0.28	0.28	0.21	405
COVID19_PFIZER/BIONTECH	Body temperature altered	50	0.85	1.09	1.35	57.4	0.69	0.87	1.08	0.53	0.53	0.41	388
COVID19_UNKNOWN MFR	Body temperature altered	1	0.23	1.53	3.76	0.5	0.34	1.02	2.61	1.57	1.58	0.30	437
COVID19_JANSSEN	Bone and joint infections	0	0.04	0.28	0.73	4.0
COVID19_MODERNA	Bone and joint infections	7	0.29	0.57	0.93	13.1	0.32	0.57	0.96	0.25	0.25	0.13	97
COVID19_PFIZER/BIONTECH	Bone and joint infections	8	0.34	0.63	1.00	14.1	0.34	0.60	0.98	0.34	0.34	0.19	96
COVID19_UNKNOWN MFR	Bone and joint infections	0	0.12	0.93	2.38	0.1
COVID19_JANSSEN	Bone and joint injuries NEC	10	0.52	0.87	1.30	12.1	0.50	0.82	1.29	0.88	0.88	0.51	176
COVID19_MODERNA	Bone and joint injuries NEC	31	0.50	0.68	0.88	48.5	0.48	0.65	0.85	0.68	0.68	0.49	155
COVID19_PFIZER/BIONTECH	Bone and joint injuries NEC	39	0.75	0.98	1.24	41.0	0.72	0.94	1.21	1.09	1.09	0.81	147
COVID19_UNKNOWN MFR	Bone and joint injuries NEC	0	0.27	0.92	1.87	0.3
COVID19_JANSSEN	Bone disorders NEC	10	0.50	0.88	1.35	12.9	0.47	0.78	1.23	0.81	0.81	0.48	190
COVID19_MODERNA	Bone disorders NEC	28	0.46	0.64	0.85	48.4	0.43	0.59	0.79	0.55	0.55	0.40	172
COVID19_PFIZER/BIONTECH	Bone disorders NEC	47	0.94	1.21	1.51	43.0	0.85	1.08	1.35	1.26	1.26	0.96	153
COVID19_UNKNOWN MFR	Bone disorders NEC	0	0.07	0.80	2.23	0.3
COVID19_JANSSEN	Bone marrow and immune tissue histopathology procedures	9	0.41	0.74	1.14	13.8	0.40	0.67	1.08	0.60	0.60	0.34	233
COVID19_MODERNA	Bone marrow and immune tissue histopathology procedures	35	0.63	0.85	1.09	45.7	0.58	0.77	1.00	0.57	0.57	0.43	207
COVID19_PFIZER/BIONTECH	Bone marrow and immune tissue histopathology procedures	37	0.70	0.93	1.19	43.8	0.64	0.84	1.09	0.74	0.74	0.55	205
COVID19_UNKNOWN MFR	Bone marrow and immune tissue histopathology procedures	0	0.12	0.83	2.10	0.3
COVID19_JANSSEN	Bone marrow and immune tissue imaging procedures	1	0.24	0.81	1.65	1.9	0.20	0.64	1.59	0.52	0.52	0.10	30
COVID19_MODERNA	Bone marrow and immune tissue imaging procedures	5	0.46	0.97	1.62	5.0	0.48	0.93	1.67	0.65	0.65	0.29	26
COVID19_PFIZER/BIONTECH	Bone marrow and immune tissue imaging procedures	5	0.46	0.96	1.60	5.3	0.46	0.90	1.62	0.79	0.79	0.35	26
COVID19_UNKNOWN MFR	Bone marrow and immune tissue imaging procedures	0	0.21	0.98	2.22	0.0
COVID19_JANSSEN	Bone neoplasms benign (excl cysts)	0	0.04	0.69	2.01	0.5
COVID19_MODERNA	Bone neoplasms benign (excl cysts)	0	0.02	0.37	1.08	1.8
COVID19_PFIZER/BIONTECH	Bone neoplasms benign (excl cysts)	1	0.14	0.78	1.84	1.8	0.21	0.66	1.64	0.59	0.59	0.10	7
COVID19_UNKNOWN MFR	Bone neoplasms benign (excl cysts)	0	0.06	0.99	2.90	0.0
COVID19_JANSSEN	Bone neoplasms malignant (excl sarcomas)	0	0.00	0.64	2.39	0.3
COVID19_MODERNA	Bone neoplasms malignant (excl sarcomas)	1	0.11	0.92	2.37	0.5	0.34	1.03	2.63	0.85	0.85	0.14	4
COVID19_PFIZER/BIONTECH	Bone neoplasms malignant (excl sarcomas)	0	0.00	0.35	1.32	1.0
COVID19_UNKNOWN MFR	Bone neoplasms malignant (excl sarcomas)	0	0.01	0.99	3.70	0.0
COVID19_JANSSEN	Bone neoplasms unspecified malignancy	0	0.06	0.90	2.59	0.1
COVID19_MODERNA	Bone neoplasms unspecified malignancy	0	0.05	0.71	2.05	0.5
COVID19_PFIZER/BIONTECH	Bone neoplasms unspecified malignancy	1	0.27	1.40	3.25	0.3	0.37	1.14	3.17	4.09	4.09	0.40	1
COVID19_UNKNOWN MFR	Bone neoplasms unspecified malignancy	0	0.07	1.00	2.86	0.0
COVID19_JANSSEN	Bone related signs and symptoms	359	1.58	1.73	1.88	222.0	1.47	1.61	1.75	1.95	1.96	1.79	2836
COVID19_MODERNA	Bone related signs and symptoms	868	0.92	0.97	1.02	946.6	0.87	0.92	0.97	1.27	1.27	1.19	2327
COVID19_PFIZER/BIONTECH	Bone related signs and symptoms	827	1.06	1.13	1.19	781.3	1.00	1.06	1.12	1.43	1.43	1.34	2368
COVID19_UNKNOWN MFR	Bone related signs and symptoms	9	0.90	1.60	2.46	5.2	0.86	1.45	2.34	1.94	1.95	1.12	3186
COVID19_JANSSEN	Bone sarcomas	0	0.01	0.77	2.74	0.2
COVID19_MODERNA	Bone sarcomas	0	0.01	0.48	1.70	0.7
COVID19_PFIZER/BIONTECH	Bone sarcomas	0	0.01	0.52	1.83	0.6
COVID19_UNKNOWN MFR	Bone sarcomas	0	0.01	0.99	3.52	0.0
COVID19_JANSSEN	Bone therapeutic procedures NEC	0	0.07	0.83	2.34	0.2
COVID19_MODERNA	Bone therapeutic procedures NEC	1	0.21	1.04	2.40	0.3	0.36	1.10	2.93	1.13	1.13	0.17	3
COVID19_PFIZER/BIONTECH	Bone therapeutic procedures NEC	0	0.05	0.61	1.70	0.8
COVID19_UNKNOWN MFR	Bone therapeutic procedures NEC	0	0.08	1.00	2.79	0.0
COVID19_JANSSEN	Bordetella infections	1	0.00	0.03	0.09	30.0	0.00	0.03	0.16	0.02	0.02	0.01	648
COVID19_MODERNA	Bordetella infections	2	0.01	0.03	0.07	42.0	0.01	0.05	0.15	0.01	0.01	0.00	647
COVID19_PFIZER/BIONTECH	Bordetella infections	1	0.00	0.01	0.04	64.9	0.00	0.01	0.06	0.01	0.01	0.00	648
COVID19_UNKNOWN MFR	Bordetella infections	0	0.00	0.14	0.75	0.9
COVID19_JANSSEN	Borrelial infections	6	0.54	1.18	2.02	6.0	0.51	0.94	1.64	0.97	0.97	0.48	96
COVID19_MODERNA	Borrelial infections	14	0.61	0.99	1.45	15.7	0.57	0.88	1.30	0.54	0.54	0.34	88
COVID19_PFIZER/BIONTECH	Borrelial infections	18	0.81	1.24	1.75	16.9	0.71	1.03	1.47	0.88	0.88	0.57	84
COVID19_UNKNOWN MFR	Borrelial infections	0	0.01	0.84	2.96	0.1
COVID19_JANSSEN	Brain radiotherapies	0	0.04	0.94	2.85	0.1
COVID19_MODERNA	Brain radiotherapies	0	0.04	0.81	2.46	0.2
COVID19_PFIZER/BIONTECH	Brain radiotherapies	0	0.04	0.83	2.52	0.2
COVID19_UNKNOWN MFR	Brain radiotherapies	0	0.05	1.00	3.03	0.0
COVID19_JANSSEN	Breast and nipple neoplasms benign	0	0.10	0.81	2.09	0.4
COVID19_MODERNA	Breast and nipple neoplasms benign	1	0.20	0.87	1.93	0.9	0.28	0.86	2.12	0.68	0.68	0.11	5
COVID19_PFIZER/BIONTECH	Breast and nipple neoplasms benign	1	0.22	0.93	2.06	1.1	0.27	0.82	2.02	0.82	0.82	0.14	5
COVID19_UNKNOWN MFR	Breast and nipple neoplasms benign	0	0.12	0.99	2.58	0.0
COVID19_JANSSEN	Breast and nipple neoplasms malignant	2	0.25	0.66	1.23	4.5	0.21	0.55	1.19	0.47	0.47	0.14	66
COVID19_MODERNA	Breast and nipple neoplasms malignant	10	0.61	1.04	1.56	10.4	0.56	0.93	1.46	0.59	0.59	0.33	58
COVID19_PFIZER/BIONTECH	Breast and nipple neoplasms malignant	7	0.37	0.70	1.10	11.9	0.35	0.62	1.05	0.47	0.47	0.24	61
COVID19_UNKNOWN MFR	Breast and nipple neoplasms malignant	0	0.24	0.96	2.06	0.1
COVID19_JANSSEN	Breast disorders NEC	8	0.58	1.13	1.82	7.6	0.57	0.99	1.63	1.13	1.13	0.62	109
COVID19_MODERNA	Breast disorders NEC	35	0.80	1.08	1.39	35.0	0.75	0.99	1.29	1.45	1.45	1.04	82
COVID19_PFIZER/BIONTECH	Breast disorders NEC	45	1.31	1.70	2.13	28.4	1.19	1.52	1.93	2.56	2.56	1.87	72
COVID19_UNKNOWN MFR	Breast disorders NEC	0	0.02	0.81	2.74	0.2
COVID19_JANSSEN	Breast infections	0	0.00	0.15	0.51	3.9
COVID19_MODERNA	Breast infections	12	0.44	0.76	1.14	17.6	0.44	0.69	1.06	0.85	0.85	0.50	48
COVID19_PFIZER/BIONTECH	Breast infections	27	1.35	1.91	2.54	15.4	1.19	1.63	2.20	3.35	3.35	2.19	33
COVID19_UNKNOWN MFR	Breast infections	0	0.01	0.89	3.06	0.1
COVID19_JANSSEN	Breast infections and inflammations	2	0.51	1.42	2.71	0.8	0.49	1.25	2.83	3.43	3.43	0.95	9
COVID19_MODERNA	Breast infections and inflammations	4	0.48	1.07	1.86	4.0	0.44	0.92	1.73	1.94	1.94	0.69	7
COVID19_PFIZER/BIONTECH	Breast infections and inflammations	2	0.30	0.85	1.61	3.2	0.27	0.69	1.49	0.91	0.91	0.25	9
COVID19_UNKNOWN MFR	Breast infections and inflammations	0	0.20	0.99	2.27	0.0
COVID19_JANSSEN	Breast neoplasm removal	0	0.04	0.84	2.55	0.2
COVID19_MODERNA	Breast neoplasm removal	0	0.03	0.59	1.78	0.7
COVID19_PFIZER/BIONTECH	Breast neoplasm removal	0	0.03	0.62	1.88	0.6
COVID19_UNKNOWN MFR	Breast neoplasm removal	0	0.05	1.00	3.01	0.0
COVID19_JANSSEN	Breast neoplasms unspecified malignancy	1	0.32	1.76	4.15	0.2	0.40	1.28	4.62	15.44	15.44	1.51	1
COVID19_MODERNA	Breast neoplasms unspecified malignancy	0	0.04	0.70	2.06	0.5
COVID19_PFIZER/BIONTECH	Breast neoplasms unspecified malignancy	0	0.04	0.73	2.15	0.4
COVID19_UNKNOWN MFR	Breast neoplasms unspecified malignancy	0	0.06	1.00	2.95	0.0
COVID19_JANSSEN	Breast radiotherapies	0	0.05	0.94	2.84	0.1
COVID19_MODERNA	Breast radiotherapies	0	0.04	0.81	2.45	0.2
COVID19_PFIZER/BIONTECH	Breast radiotherapies	0	0.04	0.83	2.51	0.2
COVID19_UNKNOWN MFR	Breast radiotherapies	0	0.05	1.00	3.01	0.0
COVID19_JANSSEN	Breast signs and symptoms	108	1.35	1.59	1.85	78.8	1.15	1.35	1.58	1.63	1.63	1.38	1022
COVID19_MODERNA	Breast signs and symptoms	376	1.12	1.22	1.33	364.5	0.95	1.03	1.12	1.69	1.70	1.53	754
COVID19_PFIZER/BIONTECH	Breast signs and symptoms	417	1.54	1.67	1.81	294.7	1.30	1.41	1.53	2.39	2.40	2.17	713
COVID19_UNKNOWN MFR	Breast signs and symptoms	2	0.43	1.09	2.01	1.9	0.37	0.92	1.98	1.22	1.22	0.38	1128
COVID19_JANSSEN	Breast therapeutic procedures NEC	2	0.49	1.36	2.57	0.9	0.48	1.21	2.72	2.81	2.81	0.79	11
COVID19_MODERNA	Breast therapeutic procedures NEC	5	0.61	1.28	2.13	3.3	0.62	1.21	2.19	2.12	2.12	0.83	8
COVID19_PFIZER/BIONTECH	Breast therapeutic procedures NEC	3	0.42	1.03	1.85	2.9	0.42	0.93	1.85	1.23	1.23	0.42	10
COVID19_UNKNOWN MFR	Breast therapeutic procedures NEC	0	0.22	0.99	2.23	0.0
COVID19_JANSSEN	Breathing abnormalities	2416	1.71	1.77	1.83	1695.8	1.38	1.42	1.47	1.64	1.69	1.63	22698
COVID19_MODERNA	Breathing abnormalities	6632	1.18	1.21	1.23	6710.1	0.97	0.99	1.01	1.22	1.23	1.20	18482
COVID19_PFIZER/BIONTECH	Breathing abnormalities	7709	1.62	1.65	1.68	5754.6	1.32	1.34	1.37	1.81	1.87	1.83	17405
COVID19_UNKNOWN MFR	Breathing abnormalities	61	1.45	1.81	2.19	39.6	1.21	1.50	1.84	1.68	1.73	1.39	25053
COVID19_JANSSEN	Brief psychotic disorder	0	0.04	0.94	2.85	0.1
COVID19_MODERNA	Brief psychotic disorder	0	0.04	0.81	2.45	0.2
COVID19_PFIZER/BIONTECH	Brief psychotic disorder	0	0.04	0.83	2.52	0.2
COVID19_UNKNOWN MFR	Brief psychotic disorder	0	0.05	1.00	3.03	0.0
COVID19_JANSSEN	Bronchial and pulmonary therapeutic procedures	2	0.24	0.79	1.61	3.0	0.28	0.72	1.55	0.79	0.79	0.24	39
COVID19_MODERNA	Bronchial and pulmonary therapeutic procedures	2	0.11	0.37	0.75	7.7	0.13	0.36	0.81	0.17	0.17	0.05	39
COVID19_PFIZER/BIONTECH	Bronchial and pulmonary therapeutic procedures	14	1.05	1.69	2.46	7.7	1.03	1.58	2.36	2.12	2.12	1.24	27
COVID19_UNKNOWN MFR	Bronchial and pulmonary therapeutic procedures	1	0.36	1.65	3.72	0.1	0.42	1.48	8.56	17.20	17.21	3.25	40
COVID19_JANSSEN	Bronchial conditions NEC	3	0.25	0.76	1.50	5.2	0.28	0.64	1.28	0.50	0.50	0.19	92
COVID19_MODERNA	Bronchial conditions NEC	11	0.53	0.93	1.42	13.8	0.49	0.79	1.23	0.45	0.45	0.26	84
COVID19_PFIZER/BIONTECH	Bronchial conditions NEC	13	0.62	1.03	1.52	15.4	0.54	0.84	1.26	0.65	0.65	0.40	82
COVID19_UNKNOWN MFR	Bronchial conditions NEC	0	0.03	0.86	2.75	0.1
COVID19_JANSSEN	Bronchospasm and obstruction	185	0.69	0.78	0.87	258.0	0.64	0.72	0.81	0.72	0.71	0.63	3997
COVID19_MODERNA	Bronchospasm and obstruction	919	0.91	0.96	1.02	1006.2	0.87	0.91	0.96	0.96	0.96	0.90	3263
COVID19_PFIZER/BIONTECH	Bronchospasm and obstruction	1029	1.18	1.24	1.31	884.5	1.10	1.16	1.22	1.34	1.34	1.26	3153
COVID19_UNKNOWN MFR	Bronchospasm and obstruction	3	0.27	0.65	1.15	6.3	0.24	0.56	1.11	0.49	0.49	0.19	4179
COVID19_JANSSEN	Brucella infections	0	0.04	0.94	2.86	0.1
COVID19_MODERNA	Brucella infections	0	0.04	0.81	2.46	0.2
COVID19_PFIZER/BIONTECH	Brucella infections	0	0.04	0.83	2.53	0.2
COVID19_UNKNOWN MFR	Brucella infections	0	0.05	1.00	3.04	0.0
COVID19_JANSSEN	Bullous conditions	95	0.54	0.65	0.76	261.4	0.31	0.37	0.43	0.33	0.33	0.28	4461
COVID19_MODERNA	Bullous conditions	504	0.90	0.97	1.04	827.3	0.57	0.61	0.66	0.42	0.42	0.39	4052
COVID19_PFIZER/BIONTECH	Bullous conditions	386	0.74	0.80	0.87	806.5	0.44	0.48	0.52	0.38	0.38	0.35	4170
COVID19_UNKNOWN MFR	Bullous conditions	4	0.39	0.95	1.70	7.2	0.29	0.61	1.14	0.60	0.60	0.26	4552
COVID19_JANSSEN	Burkitt's lymphomas	0	0.06	0.95	2.73	0.1
COVID19_MODERNA	Burkitt's lymphomas	0	0.06	0.83	2.39	0.2
COVID19_PFIZER/BIONTECH	Burkitt's lymphomas	1	0.31	1.61	3.76	0.3	0.38	1.17	3.35	12.28	12.28	0.84	0
COVID19_UNKNOWN MFR	Burkitt's lymphomas	0	0.07	1.00	2.88	0.0
COVID19_JANSSEN	Bursal disorders	16	0.40	0.63	0.91	44.1	0.25	0.38	0.56	0.40	0.40	0.27	611
COVID19_MODERNA	Bursal disorders	59	0.43	0.54	0.67	186.3	0.26	0.32	0.40	0.35	0.35	0.28	568
COVID19_PFIZER/BIONTECH	Bursal disorders	45	0.39	0.50	0.63	154.0	0.23	0.30	0.38	0.32	0.32	0.25	582
COVID19_UNKNOWN MFR	Bursal disorders	1	0.14	1.35	3.60	1.0	0.27	0.83	2.05	1.10	1.10	0.21	626
COVID19_JANSSEN	Calcium metabolism disorders	2	0.22	0.64	1.25	4.0	0.23	0.60	1.30	0.48	0.48	0.15	64
COVID19_MODERNA	Calcium metabolism disorders	15	0.59	0.93	1.33	16.6	0.59	0.89	1.30	1.00	1.00	0.62	51
COVID19_PFIZER/BIONTECH	Calcium metabolism disorders	16	0.72	1.12	1.59	14.3	0.72	1.07	1.56	1.31	1.31	0.82	50
COVID19_UNKNOWN MFR	Calcium metabolism disorders	0	0.16	0.95	2.29	0.1
COVID19_JANSSEN	Caliciviral infections	0	0.00	0.04	0.25	1.9
COVID19_MODERNA	Caliciviral infections	1	0.02	0.38	1.10	3.3	0.14	0.47	1.20	0.05	0.05	0.01	71
COVID19_PFIZER/BIONTECH	Caliciviral infections	0	0.00	0.03	0.14	3.4
COVID19_UNKNOWN MFR	Caliciviral infections	0	0.00	0.63	3.68	0.1
COVID19_JANSSEN	Campylobacter infections	1	0.07	0.84	2.32	1.7	0.22	0.69	1.70	0.74	0.74	0.14	21
COVID19_MODERNA	Campylobacter infections	0	0.00	0.09	0.45	2.4
COVID19_PFIZER/BIONTECH	Campylobacter infections	2	0.14	0.68	1.55	3.5	0.25	0.64	1.40	0.41	0.41	0.12	20
COVID19_UNKNOWN MFR	Campylobacter infections	0	0.00	0.88	4.26	0.0
COVID19_JANSSEN	Candida infections	6	0.33	0.70	1.17	9.6	0.35	0.65	1.14	0.53	0.53	0.27	175
COVID19_MODERNA	Candida infections	28	0.66	0.92	1.21	31.5	0.65	0.88	1.18	0.62	0.62	0.44	153
COVID19_PFIZER/BIONTECH	Candida infections	31	0.78	1.07	1.39	30.6	0.74	1.00	1.32	0.85	0.85	0.61	150
COVID19_UNKNOWN MFR	Candida infections	0	0.08	0.84	2.30	0.2
COVID19_JANSSEN	Carbohydrate tolerance analyses (incl diabetes)	363	1.17	1.27	1.39	290.4	1.14	1.25	1.36	1.33	1.33	1.22	4216
COVID19_MODERNA	Carbohydrate tolerance analyses (incl diabetes)	1082	0.93	0.97	1.02	1123.0	0.92	0.96	1.01	1.05	1.05	0.99	3497
COVID19_PFIZER/BIONTECH	Carbohydrate tolerance analyses (incl diabetes)	1282	1.28	1.34	1.41	970.1	1.26	1.32	1.38	1.59	1.60	1.51	3297
COVID19_UNKNOWN MFR	Carbohydrate tolerance analyses (incl diabetes)	14	1.09	1.71	2.43	7.0	1.11	1.71	2.56	2.11	2.13	1.37	4565
COVID19_JANSSEN	Carcinoid tumours	0	0.07	0.91	2.57	0.1
COVID19_MODERNA	Carcinoid tumours	1	0.26	1.34	3.09	0.3	0.36	1.11	2.96	3.40	3.40	0.33	1
COVID19_PFIZER/BIONTECH	Carcinoid tumours	0	0.06	0.75	2.12	0.4
COVID19_UNKNOWN MFR	Carcinoid tumours	0	0.07	1.00	2.83	0.0
COVID19_JANSSEN	Cardiac and vascular procedural complications	3	0.79	2.46	4.86	0.8	0.71	1.67	4.06	3.09	3.09	1.09	15
COVID19_MODERNA	Cardiac and vascular procedural complications	3	0.31	0.96	1.89	4.4	0.32	0.72	1.43	0.68	0.68	0.24	15
COVID19_PFIZER/BIONTECH	Cardiac and vascular procedural complications	6	0.87	1.89	3.23	3.6	0.72	1.34	2.34	2.05	2.05	0.90	12
COVID19_UNKNOWN MFR	Cardiac and vascular procedural complications	0	0.02	0.97	3.30	0.0
COVID19_JANSSEN	Cardiac auscultatory investigations	6	0.55	1.11	1.83	5.7	0.53	0.98	1.70	0.94	0.94	0.47	99
COVID19_MODERNA	Cardiac auscultatory investigations	11	0.48	0.82	1.23	14.9	0.46	0.74	1.15	0.40	0.40	0.24	94
COVID19_PFIZER/BIONTECH	Cardiac auscultatory investigations	14	0.60	0.96	1.38	16.6	0.54	0.84	1.24	0.63	0.63	0.39	91
COVID19_UNKNOWN MFR	Cardiac auscultatory investigations	0	0.15	0.93	2.26	0.1
COVID19_JANSSEN	Cardiac complications associated with device	1	0.30	1.52	3.51	0.3	0.36	1.11	3.00	5.15	5.15	0.77	3
COVID19_MODERNA	Cardiac complications associated with device	2	0.44	1.52	3.12	1.3	0.42	1.05	2.30	3.40	3.40	0.66	2
COVID19_PFIZER/BIONTECH	Cardiac complications associated with device	0	0.05	0.61	1.70	0.8
COVID19_UNKNOWN MFR	Cardiac complications associated with device	1	0.36	1.82	4.20	0.0	0.45	1.77	14.81	229.28	229.54	34.32	3
COVID19_JANSSEN	Cardiac conduction disorders	16	1.00	1.57	2.23	12.4	0.81	1.21	1.76	1.32	1.32	0.86	187
COVID19_MODERNA	Cardiac conduction disorders	57	1.09	1.37	1.68	52.7	0.86	1.07	1.32	1.33	1.33	1.02	146
COVID19_PFIZER/BIONTECH	Cardiac conduction disorders	75	1.74	2.13	2.54	44.7	1.35	1.63	1.96	2.40	2.40	1.89	128
COVID19_UNKNOWN MFR	Cardiac conduction disorders	1	0.32	1.42	3.16	0.3	0.36	1.10	2.94	3.41	3.41	0.65	202
COVID19_JANSSEN	Cardiac device therapeutic procedures	7	0.63	1.24	2.02	5.3	0.65	1.17	1.97	1.04	1.04	0.55	104
COVID19_MODERNA	Cardiac device therapeutic procedures	40	0.98	1.29	1.63	30.8	0.97	1.26	1.62	1.91	1.91	1.38	71
COVID19_PFIZER/BIONTECH	Cardiac device therapeutic procedures	35	1.05	1.42	1.82	24.6	1.03	1.37	1.78	1.89	1.89	1.35	76
COVID19_UNKNOWN MFR	Cardiac device therapeutic procedures	0	0.09	0.89	2.38	0.2
COVID19_JANSSEN	Cardiac disorders NEC	42	1.28	1.68	2.12	30.5	1.03	1.33	1.70	1.41	1.41	1.08	460
COVID19_MODERNA	Cardiac disorders NEC	93	0.92	1.10	1.29	104.7	0.75	0.89	1.05	0.77	0.77	0.64	409
COVID19_PFIZER/BIONTECH	Cardiac disorders NEC	148	1.64	1.88	2.15	97.5	1.31	1.50	1.71	1.71	1.71	1.46	354
COVID19_UNKNOWN MFR	Cardiac disorders NEC	0	0.04	0.62	1.80	0.7
COVID19_JANSSEN	Cardiac disorders congenital NEC	1	0.22	1.31	3.15	0.4	0.35	1.04	2.69	1.93	1.93	0.34	8
COVID19_MODERNA	Cardiac disorders congenital NEC	0	0.01	0.31	0.95	2.0
COVID19_PFIZER/BIONTECH	Cardiac disorders congenital NEC	1	0.12	0.71	1.72	1.0	0.28	0.84	2.08	0.51	0.51	0.09	8
COVID19_UNKNOWN MFR	Cardiac disorders congenital NEC	0	0.04	0.99	3.05	0.0
COVID19_JANSSEN	Cardiac function diagnostic procedures	296	1.44	1.59	1.74	253.7	1.06	1.16	1.28	1.33	1.34	1.21	3425
COVID19_MODERNA	Cardiac function diagnostic procedures	943	1.20	1.27	1.34	969.9	0.92	0.97	1.02	1.15	1.15	1.08	2778
COVID19_PFIZER/BIONTECH	Cardiac function diagnostic procedures	1228	1.89	1.98	2.07	826.4	1.42	1.48	1.56	2.02	2.03	1.91	2493
COVID19_UNKNOWN MFR	Cardiac function diagnostic procedures	11	1.24	2.15	3.26	6.0	0.95	1.54	2.40	2.04	2.05	1.25	3710
COVID19_JANSSEN	Cardiac histopathology procedures	2	0.42	1.26	2.46	1.2	0.44	1.10	2.42	2.21	2.21	0.64	14
COVID19_MODERNA	Cardiac histopathology procedures	3	0.31	0.80	1.47	3.9	0.35	0.78	1.55	0.78	0.78	0.27	13
COVID19_PFIZER/BIONTECH	Cardiac histopathology procedures	6	0.72	1.45	2.38	3.5	0.73	1.36	2.38	2.46	2.46	1.05	10
COVID19_UNKNOWN MFR	Cardiac histopathology procedures	0	0.16	0.99	2.38	0.0
COVID19_JANSSEN	Cardiac hypertensive complications	1	0.26	1.37	3.19	0.5	0.34	1.02	2.59	2.57	2.57	0.44	6
COVID19_MODERNA	Cardiac hypertensive complications	0	0.03	0.41	1.19	1.6
COVID19_PFIZER/BIONTECH	Cardiac hypertensive complications	3	0.58	1.65	3.17	1.5	0.57	1.28	2.61	3.07	3.07	0.87	4
COVID19_UNKNOWN MFR	Cardiac hypertensive complications	0	0.07	0.99	2.85	0.0
COVID19_JANSSEN	Cardiac imaging procedures	65	1.22	1.51	1.82	61.7	0.85	1.04	1.27	1.59	1.59	1.28	633
COVID19_MODERNA	Cardiac imaging procedures	215	1.36	1.52	1.70	196.5	0.97	1.09	1.22	1.51	1.51	1.32	483
COVID19_PFIZER/BIONTECH	Cardiac imaging procedures	303	2.28	2.51	2.75	170.1	1.61	1.77	1.94	3.14	3.15	2.77	395
COVID19_UNKNOWN MFR	Cardiac imaging procedures	3	0.70	2.01	3.87	1.3	0.60	1.35	2.79	2.97	2.98	1.15	695
COVID19_JANSSEN	Cardiac infections	1	0.25	0.92	1.94	1.2	0.26	0.79	1.93	0.81	0.81	0.15	19
COVID19_MODERNA	Cardiac infections	4	0.45	1.03	1.81	3.4	0.49	1.02	1.92	0.85	0.85	0.34	16
COVID19_PFIZER/BIONTECH	Cardiac infections	4	0.46	1.05	1.85	3.5	0.49	1.01	1.90	1.02	1.02	0.41	16
COVID19_UNKNOWN MFR	Cardiac infections	0	0.17	0.98	2.34	0.0
COVID19_JANSSEN	Cardiac infections and inflammations NEC	0	0.11	0.82	2.07	0.4
COVID19_MODERNA	Cardiac infections and inflammations NEC	1	0.21	0.88	1.91	1.2	0.26	0.78	1.92	0.68	0.68	0.11	5
COVID19_PFIZER/BIONTECH	Cardiac infections and inflammations NEC	2	0.41	1.29	2.56	1.2	0.44	1.11	2.44	2.05	2.05	0.49	4
COVID19_UNKNOWN MFR	Cardiac infections and inflammations NEC	0	0.14	1.00	2.51	0.0
COVID19_JANSSEN	Cardiac malpositions congenital	0	0.04	0.94	2.86	0.1
COVID19_MODERNA	Cardiac malpositions congenital	0	0.04	0.81	2.46	0.2
COVID19_PFIZER/BIONTECH	Cardiac malpositions congenital	0	0.04	0.83	2.52	0.2
COVID19_UNKNOWN MFR	Cardiac malpositions congenital	0	0.05	1.00	3.03	0.0
COVID19_JANSSEN	Cardiac neoplasms NEC	0	0.07	0.95	2.72	0.1
COVID19_MODERNA	Cardiac neoplasms NEC	1	0.30	1.57	3.64	0.3	0.36	1.11	3.00	10.19	10.19	0.69	0
COVID19_PFIZER/BIONTECH	Cardiac neoplasms NEC	0	0.06	0.85	2.44	0.2
COVID19_UNKNOWN MFR	Cardiac neoplasms NEC	0	0.07	1.00	2.86	0.0
COVID19_JANSSEN	Cardiac septal defects congenital	3	0.24	0.76	1.51	4.5	0.31	0.71	1.41	0.67	0.67	0.25	69
COVID19_MODERNA	Cardiac septal defects congenital	11	0.60	1.05	1.61	10.8	0.60	0.98	1.51	0.61	0.61	0.36	61
COVID19_PFIZER/BIONTECH	Cardiac septal defects congenital	15	0.82	1.31	1.90	12.1	0.77	1.17	1.72	1.08	1.08	0.67	57
COVID19_UNKNOWN MFR	Cardiac septal defects congenital	0	0.01	0.85	3.13	0.1
COVID19_JANSSEN	Cardiac signs and symptoms NEC	666	1.41	1.50	1.60	540.0	1.16	1.23	1.31	1.60	1.61	1.51	6429
COVID19_MODERNA	Cardiac signs and symptoms NEC	2280	1.21	1.25	1.30	2200.3	1.00	1.04	1.07	1.61	1.62	1.55	4815
COVID19_PFIZER/BIONTECH	Cardiac signs and symptoms NEC	2655	1.69	1.75	1.81	1843.7	1.39	1.44	1.49	2.45	2.48	2.38	4440
COVID19_UNKNOWN MFR	Cardiac signs and symptoms NEC	14	0.86	1.39	2.01	11.8	0.73	1.12	1.66	1.36	1.37	0.88	7081
COVID19_JANSSEN	Cardiac therapeutic procedures NEC	14	0.86	1.37	1.98	12.1	0.71	1.10	1.63	1.14	1.14	0.72	190
COVID19_MODERNA	Cardiac therapeutic procedures NEC	52	0.99	1.26	1.55	53.0	0.77	0.97	1.21	1.16	1.16	0.89	152
COVID19_PFIZER/BIONTECH	Cardiac therapeutic procedures NEC	73	1.68	2.05	2.46	44.7	1.31	1.59	1.92	2.28	2.28	1.79	131
COVID19_UNKNOWN MFR	Cardiac therapeutic procedures NEC	0	0.17	0.88	2.06	0.3
COVID19_JANSSEN	Cardiac valve disorders NEC	0	0.05	0.53	1.42	1.2
COVID19_MODERNA	Cardiac valve disorders NEC	4	0.37	0.90	1.62	5.2	0.37	0.77	1.46	0.76	0.76	0.30	18
COVID19_PFIZER/BIONTECH	Cardiac valve disorders NEC	8	0.92	1.74	2.77	4.6	0.82	1.43	2.37	2.34	2.34	1.13	14
COVID19_UNKNOWN MFR	Cardiac valve disorders NEC	0	0.10	0.98	2.63	0.0
COVID19_JANSSEN	Cardiac valve disorders congenital	1	0.23	1.46	3.58	0.3	0.36	1.11	2.98	2.57	2.57	0.44	6
COVID19_MODERNA	Cardiac valve disorders congenital	0	0.01	0.34	1.09	1.6
COVID19_PFIZER/BIONTECH	Cardiac valve disorders congenital	1	0.13	0.83	2.03	0.9	0.28	0.86	2.12	0.68	0.68	0.12	6
COVID19_UNKNOWN MFR	Cardiac valve disorders congenital	0	0.03	0.99	3.18	0.0
COVID19_JANSSEN	Cardiac valve therapeutic procedures	1	0.32	1.18	2.49	0.6	0.33	0.98	2.48	1.93	1.93	0.34	8
COVID19_MODERNA	Cardiac valve therapeutic procedures	1	0.20	0.74	1.56	2.2	0.19	0.60	1.48	0.42	0.42	0.07	8
COVID19_PFIZER/BIONTECH	Cardiac valve therapeutic procedures	1	0.21	0.79	1.67	2.0	0.20	0.64	1.57	0.51	0.51	0.09	8
COVID19_UNKNOWN MFR	Cardiac valve therapeutic procedures	0	0.17	0.99	2.37	0.0
COVID19_JANSSEN	Cardiomyopathies	7	0.50	1.00	1.63	7.6	0.50	0.89	1.50	0.85	0.85	0.45	127
COVID19_MODERNA	Cardiomyopathies	22	0.60	0.88	1.20	28.7	0.54	0.77	1.06	0.67	0.67	0.45	112
COVID19_PFIZER/BIONTECH	Cardiomyopathies	41	1.33	1.74	2.21	26.4	1.15	1.49	1.91	1.81	1.81	1.33	93
COVID19_UNKNOWN MFR	Cardiomyopathies	0	0.05	0.85	2.49	0.2
COVID19_JANSSEN	Cardiovascular disorders congenital NEC	0	0.04	0.94	2.86	0.1
COVID19_MODERNA	Cardiovascular disorders congenital NEC	0	0.04	0.81	2.46	0.2
COVID19_PFIZER/BIONTECH	Cardiovascular disorders congenital NEC	0	0.04	0.83	2.52	0.2
COVID19_UNKNOWN MFR	Cardiovascular disorders congenital NEC	0	0.05	1.00	3.03	0.0
COVID19_JANSSEN	Cardiovascular injuries	3	0.45	0.94	1.57	3.4	0.37	0.84	1.67	0.81	0.81	0.31	57
COVID19_MODERNA	Cardiovascular injuries	12	0.60	0.95	1.37	13.0	0.57	0.90	1.37	0.85	0.85	0.50	48
COVID19_PFIZER/BIONTECH	Cardiovascular injuries	12	0.65	1.03	1.48	11.6	0.63	0.99	1.51	1.02	1.02	0.60	48
COVID19_UNKNOWN MFR	Cardiovascular injuries	0	0.36	0.98	1.85	0.1
COVID19_JANSSEN	Cardiovascular neoplasms benign	0	0.06	0.53	1.40	1.3
COVID19_MODERNA	Cardiovascular neoplasms benign	2	0.19	0.63	1.26	2.7	0.30	0.75	1.63	0.36	0.36	0.11	19
COVID19_PFIZER/BIONTECH	Cardiovascular neoplasms benign	3	0.30	0.82	1.55	2.8	0.42	0.93	1.86	0.68	0.68	0.25	18
COVID19_UNKNOWN MFR	Cardiovascular neoplasms benign	0	0.11	0.98	2.57	0.0
COVID19_JANSSEN	Cardiovascular neoplasms malignant and unspecified	0	0.03	0.88	2.76	0.1
COVID19_MODERNA	Cardiovascular neoplasms malignant and unspecified	0	0.02	0.66	2.07	0.5
COVID19_PFIZER/BIONTECH	Cardiovascular neoplasms malignant and unspecified	0	0.02	0.69	2.17	0.4
COVID19_UNKNOWN MFR	Cardiovascular neoplasms malignant and unspecified	0	0.04	1.00	3.14	0.0
COVID19_JANSSEN	Cartilage disorders	3	0.23	0.68	1.31	5.4	0.28	0.62	1.25	0.63	0.63	0.24	73
COVID19_MODERNA	Cartilage disorders	10	0.36	0.63	0.98	17.1	0.37	0.61	0.96	0.51	0.51	0.29	66
COVID19_PFIZER/BIONTECH	Cartilage disorders	24	1.07	1.54	2.08	16.3	0.99	1.38	1.89	1.89	1.89	1.26	52
COVID19_UNKNOWN MFR	Cartilage disorders	0	0.05	0.90	2.68	0.1
COVID19_JANSSEN	Cataract conditions	4	0.37	0.88	1.56	4.5	0.41	0.85	1.60	0.88	0.88	0.38	70
COVID19_MODERNA	Cataract conditions	7	0.28	0.55	0.88	13.4	0.31	0.56	0.95	0.36	0.36	0.19	67
COVID19_PFIZER/BIONTECH	Cataract conditions	18	0.83	1.26	1.76	13.2	0.87	1.28	1.82	1.32	1.32	0.84	56
COVID19_UNKNOWN MFR	Cataract conditions	0	0.12	0.92	2.34	0.1
COVID19_JANSSEN	Cell marker analyses	4	0.13	0.37	0.70	14.1	0.16	0.35	0.66	0.27	0.27	0.12	226
COVID19_MODERNA	Cell marker analyses	21	0.41	0.60	0.83	38.8	0.39	0.56	0.77	0.34	0.34	0.23	209
COVID19_PFIZER/BIONTECH	Cell marker analyses	24	0.49	0.70	0.95	40.4	0.43	0.60	0.83	0.48	0.48	0.33	206
COVID19_UNKNOWN MFR	Cell marker analyses	0	0.00	0.54	2.32	0.3
COVID19_JANSSEN	Cell metabolism disorders NEC	1	0.08	0.75	2.00	1.5	0.23	0.72	1.78	0.64	0.64	0.12	24
COVID19_MODERNA	Cell metabolism disorders NEC	1	0.04	0.35	0.92	3.5	0.13	0.45	1.16	0.14	0.14	0.03	24
COVID19_PFIZER/BIONTECH	Cell metabolism disorders NEC	0	0.00	0.09	0.37	4.1
COVID19_UNKNOWN MFR	Cell metabolism disorders NEC	0	0.00	0.92	3.82	0.0
COVID19_JANSSEN	Cellular antitumour therapies	0	0.05	0.94	2.84	0.1
COVID19_MODERNA	Cellular antitumour therapies	0	0.04	0.81	2.45	0.2
COVID19_PFIZER/BIONTECH	Cellular antitumour therapies	0	0.04	0.83	2.51	0.2
COVID19_UNKNOWN MFR	Cellular antitumour therapies	0	0.05	1.00	3.01	0.0
COVID19_JANSSEN	Central nervous system and spinal infections	16	0.31	0.49	0.70	49.3	0.23	0.34	0.50	0.25	0.25	0.16	1001
COVID19_MODERNA	Central nervous system and spinal infections	46	0.46	0.59	0.74	99.2	0.37	0.47	0.59	0.16	0.16	0.13	971
COVID19_PFIZER/BIONTECH	Central nervous system and spinal infections	48	0.42	0.54	0.68	124.2	0.31	0.39	0.49	0.20	0.20	0.16	969
COVID19_UNKNOWN MFR	Central nervous system and spinal infections	0	0.04	0.57	1.62	0.9
COVID19_JANSSEN	Central nervous system aneurysms and dissections	10	1.83	3.31	5.14	3.1	1.34	2.28	3.88	4.06	4.06	2.26	38
COVID19_MODERNA	Central nervous system aneurysms and dissections	15	0.88	1.42	2.05	13.1	0.72	1.09	1.60	1.54	1.54	0.93	33
COVID19_PFIZER/BIONTECH	Central nervous system aneurysms and dissections	16	1.10	1.74	2.49	11.2	0.88	1.32	1.91	2.05	2.05	1.24	32
COVID19_UNKNOWN MFR	Central nervous system aneurysms and dissections	0	0.01	0.89	3.27	0.1
COVID19_JANSSEN	Central nervous system disorders congenital NEC	0	0.00	0.26	1.06	1.2
COVID19_MODERNA	Central nervous system disorders congenital NEC	0	0.00	0.15	0.59	2.6
COVID19_PFIZER/BIONTECH	Central nervous system disorders congenital NEC	2	0.16	0.70	1.56	2.8	0.30	0.75	1.61	0.55	0.55	0.16	15
COVID19_UNKNOWN MFR	Central nervous system disorders congenital NEC	0	0.00	0.93	3.73	0.0
COVID19_JANSSEN	Central nervous system haemorrhages and cerebrovascular accidents	369	2.68	2.92	3.18	150.1	2.23	2.44	2.65	2.35	2.36	2.15	2429
COVID19_MODERNA	Central nervous system haemorrhages and cerebrovascular accidents	864	1.25	1.32	1.40	732.4	1.11	1.18	1.25	1.52	1.52	1.42	1934
COVID19_PFIZER/BIONTECH	Central nervous system haemorrhages and cerebrovascular accidents	1011	1.79	1.88	1.98	616.5	1.55	1.64	1.72	2.32	2.33	2.18	1787
COVID19_UNKNOWN MFR	Central nervous system haemorrhages and cerebrovascular accidents	16	2.06	3.21	4.58	4.7	1.75	2.71	4.22	3.96	4.01	2.65	2782
COVID19_JANSSEN	Central nervous system histopathology procedures	1	0.03	0.43	1.23	2.8	0.16	0.52	1.31	0.32	0.32	0.06	49
COVID19_MODERNA	Central nervous system histopathology procedures	4	0.25	0.71	1.35	5.9	0.34	0.71	1.34	0.30	0.30	0.13	46
COVID19_PFIZER/BIONTECH	Central nervous system histopathology procedures	2	0.06	0.32	0.74	7.1	0.14	0.39	0.86	0.17	0.17	0.05	48
COVID19_UNKNOWN MFR	Central nervous system histopathology procedures	0	0.00	0.67	3.79	0.1
COVID19_JANSSEN	Central nervous system imaging procedures	575	1.85	1.98	2.12	353.7	1.51	1.62	1.73	1.64	1.65	1.54	5399
COVID19_MODERNA	Central nervous system imaging procedures	1168	0.89	0.93	0.98	1425.1	0.78	0.82	0.86	0.83	0.82	0.78	4806
COVID19_PFIZER/BIONTECH	Central nervous system imaging procedures	1317	1.19	1.24	1.30	1240.7	1.01	1.06	1.11	1.16	1.16	1.10	4657
COVID19_UNKNOWN MFR	Central nervous system imaging procedures	21	1.73	2.55	3.50	8.8	1.44	2.07	2.91	2.43	2.46	1.71	5953
COVID19_JANSSEN	Central nervous system inflammatory disorders NEC	1	0.07	0.41	0.97	4.0	0.11	0.41	1.06	0.29	0.29	0.06	53
COVID19_MODERNA	Central nervous system inflammatory disorders NEC	3	0.12	0.35	0.68	10.1	0.16	0.38	0.77	0.20	0.20	0.08	51
COVID19_PFIZER/BIONTECH	Central nervous system inflammatory disorders NEC	3	0.12	0.35	0.68	10.2	0.16	0.37	0.76	0.24	0.24	0.09	51
COVID19_UNKNOWN MFR	Central nervous system inflammatory disorders NEC	0	0.05	0.92	2.74	0.1
COVID19_JANSSEN	Central nervous system neoplasms malignant NEC	0	0.02	0.77	2.48	0.2
COVID19_MODERNA	Central nervous system neoplasms malignant NEC	0	0.01	0.48	1.53	0.9
COVID19_PFIZER/BIONTECH	Central nervous system neoplasms malignant NEC	3	0.79	2.37	4.66	1.0	0.67	1.53	3.38	12.28	12.28	1.84	1
COVID19_UNKNOWN MFR	Central nervous system neoplasms malignant NEC	0	0.03	0.99	3.18	0.0
COVID19_JANSSEN	Central nervous system vascular disorders NEC	24	1.41	2.04	2.77	13.1	1.20	1.68	2.30	1.66	1.66	1.17	223
COVID19_MODERNA	Central nervous system vascular disorders NEC	51	0.83	1.07	1.32	52.1	0.77	0.97	1.21	0.88	0.88	0.68	196
COVID19_PFIZER/BIONTECH	Central nervous system vascular disorders NEC	58	1.10	1.38	1.69	47.5	0.97	1.20	1.48	1.26	1.26	0.98	189
COVID19_UNKNOWN MFR	Central nervous system vascular disorders NEC	2	0.71	3.19	7.14	0.4	0.59	1.59	5.07	5.62	5.63	1.75	245
COVID19_JANSSEN	Cerebellar disorders congenital	1	0.13	0.86	2.11	1.2	0.26	0.80	1.96	0.74	0.74	0.14	21
COVID19_MODERNA	Cerebellar disorders congenital	4	0.37	0.97	1.79	3.9	0.46	0.94	1.78	0.76	0.76	0.30	18
COVID19_PFIZER/BIONTECH	Cerebellar disorders congenital	4	0.40	1.03	1.91	3.5	0.48	0.99	1.87	0.91	0.91	0.37	18
COVID19_UNKNOWN MFR	Cerebellar disorders congenital	0	0.03	0.97	3.11	0.0
COVID19_JANSSEN	Cerebral disorders congenital	0	0.04	0.37	0.99	2.4
COVID19_MODERNA	Cerebral disorders congenital	3	0.22	0.61	1.15	6.0	0.25	0.57	1.15	0.22	0.22	0.08	47
COVID19_PFIZER/BIONTECH	Cerebral disorders congenital	10	0.82	1.45	2.22	6.6	0.80	1.32	2.08	1.02	1.02	0.57	40
COVID19_UNKNOWN MFR	Cerebral disorders congenital	0	0.10	0.95	2.55	0.1
COVID19_JANSSEN	Cerebral injuries NEC	34	1.28	1.73	2.24	20.9	1.16	1.54	2.01	1.65	1.65	1.23	318
COVID19_MODERNA	Cerebral injuries NEC	76	0.84	1.02	1.22	79.7	0.78	0.95	1.14	0.94	0.94	0.76	276
COVID19_PFIZER/BIONTECH	Cerebral injuries NEC	82	1.04	1.26	1.49	70.7	0.96	1.15	1.37	1.24	1.24	1.01	270
COVID19_UNKNOWN MFR	Cerebral injuries NEC	3	0.88	2.47	4.72	0.5	0.81	2.09	6.96	5.91	5.93	2.28	349
COVID19_JANSSEN	Cerebrospinal fluid tests (excl microbiology)	42	0.60	0.78	0.99	83.0	0.40	0.51	0.65	0.46	0.46	0.36	1410
COVID19_MODERNA	Cerebrospinal fluid tests (excl microbiology)	69	0.35	0.43	0.52	221.9	0.26	0.32	0.38	0.17	0.17	0.14	1383
COVID19_PFIZER/BIONTECH	Cerebrospinal fluid tests (excl microbiology)	85	0.45	0.54	0.64	232.4	0.31	0.37	0.44	0.26	0.25	0.21	1367
COVID19_UNKNOWN MFR	Cerebrospinal fluid tests (excl microbiology)	0	0.01	0.33	1.14	1.4
COVID19_JANSSEN	Cerebrospinal fluid therapeutic procedures	4	0.73	1.72	3.04	1.9	0.68	1.41	2.72	1.82	1.82	0.76	34
COVID19_MODERNA	Cerebrospinal fluid therapeutic procedures	4	0.35	0.83	1.48	6.5	0.32	0.66	1.24	0.40	0.40	0.17	34
COVID19_PFIZER/BIONTECH	Cerebrospinal fluid therapeutic procedures	7	0.65	1.27	2.05	6.4	0.56	1.01	1.70	0.92	0.92	0.46	31
COVID19_UNKNOWN MFR	Cerebrospinal fluid therapeutic procedures	0	0.14	0.98	2.45	0.0
COVID19_JANSSEN	Cerebrovascular venous and sinus thrombosis	65	6.58	8.17	9.90	11.2	4.56	5.66	6.94	12.09	12.11	9.22	83
COVID19_MODERNA	Cerebrovascular venous and sinus thrombosis	29	0.70	0.98	1.30	43.9	0.49	0.67	0.89	0.83	0.83	0.59	119
COVID19_PFIZER/BIONTECH	Cerebrovascular venous and sinus thrombosis	38	1.12	1.49	1.91	37.3	0.77	1.00	1.29	1.41	1.41	1.04	110
COVID19_UNKNOWN MFR	Cerebrovascular venous and sinus thrombosis	1	0.25	2.65	7.19	0.2	0.38	1.18	3.38	4.68	4.68	0.90	147
COVID19_JANSSEN	Cervical spinal cord and nerve root disorders	4	0.50	1.21	2.17	3.3	0.50	1.03	1.94	1.72	1.72	0.72	36
COVID19_MODERNA	Cervical spinal cord and nerve root disorders	3	0.13	0.34	0.65	11.5	0.14	0.34	0.69	0.28	0.28	0.10	37
COVID19_PFIZER/BIONTECH	Cervical spinal cord and nerve root disorders	6	0.32	0.66	1.11	10.0	0.34	0.63	1.10	0.72	0.72	0.35	34
COVID19_UNKNOWN MFR	Cervical spinal cord and nerve root disorders	0	0.10	0.95	2.54	0.1
COVID19_JANSSEN	Cervix disorders NEC	2	0.07	0.35	0.82	10.9	0.09	0.26	0.61	0.21	0.21	0.07	147
COVID19_MODERNA	Cervix disorders NEC	1	0.01	0.08	0.22	20.0	0.01	0.06	0.25	0.02	0.02	0.00	148
COVID19_PFIZER/BIONTECH	Cervix disorders NEC	5	0.13	0.32	0.59	26.0	0.11	0.23	0.43	0.14	0.14	0.07	144
COVID19_UNKNOWN MFR	Cervix disorders NEC	0	0.00	0.42	2.40	0.1
COVID19_JANSSEN	Cervix infections and inflammations	0	0.07	0.95	2.72	0.1
COVID19_MODERNA	Cervix infections and inflammations	1	0.30	1.57	3.64	0.3	0.37	1.12	3.03	10.19	10.19	0.69	0
COVID19_PFIZER/BIONTECH	Cervix infections and inflammations	0	0.06	0.85	2.44	0.2
COVID19_UNKNOWN MFR	Cervix infections and inflammations	0	0.07	1.00	2.86	0.0
COVID19_JANSSEN	Cervix neoplasms	1	0.32	1.79	4.24	0.2	0.39	1.25	4.22	15.44	15.44	1.51	1
COVID19_MODERNA	Cervix neoplasms	0	0.04	0.69	2.06	0.5
COVID19_PFIZER/BIONTECH	Cervix neoplasms	0	0.04	0.72	2.15	0.4
COVID19_UNKNOWN MFR	Cervix neoplasms	0	0.05	1.00	2.99	0.0
COVID19_JANSSEN	Cervix neoplasms malignant	0	0.00	0.01	0.07	4.6
COVID19_MODERNA	Cervix neoplasms malignant	1	0.01	0.13	0.38	11.5	0.02	0.13	0.45	0.03	0.03	0.01	123
COVID19_PFIZER/BIONTECH	Cervix neoplasms malignant	1	0.01	0.10	0.28	19.2	0.01	0.06	0.27	0.03	0.03	0.01	123
COVID19_UNKNOWN MFR	Cervix neoplasms malignant	0	0.00	0.33	1.87	0.1
COVID19_JANSSEN	Cervix therapeutic procedures	1	0.02	0.28	0.83	7.3	0.04	0.23	0.68	0.16	0.16	0.03	98
COVID19_MODERNA	Cervix therapeutic procedures	0	0.00	0.01	0.05	7.4
COVID19_PFIZER/BIONTECH	Cervix therapeutic procedures	1	0.01	0.12	0.34	16.7	0.01	0.08	0.31	0.04	0.04	0.01	98
COVID19_UNKNOWN MFR	Cervix therapeutic procedures	0	0.00	0.42	2.37	0.1
COVID19_JANSSEN	Cestode infections	0	0.05	0.94	2.85	0.1
COVID19_MODERNA	Cestode infections	0	0.04	0.81	2.45	0.2
COVID19_PFIZER/BIONTECH	Cestode infections	0	0.04	0.83	2.52	0.2
COVID19_UNKNOWN MFR	Cestode infections	0	0.05	1.00	3.02	0.0
COVID19_JANSSEN	Chambers (anterior and posterior) and lens infections and inflammations	0	0.00	0.50	1.94	0.5
COVID19_MODERNA	Chambers (anterior and posterior) and lens infections and inflammations	1	0.07	0.64	1.68	1.4	0.24	0.75	1.84	0.49	0.49	0.08	7
COVID19_PFIZER/BIONTECH	Chambers (anterior and posterior) and lens infections and inflammations	0	0.00	0.24	0.92	1.6
COVID19_UNKNOWN MFR	Chambers (anterior and posterior) and lens infections and inflammations	0	0.00	0.98	3.80	0.0
COVID19_JANSSEN	Chemical injuries	0	0.09	0.76	1.96	0.5
COVID19_MODERNA	Chemical injuries	2	0.33	1.05	2.11	1.2	0.43	1.09	2.38	1.13	1.13	0.30	6
COVID19_PFIZER/BIONTECH	Chemical injuries	1	0.19	0.82	1.80	1.3	0.25	0.77	1.90	0.59	0.59	0.10	7
COVID19_UNKNOWN MFR	Chemical injuries	0	0.12	0.99	2.57	0.0
COVID19_JANSSEN	Chemistry analyses NEC	5	0.16	0.35	0.60	19.5	0.15	0.30	0.56	0.23	0.23	0.11	342
COVID19_MODERNA	Chemistry analyses NEC	25	0.32	0.45	0.60	60.5	0.31	0.43	0.58	0.26	0.26	0.19	322
COVID19_PFIZER/BIONTECH	Chemistry analyses NEC	45	0.64	0.83	1.04	59.6	0.59	0.76	0.96	0.61	0.61	0.47	302
COVID19_UNKNOWN MFR	Chemistry analyses NEC	0	0.12	0.80	1.97	0.4
COVID19_JANSSEN	Chemotherapies	5	0.32	0.72	1.24	8.3	0.33	0.64	1.15	0.53	0.53	0.25	145
COVID19_MODERNA	Chemotherapies	6	0.18	0.36	0.61	19.2	0.19	0.36	0.63	0.14	0.14	0.07	144
COVID19_PFIZER/BIONTECH	Chemotherapies	6	0.16	0.33	0.55	22.3	0.16	0.31	0.55	0.17	0.17	0.09	144
COVID19_UNKNOWN MFR	Chemotherapies	0	0.09	0.87	2.31	0.2
COVID19_JANSSEN	Chest and respiratory tract injuries NEC	5	0.55	1.13	1.88	4.1	0.54	1.06	1.91	1.29	1.29	0.60	60
COVID19_MODERNA	Chest and respiratory tract injuries NEC	20	0.85	1.25	1.72	16.2	0.82	1.18	1.65	1.51	1.51	0.97	45
COVID19_PFIZER/BIONTECH	Chest and respiratory tract injuries NEC	18	0.85	1.27	1.77	14.2	0.82	1.20	1.72	1.57	1.57	0.99	47
COVID19_UNKNOWN MFR	Chest and respiratory tract injuries NEC	0	0.23	0.96	2.10	0.1
COVID19_JANSSEN	Chest wall and mediastinal therapeutic procedures	3	0.41	1.20	2.34	2.7	0.43	0.97	1.94	0.95	0.95	0.36	49
COVID19_MODERNA	Chest wall and mediastinal therapeutic procedures	9	0.56	1.04	1.63	10.7	0.49	0.83	1.34	0.71	0.71	0.39	43
COVID19_PFIZER/BIONTECH	Chest wall and mediastinal therapeutic procedures	14	1.05	1.70	2.48	9.5	0.87	1.34	1.99	1.51	1.51	0.90	38
COVID19_UNKNOWN MFR	Chest wall and mediastinal therapeutic procedures	0	0.04	0.94	2.85	0.1
COVID19_JANSSEN	Chlamydial infections	0	0.00	0.14	0.72	1.3
COVID19_MODERNA	Chlamydial infections	1	0.02	0.24	0.68	4.5	0.09	0.37	0.97	0.17	0.17	0.03	20
COVID19_PFIZER/BIONTECH	Chlamydial infections	0	0.00	0.05	0.25	4.2
COVID19_UNKNOWN MFR	Chlamydial infections	0	0.00	0.88	4.45	0.0
COVID19_JANSSEN	Chloride imbalance	0	0.04	0.70	2.10	0.4
COVID19_MODERNA	Chloride imbalance	0	0.02	0.38	1.15	1.6
COVID19_PFIZER/BIONTECH	Chloride imbalance	0	0.02	0.42	1.26	1.4
COVID19_UNKNOWN MFR	Chloride imbalance	0	0.05	0.99	2.97	0.0
COVID19_JANSSEN	Cholecystitis and cholelithiasis	8	0.59	1.09	1.72	7.1	0.60	1.04	1.71	1.15	1.15	0.63	107
COVID19_MODERNA	Cholecystitis and cholelithiasis	44	1.02	1.32	1.66	33.6	1.00	1.28	1.62	2.10	2.11	1.54	71
COVID19_PFIZER/BIONTECH	Cholecystitis and cholelithiasis	30	0.79	1.09	1.42	28.2	0.77	1.04	1.39	1.45	1.45	1.02	85
COVID19_UNKNOWN MFR	Cholecystitis and cholelithiasis	1	0.38	1.37	2.86	0.2	0.39	1.24	4.01	6.03	6.04	1.16	114
COVID19_JANSSEN	Cholestasis and jaundice	3	0.08	0.25	0.48	17.5	0.09	0.22	0.47	0.16	0.16	0.06	288
COVID19_MODERNA	Cholestasis and jaundice	28	0.48	0.67	0.89	45.7	0.46	0.62	0.83	0.36	0.36	0.26	263
COVID19_PFIZER/BIONTECH	Cholestasis and jaundice	52	0.96	1.22	1.51	48.5	0.84	1.06	1.32	0.89	0.89	0.69	239
COVID19_UNKNOWN MFR	Cholestasis and jaundice	0	0.03	0.70	2.17	0.4
COVID19_JANSSEN	Cholesterol analyses	21	0.90	1.31	1.80	20.8	0.69	0.99	1.37	1.11	1.11	0.77	292
COVID19_MODERNA	Cholesterol analyses	41	0.57	0.75	0.95	74.3	0.43	0.56	0.71	0.51	0.51	0.39	272
COVID19_PFIZER/BIONTECH	Cholesterol analyses	105	1.79	2.11	2.46	66.1	1.33	1.56	1.83	2.07	2.07	1.70	208
COVID19_UNKNOWN MFR	Cholesterol analyses	0	0.12	0.81	2.02	0.4
COVID19_JANSSEN	Choreiform movements	0	0.27	0.77	1.47	1.3
COVID19_MODERNA	Choreiform movements	4	0.46	0.92	1.50	4.3	0.43	0.88	1.66	0.47	0.47	0.20	29
COVID19_PFIZER/BIONTECH	Choreiform movements	5	0.55	1.04	1.66	4.4	0.52	1.01	1.83	0.73	0.73	0.33	28
COVID19_UNKNOWN MFR	Choreiform movements	0	0.35	0.99	1.90	0.0
COVID19_JANSSEN	Choroid and vitreous haemorrhages and vascular disorders	1	0.19	1.03	2.44	1.0	0.28	0.84	2.08	1.54	1.54	0.28	10
COVID19_MODERNA	Choroid and vitreous haemorrhages and vascular disorders	0	0.02	0.30	0.88	2.5
COVID19_PFIZER/BIONTECH	Choroid and vitreous haemorrhages and vascular disorders	2	0.23	0.83	1.74	2.6	0.31	0.77	1.66	0.91	0.91	0.25	9
COVID19_UNKNOWN MFR	Choroid and vitreous haemorrhages and vascular disorders	0	0.06	0.98	2.90	0.0
COVID19_JANSSEN	Choroid and vitreous structural change, deposit and degeneration	32	1.28	1.74	2.27	18.6	1.21	1.62	2.13	2.01	2.01	1.48	246
COVID19_MODERNA	Choroid and vitreous structural change, deposit and degeneration	74	0.86	1.05	1.26	73.2	0.83	1.00	1.21	1.23	1.23	0.99	204
COVID19_PFIZER/BIONTECH	Choroid and vitreous structural change, deposit and degeneration	86	1.19	1.43	1.69	62.5	1.13	1.36	1.61	1.83	1.83	1.48	192
COVID19_UNKNOWN MFR	Choroid and vitreous structural change, deposit and degeneration	0	0.07	0.75	2.02	0.5
COVID19_JANSSEN	Chromosomal abnormalities NEC	2	0.36	1.51	3.29	1.0	0.47	1.19	2.65	2.38	2.38	0.68	13
COVID19_MODERNA	Chromosomal abnormalities NEC	2	0.18	0.75	1.64	2.1	0.35	0.87	1.87	0.52	0.52	0.15	13
COVID19_PFIZER/BIONTECH	Chromosomal abnormalities NEC	1	0.06	0.44	1.10	2.5	0.17	0.55	1.39	0.29	0.29	0.05	14
COVID19_UNKNOWN MFR	Chromosomal abnormalities NEC	0	0.01	0.96	3.39	0.0
COVID19_JANSSEN	Chromosome analyses	0	0.02	0.18	0.46	6.8
COVID19_MODERNA	Chromosome analyses	6	0.17	0.35	0.58	22.3	0.16	0.31	0.55	0.10	0.10	0.05	196
COVID19_PFIZER/BIONTECH	Chromosome analyses	11	0.32	0.55	0.83	25.1	0.29	0.47	0.72	0.24	0.24	0.14	191
COVID19_UNKNOWN MFR	Chromosome analyses	0	0.10	0.89	2.35	0.2
COVID19_JANSSEN	Chronic polyneuropathies	4	0.16	0.43	0.80	11.0	0.20	0.43	0.82	0.39	0.39	0.17	160
COVID19_MODERNA	Chronic polyneuropathies	4	0.05	0.14	0.26	30.9	0.07	0.16	0.32	0.09	0.09	0.04	160
COVID19_PFIZER/BIONTECH	Chronic polyneuropathies	15	0.31	0.50	0.72	31.1	0.33	0.50	0.74	0.41	0.41	0.26	149
COVID19_UNKNOWN MFR	Chronic polyneuropathies	0	0.01	0.70	2.46	0.3
COVID19_JANSSEN	Circulatory collapse and shock	24	0.68	0.98	1.32	28.6	0.60	0.83	1.14	0.71	0.71	0.50	523
COVID19_MODERNA	Circulatory collapse and shock	39	0.42	0.56	0.71	79.4	0.38	0.50	0.64	0.26	0.26	0.20	508
COVID19_PFIZER/BIONTECH	Circulatory collapse and shock	73	0.83	1.01	1.22	83.1	0.72	0.88	1.06	0.63	0.63	0.51	474
COVID19_UNKNOWN MFR	Circulatory collapse and shock	0	0.05	0.66	1.88	0.6
COVID19_JANSSEN	Clostridia infections	2	0.15	0.59	1.26	4.0	0.23	0.60	1.29	0.41	0.41	0.13	76
COVID19_MODERNA	Clostridia infections	18	0.67	1.02	1.44	18.3	0.66	0.96	1.37	1.02	1.02	0.66	60
COVID19_PFIZER/BIONTECH	Clostridia infections	22	1.02	1.49	2.04	15.5	0.95	1.34	1.85	1.61	1.61	1.06	56
COVID19_UNKNOWN MFR	Clostridia infections	0	0.02	0.87	2.84	0.1
COVID19_JANSSEN	Coagulation and bleeding analyses	544	3.14	3.38	3.62	182.7	2.75	2.96	3.17	3.92	3.96	3.66	2143
COVID19_MODERNA	Coagulation and bleeding analyses	624	0.88	0.94	1.00	726.9	0.80	0.86	0.92	1.03	1.03	0.95	2063
COVID19_PFIZER/BIONTECH	Coagulation and bleeding analyses	809	1.36	1.44	1.52	624.0	1.22	1.30	1.37	1.76	1.77	1.65	1878
COVID19_UNKNOWN MFR	Coagulation and bleeding analyses	15	1.87	2.95	4.22	4.4	1.70	2.67	4.22	3.86	3.91	2.55	2672
COVID19_JANSSEN	Coagulation disorders congenital	8	1.01	1.85	2.90	3.3	1.01	1.78	3.00	3.34	3.34	1.76	37
COVID19_MODERNA	Coagulation disorders congenital	12	0.60	0.99	1.45	12.2	0.60	0.95	1.45	1.24	1.24	0.71	33
COVID19_PFIZER/BIONTECH	Coagulation disorders congenital	12	0.67	1.10	1.62	10.8	0.67	1.06	1.61	1.49	1.49	0.86	33
COVID19_UNKNOWN MFR	Coagulation disorders congenital	0	0.19	0.97	2.23	0.1
COVID19_JANSSEN	Coagulation factor deficiencies	0	0.05	0.82	2.38	0.2
COVID19_MODERNA	Coagulation factor deficiencies	2	0.43	1.55	3.22	1.1	0.46	1.15	2.55	3.40	3.40	0.66	2
COVID19_PFIZER/BIONTECH	Coagulation factor deficiencies	0	0.04	0.58	1.69	0.8
COVID19_UNKNOWN MFR	Coagulation factor deficiencies	0	0.06	1.00	2.89	0.0

Plain text view

Sheet: Masked
Vaccine Type + Manufacturer | Event: HLT | N | ER05 | ERAM | ER95 | E | EB05 | EBGM | EB95 | PRR | ROR | ROR05 | PRR_B
COVID19_MODERNA | Coronary artery disorders NEC | 73 | 1.38 | 1.69 | 2.03 | 64.3 | 0.93 | 1.12 | 1.35 | 1.37 | 1.37 | 1.09 | 181
COVID19_PFIZER/BIONTECH | Coronary artery disorders NEC | 90 | 2.01 | 2.41 | 2.84 | 56.4 | 1.31 | 1.56 | 1.85 | 2.25 | 2.25 | 1.81 | 164
COVID19_JANSSEN | Death and sudden death | 303 | 1.39 | 1.53 | 1.68 | 303.1 | 0.91 | 1.00 | 1.10 | 0.71 | 0.71 | 0.64 | 6612
COVID19_MODERNA | Death and sudden death | 1903 | 2.08 | 2.16 | 2.25 | 1387.9 | 1.32 | 1.37 | 1.42 | 1.29 | 1.29 | 1.24 | 5012
COVID19_PFIZER/BIONTECH | Death and sudden death | 1984 | 2.35 | 2.44 | 2.53 | 1278.3 | 1.49 | 1.55 | 1.61 | 1.65 | 1.66 | 1.59 | 4931
COVID19_MODERNA | Dementia (excl Alzheimer's type) | 43 | 1.94 | 2.54 | 3.20 | 29.8 | 1.08 | 1.40 | 1.77 | 1.64 | 1.64 | 1.21 | 89
COVID19_PFIZER/BIONTECH | Dementia (excl Alzheimer's type) | 52 | 2.54 | 3.23 | 4.00 | 27.1 | 1.45 | 1.83 | 2.28 | 2.66 | 2.66 | 1.99 | 80
COVID19_MODERNA | Device issues NEC | 123 | 8.62 | 10.07 | 11.60 | 36.9 | 2.77 | 3.22 | 3.74 | 4.69 | 4.70 | 3.74 | 89
COVID19_PFIZER/BIONTECH | Exposures to agents or circumstances NEC | 244 | 5.19 | 5.79 | 6.41 | 81.7 | 2.64 | 2.94 | 3.26 | 6.70 | 6.72 | 5.66 | 149
COVID19_MODERNA | Herpes viral infections | 1159 | 1.05 | 1.10 | 1.15 | 2368.4 | 0.47 | 0.49 | 0.51 | 0.28 | 0.28 | 0.26 | 13891
COVID19_PFIZER/BIONTECH | Herpes viral infections | 1380 | 1.28 | 1.34 | 1.40 | 2501.7 | 0.53 | 0.55 | 0.58 | 0.41 | 0.41 | 0.39 | 13670
COVID19_MODERNA | Intentional product use issues | 22 | 3.68 | 5.41 | 7.41 | 7.6 | 1.72 | 2.46 | 3.49 | 14.94 | 14.94 | 6.61 | 5
COVID19_JANSSEN | Non-site specific embolism and thrombosis | 514 | 7.16 | 7.71 | 8.27 | 111.8 | 4.25 | 4.58 | 4.92 | 6.92 | 7.01 | 6.42 | 1146
COVID19_MODERNA | Non-site specific embolism and thrombosis | 387 | 1.21 | 1.32 | 1.43 | 460.1 | 0.77 | 0.84 | 0.91 | 1.03 | 1.03 | 0.94 | 1273
COVID19_PFIZER/BIONTECH | Non-site specific embolism and thrombosis | 640 | 2.45 | 2.62 | 2.79 | 391.9 | 1.53 | 1.63 | 1.74 | 2.57 | 2.58 | 2.37 | 1020
COVID19_MODERNA | Noninfectious myocarditis | 130 | 1.27 | 1.48 | 1.70 | 133.9 | 0.84 | 0.97 | 1.11 | 0.97 | 0.97 | 0.83 | 454
COVID19_PFIZER/BIONTECH | Noninfectious myocarditis | 268 | 2.80 | 3.10 | 3.42 | 131.2 | 1.83 | 2.02 | 2.23 | 3.47 | 3.48 | 3.03 | 316
COVID19_JANSSEN | Off label uses | 91 | 5.30 | 6.35 | 7.48 | 34.9 | 2.10 | 2.51 | 2.97 | 3.41 | 3.42 | 2.82 | 412
COVID19_PFIZER/BIONTECH | Off label uses | 260 | 6.13 | 6.81 | 7.52 | 98.9 | 2.34 | 2.59 | 2.87 | 4.38 | 4.39 | 3.79 | 243
COVID19_JANSSEN | Peripheral embolism and thrombosis | 390 | 6.42 | 6.99 | 7.58 | 87.3 | 4.08 | 4.44 | 4.83 | 7.00 | 7.07 | 6.39 | 860
COVID19_MODERNA | Product distribution and storage issues | 614 | 24.88 | 26.63 | 28.42 | 49.5 | 11.56 | 12.36 | 13.20 | 11.78 | 11.83 | 10.28 | 177
COVID19_PFIZER/BIONTECH | Product distribution and storage issues | 41 | 1.74 | 2.29 | 2.91 | 41.1 | 0.76 | 0.99 | 1.26 | 0.22 | 0.22 | 0.17 | 750
COVID19_PFIZER/BIONTECH | Product preparation errors and issues | 580 | 3.91 | 4.19 | 4.48 | 236.3 | 2.28 | 2.44 | 2.61 | 1.95 | 1.95 | 1.80 | 1220
COVID19_PFIZER/BIONTECH | Sodium imbalance | 93 | 2.56 | 3.06 | 3.59 | 46.1 | 1.65 | 1.96 | 2.31 | 2.88 | 2.89 | 2.31 | 132

Sheet: All DECs
Vaccine Type + Manufacturer | Event: HLT | N | ER05 | ERAM | ER95 | E | EB05 | EBGM | EB95 | PRR | ROR | ROR05 | PRR_B
COVID19_JANSSEN | Abdominal and gastrointestinal infections | 47 | 0.84 | 1.09 | 1.36 | 62.0 | 0.60 | 0.76 | 0.96 | 0.68 | 0.68 | 0.53 | 1063
COVID19_MODERNA | Abdominal and gastrointestinal infections | 155 | 1.02 | 1.18 | 1.33 | 179.3 | 0.76 | 0.86 | 0.98 | 0.55 | 0.55 | 0.48 | 955
COVID19_PFIZER/BIONTECH | Abdominal and gastrointestinal infections | 291 | 2.06 | 2.28 | 2.50 | 180.5 | 1.45 | 1.60 | 1.76 | 1.45 | 1.46 | 1.30 | 819
COVID19_UNKNOWN MFR | Abdominal and gastrointestinal infections | 0 | 0.01 | 0.42 | 1.41 | 1.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal and gastrointestinal injuries NEC | 23 | 0.93 | 1.34 | 1.80 | 19.3 | 0.82 | 1.15 | 1.58 | 1.32 | 1.32 | 0.92 | 270
COVID19_MODERNA | Abdominal and gastrointestinal injuries NEC | 45 | 0.67 | 0.87 | 1.09 | 58.7 | 0.60 | 0.77 | 0.97 | 0.62 | 0.62 | 0.47 | 248
COVID19_PFIZER/BIONTECH | Abdominal and gastrointestinal injuries NEC | 58 | 0.95 | 1.19 | 1.46 | 54.8 | 0.84 | 1.05 | 1.29 | 1.01 | 1.01 | 0.79 | 235
COVID19_UNKNOWN MFR | Abdominal and gastrointestinal injuries NEC | 1 | 0.37 | 1.23 | 2.51 | 0.4 | 0.35 | 1.05 | 2.73 | 2.36 | 2.36 | 0.45 | 292
COVID19_JANSSEN | Abdominal findings abnormal | 10 | 1.16 | 2.09 | 3.24 | 4.6 | 1.03 | 1.72 | 2.74 | 1.72 | 1.72 | 0.99 | 90
COVID19_MODERNA | Abdominal findings abnormal | 16 | 0.63 | 0.99 | 1.42 | 17.0 | 0.62 | 0.92 | 1.34 | 0.65 | 0.65 | 0.41 | 84
COVID19_PFIZER/BIONTECH | Abdominal findings abnormal | 13 | 0.54 | 0.90 | 1.33 | 15.9 | 0.52 | 0.81 | 1.22 | 0.61 | 0.61 | 0.38 | 87
COVID19_UNKNOWN MFR | Abdominal findings abnormal | 0 | 0.01 | 0.85 | 3.03 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal hernias NEC | 1 | 0.26 | 1.23 | 2.77 | 0.5 | 0.33 | 1.00 | 2.54 | 1.19 | 1.19 | 0.22 | 13
COVID19_MODERNA | Abdominal hernias NEC | 3 | 0.43 | 1.20 | 2.27 | 2.6 | 0.44 | 0.97 | 1.95 | 0.93 | 0.93 | 0.32 | 11
COVID19_PFIZER/BIONTECH | Abdominal hernias NEC | 3 | 0.46 | 1.27 | 2.40 | 2.2 | 0.48 | 1.07 | 2.14 | 1.12 | 1.12 | 0.38 | 11
COVID19_UNKNOWN MFR | Abdominal hernias NEC | 0 | 0.10 | 0.99 | 2.67 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal therapeutic procedures NEC | 8 | 0.78 | 1.52 | 2.47 | 5.7 | 0.70 | 1.22 | 2.00 | 0.97 | 0.97 | 0.53 | 127
COVID19_MODERNA | Abdominal therapeutic procedures NEC | 18 | 0.66 | 1.01 | 1.43 | 19.3 | 0.63 | 0.92 | 1.31 | 0.52 | 0.52 | 0.34 | 117
COVID19_PFIZER/BIONTECH | Abdominal therapeutic procedures NEC | 24 | 0.99 | 1.43 | 1.94 | 19.4 | 0.85 | 1.19 | 1.62 | 0.89 | 0.89 | 0.61 | 111
COVID19_UNKNOWN MFR | Abdominal therapeutic procedures NEC | 1 | 0.29 | 2.23 | 5.69 | 0.1 | 0.40 | 1.31 | 5.13 | 5.13 | 5.14 | 0.99 | 134
COVID19_JANSSEN | Abdominal wall conditions NEC | 0 | 0.06 | 0.68 | 1.86 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Abdominal wall conditions NEC | 4 | 0.60 | 1.49 | 2.69 | 2.7 | 0.57 | 1.18 | 2.23 | 2.26 | 2.26 | 0.78 | 6
COVID19_PFIZER/BIONTECH | Abdominal wall conditions NEC | 4 | 0.66 | 1.63 | 2.95 | 2.1 | 0.64 | 1.33 | 2.55 | 2.73 | 2.73 | 0.94 | 6
COVID19_UNKNOWN MFR | Abdominal wall conditions NEC | 0 | 0.09 | 0.99 | 2.73 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Abnormal behaviour NEC | 27 | 0.55 | 0.77 | 1.01 | 41.8 | 0.48 | 0.65 | 0.88 | 0.24 | 0.24 | 0.18 | 1712
COVID19_MODERNA | Abnormal behaviour NEC | 89 | 0.77 | 0.92 | 1.09 | 108.7 | 0.69 | 0.82 | 0.97 | 0.18 | 0.18 | 0.15 | 1650
COVID19_PFIZER/BIONTECH | Abnormal behaviour NEC | 112 | 0.80 | 0.94 | 1.09 | 148.6 | 0.65 | 0.75 | 0.88 | 0.28 | 0.28 | 0.24 | 1627
COVID19_UNKNOWN MFR | Abnormal behaviour NEC | 0 | 0.21 | 0.75 | 1.58 | 1.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Abnormal food elimination | 0 | 0.06 | 0.86 | 2.48 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Abnormal food elimination | 0 | 0.04 | 0.62 | 1.79 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abnormal food elimination | 1 | 0.24 | 1.24 | 2.90 | 0.6 | 0.32 | 0.97 | 2.45 | 2.05 | 2.05 | 0.27 | 2
COVID19_UNKNOWN MFR | Abnormal food elimination | 0 | 0.07 | 1.00 | 2.88 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Abnormal gene carriers | 1 | 0.34 | 1.87 | 4.44 | 0.1 | 0.43 | 1.48 | 8.71 | 46.31 | 46.32 | 3.16 | 0
COVID19_MODERNA | Abnormal gene carriers | 0 | 0.04 | 0.82 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abnormal gene carriers | 0 | 0.04 | 0.84 | 2.50 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abnormal gene carriers | 0 | 0.05 | 1.00 | 2.98 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Abnormal reflexes | 13 | 0.36 | 0.60 | 0.89 | 29.0 | 0.30 | 0.47 | 0.71 | 0.42 | 0.42 | 0.27 | 477
COVID19_MODERNA | Abnormal reflexes | 29 | 0.31 | 0.43 | 0.57 | 81.7 | 0.27 | 0.37 | 0.49 | 0.21 | 0.21 | 0.16 | 461
COVID19_PFIZER/BIONTECH | Abnormal reflexes | 35 | 0.40 | 0.54 | 0.70 | 83.2 | 0.33 | 0.43 | 0.56 | 0.32 | 0.32 | 0.24 | 455
COVID19_UNKNOWN MFR | Abnormal reflexes | 1 | 0.22 | 1.31 | 3.14 | 0.7 | 0.31 | 0.93 | 2.32 | 1.41 | 1.41 | 0.27 | 489
COVID19_JANSSEN | Abnormal sleep-related events | 1 | 0.06 | 0.57 | 1.56 | 2.3 | 0.18 | 0.58 | 1.46 | 0.52 | 0.52 | 0.10 | 30
COVID19_MODERNA | Abnormal sleep-related events | 5 | 0.31 | 0.77 | 1.38 | 6.4 | 0.40 | 0.78 | 1.41 | 0.65 | 0.65 | 0.29 | 26
COVID19_PFIZER/BIONTECH | Abnormal sleep-related events | 8 | 0.65 | 1.29 | 2.10 | 6.4 | 0.65 | 1.13 | 1.85 | 1.42 | 1.42 | 0.73 | 23
COVID19_UNKNOWN MFR | Abnormal sleep-related events | 0 | 0.00 | 0.88 | 3.87 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Abortion related conditions and complications | 0 | 0.01 | 0.41 | 1.40 | 1.0 |  |  |  |  |  |  | 
COVID19_MODERNA | Abortion related conditions and complications | 6 | 0.66 | 1.43 | 2.45 | 3.7 | 0.71 | 1.31 | 2.30 | 3.40 | 3.40 | 1.31 | 6
COVID19_PFIZER/BIONTECH | Abortion related conditions and complications | 2 | 0.16 | 0.66 | 1.43 | 3.2 | 0.27 | 0.68 | 1.47 | 0.82 | 0.82 | 0.23 | 10
COVID19_UNKNOWN MFR | Abortion related conditions and complications | 0 | 0.02 | 0.97 | 3.33 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Abortions not specified as induced or spontaneous | 0 | 0.00 | 0.12 | 0.53 | 2.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Abortions not specified as induced or spontaneous | 7 | 0.43 | 0.89 | 1.49 | 11.1 | 0.37 | 0.66 | 1.11 | 0.68 | 0.68 | 0.34 | 35
COVID19_PFIZER/BIONTECH | Abortions not specified as induced or spontaneous | 7 | 0.43 | 0.90 | 1.51 | 11.1 | 0.37 | 0.66 | 1.11 | 0.82 | 0.82 | 0.41 | 35
COVID19_UNKNOWN MFR | Abortions not specified as induced or spontaneous | 0 | 0.00 | 0.86 | 3.70 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Abortions spontaneous | 34 | 0.47 | 0.64 | 0.82 | 55.4 | 0.47 | 0.62 | 0.81 | 0.87 | 0.87 | 0.65 | 604
COVID19_MODERNA | Abortions spontaneous | 172 | 0.75 | 0.85 | 0.96 | 206.9 | 0.73 | 0.83 | 0.94 | 1.25 | 1.25 | 1.08 | 466
COVID19_PFIZER/BIONTECH | Abortions spontaneous | 238 | 1.17 | 1.31 | 1.45 | 186.4 | 1.14 | 1.27 | 1.41 | 2.44 | 2.44 | 2.13 | 400
COVID19_UNKNOWN MFR | Abortions spontaneous | 0 | 0.02 | 0.47 | 1.43 | 1.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Absence seizures | 5 | 0.40 | 0.88 | 1.52 | 7.4 | 0.36 | 0.70 | 1.25 | 0.41 | 0.41 | 0.19 | 190
COVID19_MODERNA | Absence seizures | 6 | 0.25 | 0.51 | 0.85 | 15.1 | 0.24 | 0.45 | 0.78 | 0.11 | 0.11 | 0.05 | 189
COVID19_PFIZER/BIONTECH | Absence seizures | 14 | 0.54 | 0.86 | 1.25 | 20.9 | 0.44 | 0.68 | 1.01 | 0.32 | 0.32 | 0.20 | 181
COVID19_UNKNOWN MFR | Absence seizures | 1 | 0.35 | 1.52 | 3.35 | 0.2 | 0.39 | 1.24 | 4.01 | 3.55 | 3.55 | 0.68 | 194
COVID19_JANSSEN | Accelerated and malignant hypertension | 11 | 0.94 | 1.58 | 2.36 | 8.2 | 0.76 | 1.22 | 1.89 | 1.45 | 1.45 | 0.86 | 117
COVID19_MODERNA | Accelerated and malignant hypertension | 39 | 1.09 | 1.44 | 1.83 | 35.4 | 0.83 | 1.08 | 1.39 | 1.49 | 1.49 | 1.09 | 89
COVID19_PFIZER/BIONTECH | Accelerated and malignant hypertension | 51 | 1.73 | 2.20 | 2.72 | 29.6 | 1.32 | 1.66 | 2.07 | 2.71 | 2.71 | 2.02 | 77
COVID19_UNKNOWN MFR | Accelerated and malignant hypertension | 0 | 0.17 | 0.93 | 2.18 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Accidental exposures to product | 13 | 0.58 | 0.97 | 1.43 | 18.4 | 0.46 | 0.71 | 1.07 | 0.72 | 0.72 | 0.45 | 280
COVID19_MODERNA | Accidental exposures to product | 7 | 0.14 | 0.28 | 0.46 | 34.1 | 0.13 | 0.24 | 0.40 | 0.08 | 0.08 | 0.04 | 286
COVID19_PFIZER/BIONTECH | Accidental exposures to product | 15 | 0.30 | 0.47 | 0.69 | 43.5 | 0.24 | 0.37 | 0.54 | 0.22 | 0.22 | 0.14 | 278
COVID19_UNKNOWN MFR | Accidental exposures to product | 1 | 0.23 | 1.59 | 3.95 | 0.5 | 0.34 | 1.03 | 2.63 | 2.36 | 2.36 | 0.45 | 292
COVID19_JANSSEN | Acnes | 22 | 0.65 | 0.95 | 1.29 | 28.2 | 0.55 | 0.78 | 1.08 | 0.75 | 0.75 | 0.53 | 451
COVID19_MODERNA | Acnes | 69 | 0.65 | 0.80 | 0.97 | 102.6 | 0.55 | 0.68 | 0.82 | 0.58 | 0.58 | 0.47 | 404
COVID19_PFIZER/BIONTECH | Acnes | 67 | 0.71 | 0.88 | 1.06 | 92.6 | 0.59 | 0.73 | 0.88 | 0.68 | 0.68 | 0.54 | 406
COVID19_UNKNOWN MFR | Acnes | 0 | 0.09 | 0.73 | 1.89 | 0.6 |  |  |  |  |  |  | 
COVID19_JANSSEN | Acquired immunodeficiency syndromes | 0 | 0.05 | 0.94 | 2.83 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Acquired immunodeficiency syndromes | 0 | 0.04 | 0.81 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acquired immunodeficiency syndromes | 0 | 0.04 | 0.84 | 2.51 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acquired immunodeficiency syndromes | 0 | 0.05 | 1.00 | 3.00 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Acute and chronic pancreatitis | 11 | 0.45 | 0.77 | 1.16 | 15.6 | 0.44 | 0.72 | 1.11 | 0.77 | 0.77 | 0.46 | 220
COVID19_MODERNA | Acute and chronic pancreatitis | 65 | 0.99 | 1.23 | 1.48 | 56.2 | 0.93 | 1.14 | 1.39 | 1.33 | 1.33 | 1.05 | 166
COVID19_PFIZER/BIONTECH | Acute and chronic pancreatitis | 75 | 1.31 | 1.60 | 1.91 | 49.8 | 1.22 | 1.47 | 1.77 | 1.97 | 1.97 | 1.56 | 156
COVID19_UNKNOWN MFR | Acute and chronic pancreatitis | 0 | 0.08 | 0.79 | 2.11 | 0.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Acute and chronic sarcoidosis | 1 | 0.12 | 0.60 | 1.40 | 2.9 | 0.15 | 0.51 | 1.28 | 0.48 | 0.48 | 0.09 | 32
COVID19_MODERNA | Acute and chronic sarcoidosis | 3 | 0.19 | 0.55 | 1.06 | 6.7 | 0.23 | 0.53 | 1.06 | 0.34 | 0.34 | 0.13 | 30
COVID19_PFIZER/BIONTECH | Acute and chronic sarcoidosis | 7 | 0.55 | 1.09 | 1.78 | 7.2 | 0.52 | 0.93 | 1.56 | 1.10 | 1.10 | 0.55 | 26
COVID19_UNKNOWN MFR | Acute and chronic sarcoidosis | 0 | 0.07 | 0.96 | 2.74 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Acute and chronic thyroiditis | 2 | 0.05 | 0.23 | 0.49 | 13.6 | 0.06 | 0.21 | 0.50 | 0.16 | 0.16 | 0.05 | 196
COVID19_MODERNA | Acute and chronic thyroiditis | 16 | 0.37 | 0.58 | 0.83 | 32.1 | 0.35 | 0.52 | 0.75 | 0.30 | 0.30 | 0.19 | 182
COVID19_PFIZER/BIONTECH | Acute and chronic thyroiditis | 32 | 0.79 | 1.08 | 1.41 | 35.7 | 0.67 | 0.89 | 1.17 | 0.79 | 0.79 | 0.57 | 166
COVID19_UNKNOWN MFR | Acute and chronic thyroiditis | 0 | 0.01 | 0.68 | 2.52 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Acute polyneuropathies | 61 | 0.71 | 0.88 | 1.07 | 118.4 | 0.42 | 0.52 | 0.64 | 0.55 | 0.55 | 0.45 | 1700
COVID19_MODERNA | Acute polyneuropathies | 99 | 0.37 | 0.44 | 0.52 | 372.1 | 0.23 | 0.27 | 0.32 | 0.20 | 0.20 | 0.17 | 1662
COVID19_PFIZER/BIONTECH | Acute polyneuropathies | 125 | 0.52 | 0.61 | 0.70 | 346.0 | 0.31 | 0.36 | 0.42 | 0.31 | 0.31 | 0.27 | 1636
COVID19_UNKNOWN MFR | Acute polyneuropathies | 4 | 0.71 | 1.91 | 3.58 | 3.0 | 0.53 | 1.10 | 2.07 | 1.57 | 1.57 | 0.69 | 1757
COVID19_JANSSEN | Adenoviral infections | 0 | 0.00 | 0.28 | 1.08 | 1.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Adenoviral infections | 2 | 0.13 | 0.58 | 1.28 | 2.0 | 0.35 | 0.88 | 1.89 | 0.16 | 0.16 | 0.05 | 43
COVID19_PFIZER/BIONTECH | Adenoviral infections | 2 | 0.12 | 0.54 | 1.19 | 4.0 | 0.23 | 0.59 | 1.29 | 0.19 | 0.19 | 0.06 | 43
COVID19_UNKNOWN MFR | Adenoviral infections | 0 | 0.00 | 0.94 | 3.60 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Adjustment disorders | 0 | 0.00 | 0.23 | 1.02 | 1.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Adjustment disorders | 0 | 0.00 | 0.08 | 0.36 | 3.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adjustment disorders | 2 | 0.13 | 0.61 | 1.38 | 2.6 | 0.31 | 0.77 | 1.67 | 0.59 | 0.59 | 0.17 | 14
COVID19_UNKNOWN MFR | Adjustment disorders | 0 | 0.00 | 0.94 | 4.09 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Administration site reactions NEC | 2 | 0.03 | 0.12 | 0.26 | 20.6 | 0.03 | 0.13 | 0.34 | 0.07 | 0.07 | 0.02 | 433
COVID19_MODERNA | Administration site reactions NEC | 29 | 0.25 | 0.35 | 0.46 | 72.4 | 0.30 | 0.41 | 0.55 | 0.24 | 0.24 | 0.18 | 406
COVID19_PFIZER/BIONTECH | Administration site reactions NEC | 9 | 0.07 | 0.13 | 0.21 | 67.3 | 0.08 | 0.15 | 0.24 | 0.09 | 0.09 | 0.05 | 426
COVID19_UNKNOWN MFR | Administration site reactions NEC | 0 | 0.01 | 0.57 | 1.92 | 0.5 |  |  |  |  |  |  | 
COVID19_JANSSEN | Adrenal cortex tests | 2 | 0.15 | 0.55 | 1.16 | 4.9 | 0.20 | 0.52 | 1.14 | 0.39 | 0.39 | 0.12 | 80
COVID19_MODERNA | Adrenal cortex tests | 12 | 0.47 | 0.79 | 1.18 | 16.6 | 0.46 | 0.73 | 1.11 | 0.58 | 0.58 | 0.35 | 70
COVID19_PFIZER/BIONTECH | Adrenal cortex tests | 12 | 0.51 | 0.86 | 1.29 | 15.6 | 0.49 | 0.77 | 1.17 | 0.70 | 0.70 | 0.42 | 70
COVID19_UNKNOWN MFR | Adrenal cortex tests | 0 | 0.05 | 0.91 | 2.73 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Adrenal cortical hyperfunctions | 1 | 0.22 | 1.34 | 3.26 | 0.5 | 0.33 | 1.00 | 2.53 | 1.40 | 1.40 | 0.25 | 11
COVID19_MODERNA | Adrenal cortical hyperfunctions | 1 | 0.12 | 0.74 | 1.79 | 1.5 | 0.24 | 0.73 | 1.80 | 0.31 | 0.31 | 0.06 | 11
COVID19_PFIZER/BIONTECH | Adrenal cortical hyperfunctions | 0 | 0.01 | 0.34 | 1.09 | 1.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adrenal cortical hyperfunctions | 0 | 0.03 | 0.98 | 3.12 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Adrenal cortical hypofunctions | 2 | 0.18 | 0.70 | 1.51 | 3.7 | 0.24 | 0.62 | 1.35 | 0.62 | 0.62 | 0.19 | 50
COVID19_MODERNA | Adrenal cortical hypofunctions | 9 | 0.48 | 0.89 | 1.41 | 11.3 | 0.47 | 0.80 | 1.28 | 0.71 | 0.71 | 0.39 | 43
COVID19_PFIZER/BIONTECH | Adrenal cortical hypofunctions | 9 | 0.52 | 0.97 | 1.53 | 10.6 | 0.50 | 0.84 | 1.34 | 0.86 | 0.86 | 0.47 | 43
COVID19_UNKNOWN MFR | Adrenal cortical hypofunctions | 0 | 0.02 | 0.91 | 3.03 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Adrenal gland disorders NEC | 3 | 0.52 | 1.16 | 1.99 | 2.0 | 0.50 | 1.11 | 2.23 | 1.60 | 1.60 | 0.59 | 29
COVID19_MODERNA | Adrenal gland disorders NEC | 10 | 0.69 | 1.16 | 1.72 | 8.8 | 0.64 | 1.06 | 1.67 | 1.54 | 1.54 | 0.82 | 22
COVID19_PFIZER/BIONTECH | Adrenal gland disorders NEC | 5 | 0.41 | 0.80 | 1.30 | 7.5 | 0.35 | 0.69 | 1.24 | 0.76 | 0.76 | 0.34 | 27
COVID19_UNKNOWN MFR | Adrenal gland disorders NEC | 0 | 0.30 | 0.99 | 1.99 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Adrenal gland therapeutic procedures | 0 | 0.05 | 0.94 | 2.81 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Adrenal gland therapeutic procedures | 0 | 0.04 | 0.82 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adrenal gland therapeutic procedures | 0 | 0.04 | 0.84 | 2.50 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adrenal gland therapeutic procedures | 0 | 0.05 | 1.00 | 2.98 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Adrenal medulla tests | 4 | 0.39 | 0.94 | 1.70 | 4.4 | 0.42 | 0.86 | 1.62 | 1.14 | 1.14 | 0.49 | 54
COVID19_MODERNA | Adrenal medulla tests | 26 | 1.10 | 1.55 | 2.07 | 17.4 | 1.02 | 1.41 | 1.91 | 2.76 | 2.76 | 1.79 | 32
COVID19_PFIZER/BIONTECH | Adrenal medulla tests | 16 | 0.72 | 1.12 | 1.59 | 14.8 | 0.69 | 1.04 | 1.51 | 1.56 | 1.56 | 0.96 | 42
COVID19_UNKNOWN MFR | Adrenal medulla tests | 0 | 0.10 | 0.94 | 2.52 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Adrenal neoplasms benign | 1 | 0.34 | 1.64 | 3.74 | 0.2 | 0.39 | 1.26 | 4.24 | 15.44 | 15.44 | 1.51 | 1
COVID19_MODERNA | Adrenal neoplasms benign | 1 | 0.27 | 1.32 | 3.01 | 0.7 | 0.31 | 0.93 | 2.32 | 3.40 | 3.40 | 0.33 | 1
COVID19_PFIZER/BIONTECH | Adrenal neoplasms benign | 0 | 0.07 | 0.76 | 2.11 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adrenal neoplasms benign | 0 | 0.09 | 1.00 | 2.76 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Adrenal neoplasms malignant | 0 | 0.05 | 0.94 | 2.83 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Adrenal neoplasms malignant | 0 | 0.04 | 0.81 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adrenal neoplasms malignant | 0 | 0.04 | 0.84 | 2.51 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adrenal neoplasms malignant | 0 | 0.05 | 1.00 | 3.00 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Adverse effect absent | 337 | 0.14 | 0.15 | 0.17 | 2115.8 | 0.15 | 0.16 | 0.18 | 0.09 | 0.08 | 0.07 | 58963
COVID19_MODERNA | Adverse effect absent | 1552 | 0.35 | 0.36 | 0.38 | 3937.4 | 0.38 | 0.39 | 0.41 | 0.09 | 0.08 | 0.08 | 57748
COVID19_PFIZER/BIONTECH | Adverse effect absent | 958 | 0.23 | 0.25 | 0.26 | 3584.4 | 0.25 | 0.27 | 0.28 | 0.07 | 0.06 | 0.06 | 58342
COVID19_UNKNOWN MFR | Adverse effect absent | 4 | 0.04 | 0.10 | 0.18 | 50.3 | 0.04 | 0.09 | 0.19 | 0.05 | 0.04 | 0.02 | 59296
COVID19_JANSSEN | Aeromonas infections | 0 | 0.03 | 0.88 | 2.75 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Aeromonas infections | 0 | 0.03 | 0.66 | 2.07 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aeromonas infections | 0 | 0.03 | 0.69 | 2.17 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aeromonas infections | 0 | 0.04 | 1.00 | 3.11 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Affect alterations NEC | 17 | 1.29 | 1.96 | 2.74 | 7.8 | 1.25 | 1.86 | 2.70 | 2.00 | 2.00 | 1.31 | 131
COVID19_MODERNA | Affect alterations NEC | 14 | 0.45 | 0.72 | 1.03 | 21.4 | 0.43 | 0.67 | 0.99 | 0.36 | 0.36 | 0.22 | 134
COVID19_PFIZER/BIONTECH | Affect alterations NEC | 18 | 0.56 | 0.84 | 1.16 | 22.6 | 0.54 | 0.79 | 1.13 | 0.57 | 0.57 | 0.38 | 130
COVID19_UNKNOWN MFR | Affect alterations NEC | 0 | 0.21 | 0.93 | 2.07 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Age related issues | 10 | 1.97 | 3.56 | 5.54 | 3.2 | 1.32 | 2.24 | 3.78 | 4.54 | 4.54 | 2.51 | 34
COVID19_MODERNA | Age related issues | 11 | 0.63 | 1.11 | 1.70 | 13.5 | 0.50 | 0.81 | 1.26 | 1.13 | 1.13 | 0.64 | 33
COVID19_PFIZER/BIONTECH | Age related issues | 14 | 0.99 | 1.63 | 2.39 | 11.4 | 0.75 | 1.15 | 1.71 | 1.91 | 1.91 | 1.12 | 30
COVID19_UNKNOWN MFR | Age related issues | 0 | 0.00 | 0.90 | 3.40 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Alcohol product use | 2 | 0.43 | 1.25 | 2.41 | 1.3 | 0.42 | 1.06 | 2.32 | 2.21 | 2.21 | 0.64 | 14
COVID19_MODERNA | Alcohol product use | 4 | 0.44 | 1.01 | 1.76 | 4.6 | 0.41 | 0.84 | 1.58 | 1.13 | 1.13 | 0.44 | 12
COVID19_PFIZER/BIONTECH | Alcohol product use | 5 | 0.60 | 1.26 | 2.14 | 4.0 | 0.56 | 1.09 | 1.96 | 1.86 | 1.86 | 0.77 | 11
COVID19_UNKNOWN MFR | Alcohol product use | 0 | 0.18 | 0.99 | 2.33 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Allergic conditions NEC | 139 | 0.52 | 0.60 | 0.69 | 274.6 | 0.44 | 0.51 | 0.58 | 0.47 | 0.47 | 0.41 | 4556
COVID19_MODERNA | Allergic conditions NEC | 607 | 0.69 | 0.74 | 0.79 | 945.3 | 0.60 | 0.64 | 0.69 | 0.50 | 0.50 | 0.47 | 4088
COVID19_PFIZER/BIONTECH | Allergic conditions NEC | 730 | 0.92 | 0.98 | 1.04 | 872.3 | 0.79 | 0.84 | 0.89 | 0.75 | 0.75 | 0.70 | 3965
COVID19_UNKNOWN MFR | Allergic conditions NEC | 1 | 0.10 | 0.39 | 0.81 | 6.7 | 0.05 | 0.26 | 0.73 | 0.15 | 0.15 | 0.03 | 4694
COVID19_JANSSEN | Allergies to foods, food additives, drugs and other chemicals | 20 | 0.23 | 0.34 | 0.47 | 79.3 | 0.18 | 0.27 | 0.37 | 0.21 | 0.21 | 0.15 | 1459
COVID19_MODERNA | Allergies to foods, food additives, drugs and other chemicals | 91 | 0.46 | 0.55 | 0.65 | 196.0 | 0.39 | 0.47 | 0.55 | 0.22 | 0.22 | 0.19 | 1388
COVID19_PFIZER/BIONTECH | Allergies to foods, food additives, drugs and other chemicals | 160 | 0.82 | 0.94 | 1.07 | 215.9 | 0.65 | 0.74 | 0.84 | 0.50 | 0.50 | 0.43 | 1319
COVID19_UNKNOWN MFR | Allergies to foods, food additives, drugs and other chemicals | 1 | 0.11 | 0.74 | 1.81 | 2.1 | 0.19 | 0.62 | 1.53 | 0.47 | 0.47 | 0.09 | 1478
COVID19_JANSSEN | Alopecias | 42 | 1.05 | 1.38 | 1.74 | 40.8 | 0.79 | 1.01 | 1.29 | 0.99 | 0.99 | 0.76 | 658
COVID19_MODERNA | Alopecias | 79 | 0.57 | 0.70 | 0.83 | 134.2 | 0.49 | 0.59 | 0.71 | 0.43 | 0.43 | 0.36 | 621
COVID19_PFIZER/BIONTECH | Alopecias | 82 | 0.68 | 0.82 | 0.98 | 127.2 | 0.54 | 0.65 | 0.77 | 0.54 | 0.54 | 0.45 | 618
COVID19_UNKNOWN MFR | Alopecias | 1 | 0.18 | 1.18 | 2.91 | 0.9 | 0.28 | 0.86 | 2.11 | 0.98 | 0.98 | 0.19 | 699
COVID19_JANSSEN | Alphaviral infections | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Alphaviral infections | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alphaviral infections | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alphaviral infections | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Alzheimer's disease (incl subtypes) | 1 | 0.21 | 0.86 | 1.87 | 1.2 | 0.26 | 0.78 | 1.93 | 0.74 | 0.74 | 0.14 | 21
COVID19_MODERNA | Alzheimer's disease (incl subtypes) | 9 | 0.76 | 1.37 | 2.13 | 6.4 | 0.74 | 1.24 | 2.00 | 2.35 | 2.35 | 1.15 | 13
COVID19_PFIZER/BIONTECH | Alzheimer's disease (incl subtypes) | 5 | 0.43 | 0.94 | 1.61 | 5.5 | 0.45 | 0.87 | 1.57 | 1.20 | 1.20 | 0.52 | 17
COVID19_UNKNOWN MFR | Alzheimer's disease (incl subtypes) | 0 | 0.14 | 0.98 | 2.46 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Amblyopic vision impairment | 1 | 0.30 | 0.95 | 1.89 | 1.1 | 0.27 | 0.81 | 1.99 | 0.81 | 0.81 | 0.15 | 19
COVID19_MODERNA | Amblyopic vision impairment | 1 | 0.16 | 0.51 | 1.01 | 3.9 | 0.11 | 0.41 | 1.07 | 0.18 | 0.18 | 0.03 | 19
COVID19_PFIZER/BIONTECH | Amblyopic vision impairment | 5 | 0.56 | 1.15 | 1.91 | 3.7 | 0.58 | 1.13 | 2.05 | 1.36 | 1.36 | 0.58 | 15
COVID19_UNKNOWN MFR | Amblyopic vision impairment | 0 | 0.24 | 0.99 | 2.17 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Amniotic fluid and cavity disorders of pregnancy NEC | 0 | 0.00 | 0.06 | 0.31 | 2.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Amniotic fluid and cavity disorders of pregnancy NEC | 3 | 0.10 | 0.35 | 0.72 | 12.1 | 0.13 | 0.32 | 0.66 | 0.24 | 0.24 | 0.09 | 42
COVID19_PFIZER/BIONTECH | Amniotic fluid and cavity disorders of pregnancy NEC | 3 | 0.11 | 0.37 | 0.77 | 11.3 | 0.14 | 0.34 | 0.70 | 0.29 | 0.29 | 0.11 | 42
COVID19_UNKNOWN MFR | Amniotic fluid and cavity disorders of pregnancy NEC | 0 | 0.00 | 0.71 | 3.84 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Amoebic infections | 0 | 0.00 | 0.38 | 2.11 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Amoebic infections | 0 | 0.00 | 0.14 | 0.78 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amoebic infections | 0 | 0.00 | 0.16 | 0.89 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amoebic infections | 0 | 0.00 | 0.96 | 5.32 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Amyloidoses | 0 | 0.10 | 0.89 | 2.33 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Amyloidoses | 1 | 0.26 | 1.15 | 2.55 | 0.6 | 0.32 | 0.96 | 2.40 | 1.70 | 1.70 | 0.23 | 2
COVID19_PFIZER/BIONTECH | Amyloidoses | 1 | 0.27 | 1.20 | 2.67 | 0.4 | 0.35 | 1.05 | 2.72 | 2.05 | 2.05 | 0.27 | 2
COVID19_UNKNOWN MFR | Amyloidoses | 0 | 0.11 | 1.00 | 2.62 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anaemia deficiencies | 1 | 0.09 | 0.59 | 1.44 | 2.5 | 0.17 | 0.56 | 1.39 | 0.36 | 0.36 | 0.07 | 43
COVID19_MODERNA | Anaemia deficiencies | 4 | 0.23 | 0.61 | 1.12 | 8.6 | 0.25 | 0.53 | 1.00 | 0.34 | 0.34 | 0.14 | 40
COVID19_PFIZER/BIONTECH | Anaemia deficiencies | 8 | 0.58 | 1.13 | 1.82 | 8.2 | 0.54 | 0.94 | 1.54 | 0.91 | 0.91 | 0.48 | 36
COVID19_UNKNOWN MFR | Anaemia deficiencies | 0 | 0.02 | 0.93 | 3.07 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anaemias NEC | 25 | 0.67 | 0.96 | 1.28 | 30.5 | 0.59 | 0.82 | 1.11 | 0.68 | 0.68 | 0.48 | 570
COVID19_MODERNA | Anaemias NEC | 97 | 0.74 | 0.88 | 1.03 | 124.0 | 0.66 | 0.78 | 0.92 | 0.66 | 0.66 | 0.55 | 498
COVID19_PFIZER/BIONTECH | Anaemias NEC | 106 | 0.92 | 1.08 | 1.26 | 112.6 | 0.80 | 0.94 | 1.10 | 0.89 | 0.89 | 0.74 | 489
COVID19_UNKNOWN MFR | Anaemias NEC | 3 | 0.74 | 2.06 | 3.92 | 0.8 | 0.70 | 1.64 | 3.85 | 3.49 | 3.49 | 1.35 | 592
COVID19_JANSSEN | Anaemias congenital (excl haemoglobinopathies) | 1 | 0.34 | 1.87 | 4.44 | 0.0 | 0.44 | 1.66 | 12.37 | 46.31 | 46.32 | 3.16 | 0
COVID19_MODERNA | Anaemias congenital (excl haemoglobinopathies) | 0 | 0.04 | 0.82 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anaemias congenital (excl haemoglobinopathies) | 0 | 0.04 | 0.84 | 2.50 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaemias congenital (excl haemoglobinopathies) | 0 | 0.05 | 1.00 | 2.98 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anaemias due to chronic disorders | 0 | 0.09 | 0.88 | 2.37 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Anaemias due to chronic disorders | 2 | 0.49 | 1.64 | 3.34 | 1.0 | 0.46 | 1.16 | 2.59 | 6.79 | 6.79 | 0.91 | 1
COVID19_PFIZER/BIONTECH | Anaemias due to chronic disorders | 1 | 0.26 | 1.21 | 2.73 | 0.9 | 0.29 | 0.88 | 2.18 | 2.05 | 2.05 | 0.27 | 2
COVID19_UNKNOWN MFR | Anaemias due to chronic disorders | 0 | 0.10 | 1.00 | 2.68 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anaemias haemolytic NEC | 1 | 0.15 | 0.52 | 1.08 | 4.1 | 0.11 | 0.40 | 1.05 | 0.25 | 0.25 | 0.05 | 61
COVID19_MODERNA | Anaemias haemolytic NEC | 8 | 0.41 | 0.76 | 1.18 | 11.8 | 0.40 | 0.70 | 1.14 | 0.50 | 0.50 | 0.27 | 54
COVID19_PFIZER/BIONTECH | Anaemias haemolytic NEC | 20 | 1.12 | 1.65 | 2.26 | 11.8 | 1.08 | 1.55 | 2.18 | 1.95 | 1.95 | 1.25 | 42
COVID19_UNKNOWN MFR | Anaemias haemolytic NEC | 0 | 0.19 | 0.96 | 2.22 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anaemias haemolytic immune | 1 | 0.09 | 0.45 | 1.02 | 3.9 | 0.11 | 0.42 | 1.08 | 0.20 | 0.20 | 0.04 | 79
COVID19_MODERNA | Anaemias haemolytic immune | 13 | 0.65 | 1.07 | 1.58 | 12.9 | 0.63 | 0.98 | 1.47 | 0.66 | 0.66 | 0.40 | 67
COVID19_PFIZER/BIONTECH | Anaemias haemolytic immune | 9 | 0.42 | 0.76 | 1.19 | 12.9 | 0.42 | 0.71 | 1.14 | 0.52 | 0.52 | 0.29 | 71
COVID19_UNKNOWN MFR | Anaemias haemolytic immune | 0 | 0.08 | 0.92 | 2.53 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anaemias haemolytic mechanical factor | 0 | 0.00 | 0.31 | 1.34 | 0.8 |  |  |  |  |  |  | 
COVID19_MODERNA | Anaemias haemolytic mechanical factor | 0 | 0.00 | 0.22 | 0.96 | 1.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anaemias haemolytic mechanical factor | 2 | 0.23 | 1.09 | 2.47 | 2.5 | 0.31 | 0.78 | 1.69 | 0.24 | 0.24 | 0.07 | 34
COVID19_UNKNOWN MFR | Anaemias haemolytic mechanical factor | 0 | 0.00 | 0.94 | 4.14 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anaesthesia and allied procedures | 2 | 0.23 | 0.81 | 1.67 | 2.9 | 0.29 | 0.72 | 1.57 | 0.61 | 0.61 | 0.19 | 51
COVID19_MODERNA | Anaesthesia and allied procedures | 12 | 0.63 | 1.07 | 1.59 | 13.1 | 0.56 | 0.89 | 1.36 | 0.99 | 0.99 | 0.58 | 41
COVID19_PFIZER/BIONTECH | Anaesthesia and allied procedures | 13 | 0.79 | 1.30 | 1.92 | 11.4 | 0.69 | 1.08 | 1.62 | 1.33 | 1.33 | 0.79 | 40
COVID19_UNKNOWN MFR | Anaesthesia and allied procedures | 0 | 0.07 | 0.94 | 2.67 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anaesthetic and allied procedural complications | 0 | 0.05 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Anaesthetic and allied procedural complications | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anaesthetic and allied procedural complications | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaesthetic and allied procedural complications | 0 | 0.05 | 1.00 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anal and rectal disorders NEC | 0 | 0.05 | 0.47 | 1.28 | 1.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Anal and rectal disorders NEC | 1 | 0.09 | 0.43 | 0.98 | 3.7 | 0.12 | 0.43 | 1.12 | 0.10 | 0.10 | 0.02 | 35
COVID19_PFIZER/BIONTECH | Anal and rectal disorders NEC | 3 | 0.27 | 0.76 | 1.43 | 4.6 | 0.31 | 0.70 | 1.39 | 0.37 | 0.37 | 0.14 | 33
COVID19_UNKNOWN MFR | Anal and rectal disorders NEC | 0 | 0.09 | 0.97 | 2.63 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anal and rectal pains | 0 | 0.03 | 0.36 | 0.99 | 2.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Anal and rectal pains | 5 | 0.27 | 0.61 | 1.05 | 9.4 | 0.29 | 0.58 | 1.04 | 0.61 | 0.61 | 0.27 | 28
COVID19_PFIZER/BIONTECH | Anal and rectal pains | 13 | 0.96 | 1.58 | 2.32 | 7.9 | 0.93 | 1.46 | 2.19 | 2.66 | 2.66 | 1.48 | 20
COVID19_UNKNOWN MFR | Anal and rectal pains | 0 | 0.09 | 0.96 | 2.61 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anal and rectal signs and symptoms | 1 | 0.12 | 0.52 | 1.16 | 3.3 | 0.13 | 0.47 | 1.19 | 0.28 | 0.28 | 0.05 | 56
COVID19_MODERNA | Anal and rectal signs and symptoms | 15 | 0.68 | 1.08 | 1.55 | 13.6 | 0.70 | 1.06 | 1.55 | 1.21 | 1.21 | 0.74 | 42
COVID19_PFIZER/BIONTECH | Anal and rectal signs and symptoms | 17 | 0.91 | 1.40 | 1.98 | 11.7 | 0.91 | 1.34 | 1.93 | 1.74 | 1.74 | 1.08 | 40
COVID19_UNKNOWN MFR | Anal and rectal signs and symptoms | 0 | 0.11 | 0.95 | 2.48 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anal and rectal ulcers and perforation | 0 | 0.00 | 0.71 | 2.84 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Anal and rectal ulcers and perforation | 0 | 0.00 | 0.40 | 1.59 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anal and rectal ulcers and perforation | 0 | 0.00 | 0.43 | 1.73 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal and rectal ulcers and perforation | 0 | 0.00 | 0.99 | 3.95 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anal canal neoplasms malignant | 0 | 0.02 | 0.81 | 2.65 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Anal canal neoplasms malignant | 0 | 0.01 | 0.54 | 1.75 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anal canal neoplasms malignant | 0 | 0.02 | 0.57 | 1.87 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal canal neoplasms malignant | 0 | 0.03 | 1.00 | 3.24 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Analgesia supportive care | 2 | 0.42 | 1.19 | 2.28 | 1.4 | 0.41 | 1.03 | 2.25 | 1.72 | 1.72 | 0.50 | 18
COVID19_MODERNA | Analgesia supportive care | 2 | 0.23 | 0.64 | 1.22 | 4.8 | 0.20 | 0.53 | 1.15 | 0.38 | 0.38 | 0.11 | 18
COVID19_PFIZER/BIONTECH | Analgesia supportive care | 3 | 0.34 | 0.84 | 1.52 | 4.2 | 0.33 | 0.73 | 1.46 | 0.72 | 0.72 | 0.26 | 17
COVID19_UNKNOWN MFR | Analgesia supportive care | 0 | 0.20 | 0.99 | 2.26 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anaphylactic and anaphylactoid responses | 87 | 0.60 | 0.72 | 0.86 | 164.0 | 0.45 | 0.53 | 0.63 | 0.56 | 0.56 | 0.47 | 2397
COVID19_MODERNA | Anaphylactic and anaphylactoid responses | 492 | 1.09 | 1.18 | 1.27 | 553.1 | 0.83 | 0.89 | 0.96 | 0.84 | 0.84 | 0.77 | 1992
COVID19_PFIZER/BIONTECH | Anaphylactic and anaphylactoid responses | 748 | 1.85 | 1.97 | 2.09 | 509.9 | 1.38 | 1.46 | 1.55 | 1.76 | 1.77 | 1.65 | 1736
COVID19_UNKNOWN MFR | Anaphylactic and anaphylactoid responses | 4 | 0.53 | 1.25 | 2.22 | 3.8 | 0.46 | 0.96 | 1.80 | 1.11 | 1.11 | 0.49 | 2480
COVID19_JANSSEN | Anaplastic large cell lymphomas T- and null-cell types | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Anaplastic large cell lymphomas T- and null-cell types | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anaplastic large cell lymphomas T- and null-cell types | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaplastic large cell lymphomas T- and null-cell types | 0 | 0.05 | 1.00 | 3.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Aneurysms and dissections non-site specific | 4 | 0.59 | 1.44 | 2.58 | 2.3 | 0.61 | 1.27 | 2.42 | 2.06 | 2.06 | 0.86 | 30
COVID19_MODERNA | Aneurysms and dissections non-site specific | 12 | 0.77 | 1.29 | 1.92 | 9.1 | 0.76 | 1.21 | 1.85 | 1.85 | 1.85 | 1.03 | 22
COVID19_PFIZER/BIONTECH | Aneurysms and dissections non-site specific | 11 | 0.79 | 1.36 | 2.05 | 7.7 | 0.79 | 1.28 | 1.98 | 1.96 | 1.96 | 1.07 | 23
COVID19_UNKNOWN MFR | Aneurysms and dissections non-site specific | 0 | 0.10 | 0.96 | 2.54 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Angioedemas | 39 | 0.54 | 0.71 | 0.90 | 60.4 | 0.50 | 0.65 | 0.84 | 0.65 | 0.65 | 0.50 | 929
COVID19_MODERNA | Angioedemas | 234 | 1.00 | 1.12 | 1.24 | 223.1 | 0.94 | 1.05 | 1.16 | 1.08 | 1.08 | 0.96 | 734
COVID19_PFIZER/BIONTECH | Angioedemas | 235 | 1.14 | 1.27 | 1.41 | 199.2 | 1.06 | 1.18 | 1.31 | 1.31 | 1.31 | 1.16 | 733
COVID19_UNKNOWN MFR | Angioedemas | 0 | 0.14 | 0.64 | 1.46 | 1.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anorectal therapeutic procedures | 2 | 0.59 | 2.05 | 4.22 | 0.5 | 0.56 | 1.48 | 4.02 | 7.72 | 7.72 | 1.86 | 4
COVID19_MODERNA | Anorectal therapeutic procedures | 1 | 0.17 | 0.86 | 1.98 | 1.3 | 0.25 | 0.77 | 1.88 | 0.68 | 0.68 | 0.11 | 5
COVID19_PFIZER/BIONTECH | Anorectal therapeutic procedures | 0 | 0.04 | 0.50 | 1.42 | 1.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anorectal therapeutic procedures | 0 | 0.08 | 0.99 | 2.79 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anterior pituitary hyperfunction | 0 | 0.00 | 0.19 | 1.09 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Anterior pituitary hyperfunction | 0 | 0.00 | 0.06 | 0.34 | 1.6 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anterior pituitary hyperfunction | 0 | 0.00 | 0.07 | 0.39 | 1.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anterior pituitary hyperfunction | 0 | 0.00 | 0.91 | 5.27 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anterior pituitary hypofunction | 0 | 0.11 | 0.80 | 2.01 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Anterior pituitary hypofunction | 2 | 0.36 | 1.13 | 2.23 | 1.1 | 0.45 | 1.14 | 2.52 | 1.36 | 1.36 | 0.34 | 5
COVID19_PFIZER/BIONTECH | Anterior pituitary hypofunction | 1 | 0.21 | 0.88 | 1.91 | 1.2 | 0.26 | 0.80 | 1.96 | 0.68 | 0.68 | 0.12 | 6
COVID19_UNKNOWN MFR | Anterior pituitary hypofunction | 0 | 0.14 | 0.99 | 2.50 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Antiinfective therapies | 1 | 0.26 | 0.90 | 1.84 | 1.2 | 0.26 | 0.80 | 1.96 | 0.86 | 0.86 | 0.16 | 18
COVID19_MODERNA | Antiinfective therapies | 9 | 0.82 | 1.45 | 2.23 | 5.9 | 0.78 | 1.33 | 2.13 | 3.06 | 3.06 | 1.44 | 10
COVID19_PFIZER/BIONTECH | Antiinfective therapies | 5 | 0.50 | 1.05 | 1.76 | 5.0 | 0.48 | 0.93 | 1.68 | 1.46 | 1.46 | 0.62 | 14
COVID19_UNKNOWN MFR | Antiinfective therapies | 0 | 0.20 | 0.99 | 2.26 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anxiety disorders NEC | 3 | 0.28 | 0.87 | 1.72 | 3.9 | 0.35 | 0.78 | 1.55 | 0.77 | 0.77 | 0.29 | 60
COVID19_MODERNA | Anxiety disorders NEC | 15 | 0.93 | 1.48 | 2.15 | 9.4 | 0.95 | 1.44 | 2.12 | 1.06 | 1.06 | 0.65 | 48
COVID19_PFIZER/BIONTECH | Anxiety disorders NEC | 5 | 0.23 | 0.53 | 0.94 | 10.3 | 0.27 | 0.54 | 0.97 | 0.35 | 0.35 | 0.16 | 58
COVID19_UNKNOWN MFR | Anxiety disorders NEC | 0 | 0.02 | 0.90 | 3.00 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Anxiety symptoms | 631 | 1.48 | 1.58 | 1.68 | 516.4 | 1.14 | 1.22 | 1.30 | 1.45 | 1.46 | 1.36 | 6708
COVID19_MODERNA | Anxiety symptoms | 1791 | 1.17 | 1.21 | 1.26 | 1874.5 | 0.92 | 0.96 | 0.99 | 1.10 | 1.10 | 1.05 | 5548
COVID19_PFIZER/BIONTECH | Anxiety symptoms | 2451 | 1.86 | 1.92 | 1.99 | 1643.0 | 1.44 | 1.49 | 1.54 | 2.05 | 2.08 | 1.99 | 4888
COVID19_UNKNOWN MFR | Anxiety symptoms | 8 | 0.50 | 0.95 | 1.50 | 11.3 | 0.42 | 0.72 | 1.18 | 0.75 | 0.75 | 0.42 | 7331
COVID19_JANSSEN | Aortic aneurysms and dissections | 4 | 0.63 | 1.66 | 3.09 | 2.0 | 0.65 | 1.36 | 2.62 | 1.72 | 1.72 | 0.72 | 36
COVID19_MODERNA | Aortic aneurysms and dissections | 12 | 0.72 | 1.23 | 1.85 | 10.2 | 0.70 | 1.11 | 1.69 | 1.46 | 1.46 | 0.83 | 28
COVID19_PFIZER/BIONTECH | Aortic aneurysms and dissections | 14 | 1.01 | 1.64 | 2.40 | 8.7 | 0.93 | 1.44 | 2.14 | 2.20 | 2.20 | 1.28 | 26
COVID19_UNKNOWN MFR | Aortic aneurysms and dissections | 0 | 0.02 | 0.91 | 3.06 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Aortic embolism and thrombosis | 2 | 0.49 | 1.77 | 3.70 | 0.7 | 0.52 | 1.31 | 3.07 | 3.43 | 3.43 | 0.95 | 9
COVID19_MODERNA | Aortic embolism and thrombosis | 2 | 0.24 | 0.86 | 1.79 | 3.5 | 0.25 | 0.64 | 1.40 | 0.76 | 0.76 | 0.21 | 9
COVID19_PFIZER/BIONTECH | Aortic embolism and thrombosis | 6 | 1.03 | 2.19 | 3.71 | 2.7 | 0.84 | 1.58 | 2.81 | 4.91 | 4.91 | 1.81 | 5
COVID19_UNKNOWN MFR | Aortic embolism and thrombosis | 1 | 0.35 | 1.92 | 4.51 | 0.0 | 0.44 | 1.71 | 13.62 | 68.78 | 68.86 | 12.26 | 10
COVID19_JANSSEN | Aortic infections and inflammations | 0 | 0.07 | 0.91 | 2.55 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Aortic infections and inflammations | 1 | 0.27 | 1.33 | 3.05 | 0.7 | 0.31 | 0.95 | 2.36 | 3.40 | 3.40 | 0.33 | 1
COVID19_PFIZER/BIONTECH | Aortic infections and inflammations | 0 | 0.06 | 0.76 | 2.12 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortic infections and inflammations | 0 | 0.08 | 1.00 | 2.79 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Aortic necrosis and vascular insufficiency | 2 | 0.41 | 1.57 | 3.35 | 1.8 | 0.37 | 0.93 | 2.02 | 0.74 | 0.74 | 0.22 | 42
COVID19_MODERNA | Aortic necrosis and vascular insufficiency | 14 | 1.11 | 1.81 | 2.65 | 13.3 | 0.66 | 1.01 | 1.50 | 1.59 | 1.59 | 0.93 | 30
COVID19_PFIZER/BIONTECH | Aortic necrosis and vascular insufficiency | 21 | 2.35 | 3.47 | 4.78 | 10.8 | 1.22 | 1.74 | 2.44 | 3.74 | 3.74 | 2.28 | 23
COVID19_UNKNOWN MFR | Aortic necrosis and vascular insufficiency | 1 | 0.34 | 2.09 | 5.08 | 0.1 | 0.42 | 1.46 | 8.23 | 16.00 | 16.01 | 3.03 | 43
COVID19_JANSSEN | Aortic therapeutic procedures | 1 | 0.27 | 1.44 | 3.38 | 0.6 | 0.33 | 0.98 | 2.47 | 3.09 | 3.09 | 0.51 | 5
COVID19_MODERNA | Aortic therapeutic procedures | 0 | 0.03 | 0.44 | 1.29 | 1.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aortic therapeutic procedures | 3 | 0.63 | 1.81 | 3.49 | 1.5 | 0.57 | 1.30 | 2.66 | 4.09 | 4.09 | 1.07 | 3
COVID19_UNKNOWN MFR | Aortic therapeutic procedures | 0 | 0.06 | 0.99 | 2.90 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Aortic valvular disorders | 5 | 0.97 | 2.19 | 3.81 | 1.6 | 0.91 | 1.83 | 3.64 | 2.34 | 2.34 | 1.06 | 33
COVID19_MODERNA | Aortic valvular disorders | 9 | 0.50 | 0.91 | 1.43 | 10.4 | 0.51 | 0.85 | 1.37 | 1.05 | 1.05 | 0.56 | 29
COVID19_PFIZER/BIONTECH | Aortic valvular disorders | 14 | 1.05 | 1.69 | 2.46 | 8.3 | 0.97 | 1.49 | 2.22 | 2.39 | 2.39 | 1.37 | 24
COVID19_UNKNOWN MFR | Aortic valvular disorders | 0 | 0.08 | 0.95 | 2.67 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Apocrine and eccrine gland disorders | 2897 | 1.88 | 1.94 | 2.00 | 1607.4 | 1.75 | 1.80 | 1.86 | 2.74 | 2.88 | 2.79 | 16353
COVID19_MODERNA | Apocrine and eccrine gland disorders | 5448 | 1.03 | 1.05 | 1.08 | 5532.1 | 0.96 | 0.99 | 1.01 | 1.34 | 1.35 | 1.32 | 13802
COVID19_PFIZER/BIONTECH | Apocrine and eccrine gland disorders | 5415 | 1.18 | 1.21 | 1.24 | 4800.5 | 1.10 | 1.13 | 1.15 | 1.60 | 1.63 | 1.59 | 13835
COVID19_UNKNOWN MFR | Apocrine and eccrine gland disorders | 46 | 1.13 | 1.45 | 1.80 | 32.8 | 1.07 | 1.36 | 1.72 | 1.65 | 1.68 | 1.31 | 19204
COVID19_JANSSEN | Appetite disorders | 845 | 1.57 | 1.66 | 1.76 | 552.8 | 1.44 | 1.53 | 1.61 | 1.34 | 1.35 | 1.27 | 9747
COVID19_MODERNA | Appetite disorders | 2759 | 1.15 | 1.19 | 1.23 | 2442.7 | 1.09 | 1.13 | 1.17 | 1.20 | 1.20 | 1.16 | 7833
COVID19_PFIZER/BIONTECH | Appetite disorders | 1954 | 0.98 | 1.02 | 1.06 | 2067.2 | 0.91 | 0.95 | 0.98 | 0.93 | 0.93 | 0.89 | 8638
COVID19_UNKNOWN MFR | Appetite disorders | 20 | 0.98 | 1.42 | 1.94 | 14.2 | 0.92 | 1.32 | 1.86 | 1.30 | 1.31 | 0.90 | 10572
COVID19_JANSSEN | Application and instillation site reactions | 21 | 2.29 | 3.40 | 4.68 | 6.9 | 1.76 | 2.55 | 3.67 | 2.72 | 2.73 | 1.85 | 119
COVID19_MODERNA | Application and instillation site reactions | 1 | 0.01 | 0.10 | 0.26 | 16.8 | 0.01 | 0.08 | 0.31 | 0.02 | 0.02 | 0.01 | 139
COVID19_PFIZER/BIONTECH | Application and instillation site reactions | 8 | 0.25 | 0.49 | 0.80 | 19.9 | 0.25 | 0.44 | 0.72 | 0.25 | 0.25 | 0.14 | 132
COVID19_UNKNOWN MFR | Application and instillation site reactions | 0 | 0.01 | 0.81 | 2.81 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Arboviral infections NEC | 0 | 0.04 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Arboviral infections NEC | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arboviral infections NEC | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arboviral infections NEC | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Arterial disorders congenital | 0 | 0.00 | 0.33 | 1.51 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Arterial disorders congenital | 0 | 0.00 | 0.12 | 0.53 | 2.3 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arterial disorders congenital | 2 | 0.21 | 1.02 | 2.31 | 1.3 | 0.43 | 1.07 | 2.35 | 1.02 | 1.02 | 0.28 | 8
COVID19_UNKNOWN MFR | Arterial disorders congenital | 0 | 0.00 | 0.95 | 4.36 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Arterial infections and inflammations | 4 | 0.26 | 0.63 | 1.15 | 10.4 | 0.21 | 0.45 | 0.86 | 0.20 | 0.20 | 0.09 | 317
COVID19_MODERNA | Arterial infections and inflammations | 11 | 0.47 | 0.81 | 1.22 | 17.6 | 0.40 | 0.64 | 0.99 | 0.12 | 0.12 | 0.07 | 310
COVID19_PFIZER/BIONTECH | Arterial infections and inflammations | 7 | 0.21 | 0.42 | 0.69 | 27.2 | 0.16 | 0.29 | 0.50 | 0.09 | 0.09 | 0.05 | 314
COVID19_UNKNOWN MFR | Arterial infections and inflammations | 0 | 0.07 | 0.85 | 2.39 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Arterial therapeutic procedures (excl aortic) | 28 | 2.31 | 3.24 | 4.30 | 10.1 | 1.77 | 2.44 | 3.31 | 3.13 | 3.13 | 2.23 | 138
COVID19_MODERNA | Arterial therapeutic procedures (excl aortic) | 49 | 0.99 | 1.27 | 1.58 | 44.5 | 0.86 | 1.09 | 1.36 | 1.42 | 1.42 | 1.08 | 117
COVID19_PFIZER/BIONTECH | Arterial therapeutic procedures (excl aortic) | 55 | 1.38 | 1.75 | 2.16 | 36.7 | 1.17 | 1.46 | 1.80 | 2.03 | 2.03 | 1.55 | 111
COVID19_UNKNOWN MFR | Arterial therapeutic procedures (excl aortic) | 0 | 0.00 | 0.62 | 2.57 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Arthropathies NEC | 58 | 0.76 | 0.96 | 1.17 | 72.9 | 0.64 | 0.80 | 0.98 | 0.76 | 0.76 | 0.61 | 1186
COVID19_MODERNA | Arthropathies NEC | 171 | 0.60 | 0.68 | 0.77 | 280.6 | 0.54 | 0.61 | 0.69 | 0.54 | 0.54 | 0.47 | 1073
COVID19_PFIZER/BIONTECH | Arthropathies NEC | 223 | 0.93 | 1.05 | 1.16 | 246.4 | 0.81 | 0.90 | 1.01 | 0.89 | 0.89 | 0.79 | 1021
COVID19_UNKNOWN MFR | Arthropathies NEC | 1 | 0.12 | 0.75 | 1.82 | 1.9 | 0.21 | 0.65 | 1.60 | 0.55 | 0.55 | 0.11 | 1243
COVID19_JANSSEN | Aspergillus infections | 0 | 0.00 | 0.19 | 1.09 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Aspergillus infections | 0 | 0.00 | 0.06 | 0.34 | 2.1 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aspergillus infections | 0 | 0.00 | 0.07 | 0.39 | 1.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspergillus infections | 0 | 0.00 | 0.91 | 5.09 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Asthenic conditions | 9518 | 1.56 | 1.59 | 1.62 | 6504.1 | 1.44 | 1.46 | 1.49 | 1.76 | 2.03 | 1.99 | 83382
COVID19_MODERNA | Asthenic conditions | 28056 | 1.14 | 1.15 | 1.16 | 26272.6 | 1.06 | 1.07 | 1.08 | 1.47 | 1.59 | 1.57 | 64844
COVID19_PFIZER/BIONTECH | Asthenic conditions | 24764 | 1.20 | 1.21 | 1.22 | 22060.1 | 1.11 | 1.12 | 1.13 | 1.49 | 1.62 | 1.59 | 68136
COVID19_UNKNOWN MFR | Asthenic conditions | 188 | 1.17 | 1.32 | 1.49 | 151.5 | 1.09 | 1.23 | 1.39 | 1.40 | 1.50 | 1.31 | 92712
COVID19_JANSSEN | Astroviral infections | 0 | 0.00 | 0.76 | 3.20 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Astroviral infections | 0 | 0.00 | 0.46 | 1.93 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Astroviral infections | 0 | 0.00 | 0.50 | 2.09 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Astroviral infections | 0 | 0.00 | 0.99 | 4.17 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Atmospheric pressure injuries | 0 | 0.10 | 0.78 | 2.02 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Atmospheric pressure injuries | 3 | 0.54 | 1.45 | 2.72 | 1.3 | 0.61 | 1.37 | 2.85 | 2.55 | 2.55 | 0.73 | 4
COVID19_PFIZER/BIONTECH | Atmospheric pressure injuries | 1 | 0.20 | 0.87 | 1.92 | 1.4 | 0.24 | 0.75 | 1.84 | 0.68 | 0.68 | 0.12 | 6
COVID19_UNKNOWN MFR | Atmospheric pressure injuries | 0 | 0.12 | 0.99 | 2.57 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Atopic disorders | 8 | 0.57 | 1.11 | 1.78 | 8.5 | 0.52 | 0.91 | 1.48 | 1.04 | 1.04 | 0.57 | 119
COVID19_MODERNA | Atopic disorders | 14 | 0.41 | 0.66 | 0.97 | 23.4 | 0.40 | 0.62 | 0.91 | 0.42 | 0.42 | 0.26 | 113
COVID19_PFIZER/BIONTECH | Atopic disorders | 27 | 0.89 | 1.26 | 1.67 | 24.4 | 0.79 | 1.08 | 1.45 | 1.11 | 1.11 | 0.77 | 100
COVID19_UNKNOWN MFR | Atopic disorders | 0 | 0.03 | 0.83 | 2.58 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Attention deficit and disruptive behaviour disorders | 5 | 0.62 | 1.42 | 2.50 | 3.7 | 0.59 | 1.14 | 2.06 | 0.89 | 0.89 | 0.42 | 87
COVID19_MODERNA | Attention deficit and disruptive behaviour disorders | 4 | 0.22 | 0.56 | 1.03 | 7.5 | 0.28 | 0.59 | 1.12 | 0.15 | 0.15 | 0.07 | 88
COVID19_PFIZER/BIONTECH | Attention deficit and disruptive behaviour disorders | 5 | 0.25 | 0.58 | 1.01 | 9.9 | 0.28 | 0.56 | 1.00 | 0.24 | 0.24 | 0.11 | 87
COVID19_UNKNOWN MFR | Attention deficit and disruptive behaviour disorders | 0 | 0.04 | 0.92 | 2.79 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Atypical mycobacterial infections | 0 | 0.01 | 0.56 | 1.84 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Atypical mycobacterial infections | 1 | 0.09 | 0.58 | 1.43 | 0.9 | 0.29 | 0.87 | 2.15 | 0.38 | 0.38 | 0.07 | 9
COVID19_PFIZER/BIONTECH | Atypical mycobacterial infections | 1 | 0.10 | 0.65 | 1.60 | 1.3 | 0.25 | 0.77 | 1.88 | 0.46 | 0.46 | 0.08 | 9
COVID19_UNKNOWN MFR | Atypical mycobacterial infections | 0 | 0.02 | 0.98 | 3.23 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Auditory and vestibular diagnostic procedures | 47 | 0.79 | 1.01 | 1.26 | 59.3 | 0.62 | 0.79 | 1.00 | 0.93 | 0.93 | 0.73 | 781
COVID19_MODERNA | Auditory and vestibular diagnostic procedures | 251 | 1.19 | 1.33 | 1.47 | 238.2 | 0.95 | 1.05 | 1.16 | 1.48 | 1.48 | 1.31 | 577
COVID19_PFIZER/BIONTECH | Auditory and vestibular diagnostic procedures | 318 | 1.83 | 2.01 | 2.20 | 199.9 | 1.44 | 1.58 | 1.73 | 2.55 | 2.56 | 2.27 | 510
COVID19_UNKNOWN MFR | Auditory and vestibular diagnostic procedures | 1 | 0.29 | 0.97 | 1.98 | 1.4 | 0.24 | 0.74 | 1.82 | 0.83 | 0.83 | 0.16 | 827
COVID19_JANSSEN | Auditory nerve disorders | 0 | 0.03 | 0.62 | 1.86 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Auditory nerve disorders | 0 | 0.02 | 0.30 | 0.91 | 2.3 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Auditory nerve disorders | 5 | 0.88 | 2.03 | 3.56 | 2.1 | 0.80 | 1.58 | 2.95 | 4.09 | 4.09 | 1.45 | 5
COVID19_UNKNOWN MFR | Auditory nerve disorders | 0 | 0.05 | 0.99 | 2.97 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Aural neoplasms malignant and unspecified | 0 | 0.06 | 0.95 | 2.73 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Aural neoplasms malignant and unspecified | 0 | 0.06 | 0.83 | 2.39 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aural neoplasms malignant and unspecified | 1 | 0.31 | 1.61 | 3.76 | 0.1 | 0.40 | 1.30 | 4.95 | 12.28 | 12.28 | 0.84 | 0
COVID19_UNKNOWN MFR | Aural neoplasms malignant and unspecified | 0 | 0.07 | 1.00 | 2.88 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune disorders NEC | 11 | 0.30 | 0.52 | 0.79 | 26.8 | 0.27 | 0.44 | 0.68 | 0.41 | 0.41 | 0.25 | 410
COVID19_MODERNA | Autoimmune disorders NEC | 36 | 0.41 | 0.55 | 0.71 | 70.6 | 0.39 | 0.52 | 0.67 | 0.32 | 0.32 | 0.24 | 385
COVID19_PFIZER/BIONTECH | Autoimmune disorders NEC | 46 | 0.56 | 0.72 | 0.90 | 73.9 | 0.49 | 0.63 | 0.79 | 0.50 | 0.50 | 0.39 | 375
COVID19_UNKNOWN MFR | Autoimmune disorders NEC | 0 | 0.01 | 0.56 | 1.94 | 0.5 |  |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmunity analyses | 57 | 0.61 | 0.77 | 0.94 | 100.9 | 0.46 | 0.57 | 0.70 | 0.60 | 0.60 | 0.48 | 1463
COVID19_MODERNA | Autoimmunity analyses | 193 | 0.63 | 0.71 | 0.80 | 327.0 | 0.53 | 0.59 | 0.67 | 0.49 | 0.49 | 0.43 | 1327
COVID19_PFIZER/BIONTECH | Autoimmunity analyses | 202 | 0.75 | 0.84 | 0.94 | 306.9 | 0.59 | 0.66 | 0.74 | 0.63 | 0.63 | 0.55 | 1318
COVID19_UNKNOWN MFR | Autoimmunity analyses | 3 | 0.48 | 1.45 | 2.84 | 2.4 | 0.46 | 1.02 | 2.04 | 1.36 | 1.36 | 0.53 | 1517
COVID19_JANSSEN | Autoinflammatory diseases | 0 | 0.07 | 0.77 | 2.15 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Autoinflammatory diseases | 1 | 0.18 | 0.86 | 1.97 | 0.8 | 0.30 | 0.91 | 2.27 | 0.68 | 0.68 | 0.11 | 5
COVID19_PFIZER/BIONTECH | Autoinflammatory diseases | 0 | 0.04 | 0.51 | 1.43 | 1.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoinflammatory diseases | 0 | 0.08 | 0.99 | 2.76 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Autonomic nerve therapeutic procedures | 0 | 0.10 | 0.86 | 2.25 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Autonomic nerve therapeutic procedures | 1 | 0.23 | 1.04 | 2.31 | 0.8 | 0.30 | 0.90 | 2.23 | 1.13 | 1.13 | 0.17 | 3
COVID19_PFIZER/BIONTECH | Autonomic nerve therapeutic procedures | 2 | 0.47 | 1.54 | 3.11 | 0.8 | 0.50 | 1.27 | 2.91 | 4.09 | 4.09 | 0.79 | 2
COVID19_UNKNOWN MFR | Autonomic nerve therapeutic procedures | 0 | 0.11 | 1.00 | 2.62 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Autonomic nervous system disorders | 3 | 0.07 | 0.24 | 0.49 | 20.4 | 0.07 | 0.19 | 0.41 | 0.11 | 0.11 | 0.04 | 425
COVID19_MODERNA | Autonomic nervous system disorders | 14 | 0.24 | 0.40 | 0.59 | 43.4 | 0.22 | 0.34 | 0.51 | 0.12 | 0.12 | 0.07 | 414
COVID19_PFIZER/BIONTECH | Autonomic nervous system disorders | 17 | 0.28 | 0.44 | 0.63 | 55.7 | 0.22 | 0.32 | 0.47 | 0.17 | 0.17 | 0.11 | 411
COVID19_UNKNOWN MFR | Autonomic nervous system disorders | 2 | 0.79 | 3.81 | 8.66 | 0.5 | 0.56 | 1.49 | 4.08 | 3.23 | 3.23 | 1.01 | 426
COVID19_JANSSEN | Autosomal chromosomal abnormalities | 0 | 0.06 | 0.64 | 1.75 | 0.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Autosomal chromosomal abnormalities | 1 | 0.15 | 0.73 | 1.65 | 1.1 | 0.27 | 0.82 | 2.01 | 0.31 | 0.31 | 0.06 | 11
COVID19_PFIZER/BIONTECH | Autosomal chromosomal abnormalities | 2 | 0.31 | 1.04 | 2.13 | 1.4 | 0.42 | 1.04 | 2.28 | 0.82 | 0.82 | 0.23 | 10
COVID19_UNKNOWN MFR | Autosomal chromosomal abnormalities | 0 | 0.09 | 0.99 | 2.70 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | B-cell lymphomas NEC | 2 | 0.49 | 1.28 | 2.37 | 1.0 | 0.46 | 1.16 | 2.56 | 2.57 | 2.57 | 0.73 | 12
COVID19_MODERNA | B-cell lymphomas NEC | 2 | 0.31 | 0.81 | 1.50 | 3.6 | 0.25 | 0.64 | 1.39 | 0.57 | 0.57 | 0.16 | 12
COVID19_PFIZER/BIONTECH | B-cell lymphomas NEC | 3 | 0.44 | 1.03 | 1.82 | 3.1 | 0.40 | 0.89 | 1.78 | 1.12 | 1.12 | 0.38 | 11
COVID19_UNKNOWN MFR | B-cell lymphomas NEC | 0 | 0.25 | 0.99 | 2.13 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Babesia infections | 0 | 0.02 | 0.76 | 2.49 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Babesia infections | 0 | 0.01 | 0.46 | 1.51 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Babesia infections | 1 | 0.17 | 1.14 | 2.80 | 0.4 | 0.36 | 1.08 | 2.85 | 1.36 | 1.36 | 0.20 | 3
COVID19_UNKNOWN MFR | Babesia infections | 0 | 0.03 | 0.99 | 3.25 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bacillary infections | 0 | 0.03 | 0.88 | 2.74 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Bacillary infections | 0 | 0.03 | 0.67 | 2.07 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bacillary infections | 0 | 0.03 | 0.70 | 2.17 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacillary infections | 0 | 0.04 | 1.00 | 3.10 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bacteria identification and serology (excl mycobacteria) | 98 | 0.51 | 0.60 | 0.70 | 207.3 | 0.40 | 0.48 | 0.56 | 0.37 | 0.36 | 0.31 | 4146
COVID19_MODERNA | Bacteria identification and serology (excl mycobacteria) | 312 | 0.57 | 0.63 | 0.68 | 596.7 | 0.48 | 0.52 | 0.57 | 0.27 | 0.27 | 0.24 | 3932
COVID19_PFIZER/BIONTECH | Bacteria identification and serology (excl mycobacteria) | 437 | 0.81 | 0.88 | 0.95 | 610.8 | 0.66 | 0.72 | 0.77 | 0.47 | 0.47 | 0.43 | 3807
COVID19_UNKNOWN MFR | Bacteria identification and serology (excl mycobacteria) | 2 | 0.24 | 0.67 | 1.29 | 5.0 | 0.20 | 0.51 | 1.12 | 0.32 | 0.32 | 0.10 | 4242
COVID19_JANSSEN | Bacterial infections NEC | 55 | 0.15 | 0.18 | 0.23 | 362.0 | 0.12 | 0.16 | 0.19 | 0.12 | 0.12 | 0.10 | 7048
COVID19_MODERNA | Bacterial infections NEC | 1061 | 0.79 | 0.83 | 0.88 | 1519.2 | 0.66 | 0.70 | 0.73 | 0.60 | 0.59 | 0.56 | 6042
COVID19_PFIZER/BIONTECH | Bacterial infections NEC | 304 | 0.25 | 0.28 | 0.31 | 1304.7 | 0.21 | 0.23 | 0.26 | 0.18 | 0.18 | 0.16 | 6799
COVID19_UNKNOWN MFR | Bacterial infections NEC | 3 | 0.19 | 0.50 | 0.92 | 9.4 | 0.17 | 0.40 | 0.81 | 0.29 | 0.29 | 0.11 | 7100
COVID19_JANSSEN | Bacterial infections congenital | 0 | 0.04 | 0.84 | 2.57 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Bacterial infections congenital | 0 | 0.03 | 0.58 | 1.77 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bacterial infections congenital | 0 | 0.03 | 0.61 | 1.88 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacterial infections congenital | 0 | 0.04 | 1.00 | 3.06 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bartonella infections | 0 | 0.00 | 0.18 | 1.05 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Bartonella infections | 0 | 0.00 | 0.06 | 0.32 | 1.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bartonella infections | 0 | 0.00 | 0.06 | 0.37 | 1.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bartonella infections | 0 | 0.00 | 0.90 | 5.24 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Behaviour and socialisation disturbances | 18 | 0.53 | 0.79 | 1.11 | 25.2 | 0.49 | 0.72 | 1.03 | 0.40 | 0.40 | 0.27 | 688
COVID19_MODERNA | Behaviour and socialisation disturbances | 69 | 0.82 | 1.01 | 1.22 | 73.0 | 0.77 | 0.94 | 1.14 | 0.37 | 0.37 | 0.30 | 637
COVID19_PFIZER/BIONTECH | Behaviour and socialisation disturbances | 62 | 0.68 | 0.84 | 1.02 | 83.0 | 0.61 | 0.75 | 0.92 | 0.39 | 0.39 | 0.32 | 644
COVID19_UNKNOWN MFR | Behaviour and socialisation disturbances | 2 | 0.53 | 1.51 | 2.91 | 0.7 | 0.53 | 1.35 | 3.24 | 1.95 | 1.96 | 0.61 | 704
COVID19_JANSSEN | Benign and malignant breast neoplasms | 3 | 0.74 | 2.14 | 4.13 | 0.8 | 0.71 | 1.66 | 4.00 | 5.79 | 5.79 | 1.90 | 8
COVID19_MODERNA | Benign and malignant breast neoplasms | 4 | 0.47 | 1.18 | 2.16 | 2.9 | 0.54 | 1.11 | 2.10 | 1.94 | 1.94 | 0.69 | 7
COVID19_PFIZER/BIONTECH | Benign and malignant breast neoplasms | 1 | 0.10 | 0.53 | 1.24 | 2.6 | 0.16 | 0.54 | 1.36 | 0.41 | 0.41 | 0.07 | 10
COVID19_UNKNOWN MFR | Benign and malignant breast neoplasms | 0 | 0.06 | 0.98 | 2.89 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Benign neoplasms gastrointestinal (excl oral cavity) | 0 | 0.08 | 0.61 | 1.58 | 1.0 |  |  |  |  |  |  | 
COVID19_MODERNA | Benign neoplasms gastrointestinal (excl oral cavity) | 2 | 0.19 | 0.60 | 1.21 | 4.4 | 0.22 | 0.56 | 1.22 | 0.36 | 0.36 | 0.11 | 19
COVID19_PFIZER/BIONTECH | Benign neoplasms gastrointestinal (excl oral cavity) | 4 | 0.44 | 1.05 | 1.87 | 3.8 | 0.46 | 0.96 | 1.80 | 0.96 | 0.96 | 0.39 | 17
COVID19_UNKNOWN MFR | Benign neoplasms gastrointestinal (excl oral cavity) | 0 | 0.12 | 0.98 | 2.53 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Benign oral cavity neoplasms | 0 | 0.03 | 0.88 | 2.76 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Benign oral cavity neoplasms | 0 | 0.02 | 0.66 | 2.07 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Benign oral cavity neoplasms | 0 | 0.02 | 0.69 | 2.17 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Benign oral cavity neoplasms | 0 | 0.04 | 1.00 | 3.14 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bereavement issues | 0 | 0.07 | 0.91 | 2.56 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Bereavement issues | 1 | 0.26 | 1.33 | 3.07 | 0.6 | 0.33 | 0.99 | 2.50 | 3.40 | 3.40 | 0.33 | 1
COVID19_PFIZER/BIONTECH | Bereavement issues | 0 | 0.06 | 0.75 | 2.12 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bereavement issues | 0 | 0.08 | 1.00 | 2.81 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bile duct infections and inflammations | 3 | 0.43 | 1.15 | 2.15 | 2.6 | 0.44 | 0.98 | 1.96 | 1.32 | 1.32 | 0.49 | 35
COVID19_MODERNA | Bile duct infections and inflammations | 10 | 0.55 | 0.97 | 1.48 | 10.2 | 0.57 | 0.94 | 1.48 | 1.21 | 1.21 | 0.66 | 28
COVID19_PFIZER/BIONTECH | Bile duct infections and inflammations | 13 | 0.88 | 1.43 | 2.10 | 8.7 | 0.86 | 1.35 | 2.03 | 2.13 | 2.13 | 1.21 | 25
COVID19_UNKNOWN MFR | Bile duct infections and inflammations | 0 | 0.13 | 0.97 | 2.47 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bile duct neoplasms malignant | 0 | 0.07 | 0.87 | 2.42 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Bile duct neoplasms malignant | 0 | 0.05 | 0.65 | 1.79 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bile duct neoplasms malignant | 1 | 0.25 | 1.22 | 2.80 | 0.5 | 0.34 | 1.03 | 2.63 | 2.05 | 2.05 | 0.27 | 2
COVID19_UNKNOWN MFR | Bile duct neoplasms malignant | 0 | 0.08 | 1.00 | 2.77 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Biliary tract and gallbladder therapeutic procedures | 3 | 0.35 | 0.81 | 1.44 | 4.4 | 0.32 | 0.71 | 1.42 | 0.71 | 0.71 | 0.27 | 65
COVID19_MODERNA | Biliary tract and gallbladder therapeutic procedures | 21 | 0.74 | 1.08 | 1.47 | 19.2 | 0.74 | 1.06 | 1.48 | 1.52 | 1.52 | 0.99 | 47
COVID19_PFIZER/BIONTECH | Biliary tract and gallbladder therapeutic procedures | 17 | 0.71 | 1.08 | 1.50 | 15.7 | 0.70 | 1.04 | 1.50 | 1.36 | 1.36 | 0.86 | 51
COVID19_UNKNOWN MFR | Biliary tract and gallbladder therapeutic procedures | 1 | 0.43 | 1.31 | 2.59 | 0.1 | 0.41 | 1.37 | 6.27 | 10.27 | 10.28 | 1.96 | 67
COVID19_JANSSEN | Bipolar disorders | 1 | 0.18 | 0.74 | 1.62 | 2.1 | 0.19 | 0.62 | 1.53 | 0.59 | 0.59 | 0.11 | 26
COVID19_MODERNA | Bipolar disorders | 2 | 0.17 | 0.55 | 1.09 | 5.0 | 0.20 | 0.51 | 1.11 | 0.27 | 0.27 | 0.08 | 25
COVID19_PFIZER/BIONTECH | Bipolar disorders | 3 | 0.26 | 0.70 | 1.32 | 5.2 | 0.28 | 0.64 | 1.27 | 0.51 | 0.51 | 0.19 | 24
COVID19_UNKNOWN MFR | Bipolar disorders | 1 | 0.38 | 1.58 | 3.45 | 0.0 | 0.43 | 1.57 | 10.47 | 26.46 | 26.48 | 4.95 | 26
COVID19_JANSSEN | Bladder and urethral symptoms | 184 | 1.31 | 1.49 | 1.67 | 136.1 | 1.19 | 1.34 | 1.51 | 1.36 | 1.36 | 1.20 | 2094
COVID19_MODERNA | Bladder and urethral symptoms | 496 | 0.88 | 0.95 | 1.02 | 555.2 | 0.83 | 0.89 | 0.96 | 0.95 | 0.95 | 0.87 | 1782
COVID19_PFIZER/BIONTECH | Bladder and urethral symptoms | 437 | 0.92 | 1.00 | 1.08 | 476.1 | 0.85 | 0.92 | 0.99 | 0.97 | 0.97 | 0.89 | 1841
COVID19_UNKNOWN MFR | Bladder and urethral symptoms | 5 | 0.64 | 1.36 | 2.30 | 3.4 | 0.61 | 1.19 | 2.15 | 1.51 | 1.52 | 0.72 | 2273
COVID19_JANSSEN | Bladder disorders NEC | 4 | 0.50 | 1.30 | 2.40 | 3.3 | 0.50 | 1.04 | 1.95 | 1.21 | 1.21 | 0.52 | 51
COVID19_MODERNA | Bladder disorders NEC | 14 | 0.78 | 1.27 | 1.86 | 13.4 | 0.66 | 1.01 | 1.49 | 1.16 | 1.16 | 0.70 | 41
COVID19_PFIZER/BIONTECH | Bladder disorders NEC | 12 | 0.73 | 1.24 | 1.87 | 11.4 | 0.63 | 1.00 | 1.53 | 1.14 | 1.14 | 0.67 | 43
COVID19_UNKNOWN MFR | Bladder disorders NEC | 0 | 0.03 | 0.92 | 2.96 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bladder disorders congenital | 0 | 0.02 | 0.77 | 2.48 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Bladder disorders congenital | 0 | 0.01 | 0.47 | 1.52 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bladder disorders congenital | 0 | 0.01 | 0.51 | 1.64 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder disorders congenital | 0 | 0.03 | 0.99 | 3.21 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bladder infections and inflammations | 0 | 0.01 | 0.33 | 1.15 | 1.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Bladder infections and inflammations | 5 | 0.41 | 0.97 | 1.72 | 5.5 | 0.45 | 0.87 | 1.57 | 1.00 | 1.00 | 0.43 | 17
COVID19_PFIZER/BIONTECH | Bladder infections and inflammations | 1 | 0.05 | 0.33 | 0.82 | 4.9 | 0.09 | 0.34 | 0.92 | 0.20 | 0.20 | 0.04 | 21
COVID19_UNKNOWN MFR | Bladder infections and inflammations | 0 | 0.01 | 0.96 | 3.32 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bladder neoplasms malignant | 0 | 0.16 | 0.83 | 1.94 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Bladder neoplasms malignant | 3 | 0.49 | 1.23 | 2.24 | 2.2 | 0.48 | 1.07 | 2.14 | 1.27 | 1.27 | 0.42 | 8
COVID19_PFIZER/BIONTECH | Bladder neoplasms malignant | 3 | 0.52 | 1.30 | 2.37 | 2.1 | 0.49 | 1.10 | 2.21 | 1.54 | 1.54 | 0.50 | 8
COVID19_UNKNOWN MFR | Bladder neoplasms malignant | 0 | 0.19 | 0.99 | 2.32 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bladder reflux conditions | 0 | 0.00 | 0.35 | 1.83 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Bladder reflux conditions | 0 | 0.00 | 0.13 | 0.66 | 1.3 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bladder reflux conditions | 0 | 0.00 | 0.14 | 0.75 | 1.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder reflux conditions | 0 | 0.00 | 0.96 | 4.96 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bladder therapeutic procedures | 0 | 0.05 | 0.82 | 2.37 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Bladder therapeutic procedures | 0 | 0.04 | 0.55 | 1.59 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bladder therapeutic procedures | 2 | 0.46 | 1.64 | 3.41 | 0.7 | 0.52 | 1.33 | 3.15 | 4.09 | 4.09 | 0.79 | 2
COVID19_UNKNOWN MFR | Bladder therapeutic procedures | 0 | 0.07 | 1.00 | 2.88 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Blastocystis infections | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Blastocystis infections | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blastocystis infections | 0 | 0.04 | 0.83 | 2.53 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blastocystis infections | 0 | 0.05 | 1.00 | 3.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Blastomyces infections | 0 | 0.07 | 0.95 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Blastomyces infections | 1 | 0.30 | 1.57 | 3.64 | 0.3 | 0.38 | 1.17 | 3.32 | 10.19 | 10.19 | 0.69 | 0
COVID19_PFIZER/BIONTECH | Blastomyces infections | 0 | 0.06 | 0.85 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blastomyces infections | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bleeding tendencies | 7 | 0.74 | 1.49 | 2.44 | 5.0 | 0.68 | 1.21 | 2.05 | 1.07 | 1.07 | 0.56 | 101
COVID19_MODERNA | Bleeding tendencies | 14 | 0.51 | 0.83 | 1.21 | 18.9 | 0.49 | 0.75 | 1.11 | 0.51 | 0.51 | 0.32 | 94
COVID19_PFIZER/BIONTECH | Bleeding tendencies | 7 | 0.24 | 0.49 | 0.80 | 17.8 | 0.24 | 0.44 | 0.74 | 0.28 | 0.28 | 0.15 | 101
COVID19_UNKNOWN MFR | Bleeding tendencies | 0 | 0.05 | 0.90 | 2.69 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Blood and blood product treatment | 37 | 0.82 | 1.10 | 1.40 | 38.1 | 0.73 | 0.96 | 1.24 | 0.94 | 0.94 | 0.71 | 609
COVID19_MODERNA | Blood and blood product treatment | 109 | 0.70 | 0.83 | 0.96 | 144.5 | 0.64 | 0.76 | 0.88 | 0.69 | 0.69 | 0.58 | 537
COVID19_PFIZER/BIONTECH | Blood and blood product treatment | 109 | 0.80 | 0.94 | 1.09 | 130.6 | 0.71 | 0.83 | 0.97 | 0.83 | 0.83 | 0.70 | 537
COVID19_UNKNOWN MFR | Blood and blood product treatment | 2 | 0.46 | 1.45 | 2.88 | 1.0 | 0.47 | 1.17 | 2.61 | 2.14 | 2.14 | 0.67 | 644
COVID19_JANSSEN | Blood counts NEC | 612 | 1.31 | 1.40 | 1.49 | 446.9 | 1.28 | 1.37 | 1.46 | 1.49 | 1.50 | 1.39 | 6356
COVID19_MODERNA | Blood counts NEC | 1699 | 0.93 | 0.97 | 1.01 | 1791.1 | 0.91 | 0.95 | 0.99 | 1.10 | 1.10 | 1.05 | 5269
COVID19_PFIZER/BIONTECH | Blood counts NEC | 1742 | 1.12 | 1.17 | 1.21 | 1534.0 | 1.09 | 1.14 | 1.18 | 1.36 | 1.37 | 1.31 | 5226
COVID19_UNKNOWN MFR | Blood counts NEC | 17 | 1.00 | 1.48 | 2.04 | 10.1 | 1.02 | 1.52 | 2.19 | 1.68 | 1.70 | 1.13 | 6951
COVID19_JANSSEN | Blood gas and acid base analyses | 238 | 1.32 | 1.47 | 1.63 | 184.0 | 1.16 | 1.29 | 1.43 | 1.20 | 1.21 | 1.08 | 3053
COVID19_MODERNA | Blood gas and acid base analyses | 823 | 1.17 | 1.24 | 1.31 | 744.3 | 1.04 | 1.11 | 1.17 | 1.13 | 1.13 | 1.06 | 2468
COVID19_PFIZER/BIONTECH | Blood gas and acid base analyses | 1030 | 1.69 | 1.78 | 1.87 | 659.6 | 1.48 | 1.56 | 1.64 | 1.87 | 1.87 | 1.76 | 2261
COVID19_UNKNOWN MFR | Blood gas and acid base analyses | 5 | 0.52 | 1.10 | 1.85 | 4.9 | 0.48 | 0.94 | 1.70 | 1.05 | 1.05 | 0.50 | 3286
COVID19_JANSSEN | Blood grouping and cross-matching analyses | 8 | 0.78 | 1.50 | 2.42 | 5.4 | 0.74 | 1.28 | 2.10 | 1.45 | 1.45 | 0.79 | 85
COVID19_MODERNA | Blood grouping and cross-matching analyses | 13 | 0.46 | 0.76 | 1.12 | 17.4 | 0.48 | 0.75 | 1.13 | 0.55 | 0.55 | 0.34 | 80
COVID19_PFIZER/BIONTECH | Blood grouping and cross-matching analyses | 13 | 0.49 | 0.82 | 1.20 | 16.8 | 0.50 | 0.78 | 1.17 | 0.67 | 0.67 | 0.41 | 80
COVID19_UNKNOWN MFR | Blood grouping and cross-matching analyses | 0 | 0.04 | 0.88 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Blood isoimmune reactions | 0 | 0.04 | 0.89 | 2.69 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Blood isoimmune reactions | 0 | 0.03 | 0.68 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood isoimmune reactions | 0 | 0.03 | 0.71 | 2.16 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood isoimmune reactions | 0 | 0.05 | 1.00 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure disorders NEC | 14 | 0.57 | 0.91 | 1.31 | 16.3 | 0.55 | 0.85 | 1.26 | 0.87 | 0.86 | 0.55 | 250
COVID19_MODERNA | Blood pressure disorders NEC | 87 | 1.03 | 1.24 | 1.47 | 72.6 | 0.99 | 1.19 | 1.41 | 1.67 | 1.67 | 1.35 | 177
COVID19_PFIZER/BIONTECH | Blood pressure disorders NEC | 89 | 1.27 | 1.52 | 1.80 | 60.5 | 1.21 | 1.45 | 1.71 | 2.08 | 2.08 | 1.68 | 175
COVID19_UNKNOWN MFR | Blood pressure disorders NEC | 1 | 0.34 | 1.25 | 2.63 | 0.4 | 0.35 | 1.06 | 2.73 | 2.62 | 2.62 | 0.50 | 263
COVID19_JANSSEN | Body temperature altered | 10 | 0.40 | 0.73 | 1.13 | 18.0 | 0.35 | 0.58 | 0.92 | 0.36 | 0.36 | 0.21 | 428
COVID19_MODERNA | Body temperature altered | 33 | 0.53 | 0.72 | 0.94 | 52.5 | 0.48 | 0.64 | 0.83 | 0.28 | 0.28 | 0.21 | 405
COVID19_PFIZER/BIONTECH | Body temperature altered | 50 | 0.85 | 1.09 | 1.35 | 57.4 | 0.69 | 0.87 | 1.08 | 0.53 | 0.53 | 0.41 | 388
COVID19_UNKNOWN MFR | Body temperature altered | 1 | 0.23 | 1.53 | 3.76 | 0.5 | 0.34 | 1.02 | 2.61 | 1.57 | 1.58 | 0.30 | 437
COVID19_JANSSEN | Bone and joint infections | 0 | 0.04 | 0.28 | 0.73 | 4.0 |  |  |  |  |  |  | 
COVID19_MODERNA | Bone and joint infections | 7 | 0.29 | 0.57 | 0.93 | 13.1 | 0.32 | 0.57 | 0.96 | 0.25 | 0.25 | 0.13 | 97
COVID19_PFIZER/BIONTECH | Bone and joint infections | 8 | 0.34 | 0.63 | 1.00 | 14.1 | 0.34 | 0.60 | 0.98 | 0.34 | 0.34 | 0.19 | 96
COVID19_UNKNOWN MFR | Bone and joint infections | 0 | 0.12 | 0.93 | 2.38 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bone and joint injuries NEC | 10 | 0.52 | 0.87 | 1.30 | 12.1 | 0.50 | 0.82 | 1.29 | 0.88 | 0.88 | 0.51 | 176
COVID19_MODERNA | Bone and joint injuries NEC | 31 | 0.50 | 0.68 | 0.88 | 48.5 | 0.48 | 0.65 | 0.85 | 0.68 | 0.68 | 0.49 | 155
COVID19_PFIZER/BIONTECH | Bone and joint injuries NEC | 39 | 0.75 | 0.98 | 1.24 | 41.0 | 0.72 | 0.94 | 1.21 | 1.09 | 1.09 | 0.81 | 147
COVID19_UNKNOWN MFR | Bone and joint injuries NEC | 0 | 0.27 | 0.92 | 1.87 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bone disorders NEC | 10 | 0.50 | 0.88 | 1.35 | 12.9 | 0.47 | 0.78 | 1.23 | 0.81 | 0.81 | 0.48 | 190
COVID19_MODERNA | Bone disorders NEC | 28 | 0.46 | 0.64 | 0.85 | 48.4 | 0.43 | 0.59 | 0.79 | 0.55 | 0.55 | 0.40 | 172
COVID19_PFIZER/BIONTECH | Bone disorders NEC | 47 | 0.94 | 1.21 | 1.51 | 43.0 | 0.85 | 1.08 | 1.35 | 1.26 | 1.26 | 0.96 | 153
COVID19_UNKNOWN MFR | Bone disorders NEC | 0 | 0.07 | 0.80 | 2.23 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bone marrow and immune tissue histopathology procedures | 9 | 0.41 | 0.74 | 1.14 | 13.8 | 0.40 | 0.67 | 1.08 | 0.60 | 0.60 | 0.34 | 233
COVID19_MODERNA | Bone marrow and immune tissue histopathology procedures | 35 | 0.63 | 0.85 | 1.09 | 45.7 | 0.58 | 0.77 | 1.00 | 0.57 | 0.57 | 0.43 | 207
COVID19_PFIZER/BIONTECH | Bone marrow and immune tissue histopathology procedures | 37 | 0.70 | 0.93 | 1.19 | 43.8 | 0.64 | 0.84 | 1.09 | 0.74 | 0.74 | 0.55 | 205
COVID19_UNKNOWN MFR | Bone marrow and immune tissue histopathology procedures | 0 | 0.12 | 0.83 | 2.10 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bone marrow and immune tissue imaging procedures | 1 | 0.24 | 0.81 | 1.65 | 1.9 | 0.20 | 0.64 | 1.59 | 0.52 | 0.52 | 0.10 | 30
COVID19_MODERNA | Bone marrow and immune tissue imaging procedures | 5 | 0.46 | 0.97 | 1.62 | 5.0 | 0.48 | 0.93 | 1.67 | 0.65 | 0.65 | 0.29 | 26
COVID19_PFIZER/BIONTECH | Bone marrow and immune tissue imaging procedures | 5 | 0.46 | 0.96 | 1.60 | 5.3 | 0.46 | 0.90 | 1.62 | 0.79 | 0.79 | 0.35 | 26
COVID19_UNKNOWN MFR | Bone marrow and immune tissue imaging procedures | 0 | 0.21 | 0.98 | 2.22 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bone neoplasms benign (excl cysts) | 0 | 0.04 | 0.69 | 2.01 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Bone neoplasms benign (excl cysts) | 0 | 0.02 | 0.37 | 1.08 | 1.8 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone neoplasms benign (excl cysts) | 1 | 0.14 | 0.78 | 1.84 | 1.8 | 0.21 | 0.66 | 1.64 | 0.59 | 0.59 | 0.10 | 7
COVID19_UNKNOWN MFR | Bone neoplasms benign (excl cysts) | 0 | 0.06 | 0.99 | 2.90 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bone neoplasms malignant (excl sarcomas) | 0 | 0.00 | 0.64 | 2.39 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Bone neoplasms malignant (excl sarcomas) | 1 | 0.11 | 0.92 | 2.37 | 0.5 | 0.34 | 1.03 | 2.63 | 0.85 | 0.85 | 0.14 | 4
COVID19_PFIZER/BIONTECH | Bone neoplasms malignant (excl sarcomas) | 0 | 0.00 | 0.35 | 1.32 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone neoplasms malignant (excl sarcomas) | 0 | 0.01 | 0.99 | 3.70 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bone neoplasms unspecified malignancy | 0 | 0.06 | 0.90 | 2.59 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Bone neoplasms unspecified malignancy | 0 | 0.05 | 0.71 | 2.05 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone neoplasms unspecified malignancy | 1 | 0.27 | 1.40 | 3.25 | 0.3 | 0.37 | 1.14 | 3.17 | 4.09 | 4.09 | 0.40 | 1
COVID19_UNKNOWN MFR | Bone neoplasms unspecified malignancy | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bone related signs and symptoms | 359 | 1.58 | 1.73 | 1.88 | 222.0 | 1.47 | 1.61 | 1.75 | 1.95 | 1.96 | 1.79 | 2836
COVID19_MODERNA | Bone related signs and symptoms | 868 | 0.92 | 0.97 | 1.02 | 946.6 | 0.87 | 0.92 | 0.97 | 1.27 | 1.27 | 1.19 | 2327
COVID19_PFIZER/BIONTECH | Bone related signs and symptoms | 827 | 1.06 | 1.13 | 1.19 | 781.3 | 1.00 | 1.06 | 1.12 | 1.43 | 1.43 | 1.34 | 2368
COVID19_UNKNOWN MFR | Bone related signs and symptoms | 9 | 0.90 | 1.60 | 2.46 | 5.2 | 0.86 | 1.45 | 2.34 | 1.94 | 1.95 | 1.12 | 3186
COVID19_JANSSEN | Bone sarcomas | 0 | 0.01 | 0.77 | 2.74 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Bone sarcomas | 0 | 0.01 | 0.48 | 1.70 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone sarcomas | 0 | 0.01 | 0.52 | 1.83 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone sarcomas | 0 | 0.01 | 0.99 | 3.52 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bone therapeutic procedures NEC | 0 | 0.07 | 0.83 | 2.34 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Bone therapeutic procedures NEC | 1 | 0.21 | 1.04 | 2.40 | 0.3 | 0.36 | 1.10 | 2.93 | 1.13 | 1.13 | 0.17 | 3
COVID19_PFIZER/BIONTECH | Bone therapeutic procedures NEC | 0 | 0.05 | 0.61 | 1.70 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone therapeutic procedures NEC | 0 | 0.08 | 1.00 | 2.79 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bordetella infections | 1 | 0.00 | 0.03 | 0.09 | 30.0 | 0.00 | 0.03 | 0.16 | 0.02 | 0.02 | 0.01 | 648
COVID19_MODERNA | Bordetella infections | 2 | 0.01 | 0.03 | 0.07 | 42.0 | 0.01 | 0.05 | 0.15 | 0.01 | 0.01 | 0.00 | 647
COVID19_PFIZER/BIONTECH | Bordetella infections | 1 | 0.00 | 0.01 | 0.04 | 64.9 | 0.00 | 0.01 | 0.06 | 0.01 | 0.01 | 0.00 | 648
COVID19_UNKNOWN MFR | Bordetella infections | 0 | 0.00 | 0.14 | 0.75 | 0.9 |  |  |  |  |  |  | 
COVID19_JANSSEN | Borrelial infections | 6 | 0.54 | 1.18 | 2.02 | 6.0 | 0.51 | 0.94 | 1.64 | 0.97 | 0.97 | 0.48 | 96
COVID19_MODERNA | Borrelial infections | 14 | 0.61 | 0.99 | 1.45 | 15.7 | 0.57 | 0.88 | 1.30 | 0.54 | 0.54 | 0.34 | 88
COVID19_PFIZER/BIONTECH | Borrelial infections | 18 | 0.81 | 1.24 | 1.75 | 16.9 | 0.71 | 1.03 | 1.47 | 0.88 | 0.88 | 0.57 | 84
COVID19_UNKNOWN MFR | Borrelial infections | 0 | 0.01 | 0.84 | 2.96 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Brain radiotherapies | 0 | 0.04 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Brain radiotherapies | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain radiotherapies | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain radiotherapies | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Breast and nipple neoplasms benign | 0 | 0.10 | 0.81 | 2.09 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Breast and nipple neoplasms benign | 1 | 0.20 | 0.87 | 1.93 | 0.9 | 0.28 | 0.86 | 2.12 | 0.68 | 0.68 | 0.11 | 5
COVID19_PFIZER/BIONTECH | Breast and nipple neoplasms benign | 1 | 0.22 | 0.93 | 2.06 | 1.1 | 0.27 | 0.82 | 2.02 | 0.82 | 0.82 | 0.14 | 5
COVID19_UNKNOWN MFR | Breast and nipple neoplasms benign | 0 | 0.12 | 0.99 | 2.58 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Breast and nipple neoplasms malignant | 2 | 0.25 | 0.66 | 1.23 | 4.5 | 0.21 | 0.55 | 1.19 | 0.47 | 0.47 | 0.14 | 66
COVID19_MODERNA | Breast and nipple neoplasms malignant | 10 | 0.61 | 1.04 | 1.56 | 10.4 | 0.56 | 0.93 | 1.46 | 0.59 | 0.59 | 0.33 | 58
COVID19_PFIZER/BIONTECH | Breast and nipple neoplasms malignant | 7 | 0.37 | 0.70 | 1.10 | 11.9 | 0.35 | 0.62 | 1.05 | 0.47 | 0.47 | 0.24 | 61
COVID19_UNKNOWN MFR | Breast and nipple neoplasms malignant | 0 | 0.24 | 0.96 | 2.06 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Breast disorders NEC | 8 | 0.58 | 1.13 | 1.82 | 7.6 | 0.57 | 0.99 | 1.63 | 1.13 | 1.13 | 0.62 | 109
COVID19_MODERNA | Breast disorders NEC | 35 | 0.80 | 1.08 | 1.39 | 35.0 | 0.75 | 0.99 | 1.29 | 1.45 | 1.45 | 1.04 | 82
COVID19_PFIZER/BIONTECH | Breast disorders NEC | 45 | 1.31 | 1.70 | 2.13 | 28.4 | 1.19 | 1.52 | 1.93 | 2.56 | 2.56 | 1.87 | 72
COVID19_UNKNOWN MFR | Breast disorders NEC | 0 | 0.02 | 0.81 | 2.74 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Breast infections | 0 | 0.00 | 0.15 | 0.51 | 3.9 |  |  |  |  |  |  | 
COVID19_MODERNA | Breast infections | 12 | 0.44 | 0.76 | 1.14 | 17.6 | 0.44 | 0.69 | 1.06 | 0.85 | 0.85 | 0.50 | 48
COVID19_PFIZER/BIONTECH | Breast infections | 27 | 1.35 | 1.91 | 2.54 | 15.4 | 1.19 | 1.63 | 2.20 | 3.35 | 3.35 | 2.19 | 33
COVID19_UNKNOWN MFR | Breast infections | 0 | 0.01 | 0.89 | 3.06 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Breast infections and inflammations | 2 | 0.51 | 1.42 | 2.71 | 0.8 | 0.49 | 1.25 | 2.83 | 3.43 | 3.43 | 0.95 | 9
COVID19_MODERNA | Breast infections and inflammations | 4 | 0.48 | 1.07 | 1.86 | 4.0 | 0.44 | 0.92 | 1.73 | 1.94 | 1.94 | 0.69 | 7
COVID19_PFIZER/BIONTECH | Breast infections and inflammations | 2 | 0.30 | 0.85 | 1.61 | 3.2 | 0.27 | 0.69 | 1.49 | 0.91 | 0.91 | 0.25 | 9
COVID19_UNKNOWN MFR | Breast infections and inflammations | 0 | 0.20 | 0.99 | 2.27 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Breast neoplasm removal | 0 | 0.04 | 0.84 | 2.55 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Breast neoplasm removal | 0 | 0.03 | 0.59 | 1.78 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast neoplasm removal | 0 | 0.03 | 0.62 | 1.88 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast neoplasm removal | 0 | 0.05 | 1.00 | 3.01 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Breast neoplasms unspecified malignancy | 1 | 0.32 | 1.76 | 4.15 | 0.2 | 0.40 | 1.28 | 4.62 | 15.44 | 15.44 | 1.51 | 1
COVID19_MODERNA | Breast neoplasms unspecified malignancy | 0 | 0.04 | 0.70 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast neoplasms unspecified malignancy | 0 | 0.04 | 0.73 | 2.15 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast neoplasms unspecified malignancy | 0 | 0.06 | 1.00 | 2.95 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Breast radiotherapies | 0 | 0.05 | 0.94 | 2.84 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Breast radiotherapies | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast radiotherapies | 0 | 0.04 | 0.83 | 2.51 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast radiotherapies | 0 | 0.05 | 1.00 | 3.01 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Breast signs and symptoms | 108 | 1.35 | 1.59 | 1.85 | 78.8 | 1.15 | 1.35 | 1.58 | 1.63 | 1.63 | 1.38 | 1022
COVID19_MODERNA | Breast signs and symptoms | 376 | 1.12 | 1.22 | 1.33 | 364.5 | 0.95 | 1.03 | 1.12 | 1.69 | 1.70 | 1.53 | 754
COVID19_PFIZER/BIONTECH | Breast signs and symptoms | 417 | 1.54 | 1.67 | 1.81 | 294.7 | 1.30 | 1.41 | 1.53 | 2.39 | 2.40 | 2.17 | 713
COVID19_UNKNOWN MFR | Breast signs and symptoms | 2 | 0.43 | 1.09 | 2.01 | 1.9 | 0.37 | 0.92 | 1.98 | 1.22 | 1.22 | 0.38 | 1128
COVID19_JANSSEN | Breast therapeutic procedures NEC | 2 | 0.49 | 1.36 | 2.57 | 0.9 | 0.48 | 1.21 | 2.72 | 2.81 | 2.81 | 0.79 | 11
COVID19_MODERNA | Breast therapeutic procedures NEC | 5 | 0.61 | 1.28 | 2.13 | 3.3 | 0.62 | 1.21 | 2.19 | 2.12 | 2.12 | 0.83 | 8
COVID19_PFIZER/BIONTECH | Breast therapeutic procedures NEC | 3 | 0.42 | 1.03 | 1.85 | 2.9 | 0.42 | 0.93 | 1.85 | 1.23 | 1.23 | 0.42 | 10
COVID19_UNKNOWN MFR | Breast therapeutic procedures NEC | 0 | 0.22 | 0.99 | 2.23 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Breathing abnormalities | 2416 | 1.71 | 1.77 | 1.83 | 1695.8 | 1.38 | 1.42 | 1.47 | 1.64 | 1.69 | 1.63 | 22698
COVID19_MODERNA | Breathing abnormalities | 6632 | 1.18 | 1.21 | 1.23 | 6710.1 | 0.97 | 0.99 | 1.01 | 1.22 | 1.23 | 1.20 | 18482
COVID19_PFIZER/BIONTECH | Breathing abnormalities | 7709 | 1.62 | 1.65 | 1.68 | 5754.6 | 1.32 | 1.34 | 1.37 | 1.81 | 1.87 | 1.83 | 17405
COVID19_UNKNOWN MFR | Breathing abnormalities | 61 | 1.45 | 1.81 | 2.19 | 39.6 | 1.21 | 1.50 | 1.84 | 1.68 | 1.73 | 1.39 | 25053
COVID19_JANSSEN | Brief psychotic disorder | 0 | 0.04 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Brief psychotic disorder | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brief psychotic disorder | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brief psychotic disorder | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bronchial and pulmonary therapeutic procedures | 2 | 0.24 | 0.79 | 1.61 | 3.0 | 0.28 | 0.72 | 1.55 | 0.79 | 0.79 | 0.24 | 39
COVID19_MODERNA | Bronchial and pulmonary therapeutic procedures | 2 | 0.11 | 0.37 | 0.75 | 7.7 | 0.13 | 0.36 | 0.81 | 0.17 | 0.17 | 0.05 | 39
COVID19_PFIZER/BIONTECH | Bronchial and pulmonary therapeutic procedures | 14 | 1.05 | 1.69 | 2.46 | 7.7 | 1.03 | 1.58 | 2.36 | 2.12 | 2.12 | 1.24 | 27
COVID19_UNKNOWN MFR | Bronchial and pulmonary therapeutic procedures | 1 | 0.36 | 1.65 | 3.72 | 0.1 | 0.42 | 1.48 | 8.56 | 17.20 | 17.21 | 3.25 | 40
COVID19_JANSSEN | Bronchial conditions NEC | 3 | 0.25 | 0.76 | 1.50 | 5.2 | 0.28 | 0.64 | 1.28 | 0.50 | 0.50 | 0.19 | 92
COVID19_MODERNA | Bronchial conditions NEC | 11 | 0.53 | 0.93 | 1.42 | 13.8 | 0.49 | 0.79 | 1.23 | 0.45 | 0.45 | 0.26 | 84
COVID19_PFIZER/BIONTECH | Bronchial conditions NEC | 13 | 0.62 | 1.03 | 1.52 | 15.4 | 0.54 | 0.84 | 1.26 | 0.65 | 0.65 | 0.40 | 82
COVID19_UNKNOWN MFR | Bronchial conditions NEC | 0 | 0.03 | 0.86 | 2.75 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bronchospasm and obstruction | 185 | 0.69 | 0.78 | 0.87 | 258.0 | 0.64 | 0.72 | 0.81 | 0.72 | 0.71 | 0.63 | 3997
COVID19_MODERNA | Bronchospasm and obstruction | 919 | 0.91 | 0.96 | 1.02 | 1006.2 | 0.87 | 0.91 | 0.96 | 0.96 | 0.96 | 0.90 | 3263
COVID19_PFIZER/BIONTECH | Bronchospasm and obstruction | 1029 | 1.18 | 1.24 | 1.31 | 884.5 | 1.10 | 1.16 | 1.22 | 1.34 | 1.34 | 1.26 | 3153
COVID19_UNKNOWN MFR | Bronchospasm and obstruction | 3 | 0.27 | 0.65 | 1.15 | 6.3 | 0.24 | 0.56 | 1.11 | 0.49 | 0.49 | 0.19 | 4179
COVID19_JANSSEN | Brucella infections | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Brucella infections | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brucella infections | 0 | 0.04 | 0.83 | 2.53 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brucella infections | 0 | 0.05 | 1.00 | 3.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bullous conditions | 95 | 0.54 | 0.65 | 0.76 | 261.4 | 0.31 | 0.37 | 0.43 | 0.33 | 0.33 | 0.28 | 4461
COVID19_MODERNA | Bullous conditions | 504 | 0.90 | 0.97 | 1.04 | 827.3 | 0.57 | 0.61 | 0.66 | 0.42 | 0.42 | 0.39 | 4052
COVID19_PFIZER/BIONTECH | Bullous conditions | 386 | 0.74 | 0.80 | 0.87 | 806.5 | 0.44 | 0.48 | 0.52 | 0.38 | 0.38 | 0.35 | 4170
COVID19_UNKNOWN MFR | Bullous conditions | 4 | 0.39 | 0.95 | 1.70 | 7.2 | 0.29 | 0.61 | 1.14 | 0.60 | 0.60 | 0.26 | 4552
COVID19_JANSSEN | Burkitt's lymphomas | 0 | 0.06 | 0.95 | 2.73 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Burkitt's lymphomas | 0 | 0.06 | 0.83 | 2.39 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Burkitt's lymphomas | 1 | 0.31 | 1.61 | 3.76 | 0.3 | 0.38 | 1.17 | 3.35 | 12.28 | 12.28 | 0.84 | 0
COVID19_UNKNOWN MFR | Burkitt's lymphomas | 0 | 0.07 | 1.00 | 2.88 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Bursal disorders | 16 | 0.40 | 0.63 | 0.91 | 44.1 | 0.25 | 0.38 | 0.56 | 0.40 | 0.40 | 0.27 | 611
COVID19_MODERNA | Bursal disorders | 59 | 0.43 | 0.54 | 0.67 | 186.3 | 0.26 | 0.32 | 0.40 | 0.35 | 0.35 | 0.28 | 568
COVID19_PFIZER/BIONTECH | Bursal disorders | 45 | 0.39 | 0.50 | 0.63 | 154.0 | 0.23 | 0.30 | 0.38 | 0.32 | 0.32 | 0.25 | 582
COVID19_UNKNOWN MFR | Bursal disorders | 1 | 0.14 | 1.35 | 3.60 | 1.0 | 0.27 | 0.83 | 2.05 | 1.10 | 1.10 | 0.21 | 626
COVID19_JANSSEN | Calcium metabolism disorders | 2 | 0.22 | 0.64 | 1.25 | 4.0 | 0.23 | 0.60 | 1.30 | 0.48 | 0.48 | 0.15 | 64
COVID19_MODERNA | Calcium metabolism disorders | 15 | 0.59 | 0.93 | 1.33 | 16.6 | 0.59 | 0.89 | 1.30 | 1.00 | 1.00 | 0.62 | 51
COVID19_PFIZER/BIONTECH | Calcium metabolism disorders | 16 | 0.72 | 1.12 | 1.59 | 14.3 | 0.72 | 1.07 | 1.56 | 1.31 | 1.31 | 0.82 | 50
COVID19_UNKNOWN MFR | Calcium metabolism disorders | 0 | 0.16 | 0.95 | 2.29 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Caliciviral infections | 0 | 0.00 | 0.04 | 0.25 | 1.9 |  |  |  |  |  |  | 
COVID19_MODERNA | Caliciviral infections | 1 | 0.02 | 0.38 | 1.10 | 3.3 | 0.14 | 0.47 | 1.20 | 0.05 | 0.05 | 0.01 | 71
COVID19_PFIZER/BIONTECH | Caliciviral infections | 0 | 0.00 | 0.03 | 0.14 | 3.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Caliciviral infections | 0 | 0.00 | 0.63 | 3.68 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Campylobacter infections | 1 | 0.07 | 0.84 | 2.32 | 1.7 | 0.22 | 0.69 | 1.70 | 0.74 | 0.74 | 0.14 | 21
COVID19_MODERNA | Campylobacter infections | 0 | 0.00 | 0.09 | 0.45 | 2.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Campylobacter infections | 2 | 0.14 | 0.68 | 1.55 | 3.5 | 0.25 | 0.64 | 1.40 | 0.41 | 0.41 | 0.12 | 20
COVID19_UNKNOWN MFR | Campylobacter infections | 0 | 0.00 | 0.88 | 4.26 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Candida infections | 6 | 0.33 | 0.70 | 1.17 | 9.6 | 0.35 | 0.65 | 1.14 | 0.53 | 0.53 | 0.27 | 175
COVID19_MODERNA | Candida infections | 28 | 0.66 | 0.92 | 1.21 | 31.5 | 0.65 | 0.88 | 1.18 | 0.62 | 0.62 | 0.44 | 153
COVID19_PFIZER/BIONTECH | Candida infections | 31 | 0.78 | 1.07 | 1.39 | 30.6 | 0.74 | 1.00 | 1.32 | 0.85 | 0.85 | 0.61 | 150
COVID19_UNKNOWN MFR | Candida infections | 0 | 0.08 | 0.84 | 2.30 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Carbohydrate tolerance analyses (incl diabetes) | 363 | 1.17 | 1.27 | 1.39 | 290.4 | 1.14 | 1.25 | 1.36 | 1.33 | 1.33 | 1.22 | 4216
COVID19_MODERNA | Carbohydrate tolerance analyses (incl diabetes) | 1082 | 0.93 | 0.97 | 1.02 | 1123.0 | 0.92 | 0.96 | 1.01 | 1.05 | 1.05 | 0.99 | 3497
COVID19_PFIZER/BIONTECH | Carbohydrate tolerance analyses (incl diabetes) | 1282 | 1.28 | 1.34 | 1.41 | 970.1 | 1.26 | 1.32 | 1.38 | 1.59 | 1.60 | 1.51 | 3297
COVID19_UNKNOWN MFR | Carbohydrate tolerance analyses (incl diabetes) | 14 | 1.09 | 1.71 | 2.43 | 7.0 | 1.11 | 1.71 | 2.56 | 2.11 | 2.13 | 1.37 | 4565
COVID19_JANSSEN | Carcinoid tumours | 0 | 0.07 | 0.91 | 2.57 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Carcinoid tumours | 1 | 0.26 | 1.34 | 3.09 | 0.3 | 0.36 | 1.11 | 2.96 | 3.40 | 3.40 | 0.33 | 1
COVID19_PFIZER/BIONTECH | Carcinoid tumours | 0 | 0.06 | 0.75 | 2.12 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carcinoid tumours | 0 | 0.07 | 1.00 | 2.83 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac and vascular procedural complications | 3 | 0.79 | 2.46 | 4.86 | 0.8 | 0.71 | 1.67 | 4.06 | 3.09 | 3.09 | 1.09 | 15
COVID19_MODERNA | Cardiac and vascular procedural complications | 3 | 0.31 | 0.96 | 1.89 | 4.4 | 0.32 | 0.72 | 1.43 | 0.68 | 0.68 | 0.24 | 15
COVID19_PFIZER/BIONTECH | Cardiac and vascular procedural complications | 6 | 0.87 | 1.89 | 3.23 | 3.6 | 0.72 | 1.34 | 2.34 | 2.05 | 2.05 | 0.90 | 12
COVID19_UNKNOWN MFR | Cardiac and vascular procedural complications | 0 | 0.02 | 0.97 | 3.30 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac auscultatory investigations | 6 | 0.55 | 1.11 | 1.83 | 5.7 | 0.53 | 0.98 | 1.70 | 0.94 | 0.94 | 0.47 | 99
COVID19_MODERNA | Cardiac auscultatory investigations | 11 | 0.48 | 0.82 | 1.23 | 14.9 | 0.46 | 0.74 | 1.15 | 0.40 | 0.40 | 0.24 | 94
COVID19_PFIZER/BIONTECH | Cardiac auscultatory investigations | 14 | 0.60 | 0.96 | 1.38 | 16.6 | 0.54 | 0.84 | 1.24 | 0.63 | 0.63 | 0.39 | 91
COVID19_UNKNOWN MFR | Cardiac auscultatory investigations | 0 | 0.15 | 0.93 | 2.26 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac complications associated with device | 1 | 0.30 | 1.52 | 3.51 | 0.3 | 0.36 | 1.11 | 3.00 | 5.15 | 5.15 | 0.77 | 3
COVID19_MODERNA | Cardiac complications associated with device | 2 | 0.44 | 1.52 | 3.12 | 1.3 | 0.42 | 1.05 | 2.30 | 3.40 | 3.40 | 0.66 | 2
COVID19_PFIZER/BIONTECH | Cardiac complications associated with device | 0 | 0.05 | 0.61 | 1.70 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac complications associated with device | 1 | 0.36 | 1.82 | 4.20 | 0.0 | 0.45 | 1.77 | 14.81 | 229.28 | 229.54 | 34.32 | 3
COVID19_JANSSEN | Cardiac conduction disorders | 16 | 1.00 | 1.57 | 2.23 | 12.4 | 0.81 | 1.21 | 1.76 | 1.32 | 1.32 | 0.86 | 187
COVID19_MODERNA | Cardiac conduction disorders | 57 | 1.09 | 1.37 | 1.68 | 52.7 | 0.86 | 1.07 | 1.32 | 1.33 | 1.33 | 1.02 | 146
COVID19_PFIZER/BIONTECH | Cardiac conduction disorders | 75 | 1.74 | 2.13 | 2.54 | 44.7 | 1.35 | 1.63 | 1.96 | 2.40 | 2.40 | 1.89 | 128
COVID19_UNKNOWN MFR | Cardiac conduction disorders | 1 | 0.32 | 1.42 | 3.16 | 0.3 | 0.36 | 1.10 | 2.94 | 3.41 | 3.41 | 0.65 | 202
COVID19_JANSSEN | Cardiac device therapeutic procedures | 7 | 0.63 | 1.24 | 2.02 | 5.3 | 0.65 | 1.17 | 1.97 | 1.04 | 1.04 | 0.55 | 104
COVID19_MODERNA | Cardiac device therapeutic procedures | 40 | 0.98 | 1.29 | 1.63 | 30.8 | 0.97 | 1.26 | 1.62 | 1.91 | 1.91 | 1.38 | 71
COVID19_PFIZER/BIONTECH | Cardiac device therapeutic procedures | 35 | 1.05 | 1.42 | 1.82 | 24.6 | 1.03 | 1.37 | 1.78 | 1.89 | 1.89 | 1.35 | 76
COVID19_UNKNOWN MFR | Cardiac device therapeutic procedures | 0 | 0.09 | 0.89 | 2.38 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac disorders NEC | 42 | 1.28 | 1.68 | 2.12 | 30.5 | 1.03 | 1.33 | 1.70 | 1.41 | 1.41 | 1.08 | 460
COVID19_MODERNA | Cardiac disorders NEC | 93 | 0.92 | 1.10 | 1.29 | 104.7 | 0.75 | 0.89 | 1.05 | 0.77 | 0.77 | 0.64 | 409
COVID19_PFIZER/BIONTECH | Cardiac disorders NEC | 148 | 1.64 | 1.88 | 2.15 | 97.5 | 1.31 | 1.50 | 1.71 | 1.71 | 1.71 | 1.46 | 354
COVID19_UNKNOWN MFR | Cardiac disorders NEC | 0 | 0.04 | 0.62 | 1.80 | 0.7 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac disorders congenital NEC | 1 | 0.22 | 1.31 | 3.15 | 0.4 | 0.35 | 1.04 | 2.69 | 1.93 | 1.93 | 0.34 | 8
COVID19_MODERNA | Cardiac disorders congenital NEC | 0 | 0.01 | 0.31 | 0.95 | 2.0 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac disorders congenital NEC | 1 | 0.12 | 0.71 | 1.72 | 1.0 | 0.28 | 0.84 | 2.08 | 0.51 | 0.51 | 0.09 | 8
COVID19_UNKNOWN MFR | Cardiac disorders congenital NEC | 0 | 0.04 | 0.99 | 3.05 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac function diagnostic procedures | 296 | 1.44 | 1.59 | 1.74 | 253.7 | 1.06 | 1.16 | 1.28 | 1.33 | 1.34 | 1.21 | 3425
COVID19_MODERNA | Cardiac function diagnostic procedures | 943 | 1.20 | 1.27 | 1.34 | 969.9 | 0.92 | 0.97 | 1.02 | 1.15 | 1.15 | 1.08 | 2778
COVID19_PFIZER/BIONTECH | Cardiac function diagnostic procedures | 1228 | 1.89 | 1.98 | 2.07 | 826.4 | 1.42 | 1.48 | 1.56 | 2.02 | 2.03 | 1.91 | 2493
COVID19_UNKNOWN MFR | Cardiac function diagnostic procedures | 11 | 1.24 | 2.15 | 3.26 | 6.0 | 0.95 | 1.54 | 2.40 | 2.04 | 2.05 | 1.25 | 3710
COVID19_JANSSEN | Cardiac histopathology procedures | 2 | 0.42 | 1.26 | 2.46 | 1.2 | 0.44 | 1.10 | 2.42 | 2.21 | 2.21 | 0.64 | 14
COVID19_MODERNA | Cardiac histopathology procedures | 3 | 0.31 | 0.80 | 1.47 | 3.9 | 0.35 | 0.78 | 1.55 | 0.78 | 0.78 | 0.27 | 13
COVID19_PFIZER/BIONTECH | Cardiac histopathology procedures | 6 | 0.72 | 1.45 | 2.38 | 3.5 | 0.73 | 1.36 | 2.38 | 2.46 | 2.46 | 1.05 | 10
COVID19_UNKNOWN MFR | Cardiac histopathology procedures | 0 | 0.16 | 0.99 | 2.38 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac hypertensive complications | 1 | 0.26 | 1.37 | 3.19 | 0.5 | 0.34 | 1.02 | 2.59 | 2.57 | 2.57 | 0.44 | 6
COVID19_MODERNA | Cardiac hypertensive complications | 0 | 0.03 | 0.41 | 1.19 | 1.6 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac hypertensive complications | 3 | 0.58 | 1.65 | 3.17 | 1.5 | 0.57 | 1.28 | 2.61 | 3.07 | 3.07 | 0.87 | 4
COVID19_UNKNOWN MFR | Cardiac hypertensive complications | 0 | 0.07 | 0.99 | 2.85 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac imaging procedures | 65 | 1.22 | 1.51 | 1.82 | 61.7 | 0.85 | 1.04 | 1.27 | 1.59 | 1.59 | 1.28 | 633
COVID19_MODERNA | Cardiac imaging procedures | 215 | 1.36 | 1.52 | 1.70 | 196.5 | 0.97 | 1.09 | 1.22 | 1.51 | 1.51 | 1.32 | 483
COVID19_PFIZER/BIONTECH | Cardiac imaging procedures | 303 | 2.28 | 2.51 | 2.75 | 170.1 | 1.61 | 1.77 | 1.94 | 3.14 | 3.15 | 2.77 | 395
COVID19_UNKNOWN MFR | Cardiac imaging procedures | 3 | 0.70 | 2.01 | 3.87 | 1.3 | 0.60 | 1.35 | 2.79 | 2.97 | 2.98 | 1.15 | 695
COVID19_JANSSEN | Cardiac infections | 1 | 0.25 | 0.92 | 1.94 | 1.2 | 0.26 | 0.79 | 1.93 | 0.81 | 0.81 | 0.15 | 19
COVID19_MODERNA | Cardiac infections | 4 | 0.45 | 1.03 | 1.81 | 3.4 | 0.49 | 1.02 | 1.92 | 0.85 | 0.85 | 0.34 | 16
COVID19_PFIZER/BIONTECH | Cardiac infections | 4 | 0.46 | 1.05 | 1.85 | 3.5 | 0.49 | 1.01 | 1.90 | 1.02 | 1.02 | 0.41 | 16
COVID19_UNKNOWN MFR | Cardiac infections | 0 | 0.17 | 0.98 | 2.34 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac infections and inflammations NEC | 0 | 0.11 | 0.82 | 2.07 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Cardiac infections and inflammations NEC | 1 | 0.21 | 0.88 | 1.91 | 1.2 | 0.26 | 0.78 | 1.92 | 0.68 | 0.68 | 0.11 | 5
COVID19_PFIZER/BIONTECH | Cardiac infections and inflammations NEC | 2 | 0.41 | 1.29 | 2.56 | 1.2 | 0.44 | 1.11 | 2.44 | 2.05 | 2.05 | 0.49 | 4
COVID19_UNKNOWN MFR | Cardiac infections and inflammations NEC | 0 | 0.14 | 1.00 | 2.51 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac malpositions congenital | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Cardiac malpositions congenital | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac malpositions congenital | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac malpositions congenital | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac neoplasms NEC | 0 | 0.07 | 0.95 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Cardiac neoplasms NEC | 1 | 0.30 | 1.57 | 3.64 | 0.3 | 0.36 | 1.11 | 3.00 | 10.19 | 10.19 | 0.69 | 0
COVID19_PFIZER/BIONTECH | Cardiac neoplasms NEC | 0 | 0.06 | 0.85 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac neoplasms NEC | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac septal defects congenital | 3 | 0.24 | 0.76 | 1.51 | 4.5 | 0.31 | 0.71 | 1.41 | 0.67 | 0.67 | 0.25 | 69
COVID19_MODERNA | Cardiac septal defects congenital | 11 | 0.60 | 1.05 | 1.61 | 10.8 | 0.60 | 0.98 | 1.51 | 0.61 | 0.61 | 0.36 | 61
COVID19_PFIZER/BIONTECH | Cardiac septal defects congenital | 15 | 0.82 | 1.31 | 1.90 | 12.1 | 0.77 | 1.17 | 1.72 | 1.08 | 1.08 | 0.67 | 57
COVID19_UNKNOWN MFR | Cardiac septal defects congenital | 0 | 0.01 | 0.85 | 3.13 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac signs and symptoms NEC | 666 | 1.41 | 1.50 | 1.60 | 540.0 | 1.16 | 1.23 | 1.31 | 1.60 | 1.61 | 1.51 | 6429
COVID19_MODERNA | Cardiac signs and symptoms NEC | 2280 | 1.21 | 1.25 | 1.30 | 2200.3 | 1.00 | 1.04 | 1.07 | 1.61 | 1.62 | 1.55 | 4815
COVID19_PFIZER/BIONTECH | Cardiac signs and symptoms NEC | 2655 | 1.69 | 1.75 | 1.81 | 1843.7 | 1.39 | 1.44 | 1.49 | 2.45 | 2.48 | 2.38 | 4440
COVID19_UNKNOWN MFR | Cardiac signs and symptoms NEC | 14 | 0.86 | 1.39 | 2.01 | 11.8 | 0.73 | 1.12 | 1.66 | 1.36 | 1.37 | 0.88 | 7081
COVID19_JANSSEN | Cardiac therapeutic procedures NEC | 14 | 0.86 | 1.37 | 1.98 | 12.1 | 0.71 | 1.10 | 1.63 | 1.14 | 1.14 | 0.72 | 190
COVID19_MODERNA | Cardiac therapeutic procedures NEC | 52 | 0.99 | 1.26 | 1.55 | 53.0 | 0.77 | 0.97 | 1.21 | 1.16 | 1.16 | 0.89 | 152
COVID19_PFIZER/BIONTECH | Cardiac therapeutic procedures NEC | 73 | 1.68 | 2.05 | 2.46 | 44.7 | 1.31 | 1.59 | 1.92 | 2.28 | 2.28 | 1.79 | 131
COVID19_UNKNOWN MFR | Cardiac therapeutic procedures NEC | 0 | 0.17 | 0.88 | 2.06 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac valve disorders NEC | 0 | 0.05 | 0.53 | 1.42 | 1.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Cardiac valve disorders NEC | 4 | 0.37 | 0.90 | 1.62 | 5.2 | 0.37 | 0.77 | 1.46 | 0.76 | 0.76 | 0.30 | 18
COVID19_PFIZER/BIONTECH | Cardiac valve disorders NEC | 8 | 0.92 | 1.74 | 2.77 | 4.6 | 0.82 | 1.43 | 2.37 | 2.34 | 2.34 | 1.13 | 14
COVID19_UNKNOWN MFR | Cardiac valve disorders NEC | 0 | 0.10 | 0.98 | 2.63 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac valve disorders congenital | 1 | 0.23 | 1.46 | 3.58 | 0.3 | 0.36 | 1.11 | 2.98 | 2.57 | 2.57 | 0.44 | 6
COVID19_MODERNA | Cardiac valve disorders congenital | 0 | 0.01 | 0.34 | 1.09 | 1.6 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac valve disorders congenital | 1 | 0.13 | 0.83 | 2.03 | 0.9 | 0.28 | 0.86 | 2.12 | 0.68 | 0.68 | 0.12 | 6
COVID19_UNKNOWN MFR | Cardiac valve disorders congenital | 0 | 0.03 | 0.99 | 3.18 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac valve therapeutic procedures | 1 | 0.32 | 1.18 | 2.49 | 0.6 | 0.33 | 0.98 | 2.48 | 1.93 | 1.93 | 0.34 | 8
COVID19_MODERNA | Cardiac valve therapeutic procedures | 1 | 0.20 | 0.74 | 1.56 | 2.2 | 0.19 | 0.60 | 1.48 | 0.42 | 0.42 | 0.07 | 8
COVID19_PFIZER/BIONTECH | Cardiac valve therapeutic procedures | 1 | 0.21 | 0.79 | 1.67 | 2.0 | 0.20 | 0.64 | 1.57 | 0.51 | 0.51 | 0.09 | 8
COVID19_UNKNOWN MFR | Cardiac valve therapeutic procedures | 0 | 0.17 | 0.99 | 2.37 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiomyopathies | 7 | 0.50 | 1.00 | 1.63 | 7.6 | 0.50 | 0.89 | 1.50 | 0.85 | 0.85 | 0.45 | 127
COVID19_MODERNA | Cardiomyopathies | 22 | 0.60 | 0.88 | 1.20 | 28.7 | 0.54 | 0.77 | 1.06 | 0.67 | 0.67 | 0.45 | 112
COVID19_PFIZER/BIONTECH | Cardiomyopathies | 41 | 1.33 | 1.74 | 2.21 | 26.4 | 1.15 | 1.49 | 1.91 | 1.81 | 1.81 | 1.33 | 93
COVID19_UNKNOWN MFR | Cardiomyopathies | 0 | 0.05 | 0.85 | 2.49 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiovascular disorders congenital NEC | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Cardiovascular disorders congenital NEC | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiovascular disorders congenital NEC | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiovascular disorders congenital NEC | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiovascular injuries | 3 | 0.45 | 0.94 | 1.57 | 3.4 | 0.37 | 0.84 | 1.67 | 0.81 | 0.81 | 0.31 | 57
COVID19_MODERNA | Cardiovascular injuries | 12 | 0.60 | 0.95 | 1.37 | 13.0 | 0.57 | 0.90 | 1.37 | 0.85 | 0.85 | 0.50 | 48
COVID19_PFIZER/BIONTECH | Cardiovascular injuries | 12 | 0.65 | 1.03 | 1.48 | 11.6 | 0.63 | 0.99 | 1.51 | 1.02 | 1.02 | 0.60 | 48
COVID19_UNKNOWN MFR | Cardiovascular injuries | 0 | 0.36 | 0.98 | 1.85 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiovascular neoplasms benign | 0 | 0.06 | 0.53 | 1.40 | 1.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Cardiovascular neoplasms benign | 2 | 0.19 | 0.63 | 1.26 | 2.7 | 0.30 | 0.75 | 1.63 | 0.36 | 0.36 | 0.11 | 19
COVID19_PFIZER/BIONTECH | Cardiovascular neoplasms benign | 3 | 0.30 | 0.82 | 1.55 | 2.8 | 0.42 | 0.93 | 1.86 | 0.68 | 0.68 | 0.25 | 18
COVID19_UNKNOWN MFR | Cardiovascular neoplasms benign | 0 | 0.11 | 0.98 | 2.57 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cardiovascular neoplasms malignant and unspecified | 0 | 0.03 | 0.88 | 2.76 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Cardiovascular neoplasms malignant and unspecified | 0 | 0.02 | 0.66 | 2.07 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiovascular neoplasms malignant and unspecified | 0 | 0.02 | 0.69 | 2.17 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiovascular neoplasms malignant and unspecified | 0 | 0.04 | 1.00 | 3.14 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cartilage disorders | 3 | 0.23 | 0.68 | 1.31 | 5.4 | 0.28 | 0.62 | 1.25 | 0.63 | 0.63 | 0.24 | 73
COVID19_MODERNA | Cartilage disorders | 10 | 0.36 | 0.63 | 0.98 | 17.1 | 0.37 | 0.61 | 0.96 | 0.51 | 0.51 | 0.29 | 66
COVID19_PFIZER/BIONTECH | Cartilage disorders | 24 | 1.07 | 1.54 | 2.08 | 16.3 | 0.99 | 1.38 | 1.89 | 1.89 | 1.89 | 1.26 | 52
COVID19_UNKNOWN MFR | Cartilage disorders | 0 | 0.05 | 0.90 | 2.68 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cataract conditions | 4 | 0.37 | 0.88 | 1.56 | 4.5 | 0.41 | 0.85 | 1.60 | 0.88 | 0.88 | 0.38 | 70
COVID19_MODERNA | Cataract conditions | 7 | 0.28 | 0.55 | 0.88 | 13.4 | 0.31 | 0.56 | 0.95 | 0.36 | 0.36 | 0.19 | 67
COVID19_PFIZER/BIONTECH | Cataract conditions | 18 | 0.83 | 1.26 | 1.76 | 13.2 | 0.87 | 1.28 | 1.82 | 1.32 | 1.32 | 0.84 | 56
COVID19_UNKNOWN MFR | Cataract conditions | 0 | 0.12 | 0.92 | 2.34 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cell marker analyses | 4 | 0.13 | 0.37 | 0.70 | 14.1 | 0.16 | 0.35 | 0.66 | 0.27 | 0.27 | 0.12 | 226
COVID19_MODERNA | Cell marker analyses | 21 | 0.41 | 0.60 | 0.83 | 38.8 | 0.39 | 0.56 | 0.77 | 0.34 | 0.34 | 0.23 | 209
COVID19_PFIZER/BIONTECH | Cell marker analyses | 24 | 0.49 | 0.70 | 0.95 | 40.4 | 0.43 | 0.60 | 0.83 | 0.48 | 0.48 | 0.33 | 206
COVID19_UNKNOWN MFR | Cell marker analyses | 0 | 0.00 | 0.54 | 2.32 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cell metabolism disorders NEC | 1 | 0.08 | 0.75 | 2.00 | 1.5 | 0.23 | 0.72 | 1.78 | 0.64 | 0.64 | 0.12 | 24
COVID19_MODERNA | Cell metabolism disorders NEC | 1 | 0.04 | 0.35 | 0.92 | 3.5 | 0.13 | 0.45 | 1.16 | 0.14 | 0.14 | 0.03 | 24
COVID19_PFIZER/BIONTECH | Cell metabolism disorders NEC | 0 | 0.00 | 0.09 | 0.37 | 4.1 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cell metabolism disorders NEC | 0 | 0.00 | 0.92 | 3.82 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cellular antitumour therapies | 0 | 0.05 | 0.94 | 2.84 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Cellular antitumour therapies | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cellular antitumour therapies | 0 | 0.04 | 0.83 | 2.51 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cellular antitumour therapies | 0 | 0.05 | 1.00 | 3.01 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system and spinal infections | 16 | 0.31 | 0.49 | 0.70 | 49.3 | 0.23 | 0.34 | 0.50 | 0.25 | 0.25 | 0.16 | 1001
COVID19_MODERNA | Central nervous system and spinal infections | 46 | 0.46 | 0.59 | 0.74 | 99.2 | 0.37 | 0.47 | 0.59 | 0.16 | 0.16 | 0.13 | 971
COVID19_PFIZER/BIONTECH | Central nervous system and spinal infections | 48 | 0.42 | 0.54 | 0.68 | 124.2 | 0.31 | 0.39 | 0.49 | 0.20 | 0.20 | 0.16 | 969
COVID19_UNKNOWN MFR | Central nervous system and spinal infections | 0 | 0.04 | 0.57 | 1.62 | 0.9 |  |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system aneurysms and dissections | 10 | 1.83 | 3.31 | 5.14 | 3.1 | 1.34 | 2.28 | 3.88 | 4.06 | 4.06 | 2.26 | 38
COVID19_MODERNA | Central nervous system aneurysms and dissections | 15 | 0.88 | 1.42 | 2.05 | 13.1 | 0.72 | 1.09 | 1.60 | 1.54 | 1.54 | 0.93 | 33
COVID19_PFIZER/BIONTECH | Central nervous system aneurysms and dissections | 16 | 1.10 | 1.74 | 2.49 | 11.2 | 0.88 | 1.32 | 1.91 | 2.05 | 2.05 | 1.24 | 32
COVID19_UNKNOWN MFR | Central nervous system aneurysms and dissections | 0 | 0.01 | 0.89 | 3.27 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system disorders congenital NEC | 0 | 0.00 | 0.26 | 1.06 | 1.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Central nervous system disorders congenital NEC | 0 | 0.00 | 0.15 | 0.59 | 2.6 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Central nervous system disorders congenital NEC | 2 | 0.16 | 0.70 | 1.56 | 2.8 | 0.30 | 0.75 | 1.61 | 0.55 | 0.55 | 0.16 | 15
COVID19_UNKNOWN MFR | Central nervous system disorders congenital NEC | 0 | 0.00 | 0.93 | 3.73 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system haemorrhages and cerebrovascular accidents | 369 | 2.68 | 2.92 | 3.18 | 150.1 | 2.23 | 2.44 | 2.65 | 2.35 | 2.36 | 2.15 | 2429
COVID19_MODERNA | Central nervous system haemorrhages and cerebrovascular accidents | 864 | 1.25 | 1.32 | 1.40 | 732.4 | 1.11 | 1.18 | 1.25 | 1.52 | 1.52 | 1.42 | 1934
COVID19_PFIZER/BIONTECH | Central nervous system haemorrhages and cerebrovascular accidents | 1011 | 1.79 | 1.88 | 1.98 | 616.5 | 1.55 | 1.64 | 1.72 | 2.32 | 2.33 | 2.18 | 1787
COVID19_UNKNOWN MFR | Central nervous system haemorrhages and cerebrovascular accidents | 16 | 2.06 | 3.21 | 4.58 | 4.7 | 1.75 | 2.71 | 4.22 | 3.96 | 4.01 | 2.65 | 2782
COVID19_JANSSEN | Central nervous system histopathology procedures | 1 | 0.03 | 0.43 | 1.23 | 2.8 | 0.16 | 0.52 | 1.31 | 0.32 | 0.32 | 0.06 | 49
COVID19_MODERNA | Central nervous system histopathology procedures | 4 | 0.25 | 0.71 | 1.35 | 5.9 | 0.34 | 0.71 | 1.34 | 0.30 | 0.30 | 0.13 | 46
COVID19_PFIZER/BIONTECH | Central nervous system histopathology procedures | 2 | 0.06 | 0.32 | 0.74 | 7.1 | 0.14 | 0.39 | 0.86 | 0.17 | 0.17 | 0.05 | 48
COVID19_UNKNOWN MFR | Central nervous system histopathology procedures | 0 | 0.00 | 0.67 | 3.79 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system imaging procedures | 575 | 1.85 | 1.98 | 2.12 | 353.7 | 1.51 | 1.62 | 1.73 | 1.64 | 1.65 | 1.54 | 5399
COVID19_MODERNA | Central nervous system imaging procedures | 1168 | 0.89 | 0.93 | 0.98 | 1425.1 | 0.78 | 0.82 | 0.86 | 0.83 | 0.82 | 0.78 | 4806
COVID19_PFIZER/BIONTECH | Central nervous system imaging procedures | 1317 | 1.19 | 1.24 | 1.30 | 1240.7 | 1.01 | 1.06 | 1.11 | 1.16 | 1.16 | 1.10 | 4657
COVID19_UNKNOWN MFR | Central nervous system imaging procedures | 21 | 1.73 | 2.55 | 3.50 | 8.8 | 1.44 | 2.07 | 2.91 | 2.43 | 2.46 | 1.71 | 5953
COVID19_JANSSEN | Central nervous system inflammatory disorders NEC | 1 | 0.07 | 0.41 | 0.97 | 4.0 | 0.11 | 0.41 | 1.06 | 0.29 | 0.29 | 0.06 | 53
COVID19_MODERNA | Central nervous system inflammatory disorders NEC | 3 | 0.12 | 0.35 | 0.68 | 10.1 | 0.16 | 0.38 | 0.77 | 0.20 | 0.20 | 0.08 | 51
COVID19_PFIZER/BIONTECH | Central nervous system inflammatory disorders NEC | 3 | 0.12 | 0.35 | 0.68 | 10.2 | 0.16 | 0.37 | 0.76 | 0.24 | 0.24 | 0.09 | 51
COVID19_UNKNOWN MFR | Central nervous system inflammatory disorders NEC | 0 | 0.05 | 0.92 | 2.74 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system neoplasms malignant NEC | 0 | 0.02 | 0.77 | 2.48 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Central nervous system neoplasms malignant NEC | 0 | 0.01 | 0.48 | 1.53 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Central nervous system neoplasms malignant NEC | 3 | 0.79 | 2.37 | 4.66 | 1.0 | 0.67 | 1.53 | 3.38 | 12.28 | 12.28 | 1.84 | 1
COVID19_UNKNOWN MFR | Central nervous system neoplasms malignant NEC | 0 | 0.03 | 0.99 | 3.18 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system vascular disorders NEC | 24 | 1.41 | 2.04 | 2.77 | 13.1 | 1.20 | 1.68 | 2.30 | 1.66 | 1.66 | 1.17 | 223
COVID19_MODERNA | Central nervous system vascular disorders NEC | 51 | 0.83 | 1.07 | 1.32 | 52.1 | 0.77 | 0.97 | 1.21 | 0.88 | 0.88 | 0.68 | 196
COVID19_PFIZER/BIONTECH | Central nervous system vascular disorders NEC | 58 | 1.10 | 1.38 | 1.69 | 47.5 | 0.97 | 1.20 | 1.48 | 1.26 | 1.26 | 0.98 | 189
COVID19_UNKNOWN MFR | Central nervous system vascular disorders NEC | 2 | 0.71 | 3.19 | 7.14 | 0.4 | 0.59 | 1.59 | 5.07 | 5.62 | 5.63 | 1.75 | 245
COVID19_JANSSEN | Cerebellar disorders congenital | 1 | 0.13 | 0.86 | 2.11 | 1.2 | 0.26 | 0.80 | 1.96 | 0.74 | 0.74 | 0.14 | 21
COVID19_MODERNA | Cerebellar disorders congenital | 4 | 0.37 | 0.97 | 1.79 | 3.9 | 0.46 | 0.94 | 1.78 | 0.76 | 0.76 | 0.30 | 18
COVID19_PFIZER/BIONTECH | Cerebellar disorders congenital | 4 | 0.40 | 1.03 | 1.91 | 3.5 | 0.48 | 0.99 | 1.87 | 0.91 | 0.91 | 0.37 | 18
COVID19_UNKNOWN MFR | Cerebellar disorders congenital | 0 | 0.03 | 0.97 | 3.11 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral disorders congenital | 0 | 0.04 | 0.37 | 0.99 | 2.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Cerebral disorders congenital | 3 | 0.22 | 0.61 | 1.15 | 6.0 | 0.25 | 0.57 | 1.15 | 0.22 | 0.22 | 0.08 | 47
COVID19_PFIZER/BIONTECH | Cerebral disorders congenital | 10 | 0.82 | 1.45 | 2.22 | 6.6 | 0.80 | 1.32 | 2.08 | 1.02 | 1.02 | 0.57 | 40
COVID19_UNKNOWN MFR | Cerebral disorders congenital | 0 | 0.10 | 0.95 | 2.55 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral injuries NEC | 34 | 1.28 | 1.73 | 2.24 | 20.9 | 1.16 | 1.54 | 2.01 | 1.65 | 1.65 | 1.23 | 318
COVID19_MODERNA | Cerebral injuries NEC | 76 | 0.84 | 1.02 | 1.22 | 79.7 | 0.78 | 0.95 | 1.14 | 0.94 | 0.94 | 0.76 | 276
COVID19_PFIZER/BIONTECH | Cerebral injuries NEC | 82 | 1.04 | 1.26 | 1.49 | 70.7 | 0.96 | 1.15 | 1.37 | 1.24 | 1.24 | 1.01 | 270
COVID19_UNKNOWN MFR | Cerebral injuries NEC | 3 | 0.88 | 2.47 | 4.72 | 0.5 | 0.81 | 2.09 | 6.96 | 5.91 | 5.93 | 2.28 | 349
COVID19_JANSSEN | Cerebrospinal fluid tests (excl microbiology) | 42 | 0.60 | 0.78 | 0.99 | 83.0 | 0.40 | 0.51 | 0.65 | 0.46 | 0.46 | 0.36 | 1410
COVID19_MODERNA | Cerebrospinal fluid tests (excl microbiology) | 69 | 0.35 | 0.43 | 0.52 | 221.9 | 0.26 | 0.32 | 0.38 | 0.17 | 0.17 | 0.14 | 1383
COVID19_PFIZER/BIONTECH | Cerebrospinal fluid tests (excl microbiology) | 85 | 0.45 | 0.54 | 0.64 | 232.4 | 0.31 | 0.37 | 0.44 | 0.26 | 0.25 | 0.21 | 1367
COVID19_UNKNOWN MFR | Cerebrospinal fluid tests (excl microbiology) | 0 | 0.01 | 0.33 | 1.14 | 1.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cerebrospinal fluid therapeutic procedures | 4 | 0.73 | 1.72 | 3.04 | 1.9 | 0.68 | 1.41 | 2.72 | 1.82 | 1.82 | 0.76 | 34
COVID19_MODERNA | Cerebrospinal fluid therapeutic procedures | 4 | 0.35 | 0.83 | 1.48 | 6.5 | 0.32 | 0.66 | 1.24 | 0.40 | 0.40 | 0.17 | 34
COVID19_PFIZER/BIONTECH | Cerebrospinal fluid therapeutic procedures | 7 | 0.65 | 1.27 | 2.05 | 6.4 | 0.56 | 1.01 | 1.70 | 0.92 | 0.92 | 0.46 | 31
COVID19_UNKNOWN MFR | Cerebrospinal fluid therapeutic procedures | 0 | 0.14 | 0.98 | 2.45 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cerebrovascular venous and sinus thrombosis | 65 | 6.58 | 8.17 | 9.90 | 11.2 | 4.56 | 5.66 | 6.94 | 12.09 | 12.11 | 9.22 | 83
COVID19_MODERNA | Cerebrovascular venous and sinus thrombosis | 29 | 0.70 | 0.98 | 1.30 | 43.9 | 0.49 | 0.67 | 0.89 | 0.83 | 0.83 | 0.59 | 119
COVID19_PFIZER/BIONTECH | Cerebrovascular venous and sinus thrombosis | 38 | 1.12 | 1.49 | 1.91 | 37.3 | 0.77 | 1.00 | 1.29 | 1.41 | 1.41 | 1.04 | 110
COVID19_UNKNOWN MFR | Cerebrovascular venous and sinus thrombosis | 1 | 0.25 | 2.65 | 7.19 | 0.2 | 0.38 | 1.18 | 3.38 | 4.68 | 4.68 | 0.90 | 147
COVID19_JANSSEN | Cervical spinal cord and nerve root disorders | 4 | 0.50 | 1.21 | 2.17 | 3.3 | 0.50 | 1.03 | 1.94 | 1.72 | 1.72 | 0.72 | 36
COVID19_MODERNA | Cervical spinal cord and nerve root disorders | 3 | 0.13 | 0.34 | 0.65 | 11.5 | 0.14 | 0.34 | 0.69 | 0.28 | 0.28 | 0.10 | 37
COVID19_PFIZER/BIONTECH | Cervical spinal cord and nerve root disorders | 6 | 0.32 | 0.66 | 1.11 | 10.0 | 0.34 | 0.63 | 1.10 | 0.72 | 0.72 | 0.35 | 34
COVID19_UNKNOWN MFR | Cervical spinal cord and nerve root disorders | 0 | 0.10 | 0.95 | 2.54 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cervix disorders NEC | 2 | 0.07 | 0.35 | 0.82 | 10.9 | 0.09 | 0.26 | 0.61 | 0.21 | 0.21 | 0.07 | 147
COVID19_MODERNA | Cervix disorders NEC | 1 | 0.01 | 0.08 | 0.22 | 20.0 | 0.01 | 0.06 | 0.25 | 0.02 | 0.02 | 0.00 | 148
COVID19_PFIZER/BIONTECH | Cervix disorders NEC | 5 | 0.13 | 0.32 | 0.59 | 26.0 | 0.11 | 0.23 | 0.43 | 0.14 | 0.14 | 0.07 | 144
COVID19_UNKNOWN MFR | Cervix disorders NEC | 0 | 0.00 | 0.42 | 2.40 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cervix infections and inflammations | 0 | 0.07 | 0.95 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Cervix infections and inflammations | 1 | 0.30 | 1.57 | 3.64 | 0.3 | 0.37 | 1.12 | 3.03 | 10.19 | 10.19 | 0.69 | 0
COVID19_PFIZER/BIONTECH | Cervix infections and inflammations | 0 | 0.06 | 0.85 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervix infections and inflammations | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cervix neoplasms | 1 | 0.32 | 1.79 | 4.24 | 0.2 | 0.39 | 1.25 | 4.22 | 15.44 | 15.44 | 1.51 | 1
COVID19_MODERNA | Cervix neoplasms | 0 | 0.04 | 0.69 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervix neoplasms | 0 | 0.04 | 0.72 | 2.15 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervix neoplasms | 0 | 0.05 | 1.00 | 2.99 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cervix neoplasms malignant | 0 | 0.00 | 0.01 | 0.07 | 4.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Cervix neoplasms malignant | 1 | 0.01 | 0.13 | 0.38 | 11.5 | 0.02 | 0.13 | 0.45 | 0.03 | 0.03 | 0.01 | 123
COVID19_PFIZER/BIONTECH | Cervix neoplasms malignant | 1 | 0.01 | 0.10 | 0.28 | 19.2 | 0.01 | 0.06 | 0.27 | 0.03 | 0.03 | 0.01 | 123
COVID19_UNKNOWN MFR | Cervix neoplasms malignant | 0 | 0.00 | 0.33 | 1.87 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cervix therapeutic procedures | 1 | 0.02 | 0.28 | 0.83 | 7.3 | 0.04 | 0.23 | 0.68 | 0.16 | 0.16 | 0.03 | 98
COVID19_MODERNA | Cervix therapeutic procedures | 0 | 0.00 | 0.01 | 0.05 | 7.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervix therapeutic procedures | 1 | 0.01 | 0.12 | 0.34 | 16.7 | 0.01 | 0.08 | 0.31 | 0.04 | 0.04 | 0.01 | 98
COVID19_UNKNOWN MFR | Cervix therapeutic procedures | 0 | 0.00 | 0.42 | 2.37 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cestode infections | 0 | 0.05 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Cestode infections | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cestode infections | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cestode infections | 0 | 0.05 | 1.00 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Chambers (anterior and posterior) and lens infections and inflammations | 0 | 0.00 | 0.50 | 1.94 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Chambers (anterior and posterior) and lens infections and inflammations | 1 | 0.07 | 0.64 | 1.68 | 1.4 | 0.24 | 0.75 | 1.84 | 0.49 | 0.49 | 0.08 | 7
COVID19_PFIZER/BIONTECH | Chambers (anterior and posterior) and lens infections and inflammations | 0 | 0.00 | 0.24 | 0.92 | 1.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chambers (anterior and posterior) and lens infections and inflammations | 0 | 0.00 | 0.98 | 3.80 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Chemical injuries | 0 | 0.09 | 0.76 | 1.96 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Chemical injuries | 2 | 0.33 | 1.05 | 2.11 | 1.2 | 0.43 | 1.09 | 2.38 | 1.13 | 1.13 | 0.30 | 6
COVID19_PFIZER/BIONTECH | Chemical injuries | 1 | 0.19 | 0.82 | 1.80 | 1.3 | 0.25 | 0.77 | 1.90 | 0.59 | 0.59 | 0.10 | 7
COVID19_UNKNOWN MFR | Chemical injuries | 0 | 0.12 | 0.99 | 2.57 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Chemistry analyses NEC | 5 | 0.16 | 0.35 | 0.60 | 19.5 | 0.15 | 0.30 | 0.56 | 0.23 | 0.23 | 0.11 | 342
COVID19_MODERNA | Chemistry analyses NEC | 25 | 0.32 | 0.45 | 0.60 | 60.5 | 0.31 | 0.43 | 0.58 | 0.26 | 0.26 | 0.19 | 322
COVID19_PFIZER/BIONTECH | Chemistry analyses NEC | 45 | 0.64 | 0.83 | 1.04 | 59.6 | 0.59 | 0.76 | 0.96 | 0.61 | 0.61 | 0.47 | 302
COVID19_UNKNOWN MFR | Chemistry analyses NEC | 0 | 0.12 | 0.80 | 1.97 | 0.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Chemotherapies | 5 | 0.32 | 0.72 | 1.24 | 8.3 | 0.33 | 0.64 | 1.15 | 0.53 | 0.53 | 0.25 | 145
COVID19_MODERNA | Chemotherapies | 6 | 0.18 | 0.36 | 0.61 | 19.2 | 0.19 | 0.36 | 0.63 | 0.14 | 0.14 | 0.07 | 144
COVID19_PFIZER/BIONTECH | Chemotherapies | 6 | 0.16 | 0.33 | 0.55 | 22.3 | 0.16 | 0.31 | 0.55 | 0.17 | 0.17 | 0.09 | 144
COVID19_UNKNOWN MFR | Chemotherapies | 0 | 0.09 | 0.87 | 2.31 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Chest and respiratory tract injuries NEC | 5 | 0.55 | 1.13 | 1.88 | 4.1 | 0.54 | 1.06 | 1.91 | 1.29 | 1.29 | 0.60 | 60
COVID19_MODERNA | Chest and respiratory tract injuries NEC | 20 | 0.85 | 1.25 | 1.72 | 16.2 | 0.82 | 1.18 | 1.65 | 1.51 | 1.51 | 0.97 | 45
COVID19_PFIZER/BIONTECH | Chest and respiratory tract injuries NEC | 18 | 0.85 | 1.27 | 1.77 | 14.2 | 0.82 | 1.20 | 1.72 | 1.57 | 1.57 | 0.99 | 47
COVID19_UNKNOWN MFR | Chest and respiratory tract injuries NEC | 0 | 0.23 | 0.96 | 2.10 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Chest wall and mediastinal therapeutic procedures | 3 | 0.41 | 1.20 | 2.34 | 2.7 | 0.43 | 0.97 | 1.94 | 0.95 | 0.95 | 0.36 | 49
COVID19_MODERNA | Chest wall and mediastinal therapeutic procedures | 9 | 0.56 | 1.04 | 1.63 | 10.7 | 0.49 | 0.83 | 1.34 | 0.71 | 0.71 | 0.39 | 43
COVID19_PFIZER/BIONTECH | Chest wall and mediastinal therapeutic procedures | 14 | 1.05 | 1.70 | 2.48 | 9.5 | 0.87 | 1.34 | 1.99 | 1.51 | 1.51 | 0.90 | 38
COVID19_UNKNOWN MFR | Chest wall and mediastinal therapeutic procedures | 0 | 0.04 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Chlamydial infections | 0 | 0.00 | 0.14 | 0.72 | 1.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Chlamydial infections | 1 | 0.02 | 0.24 | 0.68 | 4.5 | 0.09 | 0.37 | 0.97 | 0.17 | 0.17 | 0.03 | 20
COVID19_PFIZER/BIONTECH | Chlamydial infections | 0 | 0.00 | 0.05 | 0.25 | 4.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chlamydial infections | 0 | 0.00 | 0.88 | 4.45 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Chloride imbalance | 0 | 0.04 | 0.70 | 2.10 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Chloride imbalance | 0 | 0.02 | 0.38 | 1.15 | 1.6 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chloride imbalance | 0 | 0.02 | 0.42 | 1.26 | 1.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chloride imbalance | 0 | 0.05 | 0.99 | 2.97 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cholecystitis and cholelithiasis | 8 | 0.59 | 1.09 | 1.72 | 7.1 | 0.60 | 1.04 | 1.71 | 1.15 | 1.15 | 0.63 | 107
COVID19_MODERNA | Cholecystitis and cholelithiasis | 44 | 1.02 | 1.32 | 1.66 | 33.6 | 1.00 | 1.28 | 1.62 | 2.10 | 2.11 | 1.54 | 71
COVID19_PFIZER/BIONTECH | Cholecystitis and cholelithiasis | 30 | 0.79 | 1.09 | 1.42 | 28.2 | 0.77 | 1.04 | 1.39 | 1.45 | 1.45 | 1.02 | 85
COVID19_UNKNOWN MFR | Cholecystitis and cholelithiasis | 1 | 0.38 | 1.37 | 2.86 | 0.2 | 0.39 | 1.24 | 4.01 | 6.03 | 6.04 | 1.16 | 114
COVID19_JANSSEN | Cholestasis and jaundice | 3 | 0.08 | 0.25 | 0.48 | 17.5 | 0.09 | 0.22 | 0.47 | 0.16 | 0.16 | 0.06 | 288
COVID19_MODERNA | Cholestasis and jaundice | 28 | 0.48 | 0.67 | 0.89 | 45.7 | 0.46 | 0.62 | 0.83 | 0.36 | 0.36 | 0.26 | 263
COVID19_PFIZER/BIONTECH | Cholestasis and jaundice | 52 | 0.96 | 1.22 | 1.51 | 48.5 | 0.84 | 1.06 | 1.32 | 0.89 | 0.89 | 0.69 | 239
COVID19_UNKNOWN MFR | Cholestasis and jaundice | 0 | 0.03 | 0.70 | 2.17 | 0.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cholesterol analyses | 21 | 0.90 | 1.31 | 1.80 | 20.8 | 0.69 | 0.99 | 1.37 | 1.11 | 1.11 | 0.77 | 292
COVID19_MODERNA | Cholesterol analyses | 41 | 0.57 | 0.75 | 0.95 | 74.3 | 0.43 | 0.56 | 0.71 | 0.51 | 0.51 | 0.39 | 272
COVID19_PFIZER/BIONTECH | Cholesterol analyses | 105 | 1.79 | 2.11 | 2.46 | 66.1 | 1.33 | 1.56 | 1.83 | 2.07 | 2.07 | 1.70 | 208
COVID19_UNKNOWN MFR | Cholesterol analyses | 0 | 0.12 | 0.81 | 2.02 | 0.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Choreiform movements | 0 | 0.27 | 0.77 | 1.47 | 1.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Choreiform movements | 4 | 0.46 | 0.92 | 1.50 | 4.3 | 0.43 | 0.88 | 1.66 | 0.47 | 0.47 | 0.20 | 29
COVID19_PFIZER/BIONTECH | Choreiform movements | 5 | 0.55 | 1.04 | 1.66 | 4.4 | 0.52 | 1.01 | 1.83 | 0.73 | 0.73 | 0.33 | 28
COVID19_UNKNOWN MFR | Choreiform movements | 0 | 0.35 | 0.99 | 1.90 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Choroid and vitreous haemorrhages and vascular disorders | 1 | 0.19 | 1.03 | 2.44 | 1.0 | 0.28 | 0.84 | 2.08 | 1.54 | 1.54 | 0.28 | 10
COVID19_MODERNA | Choroid and vitreous haemorrhages and vascular disorders | 0 | 0.02 | 0.30 | 0.88 | 2.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Choroid and vitreous haemorrhages and vascular disorders | 2 | 0.23 | 0.83 | 1.74 | 2.6 | 0.31 | 0.77 | 1.66 | 0.91 | 0.91 | 0.25 | 9
COVID19_UNKNOWN MFR | Choroid and vitreous haemorrhages and vascular disorders | 0 | 0.06 | 0.98 | 2.90 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Choroid and vitreous structural change, deposit and degeneration | 32 | 1.28 | 1.74 | 2.27 | 18.6 | 1.21 | 1.62 | 2.13 | 2.01 | 2.01 | 1.48 | 246
COVID19_MODERNA | Choroid and vitreous structural change, deposit and degeneration | 74 | 0.86 | 1.05 | 1.26 | 73.2 | 0.83 | 1.00 | 1.21 | 1.23 | 1.23 | 0.99 | 204
COVID19_PFIZER/BIONTECH | Choroid and vitreous structural change, deposit and degeneration | 86 | 1.19 | 1.43 | 1.69 | 62.5 | 1.13 | 1.36 | 1.61 | 1.83 | 1.83 | 1.48 | 192
COVID19_UNKNOWN MFR | Choroid and vitreous structural change, deposit and degeneration | 0 | 0.07 | 0.75 | 2.02 | 0.5 |  |  |  |  |  |  | 
COVID19_JANSSEN | Chromosomal abnormalities NEC | 2 | 0.36 | 1.51 | 3.29 | 1.0 | 0.47 | 1.19 | 2.65 | 2.38 | 2.38 | 0.68 | 13
COVID19_MODERNA | Chromosomal abnormalities NEC | 2 | 0.18 | 0.75 | 1.64 | 2.1 | 0.35 | 0.87 | 1.87 | 0.52 | 0.52 | 0.15 | 13
COVID19_PFIZER/BIONTECH | Chromosomal abnormalities NEC | 1 | 0.06 | 0.44 | 1.10 | 2.5 | 0.17 | 0.55 | 1.39 | 0.29 | 0.29 | 0.05 | 14
COVID19_UNKNOWN MFR | Chromosomal abnormalities NEC | 0 | 0.01 | 0.96 | 3.39 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Chromosome analyses | 0 | 0.02 | 0.18 | 0.46 | 6.8 |  |  |  |  |  |  | 
COVID19_MODERNA | Chromosome analyses | 6 | 0.17 | 0.35 | 0.58 | 22.3 | 0.16 | 0.31 | 0.55 | 0.10 | 0.10 | 0.05 | 196
COVID19_PFIZER/BIONTECH | Chromosome analyses | 11 | 0.32 | 0.55 | 0.83 | 25.1 | 0.29 | 0.47 | 0.72 | 0.24 | 0.24 | 0.14 | 191
COVID19_UNKNOWN MFR | Chromosome analyses | 0 | 0.10 | 0.89 | 2.35 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Chronic polyneuropathies | 4 | 0.16 | 0.43 | 0.80 | 11.0 | 0.20 | 0.43 | 0.82 | 0.39 | 0.39 | 0.17 | 160
COVID19_MODERNA | Chronic polyneuropathies | 4 | 0.05 | 0.14 | 0.26 | 30.9 | 0.07 | 0.16 | 0.32 | 0.09 | 0.09 | 0.04 | 160
COVID19_PFIZER/BIONTECH | Chronic polyneuropathies | 15 | 0.31 | 0.50 | 0.72 | 31.1 | 0.33 | 0.50 | 0.74 | 0.41 | 0.41 | 0.26 | 149
COVID19_UNKNOWN MFR | Chronic polyneuropathies | 0 | 0.01 | 0.70 | 2.46 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Circulatory collapse and shock | 24 | 0.68 | 0.98 | 1.32 | 28.6 | 0.60 | 0.83 | 1.14 | 0.71 | 0.71 | 0.50 | 523
COVID19_MODERNA | Circulatory collapse and shock | 39 | 0.42 | 0.56 | 0.71 | 79.4 | 0.38 | 0.50 | 0.64 | 0.26 | 0.26 | 0.20 | 508
COVID19_PFIZER/BIONTECH | Circulatory collapse and shock | 73 | 0.83 | 1.01 | 1.22 | 83.1 | 0.72 | 0.88 | 1.06 | 0.63 | 0.63 | 0.51 | 474
COVID19_UNKNOWN MFR | Circulatory collapse and shock | 0 | 0.05 | 0.66 | 1.88 | 0.6 |  |  |  |  |  |  | 
COVID19_JANSSEN | Clostridia infections | 2 | 0.15 | 0.59 | 1.26 | 4.0 | 0.23 | 0.60 | 1.29 | 0.41 | 0.41 | 0.13 | 76
COVID19_MODERNA | Clostridia infections | 18 | 0.67 | 1.02 | 1.44 | 18.3 | 0.66 | 0.96 | 1.37 | 1.02 | 1.02 | 0.66 | 60
COVID19_PFIZER/BIONTECH | Clostridia infections | 22 | 1.02 | 1.49 | 2.04 | 15.5 | 0.95 | 1.34 | 1.85 | 1.61 | 1.61 | 1.06 | 56
COVID19_UNKNOWN MFR | Clostridia infections | 0 | 0.02 | 0.87 | 2.84 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation and bleeding analyses | 544 | 3.14 | 3.38 | 3.62 | 182.7 | 2.75 | 2.96 | 3.17 | 3.92 | 3.96 | 3.66 | 2143
COVID19_MODERNA | Coagulation and bleeding analyses | 624 | 0.88 | 0.94 | 1.00 | 726.9 | 0.80 | 0.86 | 0.92 | 1.03 | 1.03 | 0.95 | 2063
COVID19_PFIZER/BIONTECH | Coagulation and bleeding analyses | 809 | 1.36 | 1.44 | 1.52 | 624.0 | 1.22 | 1.30 | 1.37 | 1.76 | 1.77 | 1.65 | 1878
COVID19_UNKNOWN MFR | Coagulation and bleeding analyses | 15 | 1.87 | 2.95 | 4.22 | 4.4 | 1.70 | 2.67 | 4.22 | 3.86 | 3.91 | 2.55 | 2672
COVID19_JANSSEN | Coagulation disorders congenital | 8 | 1.01 | 1.85 | 2.90 | 3.3 | 1.01 | 1.78 | 3.00 | 3.34 | 3.34 | 1.76 | 37
COVID19_MODERNA | Coagulation disorders congenital | 12 | 0.60 | 0.99 | 1.45 | 12.2 | 0.60 | 0.95 | 1.45 | 1.24 | 1.24 | 0.71 | 33
COVID19_PFIZER/BIONTECH | Coagulation disorders congenital | 12 | 0.67 | 1.10 | 1.62 | 10.8 | 0.67 | 1.06 | 1.61 | 1.49 | 1.49 | 0.86 | 33
COVID19_UNKNOWN MFR | Coagulation disorders congenital | 0 | 0.19 | 0.97 | 2.23 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor deficiencies | 0 | 0.05 | 0.82 | 2.38 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Coagulation factor deficiencies | 2 | 0.43 | 1.55 | 3.22 | 1.1 | 0.46 | 1.15 | 2.55 | 3.40 | 3.40 | 0.66 | 2
COVID19_PFIZER/BIONTECH | Coagulation factor deficiencies | 0 | 0.04 | 0.58 | 1.69 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor deficiencies | 0 | 0.06 | 1.00 | 2.89 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Coagulopathies | 24 | 1.53 | 2.21 | 2.98 | 11.7 | 1.32 | 1.85 | 2.54 | 2.17 | 2.17 | 1.51 | 171
COVID19_MODERNA | Coagulopathies | 32 | 0.68 | 0.93 | 1.22 | 39.1 | 0.61 | 0.82 | 1.08 | 0.67 | 0.67 | 0.49 | 163
COVID19_PFIZER/BIONTECH | Coagulopathies | 43 | 1.01 | 1.32 | 1.66 | 37.5 | 0.87 | 1.13 | 1.43 | 1.16 | 1.16 | 0.87 | 152
COVID19_UNKNOWN MFR | Coagulopathies | 0 | 0.04 | 0.80 | 2.37 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Coccidioides infections | 0 | 0.03 | 0.79 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Coccidioides infections | 0 | 0.02 | 0.49 | 1.54 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coccidioides infections | 3 | 0.78 | 2.32 | 4.54 | 0.9 | 0.69 | 1.62 | 3.75 | 12.28 | 12.28 | 1.84 | 1
COVID19_UNKNOWN MFR | Coccidioides infections | 0 | 0.04 | 0.99 | 3.10 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cognitive and attention disorders and disturbances NEC | 8 | 0.74 | 1.37 | 2.14 | 5.3 | 0.74 | 1.29 | 2.13 | 1.67 | 1.67 | 0.91 | 74
COVID19_MODERNA | Cognitive and attention disorders and disturbances NEC | 12 | 0.51 | 0.84 | 1.24 | 15.0 | 0.50 | 0.80 | 1.21 | 0.58 | 0.58 | 0.35 | 70
COVID19_PFIZER/BIONTECH | Cognitive and attention disorders and disturbances NEC | 18 | 0.80 | 1.21 | 1.69 | 14.7 | 0.79 | 1.17 | 1.66 | 1.15 | 1.15 | 0.74 | 64
COVID19_UNKNOWN MFR | Cognitive and attention disorders and disturbances NEC | 0 | 0.18 | 0.95 | 2.23 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Colitis (excl infective) | 21 | 0.55 | 0.82 | 1.12 | 30.2 | 0.49 | 0.70 | 0.98 | 0.66 | 0.66 | 0.46 | 488
COVID19_MODERNA | Colitis (excl infective) | 91 | 0.85 | 1.02 | 1.20 | 95.6 | 0.80 | 0.95 | 1.12 | 0.74 | 0.74 | 0.61 | 418
COVID19_PFIZER/BIONTECH | Colitis (excl infective) | 99 | 1.02 | 1.21 | 1.41 | 91.9 | 0.91 | 1.07 | 1.26 | 0.99 | 0.99 | 0.82 | 410
COVID19_UNKNOWN MFR | Colitis (excl infective) | 0 | 0.04 | 0.63 | 1.80 | 0.7 |  |  |  |  |  |  | 
COVID19_JANSSEN | Colorectal neoplasms malignant | 1 | 0.30 | 1.16 | 2.48 | 0.7 | 0.31 | 0.92 | 2.29 | 1.19 | 1.19 | 0.22 | 13
COVID19_MODERNA | Colorectal neoplasms malignant | 2 | 0.24 | 0.73 | 1.43 | 2.8 | 0.30 | 0.75 | 1.62 | 0.57 | 0.57 | 0.16 | 12
COVID19_PFIZER/BIONTECH | Colorectal neoplasms malignant | 3 | 0.42 | 1.08 | 2.00 | 2.8 | 0.42 | 0.95 | 1.89 | 1.12 | 1.12 | 0.38 | 11
COVID19_UNKNOWN MFR | Colorectal neoplasms malignant | 0 | 0.15 | 0.99 | 2.43 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Colour blindness (incl acquired) | 7 | 1.02 | 2.04 | 3.35 | 3.2 | 0.90 | 1.62 | 2.79 | 3.09 | 3.09 | 1.56 | 35
COVID19_MODERNA | Colour blindness (incl acquired) | 7 | 0.42 | 0.84 | 1.38 | 9.0 | 0.43 | 0.78 | 1.31 | 0.68 | 0.68 | 0.34 | 35
COVID19_PFIZER/BIONTECH | Colour blindness (incl acquired) | 11 | 0.76 | 1.31 | 1.98 | 8.7 | 0.72 | 1.17 | 1.81 | 1.45 | 1.45 | 0.82 | 31
COVID19_UNKNOWN MFR | Colour blindness (incl acquired) | 0 | 0.06 | 0.95 | 2.74 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Coma states | 5 | 0.35 | 0.74 | 1.25 | 8.2 | 0.33 | 0.65 | 1.17 | 0.49 | 0.49 | 0.23 | 159
COVID19_MODERNA | Coma states | 16 | 0.48 | 0.74 | 1.05 | 23.5 | 0.46 | 0.69 | 1.00 | 0.37 | 0.37 | 0.24 | 148
COVID19_PFIZER/BIONTECH | Coma states | 20 | 0.59 | 0.87 | 1.20 | 25.2 | 0.55 | 0.79 | 1.11 | 0.57 | 0.57 | 0.38 | 144
COVID19_UNKNOWN MFR | Coma states | 0 | 0.17 | 0.90 | 2.10 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Communications disorders | 7 | 0.51 | 1.00 | 1.61 | 6.8 | 0.54 | 0.97 | 1.62 | 0.73 | 0.73 | 0.39 | 148
COVID19_MODERNA | Communications disorders | 38 | 1.05 | 1.40 | 1.78 | 28.9 | 0.98 | 1.28 | 1.65 | 1.10 | 1.10 | 0.81 | 117
COVID19_PFIZER/BIONTECH | Communications disorders | 30 | 0.88 | 1.20 | 1.58 | 26.7 | 0.81 | 1.10 | 1.45 | 0.98 | 0.98 | 0.70 | 125
COVID19_UNKNOWN MFR | Communications disorders | 0 | 0.12 | 0.90 | 2.28 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Complications associated with device NEC | 3 | 0.13 | 0.39 | 0.75 | 9.8 | 0.16 | 0.39 | 0.79 | 0.34 | 0.34 | 0.13 | 138
COVID19_MODERNA | Complications associated with device NEC | 23 | 0.54 | 0.78 | 1.06 | 30.3 | 0.54 | 0.76 | 1.05 | 0.66 | 0.66 | 0.46 | 118
COVID19_PFIZER/BIONTECH | Complications associated with device NEC | 19 | 0.46 | 0.70 | 0.97 | 29.0 | 0.46 | 0.67 | 0.94 | 0.64 | 0.64 | 0.43 | 122
COVID19_UNKNOWN MFR | Complications associated with device NEC | 0 | 0.03 | 0.80 | 2.50 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Conditions associated with abnormal gas exchange | 56 | 1.43 | 1.81 | 2.22 | 34.3 | 1.26 | 1.58 | 1.95 | 1.26 | 1.26 | 1.00 | 687
COVID19_MODERNA | Conditions associated with abnormal gas exchange | 237 | 1.25 | 1.40 | 1.55 | 189.2 | 1.12 | 1.25 | 1.39 | 1.59 | 1.59 | 1.40 | 506
COVID19_PFIZER/BIONTECH | Conditions associated with abnormal gas exchange | 267 | 1.73 | 1.92 | 2.12 | 157.5 | 1.52 | 1.68 | 1.86 | 2.30 | 2.30 | 2.03 | 476
COVID19_UNKNOWN MFR | Conditions associated with abnormal gas exchange | 3 | 0.66 | 1.84 | 3.50 | 1.2 | 0.63 | 1.42 | 3.00 | 2.79 | 2.80 | 1.08 | 740
COVID19_JANSSEN | Conditions caused by cold | 1 | 0.14 | 0.66 | 1.50 | 2.1 | 0.19 | 0.61 | 1.51 | 0.52 | 0.52 | 0.10 | 30
COVID19_MODERNA | Conditions caused by cold | 13 | 0.82 | 1.35 | 1.99 | 9.0 | 0.84 | 1.32 | 1.98 | 2.45 | 2.45 | 1.35 | 18
COVID19_PFIZER/BIONTECH | Conditions caused by cold | 13 | 0.97 | 1.59 | 2.34 | 7.5 | 0.97 | 1.51 | 2.28 | 2.96 | 2.96 | 1.62 | 18
COVID19_UNKNOWN MFR | Conditions caused by cold | 0 | 0.09 | 0.97 | 2.63 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Confusion and disorientation | 521 | 1.68 | 1.80 | 1.93 | 315.4 | 1.53 | 1.65 | 1.77 | 1.90 | 1.91 | 1.77 | 4240
COVID19_MODERNA | Confusion and disorientation | 1373 | 1.09 | 1.14 | 1.19 | 1293.0 | 1.01 | 1.06 | 1.11 | 1.38 | 1.38 | 1.31 | 3388
COVID19_PFIZER/BIONTECH | Confusion and disorientation | 1294 | 1.21 | 1.26 | 1.32 | 1102.1 | 1.12 | 1.17 | 1.23 | 1.53 | 1.53 | 1.45 | 3467
COVID19_UNKNOWN MFR | Confusion and disorientation | 9 | 0.69 | 1.20 | 1.84 | 7.6 | 0.65 | 1.09 | 1.75 | 1.30 | 1.31 | 0.75 | 4752
COVID19_JANSSEN | Congenital cardiovascular anomaly therapeutic procedures | 1 | 0.32 | 1.58 | 3.62 | 0.4 | 0.36 | 1.09 | 2.86 | 7.72 | 7.72 | 1.03 | 2
COVID19_MODERNA | Congenital cardiovascular anomaly therapeutic procedures | 0 | 0.05 | 0.64 | 1.79 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital cardiovascular anomaly therapeutic procedures | 1 | 0.25 | 1.23 | 2.81 | 1.0 | 0.28 | 0.84 | 2.07 | 2.05 | 2.05 | 0.27 | 2
COVID19_UNKNOWN MFR | Congenital cardiovascular anomaly therapeutic procedures | 0 | 0.08 | 1.00 | 2.78 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Congenital disorders NEC | 0 | 0.00 | 0.10 | 0.46 | 2.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Congenital disorders NEC | 2 | 0.12 | 0.56 | 1.28 | 4.3 | 0.22 | 0.56 | 1.23 | 0.09 | 0.09 | 0.03 | 74
COVID19_PFIZER/BIONTECH | Congenital disorders NEC | 4 | 0.35 | 0.97 | 1.84 | 5.4 | 0.36 | 0.75 | 1.42 | 0.23 | 0.23 | 0.10 | 72
COVID19_UNKNOWN MFR | Congenital disorders NEC | 0 | 0.00 | 0.80 | 3.79 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Conjunctival and corneal bleeding and vascular disorders | 9 | 0.68 | 1.25 | 1.96 | 7.2 | 0.67 | 1.13 | 1.82 | 1.31 | 1.31 | 0.74 | 106
COVID19_MODERNA | Conjunctival and corneal bleeding and vascular disorders | 34 | 0.86 | 1.16 | 1.50 | 30.5 | 0.82 | 1.09 | 1.43 | 1.43 | 1.43 | 1.02 | 81
COVID19_PFIZER/BIONTECH | Conjunctival and corneal bleeding and vascular disorders | 35 | 1.05 | 1.41 | 1.82 | 25.8 | 0.99 | 1.31 | 1.71 | 1.79 | 1.79 | 1.28 | 80
COVID19_UNKNOWN MFR | Conjunctival and corneal bleeding and vascular disorders | 2 | 0.68 | 2.39 | 4.94 | 0.2 | 0.68 | 2.25 | 11.68 | 12.17 | 12.20 | 3.77 | 113
COVID19_JANSSEN | Conjunctival infections, irritations and inflammations | 2 | 0.14 | 0.45 | 0.91 | 7.1 | 0.14 | 0.39 | 0.86 | 0.26 | 0.26 | 0.08 | 121
COVID19_MODERNA | Conjunctival infections, irritations and inflammations | 10 | 0.30 | 0.53 | 0.81 | 21.0 | 0.31 | 0.51 | 0.80 | 0.30 | 0.30 | 0.18 | 113
COVID19_PFIZER/BIONTECH | Conjunctival infections, irritations and inflammations | 14 | 0.46 | 0.74 | 1.07 | 21.1 | 0.44 | 0.68 | 1.00 | 0.53 | 0.53 | 0.33 | 109
COVID19_UNKNOWN MFR | Conjunctival infections, irritations and inflammations | 0 | 0.12 | 0.91 | 2.34 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Conjunctival structural change, deposit and degeneration | 1 | 0.32 | 1.14 | 2.38 | 0.6 | 0.33 | 0.98 | 2.48 | 1.72 | 1.72 | 0.30 | 9
COVID19_MODERNA | Conjunctival structural change, deposit and degeneration | 1 | 0.20 | 0.71 | 1.47 | 2.1 | 0.19 | 0.62 | 1.53 | 0.38 | 0.38 | 0.07 | 9
COVID19_PFIZER/BIONTECH | Conjunctival structural change, deposit and degeneration | 3 | 0.50 | 1.25 | 2.28 | 1.9 | 0.51 | 1.14 | 2.29 | 1.75 | 1.75 | 0.56 | 7
COVID19_UNKNOWN MFR | Conjunctival structural change, deposit and degeneration | 0 | 0.19 | 0.99 | 2.32 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Connective tissue disorders | 1 | 0.04 | 0.43 | 1.15 | 3.3 | 0.13 | 0.47 | 1.19 | 0.29 | 0.29 | 0.06 | 53
COVID19_MODERNA | Connective tissue disorders | 3 | 0.11 | 0.36 | 0.73 | 9.2 | 0.18 | 0.41 | 0.83 | 0.20 | 0.20 | 0.08 | 51
COVID19_PFIZER/BIONTECH | Connective tissue disorders | 6 | 0.33 | 0.73 | 1.26 | 9.1 | 0.37 | 0.69 | 1.19 | 0.51 | 0.51 | 0.25 | 48
COVID19_UNKNOWN MFR | Connective tissue disorders | 0 | 0.00 | 0.84 | 3.58 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Connective tissue disorders NEC | 3 | 0.05 | 0.16 | 0.31 | 26.6 | 0.05 | 0.14 | 0.32 | 0.10 | 0.10 | 0.04 | 456
COVID19_MODERNA | Connective tissue disorders NEC | 39 | 0.40 | 0.53 | 0.67 | 80.9 | 0.38 | 0.49 | 0.63 | 0.32 | 0.32 | 0.24 | 420
COVID19_PFIZER/BIONTECH | Connective tissue disorders NEC | 36 | 0.40 | 0.53 | 0.68 | 78.4 | 0.36 | 0.47 | 0.61 | 0.35 | 0.35 | 0.26 | 423
COVID19_UNKNOWN MFR | Connective tissue disorders NEC | 1 | 0.16 | 1.33 | 3.42 | 0.8 | 0.30 | 0.92 | 2.27 | 1.50 | 1.50 | 0.29 | 458
COVID19_JANSSEN | Connective tissue disorders congenital | 5 | 1.58 | 3.89 | 7.01 | 1.4 | 0.98 | 2.02 | 4.38 | 4.54 | 4.54 | 1.97 | 17
COVID19_MODERNA | Connective tissue disorders congenital | 1 | 0.04 | 0.40 | 1.10 | 3.2 | 0.14 | 0.48 | 1.22 | 0.16 | 0.16 | 0.03 | 21
COVID19_PFIZER/BIONTECH | Connective tissue disorders congenital | 1 | 0.04 | 0.39 | 1.05 | 3.7 | 0.12 | 0.43 | 1.12 | 0.20 | 0.20 | 0.04 | 21
COVID19_UNKNOWN MFR | Connective tissue disorders congenital | 0 | 0.00 | 0.92 | 4.20 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Contraceptive methods female | 9 | 2.25 | 4.18 | 6.59 | 2.3 | 1.45 | 2.64 | 5.01 | 8.17 | 8.18 | 4.15 | 17
COVID19_MODERNA | Contraceptive methods female | 3 | 0.18 | 0.53 | 1.05 | 9.4 | 0.17 | 0.40 | 0.82 | 0.44 | 0.44 | 0.16 | 23
COVID19_PFIZER/BIONTECH | Contraceptive methods female | 12 | 1.21 | 2.06 | 3.08 | 8.0 | 0.85 | 1.34 | 2.05 | 3.51 | 3.51 | 1.84 | 14
COVID19_UNKNOWN MFR | Contraceptive methods female | 0 | 0.03 | 0.97 | 3.08 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Coordination and balance disturbances | 390 | 1.31 | 1.42 | 1.54 | 282.2 | 1.27 | 1.38 | 1.50 | 1.36 | 1.36 | 1.25 | 4437
COVID19_MODERNA | Coordination and balance disturbances | 1160 | 0.92 | 0.96 | 1.01 | 1225.3 | 0.90 | 0.95 | 0.99 | 1.07 | 1.08 | 1.02 | 3667
COVID19_PFIZER/BIONTECH | Coordination and balance disturbances | 1122 | 1.06 | 1.12 | 1.17 | 1033.2 | 1.03 | 1.09 | 1.14 | 1.24 | 1.24 | 1.17 | 3705
COVID19_UNKNOWN MFR | Coordination and balance disturbances | 12 | 0.93 | 1.53 | 2.25 | 7.3 | 0.90 | 1.43 | 2.19 | 1.71 | 1.72 | 1.07 | 4815
COVID19_JANSSEN | Copper metabolism disorders | 0 | 0.03 | 0.88 | 2.75 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Copper metabolism disorders | 0 | 0.03 | 0.66 | 2.07 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Copper metabolism disorders | 0 | 0.03 | 0.69 | 2.17 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Copper metabolism disorders | 0 | 0.04 | 1.00 | 3.11 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Corneal and scleral disorders congenital | 0 | 0.05 | 0.94 | 2.81 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Corneal and scleral disorders congenital | 0 | 0.04 | 0.82 | 2.43 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal and scleral disorders congenital | 0 | 0.05 | 0.84 | 2.49 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal and scleral disorders congenital | 0 | 0.05 | 1.00 | 2.97 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Corneal and scleral therapeutic procedures | 0 | 0.03 | 0.69 | 2.11 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Corneal and scleral therapeutic procedures | 0 | 0.02 | 0.37 | 1.14 | 1.6 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal and scleral therapeutic procedures | 2 | 0.34 | 1.27 | 2.68 | 1.0 | 0.46 | 1.15 | 2.56 | 1.64 | 1.64 | 0.41 | 5
COVID19_UNKNOWN MFR | Corneal and scleral therapeutic procedures | 0 | 0.04 | 0.99 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Corneal disorders NEC | 0 | 0.02 | 0.69 | 2.23 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Corneal disorders NEC | 0 | 0.01 | 0.37 | 1.20 | 1.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal disorders NEC | 1 | 0.14 | 0.91 | 2.23 | 0.8 | 0.29 | 0.89 | 2.19 | 0.82 | 0.82 | 0.14 | 5
COVID19_UNKNOWN MFR | Corneal disorders NEC | 0 | 0.03 | 0.99 | 3.22 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Corneal infections, oedemas and inflammations | 1 | 0.05 | 0.37 | 0.93 | 4.9 | 0.08 | 0.34 | 0.92 | 0.21 | 0.21 | 0.04 | 73
COVID19_MODERNA | Corneal infections, oedemas and inflammations | 10 | 0.51 | 0.92 | 1.43 | 13.4 | 0.46 | 0.75 | 1.19 | 0.53 | 0.53 | 0.30 | 64
COVID19_PFIZER/BIONTECH | Corneal infections, oedemas and inflammations | 13 | 0.74 | 1.23 | 1.82 | 13.3 | 0.61 | 0.95 | 1.42 | 0.87 | 0.87 | 0.53 | 61
COVID19_UNKNOWN MFR | Corneal infections, oedemas and inflammations | 0 | 0.01 | 0.86 | 3.08 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Corneal structural change, deposit and degeneration | 0 | 0.03 | 0.38 | 1.09 | 1.9 |  |  |  |  |  |  | 
COVID19_MODERNA | Corneal structural change, deposit and degeneration | 2 | 0.14 | 0.47 | 0.98 | 5.4 | 0.18 | 0.48 | 1.06 | 0.19 | 0.19 | 0.06 | 36
COVID19_PFIZER/BIONTECH | Corneal structural change, deposit and degeneration | 3 | 0.21 | 0.61 | 1.17 | 6.3 | 0.24 | 0.55 | 1.11 | 0.35 | 0.35 | 0.13 | 35
COVID19_UNKNOWN MFR | Corneal structural change, deposit and degeneration | 0 | 0.07 | 0.96 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Coronary artery disorders NEC | 32 | 2.07 | 2.83 | 3.69 | 16.3 | 1.36 | 1.82 | 2.40 | 2.23 | 2.23 | 1.63 | 222
COVID19_MODERNA | Coronary artery disorders NEC | 73 | 1.38 | 1.69 | 2.03 | 64.3 | 0.93 | 1.12 | 1.35 | 1.37 | 1.37 | 1.09 | 181
COVID19_PFIZER/BIONTECH | Coronary artery disorders NEC | 90 | 2.01 | 2.41 | 2.84 | 56.4 | 1.31 | 1.56 | 1.85 | 2.25 | 2.25 | 1.81 | 164
COVID19_UNKNOWN MFR | Coronary artery disorders NEC | 0 | 0.05 | 0.78 | 2.30 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Coronavirus infections | 556 | 1.22 | 1.31 | 1.40 | 425.3 | 1.22 | 1.31 | 1.40 | 1.47 | 1.48 | 1.38 | 5830
COVID19_MODERNA | Coronavirus infections | 1422 | 1.13 | 1.18 | 1.23 | 1528.5 | 0.89 | 0.93 | 0.97 | 0.97 | 0.97 | 0.93 | 4964
COVID19_PFIZER/BIONTECH | Coronavirus infections | 4264 | 3.51 | 3.60 | 3.69 | 1399.7 | 2.97 | 3.04 | 3.12 | 8.23 | 8.49 | 8.13 | 2122
COVID19_UNKNOWN MFR | Coronavirus infections | 16 | 0.87 | 1.38 | 1.99 | 11.5 | 0.86 | 1.29 | 1.87 | 1.73 | 1.74 | 1.15 | 6370
COVID19_JANSSEN | Cortical dysfunction NEC | 106 | 1.19 | 1.40 | 1.63 | 79.9 | 1.12 | 1.31 | 1.53 | 1.17 | 1.17 | 0.99 | 1401
COVID19_MODERNA | Cortical dysfunction NEC | 382 | 1.08 | 1.17 | 1.27 | 336.6 | 1.04 | 1.13 | 1.23 | 1.15 | 1.15 | 1.05 | 1125
COVID19_PFIZER/BIONTECH | Cortical dysfunction NEC | 373 | 1.22 | 1.33 | 1.45 | 296.1 | 1.15 | 1.26 | 1.37 | 1.35 | 1.35 | 1.22 | 1134
COVID19_UNKNOWN MFR | Cortical dysfunction NEC | 2 | 0.31 | 1.02 | 2.06 | 2.0 | 0.35 | 0.88 | 1.90 | 0.91 | 0.91 | 0.28 | 1505
COVID19_JANSSEN | Corynebacteria infections | 0 | 0.00 | 0.05 | 0.29 | 1.8 |  |  |  |  |  |  | 
COVID19_MODERNA | Corynebacteria infections | 0 | 0.00 | 0.04 | 0.23 | 2.3 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corynebacteria infections | 1 | 0.02 | 0.26 | 0.76 | 5.1 | 0.08 | 0.34 | 0.90 | 0.10 | 0.10 | 0.02 | 40
COVID19_UNKNOWN MFR | Corynebacteria infections | 0 | 0.00 | 0.56 | 3.26 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Coughing and associated symptoms | 846 | 1.03 | 1.09 | 1.16 | 836.6 | 0.96 | 1.01 | 1.07 | 1.08 | 1.08 | 1.02 | 12111
COVID19_MODERNA | Coughing and associated symptoms | 2850 | 0.92 | 0.95 | 0.98 | 3136.1 | 0.88 | 0.91 | 0.94 | 0.96 | 0.96 | 0.92 | 10107
COVID19_PFIZER/BIONTECH | Coughing and associated symptoms | 3485 | 1.30 | 1.34 | 1.37 | 2777.8 | 1.22 | 1.25 | 1.29 | 1.51 | 1.52 | 1.47 | 9472
COVID19_UNKNOWN MFR | Coughing and associated symptoms | 22 | 0.79 | 1.15 | 1.56 | 20.6 | 0.73 | 1.04 | 1.44 | 1.17 | 1.17 | 0.82 | 12935
COVID19_JANSSEN | Counterfeit, falsified and substandard products | 0 | 0.00 | 0.56 | 2.21 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Counterfeit, falsified and substandard products | 0 | 0.00 | 0.26 | 1.01 | 1.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Counterfeit, falsified and substandard products | 0 | 0.00 | 0.29 | 1.12 | 1.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Counterfeit, falsified and substandard products | 0 | 0.00 | 0.98 | 3.85 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Coxiella infections | 0 | 0.00 | 0.42 | 1.91 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Coxiella infections | 0 | 0.00 | 0.16 | 0.74 | 1.6 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coxiella infections | 1 | 0.07 | 0.78 | 2.14 | 0.5 | 0.34 | 1.01 | 2.58 | 0.68 | 0.68 | 0.12 | 6
COVID19_UNKNOWN MFR | Coxiella infections | 0 | 0.00 | 0.97 | 4.39 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Coxsackie viral infections | 0 | 0.07 | 0.58 | 1.48 | 1.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Coxsackie viral infections | 0 | 0.05 | 0.37 | 0.95 | 2.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coxsackie viral infections | 1 | 0.11 | 0.48 | 1.05 | 3.9 | 0.11 | 0.41 | 1.07 | 0.07 | 0.07 | 0.01 | 56
COVID19_UNKNOWN MFR | Coxsackie viral infections | 0 | 0.13 | 0.98 | 2.51 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cranial nerve disorders NEC | 4 | 0.51 | 1.01 | 1.66 | 3.9 | 0.45 | 0.94 | 1.77 | 1.08 | 1.08 | 0.46 | 57
COVID19_MODERNA | Cranial nerve disorders NEC | 15 | 0.70 | 1.06 | 1.49 | 13.7 | 0.69 | 1.05 | 1.54 | 1.11 | 1.11 | 0.68 | 46
COVID19_PFIZER/BIONTECH | Cranial nerve disorders NEC | 8 | 0.42 | 0.73 | 1.11 | 12.2 | 0.39 | 0.68 | 1.11 | 0.62 | 0.62 | 0.33 | 53
COVID19_UNKNOWN MFR | Cranial nerve disorders NEC | 1 | 0.49 | 1.21 | 2.19 | 0.1 | 0.41 | 1.39 | 6.69 | 11.46 | 11.48 | 2.18 | 60
COVID19_JANSSEN | Cranial nerve injuries | 1 | 0.15 | 1.01 | 2.49 | 1.4 | 0.24 | 0.74 | 1.82 | 0.74 | 0.74 | 0.14 | 21
COVID19_MODERNA | Cranial nerve injuries | 4 | 0.37 | 0.98 | 1.81 | 4.2 | 0.43 | 0.89 | 1.67 | 0.76 | 0.76 | 0.30 | 18
COVID19_PFIZER/BIONTECH | Cranial nerve injuries | 2 | 0.17 | 0.66 | 1.42 | 4.0 | 0.23 | 0.60 | 1.31 | 0.41 | 0.41 | 0.12 | 20
COVID19_UNKNOWN MFR | Cranial nerve injuries | 1 | 0.34 | 2.25 | 5.56 | 0.0 | 0.44 | 1.60 | 11.17 | 32.75 | 32.79 | 6.08 | 21
COVID19_JANSSEN | Cranial nerve therapeutic procedures | 0 | 0.05 | 0.94 | 2.84 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Cranial nerve therapeutic procedures | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cranial nerve therapeutic procedures | 0 | 0.04 | 0.83 | 2.51 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cranial nerve therapeutic procedures | 0 | 0.05 | 1.00 | 3.01 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Crime victims | 1 | 0.26 | 1.62 | 3.95 | 0.3 | 0.38 | 1.16 | 3.29 | 3.86 | 3.86 | 0.61 | 4
COVID19_MODERNA | Crime victims | 0 | 0.01 | 0.42 | 1.35 | 1.1 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Crime victims | 0 | 0.01 | 0.46 | 1.47 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Crime victims | 0 | 0.03 | 0.99 | 3.18 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Criminal activity | 1 | 0.16 | 1.47 | 3.89 | 0.3 | 0.37 | 1.12 | 3.05 | 1.93 | 1.93 | 0.34 | 8
COVID19_MODERNA | Criminal activity | 1 | 0.06 | 0.58 | 1.53 | 0.7 | 0.32 | 0.95 | 2.38 | 0.42 | 0.42 | 0.07 | 8
COVID19_PFIZER/BIONTECH | Criminal activity | 0 | 0.00 | 0.19 | 0.79 | 1.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Criminal activity | 0 | 0.00 | 0.97 | 3.95 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cryptococcal infections | 0 | 0.00 | 0.54 | 2.19 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Cryptococcal infections | 0 | 0.00 | 0.24 | 0.97 | 1.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cryptococcal infections | 0 | 0.00 | 0.27 | 1.09 | 1.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cryptococcal infections | 0 | 0.00 | 0.98 | 3.96 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Crystal arthropathic disorders | 1 | 0.19 | 1.12 | 2.68 | 0.7 | 0.31 | 0.92 | 2.28 | 1.03 | 1.03 | 0.19 | 15
COVID19_MODERNA | Crystal arthropathic disorders | 7 | 0.75 | 1.51 | 2.49 | 4.9 | 0.69 | 1.23 | 2.07 | 2.64 | 2.64 | 1.15 | 9
COVID19_PFIZER/BIONTECH | Crystal arthropathic disorders | 0 | 0.01 | 0.21 | 0.66 | 3.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Crystal arthropathic disorders | 0 | 0.04 | 0.98 | 3.00 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cystic pancreatic disorders | 1 | 0.31 | 1.33 | 2.91 | 0.4 | 0.35 | 1.04 | 2.68 | 3.09 | 3.09 | 0.51 | 5
COVID19_MODERNA | Cystic pancreatic disorders | 3 | 0.58 | 1.56 | 2.91 | 1.8 | 0.53 | 1.19 | 2.41 | 3.40 | 3.40 | 0.89 | 3
COVID19_PFIZER/BIONTECH | Cystic pancreatic disorders | 2 | 0.41 | 1.30 | 2.59 | 1.4 | 0.41 | 1.03 | 2.26 | 2.05 | 2.05 | 0.49 | 4
COVID19_UNKNOWN MFR | Cystic pancreatic disorders | 0 | 0.13 | 1.00 | 2.55 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cytokine therapies | 0 | 0.03 | 0.88 | 2.76 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Cytokine therapies | 0 | 0.02 | 0.66 | 2.07 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cytokine therapies | 0 | 0.03 | 0.69 | 2.17 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytokine therapies | 0 | 0.04 | 1.00 | 3.13 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Cytomegaloviral infections | 0 | 0.00 | 0.25 | 0.91 | 1.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Cytomegaloviral infections | 1 | 0.04 | 0.35 | 0.89 | 3.8 | 0.12 | 0.43 | 1.10 | 0.07 | 0.07 | 0.01 | 51
COVID19_PFIZER/BIONTECH | Cytomegaloviral infections | 4 | 0.31 | 0.83 | 1.56 | 5.4 | 0.37 | 0.76 | 1.43 | 0.34 | 0.34 | 0.14 | 48
COVID19_UNKNOWN MFR | Cytomegaloviral infections | 1 | 0.32 | 2.51 | 6.43 | 0.1 | 0.43 | 1.51 | 9.18 | 13.49 | 13.50 | 2.56 | 51
COVID19_JANSSEN | Death and sudden death | 303 | 1.39 | 1.53 | 1.68 | 303.1 | 0.91 | 1.00 | 1.10 | 0.71 | 0.71 | 0.64 | 6612
COVID19_MODERNA | Death and sudden death | 1903 | 2.08 | 2.16 | 2.25 | 1387.9 | 1.32 | 1.37 | 1.42 | 1.29 | 1.29 | 1.24 | 5012
COVID19_PFIZER/BIONTECH | Death and sudden death | 1984 | 2.35 | 2.44 | 2.53 | 1278.3 | 1.49 | 1.55 | 1.61 | 1.65 | 1.66 | 1.59 | 4931
COVID19_UNKNOWN MFR | Death and sudden death | 20 | 1.69 | 2.52 | 3.49 | 10.9 | 1.15 | 1.66 | 2.33 | 2.00 | 2.02 | 1.39 | 6895
COVID19_JANSSEN | Decreased physical activity levels | 4 | 0.64 | 1.47 | 2.57 | 1.9 | 0.68 | 1.41 | 2.72 | 1.82 | 1.82 | 0.76 | 34
COVID19_MODERNA | Decreased physical activity levels | 7 | 0.51 | 0.97 | 1.56 | 7.4 | 0.50 | 0.90 | 1.52 | 0.77 | 0.77 | 0.39 | 31
COVID19_PFIZER/BIONTECH | Decreased physical activity levels | 4 | 0.30 | 0.68 | 1.18 | 6.9 | 0.30 | 0.63 | 1.19 | 0.48 | 0.48 | 0.20 | 34
COVID19_UNKNOWN MFR | Decreased physical activity levels | 0 | 0.18 | 0.98 | 2.30 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Deliria | 34 | 1.00 | 1.34 | 1.72 | 25.7 | 0.96 | 1.28 | 1.67 | 1.32 | 1.32 | 0.98 | 398
COVID19_MODERNA | Deliria | 127 | 1.08 | 1.25 | 1.44 | 107.4 | 1.01 | 1.17 | 1.35 | 1.41 | 1.41 | 1.19 | 305
COVID19_PFIZER/BIONTECH | Deliria | 86 | 0.82 | 0.99 | 1.16 | 93.2 | 0.77 | 0.92 | 1.09 | 1.02 | 1.02 | 0.83 | 346
COVID19_UNKNOWN MFR | Deliria | 2 | 0.53 | 1.42 | 2.65 | 0.7 | 0.52 | 1.33 | 3.12 | 3.20 | 3.20 | 1.00 | 430
COVID19_JANSSEN | Delusional disorders | 2 | 0.61 | 2.01 | 4.09 | 0.5 | 0.57 | 1.52 | 4.33 | 10.29 | 10.29 | 2.29 | 3
COVID19_MODERNA | Delusional disorders | 1 | 0.21 | 0.95 | 2.13 | 1.1 | 0.27 | 0.81 | 2.00 | 0.85 | 0.85 | 0.14 | 4
COVID19_PFIZER/BIONTECH | Delusional disorders | 1 | 0.22 | 1.01 | 2.27 | 1.2 | 0.26 | 0.79 | 1.95 | 1.02 | 1.02 | 0.16 | 4
COVID19_UNKNOWN MFR | Delusional disorders | 0 | 0.10 | 1.00 | 2.67 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Delusional symptoms | 10 | 0.82 | 1.33 | 1.94 | 6.4 | 0.82 | 1.35 | 2.14 | 1.68 | 1.68 | 0.97 | 92
COVID19_MODERNA | Delusional symptoms | 35 | 0.94 | 1.24 | 1.58 | 27.6 | 0.93 | 1.23 | 1.60 | 1.77 | 1.77 | 1.26 | 67
COVID19_PFIZER/BIONTECH | Delusional symptoms | 25 | 0.76 | 1.06 | 1.40 | 24.4 | 0.72 | 1.00 | 1.37 | 1.33 | 1.33 | 0.91 | 77
COVID19_UNKNOWN MFR | Delusional symptoms | 0 | 0.37 | 0.97 | 1.79 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Dementia (excl Alzheimer's type) | 1 | 0.06 | 0.38 | 0.93 | 5.5 | 0.07 | 0.31 | 0.85 | 0.12 | 0.12 | 0.02 | 131
COVID19_MODERNA | Dementia (excl Alzheimer's type) | 43 | 1.94 | 2.54 | 3.20 | 29.8 | 1.08 | 1.40 | 1.77 | 1.64 | 1.64 | 1.21 | 89
COVID19_PFIZER/BIONTECH | Dementia (excl Alzheimer's type) | 52 | 2.54 | 3.23 | 4.00 | 27.1 | 1.45 | 1.83 | 2.28 | 2.66 | 2.66 | 1.99 | 80
COVID19_UNKNOWN MFR | Dementia (excl Alzheimer's type) | 1 | 0.30 | 1.89 | 4.63 | 0.2 | 0.39 | 1.21 | 3.69 | 5.25 | 5.26 | 1.01 | 131
COVID19_JANSSEN | Demyelinating disorders NEC | 9 | 0.21 | 0.40 | 0.63 | 28.2 | 0.21 | 0.35 | 0.57 | 0.33 | 0.33 | 0.19 | 426
COVID19_MODERNA | Demyelinating disorders NEC | 9 | 0.08 | 0.14 | 0.23 | 65.9 | 0.09 | 0.15 | 0.25 | 0.07 | 0.07 | 0.04 | 426
COVID19_PFIZER/BIONTECH | Demyelinating disorders NEC | 25 | 0.28 | 0.39 | 0.53 | 70.8 | 0.26 | 0.37 | 0.50 | 0.25 | 0.25 | 0.18 | 410
COVID19_UNKNOWN MFR | Demyelinating disorders NEC | 0 | 0.01 | 0.55 | 1.90 | 0.5 |  |  |  |  |  |  | 
COVID19_JANSSEN | Dental and gingival therapeutic procedures | 4 | 0.59 | 1.35 | 2.36 | 2.4 | 0.60 | 1.24 | 2.36 | 1.54 | 1.54 | 0.65 | 40
COVID19_MODERNA | Dental and gingival therapeutic procedures | 4 | 0.21 | 0.48 | 0.85 | 10.6 | 0.21 | 0.45 | 0.85 | 0.34 | 0.34 | 0.14 | 40
COVID19_PFIZER/BIONTECH | Dental and gingival therapeutic procedures | 5 | 0.31 | 0.66 | 1.11 | 8.7 | 0.32 | 0.62 | 1.12 | 0.53 | 0.53 | 0.24 | 39
COVID19_UNKNOWN MFR | Dental and gingival therapeutic procedures | 0 | 0.18 | 0.97 | 2.28 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Dental and oral soft tissue infections | 4 | 0.17 | 0.44 | 0.82 | 11.5 | 0.19 | 0.41 | 0.79 | 0.31 | 0.31 | 0.14 | 197
COVID19_MODERNA | Dental and oral soft tissue infections | 39 | 0.84 | 1.11 | 1.42 | 37.3 | 0.79 | 1.03 | 1.32 | 0.82 | 0.82 | 0.61 | 162
COVID19_PFIZER/BIONTECH | Dental and oral soft tissue infections | 34 | 0.78 | 1.06 | 1.37 | 35.8 | 0.71 | 0.94 | 1.23 | 0.83 | 0.83 | 0.61 | 167
COVID19_UNKNOWN MFR | Dental and oral soft tissue infections | 1 | 0.27 | 1.63 | 3.96 | 0.3 | 0.37 | 1.13 | 3.10 | 3.44 | 3.44 | 0.66 | 200
COVID19_JANSSEN | Dental and periodontal infections and inflammations | 1 | 0.07 | 0.89 | 2.51 | 1.5 | 0.24 | 0.73 | 1.80 | 1.03 | 1.03 | 0.19 | 15
COVID19_MODERNA | Dental and periodontal infections and inflammations | 0 | 0.00 | 0.05 | 0.26 | 3.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dental and periodontal infections and inflammations | 2 | 0.13 | 0.64 | 1.48 | 3.3 | 0.27 | 0.68 | 1.47 | 0.59 | 0.59 | 0.17 | 14
COVID19_UNKNOWN MFR | Dental and periodontal infections and inflammations | 0 | 0.00 | 0.88 | 4.67 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Dental developmental disorders and anomalies | 0 | 0.06 | 0.95 | 2.73 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Dental developmental disorders and anomalies | 0 | 0.06 | 0.83 | 2.39 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dental developmental disorders and anomalies | 1 | 0.31 | 1.61 | 3.76 | 0.2 | 0.38 | 1.19 | 3.54 | 12.28 | 12.28 | 0.84 | 0
COVID19_UNKNOWN MFR | Dental developmental disorders and anomalies | 0 | 0.07 | 1.00 | 2.88 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Dental disorders NEC | 3 | 0.43 | 1.08 | 1.97 | 2.8 | 0.42 | 0.95 | 1.89 | 0.80 | 0.80 | 0.30 | 58
COVID19_MODERNA | Dental disorders NEC | 8 | 0.48 | 0.88 | 1.38 | 9.8 | 0.47 | 0.81 | 1.33 | 0.51 | 0.51 | 0.28 | 53
COVID19_PFIZER/BIONTECH | Dental disorders NEC | 9 | 0.58 | 1.03 | 1.59 | 9.2 | 0.56 | 0.94 | 1.51 | 0.71 | 0.71 | 0.39 | 52
COVID19_UNKNOWN MFR | Dental disorders NEC | 0 | 0.18 | 0.97 | 2.28 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Dental pain and sensation disorders | 66 | 1.31 | 1.62 | 1.96 | 40.9 | 1.28 | 1.57 | 1.91 | 1.86 | 1.86 | 1.50 | 548
COVID19_MODERNA | Dental pain and sensation disorders | 182 | 0.90 | 1.02 | 1.14 | 180.5 | 0.89 | 1.00 | 1.13 | 1.43 | 1.43 | 1.24 | 432
COVID19_PFIZER/BIONTECH | Dental pain and sensation disorders | 191 | 1.16 | 1.31 | 1.47 | 147.0 | 1.15 | 1.29 | 1.45 | 1.85 | 1.85 | 1.60 | 423
COVID19_UNKNOWN MFR | Dental pain and sensation disorders | 1 | 0.21 | 1.01 | 2.29 | 1.0 | 0.28 | 0.84 | 2.07 | 1.12 | 1.12 | 0.22 | 613
COVID19_JANSSEN | Dental surface disorders | 0 | 0.00 | 0.17 | 0.95 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Dental surface disorders | 0 | 0.00 | 0.04 | 0.25 | 2.8 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dental surface disorders | 3 | 0.37 | 1.31 | 2.71 | 2.5 | 0.45 | 1.00 | 2.00 | 1.36 | 1.36 | 0.46 | 9
COVID19_UNKNOWN MFR | Dental surface disorders | 0 | 0.00 | 0.90 | 5.08 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Dependents | 2 | 0.50 | 1.95 | 4.18 | 0.7 | 0.51 | 1.31 | 3.06 | 2.57 | 2.57 | 0.73 | 12
COVID19_MODERNA | Dependents | 1 | 0.13 | 0.86 | 2.10 | 1.3 | 0.25 | 0.76 | 1.87 | 0.26 | 0.26 | 0.05 | 13
COVID19_PFIZER/BIONTECH | Dependents | 0 | 0.01 | 0.32 | 1.03 | 1.7 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dependents | 0 | 0.03 | 0.98 | 3.17 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Depressive disorders | 55 | 1.07 | 1.36 | 1.67 | 48.5 | 0.89 | 1.12 | 1.38 | 1.17 | 1.17 | 0.93 | 729
COVID19_MODERNA | Depressive disorders | 102 | 0.61 | 0.72 | 0.84 | 156.1 | 0.56 | 0.66 | 0.77 | 0.51 | 0.51 | 0.43 | 682
COVID19_PFIZER/BIONTECH | Depressive disorders | 117 | 0.78 | 0.92 | 1.06 | 148.3 | 0.68 | 0.79 | 0.92 | 0.72 | 0.72 | 0.61 | 667
COVID19_UNKNOWN MFR | Depressive disorders | 0 | 0.00 | 0.39 | 1.40 | 1.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Dermal and epidermal conditions NEC | 895 | 0.70 | 0.74 | 0.78 | 1354.8 | 0.63 | 0.66 | 0.70 | 0.62 | 0.61 | 0.58 | 22215
COVID19_MODERNA | Dermal and epidermal conditions NEC | 6697 | 1.20 | 1.22 | 1.25 | 6179.1 | 1.06 | 1.08 | 1.11 | 1.39 | 1.41 | 1.37 | 16413
COVID19_PFIZER/BIONTECH | Dermal and epidermal conditions NEC | 2446 | 0.53 | 0.55 | 0.56 | 5036.7 | 0.47 | 0.49 | 0.50 | 0.49 | 0.47 | 0.46 | 20664
COVID19_UNKNOWN MFR | Dermal and epidermal conditions NEC | 21 | 0.53 | 0.76 | 1.02 | 32.7 | 0.46 | 0.65 | 0.91 | 0.63 | 0.62 | 0.43 | 23089
COVID19_JANSSEN | Dermatitis and eczema | 66 | 0.53 | 0.66 | 0.80 | 117.8 | 0.46 | 0.56 | 0.69 | 0.46 | 0.46 | 0.38 | 2202
COVID19_MODERNA | Dermatitis and eczema | 391 | 0.94 | 1.02 | 1.11 | 409.0 | 0.88 | 0.96 | 1.04 | 0.71 | 0.71 | 0.65 | 1877
COVID19_PFIZER/BIONTECH | Dermatitis and eczema | 231 | 0.61 | 0.68 | 0.75 | 386.6 | 0.54 | 0.60 | 0.67 | 0.46 | 0.46 | 0.41 | 2037
COVID19_UNKNOWN MFR | Dermatitis and eczema | 1 | 0.19 | 0.66 | 1.37 | 3.0 | 0.15 | 0.50 | 1.27 | 0.30 | 0.30 | 0.06 | 2267
COVID19_JANSSEN | Dermatitis ascribed to specific agent | 3 | 0.21 | 0.57 | 1.08 | 7.1 | 0.22 | 0.50 | 1.01 | 0.40 | 0.40 | 0.15 | 116
COVID19_MODERNA | Dermatitis ascribed to specific agent | 19 | 0.61 | 0.91 | 1.27 | 23.3 | 0.56 | 0.81 | 1.15 | 0.65 | 0.65 | 0.43 | 100
COVID19_PFIZER/BIONTECH | Dermatitis ascribed to specific agent | 11 | 0.35 | 0.59 | 0.89 | 22.3 | 0.32 | 0.52 | 0.81 | 0.42 | 0.42 | 0.25 | 108
COVID19_UNKNOWN MFR | Dermatitis ascribed to specific agent | 0 | 0.11 | 0.90 | 2.34 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Device information output issues | 0 | 0.05 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Device information output issues | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Device information output issues | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Device information output issues | 0 | 0.05 | 1.00 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Device issues NEC | 6 | 0.43 | 0.97 | 1.69 | 13.0 | 0.27 | 0.51 | 0.89 | 0.45 | 0.45 | 0.23 | 206
COVID19_MODERNA | Device issues NEC | 123 | 8.62 | 10.07 | 11.60 | 36.9 | 2.77 | 3.22 | 3.74 | 4.69 | 4.70 | 3.74 | 89
COVID19_PFIZER/BIONTECH | Device issues NEC | 15 | 0.67 | 1.08 | 1.57 | 35.6 | 0.29 | 0.44 | 0.65 | 0.31 | 0.31 | 0.20 | 197
COVID19_UNKNOWN MFR | Device issues NEC | 0 | 0.00 | 0.55 | 2.82 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Device malfunction events NEC | 4 | 0.54 | 1.32 | 2.39 | 2.5 | 0.58 | 1.20 | 2.28 | 1.67 | 1.67 | 0.70 | 37
COVID19_MODERNA | Device malfunction events NEC | 11 | 0.56 | 0.96 | 1.45 | 11.7 | 0.56 | 0.91 | 1.41 | 1.25 | 1.25 | 0.70 | 30
COVID19_PFIZER/BIONTECH | Device malfunction events NEC | 15 | 0.96 | 1.52 | 2.19 | 9.5 | 0.94 | 1.43 | 2.10 | 2.36 | 2.36 | 1.39 | 26
COVID19_UNKNOWN MFR | Device malfunction events NEC | 0 | 0.08 | 0.95 | 2.62 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Device physical property and chemical issues | 101 | 1.09 | 1.29 | 1.51 | 92.5 | 0.92 | 1.08 | 1.27 | 1.20 | 1.20 | 1.01 | 1304
COVID19_MODERNA | Device physical property and chemical issues | 393 | 1.46 | 1.59 | 1.72 | 299.2 | 1.21 | 1.31 | 1.42 | 1.32 | 1.32 | 1.20 | 1012
COVID19_PFIZER/BIONTECH | Device physical property and chemical issues | 201 | 0.79 | 0.89 | 1.00 | 270.5 | 0.66 | 0.74 | 0.83 | 0.68 | 0.68 | 0.60 | 1204
COVID19_UNKNOWN MFR | Device physical property and chemical issues | 0 | 0.00 | 0.27 | 0.93 | 1.8 |  |  |  |  |  |  | 
COVID19_JANSSEN | Diabetes mellitus (incl subtypes) | 21 | 0.60 | 0.89 | 1.22 | 26.5 | 0.56 | 0.79 | 1.10 | 0.74 | 0.74 | 0.51 | 440
COVID19_MODERNA | Diabetes mellitus (incl subtypes) | 64 | 0.72 | 0.90 | 1.09 | 74.3 | 0.70 | 0.86 | 1.05 | 0.55 | 0.55 | 0.44 | 397
COVID19_PFIZER/BIONTECH | Diabetes mellitus (incl subtypes) | 89 | 1.06 | 1.28 | 1.51 | 75.6 | 0.98 | 1.17 | 1.38 | 0.98 | 0.98 | 0.81 | 372
COVID19_UNKNOWN MFR | Diabetes mellitus (incl subtypes) | 0 | 0.04 | 0.64 | 1.87 | 0.6 |  |  |  |  |  |  | 
COVID19_JANSSEN | Diabetic complications NEC | 6 | 0.55 | 1.10 | 1.79 | 5.3 | 0.56 | 1.03 | 1.79 | 1.31 | 1.31 | 0.65 | 71
COVID19_MODERNA | Diabetic complications NEC | 24 | 0.85 | 1.22 | 1.63 | 19.6 | 0.84 | 1.18 | 1.61 | 1.54 | 1.54 | 1.03 | 53
COVID19_PFIZER/BIONTECH | Diabetic complications NEC | 27 | 1.09 | 1.52 | 2.02 | 17.1 | 1.08 | 1.48 | 2.00 | 2.21 | 2.21 | 1.49 | 50
COVID19_UNKNOWN MFR | Diabetic complications NEC | 1 | 0.40 | 1.38 | 2.84 | 0.1 | 0.41 | 1.33 | 5.47 | 9.05 | 9.06 | 1.73 | 76
COVID19_JANSSEN | Diabetic complications neurological | 0 | 0.04 | 0.88 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Diabetic complications neurological | 0 | 0.03 | 0.67 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diabetic complications neurological | 2 | 0.59 | 2.22 | 4.69 | 0.5 | 0.57 | 1.50 | 4.19 | 20.47 | 20.47 | 1.60 | 0
COVID19_UNKNOWN MFR | Diabetic complications neurological | 0 | 0.04 | 1.00 | 3.07 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Dialysis related complications | 0 | 0.04 | 0.84 | 2.54 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Dialysis related complications | 0 | 0.03 | 0.59 | 1.78 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dialysis related complications | 2 | 0.52 | 1.90 | 3.99 | 0.8 | 0.50 | 1.26 | 2.89 | 8.19 | 8.19 | 1.09 | 1
COVID19_UNKNOWN MFR | Dialysis related complications | 0 | 0.05 | 1.00 | 3.00 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Diaphragmatic disorders | 5 | 1.05 | 2.29 | 3.93 | 1.5 | 0.93 | 1.89 | 3.84 | 4.82 | 4.83 | 2.08 | 16
COVID19_MODERNA | Diaphragmatic disorders | 2 | 0.16 | 0.51 | 1.02 | 5.5 | 0.18 | 0.47 | 1.04 | 0.36 | 0.36 | 0.11 | 19
COVID19_PFIZER/BIONTECH | Diaphragmatic disorders | 7 | 0.72 | 1.41 | 2.29 | 4.8 | 0.69 | 1.24 | 2.09 | 2.05 | 2.05 | 0.96 | 14
COVID19_UNKNOWN MFR | Diaphragmatic disorders | 0 | 0.13 | 0.98 | 2.51 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Diaphragmatic hernias | 3 | 0.37 | 1.19 | 2.40 | 2.1 | 0.49 | 1.09 | 2.18 | 1.16 | 1.16 | 0.43 | 40
COVID19_MODERNA | Diaphragmatic hernias | 16 | 0.91 | 1.44 | 2.07 | 11.9 | 0.84 | 1.25 | 1.82 | 2.01 | 2.01 | 1.20 | 27
COVID19_PFIZER/BIONTECH | Diaphragmatic hernias | 17 | 1.15 | 1.79 | 2.55 | 10.0 | 1.03 | 1.53 | 2.20 | 2.68 | 2.68 | 1.60 | 26
COVID19_UNKNOWN MFR | Diaphragmatic hernias | 0 | 0.00 | 0.89 | 3.37 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Diaphragmatic therapeutic procedures | 1 | 0.34 | 1.87 | 4.44 | 0.0 | 0.44 | 1.62 | 11.68 | 46.31 | 46.32 | 3.16 | 0
COVID19_MODERNA | Diaphragmatic therapeutic procedures | 0 | 0.04 | 0.82 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diaphragmatic therapeutic procedures | 0 | 0.04 | 0.84 | 2.50 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diaphragmatic therapeutic procedures | 0 | 0.05 | 1.00 | 2.98 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Diarrhoea (excl infective) | 1398 | 1.28 | 1.34 | 1.40 | 1070.5 | 1.25 | 1.31 | 1.36 | 1.32 | 1.33 | 1.27 | 16349
COVID19_MODERNA | Diarrhoea (excl infective) | 4504 | 0.99 | 1.01 | 1.04 | 4429.0 | 0.99 | 1.02 | 1.04 | 1.16 | 1.16 | 1.13 | 13243
COVID19_PFIZER/BIONTECH | Diarrhoea (excl infective) | 4445 | 1.17 | 1.20 | 1.23 | 3764.6 | 1.15 | 1.18 | 1.21 | 1.37 | 1.38 | 1.34 | 13302
COVID19_UNKNOWN MFR | Diarrhoea (excl infective) | 46 | 1.36 | 1.75 | 2.19 | 25.9 | 1.33 | 1.70 | 2.14 | 1.79 | 1.83 | 1.43 | 17701
COVID19_JANSSEN | Dietary and nutritional issues | 1 | 0.14 | 0.59 | 1.29 | 2.8 | 0.16 | 0.52 | 1.31 | 0.29 | 0.29 | 0.06 | 53
COVID19_MODERNA | Dietary and nutritional issues | 20 | 1.19 | 1.76 | 2.43 | 11.4 | 1.10 | 1.59 | 2.23 | 2.00 | 2.00 | 1.26 | 34
COVID19_PFIZER/BIONTECH | Dietary and nutritional issues | 9 | 0.52 | 0.94 | 1.46 | 10.3 | 0.51 | 0.86 | 1.38 | 0.82 | 0.82 | 0.45 | 45
COVID19_UNKNOWN MFR | Dietary and nutritional issues | 0 | 0.12 | 0.96 | 2.44 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Dietary and nutritional therapies | 9 | 0.98 | 1.84 | 2.92 | 4.6 | 0.93 | 1.57 | 2.55 | 1.56 | 1.56 | 0.88 | 89
COVID19_MODERNA | Dietary and nutritional therapies | 24 | 0.90 | 1.30 | 1.77 | 18.0 | 0.91 | 1.27 | 1.73 | 1.10 | 1.10 | 0.75 | 74
COVID19_PFIZER/BIONTECH | Dietary and nutritional therapies | 17 | 0.68 | 1.05 | 1.50 | 16.3 | 0.68 | 1.01 | 1.46 | 0.86 | 0.86 | 0.55 | 81
COVID19_UNKNOWN MFR | Dietary and nutritional therapies | 1 | 0.29 | 2.42 | 6.27 | 0.1 | 0.41 | 1.36 | 6.18 | 7.09 | 7.10 | 1.36 | 97
COVID19_JANSSEN | Diffuse large B-cell lymphomas | 1 | 0.33 | 1.53 | 3.43 | 0.2 | 0.39 | 1.22 | 3.74 | 7.72 | 7.72 | 1.03 | 2
COVID19_MODERNA | Diffuse large B-cell lymphomas | 0 | 0.07 | 0.67 | 1.79 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diffuse large B-cell lymphomas | 1 | 0.26 | 1.21 | 2.72 | 0.6 | 0.33 | 0.99 | 2.48 | 2.05 | 2.05 | 0.27 | 2
COVID19_UNKNOWN MFR | Diffuse large B-cell lymphomas | 0 | 0.10 | 1.00 | 2.67 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Digestive enzymes | 44 | 1.17 | 1.52 | 1.90 | 28.6 | 1.16 | 1.48 | 1.88 | 1.78 | 1.78 | 1.37 | 381
COVID19_MODERNA | Digestive enzymes | 129 | 1.03 | 1.19 | 1.37 | 111.5 | 0.99 | 1.15 | 1.33 | 1.48 | 1.48 | 1.24 | 296
COVID19_PFIZER/BIONTECH | Digestive enzymes | 98 | 0.89 | 1.06 | 1.24 | 95.2 | 0.87 | 1.02 | 1.20 | 1.23 | 1.23 | 1.01 | 327
COVID19_UNKNOWN MFR | Digestive enzymes | 0 | 0.22 | 0.82 | 1.72 | 0.7 |  |  |  |  |  |  | 
COVID19_JANSSEN | Disability issues | 598 | 0.87 | 0.93 | 1.00 | 727.1 | 0.77 | 0.82 | 0.88 | 0.93 | 0.93 | 0.86 | 9948
COVID19_MODERNA | Disability issues | 2370 | 0.90 | 0.93 | 0.96 | 2837.1 | 0.81 | 0.84 | 0.86 | 0.98 | 0.98 | 0.95 | 8176
COVID19_PFIZER/BIONTECH | Disability issues | 2109 | 0.93 | 0.97 | 1.00 | 2445.3 | 0.83 | 0.86 | 0.89 | 1.02 | 1.02 | 0.98 | 8437
COVID19_UNKNOWN MFR | Disability issues | 16 | 0.68 | 1.06 | 1.50 | 17.0 | 0.61 | 0.92 | 1.34 | 1.05 | 1.05 | 0.69 | 10530
COVID19_JANSSEN | Disorders of purine metabolism | 11 | 0.52 | 0.89 | 1.34 | 12.4 | 0.54 | 0.87 | 1.35 | 0.92 | 0.92 | 0.55 | 185
COVID19_MODERNA | Disorders of purine metabolism | 65 | 1.01 | 1.26 | 1.52 | 52.1 | 1.00 | 1.23 | 1.50 | 1.69 | 1.69 | 1.31 | 131
COVID19_PFIZER/BIONTECH | Disorders of purine metabolism | 62 | 1.15 | 1.43 | 1.73 | 43.4 | 1.13 | 1.40 | 1.71 | 1.89 | 1.89 | 1.47 | 134
COVID19_UNKNOWN MFR | Disorders of purine metabolism | 0 | 0.09 | 0.81 | 2.12 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Dissociative states | 16 | 1.19 | 1.87 | 2.68 | 8.2 | 1.14 | 1.71 | 2.49 | 2.33 | 2.33 | 1.50 | 106
COVID19_MODERNA | Dissociative states | 35 | 0.82 | 1.11 | 1.43 | 31.8 | 0.82 | 1.08 | 1.40 | 1.37 | 1.37 | 0.98 | 87
COVID19_PFIZER/BIONTECH | Dissociative states | 33 | 0.88 | 1.20 | 1.55 | 27.6 | 0.87 | 1.16 | 1.52 | 1.52 | 1.52 | 1.09 | 89
COVID19_UNKNOWN MFR | Dissociative states | 1 | 0.30 | 1.66 | 3.92 | 0.2 | 0.39 | 1.23 | 3.95 | 5.69 | 5.69 | 1.09 | 121
COVID19_JANSSEN | Disturbances in consciousness NEC | 3380 | 1.79 | 1.84 | 1.89 | 2106.4 | 1.56 | 1.60 | 1.65 | 1.83 | 1.91 | 1.85 | 28553
COVID19_MODERNA | Disturbances in consciousness NEC | 6165 | 0.97 | 0.99 | 1.01 | 6884.4 | 0.88 | 0.90 | 0.91 | 0.81 | 0.80 | 0.79 | 25768
COVID19_PFIZER/BIONTECH | Disturbances in consciousness NEC | 6688 | 1.18 | 1.20 | 1.22 | 6256.8 | 1.05 | 1.07 | 1.09 | 1.08 | 1.09 | 1.06 | 25245
COVID19_UNKNOWN MFR | Disturbances in consciousness NEC | 45 | 0.86 | 1.10 | 1.37 | 45.5 | 0.77 | 0.98 | 1.24 | 0.97 | 0.97 | 0.75 | 31888
COVID19_JANSSEN | Disturbances in initiating and maintaining sleep | 698 | 1.85 | 1.97 | 2.10 | 436.1 | 1.50 | 1.60 | 1.70 | 1.75 | 1.76 | 1.65 | 6167
COVID19_MODERNA | Disturbances in initiating and maintaining sleep | 1124 | 0.74 | 0.77 | 0.81 | 1772.8 | 0.60 | 0.63 | 0.67 | 0.67 | 0.66 | 0.63 | 5741
COVID19_PFIZER/BIONTECH | Disturbances in initiating and maintaining sleep | 1126 | 0.88 | 0.93 | 0.97 | 1495.7 | 0.72 | 0.75 | 0.79 | 0.80 | 0.80 | 0.76 | 5739
COVID19_UNKNOWN MFR | Disturbances in initiating and maintaining sleep | 16 | 1.08 | 1.66 | 2.33 | 10.5 | 0.92 | 1.39 | 2.01 | 1.61 | 1.62 | 1.07 | 6849
COVID19_JANSSEN | Disturbances in sleep phase rhythm | 2 | 0.24 | 1.04 | 2.29 | 2.0 | 0.36 | 0.89 | 1.92 | 0.91 | 0.91 | 0.27 | 34
COVID19_MODERNA | Disturbances in sleep phase rhythm | 3 | 0.19 | 0.59 | 1.19 | 5.3 | 0.28 | 0.63 | 1.26 | 0.31 | 0.31 | 0.11 | 33
COVID19_PFIZER/BIONTECH | Disturbances in sleep phase rhythm | 7 | 0.60 | 1.24 | 2.07 | 5.7 | 0.61 | 1.10 | 1.84 | 0.99 | 0.99 | 0.49 | 29
COVID19_UNKNOWN MFR | Disturbances in sleep phase rhythm | 0 | 0.01 | 0.92 | 3.46 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Diverticula | 0 | 0.03 | 0.41 | 1.14 | 1.8 |  |  |  |  |  |  | 
COVID19_MODERNA | Diverticula | 17 | 0.91 | 1.40 | 1.98 | 12.3 | 0.87 | 1.28 | 1.85 | 2.40 | 2.40 | 1.43 | 24
COVID19_PFIZER/BIONTECH | Diverticula | 14 | 0.94 | 1.51 | 2.20 | 9.6 | 0.87 | 1.33 | 1.98 | 2.12 | 2.12 | 1.24 | 27
COVID19_UNKNOWN MFR | Diverticula | 1 | 0.35 | 1.75 | 4.03 | 0.1 | 0.43 | 1.49 | 8.76 | 17.20 | 17.21 | 3.25 | 40
COVID19_JANSSEN | Drug and chemical abuse | 0 | 0.06 | 0.90 | 2.59 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Drug and chemical abuse | 0 | 0.05 | 0.71 | 2.05 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug and chemical abuse | 1 | 0.27 | 1.40 | 3.25 | 0.6 | 0.33 | 0.99 | 2.51 | 4.09 | 4.09 | 0.40 | 1
COVID19_UNKNOWN MFR | Drug and chemical abuse | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Duodenal and small intestinal stenosis and obstruction | 2 | 0.23 | 0.78 | 1.60 | 3.0 | 0.28 | 0.71 | 1.53 | 0.62 | 0.62 | 0.19 | 50
COVID19_MODERNA | Duodenal and small intestinal stenosis and obstruction | 20 | 1.03 | 1.53 | 2.11 | 13.4 | 0.97 | 1.39 | 1.96 | 2.12 | 2.12 | 1.33 | 32
COVID19_PFIZER/BIONTECH | Duodenal and small intestinal stenosis and obstruction | 18 | 1.05 | 1.60 | 2.24 | 11.5 | 0.98 | 1.44 | 2.05 | 2.17 | 2.17 | 1.34 | 34
COVID19_UNKNOWN MFR | Duodenal and small intestinal stenosis and obstruction | 0 | 0.09 | 0.94 | 2.58 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Duodenal ulcers and perforation | 0 | 0.05 | 0.78 | 2.27 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Duodenal ulcers and perforation | 1 | 0.18 | 0.94 | 2.19 | 1.0 | 0.27 | 0.83 | 2.04 | 0.85 | 0.85 | 0.14 | 4
COVID19_PFIZER/BIONTECH | Duodenal ulcers and perforation | 1 | 0.19 | 1.01 | 2.36 | 1.0 | 0.28 | 0.84 | 2.07 | 1.02 | 1.02 | 0.16 | 4
COVID19_UNKNOWN MFR | Duodenal ulcers and perforation | 0 | 0.06 | 0.99 | 2.89 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Dyskinesias and movement disorders NEC | 283 | 1.34 | 1.48 | 1.63 | 209.5 | 1.22 | 1.34 | 1.48 | 1.21 | 1.21 | 1.10 | 3607
COVID19_MODERNA | Dyskinesias and movement disorders NEC | 659 | 0.89 | 0.95 | 1.02 | 721.5 | 0.86 | 0.91 | 0.97 | 0.69 | 0.69 | 0.64 | 3231
COVID19_PFIZER/BIONTECH | Dyskinesias and movement disorders NEC | 687 | 1.03 | 1.09 | 1.16 | 677.9 | 0.95 | 1.01 | 1.08 | 0.88 | 0.88 | 0.82 | 3203
COVID19_UNKNOWN MFR | Dyskinesias and movement disorders NEC | 9 | 0.94 | 1.69 | 2.61 | 5.1 | 0.87 | 1.47 | 2.37 | 1.60 | 1.60 | 0.92 | 3881
COVID19_JANSSEN | Dyspeptic signs and symptoms | 128 | 1.44 | 1.67 | 1.92 | 82.9 | 1.32 | 1.52 | 1.76 | 1.89 | 1.89 | 1.62 | 1047
COVID19_MODERNA | Dyspeptic signs and symptoms | 315 | 0.92 | 1.01 | 1.10 | 335.3 | 0.86 | 0.94 | 1.03 | 1.24 | 1.24 | 1.12 | 860
COVID19_PFIZER/BIONTECH | Dyspeptic signs and symptoms | 382 | 1.35 | 1.47 | 1.59 | 281.8 | 1.24 | 1.35 | 1.47 | 1.97 | 1.98 | 1.78 | 793
COVID19_UNKNOWN MFR | Dyspeptic signs and symptoms | 1 | 0.20 | 0.78 | 1.68 | 1.9 | 0.21 | 0.65 | 1.60 | 0.59 | 0.59 | 0.11 | 1174
COVID19_JANSSEN | Dyssomnias | 44 | 0.90 | 1.17 | 1.46 | 43.0 | 0.79 | 1.01 | 1.28 | 0.92 | 0.92 | 0.71 | 739
COVID19_MODERNA | Dyssomnias | 107 | 0.63 | 0.74 | 0.86 | 167.2 | 0.55 | 0.64 | 0.75 | 0.54 | 0.54 | 0.45 | 676
COVID19_PFIZER/BIONTECH | Dyssomnias | 101 | 0.67 | 0.80 | 0.93 | 146.3 | 0.59 | 0.69 | 0.81 | 0.61 | 0.61 | 0.51 | 682
COVID19_UNKNOWN MFR | Dyssomnias | 3 | 0.66 | 1.54 | 2.71 | 1.1 | 0.65 | 1.48 | 3.18 | 2.65 | 2.65 | 1.02 | 780
COVID19_JANSSEN | Dystonias | 6 | 0.33 | 0.67 | 1.11 | 11.7 | 0.30 | 0.56 | 0.97 | 0.30 | 0.30 | 0.15 | 311
COVID19_MODERNA | Dystonias | 15 | 0.37 | 0.58 | 0.83 | 29.0 | 0.35 | 0.54 | 0.79 | 0.17 | 0.17 | 0.11 | 302
COVID19_PFIZER/BIONTECH | Dystonias | 26 | 0.62 | 0.88 | 1.17 | 35.1 | 0.54 | 0.74 | 1.00 | 0.37 | 0.37 | 0.26 | 291
COVID19_UNKNOWN MFR | Dystonias | 0 | 0.14 | 0.89 | 2.16 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | ECG investigations | 965 | 1.77 | 1.87 | 1.97 | 691.9 | 1.32 | 1.39 | 1.47 | 1.76 | 1.78 | 1.68 | 8455
COVID19_MODERNA | ECG investigations | 2723 | 1.29 | 1.33 | 1.38 | 2683.5 | 0.98 | 1.01 | 1.05 | 1.38 | 1.39 | 1.34 | 6697
COVID19_PFIZER/BIONTECH | ECG investigations | 3321 | 1.88 | 1.93 | 1.99 | 2270.3 | 1.42 | 1.46 | 1.50 | 2.23 | 2.26 | 2.18 | 6099
COVID19_UNKNOWN MFR | ECG investigations | 27 | 1.49 | 2.08 | 2.75 | 15.6 | 1.18 | 1.61 | 2.17 | 1.98 | 2.01 | 1.46 | 9393
COVID19_JANSSEN | Ear and labyrinth histopathology procedures | 0 | 0.04 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Ear and labyrinth histopathology procedures | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ear and labyrinth histopathology procedures | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear and labyrinth histopathology procedures | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ear disorders NEC | 375 | 1.27 | 1.38 | 1.50 | 272.3 | 1.26 | 1.37 | 1.49 | 1.65 | 1.66 | 1.52 | 3505
COVID19_MODERNA | Ear disorders NEC | 1068 | 0.91 | 0.96 | 1.01 | 1117.6 | 0.91 | 0.96 | 1.00 | 1.29 | 1.29 | 1.22 | 2812
COVID19_PFIZER/BIONTECH | Ear disorders NEC | 1272 | 1.30 | 1.37 | 1.43 | 938.7 | 1.29 | 1.35 | 1.42 | 2.00 | 2.01 | 1.90 | 2608
COVID19_UNKNOWN MFR | Ear disorders NEC | 9 | 0.75 | 1.26 | 1.86 | 6.3 | 0.75 | 1.26 | 2.03 | 1.60 | 1.61 | 0.93 | 3871
COVID19_JANSSEN | Ear infections | 28 | 0.65 | 0.90 | 1.18 | 36.5 | 0.56 | 0.77 | 1.03 | 0.48 | 0.48 | 0.35 | 894
COVID19_MODERNA | Ear infections | 54 | 0.50 | 0.63 | 0.78 | 91.7 | 0.47 | 0.59 | 0.74 | 0.21 | 0.21 | 0.17 | 868
COVID19_PFIZER/BIONTECH | Ear infections | 86 | 0.77 | 0.92 | 1.09 | 109.5 | 0.66 | 0.79 | 0.93 | 0.42 | 0.42 | 0.35 | 836
COVID19_UNKNOWN MFR | Ear infections | 3 | 0.70 | 1.80 | 3.31 | 0.9 | 0.68 | 1.57 | 3.54 | 2.25 | 2.25 | 0.87 | 919
COVID19_JANSSEN | Ear injuries NEC | 2 | 0.53 | 1.50 | 2.88 | 0.4 | 0.58 | 1.58 | 4.88 | 3.86 | 3.86 | 1.05 | 8
COVID19_MODERNA | Ear injuries NEC | 1 | 0.20 | 0.71 | 1.47 | 2.2 | 0.19 | 0.60 | 1.48 | 0.38 | 0.38 | 0.07 | 9
COVID19_PFIZER/BIONTECH | Ear injuries NEC | 2 | 0.35 | 1.01 | 1.94 | 1.8 | 0.37 | 0.92 | 1.99 | 1.02 | 1.02 | 0.28 | 8
COVID19_UNKNOWN MFR | Ear injuries NEC | 0 | 0.19 | 0.99 | 2.30 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Eating disorders NEC | 23 | 1.15 | 1.65 | 2.22 | 13.5 | 1.12 | 1.58 | 2.17 | 1.16 | 1.16 | 0.82 | 305
COVID19_MODERNA | Eating disorders NEC | 23 | 0.37 | 0.52 | 0.70 | 48.7 | 0.35 | 0.49 | 0.67 | 0.26 | 0.26 | 0.18 | 305
COVID19_PFIZER/BIONTECH | Eating disorders NEC | 62 | 1.12 | 1.39 | 1.69 | 47.0 | 1.05 | 1.29 | 1.58 | 0.95 | 0.95 | 0.76 | 266
COVID19_UNKNOWN MFR | Eating disorders NEC | 0 | 0.23 | 0.90 | 1.92 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Echo viral infections | 0 | 0.06 | 0.83 | 2.34 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Echo viral infections | 0 | 0.04 | 0.57 | 1.60 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Echo viral infections | 0 | 0.05 | 0.60 | 1.70 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Echo viral infections | 0 | 0.08 | 1.00 | 2.80 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Economic circumstances | 0 | 0.04 | 0.84 | 2.56 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Economic circumstances | 0 | 0.03 | 0.58 | 1.78 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Economic circumstances | 0 | 0.03 | 0.62 | 1.88 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Economic circumstances | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ectoparasitic infestations | 1 | 0.33 | 1.05 | 2.10 | 0.7 | 0.31 | 0.93 | 2.32 | 0.97 | 0.97 | 0.18 | 16
COVID19_MODERNA | Ectoparasitic infestations | 2 | 0.28 | 0.75 | 1.40 | 3.2 | 0.27 | 0.68 | 1.48 | 0.45 | 0.45 | 0.13 | 15
COVID19_PFIZER/BIONTECH | Ectoparasitic infestations | 3 | 0.42 | 1.00 | 1.79 | 2.8 | 0.42 | 0.95 | 1.89 | 0.88 | 0.88 | 0.31 | 14
COVID19_UNKNOWN MFR | Ectoparasitic infestations | 0 | 0.23 | 0.99 | 2.19 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ectopic endocrine disorders | 0 | 0.07 | 0.95 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Ectopic endocrine disorders | 1 | 0.30 | 1.57 | 3.64 | 0.3 | 0.36 | 1.11 | 3.00 | 10.19 | 10.19 | 0.69 | 0
COVID19_PFIZER/BIONTECH | Ectopic endocrine disorders | 0 | 0.06 | 0.85 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ectopic endocrine disorders | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Educational issues | 5 | 1.00 | 2.47 | 4.47 | 2.8 | 0.68 | 1.34 | 2.44 | 1.15 | 1.15 | 0.54 | 67
COVID19_MODERNA | Educational issues | 1 | 0.02 | 0.26 | 0.73 | 5.1 | 0.08 | 0.33 | 0.89 | 0.05 | 0.05 | 0.01 | 71
COVID19_PFIZER/BIONTECH | Educational issues | 2 | 0.08 | 0.39 | 0.90 | 7.6 | 0.13 | 0.37 | 0.82 | 0.12 | 0.12 | 0.04 | 70
COVID19_UNKNOWN MFR | Educational issues | 0 | 0.00 | 0.82 | 4.10 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Electrolyte imbalance NEC | 4 | 0.50 | 1.38 | 2.62 | 3.5 | 0.48 | 1.00 | 1.88 | 0.90 | 0.90 | 0.38 | 69
COVID19_MODERNA | Electrolyte imbalance NEC | 13 | 0.64 | 1.07 | 1.59 | 16.5 | 0.50 | 0.79 | 1.18 | 0.74 | 0.74 | 0.45 | 60
COVID19_PFIZER/BIONTECH | Electrolyte imbalance NEC | 27 | 1.79 | 2.53 | 3.37 | 14.2 | 1.27 | 1.75 | 2.35 | 2.40 | 2.40 | 1.61 | 46
COVID19_UNKNOWN MFR | Electrolyte imbalance NEC | 0 | 0.00 | 0.84 | 3.48 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Elevated cholesterol | 0 | 0.00 | 0.33 | 1.34 | 0.9 |  |  |  |  |  |  | 
COVID19_MODERNA | Elevated cholesterol | 3 | 0.33 | 1.09 | 2.20 | 3.2 | 0.39 | 0.88 | 1.75 | 0.68 | 0.68 | 0.24 | 15
COVID19_PFIZER/BIONTECH | Elevated cholesterol | 1 | 0.05 | 0.47 | 1.24 | 3.3 | 0.13 | 0.47 | 1.19 | 0.24 | 0.24 | 0.04 | 17
COVID19_UNKNOWN MFR | Elevated cholesterol | 0 | 0.00 | 0.95 | 3.80 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Elevated cholesterol with elevated triglycerides | 0 | 0.05 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Elevated cholesterol with elevated triglycerides | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Elevated cholesterol with elevated triglycerides | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Elevated cholesterol with elevated triglycerides | 0 | 0.05 | 1.00 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Elevated triglycerides | 0 | 0.05 | 0.82 | 2.38 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Elevated triglycerides | 1 | 0.20 | 1.05 | 2.44 | 0.8 | 0.29 | 0.89 | 2.20 | 1.13 | 1.13 | 0.17 | 3
COVID19_PFIZER/BIONTECH | Elevated triglycerides | 1 | 0.21 | 1.11 | 2.61 | 0.9 | 0.29 | 0.88 | 2.17 | 1.36 | 1.36 | 0.20 | 3
COVID19_UNKNOWN MFR | Elevated triglycerides | 0 | 0.06 | 1.00 | 2.89 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Emotional and mood disturbances NEC | 136 | 1.14 | 1.32 | 1.50 | 123.3 | 0.95 | 1.10 | 1.26 | 0.50 | 0.50 | 0.43 | 4208
COVID19_MODERNA | Emotional and mood disturbances NEC | 258 | 0.73 | 0.81 | 0.90 | 346.3 | 0.67 | 0.75 | 0.82 | 0.21 | 0.21 | 0.19 | 4086
COVID19_PFIZER/BIONTECH | Emotional and mood disturbances NEC | 315 | 0.85 | 0.93 | 1.02 | 424.7 | 0.68 | 0.74 | 0.81 | 0.32 | 0.32 | 0.29 | 4029
COVID19_UNKNOWN MFR | Emotional and mood disturbances NEC | 2 | 0.39 | 0.92 | 1.62 | 3.1 | 0.28 | 0.70 | 1.52 | 0.32 | 0.32 | 0.10 | 4342
COVID19_JANSSEN | Employment issues | 1 | 0.12 | 0.78 | 1.94 | 1.8 | 0.22 | 0.67 | 1.66 | 0.74 | 0.74 | 0.14 | 21
COVID19_MODERNA | Employment issues | 2 | 0.12 | 0.48 | 1.04 | 5.7 | 0.18 | 0.46 | 1.02 | 0.34 | 0.34 | 0.10 | 20
COVID19_PFIZER/BIONTECH | Employment issues | 3 | 0.23 | 0.71 | 1.40 | 5.3 | 0.28 | 0.63 | 1.25 | 0.65 | 0.65 | 0.23 | 19
COVID19_UNKNOWN MFR | Employment issues | 0 | 0.02 | 0.96 | 3.19 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Encephalitis NEC | 4 | 0.26 | 0.63 | 1.12 | 8.1 | 0.27 | 0.56 | 1.05 | 0.40 | 0.40 | 0.18 | 153
COVID19_MODERNA | Encephalitis NEC | 7 | 0.21 | 0.42 | 0.67 | 19.7 | 0.22 | 0.40 | 0.67 | 0.16 | 0.16 | 0.08 | 150
COVID19_PFIZER/BIONTECH | Encephalitis NEC | 14 | 0.43 | 0.69 | 1.01 | 22.6 | 0.41 | 0.63 | 0.94 | 0.40 | 0.40 | 0.25 | 143
COVID19_UNKNOWN MFR | Encephalitis NEC | 0 | 0.11 | 0.89 | 2.30 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Encephalopathies NEC | 8 | 0.28 | 0.55 | 0.88 | 18.2 | 0.27 | 0.48 | 0.78 | 0.29 | 0.29 | 0.16 | 427
COVID19_MODERNA | Encephalopathies NEC | 58 | 0.89 | 1.11 | 1.36 | 54.7 | 0.84 | 1.05 | 1.29 | 0.52 | 0.52 | 0.41 | 377
COVID19_PFIZER/BIONTECH | Encephalopathies NEC | 50 | 0.76 | 0.97 | 1.21 | 59.4 | 0.67 | 0.84 | 1.05 | 0.53 | 0.53 | 0.42 | 385
COVID19_UNKNOWN MFR | Encephalopathies NEC | 3 | 1.02 | 3.15 | 6.23 | 0.6 | 0.79 | 2.03 | 6.57 | 4.78 | 4.79 | 1.84 | 432
COVID19_JANSSEN | Encephalopathies toxic and metabolic | 7 | 0.92 | 1.76 | 2.82 | 3.3 | 0.87 | 1.58 | 2.70 | 1.83 | 1.83 | 0.95 | 59
COVID19_MODERNA | Encephalopathies toxic and metabolic | 23 | 0.92 | 1.32 | 1.78 | 18.0 | 0.87 | 1.22 | 1.68 | 1.82 | 1.82 | 1.19 | 43
COVID19_PFIZER/BIONTECH | Encephalopathies toxic and metabolic | 16 | 0.75 | 1.16 | 1.65 | 14.4 | 0.71 | 1.06 | 1.54 | 1.31 | 1.31 | 0.82 | 50
COVID19_UNKNOWN MFR | Encephalopathies toxic and metabolic | 2 | 0.65 | 1.91 | 3.70 | 0.1 | 0.75 | 3.15 | 18.36 | 21.50 | 21.54 | 6.60 | 64
COVID19_JANSSEN | Endocardial bacterial infections | 0 | 0.04 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Endocardial bacterial infections | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endocardial bacterial infections | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endocardial bacterial infections | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Endocardial disorders NEC | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Endocardial disorders NEC | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endocardial disorders NEC | 0 | 0.04 | 0.83 | 2.53 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endocardial disorders NEC | 0 | 0.05 | 1.00 | 3.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Endocrine abnormalities of gonadal function NEC | 0 | 0.00 | 0.65 | 2.59 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Endocrine abnormalities of gonadal function NEC | 0 | 0.00 | 0.33 | 1.32 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endocrine abnormalities of gonadal function NEC | 0 | 0.00 | 0.36 | 1.45 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endocrine abnormalities of gonadal function NEC | 0 | 0.00 | 0.99 | 3.94 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Endocrine abnormalities of puberty | 0 | 0.08 | 0.88 | 2.41 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Endocrine abnormalities of puberty | 1 | 0.24 | 1.16 | 2.65 | 0.4 | 0.35 | 1.06 | 2.75 | 1.70 | 1.70 | 0.23 | 2
COVID19_PFIZER/BIONTECH | Endocrine abnormalities of puberty | 0 | 0.06 | 0.69 | 1.88 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endocrine abnormalities of puberty | 0 | 0.09 | 1.00 | 2.74 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Endocrine analyses and imaging NEC | 9 | 0.59 | 1.10 | 1.73 | 9.8 | 0.53 | 0.89 | 1.43 | 0.99 | 0.99 | 0.56 | 141
COVID19_MODERNA | Endocrine analyses and imaging NEC | 16 | 0.35 | 0.55 | 0.79 | 33.4 | 0.33 | 0.50 | 0.73 | 0.41 | 0.41 | 0.26 | 134
COVID19_PFIZER/BIONTECH | Endocrine analyses and imaging NEC | 24 | 0.63 | 0.92 | 1.24 | 30.8 | 0.56 | 0.78 | 1.07 | 0.78 | 0.78 | 0.54 | 126
COVID19_UNKNOWN MFR | Endocrine analyses and imaging NEC | 0 | 0.01 | 0.79 | 2.68 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Endocrine autoimmune disorders | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Endocrine autoimmune disorders | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endocrine autoimmune disorders | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endocrine autoimmune disorders | 0 | 0.05 | 1.00 | 3.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Endocrine disorders NEC | 0 | 0.00 | 0.52 | 2.17 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Endocrine disorders NEC | 0 | 0.00 | 0.23 | 0.94 | 1.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endocrine disorders NEC | 0 | 0.00 | 0.25 | 1.05 | 1.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endocrine disorders NEC | 0 | 0.00 | 0.98 | 4.07 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Endocrine disorders congenital NEC | 0 | 0.03 | 0.88 | 2.75 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Endocrine disorders congenital NEC | 0 | 0.03 | 0.66 | 2.07 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endocrine disorders congenital NEC | 0 | 0.03 | 0.69 | 2.17 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endocrine disorders congenital NEC | 0 | 0.04 | 1.00 | 3.11 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Endocrine neoplasms benign NEC | 0 | 0.02 | 0.70 | 2.22 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Endocrine neoplasms benign NEC | 2 | 0.34 | 1.29 | 2.74 | 1.6 | 0.39 | 0.97 | 2.11 | 1.70 | 1.70 | 0.41 | 4
COVID19_PFIZER/BIONTECH | Endocrine neoplasms benign NEC | 0 | 0.01 | 0.42 | 1.33 | 1.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endocrine neoplasms benign NEC | 0 | 0.03 | 0.99 | 3.13 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Endocrine neoplasms malignant and unspecified NEC | 1 | 0.21 | 1.11 | 2.58 | 0.8 | 0.30 | 0.91 | 2.26 | 1.29 | 1.29 | 0.23 | 12
COVID19_MODERNA | Endocrine neoplasms malignant and unspecified NEC | 0 | 0.02 | 0.38 | 1.11 | 1.8 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endocrine neoplasms malignant and unspecified NEC | 3 | 0.45 | 1.28 | 2.47 | 2.3 | 0.47 | 1.05 | 2.10 | 1.23 | 1.23 | 0.42 | 10
COVID19_UNKNOWN MFR | Endocrine neoplasms malignant and unspecified NEC | 0 | 0.06 | 0.98 | 2.85 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Endometrial neoplasms malignant | 0 | 0.10 | 0.86 | 2.25 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Endometrial neoplasms malignant | 2 | 0.45 | 1.46 | 2.94 | 1.0 | 0.47 | 1.17 | 2.61 | 3.40 | 3.40 | 0.66 | 2
COVID19_PFIZER/BIONTECH | Endometrial neoplasms malignant | 1 | 0.25 | 1.10 | 2.44 | 0.8 | 0.30 | 0.90 | 2.24 | 1.36 | 1.36 | 0.20 | 3
COVID19_UNKNOWN MFR | Endometrial neoplasms malignant | 0 | 0.11 | 1.00 | 2.62 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Enterobacter infections | 0 | 0.05 | 0.72 | 2.09 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Enterobacter infections | 0 | 0.03 | 0.41 | 1.18 | 1.6 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enterobacter infections | 3 | 0.58 | 1.66 | 3.20 | 1.0 | 0.65 | 1.49 | 3.24 | 3.07 | 3.07 | 0.87 | 4
COVID19_UNKNOWN MFR | Enterobacter infections | 0 | 0.06 | 0.99 | 2.88 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Enterococcal infections | 1 | 0.25 | 1.24 | 2.84 | 0.4 | 0.35 | 1.07 | 2.78 | 1.29 | 1.29 | 0.23 | 12
COVID19_MODERNA | Enterococcal infections | 2 | 0.27 | 0.93 | 1.90 | 2.5 | 0.31 | 0.78 | 1.69 | 0.62 | 0.62 | 0.17 | 11
COVID19_PFIZER/BIONTECH | Enterococcal infections | 3 | 0.46 | 1.28 | 2.45 | 2.1 | 0.49 | 1.11 | 2.22 | 1.23 | 1.23 | 0.42 | 10
COVID19_UNKNOWN MFR | Enterococcal infections | 0 | 0.08 | 0.99 | 2.75 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Enteroviral infections NEC | 0 | 0.00 | 0.17 | 0.80 | 1.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Enteroviral infections NEC | 1 | 0.07 | 0.73 | 1.99 | 1.2 | 0.26 | 0.78 | 1.92 | 0.09 | 0.09 | 0.02 | 40
COVID19_PFIZER/BIONTECH | Enteroviral infections NEC | 0 | 0.00 | 0.09 | 0.42 | 3.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enteroviral infections NEC | 0 | 0.00 | 0.88 | 4.00 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophilic disorders | 0 | 0.01 | 0.16 | 0.51 | 4.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Eosinophilic disorders | 11 | 0.49 | 0.85 | 1.29 | 13.4 | 0.51 | 0.82 | 1.26 | 0.47 | 0.47 | 0.28 | 80
COVID19_PFIZER/BIONTECH | Eosinophilic disorders | 10 | 0.44 | 0.78 | 1.21 | 14.1 | 0.44 | 0.72 | 1.13 | 0.51 | 0.51 | 0.29 | 81
COVID19_UNKNOWN MFR | Eosinophilic disorders | 0 | 0.03 | 0.88 | 2.81 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Epiphyseal disorders | 0 | 0.00 | 0.39 | 1.93 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Epiphyseal disorders | 0 | 0.00 | 0.15 | 0.72 | 1.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epiphyseal disorders | 0 | 0.00 | 0.17 | 0.82 | 1.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epiphyseal disorders | 0 | 0.00 | 0.96 | 4.76 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Epstein-Barr viral infections | 3 | 0.13 | 0.39 | 0.77 | 11.2 | 0.14 | 0.34 | 0.70 | 0.25 | 0.25 | 0.10 | 186
COVID19_MODERNA | Epstein-Barr viral infections | 20 | 0.54 | 0.81 | 1.13 | 29.5 | 0.48 | 0.69 | 0.96 | 0.40 | 0.40 | 0.27 | 169
COVID19_PFIZER/BIONTECH | Epstein-Barr viral infections | 21 | 0.57 | 0.85 | 1.16 | 30.7 | 0.48 | 0.69 | 0.96 | 0.51 | 0.51 | 0.35 | 168
COVID19_UNKNOWN MFR | Epstein-Barr viral infections | 1 | 0.28 | 1.74 | 4.24 | 0.3 | 0.37 | 1.16 | 3.25 | 3.66 | 3.66 | 0.70 | 188
COVID19_JANSSEN | Erection and ejaculation conditions and disorders | 11 | 0.88 | 1.52 | 2.30 | 9.0 | 0.70 | 1.14 | 1.76 | 2.26 | 2.27 | 1.33 | 75
COVID19_MODERNA | Erection and ejaculation conditions and disorders | 18 | 0.81 | 1.24 | 1.74 | 18.3 | 0.66 | 0.96 | 1.37 | 0.90 | 0.90 | 0.58 | 68
COVID19_PFIZER/BIONTECH | Erection and ejaculation conditions and disorders | 25 | 1.12 | 1.60 | 2.15 | 19.6 | 0.88 | 1.22 | 1.66 | 1.68 | 1.68 | 1.14 | 61
COVID19_UNKNOWN MFR | Erection and ejaculation conditions and disorders | 0 | 0.05 | 0.88 | 2.59 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Erythemas | 617 | 0.39 | 0.42 | 0.45 | 1802.4 | 0.32 | 0.34 | 0.37 | 0.30 | 0.29 | 0.27 | 31978
COVID19_MODERNA | Erythemas | 8193 | 1.15 | 1.17 | 1.19 | 8707.4 | 0.92 | 0.94 | 0.96 | 1.14 | 1.15 | 1.12 | 24402
COVID19_PFIZER/BIONTECH | Erythemas | 3164 | 0.55 | 0.56 | 0.58 | 6959.0 | 0.44 | 0.46 | 0.47 | 0.44 | 0.43 | 0.41 | 29431
COVID19_UNKNOWN MFR | Erythemas | 22 | 0.44 | 0.64 | 0.86 | 45.5 | 0.35 | 0.50 | 0.69 | 0.47 | 0.45 | 0.32 | 32573
COVID19_JANSSEN | Escherichia infections | 3 | 0.32 | 0.94 | 1.82 | 3.5 | 0.37 | 0.83 | 1.65 | 0.52 | 0.52 | 0.20 | 89
COVID19_MODERNA | Escherichia infections | 6 | 0.24 | 0.51 | 0.86 | 14.4 | 0.25 | 0.47 | 0.81 | 0.24 | 0.24 | 0.12 | 86
COVID19_PFIZER/BIONTECH | Escherichia infections | 22 | 1.22 | 1.78 | 2.44 | 13.9 | 1.04 | 1.47 | 2.04 | 1.29 | 1.29 | 0.86 | 70
COVID19_UNKNOWN MFR | Escherichia infections | 0 | 0.04 | 0.90 | 2.75 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Eustachian tube disorders | 2 | 0.40 | 0.99 | 1.79 | 2.2 | 0.34 | 0.85 | 1.84 | 1.03 | 1.03 | 0.31 | 30
COVID19_MODERNA | Eustachian tube disorders | 9 | 0.56 | 0.96 | 1.45 | 9.8 | 0.53 | 0.89 | 1.43 | 1.33 | 1.33 | 0.70 | 23
COVID19_PFIZER/BIONTECH | Eustachian tube disorders | 9 | 0.66 | 1.13 | 1.71 | 7.9 | 0.63 | 1.06 | 1.70 | 1.60 | 1.60 | 0.84 | 23
COVID19_UNKNOWN MFR | Eustachian tube disorders | 0 | 0.29 | 0.99 | 2.01 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Exfoliative conditions | 56 | 0.88 | 1.10 | 1.35 | 55.4 | 0.80 | 1.00 | 1.24 | 0.97 | 0.97 | 0.78 | 889
COVID19_MODERNA | Exfoliative conditions | 199 | 0.84 | 0.95 | 1.06 | 237.6 | 0.74 | 0.84 | 0.94 | 0.91 | 0.91 | 0.79 | 746
COVID19_PFIZER/BIONTECH | Exfoliative conditions | 139 | 0.69 | 0.79 | 0.90 | 199.1 | 0.61 | 0.70 | 0.80 | 0.71 | 0.71 | 0.61 | 806
COVID19_UNKNOWN MFR | Exfoliative conditions | 0 | 0.30 | 0.79 | 1.47 | 1.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Exposures associated with pregnancy, delivery and lactation | 152 | 0.51 | 0.58 | 0.66 | 394.6 | 0.34 | 0.39 | 0.44 | 0.50 | 0.50 | 0.43 | 4705
COVID19_MODERNA | Exposures associated with pregnancy, delivery and lactation | 589 | 0.66 | 0.71 | 0.76 | 1238.7 | 0.45 | 0.48 | 0.51 | 0.47 | 0.47 | 0.43 | 4268
COVID19_PFIZER/BIONTECH | Exposures associated with pregnancy, delivery and lactation | 730 | 0.86 | 0.91 | 0.97 | 1192.0 | 0.58 | 0.61 | 0.65 | 0.72 | 0.72 | 0.68 | 4127
COVID19_UNKNOWN MFR | Exposures associated with pregnancy, delivery and lactation | 2 | 0.09 | 0.37 | 0.80 | 8.3 | 0.12 | 0.34 | 0.76 | 0.28 | 0.28 | 0.09 | 4855
COVID19_JANSSEN | Exposures to agents or circumstances NEC | 19 | 0.85 | 1.30 | 1.81 | 27.0 | 0.49 | 0.71 | 1.00 | 0.78 | 0.78 | 0.53 | 374
COVID19_MODERNA | Exposures to agents or circumstances NEC | 53 | 0.98 | 1.25 | 1.54 | 84.9 | 0.50 | 0.63 | 0.78 | 0.53 | 0.53 | 0.42 | 340
COVID19_PFIZER/BIONTECH | Exposures to agents or circumstances NEC | 244 | 5.19 | 5.79 | 6.41 | 81.7 | 2.64 | 2.94 | 3.26 | 6.70 | 6.72 | 5.66 | 149
COVID19_UNKNOWN MFR | Exposures to agents or circumstances NEC | 0 | 0.00 | 0.59 | 2.21 | 0.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | External ear disorders NEC | 1 | 0.10 | 0.43 | 0.97 | 4.6 | 0.09 | 0.37 | 0.97 | 0.24 | 0.24 | 0.05 | 65
COVID19_MODERNA | External ear disorders NEC | 17 | 0.69 | 1.07 | 1.51 | 17.3 | 0.65 | 0.96 | 1.38 | 1.18 | 1.18 | 0.74 | 49
COVID19_PFIZER/BIONTECH | External ear disorders NEC | 26 | 1.28 | 1.81 | 2.42 | 15.0 | 1.17 | 1.61 | 2.18 | 2.66 | 2.66 | 1.76 | 40
COVID19_UNKNOWN MFR | External ear disorders NEC | 0 | 0.10 | 0.94 | 2.50 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | External ear disorders congenital | 1 | 0.29 | 1.75 | 4.20 | 0.2 | 0.39 | 1.21 | 3.69 | 7.72 | 7.72 | 1.03 | 2
COVID19_MODERNA | External ear disorders congenital | 0 | 0.02 | 0.57 | 1.77 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | External ear disorders congenital | 0 | 0.02 | 0.61 | 1.88 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | External ear disorders congenital | 0 | 0.04 | 1.00 | 3.08 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | External ear infections and inflammations | 0 | 0.14 | 0.77 | 1.83 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | External ear infections and inflammations | 3 | 0.44 | 1.12 | 2.05 | 2.6 | 0.44 | 0.98 | 1.97 | 1.27 | 1.27 | 0.42 | 8
COVID19_PFIZER/BIONTECH | External ear infections and inflammations | 4 | 0.64 | 1.47 | 2.58 | 2.2 | 0.63 | 1.30 | 2.48 | 2.34 | 2.34 | 0.83 | 7
COVID19_UNKNOWN MFR | External ear infections and inflammations | 0 | 0.18 | 0.99 | 2.36 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | External ear therapeutic procedures | 3 | 0.59 | 1.47 | 2.67 | 1.4 | 0.59 | 1.34 | 2.77 | 2.57 | 2.57 | 0.92 | 18
COVID19_MODERNA | External ear therapeutic procedures | 5 | 0.43 | 0.90 | 1.52 | 5.5 | 0.45 | 0.88 | 1.58 | 1.06 | 1.06 | 0.46 | 16
COVID19_PFIZER/BIONTECH | External ear therapeutic procedures | 7 | 0.69 | 1.31 | 2.09 | 4.7 | 0.71 | 1.27 | 2.14 | 2.05 | 2.05 | 0.96 | 14
COVID19_UNKNOWN MFR | External ear therapeutic procedures | 0 | 0.19 | 0.99 | 2.29 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Extranodal marginal zone B-cell lymphomas (low grade B-cell) | 0 | 0.06 | 0.95 | 2.73 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Extranodal marginal zone B-cell lymphomas (low grade B-cell) | 0 | 0.06 | 0.83 | 2.39 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Extranodal marginal zone B-cell lymphomas (low grade B-cell) | 1 | 0.31 | 1.61 | 3.76 | 0.2 | 0.39 | 1.24 | 4.05 | 12.28 | 12.28 | 0.84 | 0
COVID19_UNKNOWN MFR | Extranodal marginal zone B-cell lymphomas (low grade B-cell) | 0 | 0.07 | 1.00 | 2.88 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Extremity deformities | 1 | 0.16 | 0.60 | 1.27 | 3.2 | 0.14 | 0.48 | 1.23 | 0.25 | 0.25 | 0.05 | 63
COVID19_MODERNA | Extremity deformities | 11 | 0.75 | 1.27 | 1.90 | 7.6 | 0.80 | 1.30 | 2.01 | 0.71 | 0.71 | 0.41 | 53
COVID19_PFIZER/BIONTECH | Extremity deformities | 9 | 0.58 | 1.04 | 1.60 | 8.7 | 0.58 | 0.98 | 1.58 | 0.67 | 0.67 | 0.37 | 55
COVID19_UNKNOWN MFR | Extremity deformities | 0 | 0.15 | 0.96 | 2.33 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Eye and eyelid infections | 25 | 0.65 | 0.93 | 1.25 | 29.9 | 0.60 | 0.83 | 1.13 | 0.74 | 0.74 | 0.53 | 525
COVID19_MODERNA | Eye and eyelid infections | 66 | 0.60 | 0.74 | 0.89 | 92.1 | 0.59 | 0.72 | 0.87 | 0.46 | 0.46 | 0.37 | 484
COVID19_PFIZER/BIONTECH | Eye and eyelid infections | 86 | 0.86 | 1.03 | 1.22 | 90.5 | 0.79 | 0.95 | 1.12 | 0.76 | 0.76 | 0.63 | 464
COVID19_UNKNOWN MFR | Eye and eyelid infections | 0 | 0.07 | 0.68 | 1.81 | 0.7 |  |  |  |  |  |  | 
COVID19_JANSSEN | Eye complications associated with device | 0 | 0.05 | 0.94 | 2.81 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Eye complications associated with device | 0 | 0.04 | 0.82 | 2.43 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eye complications associated with device | 0 | 0.05 | 0.84 | 2.49 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye complications associated with device | 0 | 0.05 | 1.00 | 2.97 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Eye injuries NEC | 15 | 0.85 | 1.32 | 1.87 | 10.7 | 0.85 | 1.29 | 1.89 | 1.45 | 1.45 | 0.93 | 160
COVID19_MODERNA | Eye injuries NEC | 41 | 0.78 | 1.02 | 1.29 | 40.4 | 0.78 | 1.00 | 1.28 | 1.04 | 1.04 | 0.78 | 134
COVID19_PFIZER/BIONTECH | Eye injuries NEC | 44 | 0.96 | 1.24 | 1.56 | 35.1 | 0.95 | 1.22 | 1.55 | 1.38 | 1.38 | 1.03 | 131
COVID19_UNKNOWN MFR | Eye injuries NEC | 0 | 0.25 | 0.91 | 1.92 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Eye movement disorders | 3 | 0.23 | 0.52 | 0.92 | 8.9 | 0.18 | 0.42 | 0.85 | 0.31 | 0.31 | 0.12 | 150
COVID19_MODERNA | Eye movement disorders | 31 | 0.78 | 1.06 | 1.38 | 31.2 | 0.73 | 0.98 | 1.29 | 0.86 | 0.86 | 0.62 | 122
COVID19_PFIZER/BIONTECH | Eye movement disorders | 27 | 0.74 | 1.02 | 1.35 | 28.4 | 0.69 | 0.94 | 1.26 | 0.88 | 0.88 | 0.62 | 126
COVID19_UNKNOWN MFR | Eye movement disorders | 1 | 0.43 | 1.24 | 2.40 | 0.2 | 0.38 | 1.19 | 3.49 | 4.53 | 4.53 | 0.87 | 152
COVID19_JANSSEN | Eye therapeutic procedures NEC | 4 | 0.32 | 0.74 | 1.29 | 7.0 | 0.30 | 0.63 | 1.18 | 0.61 | 0.61 | 0.26 | 102
COVID19_MODERNA | Eye therapeutic procedures NEC | 9 | 0.28 | 0.50 | 0.78 | 20.7 | 0.28 | 0.47 | 0.75 | 0.32 | 0.32 | 0.18 | 97
COVID19_PFIZER/BIONTECH | Eye therapeutic procedures NEC | 10 | 0.33 | 0.58 | 0.87 | 20.7 | 0.31 | 0.51 | 0.81 | 0.43 | 0.43 | 0.25 | 96
COVID19_UNKNOWN MFR | Eye therapeutic procedures NEC | 0 | 0.16 | 0.93 | 2.21 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid disorders congenital | 0 | 0.03 | 0.88 | 2.76 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Eyelid disorders congenital | 0 | 0.02 | 0.66 | 2.07 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eyelid disorders congenital | 0 | 0.03 | 0.69 | 2.17 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid disorders congenital | 0 | 0.04 | 1.00 | 3.13 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid movement disorders | 39 | 0.57 | 0.74 | 0.92 | 55.5 | 0.54 | 0.71 | 0.91 | 0.73 | 0.73 | 0.55 | 829
COVID19_MODERNA | Eyelid movement disorders | 171 | 0.76 | 0.86 | 0.97 | 202.9 | 0.74 | 0.84 | 0.95 | 0.83 | 0.83 | 0.72 | 697
COVID19_PFIZER/BIONTECH | Eyelid movement disorders | 200 | 0.99 | 1.12 | 1.25 | 180.0 | 0.99 | 1.11 | 1.24 | 1.23 | 1.23 | 1.07 | 668
COVID19_UNKNOWN MFR | Eyelid movement disorders | 2 | 0.56 | 1.09 | 1.77 | 1.3 | 0.43 | 1.07 | 2.35 | 1.59 | 1.59 | 0.50 | 866
COVID19_JANSSEN | Eyelid therapeutic procedures | 0 | 0.08 | 0.82 | 2.20 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Eyelid therapeutic procedures | 1 | 0.20 | 0.95 | 2.13 | 1.3 | 0.25 | 0.76 | 1.86 | 0.85 | 0.85 | 0.14 | 4
COVID19_PFIZER/BIONTECH | Eyelid therapeutic procedures | 0 | 0.06 | 0.58 | 1.56 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid therapeutic procedures | 0 | 0.10 | 1.00 | 2.68 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Facial cranial nerve disorders | 223 | 0.84 | 0.94 | 1.04 | 281.9 | 0.71 | 0.79 | 0.88 | 0.94 | 0.94 | 0.84 | 3656
COVID19_MODERNA | Facial cranial nerve disorders | 1109 | 1.20 | 1.26 | 1.33 | 1036.3 | 1.02 | 1.07 | 1.12 | 1.36 | 1.36 | 1.29 | 2770
COVID19_PFIZER/BIONTECH | Facial cranial nerve disorders | 1387 | 1.73 | 1.81 | 1.89 | 907.6 | 1.46 | 1.53 | 1.60 | 2.28 | 2.29 | 2.17 | 2492
COVID19_UNKNOWN MFR | Facial cranial nerve disorders | 9 | 0.80 | 1.38 | 2.10 | 6.7 | 0.72 | 1.21 | 1.94 | 1.60 | 1.61 | 0.93 | 3870
COVID19_JANSSEN | Facial therapeutic procedures | 0 | 0.12 | 0.77 | 1.88 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Facial therapeutic procedures | 1 | 0.19 | 0.73 | 1.56 | 2.3 | 0.18 | 0.58 | 1.45 | 0.42 | 0.42 | 0.07 | 8
COVID19_PFIZER/BIONTECH | Facial therapeutic procedures | 2 | 0.35 | 1.07 | 2.09 | 1.9 | 0.37 | 0.92 | 1.98 | 1.17 | 1.17 | 0.31 | 7
COVID19_UNKNOWN MFR | Facial therapeutic procedures | 0 | 0.15 | 0.99 | 2.43 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Factitious disorders | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Factitious disorders | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Factitious disorders | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Factitious disorders | 0 | 0.05 | 1.00 | 3.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Faecal abnormalities NEC | 35 | 0.89 | 1.19 | 1.54 | 36.1 | 0.73 | 0.96 | 1.25 | 0.53 | 0.53 | 0.40 | 1029
COVID19_MODERNA | Faecal abnormalities NEC | 95 | 0.77 | 0.91 | 1.07 | 110.6 | 0.72 | 0.86 | 1.01 | 0.33 | 0.33 | 0.28 | 969
COVID19_PFIZER/BIONTECH | Faecal abnormalities NEC | 117 | 1.00 | 1.17 | 1.35 | 122.4 | 0.82 | 0.95 | 1.11 | 0.51 | 0.51 | 0.43 | 947
COVID19_UNKNOWN MFR | Faecal abnormalities NEC | 0 | 0.04 | 0.58 | 1.69 | 0.8 |  |  |  |  |  |  | 
COVID19_JANSSEN | Faecal analyses NEC | 12 | 0.42 | 0.72 | 1.08 | 19.2 | 0.40 | 0.64 | 0.98 | 0.28 | 0.28 | 0.17 | 663
COVID19_MODERNA | Faecal analyses NEC | 44 | 0.66 | 0.86 | 1.08 | 56.0 | 0.61 | 0.79 | 1.00 | 0.24 | 0.24 | 0.18 | 631
COVID19_PFIZER/BIONTECH | Faecal analyses NEC | 38 | 0.52 | 0.69 | 0.88 | 66.9 | 0.44 | 0.57 | 0.74 | 0.24 | 0.24 | 0.19 | 637
COVID19_UNKNOWN MFR | Faecal analyses NEC | 1 | 0.23 | 1.43 | 3.46 | 0.5 | 0.33 | 1.00 | 2.55 | 1.02 | 1.02 | 0.20 | 674
COVID19_JANSSEN | Failed labour | 0 | 0.00 | 0.21 | 1.15 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Failed labour | 0 | 0.00 | 0.07 | 0.36 | 2.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Failed labour | 0 | 0.00 | 0.08 | 0.42 | 1.9 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Failed labour | 0 | 0.00 | 0.92 | 5.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Fallopian tube and ovary infections and inflammations | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Fallopian tube and ovary infections and inflammations | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fallopian tube and ovary infections and inflammations | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fallopian tube and ovary infections and inflammations | 0 | 0.05 | 1.00 | 3.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Fallopian tube neoplasms malignant | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Fallopian tube neoplasms malignant | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fallopian tube neoplasms malignant | 0 | 0.04 | 0.83 | 2.53 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fallopian tube neoplasms malignant | 0 | 0.05 | 1.00 | 3.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Fallopian tube therapeutic procedures | 0 | 0.05 | 0.85 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Fallopian tube therapeutic procedures | 2 | 0.49 | 1.77 | 3.70 | 1.0 | 0.47 | 1.18 | 2.63 | 6.79 | 6.79 | 0.91 | 1
COVID19_PFIZER/BIONTECH | Fallopian tube therapeutic procedures | 0 | 0.04 | 0.64 | 1.89 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fallopian tube therapeutic procedures | 0 | 0.06 | 1.00 | 2.95 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Family and partner issues | 1 | 0.25 | 1.21 | 2.75 | 0.7 | 0.31 | 0.94 | 2.33 | 0.67 | 0.67 | 0.13 | 23
COVID19_MODERNA | Family and partner issues | 3 | 0.43 | 1.20 | 2.29 | 2.2 | 0.47 | 1.06 | 2.12 | 0.49 | 0.49 | 0.18 | 21
COVID19_PFIZER/BIONTECH | Family and partner issues | 0 | 0.03 | 0.37 | 1.02 | 2.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Family and partner issues | 0 | 0.09 | 0.99 | 2.73 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Fascial and bursal therapeutic procedures | 1 | 0.23 | 1.11 | 2.54 | 0.7 | 0.31 | 0.92 | 2.29 | 1.54 | 1.54 | 0.28 | 10
COVID19_MODERNA | Fascial and bursal therapeutic procedures | 2 | 0.24 | 0.80 | 1.63 | 2.8 | 0.30 | 0.75 | 1.62 | 0.76 | 0.76 | 0.21 | 9
COVID19_PFIZER/BIONTECH | Fascial and bursal therapeutic procedures | 0 | 0.03 | 0.34 | 0.94 | 2.5 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fascial and bursal therapeutic procedures | 1 | 0.36 | 1.76 | 4.00 | 0.0 | 0.44 | 1.70 | 13.26 | 68.78 | 68.86 | 12.26 | 10
COVID19_JANSSEN | Fat soluble vitamin deficiencies and disorders | 3 | 0.24 | 0.77 | 1.54 | 4.9 | 0.30 | 0.67 | 1.34 | 0.56 | 0.56 | 0.21 | 83
COVID19_MODERNA | Fat soluble vitamin deficiencies and disorders | 8 | 0.32 | 0.63 | 1.02 | 14.2 | 0.34 | 0.59 | 0.97 | 0.35 | 0.35 | 0.19 | 78
COVID19_PFIZER/BIONTECH | Fat soluble vitamin deficiencies and disorders | 10 | 0.45 | 0.81 | 1.26 | 14.4 | 0.43 | 0.71 | 1.11 | 0.54 | 0.54 | 0.31 | 76
COVID19_UNKNOWN MFR | Fat soluble vitamin deficiencies and disorders | 0 | 0.00 | 0.84 | 3.26 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Fear symptoms and phobic disorders (incl social phobia) | 63 | 1.12 | 1.40 | 1.69 | 46.9 | 1.07 | 1.32 | 1.61 | 1.62 | 1.63 | 1.31 | 599
COVID19_MODERNA | Fear symptoms and phobic disorders (incl social phobia) | 145 | 0.87 | 1.00 | 1.14 | 150.4 | 0.84 | 0.96 | 1.10 | 0.95 | 0.95 | 0.82 | 517
COVID19_PFIZER/BIONTECH | Fear symptoms and phobic disorders (incl social phobia) | 179 | 1.20 | 1.36 | 1.53 | 136.9 | 1.15 | 1.30 | 1.47 | 1.52 | 1.52 | 1.31 | 483
COVID19_UNKNOWN MFR | Fear symptoms and phobic disorders (incl social phobia) | 0 | 0.13 | 0.68 | 1.60 | 1.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Febrile disorders | 9692 | 1.80 | 1.83 | 1.86 | 6029.2 | 1.58 | 1.61 | 1.63 | 1.83 | 2.13 | 2.09 | 81564
COVID19_MODERNA | Febrile disorders | 23862 | 1.15 | 1.16 | 1.18 | 22861.6 | 1.03 | 1.04 | 1.06 | 1.20 | 1.25 | 1.23 | 67394
COVID19_PFIZER/BIONTECH | Febrile disorders | 17551 | 0.99 | 1.00 | 1.01 | 19759.8 | 0.88 | 0.89 | 0.90 | 0.98 | 0.97 | 0.96 | 73705
COVID19_UNKNOWN MFR | Febrile disorders | 222 | 1.60 | 1.79 | 1.99 | 137.7 | 1.43 | 1.60 | 1.78 | 1.68 | 1.91 | 1.68 | 91034
COVID19_JANSSEN | Feelings and sensations NEC | 11033 | 1.83 | 1.86 | 1.89 | 6494.6 | 1.67 | 1.70 | 1.73 | 2.23 | 2.75 | 2.70 | 76380
COVID19_MODERNA | Feelings and sensations NEC | 28901 | 1.18 | 1.19 | 1.20 | 26188.3 | 1.09 | 1.10 | 1.11 | 1.68 | 1.86 | 1.83 | 58512
COVID19_PFIZER/BIONTECH | Feelings and sensations NEC | 23663 | 1.17 | 1.18 | 1.19 | 21775.0 | 1.08 | 1.09 | 1.10 | 1.52 | 1.65 | 1.63 | 63750
COVID19_UNKNOWN MFR | Feelings and sensations NEC | 223 | 1.47 | 1.64 | 1.83 | 146.3 | 1.35 | 1.51 | 1.69 | 1.76 | 2.02 | 1.78 | 87190
COVID19_JANSSEN | Female gonadal function disorders | 0 | 0.04 | 0.89 | 2.68 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Female gonadal function disorders | 2 | 0.56 | 2.08 | 4.37 | 0.8 | 0.50 | 1.26 | 2.87 | 16.98 | 16.98 | 1.33 | 0
COVID19_PFIZER/BIONTECH | Female gonadal function disorders | 0 | 0.04 | 0.71 | 2.15 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Female gonadal function disorders | 0 | 0.05 | 1.00 | 3.01 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Female reproductive neoplasms malignant NEC | 0 | 0.05 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Female reproductive neoplasms malignant NEC | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Female reproductive neoplasms malignant NEC | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Female reproductive neoplasms malignant NEC | 0 | 0.05 | 1.00 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Female reproductive neoplasms unspecified malignancy | 0 | 0.00 | 0.52 | 2.70 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Female reproductive neoplasms unspecified malignancy | 0 | 0.00 | 0.23 | 1.17 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Female reproductive neoplasms unspecified malignancy | 0 | 0.00 | 0.25 | 1.31 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Female reproductive neoplasms unspecified malignancy | 0 | 0.00 | 0.98 | 5.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Female reproductive tract disorders congenital | 0 | 0.06 | 0.95 | 2.73 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Female reproductive tract disorders congenital | 0 | 0.06 | 0.83 | 2.39 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Female reproductive tract disorders congenital | 1 | 0.31 | 1.61 | 3.76 | 0.3 | 0.36 | 1.11 | 3.00 | 12.28 | 12.28 | 0.84 | 0
COVID19_UNKNOWN MFR | Female reproductive tract disorders congenital | 0 | 0.07 | 1.00 | 2.88 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Female reproductive tract infections | 2 | 0.10 | 0.46 | 1.04 | 5.8 | 0.17 | 0.45 | 1.00 | 0.38 | 0.38 | 0.12 | 81
COVID19_MODERNA | Female reproductive tract infections | 7 | 0.24 | 0.50 | 0.84 | 16.1 | 0.27 | 0.48 | 0.81 | 0.31 | 0.31 | 0.16 | 76
COVID19_PFIZER/BIONTECH | Female reproductive tract infections | 10 | 0.39 | 0.71 | 1.11 | 16.9 | 0.37 | 0.62 | 0.97 | 0.56 | 0.56 | 0.32 | 73
COVID19_UNKNOWN MFR | Female reproductive tract infections | 0 | 0.00 | 0.72 | 3.30 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Fertility analyses | 0 | 0.07 | 0.91 | 2.56 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Fertility analyses | 1 | 0.26 | 1.33 | 3.07 | 0.5 | 0.33 | 1.00 | 2.51 | 3.40 | 3.40 | 0.33 | 1
COVID19_PFIZER/BIONTECH | Fertility analyses | 0 | 0.06 | 0.75 | 2.12 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fertility analyses | 0 | 0.08 | 1.00 | 2.81 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Fertility and fertilisation interventions female | 1 | 0.32 | 1.07 | 2.18 | 0.8 | 0.30 | 0.90 | 2.24 | 1.54 | 1.54 | 0.28 | 10
COVID19_MODERNA | Fertility and fertilisation interventions female | 4 | 0.54 | 1.21 | 2.09 | 3.4 | 0.49 | 1.02 | 1.92 | 1.94 | 1.94 | 0.69 | 7
COVID19_PFIZER/BIONTECH | Fertility and fertilisation interventions female | 2 | 0.33 | 0.91 | 1.72 | 2.8 | 0.30 | 0.75 | 1.62 | 0.91 | 0.91 | 0.25 | 9
COVID19_UNKNOWN MFR | Fertility and fertilisation interventions female | 0 | 0.21 | 0.99 | 2.24 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Fibrosarcomas malignant | 0 | 0.04 | 0.89 | 2.70 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Fibrosarcomas malignant | 0 | 0.03 | 0.68 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fibrosarcomas malignant | 0 | 0.03 | 0.71 | 2.16 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibrosarcomas malignant | 0 | 0.05 | 1.00 | 3.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Fibrosis NEC | 1 | 0.32 | 1.18 | 2.50 | 0.4 | 0.35 | 1.05 | 2.70 | 1.93 | 1.93 | 0.34 | 8
COVID19_MODERNA | Fibrosis NEC | 3 | 0.49 | 1.24 | 2.28 | 2.1 | 0.49 | 1.10 | 2.21 | 1.70 | 1.70 | 0.53 | 6
COVID19_PFIZER/BIONTECH | Fibrosis NEC | 3 | 0.52 | 1.33 | 2.45 | 1.9 | 0.52 | 1.16 | 2.35 | 2.05 | 2.05 | 0.64 | 6
COVID19_UNKNOWN MFR | Fibrosis NEC | 0 | 0.17 | 0.99 | 2.38 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Filovirus viral infections | 0 | 0.07 | 0.91 | 2.58 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Filovirus viral infections | 0 | 0.05 | 0.72 | 2.04 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Filovirus viral infections | 1 | 0.27 | 1.39 | 3.22 | 0.2 | 0.38 | 1.20 | 3.59 | 4.09 | 4.09 | 0.40 | 1
COVID19_UNKNOWN MFR | Filovirus viral infections | 0 | 0.07 | 1.00 | 2.84 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Flatulence, bloating and distension | 139 | 1.41 | 1.63 | 1.86 | 94.1 | 1.27 | 1.46 | 1.67 | 1.47 | 1.47 | 1.27 | 1464
COVID19_MODERNA | Flatulence, bloating and distension | 352 | 0.92 | 1.00 | 1.09 | 366.0 | 0.88 | 0.96 | 1.05 | 0.96 | 0.96 | 0.87 | 1251
COVID19_PFIZER/BIONTECH | Flatulence, bloating and distension | 367 | 1.13 | 1.24 | 1.35 | 321.2 | 1.05 | 1.14 | 1.24 | 1.22 | 1.22 | 1.10 | 1236
COVID19_UNKNOWN MFR | Flatulence, bloating and distension | 5 | 0.84 | 1.90 | 3.30 | 2.3 | 0.77 | 1.50 | 2.78 | 2.15 | 2.16 | 1.03 | 1598
COVID19_JANSSEN | Flaviviral infections | 1 | 0.02 | 0.41 | 1.19 | 3.3 | 0.13 | 0.47 | 1.19 | 0.37 | 0.37 | 0.07 | 42
COVID19_MODERNA | Flaviviral infections | 0 | 0.00 | 0.01 | 0.06 | 6.0 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Flaviviral infections | 0 | 0.00 | 0.01 | 0.06 | 6.5 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Flaviviral infections | 0 | 0.00 | 0.51 | 2.92 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Fluctuating mood symptoms | 7 | 0.54 | 1.12 | 1.86 | 7.7 | 0.49 | 0.88 | 1.49 | 0.83 | 0.83 | 0.44 | 130
COVID19_MODERNA | Fluctuating mood symptoms | 15 | 0.46 | 0.74 | 1.08 | 23.5 | 0.43 | 0.65 | 0.96 | 0.42 | 0.42 | 0.27 | 122
COVID19_PFIZER/BIONTECH | Fluctuating mood symptoms | 23 | 0.82 | 1.19 | 1.62 | 23.1 | 0.69 | 0.98 | 1.34 | 0.83 | 0.83 | 0.57 | 114
COVID19_UNKNOWN MFR | Fluctuating mood symptoms | 0 | 0.01 | 0.80 | 2.97 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Fluid intake decreased | 6 | 0.51 | 0.99 | 1.59 | 6.4 | 0.48 | 0.89 | 1.55 | 0.55 | 0.55 | 0.28 | 169
COVID19_MODERNA | Fluid intake decreased | 29 | 0.81 | 1.12 | 1.46 | 28.2 | 0.74 | 1.01 | 1.34 | 0.67 | 0.67 | 0.48 | 146
COVID19_PFIZER/BIONTECH | Fluid intake decreased | 26 | 0.78 | 1.10 | 1.45 | 26.8 | 0.69 | 0.96 | 1.29 | 0.71 | 0.71 | 0.50 | 149
COVID19_UNKNOWN MFR | Fluid intake decreased | 0 | 0.23 | 0.94 | 2.06 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Fluid intake increased | 1 | 0.17 | 0.74 | 1.65 | 1.9 | 0.20 | 0.64 | 1.58 | 0.41 | 0.41 | 0.08 | 38
COVID19_MODERNA | Fluid intake increased | 4 | 0.37 | 0.89 | 1.59 | 4.9 | 0.39 | 0.81 | 1.52 | 0.39 | 0.39 | 0.16 | 35
COVID19_PFIZER/BIONTECH | Fluid intake increased | 7 | 0.63 | 1.23 | 2.00 | 5.5 | 0.63 | 1.13 | 1.90 | 0.90 | 0.90 | 0.45 | 32
COVID19_UNKNOWN MFR | Fluid intake increased | 1 | 0.37 | 1.64 | 3.65 | 0.0 | 0.43 | 1.55 | 10.06 | 18.10 | 18.12 | 3.42 | 38
COVID19_JANSSEN | Foetal and neonatal conditions associated with product exposure | 0 | 0.05 | 0.94 | 2.81 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Foetal and neonatal conditions associated with product exposure | 0 | 0.04 | 0.82 | 2.43 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal and neonatal conditions associated with product exposure | 0 | 0.05 | 0.84 | 2.50 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal and neonatal conditions associated with product exposure | 0 | 0.05 | 1.00 | 2.97 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Foetal and neonatal diagnostic procedures | 5 | 0.13 | 0.32 | 0.59 | 23.3 | 0.13 | 0.26 | 0.47 | 0.29 | 0.29 | 0.14 | 266
COVID19_MODERNA | Foetal and neonatal diagnostic procedures | 32 | 0.39 | 0.53 | 0.70 | 87.8 | 0.28 | 0.38 | 0.49 | 0.46 | 0.46 | 0.33 | 239
COVID19_PFIZER/BIONTECH | Foetal and neonatal diagnostic procedures | 33 | 0.46 | 0.62 | 0.81 | 77.4 | 0.33 | 0.44 | 0.57 | 0.57 | 0.57 | 0.42 | 238
COVID19_UNKNOWN MFR | Foetal and neonatal diagnostic procedures | 0 | 0.00 | 0.34 | 1.75 | 0.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Foetal and neonatal histopathology procedures | 0 | 0.07 | 0.91 | 2.57 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Foetal and neonatal histopathology procedures | 0 | 0.05 | 0.72 | 2.04 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal and neonatal histopathology procedures | 1 | 0.27 | 1.39 | 3.21 | 0.5 | 0.34 | 1.03 | 2.65 | 4.09 | 4.09 | 0.40 | 1
COVID19_UNKNOWN MFR | Foetal and neonatal histopathology procedures | 0 | 0.07 | 1.00 | 2.83 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Foetal and neonatal imaging procedures | 7 | 0.11 | 0.24 | 0.40 | 43.6 | 0.10 | 0.18 | 0.32 | 0.21 | 0.21 | 0.11 | 505
COVID19_MODERNA | Foetal and neonatal imaging procedures | 60 | 0.43 | 0.54 | 0.66 | 159.4 | 0.31 | 0.38 | 0.47 | 0.45 | 0.45 | 0.36 | 452
COVID19_PFIZER/BIONTECH | Foetal and neonatal imaging procedures | 59 | 0.47 | 0.59 | 0.73 | 141.3 | 0.34 | 0.42 | 0.52 | 0.53 | 0.53 | 0.42 | 453
COVID19_UNKNOWN MFR | Foetal and neonatal imaging procedures | 0 | 0.00 | 0.29 | 1.31 | 0.8 |  |  |  |  |  |  | 
COVID19_JANSSEN | Foetal complications NEC | 1 | 0.01 | 0.15 | 0.43 | 11.9 | 0.02 | 0.13 | 0.44 | 0.10 | 0.10 | 0.02 | 154
COVID19_MODERNA | Foetal complications NEC | 11 | 0.23 | 0.41 | 0.63 | 38.7 | 0.19 | 0.31 | 0.48 | 0.26 | 0.26 | 0.16 | 144
COVID19_PFIZER/BIONTECH | Foetal complications NEC | 8 | 0.17 | 0.34 | 0.55 | 35.7 | 0.14 | 0.25 | 0.42 | 0.22 | 0.22 | 0.12 | 147
COVID19_UNKNOWN MFR | Foetal complications NEC | 0 | 0.00 | 0.56 | 2.76 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Foetal conditions due to maternal conditions | 0 | 0.00 | 0.56 | 2.35 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Foetal conditions due to maternal conditions | 0 | 0.00 | 0.25 | 1.07 | 1.1 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal conditions due to maternal conditions | 0 | 0.00 | 0.28 | 1.19 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal conditions due to maternal conditions | 0 | 0.00 | 0.98 | 4.13 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Foetal growth complications | 0 | 0.00 | 0.04 | 0.24 | 2.9 |  |  |  |  |  |  | 
COVID19_MODERNA | Foetal growth complications | 2 | 0.06 | 0.30 | 0.71 | 9.0 | 0.11 | 0.32 | 0.72 | 0.14 | 0.14 | 0.04 | 50
COVID19_PFIZER/BIONTECH | Foetal growth complications | 9 | 0.63 | 1.20 | 1.92 | 9.6 | 0.54 | 0.91 | 1.45 | 0.86 | 0.86 | 0.47 | 43
COVID19_UNKNOWN MFR | Foetal growth complications | 0 | 0.00 | 0.62 | 3.52 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Foetal position and presentation abnormalities | 0 | 0.00 | 0.08 | 0.45 | 1.8 |  |  |  |  |  |  | 
COVID19_MODERNA | Foetal position and presentation abnormalities | 0 | 0.00 | 0.03 | 0.17 | 4.8 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal position and presentation abnormalities | 0 | 0.00 | 0.03 | 0.17 | 5.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal position and presentation abnormalities | 0 | 0.00 | 0.77 | 4.20 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Foetal therapeutic procedures | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Foetal therapeutic procedures | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal therapeutic procedures | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal therapeutic procedures | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Follicular lymphomas | 0 | 0.05 | 0.94 | 2.81 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Follicular lymphomas | 0 | 0.04 | 0.82 | 2.43 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Follicular lymphomas | 0 | 0.05 | 0.84 | 2.49 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Follicular lymphomas | 0 | 0.05 | 1.00 | 2.97 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Food malabsorption and intolerance syndromes (excl sugar intolerance) | 4 | 0.20 | 0.51 | 0.93 | 11.1 | 0.20 | 0.43 | 0.81 | 0.27 | 0.27 | 0.12 | 232
COVID19_MODERNA | Food malabsorption and intolerance syndromes (excl sugar intolerance) | 13 | 0.33 | 0.55 | 0.81 | 26.7 | 0.33 | 0.51 | 0.77 | 0.20 | 0.20 | 0.12 | 223
COVID19_PFIZER/BIONTECH | Food malabsorption and intolerance syndromes (excl sugar intolerance) | 11 | 0.25 | 0.44 | 0.67 | 31.6 | 0.23 | 0.38 | 0.58 | 0.20 | 0.20 | 0.12 | 225
COVID19_UNKNOWN MFR | Food malabsorption and intolerance syndromes (excl sugar intolerance) | 0 | 0.04 | 0.82 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Fracture treatments (excl skull and spine) | 3 | 0.66 | 1.75 | 3.26 | 0.9 | 0.68 | 1.58 | 3.60 | 4.21 | 4.21 | 1.44 | 11
COVID19_MODERNA | Fracture treatments (excl skull and spine) | 2 | 0.23 | 0.72 | 1.43 | 4.2 | 0.22 | 0.57 | 1.25 | 0.57 | 0.57 | 0.16 | 12
COVID19_PFIZER/BIONTECH | Fracture treatments (excl skull and spine) | 3 | 0.36 | 0.96 | 1.80 | 3.6 | 0.36 | 0.82 | 1.63 | 1.12 | 1.12 | 0.38 | 11
COVID19_UNKNOWN MFR | Fracture treatments (excl skull and spine) | 0 | 0.14 | 0.99 | 2.48 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Fractures and dislocations NEC | 11 | 0.81 | 1.31 | 1.91 | 7.2 | 0.83 | 1.35 | 2.09 | 1.65 | 1.65 | 0.98 | 103
COVID19_MODERNA | Fractures and dislocations NEC | 22 | 0.62 | 0.89 | 1.20 | 26.3 | 0.59 | 0.83 | 1.15 | 0.81 | 0.81 | 0.55 | 92
COVID19_PFIZER/BIONTECH | Fractures and dislocations NEC | 20 | 0.61 | 0.88 | 1.20 | 24.0 | 0.57 | 0.83 | 1.16 | 0.87 | 0.87 | 0.58 | 94
COVID19_UNKNOWN MFR | Fractures and dislocations NEC | 0 | 0.33 | 0.96 | 1.85 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Fungal infections NEC | 8 | 0.45 | 0.83 | 1.29 | 10.7 | 0.44 | 0.76 | 1.24 | 0.75 | 0.75 | 0.41 | 165
COVID19_MODERNA | Fungal infections NEC | 29 | 0.60 | 0.82 | 1.08 | 36.4 | 0.59 | 0.80 | 1.06 | 0.68 | 0.68 | 0.49 | 144
COVID19_PFIZER/BIONTECH | Fungal infections NEC | 33 | 0.74 | 1.00 | 1.29 | 34.4 | 0.71 | 0.95 | 1.24 | 0.97 | 0.97 | 0.70 | 140
COVID19_UNKNOWN MFR | Fungal infections NEC | 0 | 0.17 | 0.90 | 2.07 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Fungus identification and serology | 8 | 0.49 | 0.90 | 1.41 | 10.1 | 0.46 | 0.79 | 1.30 | 0.75 | 0.75 | 0.41 | 165
COVID19_MODERNA | Fungus identification and serology | 26 | 0.62 | 0.87 | 1.16 | 33.7 | 0.56 | 0.77 | 1.05 | 0.60 | 0.60 | 0.42 | 147
COVID19_PFIZER/BIONTECH | Fungus identification and serology | 20 | 0.49 | 0.72 | 0.99 | 31.8 | 0.44 | 0.64 | 0.90 | 0.54 | 0.54 | 0.36 | 153
COVID19_UNKNOWN MFR | Fungus identification and serology | 1 | 0.38 | 1.32 | 2.73 | 0.3 | 0.38 | 1.17 | 3.34 | 4.00 | 4.00 | 0.77 | 172
COVID19_JANSSEN | Fusobacterium infections | 0 | 0.07 | 0.91 | 2.54 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Fusobacterium infections | 1 | 0.27 | 1.32 | 3.04 | 0.3 | 0.36 | 1.11 | 2.96 | 3.40 | 3.40 | 0.33 | 1
COVID19_PFIZER/BIONTECH | Fusobacterium infections | 0 | 0.06 | 0.76 | 2.11 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fusobacterium infections | 0 | 0.08 | 1.00 | 2.78 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gait disturbances | 519 | 1.36 | 1.47 | 1.57 | 381.9 | 1.26 | 1.36 | 1.46 | 1.21 | 1.21 | 1.12 | 6638
COVID19_MODERNA | Gait disturbances | 1521 | 0.93 | 0.97 | 1.01 | 1623.0 | 0.90 | 0.94 | 0.98 | 0.92 | 0.92 | 0.87 | 5636
COVID19_PFIZER/BIONTECH | Gait disturbances | 1366 | 0.98 | 1.03 | 1.07 | 1404.9 | 0.93 | 0.97 | 1.02 | 0.97 | 0.97 | 0.92 | 5791
COVID19_UNKNOWN MFR | Gait disturbances | 18 | 1.16 | 1.75 | 2.43 | 10.1 | 1.09 | 1.60 | 2.28 | 1.73 | 1.75 | 1.18 | 7139
COVID19_JANSSEN | Gallbladder disorders NEC | 3 | 0.28 | 0.84 | 1.64 | 3.8 | 0.35 | 0.79 | 1.57 | 0.79 | 0.79 | 0.30 | 59
COVID19_MODERNA | Gallbladder disorders NEC | 21 | 0.88 | 1.31 | 1.80 | 16.0 | 0.88 | 1.25 | 1.74 | 1.74 | 1.74 | 1.12 | 41
COVID19_PFIZER/BIONTECH | Gallbladder disorders NEC | 18 | 0.87 | 1.33 | 1.87 | 13.6 | 0.85 | 1.25 | 1.78 | 1.67 | 1.68 | 1.06 | 44
COVID19_UNKNOWN MFR | Gallbladder disorders NEC | 0 | 0.03 | 0.90 | 2.88 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gallbladder neoplasms malignant | 0 | 0.06 | 0.95 | 2.73 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Gallbladder neoplasms malignant | 0 | 0.06 | 0.83 | 2.39 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gallbladder neoplasms malignant | 1 | 0.31 | 1.61 | 3.76 | 0.2 | 0.39 | 1.24 | 4.05 | 12.28 | 12.28 | 0.84 | 0
COVID19_UNKNOWN MFR | Gallbladder neoplasms malignant | 0 | 0.07 | 1.00 | 2.88 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gardnerella infections | 1 | 0.30 | 1.68 | 3.96 | 0.2 | 0.39 | 1.22 | 3.82 | 7.72 | 7.72 | 1.03 | 2
COVID19_MODERNA | Gardnerella infections | 0 | 0.03 | 0.60 | 1.78 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gardnerella infections | 0 | 0.04 | 0.64 | 1.89 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gardnerella infections | 0 | 0.06 | 1.00 | 2.96 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastric and oesophageal haemorrhages | 4 | 1.01 | 2.86 | 5.47 | 1.2 | 0.82 | 1.76 | 3.80 | 2.81 | 2.81 | 1.15 | 22
COVID19_MODERNA | Gastric and oesophageal haemorrhages | 5 | 0.53 | 1.30 | 2.36 | 3.7 | 0.58 | 1.13 | 2.04 | 0.81 | 0.81 | 0.36 | 21
COVID19_PFIZER/BIONTECH | Gastric and oesophageal haemorrhages | 4 | 0.40 | 1.13 | 2.17 | 3.6 | 0.48 | 0.99 | 1.86 | 0.74 | 0.74 | 0.30 | 22
COVID19_UNKNOWN MFR | Gastric and oesophageal haemorrhages | 0 | 0.00 | 0.87 | 4.38 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastric and pyloric stenosis and obstruction | 0 | 0.01 | 0.57 | 1.92 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Gastric and pyloric stenosis and obstruction | 1 | 0.09 | 0.62 | 1.55 | 1.3 | 0.25 | 0.76 | 1.88 | 0.42 | 0.42 | 0.07 | 8
COVID19_PFIZER/BIONTECH | Gastric and pyloric stenosis and obstruction | 4 | 0.72 | 1.90 | 3.52 | 1.1 | 0.84 | 1.82 | 4.03 | 3.28 | 3.28 | 1.09 | 5
COVID19_UNKNOWN MFR | Gastric and pyloric stenosis and obstruction | 0 | 0.02 | 0.98 | 3.30 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastric disorders congenital | 0 | 0.03 | 0.76 | 2.31 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Gastric disorders congenital | 0 | 0.02 | 0.45 | 1.39 | 1.1 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastric disorders congenital | 0 | 0.02 | 0.49 | 1.50 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric disorders congenital | 0 | 0.04 | 0.99 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastric neoplasms malignant | 0 | 0.09 | 0.88 | 2.37 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Gastric neoplasms malignant | 1 | 0.25 | 1.15 | 2.60 | 0.4 | 0.35 | 1.08 | 2.81 | 1.70 | 1.70 | 0.23 | 2
COVID19_PFIZER/BIONTECH | Gastric neoplasms malignant | 0 | 0.07 | 0.70 | 1.88 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric neoplasms malignant | 0 | 0.10 | 1.00 | 2.68 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastric therapeutic procedures | 2 | 0.21 | 0.82 | 1.77 | 2.7 | 0.30 | 0.76 | 1.64 | 0.53 | 0.53 | 0.16 | 58
COVID19_MODERNA | Gastric therapeutic procedures | 8 | 0.44 | 0.85 | 1.37 | 10.8 | 0.43 | 0.75 | 1.23 | 0.52 | 0.52 | 0.28 | 52
COVID19_PFIZER/BIONTECH | Gastric therapeutic procedures | 5 | 0.26 | 0.61 | 1.08 | 9.8 | 0.28 | 0.56 | 1.01 | 0.37 | 0.37 | 0.17 | 55
COVID19_UNKNOWN MFR | Gastric therapeutic procedures | 0 | 0.02 | 0.91 | 3.02 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastric ulcers and perforation | 3 | 0.46 | 1.34 | 2.60 | 1.7 | 0.54 | 1.20 | 2.44 | 1.54 | 1.54 | 0.57 | 30
COVID19_MODERNA | Gastric ulcers and perforation | 9 | 0.75 | 1.38 | 2.17 | 6.7 | 0.71 | 1.20 | 1.93 | 1.27 | 1.27 | 0.67 | 24
COVID19_PFIZER/BIONTECH | Gastric ulcers and perforation | 6 | 0.47 | 0.99 | 1.67 | 6.2 | 0.49 | 0.92 | 1.59 | 0.91 | 0.91 | 0.43 | 27
COVID19_UNKNOWN MFR | Gastric ulcers and perforation | 0 | 0.06 | 0.95 | 2.80 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastritis (excl infective) | 4 | 0.23 | 0.57 | 1.04 | 8.9 | 0.25 | 0.52 | 0.98 | 0.47 | 0.47 | 0.20 | 132
COVID19_MODERNA | Gastritis (excl infective) | 24 | 0.63 | 0.90 | 1.21 | 28.8 | 0.59 | 0.83 | 1.13 | 0.73 | 0.73 | 0.50 | 112
COVID19_PFIZER/BIONTECH | Gastritis (excl infective) | 25 | 0.71 | 1.02 | 1.36 | 27.3 | 0.65 | 0.91 | 1.23 | 0.92 | 0.92 | 0.64 | 111
COVID19_UNKNOWN MFR | Gastritis (excl infective) | 0 | 0.07 | 0.86 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal and abdominal imaging procedures | 163 | 1.29 | 1.48 | 1.67 | 119.7 | 1.19 | 1.35 | 1.53 | 1.12 | 1.12 | 0.98 | 2256
COVID19_MODERNA | Gastrointestinal and abdominal imaging procedures | 398 | 0.82 | 0.89 | 0.97 | 462.2 | 0.79 | 0.86 | 0.93 | 0.67 | 0.67 | 0.61 | 2021
COVID19_PFIZER/BIONTECH | Gastrointestinal and abdominal imaging procedures | 487 | 1.16 | 1.25 | 1.35 | 422.8 | 1.07 | 1.15 | 1.24 | 1.03 | 1.03 | 0.95 | 1932
COVID19_UNKNOWN MFR | Gastrointestinal and abdominal imaging procedures | 4 | 0.53 | 1.30 | 2.35 | 3.0 | 0.53 | 1.10 | 2.07 | 1.14 | 1.14 | 0.50 | 2415
COVID19_JANSSEN | Gastrointestinal and abdominal pains (excl oral and throat) | 1344 | 1.96 | 2.05 | 2.14 | 749.2 | 1.71 | 1.79 | 1.87 | 2.00 | 2.04 | 1.94 | 10374
COVID19_MODERNA | Gastrointestinal and abdominal pains (excl oral and throat) | 2421 | 0.89 | 0.92 | 0.95 | 2887.0 | 0.81 | 0.84 | 0.87 | 0.88 | 0.88 | 0.85 | 9297
COVID19_PFIZER/BIONTECH | Gastrointestinal and abdominal pains (excl oral and throat) | 2765 | 1.20 | 1.24 | 1.28 | 2512.8 | 1.07 | 1.10 | 1.14 | 1.26 | 1.27 | 1.23 | 8953
COVID19_UNKNOWN MFR | Gastrointestinal and abdominal pains (excl oral and throat) | 20 | 0.86 | 1.26 | 1.74 | 17.3 | 0.77 | 1.11 | 1.56 | 1.18 | 1.18 | 0.81 | 11698
COVID19_JANSSEN | Gastrointestinal and hepatobiliary procedural complications | 0 | 0.10 | 0.66 | 1.64 | 0.9 |  |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal and hepatobiliary procedural complications | 2 | 0.24 | 0.75 | 1.48 | 2.7 | 0.30 | 0.76 | 1.65 | 0.49 | 0.49 | 0.14 | 14
COVID19_PFIZER/BIONTECH | Gastrointestinal and hepatobiliary procedural complications | 6 | 0.80 | 1.64 | 2.71 | 2.6 | 0.86 | 1.61 | 2.88 | 2.46 | 2.46 | 1.05 | 10
COVID19_UNKNOWN MFR | Gastrointestinal and hepatobiliary procedural complications | 0 | 0.14 | 0.99 | 2.46 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal atonic and hypomotility disorders NEC | 95 | 1.14 | 1.35 | 1.59 | 86.7 | 0.92 | 1.09 | 1.28 | 0.92 | 0.92 | 0.77 | 1599
COVID19_MODERNA | Gastrointestinal atonic and hypomotility disorders NEC | 266 | 0.84 | 0.93 | 1.03 | 314.1 | 0.77 | 0.85 | 0.94 | 0.63 | 0.63 | 0.57 | 1428
COVID19_PFIZER/BIONTECH | Gastrointestinal atonic and hypomotility disorders NEC | 301 | 1.10 | 1.21 | 1.33 | 292.9 | 0.93 | 1.03 | 1.13 | 0.88 | 0.88 | 0.80 | 1393
COVID19_UNKNOWN MFR | Gastrointestinal atonic and hypomotility disorders NEC | 2 | 0.33 | 1.08 | 2.19 | 2.1 | 0.34 | 0.85 | 1.85 | 0.81 | 0.81 | 0.25 | 1692
COVID19_JANSSEN | Gastrointestinal disorders NEC | 51 | 0.93 | 1.18 | 1.46 | 50.4 | 0.80 | 1.00 | 1.25 | 0.88 | 0.88 | 0.70 | 892
COVID19_MODERNA | Gastrointestinal disorders NEC | 108 | 0.61 | 0.72 | 0.83 | 169.0 | 0.55 | 0.64 | 0.75 | 0.44 | 0.44 | 0.37 | 835
COVID19_PFIZER/BIONTECH | Gastrointestinal disorders NEC | 157 | 0.98 | 1.13 | 1.28 | 161.3 | 0.85 | 0.97 | 1.10 | 0.82 | 0.82 | 0.71 | 786
COVID19_UNKNOWN MFR | Gastrointestinal disorders NEC | 2 | 0.42 | 1.33 | 2.63 | 1.3 | 0.43 | 1.07 | 2.35 | 1.46 | 1.46 | 0.46 | 941
COVID19_JANSSEN | Gastrointestinal dyskinetic disorders | 11 | 0.58 | 1.01 | 1.52 | 11.7 | 0.56 | 0.91 | 1.41 | 0.73 | 0.73 | 0.44 | 234
COVID19_MODERNA | Gastrointestinal dyskinetic disorders | 42 | 0.74 | 0.97 | 1.22 | 45.0 | 0.72 | 0.93 | 1.18 | 0.70 | 0.70 | 0.53 | 203
COVID19_PFIZER/BIONTECH | Gastrointestinal dyskinetic disorders | 47 | 0.94 | 1.21 | 1.51 | 41.5 | 0.88 | 1.11 | 1.40 | 0.97 | 0.97 | 0.74 | 198
COVID19_UNKNOWN MFR | Gastrointestinal dyskinetic disorders | 0 | 0.06 | 0.81 | 2.28 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal fistulae | 0 | 0.11 | 0.79 | 2.01 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal fistulae | 1 | 0.20 | 0.82 | 1.78 | 1.4 | 0.24 | 0.74 | 1.82 | 0.57 | 0.57 | 0.10 | 6
COVID19_PFIZER/BIONTECH | Gastrointestinal fistulae | 2 | 0.39 | 1.21 | 2.40 | 1.3 | 0.42 | 1.05 | 2.29 | 1.64 | 1.64 | 0.41 | 5
COVID19_UNKNOWN MFR | Gastrointestinal fistulae | 0 | 0.13 | 0.99 | 2.52 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal function diagnostic procedures | 2 | 0.23 | 0.74 | 1.49 | 3.3 | 0.27 | 0.68 | 1.47 | 0.42 | 0.42 | 0.13 | 74
COVID19_MODERNA | Gastrointestinal function diagnostic procedures | 9 | 0.44 | 0.79 | 1.23 | 13.4 | 0.41 | 0.69 | 1.11 | 0.46 | 0.46 | 0.25 | 67
COVID19_PFIZER/BIONTECH | Gastrointestinal function diagnostic procedures | 9 | 0.46 | 0.84 | 1.30 | 12.3 | 0.44 | 0.74 | 1.19 | 0.55 | 0.55 | 0.31 | 67
COVID19_UNKNOWN MFR | Gastrointestinal function diagnostic procedures | 0 | 0.12 | 0.95 | 2.45 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal histopathology procedures | 3 | 0.26 | 0.77 | 1.48 | 4.6 | 0.31 | 0.70 | 1.39 | 0.64 | 0.64 | 0.24 | 72
COVID19_MODERNA | Gastrointestinal histopathology procedures | 10 | 0.41 | 0.73 | 1.13 | 14.4 | 0.43 | 0.71 | 1.11 | 0.52 | 0.52 | 0.30 | 65
COVID19_PFIZER/BIONTECH | Gastrointestinal histopathology procedures | 7 | 0.28 | 0.57 | 0.93 | 13.9 | 0.30 | 0.54 | 0.92 | 0.42 | 0.42 | 0.22 | 68
COVID19_UNKNOWN MFR | Gastrointestinal histopathology procedures | 0 | 0.05 | 0.91 | 2.70 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal inflammatory disorders NEC | 7 | 0.38 | 0.76 | 1.24 | 11.1 | 0.37 | 0.66 | 1.11 | 0.51 | 0.51 | 0.27 | 214
COVID19_MODERNA | Gastrointestinal inflammatory disorders NEC | 31 | 0.84 | 1.15 | 1.50 | 28.3 | 0.80 | 1.07 | 1.42 | 0.55 | 0.55 | 0.40 | 190
COVID19_PFIZER/BIONTECH | Gastrointestinal inflammatory disorders NEC | 22 | 0.54 | 0.79 | 1.08 | 32.1 | 0.49 | 0.69 | 0.96 | 0.45 | 0.45 | 0.31 | 199
COVID19_UNKNOWN MFR | Gastrointestinal inflammatory disorders NEC | 0 | 0.04 | 0.81 | 2.40 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal mucosal dystrophies and secretion disorders | 2 | 0.45 | 1.34 | 2.62 | 1.0 | 0.46 | 1.16 | 2.58 | 2.06 | 2.06 | 0.60 | 15
COVID19_MODERNA | Gastrointestinal mucosal dystrophies and secretion disorders | 1 | 0.14 | 0.55 | 1.18 | 3.7 | 0.12 | 0.43 | 1.12 | 0.21 | 0.21 | 0.04 | 16
COVID19_PFIZER/BIONTECH | Gastrointestinal mucosal dystrophies and secretion disorders | 6 | 0.79 | 1.60 | 2.63 | 3.2 | 0.76 | 1.42 | 2.49 | 2.23 | 2.23 | 0.97 | 11
COVID19_UNKNOWN MFR | Gastrointestinal mucosal dystrophies and secretion disorders | 0 | 0.16 | 0.99 | 2.40 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal necrosis and gangrene (excl gangrenous hernia) | 1 | 0.13 | 1.30 | 3.47 | 0.6 | 0.32 | 0.96 | 2.42 | 0.67 | 0.67 | 0.13 | 23
COVID19_MODERNA | Gastrointestinal necrosis and gangrene (excl gangrenous hernia) | 3 | 0.40 | 1.32 | 2.67 | 2.4 | 0.46 | 1.03 | 2.06 | 0.49 | 0.49 | 0.18 | 21
COVID19_PFIZER/BIONTECH | Gastrointestinal necrosis and gangrene (excl gangrenous hernia) | 3 | 0.37 | 1.24 | 2.51 | 2.6 | 0.44 | 0.99 | 1.97 | 0.59 | 0.59 | 0.21 | 21
COVID19_UNKNOWN MFR | Gastrointestinal necrosis and gangrene (excl gangrenous hernia) | 0 | 0.00 | 0.95 | 3.99 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal neoplasms benign NEC | 0 | 0.07 | 0.95 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal neoplasms benign NEC | 1 | 0.30 | 1.57 | 3.64 | 0.3 | 0.36 | 1.11 | 2.99 | 10.19 | 10.19 | 0.69 | 0
COVID19_PFIZER/BIONTECH | Gastrointestinal neoplasms benign NEC | 0 | 0.06 | 0.85 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal neoplasms benign NEC | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal neoplasms malignancy unspecified NEC | 0 | 0.03 | 0.78 | 2.47 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal neoplasms malignancy unspecified NEC | 1 | 0.17 | 1.05 | 2.56 | 0.4 | 0.35 | 1.07 | 2.79 | 1.13 | 1.13 | 0.17 | 3
COVID19_PFIZER/BIONTECH | Gastrointestinal neoplasms malignancy unspecified NEC | 0 | 0.02 | 0.52 | 1.65 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal neoplasms malignancy unspecified NEC | 0 | 0.03 | 0.99 | 3.16 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal neoplasms malignant NEC | 0 | 0.01 | 0.71 | 2.37 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal neoplasms malignant NEC | 0 | 0.01 | 0.39 | 1.31 | 1.1 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal neoplasms malignant NEC | 1 | 0.15 | 1.01 | 2.51 | 1.2 | 0.26 | 0.80 | 1.97 | 1.02 | 1.02 | 0.16 | 4
COVID19_UNKNOWN MFR | Gastrointestinal neoplasms malignant NEC | 0 | 0.02 | 0.99 | 3.32 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal signs and symptoms NEC | 538 | 0.95 | 1.02 | 1.10 | 554.8 | 0.90 | 0.97 | 1.04 | 1.09 | 1.09 | 1.01 | 7612
COVID19_MODERNA | Gastrointestinal signs and symptoms NEC | 2226 | 0.97 | 1.00 | 1.04 | 2342.9 | 0.92 | 0.95 | 0.98 | 1.28 | 1.28 | 1.23 | 5924
COVID19_PFIZER/BIONTECH | Gastrointestinal signs and symptoms NEC | 2450 | 1.29 | 1.33 | 1.38 | 1943.5 | 1.22 | 1.26 | 1.30 | 1.76 | 1.78 | 1.71 | 5700
COVID19_UNKNOWN MFR | Gastrointestinal signs and symptoms NEC | 8 | 0.41 | 0.72 | 1.10 | 13.2 | 0.36 | 0.63 | 1.04 | 0.68 | 0.67 | 0.38 | 8142
COVID19_JANSSEN | Gastrointestinal spastic and hypermotility disorders | 38 | 0.99 | 1.32 | 1.69 | 32.2 | 0.88 | 1.15 | 1.49 | 1.14 | 1.14 | 0.86 | 517
COVID19_MODERNA | Gastrointestinal spastic and hypermotility disorders | 93 | 0.73 | 0.88 | 1.03 | 117.0 | 0.67 | 0.80 | 0.94 | 0.68 | 0.68 | 0.57 | 462
COVID19_PFIZER/BIONTECH | Gastrointestinal spastic and hypermotility disorders | 118 | 1.09 | 1.27 | 1.47 | 105.2 | 0.96 | 1.11 | 1.29 | 1.11 | 1.11 | 0.93 | 437
COVID19_UNKNOWN MFR | Gastrointestinal spastic and hypermotility disorders | 0 | 0.05 | 0.64 | 1.78 | 0.7 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal stenosis and obstruction NEC | 4 | 0.19 | 0.53 | 0.99 | 16.6 | 0.14 | 0.30 | 0.57 | 0.07 | 0.07 | 0.03 | 864
COVID19_MODERNA | Gastrointestinal stenosis and obstruction NEC | 22 | 0.91 | 1.33 | 1.83 | 23.7 | 0.65 | 0.92 | 1.27 | 0.09 | 0.09 | 0.06 | 846
COVID19_PFIZER/BIONTECH | Gastrointestinal stenosis and obstruction NEC | 16 | 0.44 | 0.70 | 1.00 | 54.7 | 0.21 | 0.31 | 0.45 | 0.08 | 0.08 | 0.05 | 852
COVID19_UNKNOWN MFR | Gastrointestinal stenosis and obstruction NEC | 0 | 0.00 | 0.65 | 2.67 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal therapeutic procedures NEC | 3 | 0.23 | 0.67 | 1.30 | 5.3 | 0.28 | 0.63 | 1.26 | 0.26 | 0.26 | 0.10 | 177
COVID19_MODERNA | Gastrointestinal therapeutic procedures NEC | 14 | 0.51 | 0.82 | 1.20 | 17.7 | 0.51 | 0.79 | 1.17 | 0.29 | 0.29 | 0.18 | 166
COVID19_PFIZER/BIONTECH | Gastrointestinal therapeutic procedures NEC | 19 | 0.72 | 1.09 | 1.52 | 19.6 | 0.65 | 0.95 | 1.34 | 0.48 | 0.48 | 0.32 | 161
COVID19_UNKNOWN MFR | Gastrointestinal therapeutic procedures NEC | 0 | 0.05 | 0.88 | 2.65 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal tract disorders congenital NEC | 0 | 0.05 | 0.75 | 2.17 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal tract disorders congenital NEC | 1 | 0.16 | 0.85 | 1.99 | 0.8 | 0.30 | 0.91 | 2.26 | 0.68 | 0.68 | 0.11 | 5
COVID19_PFIZER/BIONTECH | Gastrointestinal tract disorders congenital NEC | 0 | 0.03 | 0.48 | 1.40 | 1.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal tract disorders congenital NEC | 0 | 0.06 | 0.99 | 2.87 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal ulcers and perforation, site unspecified | 1 | 0.27 | 1.73 | 4.26 | 0.2 | 0.39 | 1.21 | 3.65 | 5.15 | 5.15 | 0.77 | 3
COVID19_MODERNA | Gastrointestinal ulcers and perforation, site unspecified | 0 | 0.01 | 0.46 | 1.51 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal ulcers and perforation, site unspecified | 0 | 0.01 | 0.50 | 1.63 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal ulcers and perforation, site unspecified | 0 | 0.03 | 0.99 | 3.24 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal vascular malformations | 2 | 0.55 | 1.88 | 3.87 | 0.4 | 0.58 | 1.56 | 4.68 | 5.15 | 5.15 | 1.34 | 6
COVID19_MODERNA | Gastrointestinal vascular malformations | 1 | 0.15 | 0.73 | 1.68 | 1.9 | 0.20 | 0.64 | 1.59 | 0.49 | 0.49 | 0.08 | 7
COVID19_PFIZER/BIONTECH | Gastrointestinal vascular malformations | 4 | 0.76 | 1.87 | 3.39 | 1.7 | 0.71 | 1.48 | 2.89 | 4.09 | 4.09 | 1.28 | 4
COVID19_UNKNOWN MFR | Gastrointestinal vascular malformations | 0 | 0.08 | 0.99 | 2.76 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal vascular occlusion and infarction | 8 | 0.82 | 1.59 | 2.57 | 5.3 | 0.74 | 1.29 | 2.12 | 1.82 | 1.82 | 0.98 | 68
COVID19_MODERNA | Gastrointestinal vascular occlusion and infarction | 26 | 1.02 | 1.45 | 1.94 | 20.0 | 0.91 | 1.25 | 1.69 | 1.77 | 1.77 | 1.19 | 50
COVID19_PFIZER/BIONTECH | Gastrointestinal vascular occlusion and infarction | 30 | 1.37 | 1.90 | 2.49 | 17.7 | 1.18 | 1.59 | 2.12 | 2.67 | 2.67 | 1.82 | 46
COVID19_UNKNOWN MFR | Gastrointestinal vascular occlusion and infarction | 0 | 0.02 | 0.86 | 2.91 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal, pancreatic and APUD hormone analyses | 1 | 0.15 | 0.69 | 1.55 | 1.9 | 0.20 | 0.64 | 1.59 | 0.47 | 0.47 | 0.09 | 33
COVID19_MODERNA | Gastrointestinal, pancreatic and APUD hormone analyses | 6 | 0.45 | 0.94 | 1.57 | 6.2 | 0.49 | 0.92 | 1.59 | 0.73 | 0.73 | 0.35 | 28
COVID19_PFIZER/BIONTECH | Gastrointestinal, pancreatic and APUD hormone analyses | 7 | 0.56 | 1.10 | 1.80 | 5.8 | 0.61 | 1.09 | 1.83 | 1.06 | 1.06 | 0.53 | 27
COVID19_UNKNOWN MFR | Gastrointestinal, pancreatic and APUD hormone analyses | 0 | 0.10 | 0.97 | 2.60 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gender disorders | 2 | 0.85 | 3.55 | 7.75 | 0.1 | 0.71 | 2.63 | 14.78 | 77.19 | 77.19 | 6.04 | 0
COVID19_MODERNA | Gender disorders | 0 | 0.01 | 0.57 | 2.05 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gender disorders | 0 | 0.01 | 0.61 | 2.18 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gender disorders | 0 | 0.01 | 1.00 | 3.55 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gene analyses | 10 | 0.42 | 0.76 | 1.18 | 21.6 | 0.30 | 0.49 | 0.78 | 0.40 | 0.40 | 0.23 | 391
COVID19_MODERNA | Gene analyses | 14 | 0.35 | 0.57 | 0.84 | 32.7 | 0.29 | 0.45 | 0.67 | 0.12 | 0.12 | 0.08 | 387
COVID19_PFIZER/BIONTECH | Gene analyses | 17 | 0.36 | 0.55 | 0.79 | 46.5 | 0.26 | 0.39 | 0.55 | 0.18 | 0.18 | 0.12 | 384
COVID19_UNKNOWN MFR | Gene analyses | 0 | 0.00 | 0.49 | 1.95 | 0.5 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gene mutations and other alterations NEC | 4 | 0.64 | 1.64 | 3.02 | 2.3 | 0.61 | 1.27 | 2.42 | 1.63 | 1.63 | 0.68 | 38
COVID19_MODERNA | Gene mutations and other alterations NEC | 11 | 0.85 | 1.47 | 2.23 | 7.8 | 0.78 | 1.27 | 1.96 | 1.21 | 1.21 | 0.68 | 31
COVID19_PFIZER/BIONTECH | Gene mutations and other alterations NEC | 4 | 0.25 | 0.65 | 1.19 | 7.4 | 0.28 | 0.60 | 1.12 | 0.43 | 0.43 | 0.18 | 38
COVID19_UNKNOWN MFR | Gene mutations and other alterations NEC | 0 | 0.04 | 0.95 | 2.92 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | General nutritional disorders NEC | 72 | 1.02 | 1.25 | 1.50 | 64.7 | 0.91 | 1.10 | 1.33 | 0.88 | 0.88 | 0.72 | 1269
COVID19_MODERNA | General nutritional disorders NEC | 237 | 0.90 | 1.01 | 1.12 | 251.4 | 0.85 | 0.94 | 1.05 | 0.73 | 0.73 | 0.65 | 1104
COVID19_PFIZER/BIONTECH | General nutritional disorders NEC | 231 | 1.01 | 1.12 | 1.25 | 229.8 | 0.90 | 1.00 | 1.12 | 0.85 | 0.85 | 0.76 | 1110
COVID19_UNKNOWN MFR | General nutritional disorders NEC | 2 | 0.39 | 1.13 | 2.18 | 1.7 | 0.38 | 0.94 | 2.04 | 1.03 | 1.03 | 0.32 | 1339
COVID19_JANSSEN | General signs and symptoms NEC | 3172 | 0.98 | 1.00 | 1.03 | 3759.9 | 0.82 | 0.84 | 0.87 | 0.78 | 0.76 | 0.73 | 63105
COVID19_MODERNA | General signs and symptoms NEC | 14283 | 1.03 | 1.05 | 1.06 | 16131.8 | 0.87 | 0.89 | 0.90 | 0.93 | 0.93 | 0.91 | 51994
COVID19_PFIZER/BIONTECH | General signs and symptoms NEC | 9775 | 0.84 | 0.86 | 0.87 | 13499.9 | 0.71 | 0.72 | 0.74 | 0.71 | 0.68 | 0.67 | 56502
COVID19_UNKNOWN MFR | General signs and symptoms NEC | 84 | 0.87 | 1.04 | 1.23 | 94.4 | 0.74 | 0.89 | 1.06 | 0.87 | 0.86 | 0.71 | 66193
COVID19_JANSSEN | Generalised tonic-clonic seizures | 29 | 0.67 | 0.91 | 1.19 | 34.8 | 0.61 | 0.83 | 1.11 | 0.61 | 0.61 | 0.45 | 737
COVID19_MODERNA | Generalised tonic-clonic seizures | 67 | 0.66 | 0.81 | 0.97 | 88.5 | 0.62 | 0.76 | 0.92 | 0.33 | 0.33 | 0.26 | 699
COVID19_PFIZER/BIONTECH | Generalised tonic-clonic seizures | 94 | 0.87 | 1.03 | 1.21 | 99.1 | 0.80 | 0.94 | 1.11 | 0.57 | 0.57 | 0.48 | 672
COVID19_UNKNOWN MFR | Generalised tonic-clonic seizures | 0 | 0.27 | 0.84 | 1.66 | 0.7 |  |  |  |  |  |  | 
COVID19_JANSSEN | Genetic mitochondrial abnormalities NEC | 0 | 0.02 | 0.77 | 2.48 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Genetic mitochondrial abnormalities NEC | 0 | 0.01 | 0.47 | 1.52 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genetic mitochondrial abnormalities NEC | 0 | 0.02 | 0.51 | 1.64 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genetic mitochondrial abnormalities NEC | 0 | 0.03 | 0.99 | 3.21 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Genital and urinary tract disorders NEC | 4 | 0.59 | 1.46 | 2.65 | 2.3 | 0.62 | 1.28 | 2.44 | 1.76 | 1.76 | 0.74 | 35
COVID19_MODERNA | Genital and urinary tract disorders NEC | 2 | 0.13 | 0.45 | 0.93 | 6.0 | 0.17 | 0.45 | 0.99 | 0.18 | 0.18 | 0.06 | 37
COVID19_PFIZER/BIONTECH | Genital and urinary tract disorders NEC | 6 | 0.44 | 0.92 | 1.55 | 6.6 | 0.47 | 0.88 | 1.53 | 0.74 | 0.74 | 0.36 | 33
COVID19_UNKNOWN MFR | Genital and urinary tract disorders NEC | 0 | 0.08 | 0.95 | 2.64 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Genitourinary tract infections and inflammations NEC | 0 | 0.02 | 0.68 | 2.23 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Genitourinary tract infections and inflammations NEC | 0 | 0.01 | 0.36 | 1.18 | 1.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genitourinary tract infections and inflammations NEC | 1 | 0.14 | 0.91 | 2.24 | 1.0 | 0.28 | 0.84 | 2.07 | 0.82 | 0.82 | 0.14 | 5
COVID19_UNKNOWN MFR | Genitourinary tract infections and inflammations NEC | 0 | 0.02 | 0.99 | 3.27 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Germ cell neoplasms site unspecified NEC | 0 | 0.04 | 0.89 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Germ cell neoplasms site unspecified NEC | 0 | 0.03 | 0.67 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Germ cell neoplasms site unspecified NEC | 0 | 0.03 | 0.70 | 2.16 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Germ cell neoplasms site unspecified NEC | 0 | 0.04 | 1.00 | 3.06 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gestational age and weight conditions | 0 | 0.00 | 0.01 | 0.05 | 12.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Gestational age and weight conditions | 4 | 0.14 | 0.41 | 0.78 | 14.3 | 0.16 | 0.34 | 0.65 | 0.05 | 0.05 | 0.02 | 254
COVID19_PFIZER/BIONTECH | Gestational age and weight conditions | 10 | 0.23 | 0.42 | 0.65 | 32.2 | 0.20 | 0.34 | 0.54 | 0.17 | 0.17 | 0.10 | 248
COVID19_UNKNOWN MFR | Gestational age and weight conditions | 0 | 0.00 | 0.14 | 0.82 | 0.7 |  |  |  |  |  |  | 
COVID19_JANSSEN | Giardia infections | 0 | 0.10 | 0.86 | 2.25 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Giardia infections | 1 | 0.24 | 1.04 | 2.31 | 1.0 | 0.28 | 0.84 | 2.07 | 1.13 | 1.13 | 0.17 | 3
COVID19_PFIZER/BIONTECH | Giardia infections | 1 | 0.25 | 1.10 | 2.43 | 0.9 | 0.29 | 0.87 | 2.15 | 1.36 | 1.36 | 0.20 | 3
COVID19_UNKNOWN MFR | Giardia infections | 0 | 0.11 | 1.00 | 2.61 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gingival disorders, signs and symptoms NEC | 29 | 0.82 | 1.14 | 1.49 | 25.6 | 0.81 | 1.11 | 1.47 | 1.26 | 1.26 | 0.92 | 355
COVID19_MODERNA | Gingival disorders, signs and symptoms NEC | 121 | 0.95 | 1.11 | 1.28 | 109.7 | 0.94 | 1.10 | 1.27 | 1.56 | 1.56 | 1.30 | 263
COVID19_PFIZER/BIONTECH | Gingival disorders, signs and symptoms NEC | 109 | 1.03 | 1.21 | 1.41 | 90.2 | 1.02 | 1.20 | 1.40 | 1.62 | 1.62 | 1.35 | 275
COVID19_UNKNOWN MFR | Gingival disorders, signs and symptoms NEC | 0 | 0.16 | 0.79 | 1.80 | 0.6 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gingival haemorrhages | 7 | 0.38 | 0.72 | 1.14 | 10.6 | 0.38 | 0.68 | 1.15 | 0.69 | 0.69 | 0.37 | 157
COVID19_MODERNA | Gingival haemorrhages | 52 | 0.99 | 1.25 | 1.55 | 40.4 | 1.00 | 1.26 | 1.57 | 1.58 | 1.58 | 1.20 | 112
COVID19_PFIZER/BIONTECH | Gingival haemorrhages | 41 | 0.87 | 1.15 | 1.45 | 35.2 | 0.88 | 1.14 | 1.46 | 1.36 | 1.37 | 1.01 | 123
COVID19_UNKNOWN MFR | Gingival haemorrhages | 1 | 0.39 | 1.29 | 2.63 | 0.3 | 0.38 | 1.17 | 3.33 | 4.22 | 4.22 | 0.81 | 163
COVID19_JANSSEN | Glaucomas (excl congenital) | 0 | 0.06 | 0.39 | 0.95 | 2.9 |  |  |  |  |  |  | 
COVID19_MODERNA | Glaucomas (excl congenital) | 7 | 0.42 | 0.80 | 1.29 | 9.1 | 0.43 | 0.77 | 1.30 | 0.61 | 0.61 | 0.31 | 39
COVID19_PFIZER/BIONTECH | Glaucomas (excl congenital) | 12 | 0.79 | 1.30 | 1.93 | 9.0 | 0.77 | 1.22 | 1.86 | 1.45 | 1.45 | 0.83 | 34
COVID19_UNKNOWN MFR | Glaucomas (excl congenital) | 0 | 0.15 | 0.96 | 2.34 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Glial tumours malignant | 0 | 0.04 | 0.76 | 2.31 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Glial tumours malignant | 1 | 0.16 | 0.93 | 2.23 | 0.6 | 0.32 | 0.96 | 2.42 | 0.85 | 0.85 | 0.14 | 4
COVID19_PFIZER/BIONTECH | Glial tumours malignant | 0 | 0.02 | 0.49 | 1.50 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glial tumours malignant | 0 | 0.05 | 0.99 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Glomerulonephritis and nephrotic syndrome | 3 | 0.19 | 0.53 | 1.02 | 7.8 | 0.20 | 0.47 | 0.95 | 0.35 | 0.35 | 0.13 | 132
COVID19_MODERNA | Glomerulonephritis and nephrotic syndrome | 6 | 0.20 | 0.41 | 0.70 | 17.8 | 0.20 | 0.39 | 0.67 | 0.16 | 0.16 | 0.08 | 129
COVID19_PFIZER/BIONTECH | Glomerulonephritis and nephrotic syndrome | 9 | 0.29 | 0.54 | 0.84 | 20.3 | 0.28 | 0.48 | 0.77 | 0.29 | 0.29 | 0.17 | 126
COVID19_UNKNOWN MFR | Glomerulonephritis and nephrotic syndrome | 0 | 0.06 | 0.87 | 2.49 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Glossopharyngeal nerve disorders | 0 | 0.05 | 0.78 | 2.27 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Glossopharyngeal nerve disorders | 1 | 0.18 | 0.94 | 2.19 | 1.6 | 0.23 | 0.70 | 1.72 | 0.85 | 0.85 | 0.14 | 4
COVID19_PFIZER/BIONTECH | Glossopharyngeal nerve disorders | 0 | 0.03 | 0.53 | 1.53 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glossopharyngeal nerve disorders | 0 | 0.06 | 0.99 | 2.89 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Granulomatous and deep cutaneous inflammatory conditions | 1 | 0.17 | 0.78 | 1.77 | 1.8 | 0.22 | 0.67 | 1.66 | 0.47 | 0.47 | 0.09 | 33
COVID19_MODERNA | Granulomatous and deep cutaneous inflammatory conditions | 5 | 0.47 | 1.05 | 1.81 | 4.8 | 0.49 | 0.96 | 1.73 | 0.59 | 0.59 | 0.26 | 29
COVID19_PFIZER/BIONTECH | Granulomatous and deep cutaneous inflammatory conditions | 1 | 0.08 | 0.38 | 0.87 | 5.1 | 0.08 | 0.34 | 0.90 | 0.12 | 0.12 | 0.02 | 33
COVID19_UNKNOWN MFR | Granulomatous and deep cutaneous inflammatory conditions | 0 | 0.09 | 0.97 | 2.63 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Great vessel disorders congenital | 0 | 0.00 | 0.58 | 2.37 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Great vessel disorders congenital | 0 | 0.00 | 0.27 | 1.09 | 1.1 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Great vessel disorders congenital | 0 | 0.00 | 0.30 | 1.22 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Great vessel disorders congenital | 0 | 0.00 | 0.98 | 4.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Gynaecological therapeutic procedures NEC | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Gynaecological therapeutic procedures NEC | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gynaecological therapeutic procedures NEC | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gynaecological therapeutic procedures NEC | 0 | 0.05 | 1.00 | 3.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Haem metabolism analyses | 7 | 0.72 | 1.42 | 2.31 | 5.3 | 0.65 | 1.16 | 1.95 | 1.46 | 1.46 | 0.76 | 74
COVID19_MODERNA | Haem metabolism analyses | 7 | 0.31 | 0.62 | 1.00 | 13.6 | 0.31 | 0.55 | 0.93 | 0.32 | 0.32 | 0.17 | 74
COVID19_PFIZER/BIONTECH | Haem metabolism analyses | 19 | 0.95 | 1.43 | 1.98 | 14.9 | 0.83 | 1.21 | 1.71 | 1.25 | 1.25 | 0.82 | 62
COVID19_UNKNOWN MFR | Haem metabolism analyses | 0 | 0.10 | 0.93 | 2.44 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Haematologic neoplasms NEC | 2 | 0.32 | 1.10 | 2.26 | 1.6 | 0.39 | 0.97 | 2.11 | 1.24 | 1.24 | 0.37 | 25
COVID19_MODERNA | Haematologic neoplasms NEC | 2 | 0.20 | 0.71 | 1.46 | 3.1 | 0.28 | 0.70 | 1.52 | 0.27 | 0.27 | 0.08 | 25
COVID19_PFIZER/BIONTECH | Haematologic neoplasms NEC | 1 | 0.08 | 0.41 | 0.94 | 3.8 | 0.12 | 0.42 | 1.09 | 0.16 | 0.16 | 0.03 | 26
COVID19_UNKNOWN MFR | Haematologic neoplasms NEC | 0 | 0.07 | 0.96 | 2.72 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Haematological analyses NEC | 94 | 0.69 | 0.83 | 0.97 | 122.7 | 0.65 | 0.77 | 0.90 | 0.79 | 0.79 | 0.66 | 1847
COVID19_MODERNA | Haematological analyses NEC | 295 | 0.65 | 0.71 | 0.78 | 436.3 | 0.61 | 0.68 | 0.74 | 0.61 | 0.61 | 0.55 | 1646
COVID19_PFIZER/BIONTECH | Haematological analyses NEC | 370 | 0.93 | 1.01 | 1.10 | 389.6 | 0.87 | 0.95 | 1.03 | 0.96 | 0.96 | 0.88 | 1571
COVID19_UNKNOWN MFR | Haematological analyses NEC | 0 | 0.12 | 0.49 | 1.07 | 2.7 |  |  |  |  |  |  | 
COVID19_JANSSEN | Haematological cysts and polyps | 0 | 0.04 | 0.88 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Haematological cysts and polyps | 0 | 0.03 | 0.67 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haematological cysts and polyps | 0 | 0.03 | 0.70 | 2.16 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematological cysts and polyps | 0 | 0.04 | 1.00 | 3.07 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Haematological disorders | 7 | 0.55 | 1.09 | 1.77 | 6.8 | 0.54 | 0.97 | 1.63 | 1.02 | 1.02 | 0.54 | 106
COVID19_MODERNA | Haematological disorders | 6 | 0.16 | 0.32 | 0.54 | 23.0 | 0.16 | 0.30 | 0.53 | 0.19 | 0.19 | 0.10 | 107
COVID19_PFIZER/BIONTECH | Haematological disorders | 24 | 0.83 | 1.20 | 1.61 | 21.5 | 0.78 | 1.08 | 1.48 | 1.10 | 1.10 | 0.76 | 89
COVID19_UNKNOWN MFR | Haematological disorders | 0 | 0.09 | 0.90 | 2.41 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Haematological disorders congenital NEC | 0 | 0.04 | 0.80 | 2.42 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Haematological disorders congenital NEC | 0 | 0.03 | 0.52 | 1.56 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haematological disorders congenital NEC | 2 | 0.46 | 1.69 | 3.55 | 0.7 | 0.52 | 1.34 | 3.19 | 4.09 | 4.09 | 0.79 | 2
COVID19_UNKNOWN MFR | Haematological disorders congenital NEC | 0 | 0.05 | 0.99 | 3.00 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Haematological therapeutic procedures NEC | 115 | 3.99 | 4.68 | 5.42 | 34.6 | 2.74 | 3.21 | 3.75 | 4.38 | 4.39 | 3.69 | 405
COVID19_MODERNA | Haematological therapeutic procedures NEC | 149 | 1.17 | 1.34 | 1.53 | 149.3 | 0.87 | 0.99 | 1.14 | 1.36 | 1.36 | 1.16 | 371
COVID19_PFIZER/BIONTECH | Haematological therapeutic procedures NEC | 194 | 1.89 | 2.13 | 2.39 | 124.6 | 1.37 | 1.54 | 1.73 | 2.44 | 2.44 | 2.10 | 326
COVID19_UNKNOWN MFR | Haematological therapeutic procedures NEC | 2 | 0.50 | 2.28 | 5.11 | 0.9 | 0.49 | 1.23 | 2.77 | 2.66 | 2.66 | 0.83 | 518
COVID19_JANSSEN | Haemoglobinopathies congenital | 0 | 0.01 | 0.49 | 1.63 | 0.8 |  |  |  |  |  |  | 
COVID19_MODERNA | Haemoglobinopathies congenital | 1 | 0.08 | 0.52 | 1.30 | 1.7 | 0.22 | 0.68 | 1.68 | 0.31 | 0.31 | 0.06 | 11
COVID19_PFIZER/BIONTECH | Haemoglobinopathies congenital | 3 | 0.39 | 1.21 | 2.38 | 2.0 | 0.50 | 1.12 | 2.26 | 1.36 | 1.36 | 0.46 | 9
COVID19_UNKNOWN MFR | Haemoglobinopathies congenital | 0 | 0.02 | 0.97 | 3.24 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Haemolyses NEC | 0 | 0.00 | 0.21 | 0.73 | 2.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Haemolyses NEC | 6 | 0.43 | 0.93 | 1.60 | 7.1 | 0.45 | 0.83 | 1.44 | 0.47 | 0.47 | 0.23 | 43
COVID19_PFIZER/BIONTECH | Haemolyses NEC | 3 | 0.16 | 0.49 | 0.98 | 7.8 | 0.20 | 0.47 | 0.95 | 0.27 | 0.27 | 0.10 | 46
COVID19_UNKNOWN MFR | Haemolyses NEC | 0 | 0.01 | 0.91 | 3.25 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Haemophilus infections | 0 | 0.00 | 0.04 | 0.22 | 2.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Haemophilus infections | 1 | 0.02 | 0.29 | 0.84 | 3.2 | 0.14 | 0.48 | 1.22 | 0.05 | 0.05 | 0.01 | 73
COVID19_PFIZER/BIONTECH | Haemophilus infections | 0 | 0.00 | 0.02 | 0.12 | 5.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemophilus infections | 0 | 0.00 | 0.55 | 3.17 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhages NEC | 53 | 0.68 | 0.86 | 1.06 | 65.5 | 0.64 | 0.81 | 1.00 | 0.77 | 0.77 | 0.61 | 1062
COVID19_MODERNA | Haemorrhages NEC | 183 | 0.68 | 0.77 | 0.87 | 248.5 | 0.65 | 0.74 | 0.83 | 0.67 | 0.67 | 0.58 | 932
COVID19_PFIZER/BIONTECH | Haemorrhages NEC | 239 | 1.02 | 1.14 | 1.26 | 223.0 | 0.96 | 1.07 | 1.19 | 1.12 | 1.12 | 0.99 | 876
COVID19_UNKNOWN MFR | Haemorrhages NEC | 2 | 0.39 | 1.11 | 2.11 | 1.7 | 0.38 | 0.96 | 2.07 | 1.24 | 1.24 | 0.39 | 1113
COVID19_JANSSEN | Haemorrhagic complications of pregnancy | 3 | 0.18 | 0.62 | 1.27 | 6.2 | 0.25 | 0.56 | 1.12 | 0.68 | 0.68 | 0.26 | 68
COVID19_MODERNA | Haemorrhagic complications of pregnancy | 13 | 0.40 | 0.67 | 1.00 | 24.6 | 0.35 | 0.55 | 0.83 | 0.76 | 0.76 | 0.46 | 58
COVID19_PFIZER/BIONTECH | Haemorrhagic complications of pregnancy | 20 | 0.77 | 1.16 | 1.61 | 21.5 | 0.64 | 0.92 | 1.28 | 1.61 | 1.61 | 1.04 | 51
COVID19_UNKNOWN MFR | Haemorrhagic complications of pregnancy | 0 | 0.00 | 0.73 | 3.36 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhoids and gastrointestinal varices (excl oesophageal) | 13 | 1.27 | 2.06 | 3.00 | 5.1 | 1.29 | 2.03 | 3.13 | 3.58 | 3.59 | 2.16 | 56
COVID19_MODERNA | Haemorrhoids and gastrointestinal varices (excl oesophageal) | 15 | 0.54 | 0.85 | 1.21 | 18.5 | 0.53 | 0.81 | 1.18 | 0.94 | 0.94 | 0.58 | 54
COVID19_PFIZER/BIONTECH | Haemorrhoids and gastrointestinal varices (excl oesophageal) | 18 | 0.73 | 1.10 | 1.53 | 16.4 | 0.72 | 1.06 | 1.51 | 1.45 | 1.45 | 0.92 | 51
COVID19_UNKNOWN MFR | Haemorrhoids and gastrointestinal varices (excl oesophageal) | 0 | 0.19 | 0.95 | 2.19 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hallucinations (excl sleep-related) | 88 | 1.49 | 1.79 | 2.12 | 54.5 | 1.32 | 1.58 | 1.87 | 1.62 | 1.62 | 1.35 | 840
COVID19_MODERNA | Hallucinations (excl sleep-related) | 274 | 1.20 | 1.33 | 1.47 | 224.1 | 1.10 | 1.22 | 1.34 | 1.42 | 1.42 | 1.26 | 654
COVID19_PFIZER/BIONTECH | Hallucinations (excl sleep-related) | 202 | 1.01 | 1.14 | 1.28 | 195.5 | 0.92 | 1.03 | 1.15 | 1.14 | 1.14 | 1.00 | 726
COVID19_UNKNOWN MFR | Hallucinations (excl sleep-related) | 5 | 1.07 | 2.35 | 4.03 | 1.4 | 0.96 | 1.98 | 4.22 | 3.73 | 3.74 | 1.79 | 923
COVID19_JANSSEN | Head, neck and oral cavity therapeutic procedures NEC | 1 | 0.16 | 1.03 | 2.53 | 0.8 | 0.30 | 0.89 | 2.20 | 1.29 | 1.29 | 0.23 | 12
COVID19_MODERNA | Head, neck and oral cavity therapeutic procedures NEC | 0 | 0.01 | 0.23 | 0.74 | 2.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Head, neck and oral cavity therapeutic procedures NEC | 0 | 0.01 | 0.23 | 0.75 | 2.7 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Head, neck and oral cavity therapeutic procedures NEC | 0 | 0.03 | 0.97 | 3.13 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Headaches NEC | 11611 | 1.89 | 1.92 | 1.95 | 6442.6 | 1.78 | 1.80 | 1.83 | 2.38 | 3.02 | 2.96 | 75159
COVID19_MODERNA | Headaches NEC | 27510 | 1.12 | 1.13 | 1.15 | 25362.3 | 1.07 | 1.09 | 1.10 | 1.58 | 1.72 | 1.70 | 59260
COVID19_PFIZER/BIONTECH | Headaches NEC | 24222 | 1.18 | 1.20 | 1.21 | 21286.0 | 1.13 | 1.14 | 1.15 | 1.59 | 1.73 | 1.71 | 62548
COVID19_UNKNOWN MFR | Headaches NEC | 237 | 1.55 | 1.73 | 1.92 | 143.9 | 1.47 | 1.63 | 1.82 | 1.88 | 2.21 | 1.95 | 86533
COVID19_JANSSEN | Healing abnormal NEC | 1 | 0.13 | 0.57 | 1.25 | 3.3 | 0.14 | 0.47 | 1.19 | 0.26 | 0.26 | 0.05 | 60
COVID19_MODERNA | Healing abnormal NEC | 6 | 0.29 | 0.59 | 0.99 | 12.6 | 0.28 | 0.52 | 0.91 | 0.37 | 0.37 | 0.18 | 55
COVID19_PFIZER/BIONTECH | Healing abnormal NEC | 7 | 0.38 | 0.75 | 1.22 | 11.2 | 0.36 | 0.65 | 1.10 | 0.53 | 0.53 | 0.27 | 54
COVID19_UNKNOWN MFR | Healing abnormal NEC | 0 | 0.11 | 0.95 | 2.47 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hearing disorders NEC | 4 | 0.55 | 1.11 | 1.84 | 3.4 | 0.50 | 1.03 | 1.94 | 1.40 | 1.40 | 0.59 | 44
COVID19_MODERNA | Hearing disorders NEC | 8 | 0.45 | 0.79 | 1.20 | 11.3 | 0.42 | 0.72 | 1.18 | 0.68 | 0.68 | 0.36 | 40
COVID19_PFIZER/BIONTECH | Hearing disorders NEC | 9 | 0.54 | 0.93 | 1.39 | 10.1 | 0.51 | 0.87 | 1.39 | 0.95 | 0.95 | 0.51 | 39
COVID19_UNKNOWN MFR | Hearing disorders NEC | 0 | 0.32 | 0.98 | 1.93 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hearing disorders congenital | 0 | 0.06 | 0.90 | 2.62 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Hearing disorders congenital | 0 | 0.04 | 0.71 | 2.05 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hearing disorders congenital | 0 | 0.05 | 0.73 | 2.14 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hearing disorders congenital | 0 | 0.06 | 1.00 | 2.90 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hearing losses | 181 | 1.12 | 1.27 | 1.42 | 182.2 | 0.88 | 0.99 | 1.12 | 1.19 | 1.19 | 1.04 | 2359
COVID19_MODERNA | Hearing losses | 524 | 0.99 | 1.07 | 1.15 | 620.1 | 0.79 | 0.85 | 0.91 | 0.88 | 0.88 | 0.81 | 2016
COVID19_PFIZER/BIONTECH | Hearing losses | 830 | 1.79 | 1.90 | 2.01 | 555.7 | 1.41 | 1.49 | 1.58 | 1.99 | 1.99 | 1.86 | 1710
COVID19_UNKNOWN MFR | Hearing losses | 6 | 0.74 | 1.46 | 2.38 | 4.3 | 0.64 | 1.19 | 2.06 | 1.63 | 1.63 | 0.83 | 2534
COVID19_JANSSEN | Heart failure signs and symptoms | 0 | 0.00 | 0.59 | 3.13 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Heart failure signs and symptoms | 0 | 0.00 | 0.27 | 1.47 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Heart failure signs and symptoms | 0 | 0.00 | 0.30 | 1.63 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heart failure signs and symptoms | 0 | 0.00 | 0.98 | 5.26 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Heart failures NEC | 30 | 0.91 | 1.26 | 1.65 | 31.4 | 0.70 | 0.94 | 1.25 | 0.77 | 0.77 | 0.57 | 598
COVID19_MODERNA | Heart failures NEC | 182 | 1.43 | 1.62 | 1.82 | 152.8 | 1.05 | 1.19 | 1.34 | 1.39 | 1.39 | 1.20 | 446
COVID19_PFIZER/BIONTECH | Heart failures NEC | 225 | 2.05 | 2.29 | 2.55 | 134.0 | 1.49 | 1.66 | 1.85 | 2.29 | 2.29 | 2.00 | 403
COVID19_UNKNOWN MFR | Heart failures NEC | 3 | 0.72 | 2.00 | 3.79 | 1.1 | 0.64 | 1.45 | 3.10 | 3.30 | 3.31 | 1.27 | 625
COVID19_JANSSEN | Heart rate and pulse investigations | 1194 | 1.93 | 2.03 | 2.13 | 761.3 | 1.49 | 1.57 | 1.64 | 2.02 | 2.05 | 1.95 | 9138
COVID19_MODERNA | Heart rate and pulse investigations | 3174 | 1.29 | 1.33 | 1.37 | 3030.2 | 1.02 | 1.05 | 1.08 | 1.51 | 1.52 | 1.47 | 7158
COVID19_PFIZER/BIONTECH | Heart rate and pulse investigations | 3678 | 1.78 | 1.83 | 1.88 | 2566.2 | 1.39 | 1.43 | 1.47 | 2.26 | 2.30 | 2.23 | 6654
COVID19_UNKNOWN MFR | Heart rate and pulse investigations | 15 | 0.72 | 1.10 | 1.54 | 17.1 | 0.57 | 0.87 | 1.27 | 1.00 | 1.00 | 0.65 | 10317
COVID19_JANSSEN | Heat injuries (excl thermal burns) | 0 | 0.00 | 0.32 | 1.23 | 1.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Heat injuries (excl thermal burns) | 3 | 0.29 | 0.94 | 1.90 | 3.3 | 0.38 | 0.86 | 1.71 | 0.57 | 0.57 | 0.20 | 18
COVID19_PFIZER/BIONTECH | Heat injuries (excl thermal burns) | 2 | 0.16 | 0.70 | 1.54 | 3.6 | 0.25 | 0.64 | 1.39 | 0.43 | 0.43 | 0.13 | 19
COVID19_UNKNOWN MFR | Heat injuries (excl thermal burns) | 0 | 0.00 | 0.95 | 3.63 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Helicobacter infections | 0 | 0.13 | 0.61 | 1.38 | 1.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Helicobacter infections | 4 | 0.44 | 0.98 | 1.69 | 4.5 | 0.41 | 0.86 | 1.61 | 0.65 | 0.65 | 0.26 | 21
COVID19_PFIZER/BIONTECH | Helicobacter infections | 3 | 0.33 | 0.80 | 1.44 | 4.5 | 0.31 | 0.70 | 1.41 | 0.56 | 0.56 | 0.20 | 22
COVID19_UNKNOWN MFR | Helicobacter infections | 0 | 0.21 | 0.99 | 2.22 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Helminthic infections NEC | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Helminthic infections NEC | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Helminthic infections NEC | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Helminthic infections NEC | 0 | 0.05 | 1.00 | 3.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic and hepatobiliary disorders NEC | 1 | 0.04 | 0.28 | 0.69 | 5.9 | 0.06 | 0.29 | 0.80 | 0.14 | 0.14 | 0.03 | 107
COVID19_MODERNA | Hepatic and hepatobiliary disorders NEC | 19 | 0.63 | 0.96 | 1.34 | 20.2 | 0.64 | 0.92 | 1.31 | 0.73 | 0.73 | 0.48 | 89
COVID19_PFIZER/BIONTECH | Hepatic and hepatobiliary disorders NEC | 24 | 0.92 | 1.33 | 1.80 | 19.0 | 0.87 | 1.21 | 1.66 | 1.17 | 1.17 | 0.80 | 84
COVID19_UNKNOWN MFR | Hepatic and hepatobiliary disorders NEC | 0 | 0.02 | 0.83 | 2.80 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic enzymes and function abnormalities | 3 | 0.29 | 0.86 | 1.68 | 4.7 | 0.31 | 0.69 | 1.37 | 0.42 | 0.42 | 0.16 | 111
COVID19_MODERNA | Hepatic enzymes and function abnormalities | 3 | 0.11 | 0.32 | 0.62 | 13.6 | 0.12 | 0.29 | 0.60 | 0.09 | 0.09 | 0.04 | 111
COVID19_PFIZER/BIONTECH | Hepatic enzymes and function abnormalities | 8 | 0.38 | 0.73 | 1.18 | 14.3 | 0.34 | 0.59 | 0.97 | 0.31 | 0.31 | 0.17 | 106
COVID19_UNKNOWN MFR | Hepatic enzymes and function abnormalities | 0 | 0.03 | 0.91 | 2.84 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic failure and associated disorders | 7 | 0.69 | 1.37 | 2.24 | 4.9 | 0.68 | 1.22 | 2.06 | 1.29 | 1.29 | 0.67 | 84
COVID19_MODERNA | Hepatic failure and associated disorders | 21 | 0.78 | 1.15 | 1.57 | 19.7 | 0.73 | 1.04 | 1.45 | 1.02 | 1.02 | 0.68 | 70
COVID19_PFIZER/BIONTECH | Hepatic failure and associated disorders | 18 | 0.72 | 1.10 | 1.54 | 17.6 | 0.68 | 1.00 | 1.42 | 1.01 | 1.01 | 0.66 | 73
COVID19_UNKNOWN MFR | Hepatic failure and associated disorders | 1 | 0.34 | 1.61 | 3.66 | 0.1 | 0.40 | 1.30 | 4.98 | 7.64 | 7.65 | 1.46 | 90
COVID19_JANSSEN | Hepatic fibrosis and cirrhosis | 0 | 0.01 | 0.29 | 0.90 | 2.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Hepatic fibrosis and cirrhosis | 8 | 0.57 | 1.09 | 1.75 | 8.3 | 0.53 | 0.92 | 1.51 | 0.82 | 0.82 | 0.43 | 33
COVID19_PFIZER/BIONTECH | Hepatic fibrosis and cirrhosis | 14 | 1.20 | 1.94 | 2.84 | 7.7 | 1.03 | 1.58 | 2.36 | 2.12 | 2.12 | 1.24 | 27
COVID19_UNKNOWN MFR | Hepatic fibrosis and cirrhosis | 0 | 0.04 | 0.94 | 2.89 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic neoplasms malignant | 1 | 0.16 | 1.60 | 4.29 | 0.3 | 0.37 | 1.13 | 3.06 | 2.21 | 2.21 | 0.38 | 7
COVID19_MODERNA | Hepatic neoplasms malignant | 0 | 0.00 | 0.17 | 0.74 | 1.8 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic neoplasms malignant | 1 | 0.07 | 0.71 | 1.91 | 0.8 | 0.30 | 0.89 | 2.21 | 0.59 | 0.59 | 0.10 | 7
COVID19_UNKNOWN MFR | Hepatic neoplasms malignant | 0 | 0.00 | 0.97 | 4.11 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic therapeutic procedures | 1 | 0.10 | 1.01 | 2.71 | 0.9 | 0.28 | 0.86 | 2.12 | 1.10 | 1.10 | 0.20 | 14
COVID19_MODERNA | Hepatic therapeutic procedures | 1 | 0.04 | 0.39 | 1.05 | 2.0 | 0.20 | 0.63 | 1.57 | 0.24 | 0.24 | 0.04 | 14
COVID19_PFIZER/BIONTECH | Hepatic therapeutic procedures | 1 | 0.04 | 0.42 | 1.13 | 2.2 | 0.19 | 0.60 | 1.49 | 0.29 | 0.29 | 0.05 | 14
COVID19_UNKNOWN MFR | Hepatic therapeutic procedures | 0 | 0.00 | 0.94 | 4.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic vascular disorders | 18 | 2.47 | 3.80 | 5.36 | 6.1 | 1.62 | 2.41 | 3.55 | 4.79 | 4.79 | 3.08 | 58
COVID19_MODERNA | Hepatic vascular disorders | 18 | 0.76 | 1.17 | 1.65 | 20.5 | 0.59 | 0.87 | 1.24 | 1.05 | 1.05 | 0.68 | 58
COVID19_PFIZER/BIONTECH | Hepatic vascular disorders | 31 | 1.63 | 2.25 | 2.95 | 18.2 | 1.19 | 1.60 | 2.12 | 2.82 | 2.82 | 1.92 | 45
COVID19_UNKNOWN MFR | Hepatic vascular disorders | 0 | 0.00 | 0.76 | 3.33 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis virus infections | 0 | 0.00 | 0.00 | 0.01 | 37.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis virus infections | 5 | 0.03 | 0.08 | 0.15 | 40.6 | 0.07 | 0.14 | 0.28 | 0.02 | 0.02 | 0.01 | 734
COVID19_PFIZER/BIONTECH | Hepatitis virus infections | 7 | 0.04 | 0.09 | 0.16 | 70.7 | 0.06 | 0.11 | 0.19 | 0.04 | 0.04 | 0.02 | 732
COVID19_UNKNOWN MFR | Hepatitis virus infections | 0 | 0.00 | 0.08 | 0.44 | 0.9 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hepatobiliary abnormalities congenital | 0 | 0.00 | 0.28 | 1.61 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Hepatobiliary abnormalities congenital | 0 | 0.00 | 0.10 | 0.54 | 1.1 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatobiliary abnormalities congenital | 0 | 0.00 | 0.11 | 0.62 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatobiliary abnormalities congenital | 0 | 0.00 | 0.94 | 5.40 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hepatobiliary and spleen infections | 1 | 0.25 | 0.86 | 1.78 | 1.3 | 0.25 | 0.76 | 1.87 | 0.62 | 0.62 | 0.12 | 25
COVID19_MODERNA | Hepatobiliary and spleen infections | 9 | 0.76 | 1.34 | 2.06 | 6.1 | 0.76 | 1.28 | 2.06 | 1.80 | 1.80 | 0.91 | 17
COVID19_PFIZER/BIONTECH | Hepatobiliary and spleen infections | 4 | 0.36 | 0.82 | 1.43 | 5.4 | 0.36 | 0.75 | 1.41 | 0.74 | 0.74 | 0.30 | 22
COVID19_UNKNOWN MFR | Hepatobiliary and spleen infections | 0 | 0.20 | 0.98 | 2.26 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hepatobiliary histopathology procedures | 1 | 0.06 | 0.44 | 1.11 | 3.8 | 0.12 | 0.43 | 1.10 | 0.27 | 0.27 | 0.05 | 57
COVID19_MODERNA | Hepatobiliary histopathology procedures | 3 | 0.12 | 0.38 | 0.76 | 9.5 | 0.17 | 0.40 | 0.81 | 0.19 | 0.19 | 0.07 | 55
COVID19_PFIZER/BIONTECH | Hepatobiliary histopathology procedures | 14 | 0.95 | 1.55 | 2.27 | 10.2 | 0.82 | 1.26 | 1.88 | 1.30 | 1.30 | 0.79 | 44
COVID19_UNKNOWN MFR | Hepatobiliary histopathology procedures | 0 | 0.01 | 0.89 | 3.14 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hepatobiliary imaging procedures | 12 | 0.69 | 1.14 | 1.68 | 11.0 | 0.65 | 1.04 | 1.58 | 1.13 | 1.13 | 0.69 | 164
COVID19_MODERNA | Hepatobiliary imaging procedures | 35 | 0.62 | 0.83 | 1.07 | 44.5 | 0.60 | 0.79 | 1.02 | 0.84 | 0.84 | 0.62 | 141
COVID19_PFIZER/BIONTECH | Hepatobiliary imaging procedures | 42 | 0.90 | 1.17 | 1.47 | 37.9 | 0.85 | 1.09 | 1.39 | 1.28 | 1.28 | 0.96 | 134
COVID19_UNKNOWN MFR | Hepatobiliary imaging procedures | 1 | 0.36 | 1.33 | 2.80 | 0.3 | 0.37 | 1.16 | 3.26 | 3.93 | 3.93 | 0.76 | 175
COVID19_JANSSEN | Hepatobiliary neoplasms benign | 1 | 0.30 | 1.30 | 2.87 | 0.5 | 0.34 | 1.01 | 2.58 | 2.57 | 2.57 | 0.44 | 6
COVID19_MODERNA | Hepatobiliary neoplasms benign | 1 | 0.19 | 0.81 | 1.79 | 1.7 | 0.22 | 0.68 | 1.68 | 0.57 | 0.57 | 0.10 | 6
COVID19_PFIZER/BIONTECH | Hepatobiliary neoplasms benign | 1 | 0.20 | 0.87 | 1.93 | 1.5 | 0.23 | 0.72 | 1.76 | 0.68 | 0.68 | 0.12 | 6
COVID19_UNKNOWN MFR | Hepatobiliary neoplasms benign | 0 | 0.12 | 0.99 | 2.59 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hepatobiliary neoplasms malignancy unspecified | 0 | 0.07 | 0.84 | 2.32 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Hepatobiliary neoplasms malignancy unspecified | 1 | 0.21 | 1.04 | 2.38 | 0.9 | 0.28 | 0.86 | 2.12 | 1.13 | 1.13 | 0.17 | 3
COVID19_PFIZER/BIONTECH | Hepatobiliary neoplasms malignancy unspecified | 0 | 0.05 | 0.61 | 1.70 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatobiliary neoplasms malignancy unspecified | 0 | 0.08 | 1.00 | 2.76 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hepatobiliary signs and symptoms | 13 | 0.87 | 1.44 | 2.12 | 9.6 | 0.80 | 1.24 | 1.87 | 1.41 | 1.41 | 0.88 | 142
COVID19_MODERNA | Hepatobiliary signs and symptoms | 19 | 0.47 | 0.70 | 0.98 | 28.9 | 0.46 | 0.67 | 0.94 | 0.47 | 0.47 | 0.32 | 136
COVID19_PFIZER/BIONTECH | Hepatobiliary signs and symptoms | 24 | 0.64 | 0.91 | 1.23 | 28.7 | 0.60 | 0.83 | 1.14 | 0.75 | 0.75 | 0.52 | 131
COVID19_UNKNOWN MFR | Hepatobiliary signs and symptoms | 0 | 0.06 | 0.84 | 2.41 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hepatocellular damage and hepatitis NEC | 20 | 0.70 | 1.05 | 1.45 | 21.7 | 0.63 | 0.91 | 1.27 | 0.93 | 0.93 | 0.64 | 333
COVID19_MODERNA | Hepatocellular damage and hepatitis NEC | 39 | 0.52 | 0.69 | 0.88 | 60.2 | 0.50 | 0.65 | 0.84 | 0.42 | 0.42 | 0.32 | 314
COVID19_PFIZER/BIONTECH | Hepatocellular damage and hepatitis NEC | 53 | 0.77 | 0.97 | 1.20 | 60.2 | 0.70 | 0.88 | 1.09 | 0.72 | 0.72 | 0.57 | 300
COVID19_UNKNOWN MFR | Hepatocellular damage and hepatitis NEC | 0 | 0.03 | 0.67 | 2.02 | 0.5 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hernia repairs | 1 | 0.32 | 1.08 | 2.19 | 0.8 | 0.30 | 0.90 | 2.23 | 0.91 | 0.91 | 0.17 | 17
COVID19_MODERNA | Hernia repairs | 3 | 0.34 | 0.84 | 1.51 | 3.9 | 0.35 | 0.78 | 1.55 | 0.68 | 0.68 | 0.24 | 15
COVID19_PFIZER/BIONTECH | Hernia repairs | 4 | 0.52 | 1.16 | 2.01 | 3.1 | 0.52 | 1.07 | 2.02 | 1.17 | 1.17 | 0.46 | 14
COVID19_UNKNOWN MFR | Hernia repairs | 0 | 0.21 | 0.99 | 2.24 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hernias NEC | 1 | 0.21 | 0.81 | 1.73 | 1.5 | 0.24 | 0.73 | 1.80 | 0.64 | 0.64 | 0.12 | 24
COVID19_MODERNA | Hernias NEC | 3 | 0.34 | 0.87 | 1.61 | 3.4 | 0.37 | 0.84 | 1.67 | 0.46 | 0.46 | 0.17 | 22
COVID19_PFIZER/BIONTECH | Hernias NEC | 4 | 0.40 | 0.94 | 1.65 | 4.0 | 0.44 | 0.92 | 1.73 | 0.78 | 0.78 | 0.32 | 21
COVID19_UNKNOWN MFR | Hernias NEC | 0 | 0.16 | 0.98 | 2.36 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Herpes viral infections | 274 | 0.73 | 0.81 | 0.89 | 908.2 | 0.27 | 0.30 | 0.33 | 0.29 | 0.28 | 0.25 | 14776
COVID19_MODERNA | Herpes viral infections | 1159 | 1.05 | 1.10 | 1.15 | 2368.4 | 0.47 | 0.49 | 0.51 | 0.28 | 0.28 | 0.26 | 13891
COVID19_PFIZER/BIONTECH | Herpes viral infections | 1380 | 1.28 | 1.34 | 1.40 | 2501.7 | 0.53 | 0.55 | 0.58 | 0.41 | 0.41 | 0.39 | 13670
COVID19_UNKNOWN MFR | Herpes viral infections | 21 | 1.11 | 1.65 | 2.27 | 26.0 | 0.56 | 0.81 | 1.12 | 0.96 | 0.96 | 0.67 | 15029
COVID19_JANSSEN | High risk pregnancies | 0 | 0.06 | 0.56 | 1.51 | 1.1 |  |  |  |  |  |  | 
COVID19_MODERNA | High risk pregnancies | 3 | 0.30 | 0.83 | 1.57 | 4.1 | 0.33 | 0.75 | 1.49 | 1.02 | 1.02 | 0.35 | 10
COVID19_PFIZER/BIONTECH | High risk pregnancies | 3 | 0.33 | 0.92 | 1.74 | 3.7 | 0.36 | 0.80 | 1.60 | 1.23 | 1.23 | 0.42 | 10
COVID19_UNKNOWN MFR | High risk pregnancies | 0 | 0.10 | 0.99 | 2.64 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Histiocytoses | 0 | 0.00 | 0.36 | 1.62 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Histiocytoses | 0 | 0.00 | 0.13 | 0.59 | 2.0 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Histiocytoses | 0 | 0.00 | 0.15 | 0.67 | 1.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Histiocytoses | 0 | 0.00 | 0.96 | 4.37 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Histopathology procedures NEC | 38 | 0.59 | 0.79 | 1.00 | 58.3 | 0.50 | 0.66 | 0.85 | 0.57 | 0.57 | 0.43 | 1033
COVID19_MODERNA | Histopathology procedures NEC | 133 | 0.69 | 0.80 | 0.92 | 185.9 | 0.62 | 0.72 | 0.82 | 0.48 | 0.48 | 0.41 | 938
COVID19_PFIZER/BIONTECH | Histopathology procedures NEC | 184 | 1.04 | 1.18 | 1.32 | 183.6 | 0.88 | 1.00 | 1.13 | 0.85 | 0.85 | 0.74 | 887
COVID19_UNKNOWN MFR | Histopathology procedures NEC | 5 | 1.02 | 2.20 | 3.75 | 1.5 | 0.92 | 1.87 | 3.79 | 3.23 | 3.24 | 1.55 | 1066
COVID19_JANSSEN | Histoplasma infections | 1 | 0.33 | 1.55 | 3.52 | 0.2 | 0.39 | 1.23 | 3.85 | 7.72 | 7.72 | 1.03 | 2
COVID19_MODERNA | Histoplasma infections | 1 | 0.24 | 1.16 | 2.64 | 0.8 | 0.30 | 0.89 | 2.21 | 1.70 | 1.70 | 0.23 | 2
COVID19_PFIZER/BIONTECH | Histoplasma infections | 0 | 0.06 | 0.69 | 1.88 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Histoplasma infections | 0 | 0.09 | 1.00 | 2.73 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hodgkin's disease NEC | 0 | 0.08 | 0.61 | 1.56 | 1.0 |  |  |  |  |  |  | 
COVID19_MODERNA | Hodgkin's disease NEC | 1 | 0.13 | 0.54 | 1.18 | 2.6 | 0.17 | 0.55 | 1.37 | 0.23 | 0.23 | 0.04 | 15
COVID19_PFIZER/BIONTECH | Hodgkin's disease NEC | 1 | 0.13 | 0.55 | 1.21 | 2.8 | 0.16 | 0.53 | 1.32 | 0.27 | 0.27 | 0.05 | 15
COVID19_UNKNOWN MFR | Hodgkin's disease NEC | 0 | 0.12 | 0.99 | 2.54 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hormonal therapeutic procedures NEC | 1 | 0.06 | 0.46 | 1.19 | 2.8 | 0.16 | 0.53 | 1.33 | 0.35 | 0.35 | 0.07 | 44
COVID19_MODERNA | Hormonal therapeutic procedures NEC | 15 | 0.76 | 1.22 | 1.77 | 12.1 | 0.77 | 1.17 | 1.71 | 1.70 | 1.70 | 1.01 | 30
COVID19_PFIZER/BIONTECH | Hormonal therapeutic procedures NEC | 15 | 0.90 | 1.45 | 2.10 | 10.2 | 0.89 | 1.35 | 1.98 | 2.05 | 2.05 | 1.22 | 30
COVID19_UNKNOWN MFR | Hormonal therapeutic procedures NEC | 0 | 0.01 | 0.90 | 3.26 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Housing circumstances | 1 | 0.35 | 1.46 | 3.20 | 0.2 | 0.39 | 1.24 | 3.99 | 7.72 | 7.72 | 1.03 | 2
COVID19_MODERNA | Housing circumstances | 1 | 0.27 | 1.14 | 2.50 | 0.6 | 0.32 | 0.97 | 2.43 | 1.70 | 1.70 | 0.23 | 2
COVID19_PFIZER/BIONTECH | Housing circumstances | 1 | 0.28 | 1.19 | 2.61 | 0.5 | 0.33 | 1.00 | 2.51 | 2.05 | 2.05 | 0.27 | 2
COVID19_UNKNOWN MFR | Housing circumstances | 0 | 0.13 | 1.00 | 2.55 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hydrocephalic conditions | 3 | 0.53 | 1.28 | 2.30 | 2.1 | 0.49 | 1.09 | 2.18 | 1.25 | 1.25 | 0.47 | 37
COVID19_MODERNA | Hydrocephalic conditions | 1 | 0.12 | 0.41 | 0.83 | 6.4 | 0.06 | 0.27 | 0.76 | 0.09 | 0.09 | 0.02 | 39
COVID19_PFIZER/BIONTECH | Hydrocephalic conditions | 5 | 0.44 | 0.91 | 1.52 | 6.5 | 0.40 | 0.77 | 1.39 | 0.59 | 0.59 | 0.27 | 35
COVID19_UNKNOWN MFR | Hydrocephalic conditions | 0 | 0.21 | 0.98 | 2.21 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hyperacusia | 48 | 1.18 | 1.51 | 1.89 | 36.3 | 1.01 | 1.29 | 1.62 | 1.34 | 1.34 | 1.05 | 552
COVID19_MODERNA | Hyperacusia | 92 | 0.70 | 0.84 | 0.98 | 120.9 | 0.64 | 0.76 | 0.90 | 0.62 | 0.62 | 0.51 | 508
COVID19_PFIZER/BIONTECH | Hyperacusia | 122 | 1.05 | 1.22 | 1.41 | 113.9 | 0.92 | 1.07 | 1.23 | 1.05 | 1.05 | 0.88 | 478
COVID19_UNKNOWN MFR | Hyperacusia | 1 | 0.18 | 1.21 | 3.00 | 0.8 | 0.30 | 0.91 | 2.24 | 1.15 | 1.15 | 0.22 | 599
COVID19_JANSSEN | Hyperglycaemic conditions NEC | 11 | 0.61 | 1.03 | 1.54 | 11.7 | 0.56 | 0.91 | 1.41 | 0.94 | 0.94 | 0.56 | 181
COVID19_MODERNA | Hyperglycaemic conditions NEC | 46 | 0.85 | 1.09 | 1.36 | 46.4 | 0.77 | 0.98 | 1.24 | 1.07 | 1.07 | 0.81 | 146
COVID19_PFIZER/BIONTECH | Hyperglycaemic conditions NEC | 57 | 1.21 | 1.52 | 1.86 | 41.1 | 1.09 | 1.36 | 1.67 | 1.73 | 1.73 | 1.33 | 135
COVID19_UNKNOWN MFR | Hyperglycaemic conditions NEC | 1 | 0.37 | 1.31 | 2.73 | 0.3 | 0.37 | 1.13 | 3.09 | 3.60 | 3.60 | 0.69 | 191
COVID19_JANSSEN | Hyperkeratoses | 0 | 0.11 | 0.48 | 1.04 | 2.9 |  |  |  |  |  |  | 
COVID19_MODERNA | Hyperkeratoses | 5 | 0.33 | 0.67 | 1.11 | 9.3 | 0.30 | 0.59 | 1.06 | 0.33 | 0.33 | 0.15 | 52
COVID19_PFIZER/BIONTECH | Hyperkeratoses | 4 | 0.27 | 0.58 | 1.00 | 9.0 | 0.24 | 0.51 | 0.97 | 0.31 | 0.31 | 0.13 | 53
COVID19_UNKNOWN MFR | Hyperkeratoses | 0 | 0.23 | 0.97 | 2.13 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hyperlipidaemias NEC | 2 | 0.27 | 0.90 | 1.83 | 2.5 | 0.32 | 0.79 | 1.71 | 0.70 | 0.70 | 0.21 | 44
COVID19_MODERNA | Hyperlipidaemias NEC | 15 | 0.84 | 1.33 | 1.91 | 12.8 | 0.73 | 1.11 | 1.63 | 1.64 | 1.64 | 0.98 | 31
COVID19_PFIZER/BIONTECH | Hyperlipidaemias NEC | 13 | 0.84 | 1.39 | 2.04 | 10.5 | 0.74 | 1.16 | 1.74 | 1.61 | 1.61 | 0.94 | 33
COVID19_UNKNOWN MFR | Hyperlipidaemias NEC | 0 | 0.09 | 0.95 | 2.59 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hyperparathyroid disorders | 0 | 0.05 | 0.81 | 2.40 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Hyperparathyroid disorders | 3 | 0.71 | 2.07 | 4.01 | 0.9 | 0.68 | 1.59 | 3.63 | 10.19 | 10.19 | 1.52 | 1
COVID19_PFIZER/BIONTECH | Hyperparathyroid disorders | 0 | 0.03 | 0.57 | 1.68 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperparathyroid disorders | 0 | 0.06 | 0.99 | 2.94 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hyperpigmentation disorders | 4 | 0.42 | 0.84 | 1.38 | 5.5 | 0.36 | 0.74 | 1.40 | 0.71 | 0.71 | 0.31 | 87
COVID19_MODERNA | Hyperpigmentation disorders | 15 | 0.51 | 0.78 | 1.09 | 19.8 | 0.50 | 0.76 | 1.12 | 0.67 | 0.67 | 0.42 | 76
COVID19_PFIZER/BIONTECH | Hyperpigmentation disorders | 11 | 0.41 | 0.67 | 0.98 | 17.9 | 0.39 | 0.63 | 0.98 | 0.56 | 0.56 | 0.33 | 80
COVID19_UNKNOWN MFR | Hyperpigmentation disorders | 0 | 0.33 | 0.97 | 1.88 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hypertension associated disorders of pregnancy | 3 | 0.14 | 0.46 | 0.95 | 8.8 | 0.18 | 0.42 | 0.86 | 0.46 | 0.46 | 0.18 | 100
COVID19_MODERNA | Hypertension associated disorders of pregnancy | 6 | 0.11 | 0.24 | 0.41 | 33.3 | 0.11 | 0.21 | 0.38 | 0.21 | 0.21 | 0.11 | 97
COVID19_PFIZER/BIONTECH | Hypertension associated disorders of pregnancy | 15 | 0.41 | 0.66 | 0.96 | 29.5 | 0.35 | 0.53 | 0.78 | 0.70 | 0.70 | 0.44 | 88
COVID19_UNKNOWN MFR | Hypertension associated disorders of pregnancy | 0 | 0.00 | 0.62 | 3.03 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hypertension complications | 0 | 0.04 | 0.88 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Hypertension complications | 0 | 0.03 | 0.67 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypertension complications | 2 | 0.59 | 2.22 | 4.69 | 0.4 | 0.60 | 1.65 | 5.67 | 20.47 | 20.47 | 1.60 | 0
COVID19_UNKNOWN MFR | Hypertension complications | 0 | 0.04 | 1.00 | 3.07 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hypertrichoses | 0 | 0.02 | 0.56 | 1.76 | 0.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Hypertrichoses | 0 | 0.01 | 0.38 | 1.20 | 1.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypertrichoses | 0 | 0.01 | 0.33 | 1.04 | 1.7 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertrichoses | 0 | 0.03 | 0.98 | 3.12 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hypervitaminoses NEC | 0 | 0.06 | 0.95 | 2.73 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Hypervitaminoses NEC | 0 | 0.06 | 0.83 | 2.39 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypervitaminoses NEC | 1 | 0.31 | 1.61 | 3.76 | 0.1 | 0.41 | 1.33 | 5.60 | 12.28 | 12.28 | 0.84 | 0
COVID19_UNKNOWN MFR | Hypervitaminoses NEC | 0 | 0.07 | 1.00 | 2.88 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hypoglossal nerve disorders | 1 | 0.25 | 0.84 | 1.70 | 1.6 | 0.23 | 0.71 | 1.75 | 0.57 | 0.57 | 0.11 | 27
COVID19_MODERNA | Hypoglossal nerve disorders | 4 | 0.36 | 0.81 | 1.40 | 5.3 | 0.37 | 0.76 | 1.43 | 0.57 | 0.57 | 0.23 | 24
COVID19_PFIZER/BIONTECH | Hypoglossal nerve disorders | 9 | 0.85 | 1.49 | 2.29 | 5.1 | 0.86 | 1.46 | 2.35 | 1.94 | 1.94 | 1.00 | 19
COVID19_UNKNOWN MFR | Hypoglossal nerve disorders | 0 | 0.21 | 0.98 | 2.21 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hypoglycaemic conditions NEC | 8 | 0.50 | 0.93 | 1.47 | 10.8 | 0.43 | 0.75 | 1.23 | 0.64 | 0.64 | 0.35 | 194
COVID19_MODERNA | Hypoglycaemic conditions NEC | 29 | 0.67 | 0.93 | 1.22 | 40.3 | 0.53 | 0.72 | 0.96 | 0.57 | 0.57 | 0.41 | 173
COVID19_PFIZER/BIONTECH | Hypoglycaemic conditions NEC | 63 | 1.72 | 2.13 | 2.58 | 36.4 | 1.36 | 1.67 | 2.04 | 1.86 | 1.86 | 1.45 | 139
COVID19_UNKNOWN MFR | Hypoglycaemic conditions NEC | 3 | 0.90 | 2.32 | 4.27 | 0.3 | 0.99 | 3.46 | 14.01 | 10.37 | 10.40 | 3.99 | 199
COVID19_JANSSEN | Hypoparathyroid disorders | 0 | 0.01 | 0.77 | 2.75 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Hypoparathyroid disorders | 0 | 0.01 | 0.48 | 1.69 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypoparathyroid disorders | 0 | 0.01 | 0.51 | 1.83 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypoparathyroid disorders | 0 | 0.01 | 0.99 | 3.53 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hypopigmentation disorders | 1 | 0.06 | 0.43 | 1.08 | 3.7 | 0.12 | 0.43 | 1.12 | 0.26 | 0.26 | 0.05 | 60
COVID19_MODERNA | Hypopigmentation disorders | 8 | 0.46 | 0.90 | 1.46 | 9.4 | 0.48 | 0.84 | 1.37 | 0.51 | 0.51 | 0.28 | 53
COVID19_PFIZER/BIONTECH | Hypopigmentation disorders | 6 | 0.31 | 0.67 | 1.15 | 10.3 | 0.33 | 0.62 | 1.08 | 0.45 | 0.45 | 0.22 | 55
COVID19_UNKNOWN MFR | Hypopigmentation disorders | 0 | 0.01 | 0.89 | 3.12 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hypothalamic analyses | 0 | 0.07 | 0.95 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Hypothalamic analyses | 1 | 0.30 | 1.57 | 3.64 | 0.3 | 0.37 | 1.12 | 3.03 | 10.19 | 10.19 | 0.69 | 0
COVID19_PFIZER/BIONTECH | Hypothalamic analyses | 0 | 0.06 | 0.85 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypothalamic analyses | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Hypothalamic and pituitary disorders NEC | 0 | 0.02 | 0.52 | 1.62 | 0.8 |  |  |  |  |  |  | 
COVID19_MODERNA | Hypothalamic and pituitary disorders NEC | 2 | 0.25 | 0.93 | 1.98 | 2.3 | 0.33 | 0.82 | 1.78 | 0.68 | 0.68 | 0.19 | 10
COVID19_PFIZER/BIONTECH | Hypothalamic and pituitary disorders NEC | 1 | 0.10 | 0.60 | 1.45 | 2.4 | 0.17 | 0.57 | 1.42 | 0.37 | 0.37 | 0.07 | 11
COVID19_UNKNOWN MFR | Hypothalamic and pituitary disorders NEC | 0 | 0.04 | 0.98 | 3.05 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Imaging procedures NEC | 1638 | 1.89 | 1.96 | 2.05 | 945.1 | 1.66 | 1.73 | 1.80 | 1.92 | 1.96 | 1.88 | 13176
COVID19_MODERNA | Imaging procedures NEC | 3020 | 0.83 | 0.86 | 0.88 | 3865.5 | 0.76 | 0.78 | 0.81 | 0.87 | 0.87 | 0.84 | 11794
COVID19_PFIZER/BIONTECH | Imaging procedures NEC | 3598 | 1.18 | 1.22 | 1.25 | 3299.3 | 1.06 | 1.09 | 1.12 | 1.31 | 1.32 | 1.28 | 11216
COVID19_UNKNOWN MFR | Imaging procedures NEC | 35 | 1.22 | 1.63 | 2.08 | 22.9 | 1.11 | 1.46 | 1.90 | 1.63 | 1.66 | 1.25 | 14779
COVID19_JANSSEN | Immune and associated conditions NEC | 20 | 0.39 | 0.58 | 0.81 | 75.3 | 0.19 | 0.28 | 0.39 | 0.27 | 0.27 | 0.18 | 1153
COVID19_MODERNA | Immune and associated conditions NEC | 49 | 0.52 | 0.67 | 0.83 | 109.4 | 0.36 | 0.46 | 0.57 | 0.15 | 0.15 | 0.12 | 1124
COVID19_PFIZER/BIONTECH | Immune and associated conditions NEC | 67 | 0.60 | 0.75 | 0.90 | 169.4 | 0.33 | 0.40 | 0.49 | 0.25 | 0.25 | 0.20 | 1106
COVID19_UNKNOWN MFR | Immune and associated conditions NEC | 1 | 0.19 | 1.03 | 2.42 | 2.1 | 0.19 | 0.61 | 1.52 | 0.59 | 0.59 | 0.11 | 1172
COVID19_JANSSEN | Immune response protein analyses NEC | 4 | 0.10 | 0.26 | 0.48 | 21.5 | 0.10 | 0.23 | 0.45 | 0.17 | 0.17 | 0.08 | 355
COVID19_MODERNA | Immune response protein analyses NEC | 48 | 0.69 | 0.89 | 1.11 | 60.4 | 0.63 | 0.80 | 1.00 | 0.52 | 0.52 | 0.41 | 311
COVID19_PFIZER/BIONTECH | Immune response protein analyses NEC | 51 | 0.75 | 0.96 | 1.19 | 62.3 | 0.65 | 0.82 | 1.02 | 0.68 | 0.68 | 0.53 | 308
COVID19_UNKNOWN MFR | Immune response protein analyses NEC | 0 | 0.03 | 0.66 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_JANSSEN | Immune system abnormalities congenital | 0 | 0.00 | 0.42 | 1.64 | 0.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Immune system abnormalities congenital | 0 | 0.00 | 0.25 | 0.98 | 1.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immune system abnormalities congenital | 1 | 0.07 | 0.59 | 1.54 | 1.8 | 0.21 | 0.66 | 1.63 | 0.14 | 0.14 | 0.03 | 29
COVID19_UNKNOWN MFR | Immune system abnormalities congenital | 0 | 0.00 | 0.96 | 3.74 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Immunisations | 15 | 0.53 | 0.84 | 1.20 | 19.8 | 0.50 | 0.76 | 1.11 | 0.82 | 0.82 | 0.53 | 284
COVID19_MODERNA | Immunisations | 82 | 0.99 | 1.19 | 1.41 | 72.6 | 0.93 | 1.12 | 1.34 | 1.28 | 1.28 | 1.04 | 217
COVID19_PFIZER/BIONTECH | Immunisations | 56 | 0.76 | 0.95 | 1.17 | 62.7 | 0.71 | 0.89 | 1.10 | 0.94 | 0.94 | 0.74 | 243
COVID19_UNKNOWN MFR | Immunisations | 1 | 0.31 | 1.29 | 2.80 | 0.4 | 0.35 | 1.05 | 2.70 | 2.31 | 2.31 | 0.44 | 298
COVID19_JANSSEN | Immunodeficiency disorders NEC | 0 | 0.02 | 0.14 | 0.38 | 8.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Immunodeficiency disorders NEC | 8 | 0.22 | 0.41 | 0.66 | 22.9 | 0.22 | 0.39 | 0.64 | 0.14 | 0.14 | 0.08 | 198
COVID19_PFIZER/BIONTECH | Immunodeficiency disorders NEC | 17 | 0.47 | 0.73 | 1.03 | 27.2 | 0.43 | 0.64 | 0.92 | 0.37 | 0.37 | 0.24 | 189
COVID19_UNKNOWN MFR | Immunodeficiency disorders NEC | 0 | 0.09 | 0.86 | 2.26 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Immunoglobulin analyses | 18 | 0.34 | 0.51 | 0.72 | 47.2 | 0.27 | 0.40 | 0.57 | 0.33 | 0.33 | 0.22 | 850
COVID19_MODERNA | Immunoglobulin analyses | 64 | 0.50 | 0.62 | 0.75 | 123.0 | 0.43 | 0.53 | 0.64 | 0.27 | 0.27 | 0.22 | 804
COVID19_PFIZER/BIONTECH | Immunoglobulin analyses | 103 | 0.81 | 0.96 | 1.12 | 133.2 | 0.66 | 0.77 | 0.91 | 0.55 | 0.55 | 0.46 | 765
COVID19_UNKNOWN MFR | Immunoglobulin analyses | 0 | 0.06 | 0.59 | 1.58 | 1.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Immunology analyses NEC | 103 | 0.97 | 1.14 | 1.33 | 117.4 | 0.74 | 0.88 | 1.02 | 0.80 | 0.80 | 0.68 | 1980
COVID19_MODERNA | Immunology analyses NEC | 169 | 0.57 | 0.65 | 0.74 | 303.1 | 0.49 | 0.56 | 0.63 | 0.30 | 0.30 | 0.26 | 1914
COVID19_PFIZER/BIONTECH | Immunology analyses NEC | 214 | 0.73 | 0.82 | 0.91 | 323.2 | 0.59 | 0.66 | 0.74 | 0.47 | 0.47 | 0.42 | 1869
COVID19_UNKNOWN MFR | Immunology analyses NEC | 1 | 0.15 | 0.66 | 1.46 | 2.9 | 0.15 | 0.51 | 1.28 | 0.33 | 0.33 | 0.06 | 2082
COVID19_JANSSEN | Immunology skin tests NEC | 2 | 0.08 | 0.32 | 0.68 | 9.6 | 0.10 | 0.30 | 0.68 | 0.13 | 0.13 | 0.04 | 237
COVID19_MODERNA | Immunology skin tests NEC | 22 | 0.60 | 0.88 | 1.21 | 27.2 | 0.57 | 0.81 | 1.12 | 0.34 | 0.34 | 0.24 | 217
COVID19_PFIZER/BIONTECH | Immunology skin tests NEC | 14 | 0.35 | 0.56 | 0.82 | 30.7 | 0.31 | 0.48 | 0.71 | 0.26 | 0.26 | 0.16 | 225
COVID19_UNKNOWN MFR | Immunology skin tests NEC | 0 | 0.02 | 0.79 | 2.57 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Implant and catheter site reactions | 2 | 0.46 | 1.49 | 3.01 | 1.1 | 0.46 | 1.14 | 2.53 | 2.81 | 2.81 | 0.79 | 11
COVID19_MODERNA | Implant and catheter site reactions | 2 | 0.24 | 0.77 | 1.55 | 3.3 | 0.27 | 0.68 | 1.46 | 0.62 | 0.62 | 0.17 | 11
COVID19_PFIZER/BIONTECH | Implant and catheter site reactions | 4 | 0.55 | 1.32 | 2.37 | 3.0 | 0.53 | 1.11 | 2.09 | 1.82 | 1.82 | 0.68 | 9
COVID19_UNKNOWN MFR | Implant and catheter site reactions | 0 | 0.11 | 0.98 | 2.60 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Impulse control disorders | 0 | 0.05 | 0.67 | 1.86 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Impulse control disorders | 3 | 0.48 | 1.34 | 2.57 | 1.8 | 0.53 | 1.19 | 2.40 | 0.93 | 0.93 | 0.32 | 11
COVID19_PFIZER/BIONTECH | Impulse control disorders | 2 | 0.30 | 1.03 | 2.12 | 2.0 | 0.36 | 0.89 | 1.92 | 0.68 | 0.68 | 0.19 | 12
COVID19_UNKNOWN MFR | Impulse control disorders | 0 | 0.08 | 0.99 | 2.77 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Inborn errors of amino acid metabolism | 0 | 0.02 | 0.43 | 1.36 | 1.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Inborn errors of amino acid metabolism | 1 | 0.07 | 0.45 | 1.08 | 2.4 | 0.18 | 0.58 | 1.44 | 0.11 | 0.11 | 0.02 | 32
COVID19_PFIZER/BIONTECH | Inborn errors of amino acid metabolism | 5 | 0.56 | 1.29 | 2.27 | 3.2 | 0.64 | 1.24 | 2.24 | 0.73 | 0.73 | 0.33 | 28
COVID19_UNKNOWN MFR | Inborn errors of amino acid metabolism | 0 | 0.04 | 0.97 | 3.05 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Inborn errors of bilirubin metabolism | 0 | 0.04 | 0.88 | 2.73 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Inborn errors of bilirubin metabolism | 0 | 0.03 | 0.67 | 2.07 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inborn errors of bilirubin metabolism | 0 | 0.03 | 0.70 | 2.16 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inborn errors of bilirubin metabolism | 0 | 0.04 | 1.00 | 3.08 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Inborn errors of carbohydrate metabolism (excl glucose) | 0 | 0.11 | 0.82 | 2.06 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Inborn errors of carbohydrate metabolism (excl glucose) | 1 | 0.22 | 0.88 | 1.91 | 0.7 | 0.31 | 0.92 | 2.29 | 0.68 | 0.68 | 0.11 | 5
COVID19_PFIZER/BIONTECH | Inborn errors of carbohydrate metabolism (excl glucose) | 1 | 0.23 | 0.94 | 2.04 | 0.8 | 0.30 | 0.91 | 2.25 | 0.82 | 0.82 | 0.14 | 5
COVID19_UNKNOWN MFR | Inborn errors of carbohydrate metabolism (excl glucose) | 0 | 0.14 | 1.00 | 2.50 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Inborn errors of lipid metabolism | 0 | 0.00 | 0.39 | 1.66 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Inborn errors of lipid metabolism | 0 | 0.00 | 0.15 | 0.62 | 2.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inborn errors of lipid metabolism | 4 | 0.71 | 1.95 | 3.69 | 2.0 | 0.66 | 1.37 | 2.64 | 2.73 | 2.73 | 0.94 | 6
COVID19_UNKNOWN MFR | Inborn errors of lipid metabolism | 0 | 0.00 | 0.96 | 4.11 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Inborn errors of metabolism NEC | 0 | 0.00 | 0.56 | 2.35 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Inborn errors of metabolism NEC | 0 | 0.00 | 0.25 | 1.06 | 1.1 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inborn errors of metabolism NEC | 0 | 0.00 | 0.28 | 1.18 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inborn errors of metabolism NEC | 0 | 0.00 | 0.98 | 4.14 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Inborn errors of porphyrin metabolism | 0 | 0.04 | 0.84 | 2.54 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Inborn errors of porphyrin metabolism | 0 | 0.03 | 0.59 | 1.78 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inborn errors of porphyrin metabolism | 2 | 0.52 | 1.90 | 3.98 | 0.7 | 0.51 | 1.30 | 3.02 | 8.19 | 8.19 | 1.09 | 1
COVID19_UNKNOWN MFR | Inborn errors of porphyrin metabolism | 0 | 0.05 | 1.00 | 3.00 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Increased intracranial pressure disorders | 20 | 1.11 | 1.65 | 2.28 | 12.5 | 1.02 | 1.47 | 2.07 | 1.48 | 1.49 | 1.01 | 208
COVID19_MODERNA | Increased intracranial pressure disorders | 26 | 0.50 | 0.71 | 0.94 | 38.4 | 0.50 | 0.68 | 0.92 | 0.44 | 0.44 | 0.31 | 202
COVID19_PFIZER/BIONTECH | Increased intracranial pressure disorders | 47 | 1.01 | 1.30 | 1.63 | 38.5 | 0.94 | 1.20 | 1.51 | 1.06 | 1.06 | 0.81 | 181
COVID19_UNKNOWN MFR | Increased intracranial pressure disorders | 1 | 0.32 | 1.40 | 3.11 | 0.3 | 0.37 | 1.12 | 3.04 | 3.03 | 3.03 | 0.58 | 227
COVID19_JANSSEN | Increased physical activity levels | 108 | 1.60 | 1.89 | 2.19 | 66.8 | 1.35 | 1.59 | 1.85 | 1.57 | 1.58 | 1.33 | 1060
COVID19_MODERNA | Increased physical activity levels | 226 | 0.97 | 1.08 | 1.20 | 231.8 | 0.87 | 0.97 | 1.08 | 0.82 | 0.81 | 0.72 | 942
COVID19_PFIZER/BIONTECH | Increased physical activity levels | 201 | 0.96 | 1.09 | 1.21 | 216.1 | 0.83 | 0.93 | 1.04 | 0.85 | 0.85 | 0.75 | 967
COVID19_UNKNOWN MFR | Increased physical activity levels | 2 | 0.38 | 1.26 | 2.55 | 1.5 | 0.40 | 0.99 | 2.16 | 1.18 | 1.18 | 0.37 | 1166
COVID19_JANSSEN | Induced abortion complications | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Induced abortion complications | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Induced abortion complications | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Induced abortion complications | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Induced abortions | 0 | 0.00 | 0.20 | 0.69 | 2.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Induced abortions | 7 | 0.43 | 0.88 | 1.46 | 8.5 | 0.46 | 0.82 | 1.37 | 0.72 | 0.72 | 0.36 | 33
COVID19_PFIZER/BIONTECH | Induced abortions | 6 | 0.36 | 0.79 | 1.35 | 8.7 | 0.38 | 0.71 | 1.23 | 0.72 | 0.72 | 0.35 | 34
COVID19_UNKNOWN MFR | Induced abortions | 0 | 0.01 | 0.91 | 3.22 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Infancy, childhood and adolescence psychiatric disorders NEC | 0 | 0.00 | 0.19 | 1.03 | 0.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Infancy, childhood and adolescence psychiatric disorders NEC | 0 | 0.00 | 0.06 | 0.32 | 2.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infancy, childhood and adolescence psychiatric disorders NEC | 0 | 0.00 | 0.06 | 0.34 | 2.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infancy, childhood and adolescence psychiatric disorders NEC | 0 | 0.00 | 0.91 | 4.95 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Infections NEC | 59 | 0.40 | 0.51 | 0.62 | 192.2 | 0.25 | 0.31 | 0.38 | 0.27 | 0.27 | 0.21 | 3408
COVID19_MODERNA | Infections NEC | 245 | 0.62 | 0.69 | 0.76 | 490.4 | 0.45 | 0.50 | 0.56 | 0.26 | 0.26 | 0.23 | 3222
COVID19_PFIZER/BIONTECH | Infections NEC | 184 | 0.45 | 0.51 | 0.58 | 547.8 | 0.30 | 0.34 | 0.38 | 0.23 | 0.23 | 0.20 | 3283
COVID19_UNKNOWN MFR | Infections NEC | 1 | 0.07 | 0.45 | 1.10 | 5.4 | 0.07 | 0.32 | 0.86 | 0.20 | 0.20 | 0.04 | 3466
COVID19_JANSSEN | Infections congenital NEC | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Infections congenital NEC | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infections congenital NEC | 0 | 0.04 | 0.83 | 2.53 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infections congenital NEC | 0 | 0.05 | 1.00 | 3.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Infectious disorders carrier | 0 | 0.09 | 0.75 | 1.97 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Infectious disorders carrier | 1 | 0.17 | 0.75 | 1.67 | 0.8 | 0.30 | 0.90 | 2.24 | 0.49 | 0.49 | 0.08 | 7
COVID19_PFIZER/BIONTECH | Infectious disorders carrier | 1 | 0.18 | 0.81 | 1.81 | 1.0 | 0.27 | 0.83 | 2.04 | 0.59 | 0.59 | 0.10 | 7
COVID19_UNKNOWN MFR | Infectious disorders carrier | 0 | 0.11 | 0.99 | 2.61 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Infectious pericarditis | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Infectious pericarditis | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infectious pericarditis | 0 | 0.04 | 0.83 | 2.53 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infectious pericarditis | 0 | 0.05 | 1.00 | 3.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Infectious transmissions | 0 | 0.00 | 0.01 | 0.05 | 15.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Infectious transmissions | 4 | 0.05 | 0.15 | 0.29 | 28.2 | 0.07 | 0.17 | 0.35 | 0.03 | 0.03 | 0.01 | 463
COVID19_PFIZER/BIONTECH | Infectious transmissions | 3 | 0.03 | 0.09 | 0.19 | 43.3 | 0.03 | 0.08 | 0.19 | 0.03 | 0.03 | 0.01 | 464
COVID19_UNKNOWN MFR | Infectious transmissions | 0 | 0.00 | 0.23 | 1.31 | 0.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Inflammations | 123 | 0.76 | 0.89 | 1.02 | 171.1 | 0.62 | 0.72 | 0.83 | 0.70 | 0.70 | 0.60 | 2707
COVID19_MODERNA | Inflammations | 465 | 0.76 | 0.82 | 0.88 | 710.1 | 0.61 | 0.66 | 0.71 | 0.67 | 0.67 | 0.61 | 2365
COVID19_PFIZER/BIONTECH | Inflammations | 340 | 0.65 | 0.71 | 0.77 | 599.9 | 0.52 | 0.57 | 0.62 | 0.56 | 0.56 | 0.51 | 2490
COVID19_UNKNOWN MFR | Inflammations | 4 | 0.49 | 1.10 | 1.92 | 4.3 | 0.43 | 0.88 | 1.65 | 0.97 | 0.97 | 0.43 | 2826
COVID19_JANSSEN | Inflammatory disorders following infection | 0 | 0.04 | 0.69 | 2.04 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Inflammatory disorders following infection | 0 | 0.02 | 0.37 | 1.10 | 1.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inflammatory disorders following infection | 1 | 0.13 | 0.69 | 1.62 | 1.8 | 0.21 | 0.66 | 1.64 | 0.15 | 0.15 | 0.03 | 28
COVID19_UNKNOWN MFR | Inflammatory disorders following infection | 0 | 0.06 | 0.99 | 2.92 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Influenza viral infections | 106 | 0.95 | 1.13 | 1.31 | 180.1 | 0.50 | 0.59 | 0.69 | 0.52 | 0.52 | 0.44 | 3125
COVID19_MODERNA | Influenza viral infections | 146 | 0.47 | 0.54 | 0.62 | 454.4 | 0.28 | 0.32 | 0.37 | 0.16 | 0.16 | 0.14 | 3085
COVID19_PFIZER/BIONTECH | Influenza viral infections | 157 | 0.54 | 0.62 | 0.71 | 460.5 | 0.30 | 0.34 | 0.39 | 0.21 | 0.21 | 0.18 | 3074
COVID19_UNKNOWN MFR | Influenza viral infections | 2 | 0.16 | 0.71 | 1.57 | 4.8 | 0.20 | 0.53 | 1.15 | 0.43 | 0.43 | 0.13 | 3229
COVID19_JANSSEN | Infusion site reactions | 0 | 0.11 | 0.71 | 1.76 | 0.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Infusion site reactions | 2 | 0.26 | 0.81 | 1.60 | 2.8 | 0.29 | 0.74 | 1.60 | 0.76 | 0.76 | 0.21 | 9
COVID19_PFIZER/BIONTECH | Infusion site reactions | 3 | 0.43 | 1.12 | 2.07 | 2.5 | 0.45 | 1.00 | 2.00 | 1.54 | 1.54 | 0.50 | 8
COVID19_UNKNOWN MFR | Infusion site reactions | 0 | 0.15 | 0.99 | 2.46 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Inguinal hernias | 0 | 0.05 | 0.50 | 1.37 | 1.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Inguinal hernias | 4 | 0.51 | 1.24 | 2.25 | 2.9 | 0.54 | 1.12 | 2.12 | 0.72 | 0.72 | 0.29 | 19
COVID19_PFIZER/BIONTECH | Inguinal hernias | 3 | 0.32 | 0.90 | 1.71 | 3.3 | 0.38 | 0.86 | 1.71 | 0.61 | 0.61 | 0.22 | 20
COVID19_UNKNOWN MFR | Inguinal hernias | 0 | 0.09 | 0.98 | 2.66 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Injection site reactions | 3374 | 0.58 | 0.60 | 0.62 | 6785.8 | 0.48 | 0.50 | 0.51 | 0.48 | 0.43 | 0.41 | 108677
COVID19_MODERNA | Injection site reactions | 35768 | 1.39 | 1.40 | 1.42 | 30543.4 | 1.16 | 1.17 | 1.18 | 1.59 | 1.80 | 1.78 | 76283
COVID19_PFIZER/BIONTECH | Injection site reactions | 9899 | 0.47 | 0.48 | 0.49 | 24899.3 | 0.39 | 0.40 | 0.40 | 0.40 | 0.34 | 0.34 | 102152
COVID19_UNKNOWN MFR | Injection site reactions | 83 | 0.53 | 0.64 | 0.76 | 163.0 | 0.43 | 0.51 | 0.61 | 0.51 | 0.46 | 0.38 | 111968
COVID19_JANSSEN | Inner ear disorders NEC | 5 | 0.30 | 0.64 | 1.09 | 9.7 | 0.29 | 0.56 | 1.02 | 0.62 | 0.62 | 0.29 | 125
COVID19_MODERNA | Inner ear disorders NEC | 41 | 1.04 | 1.36 | 1.72 | 31.7 | 0.97 | 1.26 | 1.61 | 1.56 | 1.56 | 1.15 | 89
COVID19_PFIZER/BIONTECH | Inner ear disorders NEC | 32 | 0.88 | 1.19 | 1.55 | 28.8 | 0.81 | 1.09 | 1.43 | 1.34 | 1.34 | 0.96 | 98
COVID19_UNKNOWN MFR | Inner ear disorders NEC | 0 | 0.15 | 0.90 | 2.17 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Inner ear infections and inflammations | 2 | 0.41 | 1.17 | 2.24 | 1.4 | 0.41 | 1.02 | 2.23 | 1.54 | 1.54 | 0.46 | 20
COVID19_MODERNA | Inner ear infections and inflammations | 8 | 0.71 | 1.30 | 2.03 | 5.8 | 0.70 | 1.22 | 2.00 | 1.94 | 1.94 | 0.94 | 14
COVID19_PFIZER/BIONTECH | Inner ear infections and inflammations | 7 | 0.69 | 1.32 | 2.10 | 4.8 | 0.69 | 1.23 | 2.08 | 1.91 | 1.91 | 0.90 | 15
COVID19_UNKNOWN MFR | Inner ear infections and inflammations | 0 | 0.19 | 0.98 | 2.29 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Inner ear signs and symptoms | 991 | 1.69 | 1.78 | 1.87 | 704.7 | 1.33 | 1.40 | 1.48 | 1.85 | 1.87 | 1.77 | 8294
COVID19_MODERNA | Inner ear signs and symptoms | 2828 | 1.25 | 1.29 | 1.33 | 2703.7 | 1.01 | 1.05 | 1.08 | 1.49 | 1.50 | 1.44 | 6457
COVID19_PFIZER/BIONTECH | Inner ear signs and symptoms | 3366 | 1.79 | 1.84 | 1.89 | 2282.0 | 1.43 | 1.47 | 1.52 | 2.33 | 2.37 | 2.28 | 5919
COVID19_UNKNOWN MFR | Inner ear signs and symptoms | 17 | 0.84 | 1.28 | 1.80 | 15.9 | 0.70 | 1.03 | 1.49 | 1.26 | 1.27 | 0.85 | 9268
COVID19_JANSSEN | Inner ear therapeutic procedures | 2 | 0.39 | 1.31 | 2.65 | 1.2 | 0.43 | 1.09 | 2.38 | 1.19 | 1.19 | 0.36 | 26
COVID19_MODERNA | Inner ear therapeutic procedures | 5 | 0.51 | 1.14 | 1.97 | 4.2 | 0.54 | 1.04 | 1.88 | 0.74 | 0.74 | 0.33 | 23
COVID19_PFIZER/BIONTECH | Inner ear therapeutic procedures | 2 | 0.19 | 0.64 | 1.29 | 3.9 | 0.24 | 0.60 | 1.31 | 0.32 | 0.32 | 0.09 | 26
COVID19_UNKNOWN MFR | Inner ear therapeutic procedures | 0 | 0.10 | 0.98 | 2.62 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Intellectual disabilities | 1 | 0.09 | 0.67 | 1.71 | 2.2 | 0.19 | 0.60 | 1.50 | 0.31 | 0.31 | 0.06 | 50
COVID19_MODERNA | Intellectual disabilities | 2 | 0.16 | 0.67 | 1.47 | 3.1 | 0.28 | 0.70 | 1.51 | 0.14 | 0.14 | 0.04 | 49
COVID19_PFIZER/BIONTECH | Intellectual disabilities | 4 | 0.33 | 0.87 | 1.62 | 5.5 | 0.36 | 0.75 | 1.41 | 0.35 | 0.35 | 0.15 | 47
COVID19_UNKNOWN MFR | Intellectual disabilities | 0 | 0.01 | 0.92 | 3.29 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Intentional product misuses | 0 | 0.00 | 0.16 | 0.90 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Intentional product misuses | 1 | 0.03 | 0.47 | 1.37 | 1.4 | 0.24 | 0.73 | 1.81 | 0.38 | 0.38 | 0.07 | 9
COVID19_PFIZER/BIONTECH | Intentional product misuses | 1 | 0.04 | 0.55 | 1.57 | 1.1 | 0.27 | 0.81 | 2.00 | 0.46 | 0.46 | 0.08 | 9
COVID19_UNKNOWN MFR | Intentional product misuses | 0 | 0.00 | 0.89 | 5.10 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Intentional product use issues | 0 | 0.00 | 0.36 | 1.43 | 0.8 |  |  |  |  |  |  | 
COVID19_MODERNA | Intentional product use issues | 22 | 3.68 | 5.41 | 7.41 | 7.6 | 1.72 | 2.46 | 3.49 | 14.94 | 14.94 | 6.61 | 5
COVID19_PFIZER/BIONTECH | Intentional product use issues | 1 | 0.05 | 0.42 | 1.11 | 6.1 | 0.06 | 0.28 | 0.78 | 0.16 | 0.16 | 0.03 | 26
COVID19_UNKNOWN MFR | Intentional product use issues | 0 | 0.00 | 0.95 | 3.82 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Interactions | 3 | 0.23 | 0.76 | 1.53 | 5.3 | 0.28 | 0.63 | 1.26 | 0.59 | 0.59 | 0.23 | 78
COVID19_MODERNA | Interactions | 8 | 0.37 | 0.72 | 1.16 | 12.2 | 0.39 | 0.68 | 1.11 | 0.37 | 0.37 | 0.20 | 73
COVID19_PFIZER/BIONTECH | Interactions | 10 | 0.48 | 0.86 | 1.34 | 14.1 | 0.44 | 0.72 | 1.14 | 0.58 | 0.58 | 0.33 | 71
COVID19_UNKNOWN MFR | Interactions | 0 | 0.00 | 0.77 | 3.02 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Intervertebral disc disorders NEC | 11 | 0.52 | 0.90 | 1.37 | 14.3 | 0.48 | 0.77 | 1.19 | 0.95 | 0.95 | 0.57 | 179
COVID19_MODERNA | Intervertebral disc disorders NEC | 34 | 0.54 | 0.74 | 0.95 | 52.5 | 0.49 | 0.65 | 0.85 | 0.74 | 0.74 | 0.54 | 156
COVID19_PFIZER/BIONTECH | Intervertebral disc disorders NEC | 38 | 0.72 | 0.96 | 1.22 | 45.6 | 0.64 | 0.83 | 1.07 | 1.02 | 1.02 | 0.76 | 152
COVID19_UNKNOWN MFR | Intervertebral disc disorders NEC | 0 | 0.02 | 0.73 | 2.38 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal disorders congenital | 0 | 0.00 | 0.52 | 1.95 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Intestinal disorders congenital | 0 | 0.00 | 0.22 | 0.84 | 1.8 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal disorders congenital | 1 | 0.08 | 0.66 | 1.71 | 1.3 | 0.25 | 0.76 | 1.88 | 0.22 | 0.22 | 0.04 | 19
COVID19_UNKNOWN MFR | Intestinal disorders congenital | 0 | 0.01 | 0.98 | 3.68 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal haemorrhages | 24 | 1.64 | 2.36 | 3.19 | 12.8 | 1.22 | 1.71 | 2.34 | 1.51 | 1.51 | 1.06 | 245
COVID19_MODERNA | Intestinal haemorrhages | 49 | 0.95 | 1.22 | 1.52 | 55.2 | 0.70 | 0.88 | 1.11 | 0.76 | 0.76 | 0.58 | 220
COVID19_PFIZER/BIONTECH | Intestinal haemorrhages | 78 | 1.82 | 2.21 | 2.64 | 48.8 | 1.30 | 1.56 | 1.87 | 1.67 | 1.67 | 1.34 | 191
COVID19_UNKNOWN MFR | Intestinal haemorrhages | 0 | 0.02 | 0.75 | 2.43 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal ulcers and perforation NEC | 0 | 0.01 | 0.31 | 1.07 | 1.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Intestinal ulcers and perforation NEC | 7 | 0.59 | 1.21 | 2.01 | 6.6 | 0.55 | 0.99 | 1.66 | 0.66 | 0.66 | 0.34 | 36
COVID19_PFIZER/BIONTECH | Intestinal ulcers and perforation NEC | 11 | 1.10 | 1.91 | 2.92 | 6.1 | 0.94 | 1.52 | 2.37 | 1.41 | 1.41 | 0.79 | 32
COVID19_UNKNOWN MFR | Intestinal ulcers and perforation NEC | 1 | 0.33 | 2.28 | 5.68 | 0.0 | 0.43 | 1.56 | 10.30 | 16.38 | 16.39 | 3.10 | 42
COVID19_JANSSEN | Investigations NEC | 1666 | 1.64 | 1.71 | 1.78 | 1175.9 | 1.36 | 1.42 | 1.47 | 1.47 | 1.49 | 1.43 | 17499
COVID19_MODERNA | Investigations NEC | 3393 | 0.83 | 0.85 | 0.88 | 4371.3 | 0.76 | 0.78 | 0.80 | 0.73 | 0.72 | 0.70 | 15772
COVID19_PFIZER/BIONTECH | Investigations NEC | 4335 | 1.24 | 1.27 | 1.31 | 3895.0 | 1.09 | 1.11 | 1.14 | 1.20 | 1.20 | 1.17 | 14830
COVID19_UNKNOWN MFR | Investigations NEC | 39 | 1.20 | 1.58 | 2.01 | 28.8 | 1.01 | 1.31 | 1.68 | 1.40 | 1.42 | 1.09 | 19126
COVID19_JANSSEN | Iris and ciliary body bleeding and vascular disorders | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Iris and ciliary body bleeding and vascular disorders | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Iris and ciliary body bleeding and vascular disorders | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iris and ciliary body bleeding and vascular disorders | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Iris and ciliary body structural change, deposit and degeneration | 1 | 0.17 | 0.84 | 1.94 | 1.5 | 0.24 | 0.73 | 1.79 | 0.67 | 0.67 | 0.13 | 23
COVID19_MODERNA | Iris and ciliary body structural change, deposit and degeneration | 11 | 1.05 | 1.81 | 2.73 | 5.5 | 1.01 | 1.65 | 2.57 | 2.87 | 2.87 | 1.47 | 13
COVID19_PFIZER/BIONTECH | Iris and ciliary body structural change, deposit and degeneration | 7 | 0.69 | 1.37 | 2.24 | 4.8 | 0.70 | 1.25 | 2.11 | 1.69 | 1.69 | 0.81 | 17
COVID19_UNKNOWN MFR | Iris and ciliary body structural change, deposit and degeneration | 0 | 0.08 | 0.97 | 2.73 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Iris and ciliary body therapeutic procedures | 0 | 0.06 | 0.87 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Iris and ciliary body therapeutic procedures | 0 | 0.05 | 0.63 | 1.79 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Iris and ciliary body therapeutic procedures | 1 | 0.24 | 1.23 | 2.86 | 0.5 | 0.34 | 1.03 | 2.63 | 2.05 | 2.05 | 0.27 | 2
COVID19_UNKNOWN MFR | Iris and ciliary body therapeutic procedures | 0 | 0.07 | 1.00 | 2.83 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Iris and uveal tract infections, irritations and inflammations | 3 | 0.09 | 0.30 | 0.60 | 13.5 | 0.12 | 0.29 | 0.60 | 0.22 | 0.22 | 0.09 | 207
COVID19_MODERNA | Iris and uveal tract infections, irritations and inflammations | 33 | 0.65 | 0.88 | 1.15 | 42.2 | 0.59 | 0.78 | 1.02 | 0.63 | 0.63 | 0.46 | 177
COVID19_PFIZER/BIONTECH | Iris and uveal tract infections, irritations and inflammations | 32 | 0.68 | 0.93 | 1.21 | 40.2 | 0.60 | 0.80 | 1.05 | 0.74 | 0.74 | 0.54 | 178
COVID19_UNKNOWN MFR | Iris and uveal tract infections, irritations and inflammations | 0 | 0.01 | 0.67 | 2.45 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Iron deficiencies | 0 | 0.01 | 0.32 | 1.09 | 1.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Iron deficiencies | 1 | 0.05 | 0.36 | 0.90 | 4.4 | 0.10 | 0.38 | 1.00 | 0.13 | 0.13 | 0.02 | 27
COVID19_PFIZER/BIONTECH | Iron deficiencies | 3 | 0.25 | 0.78 | 1.54 | 4.6 | 0.31 | 0.69 | 1.38 | 0.49 | 0.49 | 0.18 | 25
COVID19_UNKNOWN MFR | Iron deficiencies | 0 | 0.02 | 0.95 | 3.26 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Iron excess | 0 | 0.05 | 0.71 | 2.00 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Iron excess | 1 | 0.14 | 0.73 | 1.68 | 1.5 | 0.24 | 0.73 | 1.79 | 0.49 | 0.49 | 0.08 | 7
COVID19_PFIZER/BIONTECH | Iron excess | 1 | 0.15 | 0.79 | 1.83 | 1.5 | 0.23 | 0.72 | 1.76 | 0.59 | 0.59 | 0.10 | 7
COVID19_UNKNOWN MFR | Iron excess | 0 | 0.07 | 0.99 | 2.82 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Iron metabolism disorders NEC | 0 | 0.05 | 0.94 | 2.84 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Iron metabolism disorders NEC | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Iron metabolism disorders NEC | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iron metabolism disorders NEC | 0 | 0.05 | 1.00 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ischaemic coronary artery disorders | 119 | 1.52 | 1.77 | 2.05 | 84.7 | 1.19 | 1.39 | 1.61 | 1.47 | 1.48 | 1.26 | 1246
COVID19_MODERNA | Ischaemic coronary artery disorders | 387 | 1.23 | 1.34 | 1.45 | 360.6 | 0.99 | 1.07 | 1.16 | 1.34 | 1.35 | 1.22 | 978
COVID19_PFIZER/BIONTECH | Ischaemic coronary artery disorders | 615 | 2.34 | 2.50 | 2.67 | 308.9 | 1.86 | 1.98 | 2.12 | 3.36 | 3.37 | 3.08 | 750
COVID19_UNKNOWN MFR | Ischaemic coronary artery disorders | 3 | 0.46 | 1.37 | 2.69 | 2.4 | 0.46 | 1.02 | 2.04 | 1.52 | 1.52 | 0.59 | 1362
COVID19_JANSSEN | Islet cell neoplasms and APUDoma NEC | 0 | 0.07 | 0.91 | 2.56 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Islet cell neoplasms and APUDoma NEC | 1 | 0.26 | 1.33 | 3.07 | 0.3 | 0.36 | 1.11 | 2.99 | 3.40 | 3.40 | 0.33 | 1
COVID19_PFIZER/BIONTECH | Islet cell neoplasms and APUDoma NEC | 0 | 0.06 | 0.75 | 2.12 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Islet cell neoplasms and APUDoma NEC | 0 | 0.08 | 1.00 | 2.81 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Joint related disorders NEC | 35 | 0.54 | 0.73 | 0.95 | 73.0 | 0.37 | 0.49 | 0.64 | 0.52 | 0.51 | 0.39 | 1050
COVID19_MODERNA | Joint related disorders NEC | 118 | 0.50 | 0.58 | 0.67 | 299.4 | 0.34 | 0.40 | 0.46 | 0.41 | 0.41 | 0.35 | 967
COVID19_PFIZER/BIONTECH | Joint related disorders NEC | 99 | 0.50 | 0.59 | 0.69 | 251.2 | 0.34 | 0.40 | 0.47 | 0.41 | 0.41 | 0.35 | 986
COVID19_UNKNOWN MFR | Joint related disorders NEC | 2 | 0.36 | 1.36 | 2.90 | 1.8 | 0.37 | 0.93 | 2.02 | 1.27 | 1.27 | 0.40 | 1083
COVID19_JANSSEN | Joint related signs and symptoms | 2380 | 1.10 | 1.14 | 1.18 | 2116.8 | 1.09 | 1.12 | 1.16 | 1.33 | 1.35 | 1.31 | 27604
COVID19_MODERNA | Joint related signs and symptoms | 9105 | 1.02 | 1.04 | 1.05 | 8848.9 | 1.01 | 1.03 | 1.05 | 1.48 | 1.52 | 1.48 | 20879
COVID19_PFIZER/BIONTECH | Joint related signs and symptoms | 8020 | 1.08 | 1.10 | 1.12 | 7336.7 | 1.07 | 1.09 | 1.11 | 1.50 | 1.53 | 1.50 | 21964
COVID19_UNKNOWN MFR | Joint related signs and symptoms | 65 | 1.06 | 1.31 | 1.58 | 49.7 | 1.05 | 1.29 | 1.57 | 1.49 | 1.53 | 1.24 | 29919
COVID19_JANSSEN | Joint therapeutic procedures | 8 | 0.42 | 0.79 | 1.26 | 11.6 | 0.41 | 0.70 | 1.16 | 0.64 | 0.64 | 0.35 | 194
COVID19_MODERNA | Joint therapeutic procedures | 19 | 0.27 | 0.40 | 0.56 | 55.6 | 0.25 | 0.36 | 0.51 | 0.35 | 0.35 | 0.24 | 183
COVID19_PFIZER/BIONTECH | Joint therapeutic procedures | 19 | 0.33 | 0.50 | 0.69 | 45.4 | 0.30 | 0.44 | 0.62 | 0.43 | 0.43 | 0.29 | 183
COVID19_UNKNOWN MFR | Joint therapeutic procedures | 0 | 0.08 | 0.81 | 2.21 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Kaposi's sarcomas | 0 | 0.04 | 0.89 | 2.68 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Kaposi's sarcomas | 0 | 0.03 | 0.68 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Kaposi's sarcomas | 0 | 0.04 | 0.72 | 2.15 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Kaposi's sarcomas | 0 | 0.05 | 1.00 | 3.00 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Klebsiella infections | 0 | 0.01 | 0.44 | 1.53 | 0.8 |  |  |  |  |  |  | 
COVID19_MODERNA | Klebsiella infections | 0 | 0.00 | 0.17 | 0.58 | 3.3 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Klebsiella infections | 6 | 0.88 | 1.92 | 3.28 | 2.5 | 0.88 | 1.67 | 2.99 | 3.51 | 3.51 | 1.41 | 7
COVID19_UNKNOWN MFR | Klebsiella infections | 0 | 0.02 | 0.97 | 3.35 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Labour onset and length abnormalities | 7 | 0.21 | 0.45 | 0.75 | 23.7 | 0.18 | 0.34 | 0.57 | 0.41 | 0.41 | 0.22 | 263
COVID19_MODERNA | Labour onset and length abnormalities | 26 | 0.31 | 0.44 | 0.58 | 88.9 | 0.22 | 0.30 | 0.41 | 0.36 | 0.36 | 0.26 | 244
COVID19_PFIZER/BIONTECH | Labour onset and length abnormalities | 43 | 0.62 | 0.81 | 1.02 | 78.8 | 0.43 | 0.55 | 0.70 | 0.78 | 0.78 | 0.59 | 227
COVID19_UNKNOWN MFR | Labour onset and length abnormalities | 0 | 0.00 | 0.35 | 1.79 | 0.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lacrimal apparatus therapeutic procedures | 0 | 0.05 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Lacrimal apparatus therapeutic procedures | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lacrimal apparatus therapeutic procedures | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lacrimal apparatus therapeutic procedures | 0 | 0.05 | 1.00 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lacrimation disorders | 94 | 0.94 | 1.12 | 1.32 | 87.9 | 0.90 | 1.06 | 1.25 | 1.21 | 1.21 | 1.02 | 1197
COVID19_MODERNA | Lacrimation disorders | 306 | 0.83 | 0.92 | 1.00 | 349.2 | 0.80 | 0.88 | 0.96 | 1.06 | 1.06 | 0.95 | 985
COVID19_PFIZER/BIONTECH | Lacrimation disorders | 348 | 1.12 | 1.23 | 1.34 | 297.2 | 1.07 | 1.17 | 1.27 | 1.51 | 1.51 | 1.36 | 943
COVID19_UNKNOWN MFR | Lacrimation disorders | 1 | 0.25 | 0.79 | 1.57 | 2.1 | 0.20 | 0.62 | 1.54 | 0.53 | 0.53 | 0.10 | 1290
COVID19_JANSSEN | Lactation disorders | 7 | 0.72 | 1.41 | 2.29 | 4.8 | 0.69 | 1.24 | 2.09 | 2.16 | 2.16 | 1.11 | 50
COVID19_MODERNA | Lactation disorders | 24 | 0.87 | 1.24 | 1.68 | 19.2 | 0.86 | 1.20 | 1.64 | 2.47 | 2.47 | 1.59 | 33
COVID19_PFIZER/BIONTECH | Lactation disorders | 18 | 0.71 | 1.08 | 1.51 | 16.8 | 0.71 | 1.04 | 1.48 | 1.89 | 1.89 | 1.18 | 39
COVID19_UNKNOWN MFR | Lactation disorders | 0 | 0.10 | 0.94 | 2.50 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Large intestinal stenosis and obstruction | 0 | 0.07 | 0.77 | 2.15 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Large intestinal stenosis and obstruction | 3 | 0.58 | 1.63 | 3.10 | 1.9 | 0.52 | 1.16 | 2.34 | 3.40 | 3.40 | 0.89 | 3
COVID19_PFIZER/BIONTECH | Large intestinal stenosis and obstruction | 2 | 0.39 | 1.34 | 2.75 | 1.6 | 0.40 | 0.99 | 2.15 | 2.05 | 2.05 | 0.49 | 4
COVID19_UNKNOWN MFR | Large intestinal stenosis and obstruction | 0 | 0.08 | 0.99 | 2.76 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Large intestine therapeutic procedures | 20 | 0.59 | 0.88 | 1.23 | 25.3 | 0.55 | 0.79 | 1.11 | 0.56 | 0.56 | 0.38 | 552
COVID19_MODERNA | Large intestine therapeutic procedures | 76 | 0.85 | 1.04 | 1.24 | 75.8 | 0.82 | 1.00 | 1.20 | 0.52 | 0.52 | 0.43 | 496
COVID19_PFIZER/BIONTECH | Large intestine therapeutic procedures | 115 | 1.41 | 1.66 | 1.92 | 79.9 | 1.22 | 1.42 | 1.65 | 1.03 | 1.03 | 0.87 | 457
COVID19_UNKNOWN MFR | Large intestine therapeutic procedures | 0 | 0.01 | 0.58 | 2.02 | 0.5 |  |  |  |  |  |  | 
COVID19_JANSSEN | Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms) | 5 | 0.51 | 1.17 | 2.04 | 4.1 | 0.54 | 1.06 | 1.91 | 1.38 | 1.38 | 0.64 | 56
COVID19_MODERNA | Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms) | 10 | 0.43 | 0.76 | 1.17 | 13.3 | 0.46 | 0.76 | 1.19 | 0.67 | 0.67 | 0.38 | 51
COVID19_PFIZER/BIONTECH | Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms) | 16 | 0.79 | 1.24 | 1.77 | 12.6 | 0.80 | 1.20 | 1.74 | 1.46 | 1.46 | 0.90 | 45
COVID19_UNKNOWN MFR | Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms) | 0 | 0.06 | 0.92 | 2.66 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Laryngeal and tracheal disorders congenital | 0 | 0.06 | 0.66 | 1.81 | 0.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Laryngeal and tracheal disorders congenital | 0 | 0.03 | 0.34 | 0.94 | 2.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngeal and tracheal disorders congenital | 1 | 0.14 | 0.67 | 1.51 | 0.7 | 0.32 | 0.95 | 2.37 | 0.41 | 0.41 | 0.07 | 10
COVID19_UNKNOWN MFR | Laryngeal and tracheal disorders congenital | 0 | 0.09 | 0.99 | 2.70 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Laryngeal neoplasms malignant | 0 | 0.05 | 0.94 | 2.84 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Laryngeal neoplasms malignant | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngeal neoplasms malignant | 0 | 0.04 | 0.83 | 2.51 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngeal neoplasms malignant | 0 | 0.05 | 1.00 | 3.01 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Laryngeal spasm, oedema and obstruction | 2 | 0.08 | 0.26 | 0.53 | 14.3 | 0.06 | 0.20 | 0.48 | 0.12 | 0.12 | 0.04 | 249
COVID19_MODERNA | Laryngeal spasm, oedema and obstruction | 29 | 0.52 | 0.73 | 0.96 | 50.2 | 0.43 | 0.59 | 0.78 | 0.44 | 0.44 | 0.32 | 222
COVID19_PFIZER/BIONTECH | Laryngeal spasm, oedema and obstruction | 79 | 1.69 | 2.06 | 2.45 | 46.6 | 1.37 | 1.65 | 1.98 | 1.88 | 1.88 | 1.50 | 172
COVID19_UNKNOWN MFR | Laryngeal spasm, oedema and obstruction | 0 | 0.09 | 0.84 | 2.23 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Laryngeal therapeutic procedures | 0 | 0.05 | 0.94 | 2.83 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Laryngeal therapeutic procedures | 0 | 0.04 | 0.81 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngeal therapeutic procedures | 0 | 0.04 | 0.84 | 2.51 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngeal therapeutic procedures | 0 | 0.05 | 1.00 | 3.00 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Learning disorders | 1 | 0.04 | 0.31 | 0.79 | 5.6 | 0.07 | 0.31 | 0.84 | 0.13 | 0.13 | 0.03 | 118
COVID19_MODERNA | Learning disorders | 5 | 0.21 | 0.50 | 0.89 | 12.4 | 0.23 | 0.46 | 0.83 | 0.15 | 0.15 | 0.07 | 114
COVID19_PFIZER/BIONTECH | Learning disorders | 3 | 0.09 | 0.27 | 0.55 | 15.6 | 0.10 | 0.25 | 0.53 | 0.11 | 0.11 | 0.04 | 116
COVID19_UNKNOWN MFR | Learning disorders | 0 | 0.00 | 0.83 | 3.12 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Left ventricular failures | 2 | 0.17 | 0.74 | 1.63 | 2.8 | 0.29 | 0.74 | 1.60 | 0.58 | 0.58 | 0.18 | 53
COVID19_MODERNA | Left ventricular failures | 21 | 1.02 | 1.51 | 2.08 | 14.9 | 0.93 | 1.32 | 1.84 | 2.10 | 2.10 | 1.33 | 34
COVID19_PFIZER/BIONTECH | Left ventricular failures | 23 | 1.30 | 1.89 | 2.58 | 12.6 | 1.19 | 1.67 | 2.30 | 2.94 | 2.94 | 1.88 | 32
COVID19_UNKNOWN MFR | Left ventricular failures | 0 | 0.00 | 0.83 | 3.23 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Legionella infections | 0 | 0.06 | 0.76 | 2.16 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Legionella infections | 1 | 0.17 | 0.86 | 1.98 | 1.2 | 0.25 | 0.78 | 1.91 | 0.68 | 0.68 | 0.11 | 5
COVID19_PFIZER/BIONTECH | Legionella infections | 1 | 0.18 | 0.92 | 2.14 | 1.1 | 0.27 | 0.82 | 2.02 | 0.82 | 0.82 | 0.14 | 5
COVID19_UNKNOWN MFR | Legionella infections | 0 | 0.07 | 0.99 | 2.82 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Leiomyosarcomas | 0 | 0.05 | 0.94 | 2.84 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Leiomyosarcomas | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leiomyosarcomas | 0 | 0.04 | 0.83 | 2.51 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leiomyosarcomas | 0 | 0.05 | 1.00 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lens structural change, deposit and degeneration (excl cataracts) | 0 | 0.12 | 0.85 | 2.13 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Lens structural change, deposit and degeneration (excl cataracts) | 1 | 0.23 | 0.95 | 2.07 | 1.0 | 0.28 | 0.84 | 2.07 | 0.85 | 0.85 | 0.14 | 4
COVID19_PFIZER/BIONTECH | Lens structural change, deposit and degeneration (excl cataracts) | 2 | 0.44 | 1.39 | 2.75 | 0.9 | 0.49 | 1.22 | 2.76 | 2.73 | 2.73 | 0.61 | 3
COVID19_UNKNOWN MFR | Lens structural change, deposit and degeneration (excl cataracts) | 0 | 0.14 | 1.00 | 2.51 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lens therapeutic procedures | 0 | 0.04 | 0.52 | 1.47 | 1.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Lens therapeutic procedures | 0 | 0.02 | 0.21 | 0.59 | 4.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lens therapeutic procedures | 2 | 0.19 | 0.65 | 1.35 | 3.4 | 0.26 | 0.66 | 1.43 | 0.48 | 0.48 | 0.14 | 17
COVID19_UNKNOWN MFR | Lens therapeutic procedures | 0 | 0.07 | 0.98 | 2.77 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Leprous infections | 0 | 0.00 | 0.79 | 3.13 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Leprous infections | 0 | 0.00 | 0.50 | 1.99 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leprous infections | 0 | 0.00 | 0.54 | 2.13 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leprous infections | 0 | 0.00 | 0.99 | 3.94 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Leptospira infections | 1 | 0.28 | 1.64 | 3.94 | 0.2 | 0.38 | 1.19 | 3.52 | 5.15 | 5.15 | 0.77 | 3
COVID19_MODERNA | Leptospira infections | 0 | 0.02 | 0.51 | 1.55 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leptospira infections | 0 | 0.02 | 0.54 | 1.67 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leptospira infections | 0 | 0.04 | 0.99 | 3.05 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Leukaemias NEC | 0 | 0.05 | 0.33 | 0.83 | 3.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Leukaemias NEC | 5 | 0.29 | 0.63 | 1.07 | 9.0 | 0.31 | 0.60 | 1.08 | 0.27 | 0.27 | 0.13 | 62
COVID19_PFIZER/BIONTECH | Leukaemias NEC | 13 | 0.81 | 1.32 | 1.93 | 10.0 | 0.77 | 1.21 | 1.81 | 0.99 | 0.99 | 0.59 | 54
COVID19_UNKNOWN MFR | Leukaemias NEC | 0 | 0.14 | 0.95 | 2.37 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Leukaemias acute NEC | 0 | 0.17 | 0.82 | 1.88 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Leukaemias acute NEC | 2 | 0.37 | 1.04 | 1.99 | 1.4 | 0.42 | 1.04 | 2.27 | 1.13 | 1.13 | 0.30 | 6
COVID19_PFIZER/BIONTECH | Leukaemias acute NEC | 2 | 0.40 | 1.11 | 2.12 | 1.2 | 0.44 | 1.11 | 2.44 | 1.36 | 1.36 | 0.36 | 6
COVID19_UNKNOWN MFR | Leukaemias acute NEC | 0 | 0.20 | 1.00 | 2.28 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Leukaemias acute lymphocytic | 0 | 0.02 | 0.47 | 1.42 | 1.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Leukaemias acute lymphocytic | 0 | 0.01 | 0.26 | 0.77 | 2.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leukaemias acute lymphocytic | 1 | 0.08 | 0.48 | 1.13 | 2.6 | 0.17 | 0.55 | 1.38 | 0.18 | 0.18 | 0.03 | 23
COVID19_UNKNOWN MFR | Leukaemias acute lymphocytic | 0 | 0.05 | 0.97 | 2.93 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Leukaemias acute myeloid | 1 | 0.24 | 0.86 | 1.80 | 1.4 | 0.24 | 0.74 | 1.82 | 0.48 | 0.48 | 0.09 | 32
COVID19_MODERNA | Leukaemias acute myeloid | 5 | 0.35 | 0.74 | 1.25 | 7.8 | 0.35 | 0.68 | 1.21 | 0.61 | 0.61 | 0.27 | 28
COVID19_PFIZER/BIONTECH | Leukaemias acute myeloid | 14 | 1.21 | 1.92 | 2.78 | 6.5 | 1.17 | 1.80 | 2.70 | 3.02 | 3.02 | 1.69 | 19
COVID19_UNKNOWN MFR | Leukaemias acute myeloid | 0 | 0.18 | 0.98 | 2.31 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Leukaemias chronic NEC | 0 | 0.05 | 0.94 | 2.83 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Leukaemias chronic NEC | 0 | 0.04 | 0.81 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leukaemias chronic NEC | 0 | 0.04 | 0.84 | 2.51 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leukaemias chronic NEC | 0 | 0.05 | 1.00 | 3.00 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Leukaemias chronic T-cell | 0 | 0.05 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Leukaemias chronic T-cell | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leukaemias chronic T-cell | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leukaemias chronic T-cell | 0 | 0.05 | 1.00 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Leukaemias chronic lymphocytic | 0 | 0.05 | 0.56 | 1.54 | 1.0 |  |  |  |  |  |  | 
COVID19_MODERNA | Leukaemias chronic lymphocytic | 3 | 0.27 | 0.76 | 1.45 | 3.2 | 0.39 | 0.87 | 1.73 | 0.68 | 0.68 | 0.24 | 15
COVID19_PFIZER/BIONTECH | Leukaemias chronic lymphocytic | 4 | 0.45 | 1.11 | 2.01 | 3.2 | 0.51 | 1.05 | 1.99 | 1.17 | 1.17 | 0.46 | 14
COVID19_UNKNOWN MFR | Leukaemias chronic lymphocytic | 0 | 0.09 | 0.98 | 2.67 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Leukaemias chronic myeloid | 0 | 0.03 | 0.72 | 2.21 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Leukaemias chronic myeloid | 0 | 0.02 | 0.40 | 1.24 | 1.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leukaemias chronic myeloid | 1 | 0.15 | 0.92 | 2.20 | 0.7 | 0.32 | 0.95 | 2.37 | 0.82 | 0.82 | 0.14 | 5
COVID19_UNKNOWN MFR | Leukaemias chronic myeloid | 0 | 0.04 | 0.99 | 3.06 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Leukaemias lymphocytic NEC | 0 | 0.00 | 0.79 | 3.12 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Leukaemias lymphocytic NEC | 0 | 0.00 | 0.51 | 1.99 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leukaemias lymphocytic NEC | 0 | 0.00 | 0.54 | 2.14 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leukaemias lymphocytic NEC | 0 | 0.00 | 0.99 | 3.92 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Leukaemias myeloid NEC | 0 | 0.00 | 0.56 | 2.09 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Leukaemias myeloid NEC | 1 | 0.09 | 0.72 | 1.86 | 0.8 | 0.30 | 0.92 | 2.28 | 0.57 | 0.57 | 0.10 | 6
COVID19_PFIZER/BIONTECH | Leukaemias myeloid NEC | 0 | 0.00 | 0.28 | 1.06 | 1.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leukaemias myeloid NEC | 0 | 0.01 | 0.98 | 3.65 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Leukocytoses NEC | 15 | 0.46 | 0.73 | 1.05 | 27.6 | 0.37 | 0.56 | 0.83 | 0.48 | 0.48 | 0.31 | 486
COVID19_MODERNA | Leukocytoses NEC | 52 | 0.61 | 0.78 | 0.96 | 84.5 | 0.49 | 0.62 | 0.77 | 0.39 | 0.39 | 0.31 | 449
COVID19_PFIZER/BIONTECH | Leukocytoses NEC | 74 | 0.93 | 1.14 | 1.36 | 84.5 | 0.72 | 0.87 | 1.05 | 0.71 | 0.71 | 0.58 | 427
COVID19_UNKNOWN MFR | Leukocytoses NEC | 1 | 0.28 | 1.21 | 2.65 | 0.7 | 0.31 | 0.93 | 2.30 | 1.38 | 1.38 | 0.27 | 500
COVID19_JANSSEN | Leukopenias NEC | 5 | 0.24 | 0.57 | 1.01 | 11.1 | 0.26 | 0.51 | 0.91 | 0.40 | 0.40 | 0.19 | 193
COVID19_MODERNA | Leukopenias NEC | 20 | 0.51 | 0.76 | 1.06 | 29.0 | 0.48 | 0.70 | 0.98 | 0.38 | 0.38 | 0.26 | 178
COVID19_PFIZER/BIONTECH | Leukopenias NEC | 24 | 0.62 | 0.90 | 1.21 | 31.2 | 0.55 | 0.77 | 1.05 | 0.56 | 0.56 | 0.40 | 174
COVID19_UNKNOWN MFR | Leukopenias NEC | 0 | 0.02 | 0.76 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lid bleeding and vascular disorders | 0 | 0.07 | 0.91 | 2.54 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Lid bleeding and vascular disorders | 1 | 0.27 | 1.32 | 3.04 | 0.7 | 0.32 | 0.95 | 2.38 | 3.40 | 3.40 | 0.33 | 1
COVID19_PFIZER/BIONTECH | Lid bleeding and vascular disorders | 0 | 0.06 | 0.76 | 2.11 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lid bleeding and vascular disorders | 0 | 0.08 | 1.00 | 2.78 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lid, lash and lacrimal infections, irritations and inflammations | 52 | 0.53 | 0.66 | 0.81 | 84.5 | 0.49 | 0.62 | 0.77 | 0.61 | 0.60 | 0.48 | 1327
COVID19_MODERNA | Lid, lash and lacrimal infections, irritations and inflammations | 268 | 0.73 | 0.80 | 0.88 | 348.2 | 0.70 | 0.77 | 0.85 | 0.82 | 0.82 | 0.73 | 1111
COVID19_PFIZER/BIONTECH | Lid, lash and lacrimal infections, irritations and inflammations | 317 | 1.01 | 1.11 | 1.21 | 295.2 | 0.98 | 1.07 | 1.17 | 1.22 | 1.22 | 1.10 | 1062
COVID19_UNKNOWN MFR | Lid, lash and lacrimal infections, irritations and inflammations | 0 | 0.38 | 0.80 | 1.33 | 1.9 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lid, lash and lacrimal structural disorders | 3 | 0.31 | 0.82 | 1.54 | 4.1 | 0.33 | 0.75 | 1.50 | 0.80 | 0.80 | 0.30 | 58
COVID19_MODERNA | Lid, lash and lacrimal structural disorders | 21 | 0.95 | 1.40 | 1.92 | 14.7 | 0.94 | 1.34 | 1.87 | 1.78 | 1.78 | 1.14 | 40
COVID19_PFIZER/BIONTECH | Lid, lash and lacrimal structural disorders | 18 | 0.90 | 1.36 | 1.90 | 12.9 | 0.89 | 1.30 | 1.85 | 1.71 | 1.71 | 1.08 | 43
COVID19_UNKNOWN MFR | Lid, lash and lacrimal structural disorders | 1 | 0.37 | 1.53 | 3.34 | 0.1 | 0.41 | 1.38 | 6.48 | 11.46 | 11.48 | 2.18 | 60
COVID19_JANSSEN | Ligament disorders | 2 | 0.37 | 0.98 | 1.83 | 2.3 | 0.33 | 0.82 | 1.77 | 1.10 | 1.10 | 0.33 | 28
COVID19_MODERNA | Ligament disorders | 6 | 0.44 | 0.85 | 1.37 | 8.2 | 0.40 | 0.75 | 1.29 | 0.85 | 0.85 | 0.40 | 24
COVID19_PFIZER/BIONTECH | Ligament disorders | 4 | 0.33 | 0.72 | 1.24 | 7.1 | 0.29 | 0.61 | 1.16 | 0.63 | 0.63 | 0.26 | 26
COVID19_UNKNOWN MFR | Ligament disorders | 0 | 0.24 | 0.98 | 2.14 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Limb fractures and dislocations | 17 | 0.91 | 1.39 | 1.95 | 11.9 | 0.89 | 1.32 | 1.90 | 1.22 | 1.22 | 0.81 | 215
COVID19_MODERNA | Limb fractures and dislocations | 68 | 0.99 | 1.22 | 1.47 | 60.4 | 0.91 | 1.11 | 1.35 | 1.41 | 1.41 | 1.11 | 164
COVID19_PFIZER/BIONTECH | Limb fractures and dislocations | 59 | 1.01 | 1.26 | 1.54 | 50.9 | 0.92 | 1.14 | 1.41 | 1.40 | 1.40 | 1.09 | 173
COVID19_UNKNOWN MFR | Limb fractures and dislocations | 0 | 0.13 | 0.84 | 2.04 | 0.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Limb therapeutic procedures | 4 | 0.35 | 0.86 | 1.57 | 5.1 | 0.38 | 0.78 | 1.47 | 0.76 | 0.76 | 0.33 | 81
COVID19_MODERNA | Limb therapeutic procedures | 22 | 0.83 | 1.21 | 1.65 | 18.1 | 0.82 | 1.17 | 1.61 | 1.19 | 1.19 | 0.79 | 63
COVID19_PFIZER/BIONTECH | Limb therapeutic procedures | 11 | 0.41 | 0.71 | 1.08 | 16.5 | 0.42 | 0.68 | 1.06 | 0.61 | 0.61 | 0.36 | 74
COVID19_UNKNOWN MFR | Limb therapeutic procedures | 0 | 0.07 | 0.91 | 2.58 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lip and oral cavity neoplasms benign | 0 | 0.00 | 0.80 | 3.10 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Lip and oral cavity neoplasms benign | 0 | 0.00 | 0.52 | 2.01 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lip and oral cavity neoplasms benign | 0 | 0.00 | 0.56 | 2.15 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lip and oral cavity neoplasms benign | 0 | 0.00 | 0.99 | 3.85 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lip and oral cavity neoplasms malignant | 0 | 0.00 | 0.49 | 2.06 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Lip and oral cavity neoplasms malignant | 1 | 0.08 | 0.73 | 1.96 | 0.5 | 0.34 | 1.01 | 2.57 | 0.57 | 0.57 | 0.10 | 6
COVID19_PFIZER/BIONTECH | Lip and oral cavity neoplasms malignant | 0 | 0.00 | 0.23 | 0.96 | 1.3 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lip and oral cavity neoplasms malignant | 0 | 0.00 | 0.98 | 4.10 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lip therapeutic procedures | 0 | 0.07 | 0.95 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Lip therapeutic procedures | 1 | 0.30 | 1.57 | 3.64 | 0.4 | 0.35 | 1.06 | 2.77 | 10.19 | 10.19 | 0.69 | 0
COVID19_PFIZER/BIONTECH | Lip therapeutic procedures | 0 | 0.06 | 0.85 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lip therapeutic procedures | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lipid metabolism and deposit disorders NEC | 1 | 0.26 | 0.91 | 1.89 | 1.3 | 0.25 | 0.76 | 1.87 | 0.81 | 0.81 | 0.15 | 19
COVID19_MODERNA | Lipid metabolism and deposit disorders NEC | 3 | 0.32 | 0.80 | 1.45 | 4.4 | 0.32 | 0.71 | 1.42 | 0.60 | 0.60 | 0.21 | 17
COVID19_PFIZER/BIONTECH | Lipid metabolism and deposit disorders NEC | 3 | 0.33 | 0.83 | 1.52 | 4.1 | 0.33 | 0.75 | 1.49 | 0.72 | 0.72 | 0.26 | 17
COVID19_UNKNOWN MFR | Lipid metabolism and deposit disorders NEC | 0 | 0.19 | 0.98 | 2.30 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lipodystrophies | 1 | 0.29 | 1.23 | 2.70 | 0.4 | 0.35 | 1.05 | 2.73 | 1.54 | 1.54 | 0.28 | 10
COVID19_MODERNA | Lipodystrophies | 2 | 0.28 | 0.89 | 1.79 | 2.2 | 0.34 | 0.85 | 1.84 | 0.76 | 0.76 | 0.21 | 9
COVID19_PFIZER/BIONTECH | Lipodystrophies | 0 | 0.05 | 0.44 | 1.12 | 2.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipodystrophies | 0 | 0.12 | 0.99 | 2.55 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lipoprotein and lipid tests NEC | 22 | 0.83 | 1.19 | 1.59 | 18.0 | 0.83 | 1.18 | 1.63 | 1.50 | 1.50 | 1.04 | 226
COVID19_MODERNA | Lipoprotein and lipid tests NEC | 76 | 0.95 | 1.16 | 1.38 | 66.4 | 0.94 | 1.13 | 1.36 | 1.50 | 1.50 | 1.20 | 172
COVID19_PFIZER/BIONTECH | Lipoprotein and lipid tests NEC | 56 | 0.79 | 0.99 | 1.21 | 57.4 | 0.78 | 0.97 | 1.20 | 1.19 | 1.19 | 0.93 | 192
COVID19_UNKNOWN MFR | Lipoprotein and lipid tests NEC | 1 | 0.45 | 1.13 | 2.08 | 0.4 | 0.35 | 1.06 | 2.75 | 2.79 | 2.79 | 0.54 | 247
COVID19_JANSSEN | Listeria infections | 0 | 0.05 | 0.89 | 2.67 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Listeria infections | 0 | 0.04 | 0.69 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Listeria infections | 0 | 0.04 | 0.72 | 2.15 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Listeria infections | 0 | 0.05 | 1.00 | 2.99 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Liver function analyses | 141 | 0.86 | 0.99 | 1.13 | 171.8 | 0.71 | 0.82 | 0.94 | 0.79 | 0.79 | 0.68 | 2763
COVID19_MODERNA | Liver function analyses | 475 | 0.86 | 0.92 | 1.00 | 573.0 | 0.77 | 0.83 | 0.89 | 0.66 | 0.66 | 0.61 | 2429
COVID19_PFIZER/BIONTECH | Liver function analyses | 554 | 1.12 | 1.20 | 1.29 | 537.4 | 0.96 | 1.03 | 1.10 | 0.97 | 0.97 | 0.89 | 2350
COVID19_UNKNOWN MFR | Liver function analyses | 3 | 0.34 | 0.89 | 1.64 | 4.3 | 0.32 | 0.72 | 1.44 | 0.71 | 0.71 | 0.27 | 2901
COVID19_JANSSEN | Lower respiratory tract and lung infections | 106 | 0.67 | 0.80 | 0.93 | 197.2 | 0.46 | 0.54 | 0.63 | 0.44 | 0.44 | 0.38 | 3691
COVID19_MODERNA | Lower respiratory tract and lung infections | 482 | 0.96 | 1.04 | 1.12 | 644.8 | 0.69 | 0.75 | 0.81 | 0.49 | 0.49 | 0.45 | 3315
COVID19_PFIZER/BIONTECH | Lower respiratory tract and lung infections | 545 | 1.13 | 1.21 | 1.30 | 640.7 | 0.79 | 0.85 | 0.91 | 0.69 | 0.69 | 0.63 | 3252
COVID19_UNKNOWN MFR | Lower respiratory tract and lung infections | 5 | 0.50 | 1.11 | 1.91 | 6.0 | 0.42 | 0.82 | 1.48 | 0.91 | 0.91 | 0.43 | 3792
COVID19_JANSSEN | Lower respiratory tract inflammatory and immunologic conditions | 11 | 0.46 | 0.79 | 1.19 | 14.7 | 0.47 | 0.75 | 1.16 | 0.66 | 0.66 | 0.40 | 258
COVID19_MODERNA | Lower respiratory tract inflammatory and immunologic conditions | 63 | 1.00 | 1.24 | 1.51 | 56.7 | 0.89 | 1.10 | 1.34 | 1.04 | 1.04 | 0.82 | 206
COVID19_PFIZER/BIONTECH | Lower respiratory tract inflammatory and immunologic conditions | 75 | 1.30 | 1.58 | 1.89 | 52.0 | 1.17 | 1.41 | 1.70 | 1.58 | 1.58 | 1.26 | 194
COVID19_UNKNOWN MFR | Lower respiratory tract inflammatory and immunologic conditions | 1 | 0.29 | 1.31 | 2.93 | 0.5 | 0.34 | 1.04 | 2.67 | 2.57 | 2.57 | 0.49 | 268
COVID19_JANSSEN | Lower respiratory tract signs and symptoms | 83 | 1.48 | 1.79 | 2.12 | 59.9 | 1.14 | 1.36 | 1.63 | 1.49 | 1.49 | 1.23 | 862
COVID19_MODERNA | Lower respiratory tract signs and symptoms | 276 | 1.28 | 1.41 | 1.56 | 255.9 | 0.97 | 1.08 | 1.19 | 1.40 | 1.40 | 1.25 | 669
COVID19_PFIZER/BIONTECH | Lower respiratory tract signs and symptoms | 349 | 1.94 | 2.13 | 2.32 | 216.3 | 1.47 | 1.61 | 1.75 | 2.40 | 2.40 | 2.15 | 596
COVID19_UNKNOWN MFR | Lower respiratory tract signs and symptoms | 6 | 1.38 | 2.88 | 4.83 | 1.6 | 1.10 | 2.18 | 4.52 | 4.39 | 4.42 | 2.25 | 939
COVID19_JANSSEN | Lumbar spinal cord and nerve root disorders | 29 | 1.43 | 1.96 | 2.56 | 14.7 | 1.34 | 1.82 | 2.43 | 2.50 | 2.50 | 1.80 | 179
COVID19_MODERNA | Lumbar spinal cord and nerve root disorders | 51 | 0.73 | 0.93 | 1.15 | 60.3 | 0.67 | 0.84 | 1.05 | 1.10 | 1.10 | 0.85 | 157
COVID19_PFIZER/BIONTECH | Lumbar spinal cord and nerve root disorders | 59 | 1.02 | 1.27 | 1.55 | 50.3 | 0.93 | 1.16 | 1.42 | 1.62 | 1.62 | 1.26 | 149
COVID19_UNKNOWN MFR | Lumbar spinal cord and nerve root disorders | 0 | 0.26 | 0.91 | 1.88 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lupus erythematosus (incl subtypes) | 6 | 0.20 | 0.44 | 0.76 | 18.5 | 0.20 | 0.37 | 0.65 | 0.34 | 0.34 | 0.17 | 273
COVID19_MODERNA | Lupus erythematosus (incl subtypes) | 37 | 0.65 | 0.87 | 1.12 | 47.8 | 0.59 | 0.77 | 1.00 | 0.52 | 0.52 | 0.39 | 242
COVID19_PFIZER/BIONTECH | Lupus erythematosus (incl subtypes) | 32 | 0.57 | 0.78 | 1.01 | 50.3 | 0.48 | 0.64 | 0.85 | 0.53 | 0.53 | 0.39 | 247
COVID19_UNKNOWN MFR | Lupus erythematosus (incl subtypes) | 0 | 0.01 | 0.63 | 2.28 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lymphangiopathies | 0 | 0.04 | 0.89 | 2.68 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Lymphangiopathies | 0 | 0.03 | 0.69 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphangiopathies | 0 | 0.04 | 0.72 | 2.15 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphangiopathies | 0 | 0.05 | 1.00 | 3.00 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lymphatic system disorders NEC | 421 | 0.49 | 0.54 | 0.58 | 965.7 | 0.40 | 0.44 | 0.47 | 0.55 | 0.55 | 0.51 | 11743
COVID19_MODERNA | Lymphatic system disorders NEC | 4397 | 1.39 | 1.43 | 1.46 | 3752.3 | 1.14 | 1.17 | 1.20 | 1.92 | 1.95 | 1.89 | 7767
COVID19_PFIZER/BIONTECH | Lymphatic system disorders NEC | 4674 | 1.74 | 1.78 | 1.83 | 3199.7 | 1.43 | 1.46 | 1.50 | 2.55 | 2.62 | 2.54 | 7490
COVID19_UNKNOWN MFR | Lymphatic system disorders NEC | 20 | 0.80 | 1.17 | 1.60 | 20.4 | 0.67 | 0.96 | 1.35 | 1.13 | 1.14 | 0.78 | 12144
COVID19_JANSSEN | Lymphatic system disorders congenital | 0 | 0.04 | 0.70 | 2.10 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Lymphatic system disorders congenital | 1 | 0.14 | 0.77 | 1.83 | 1.0 | 0.27 | 0.83 | 2.05 | 0.57 | 0.57 | 0.10 | 6
COVID19_PFIZER/BIONTECH | Lymphatic system disorders congenital | 0 | 0.02 | 0.42 | 1.26 | 1.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphatic system disorders congenital | 0 | 0.05 | 0.99 | 2.95 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lymphoedemas | 2 | 0.17 | 0.46 | 0.87 | 7.2 | 0.14 | 0.39 | 0.86 | 0.28 | 0.28 | 0.09 | 109
COVID19_MODERNA | Lymphoedemas | 32 | 0.74 | 1.01 | 1.30 | 31.9 | 0.74 | 0.99 | 1.30 | 1.38 | 1.38 | 0.97 | 79
COVID19_PFIZER/BIONTECH | Lymphoedemas | 43 | 1.23 | 1.60 | 2.01 | 26.1 | 1.23 | 1.58 | 2.01 | 2.59 | 2.59 | 1.88 | 68
COVID19_UNKNOWN MFR | Lymphoedemas | 1 | 0.40 | 1.31 | 2.64 | 0.2 | 0.39 | 1.24 | 4.07 | 6.25 | 6.26 | 1.20 | 110
COVID19_JANSSEN | Lymphoid tissue therapeutic procedures | 2 | 0.14 | 0.55 | 1.18 | 5.4 | 0.18 | 0.48 | 1.06 | 0.42 | 0.42 | 0.13 | 73
COVID19_MODERNA | Lymphoid tissue therapeutic procedures | 6 | 0.25 | 0.54 | 0.92 | 14.1 | 0.25 | 0.47 | 0.83 | 0.30 | 0.30 | 0.15 | 69
COVID19_PFIZER/BIONTECH | Lymphoid tissue therapeutic procedures | 12 | 0.60 | 1.02 | 1.52 | 14.5 | 0.52 | 0.82 | 1.25 | 0.78 | 0.78 | 0.46 | 63
COVID19_UNKNOWN MFR | Lymphoid tissue therapeutic procedures | 0 | 0.02 | 0.89 | 2.91 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lymphomas unspecified NEC | 0 | 0.05 | 0.37 | 0.91 | 3.0 |  |  |  |  |  |  | 
COVID19_MODERNA | Lymphomas unspecified NEC | 2 | 0.13 | 0.40 | 0.78 | 8.7 | 0.11 | 0.33 | 0.74 | 0.14 | 0.14 | 0.04 | 49
COVID19_PFIZER/BIONTECH | Lymphomas unspecified NEC | 9 | 0.61 | 1.09 | 1.68 | 8.8 | 0.58 | 0.97 | 1.56 | 0.88 | 0.88 | 0.48 | 42
COVID19_UNKNOWN MFR | Lymphomas unspecified NEC | 0 | 0.14 | 0.95 | 2.37 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lymphoproliferative disorders NEC (excl leukaemias and lymphomas) | 0 | 0.04 | 0.71 | 2.09 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Lymphoproliferative disorders NEC (excl leukaemias and lymphomas) | 1 | 0.14 | 0.78 | 1.83 | 1.3 | 0.25 | 0.77 | 1.88 | 0.57 | 0.57 | 0.10 | 6
COVID19_PFIZER/BIONTECH | Lymphoproliferative disorders NEC (excl leukaemias and lymphomas) | 1 | 0.16 | 0.85 | 1.99 | 1.4 | 0.24 | 0.75 | 1.84 | 0.68 | 0.68 | 0.12 | 6
COVID19_UNKNOWN MFR | Lymphoproliferative disorders NEC (excl leukaemias and lymphomas) | 0 | 0.06 | 0.99 | 2.90 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lysosomal enzyme analyses | 0 | 0.02 | 0.73 | 2.34 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Lysosomal enzyme analyses | 2 | 0.37 | 1.44 | 3.07 | 0.9 | 0.48 | 1.20 | 2.70 | 2.26 | 2.26 | 0.50 | 3
COVID19_PFIZER/BIONTECH | Lysosomal enzyme analyses | 0 | 0.01 | 0.46 | 1.47 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lysosomal enzyme analyses | 0 | 0.03 | 0.99 | 3.17 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Lysosomal storage disorders | 0 | 0.00 | 0.41 | 1.88 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Lysosomal storage disorders | 0 | 0.00 | 0.16 | 0.72 | 1.6 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lysosomal storage disorders | 0 | 0.00 | 0.18 | 0.81 | 1.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lysosomal storage disorders | 0 | 0.00 | 0.97 | 4.46 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Magnesium metabolism disorders | 1 | 0.11 | 0.74 | 1.83 | 1.5 | 0.23 | 0.71 | 1.76 | 0.50 | 0.50 | 0.09 | 31
COVID19_MODERNA | Magnesium metabolism disorders | 12 | 0.74 | 1.25 | 1.88 | 9.0 | 0.77 | 1.22 | 1.86 | 2.04 | 2.04 | 1.12 | 20
COVID19_PFIZER/BIONTECH | Magnesium metabolism disorders | 14 | 1.11 | 1.82 | 2.66 | 7.1 | 1.09 | 1.69 | 2.52 | 3.18 | 3.18 | 1.77 | 18
COVID19_UNKNOWN MFR | Magnesium metabolism disorders | 0 | 0.02 | 0.93 | 3.11 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Malabsorption syndromes | 2 | 0.15 | 0.57 | 1.19 | 5.2 | 0.19 | 0.50 | 1.09 | 0.33 | 0.33 | 0.10 | 95
COVID19_MODERNA | Malabsorption syndromes | 3 | 0.12 | 0.36 | 0.70 | 10.9 | 0.15 | 0.35 | 0.72 | 0.11 | 0.11 | 0.04 | 94
COVID19_PFIZER/BIONTECH | Malabsorption syndromes | 8 | 0.38 | 0.72 | 1.16 | 13.5 | 0.36 | 0.62 | 1.02 | 0.37 | 0.37 | 0.20 | 89
COVID19_UNKNOWN MFR | Malabsorption syndromes | 0 | 0.04 | 0.90 | 2.74 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Male gonadal function disorders | 0 | 0.09 | 0.88 | 2.38 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Male gonadal function disorders | 1 | 0.25 | 1.16 | 2.61 | 0.6 | 0.33 | 0.98 | 2.47 | 1.70 | 1.70 | 0.23 | 2
COVID19_PFIZER/BIONTECH | Male gonadal function disorders | 0 | 0.07 | 0.70 | 1.88 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Male gonadal function disorders | 0 | 0.10 | 1.00 | 2.69 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Male reproductive tract disorders congenital | 0 | 0.01 | 0.36 | 1.14 | 1.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Male reproductive tract disorders congenital | 2 | 0.21 | 0.79 | 1.69 | 1.5 | 0.41 | 1.02 | 2.21 | 0.32 | 0.32 | 0.10 | 21
COVID19_PFIZER/BIONTECH | Male reproductive tract disorders congenital | 1 | 0.07 | 0.42 | 1.02 | 2.5 | 0.17 | 0.56 | 1.41 | 0.19 | 0.19 | 0.04 | 22
COVID19_UNKNOWN MFR | Male reproductive tract disorders congenital | 0 | 0.03 | 0.95 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Male reproductive tract infections | 1 | 0.06 | 0.47 | 1.20 | 3.4 | 0.13 | 0.46 | 1.17 | 0.37 | 0.37 | 0.07 | 42
COVID19_MODERNA | Male reproductive tract infections | 9 | 0.66 | 1.24 | 1.96 | 8.0 | 0.62 | 1.05 | 1.68 | 0.90 | 0.90 | 0.49 | 34
COVID19_PFIZER/BIONTECH | Male reproductive tract infections | 11 | 0.86 | 1.50 | 2.30 | 8.2 | 0.76 | 1.22 | 1.89 | 1.41 | 1.41 | 0.79 | 32
COVID19_UNKNOWN MFR | Male reproductive tract infections | 0 | 0.01 | 0.91 | 3.22 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Manufacturing issues NEC | 1 | 0.34 | 1.64 | 3.74 | 0.2 | 0.40 | 1.28 | 4.62 | 15.44 | 15.44 | 1.51 | 1
COVID19_MODERNA | Manufacturing issues NEC | 1 | 0.27 | 1.32 | 3.01 | 0.1 | 0.42 | 1.46 | 8.23 | 3.40 | 3.40 | 0.33 | 1
COVID19_PFIZER/BIONTECH | Manufacturing issues NEC | 0 | 0.07 | 0.76 | 2.11 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Manufacturing issues NEC | 0 | 0.09 | 1.00 | 2.76 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Manufacturing production issues | 0 | 0.05 | 0.94 | 2.84 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Manufacturing production issues | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Manufacturing production issues | 0 | 0.04 | 0.83 | 2.51 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Manufacturing production issues | 0 | 0.05 | 1.00 | 3.01 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Marginal zone lymphomas NEC | 0 | 0.02 | 0.80 | 2.69 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Marginal zone lymphomas NEC | 0 | 0.01 | 0.51 | 1.73 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Marginal zone lymphomas NEC | 1 | 0.19 | 1.32 | 3.28 | 0.5 | 0.33 | 1.00 | 2.53 | 2.05 | 2.05 | 0.27 | 2
COVID19_UNKNOWN MFR | Marginal zone lymphomas NEC | 0 | 0.02 | 0.99 | 3.37 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Marrow depression and hypoplastic anaemias | 4 | 0.34 | 0.73 | 1.24 | 6.8 | 0.30 | 0.63 | 1.20 | 0.50 | 0.50 | 0.22 | 124
COVID19_MODERNA | Marrow depression and hypoplastic anaemias | 20 | 0.62 | 0.90 | 1.23 | 24.2 | 0.57 | 0.82 | 1.16 | 0.63 | 0.63 | 0.42 | 108
COVID19_PFIZER/BIONTECH | Marrow depression and hypoplastic anaemias | 26 | 0.85 | 1.19 | 1.58 | 23.1 | 0.79 | 1.09 | 1.48 | 1.04 | 1.04 | 0.73 | 102
COVID19_UNKNOWN MFR | Marrow depression and hypoplastic anaemias | 0 | 0.25 | 0.94 | 2.00 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Mass conditions NEC | 127 | 0.84 | 0.98 | 1.12 | 145.7 | 0.75 | 0.87 | 1.00 | 0.92 | 0.92 | 0.79 | 2125
COVID19_MODERNA | Mass conditions NEC | 562 | 0.92 | 0.99 | 1.06 | 624.3 | 0.84 | 0.90 | 0.96 | 1.13 | 1.13 | 1.04 | 1690
COVID19_PFIZER/BIONTECH | Mass conditions NEC | 234 | 0.46 | 0.51 | 0.56 | 515.2 | 0.41 | 0.46 | 0.51 | 0.48 | 0.47 | 0.42 | 2018
COVID19_UNKNOWN MFR | Mass conditions NEC | 3 | 0.43 | 0.99 | 1.75 | 3.4 | 0.37 | 0.84 | 1.67 | 0.92 | 0.92 | 0.35 | 2249
COVID19_JANSSEN | Mastectomies | 0 | 0.04 | 0.76 | 2.31 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Mastectomies | 0 | 0.02 | 0.46 | 1.39 | 1.1 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mastectomies | 1 | 0.18 | 1.01 | 2.41 | 0.8 | 0.30 | 0.92 | 2.28 | 1.02 | 1.02 | 0.16 | 4
COVID19_UNKNOWN MFR | Mastectomies | 0 | 0.05 | 0.99 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Mastoid disorders | 1 | 0.25 | 1.26 | 2.88 | 0.6 | 0.33 | 0.99 | 2.51 | 1.93 | 1.93 | 0.34 | 8
COVID19_MODERNA | Mastoid disorders | 1 | 0.14 | 0.68 | 1.56 | 2.9 | 0.15 | 0.51 | 1.29 | 0.42 | 0.42 | 0.07 | 8
COVID19_PFIZER/BIONTECH | Mastoid disorders | 6 | 1.15 | 2.42 | 4.06 | 2.3 | 0.92 | 1.75 | 3.19 | 8.19 | 8.19 | 2.56 | 3
COVID19_UNKNOWN MFR | Mastoid disorders | 0 | 0.08 | 0.99 | 2.77 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Maternal complications of delivery NEC | 0 | 0.01 | 0.56 | 1.99 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Maternal complications of delivery NEC | 1 | 0.09 | 0.66 | 1.69 | 2.5 | 0.17 | 0.56 | 1.41 | 0.49 | 0.49 | 0.08 | 7
COVID19_PFIZER/BIONTECH | Maternal complications of delivery NEC | 0 | 0.00 | 0.28 | 1.01 | 1.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Maternal complications of delivery NEC | 0 | 0.01 | 0.98 | 3.48 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Maternal complications of labour NEC | 0 | 0.05 | 0.50 | 1.38 | 1.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Maternal complications of labour NEC | 3 | 0.31 | 0.86 | 1.63 | 4.9 | 0.30 | 0.67 | 1.34 | 0.73 | 0.73 | 0.26 | 14
COVID19_PFIZER/BIONTECH | Maternal complications of labour NEC | 6 | 0.69 | 1.45 | 2.43 | 4.6 | 0.61 | 1.13 | 1.97 | 2.23 | 2.23 | 0.97 | 11
COVID19_UNKNOWN MFR | Maternal complications of labour NEC | 0 | 0.09 | 0.98 | 2.68 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Maternal complications of pregnancy NEC | 2 | 0.07 | 0.33 | 0.76 | 8.3 | 0.12 | 0.34 | 0.77 | 0.33 | 0.33 | 0.10 | 95
COVID19_MODERNA | Maternal complications of pregnancy NEC | 13 | 0.32 | 0.55 | 0.81 | 30.1 | 0.29 | 0.46 | 0.69 | 0.53 | 0.53 | 0.32 | 84
COVID19_PFIZER/BIONTECH | Maternal complications of pregnancy NEC | 22 | 0.69 | 1.02 | 1.40 | 27.0 | 0.57 | 0.81 | 1.13 | 1.20 | 1.20 | 0.81 | 75
COVID19_UNKNOWN MFR | Maternal complications of pregnancy NEC | 0 | 0.00 | 0.60 | 2.95 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Mediastinal disorders | 1 | 0.22 | 0.88 | 1.90 | 1.8 | 0.22 | 0.67 | 1.66 | 0.70 | 0.70 | 0.13 | 22
COVID19_MODERNA | Mediastinal disorders | 6 | 0.50 | 1.02 | 1.68 | 5.9 | 0.51 | 0.95 | 1.65 | 1.20 | 1.20 | 0.55 | 17
COVID19_PFIZER/BIONTECH | Mediastinal disorders | 9 | 0.95 | 1.70 | 2.64 | 5.1 | 0.86 | 1.46 | 2.35 | 2.63 | 2.63 | 1.30 | 14
COVID19_UNKNOWN MFR | Mediastinal disorders | 0 | 0.15 | 0.98 | 2.43 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Mediastinal neoplasms malignancy unspecified NEC | 0 | 0.06 | 0.90 | 2.59 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Mediastinal neoplasms malignancy unspecified NEC | 0 | 0.05 | 0.71 | 2.05 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mediastinal neoplasms malignancy unspecified NEC | 1 | 0.27 | 1.40 | 3.25 | 0.4 | 0.36 | 1.09 | 2.87 | 4.09 | 4.09 | 0.40 | 1
COVID19_UNKNOWN MFR | Mediastinal neoplasms malignancy unspecified NEC | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Medication errors, product use errors and issues NEC | 82 | 0.72 | 0.87 | 1.03 | 121.1 | 0.56 | 0.68 | 0.81 | 0.60 | 0.60 | 0.50 | 2108
COVID19_MODERNA | Medication errors, product use errors and issues NEC | 159 | 0.51 | 0.58 | 0.66 | 329.4 | 0.43 | 0.49 | 0.55 | 0.27 | 0.27 | 0.23 | 2031
COVID19_PFIZER/BIONTECH | Medication errors, product use errors and issues NEC | 374 | 1.32 | 1.44 | 1.56 | 325.2 | 1.05 | 1.15 | 1.25 | 0.84 | 0.84 | 0.77 | 1816
COVID19_UNKNOWN MFR | Medication errors, product use errors and issues NEC | 1 | 0.07 | 0.53 | 1.37 | 3.0 | 0.15 | 0.50 | 1.26 | 0.31 | 0.31 | 0.06 | 2189
COVID19_JANSSEN | Memory loss (excl dementia) | 136 | 1.18 | 1.37 | 1.57 | 116.0 | 1.01 | 1.16 | 1.34 | 1.13 | 1.14 | 0.98 | 1851
COVID19_MODERNA | Memory loss (excl dementia) | 403 | 0.87 | 0.95 | 1.03 | 445.7 | 0.83 | 0.90 | 0.98 | 0.86 | 0.86 | 0.79 | 1584
COVID19_PFIZER/BIONTECH | Memory loss (excl dementia) | 402 | 1.04 | 1.14 | 1.23 | 395.6 | 0.94 | 1.01 | 1.10 | 1.04 | 1.04 | 0.95 | 1585
COVID19_UNKNOWN MFR | Memory loss (excl dementia) | 3 | 0.37 | 1.16 | 2.30 | 2.9 | 0.42 | 0.93 | 1.85 | 1.04 | 1.04 | 0.40 | 1984
COVID19_JANSSEN | Meningiomas benign | 0 | 0.07 | 0.95 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Meningiomas benign | 1 | 0.30 | 1.57 | 3.64 | 0.3 | 0.37 | 1.12 | 3.03 | 10.19 | 10.19 | 0.69 | 0
COVID19_PFIZER/BIONTECH | Meningiomas benign | 0 | 0.06 | 0.85 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningiomas benign | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Menopausal effects NEC | 0 | 0.00 | 0.06 | 0.34 | 2.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Menopausal effects NEC | 2 | 0.09 | 0.46 | 1.07 | 7.7 | 0.13 | 0.36 | 0.81 | 0.11 | 0.11 | 0.03 | 61
COVID19_PFIZER/BIONTECH | Menopausal effects NEC | 3 | 0.16 | 0.58 | 1.20 | 9.5 | 0.17 | 0.40 | 0.81 | 0.21 | 0.21 | 0.08 | 60
COVID19_UNKNOWN MFR | Menopausal effects NEC | 0 | 0.00 | 0.72 | 3.99 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Menopausal effects on the genitourinary tract | 19 | 2.90 | 4.41 | 6.18 | 5.4 | 1.91 | 2.88 | 4.34 | 5.53 | 5.54 | 3.57 | 53
COVID19_MODERNA | Menopausal effects on the genitourinary tract | 19 | 0.75 | 1.13 | 1.59 | 21.6 | 0.60 | 0.87 | 1.23 | 1.22 | 1.22 | 0.78 | 53
COVID19_PFIZER/BIONTECH | Menopausal effects on the genitourinary tract | 33 | 1.69 | 2.31 | 3.01 | 18.3 | 1.27 | 1.69 | 2.22 | 3.46 | 3.46 | 2.35 | 39
COVID19_UNKNOWN MFR | Menopausal effects on the genitourinary tract | 0 | 0.00 | 0.76 | 3.36 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Menstruation and uterine bleeding NEC | 290 | 2.40 | 2.65 | 2.91 | 124.1 | 2.10 | 2.31 | 2.54 | 3.19 | 3.21 | 2.88 | 1404
COVID19_MODERNA | Menstruation and uterine bleeding NEC | 351 | 0.76 | 0.83 | 0.90 | 457.8 | 0.70 | 0.77 | 0.84 | 0.89 | 0.89 | 0.80 | 1343
COVID19_PFIZER/BIONTECH | Menstruation and uterine bleeding NEC | 548 | 1.35 | 1.45 | 1.56 | 416.8 | 1.22 | 1.31 | 1.41 | 1.96 | 1.96 | 1.80 | 1146
COVID19_UNKNOWN MFR | Menstruation and uterine bleeding NEC | 3 | 0.39 | 1.34 | 2.75 | 2.5 | 0.45 | 1.00 | 1.99 | 1.22 | 1.22 | 0.47 | 1691
COVID19_JANSSEN | Menstruation with decreased bleeding | 73 | 2.62 | 3.21 | 3.85 | 32.4 | 1.78 | 2.16 | 2.61 | 3.03 | 3.03 | 2.46 | 372
COVID19_MODERNA | Menstruation with decreased bleeding | 85 | 0.80 | 0.97 | 1.15 | 114.7 | 0.62 | 0.74 | 0.88 | 0.80 | 0.80 | 0.66 | 360
COVID19_PFIZER/BIONTECH | Menstruation with decreased bleeding | 109 | 1.19 | 1.40 | 1.63 | 106.2 | 0.87 | 1.02 | 1.19 | 1.33 | 1.33 | 1.11 | 336
COVID19_UNKNOWN MFR | Menstruation with decreased bleeding | 1 | 0.15 | 1.70 | 4.65 | 0.7 | 0.32 | 0.95 | 2.38 | 1.55 | 1.55 | 0.30 | 444
COVID19_JANSSEN | Menstruation with increased bleeding | 178 | 3.16 | 3.60 | 4.05 | 60.6 | 2.53 | 2.87 | 3.25 | 4.75 | 4.76 | 4.14 | 579
COVID19_MODERNA | Menstruation with increased bleeding | 179 | 0.80 | 0.91 | 1.02 | 236.4 | 0.67 | 0.76 | 0.86 | 1.05 | 1.05 | 0.91 | 578
COVID19_PFIZER/BIONTECH | Menstruation with increased bleeding | 280 | 1.48 | 1.63 | 1.80 | 207.9 | 1.22 | 1.34 | 1.48 | 2.40 | 2.41 | 2.13 | 477
COVID19_UNKNOWN MFR | Menstruation with increased bleeding | 0 | 0.00 | 0.23 | 1.07 | 1.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Mental disorders NEC | 64 | 1.24 | 1.53 | 1.86 | 43.0 | 1.18 | 1.45 | 1.77 | 1.23 | 1.23 | 0.99 | 806
COVID19_MODERNA | Mental disorders NEC | 213 | 0.98 | 1.10 | 1.22 | 201.0 | 0.94 | 1.06 | 1.18 | 1.10 | 1.10 | 0.97 | 657
COVID19_PFIZER/BIONTECH | Mental disorders NEC | 231 | 1.26 | 1.41 | 1.57 | 171.9 | 1.20 | 1.34 | 1.49 | 1.48 | 1.48 | 1.31 | 639
COVID19_UNKNOWN MFR | Mental disorders NEC | 4 | 0.80 | 1.80 | 3.11 | 1.3 | 0.80 | 1.71 | 3.58 | 3.18 | 3.19 | 1.40 | 866
COVID19_JANSSEN | Mental disorders due to a general medical condition NEC | 0 | 0.00 | 0.35 | 1.25 | 1.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Mental disorders due to a general medical condition NEC | 0 | 0.00 | 0.20 | 0.70 | 2.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mental disorders due to a general medical condition NEC | 2 | 0.17 | 0.71 | 1.54 | 3.1 | 0.28 | 0.70 | 1.52 | 0.37 | 0.37 | 0.11 | 22
COVID19_UNKNOWN MFR | Mental disorders due to a general medical condition NEC | 0 | 0.01 | 0.96 | 3.39 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Mental impairment (excl dementia and memory loss) | 219 | 1.25 | 1.40 | 1.56 | 187.2 | 1.04 | 1.17 | 1.30 | 1.25 | 1.25 | 1.11 | 2706
COVID19_MODERNA | Mental impairment (excl dementia and memory loss) | 605 | 0.95 | 1.01 | 1.08 | 649.5 | 0.87 | 0.93 | 1.00 | 0.89 | 0.89 | 0.82 | 2320
COVID19_PFIZER/BIONTECH | Mental impairment (excl dementia and memory loss) | 600 | 1.09 | 1.16 | 1.24 | 596.0 | 0.94 | 1.01 | 1.08 | 1.06 | 1.06 | 0.98 | 2325
COVID19_UNKNOWN MFR | Mental impairment (excl dementia and memory loss) | 2 | 0.15 | 0.62 | 1.35 | 4.4 | 0.22 | 0.56 | 1.23 | 0.47 | 0.47 | 0.15 | 2923
COVID19_JANSSEN | Metabolic acidoses (excl diabetic acidoses) | 10 | 0.72 | 1.28 | 1.98 | 7.6 | 0.72 | 1.19 | 1.88 | 0.89 | 0.89 | 0.52 | 174
COVID19_MODERNA | Metabolic acidoses (excl diabetic acidoses) | 34 | 0.83 | 1.13 | 1.46 | 29.2 | 0.86 | 1.14 | 1.48 | 0.77 | 0.77 | 0.56 | 150
COVID19_PFIZER/BIONTECH | Metabolic acidoses (excl diabetic acidoses) | 32 | 0.86 | 1.17 | 1.52 | 27.8 | 0.84 | 1.12 | 1.48 | 0.86 | 0.86 | 0.63 | 152
COVID19_UNKNOWN MFR | Metabolic acidoses (excl diabetic acidoses) | 1 | 0.28 | 1.67 | 4.00 | 0.2 | 0.38 | 1.19 | 3.49 | 3.76 | 3.76 | 0.72 | 183
COVID19_JANSSEN | Metabolic alkaloses | 0 | 0.00 | 0.36 | 2.00 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Metabolic alkaloses | 0 | 0.00 | 0.13 | 0.72 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metabolic alkaloses | 0 | 0.00 | 0.15 | 0.82 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metabolic alkaloses | 0 | 0.00 | 0.96 | 5.38 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Metabolic bone disorders | 1 | 0.13 | 0.61 | 1.37 | 2.5 | 0.17 | 0.56 | 1.41 | 0.32 | 0.32 | 0.06 | 48
COVID19_MODERNA | Metabolic bone disorders | 6 | 0.32 | 0.66 | 1.11 | 9.5 | 0.36 | 0.66 | 1.15 | 0.47 | 0.47 | 0.23 | 43
COVID19_PFIZER/BIONTECH | Metabolic bone disorders | 12 | 0.81 | 1.37 | 2.04 | 8.7 | 0.79 | 1.25 | 1.91 | 1.33 | 1.33 | 0.77 | 37
COVID19_UNKNOWN MFR | Metabolic bone disorders | 0 | 0.09 | 0.95 | 2.59 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Metabolic disorders NEC | 1 | 0.07 | 0.54 | 1.38 | 2.6 | 0.17 | 0.54 | 1.37 | 0.31 | 0.31 | 0.06 | 50
COVID19_MODERNA | Metabolic disorders NEC | 4 | 0.22 | 0.58 | 1.09 | 7.7 | 0.28 | 0.58 | 1.09 | 0.29 | 0.29 | 0.12 | 47
COVID19_PFIZER/BIONTECH | Metabolic disorders NEC | 7 | 0.49 | 1.01 | 1.68 | 7.5 | 0.50 | 0.90 | 1.51 | 0.65 | 0.65 | 0.33 | 44
COVID19_UNKNOWN MFR | Metabolic disorders NEC | 0 | 0.01 | 0.90 | 3.37 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Metabolism tests NEC | 409 | 1.17 | 1.27 | 1.37 | 320.8 | 1.17 | 1.27 | 1.38 | 1.41 | 1.42 | 1.30 | 4467
COVID19_MODERNA | Metabolism tests NEC | 1310 | 0.96 | 1.00 | 1.05 | 1303.7 | 0.96 | 1.00 | 1.05 | 1.25 | 1.25 | 1.19 | 3566
COVID19_PFIZER/BIONTECH | Metabolism tests NEC | 1395 | 1.21 | 1.26 | 1.32 | 1107.7 | 1.20 | 1.26 | 1.32 | 1.64 | 1.65 | 1.56 | 3481
COVID19_UNKNOWN MFR | Metabolism tests NEC | 13 | 0.95 | 1.49 | 2.13 | 7.4 | 0.98 | 1.53 | 2.30 | 1.84 | 1.85 | 1.17 | 4863
COVID19_JANSSEN | Metastases to specified sites | 0 | 0.01 | 0.32 | 1.02 | 1.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Metastases to specified sites | 5 | 0.38 | 0.89 | 1.56 | 6.1 | 0.42 | 0.81 | 1.46 | 0.71 | 0.71 | 0.32 | 24
COVID19_PFIZER/BIONTECH | Metastases to specified sites | 6 | 0.51 | 1.10 | 1.87 | 5.6 | 0.53 | 0.99 | 1.72 | 1.07 | 1.07 | 0.50 | 23
COVID19_UNKNOWN MFR | Metastases to specified sites | 0 | 0.03 | 0.94 | 3.05 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Metastases to unknown and unspecified sites | 0 | 0.06 | 0.86 | 2.48 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Metastases to unknown and unspecified sites | 0 | 0.04 | 0.62 | 1.79 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metastases to unknown and unspecified sites | 2 | 0.52 | 1.83 | 3.79 | 0.8 | 0.50 | 1.26 | 2.88 | 8.19 | 8.19 | 1.09 | 1
COVID19_UNKNOWN MFR | Metastases to unknown and unspecified sites | 0 | 0.07 | 1.00 | 2.87 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Microbiology and serology tests NEC | 112 | 0.82 | 0.97 | 1.12 | 157.2 | 0.61 | 0.71 | 0.83 | 0.52 | 0.52 | 0.44 | 3346
COVID19_MODERNA | Microbiology and serology tests NEC | 361 | 0.79 | 0.86 | 0.94 | 513.6 | 0.65 | 0.70 | 0.77 | 0.40 | 0.39 | 0.36 | 3097
COVID19_PFIZER/BIONTECH | Microbiology and serology tests NEC | 427 | 1.00 | 1.08 | 1.17 | 510.9 | 0.77 | 0.84 | 0.90 | 0.58 | 0.57 | 0.53 | 3031
COVID19_UNKNOWN MFR | Microbiology and serology tests NEC | 3 | 0.39 | 0.98 | 1.79 | 4.1 | 0.33 | 0.75 | 1.49 | 0.60 | 0.60 | 0.23 | 3455
COVID19_JANSSEN | Middle ear disorders NEC | 10 | 0.86 | 1.46 | 2.18 | 6.0 | 0.87 | 1.43 | 2.26 | 1.98 | 1.98 | 1.14 | 78
COVID19_MODERNA | Middle ear disorders NEC | 17 | 0.50 | 0.75 | 1.05 | 23.3 | 0.50 | 0.74 | 1.06 | 0.81 | 0.81 | 0.52 | 71
COVID19_PFIZER/BIONTECH | Middle ear disorders NEC | 26 | 0.90 | 1.26 | 1.67 | 19.9 | 0.91 | 1.25 | 1.70 | 1.72 | 1.72 | 1.17 | 62
COVID19_UNKNOWN MFR | Middle ear disorders NEC | 0 | 0.26 | 0.96 | 2.01 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Middle ear infections and inflammations | 0 | 0.00 | 0.19 | 0.88 | 1.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Middle ear infections and inflammations | 2 | 0.21 | 1.02 | 2.34 | 2.1 | 0.34 | 0.86 | 1.85 | 0.23 | 0.23 | 0.07 | 30
COVID19_PFIZER/BIONTECH | Middle ear infections and inflammations | 0 | 0.00 | 0.09 | 0.40 | 2.9 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Middle ear infections and inflammations | 0 | 0.00 | 0.89 | 4.19 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Middle ear therapeutic procedures | 0 | 0.02 | 0.43 | 1.28 | 1.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Middle ear therapeutic procedures | 1 | 0.08 | 0.46 | 1.09 | 2.5 | 0.17 | 0.56 | 1.41 | 0.09 | 0.09 | 0.02 | 38
COVID19_PFIZER/BIONTECH | Middle ear therapeutic procedures | 0 | 0.01 | 0.21 | 0.62 | 3.9 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Middle ear therapeutic procedures | 0 | 0.06 | 0.97 | 2.85 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Migraine headaches | 813 | 2.11 | 2.24 | 2.37 | 407.2 | 1.88 | 1.99 | 2.11 | 2.96 | 3.00 | 2.82 | 4247
COVID19_MODERNA | Migraine headaches | 1550 | 1.08 | 1.12 | 1.17 | 1517.1 | 0.98 | 1.02 | 1.07 | 1.50 | 1.51 | 1.43 | 3510
COVID19_PFIZER/BIONTECH | Migraine headaches | 1476 | 1.19 | 1.25 | 1.30 | 1310.6 | 1.08 | 1.13 | 1.18 | 1.69 | 1.69 | 1.61 | 3584
COVID19_UNKNOWN MFR | Migraine headaches | 16 | 1.24 | 1.94 | 2.76 | 8.4 | 1.11 | 1.67 | 2.43 | 2.18 | 2.20 | 1.45 | 5044
COVID19_JANSSEN | Mineral and electrolyte analyses | 179 | 1.04 | 1.18 | 1.33 | 160.4 | 0.98 | 1.11 | 1.25 | 1.09 | 1.09 | 0.96 | 2544
COVID19_MODERNA | Mineral and electrolyte analyses | 593 | 0.90 | 0.96 | 1.03 | 630.1 | 0.88 | 0.94 | 1.01 | 0.95 | 0.95 | 0.88 | 2130
COVID19_PFIZER/BIONTECH | Mineral and electrolyte analyses | 708 | 1.25 | 1.33 | 1.41 | 556.0 | 1.20 | 1.27 | 1.35 | 1.44 | 1.44 | 1.34 | 2015
COVID19_UNKNOWN MFR | Mineral and electrolyte analyses | 9 | 1.07 | 1.92 | 2.98 | 4.0 | 1.01 | 1.72 | 2.81 | 2.28 | 2.29 | 1.32 | 2714
COVID19_JANSSEN | Mineral related disorders NEC | 0 | 0.07 | 0.91 | 2.54 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Mineral related disorders NEC | 1 | 0.27 | 1.33 | 3.04 | 0.3 | 0.36 | 1.11 | 2.97 | 3.40 | 3.40 | 0.33 | 1
COVID19_PFIZER/BIONTECH | Mineral related disorders NEC | 0 | 0.06 | 0.76 | 2.11 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mineral related disorders NEC | 0 | 0.08 | 1.00 | 2.79 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Mitral valvular disorders | 5 | 0.47 | 1.09 | 1.91 | 4.7 | 0.50 | 0.97 | 1.74 | 0.99 | 0.99 | 0.46 | 78
COVID19_MODERNA | Mitral valvular disorders | 22 | 0.76 | 1.11 | 1.51 | 21.1 | 0.72 | 1.02 | 1.41 | 1.23 | 1.23 | 0.81 | 61
COVID19_PFIZER/BIONTECH | Mitral valvular disorders | 29 | 1.23 | 1.71 | 2.25 | 17.7 | 1.14 | 1.54 | 2.06 | 2.20 | 2.20 | 1.51 | 54
COVID19_UNKNOWN MFR | Mitral valvular disorders | 0 | 0.04 | 0.88 | 2.68 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Mixed acid-base disorders | 1 | 0.15 | 0.73 | 1.66 | 2.0 | 0.20 | 0.63 | 1.56 | 0.34 | 0.34 | 0.07 | 45
COVID19_MODERNA | Mixed acid-base disorders | 7 | 0.53 | 1.05 | 1.71 | 6.9 | 0.53 | 0.96 | 1.61 | 0.61 | 0.61 | 0.31 | 39
COVID19_PFIZER/BIONTECH | Mixed acid-base disorders | 13 | 1.14 | 1.87 | 2.75 | 6.8 | 1.04 | 1.63 | 2.46 | 1.61 | 1.61 | 0.94 | 33
COVID19_UNKNOWN MFR | Mixed acid-base disorders | 0 | 0.09 | 0.96 | 2.62 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Mixed cranial nerve disorders | 1 | 0.20 | 1.12 | 2.65 | 0.9 | 0.28 | 0.86 | 2.13 | 1.40 | 1.40 | 0.25 | 11
COVID19_MODERNA | Mixed cranial nerve disorders | 1 | 0.14 | 0.81 | 1.93 | 2.1 | 0.19 | 0.62 | 1.54 | 0.31 | 0.31 | 0.06 | 11
COVID19_PFIZER/BIONTECH | Mixed cranial nerve disorders | 1 | 0.12 | 0.68 | 1.62 | 2.5 | 0.17 | 0.56 | 1.41 | 0.37 | 0.37 | 0.07 | 11
COVID19_UNKNOWN MFR | Mixed cranial nerve disorders | 0 | 0.05 | 0.98 | 2.93 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Molluscum contagiosum viral infections | 0 | 0.06 | 0.71 | 1.95 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Molluscum contagiosum viral infections | 0 | 0.05 | 0.56 | 1.56 | 1.0 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Molluscum contagiosum viral infections | 1 | 0.17 | 0.83 | 1.88 | 1.4 | 0.24 | 0.74 | 1.81 | 0.32 | 0.32 | 0.06 | 13
COVID19_UNKNOWN MFR | Molluscum contagiosum viral infections | 0 | 0.09 | 0.99 | 2.72 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Monoclonal antibody therapies | 0 | 0.02 | 0.80 | 2.68 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Monoclonal antibody therapies | 0 | 0.01 | 0.52 | 1.74 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Monoclonal antibody therapies | 3 | 0.92 | 2.82 | 5.56 | 0.8 | 0.71 | 1.69 | 4.16 | 28.65 | 28.65 | 2.38 | 0
COVID19_UNKNOWN MFR | Monoclonal antibody therapies | 0 | 0.02 | 0.99 | 3.32 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Mononeuropathies | 19 | 0.58 | 0.88 | 1.21 | 24.4 | 0.54 | 0.78 | 1.10 | 0.90 | 0.90 | 0.61 | 326
COVID19_MODERNA | Mononeuropathies | 40 | 0.37 | 0.49 | 0.62 | 90.6 | 0.35 | 0.45 | 0.58 | 0.45 | 0.45 | 0.34 | 305
COVID19_PFIZER/BIONTECH | Mononeuropathies | 85 | 0.98 | 1.18 | 1.40 | 78.8 | 0.90 | 1.07 | 1.27 | 1.34 | 1.34 | 1.09 | 260
COVID19_UNKNOWN MFR | Mononeuropathies | 1 | 0.30 | 1.21 | 2.62 | 0.6 | 0.32 | 0.98 | 2.46 | 2.00 | 2.00 | 0.39 | 344
COVID19_JANSSEN | Mood alterations with depressive symptoms | 36 | 0.89 | 1.20 | 1.53 | 33.3 | 0.81 | 1.06 | 1.38 | 0.90 | 0.90 | 0.68 | 621
COVID19_MODERNA | Mood alterations with depressive symptoms | 80 | 0.65 | 0.79 | 0.94 | 105.6 | 0.63 | 0.76 | 0.91 | 0.47 | 0.47 | 0.39 | 577
COVID19_PFIZER/BIONTECH | Mood alterations with depressive symptoms | 105 | 0.92 | 1.09 | 1.27 | 105.1 | 0.85 | 0.99 | 1.16 | 0.78 | 0.78 | 0.65 | 552
COVID19_UNKNOWN MFR | Mood alterations with depressive symptoms | 0 | 0.07 | 0.67 | 1.76 | 0.7 |  |  |  |  |  |  | 
COVID19_JANSSEN | Mood alterations with manic symptoms | 2 | 0.32 | 0.87 | 1.65 | 2.7 | 0.30 | 0.75 | 1.63 | 0.86 | 0.86 | 0.26 | 36
COVID19_MODERNA | Mood alterations with manic symptoms | 16 | 0.92 | 1.42 | 2.00 | 10.7 | 0.91 | 1.37 | 1.99 | 2.47 | 2.47 | 1.44 | 22
COVID19_PFIZER/BIONTECH | Mood alterations with manic symptoms | 9 | 0.57 | 1.00 | 1.53 | 9.3 | 0.55 | 0.93 | 1.49 | 1.27 | 1.27 | 0.68 | 29
COVID19_UNKNOWN MFR | Mood alterations with manic symptoms | 0 | 0.21 | 0.98 | 2.19 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Mood disorders NEC | 21 | 0.70 | 1.04 | 1.43 | 24.7 | 0.59 | 0.84 | 1.18 | 0.48 | 0.48 | 0.34 | 672
COVID19_MODERNA | Mood disorders NEC | 45 | 0.57 | 0.74 | 0.93 | 63.9 | 0.55 | 0.71 | 0.89 | 0.24 | 0.24 | 0.18 | 648
COVID19_PFIZER/BIONTECH | Mood disorders NEC | 37 | 0.44 | 0.59 | 0.76 | 75.9 | 0.38 | 0.50 | 0.64 | 0.23 | 0.23 | 0.18 | 656
COVID19_UNKNOWN MFR | Mood disorders NEC | 0 | 0.05 | 0.67 | 1.92 | 0.6 |  |  |  |  |  |  | 
COVID19_JANSSEN | Moraxella infections | 0 | 0.08 | 0.91 | 2.53 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Moraxella infections | 0 | 0.06 | 0.73 | 2.03 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Moraxella infections | 1 | 0.28 | 1.37 | 3.15 | 0.2 | 0.40 | 1.28 | 4.65 | 4.09 | 4.09 | 0.40 | 1
COVID19_UNKNOWN MFR | Moraxella infections | 0 | 0.08 | 1.00 | 2.78 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Motor neurone diseases | 1 | 0.03 | 0.30 | 0.82 | 4.8 | 0.09 | 0.35 | 0.93 | 0.22 | 0.22 | 0.04 | 70
COVID19_MODERNA | Motor neurone diseases | 4 | 0.12 | 0.34 | 0.65 | 13.1 | 0.17 | 0.37 | 0.71 | 0.20 | 0.20 | 0.09 | 67
COVID19_PFIZER/BIONTECH | Motor neurone diseases | 9 | 0.42 | 0.79 | 1.26 | 12.8 | 0.42 | 0.72 | 1.15 | 0.59 | 0.59 | 0.33 | 62
COVID19_UNKNOWN MFR | Motor neurone diseases | 0 | 0.00 | 0.79 | 3.37 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Mucosal findings abnormal | 14 | 0.94 | 1.50 | 2.17 | 9.4 | 0.88 | 1.35 | 2.01 | 1.44 | 1.44 | 0.91 | 150
COVID19_MODERNA | Mucosal findings abnormal | 19 | 0.44 | 0.66 | 0.91 | 30.0 | 0.44 | 0.65 | 0.91 | 0.45 | 0.45 | 0.30 | 145
COVID19_PFIZER/BIONTECH | Mucosal findings abnormal | 25 | 0.65 | 0.92 | 1.22 | 28.6 | 0.63 | 0.87 | 1.18 | 0.74 | 0.74 | 0.52 | 139
COVID19_UNKNOWN MFR | Mucosal findings abnormal | 0 | 0.14 | 0.90 | 2.19 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Multiple cardiac abnormalities congenital | 0 | 0.04 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Multiple cardiac abnormalities congenital | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Multiple cardiac abnormalities congenital | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Multiple cardiac abnormalities congenital | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Multiple pregnancies | 1 | 0.05 | 0.70 | 2.01 | 2.1 | 0.19 | 0.61 | 1.52 | 0.59 | 0.59 | 0.11 | 26
COVID19_MODERNA | Multiple pregnancies | 0 | 0.00 | 0.04 | 0.22 | 2.8 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Multiple pregnancies | 1 | 0.02 | 0.30 | 0.86 | 5.2 | 0.08 | 0.33 | 0.88 | 0.16 | 0.16 | 0.03 | 26
COVID19_UNKNOWN MFR | Multiple pregnancies | 0 | 0.00 | 0.72 | 4.13 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Multiple sclerosis acute and progressive | 9 | 0.19 | 0.36 | 0.57 | 35.0 | 0.17 | 0.29 | 0.46 | 0.29 | 0.29 | 0.17 | 482
COVID19_MODERNA | Multiple sclerosis acute and progressive | 38 | 0.41 | 0.54 | 0.70 | 84.8 | 0.35 | 0.46 | 0.59 | 0.28 | 0.28 | 0.22 | 453
COVID19_PFIZER/BIONTECH | Multiple sclerosis acute and progressive | 57 | 0.65 | 0.82 | 1.00 | 89.8 | 0.51 | 0.64 | 0.79 | 0.54 | 0.54 | 0.43 | 434
COVID19_UNKNOWN MFR | Multiple sclerosis acute and progressive | 0 | 0.00 | 0.39 | 1.64 | 0.6 |  |  |  |  |  |  | 
COVID19_JANSSEN | Mumps viral infections | 0 | 0.00 | 0.04 | 0.19 | 4.0 |  |  |  |  |  |  | 
COVID19_MODERNA | Mumps viral infections | 1 | 0.01 | 0.17 | 0.49 | 7.5 | 0.04 | 0.23 | 0.67 | 0.03 | 0.03 | 0.01 | 134
COVID19_PFIZER/BIONTECH | Mumps viral infections | 0 | 0.00 | 0.02 | 0.09 | 8.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mumps viral infections | 0 | 0.00 | 0.53 | 2.94 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Muscle and soft tissue infections | 1 | 0.07 | 0.46 | 1.13 | 4.3 | 0.10 | 0.38 | 1.01 | 0.17 | 0.17 | 0.03 | 91
COVID19_MODERNA | Muscle and soft tissue infections | 7 | 0.39 | 0.79 | 1.32 | 12.4 | 0.33 | 0.60 | 1.01 | 0.28 | 0.28 | 0.15 | 85
COVID19_PFIZER/BIONTECH | Muscle and soft tissue infections | 7 | 0.37 | 0.76 | 1.25 | 13.1 | 0.32 | 0.57 | 0.96 | 0.34 | 0.34 | 0.18 | 85
COVID19_UNKNOWN MFR | Muscle and soft tissue infections | 0 | 0.02 | 0.90 | 3.01 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Muscle infections and inflammations | 5 | 0.26 | 0.55 | 0.93 | 12.4 | 0.23 | 0.46 | 0.83 | 0.36 | 0.36 | 0.17 | 217
COVID19_MODERNA | Muscle infections and inflammations | 23 | 0.41 | 0.59 | 0.79 | 45.7 | 0.37 | 0.52 | 0.71 | 0.39 | 0.39 | 0.27 | 199
COVID19_PFIZER/BIONTECH | Muscle infections and inflammations | 21 | 0.41 | 0.61 | 0.83 | 41.2 | 0.37 | 0.53 | 0.73 | 0.43 | 0.43 | 0.29 | 201
COVID19_UNKNOWN MFR | Muscle infections and inflammations | 0 | 0.15 | 0.88 | 2.11 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Muscle pains | 3025 | 1.45 | 1.49 | 1.54 | 2241.9 | 1.31 | 1.35 | 1.39 | 1.71 | 1.77 | 1.71 | 27363
COVID19_MODERNA | Muscle pains | 8663 | 1.05 | 1.07 | 1.09 | 8969.1 | 0.95 | 0.97 | 0.98 | 1.35 | 1.38 | 1.35 | 21725
COVID19_PFIZER/BIONTECH | Muscle pains | 7676 | 1.11 | 1.13 | 1.16 | 7492.3 | 1.00 | 1.02 | 1.04 | 1.38 | 1.41 | 1.38 | 22712
COVID19_UNKNOWN MFR | Muscle pains | 59 | 1.01 | 1.26 | 1.53 | 51.3 | 0.92 | 1.14 | 1.39 | 1.34 | 1.36 | 1.09 | 30329
COVID19_JANSSEN | Muscle related signs and symptoms NEC | 1095 | 1.92 | 2.02 | 2.13 | 607.8 | 1.71 | 1.80 | 1.89 | 2.24 | 2.28 | 2.16 | 7551
COVID19_MODERNA | Muscle related signs and symptoms NEC | 1934 | 0.89 | 0.92 | 0.96 | 2316.0 | 0.80 | 0.84 | 0.87 | 0.98 | 0.98 | 0.94 | 6712
COVID19_PFIZER/BIONTECH | Muscle related signs and symptoms NEC | 2012 | 1.08 | 1.12 | 1.17 | 1993.3 | 0.97 | 1.01 | 1.05 | 1.24 | 1.25 | 1.19 | 6634
COVID19_UNKNOWN MFR | Muscle related signs and symptoms NEC | 21 | 1.08 | 1.57 | 2.13 | 13.6 | 1.00 | 1.44 | 2.00 | 1.68 | 1.69 | 1.18 | 8625
COVID19_JANSSEN | Muscle therapeutic procedures | 0 | 0.00 | 0.55 | 2.08 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Muscle therapeutic procedures | 0 | 0.00 | 0.24 | 0.93 | 1.6 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscle therapeutic procedures | 0 | 0.00 | 0.27 | 1.03 | 1.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle therapeutic procedures | 0 | 0.00 | 0.98 | 3.73 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Muscle tone abnormal | 12 | 0.27 | 0.44 | 0.66 | 48.9 | 0.17 | 0.27 | 0.41 | 0.10 | 0.10 | 0.06 | 1863
COVID19_MODERNA | Muscle tone abnormal | 39 | 0.45 | 0.60 | 0.76 | 84.5 | 0.36 | 0.47 | 0.60 | 0.07 | 0.07 | 0.06 | 1836
COVID19_PFIZER/BIONTECH | Muscle tone abnormal | 47 | 0.43 | 0.55 | 0.69 | 144.5 | 0.26 | 0.33 | 0.42 | 0.11 | 0.11 | 0.08 | 1828
COVID19_UNKNOWN MFR | Muscle tone abnormal | 0 | 0.10 | 0.69 | 1.72 | 0.8 |  |  |  |  |  |  | 
COVID19_JANSSEN | Muscle tone abnormalities | 38 | 0.79 | 1.04 | 1.33 | 40.6 | 0.71 | 0.93 | 1.19 | 0.81 | 0.81 | 0.62 | 723
COVID19_MODERNA | Muscle tone abnormalities | 99 | 0.74 | 0.87 | 1.02 | 122.5 | 0.68 | 0.81 | 0.95 | 0.51 | 0.51 | 0.43 | 662
COVID19_PFIZER/BIONTECH | Muscle tone abnormalities | 98 | 0.76 | 0.90 | 1.05 | 121.6 | 0.68 | 0.81 | 0.95 | 0.61 | 0.61 | 0.51 | 663
COVID19_UNKNOWN MFR | Muscle tone abnormalities | 1 | 0.28 | 1.07 | 2.26 | 0.9 | 0.29 | 0.86 | 2.13 | 0.91 | 0.91 | 0.17 | 760
COVID19_JANSSEN | Muscle weakness conditions | 390 | 0.98 | 1.07 | 1.16 | 433.9 | 0.83 | 0.90 | 0.98 | 0.97 | 0.97 | 0.89 | 6193
COVID19_MODERNA | Muscle weakness conditions | 1157 | 0.72 | 0.76 | 0.80 | 1724.6 | 0.64 | 0.67 | 0.70 | 0.72 | 0.72 | 0.68 | 5426
COVID19_PFIZER/BIONTECH | Muscle weakness conditions | 1236 | 0.92 | 0.97 | 1.01 | 1482.1 | 0.80 | 0.83 | 0.87 | 0.95 | 0.95 | 0.90 | 5347
COVID19_UNKNOWN MFR | Muscle weakness conditions | 10 | 0.63 | 1.11 | 1.71 | 10.5 | 0.56 | 0.93 | 1.46 | 1.05 | 1.05 | 0.62 | 6573
COVID19_JANSSEN | Muscle, tendon and ligament injuries | 26 | 0.65 | 0.91 | 1.20 | 30.9 | 0.61 | 0.84 | 1.13 | 0.97 | 0.97 | 0.69 | 415
COVID19_MODERNA | Muscle, tendon and ligament injuries | 54 | 0.40 | 0.50 | 0.62 | 115.9 | 0.38 | 0.47 | 0.59 | 0.47 | 0.47 | 0.37 | 387
COVID19_PFIZER/BIONTECH | Muscle, tendon and ligament injuries | 100 | 0.88 | 1.05 | 1.22 | 100.9 | 0.84 | 0.99 | 1.16 | 1.20 | 1.20 | 1.00 | 341
COVID19_UNKNOWN MFR | Muscle, tendon and ligament injuries | 0 | 0.21 | 0.80 | 1.71 | 0.7 |  |  |  |  |  |  | 
COVID19_JANSSEN | Musculoskeletal and connective tissue conditions NEC | 915 | 0.98 | 1.03 | 1.09 | 1087.5 | 0.80 | 0.84 | 0.89 | 0.87 | 0.87 | 0.82 | 16256
COVID19_MODERNA | Musculoskeletal and connective tissue conditions NEC | 3603 | 0.91 | 0.94 | 0.96 | 4668.7 | 0.75 | 0.77 | 0.79 | 0.90 | 0.90 | 0.87 | 13568
COVID19_PFIZER/BIONTECH | Musculoskeletal and connective tissue conditions NEC | 2573 | 0.79 | 0.81 | 0.84 | 3869.3 | 0.64 | 0.67 | 0.69 | 0.72 | 0.72 | 0.69 | 14598
COVID19_UNKNOWN MFR | Musculoskeletal and connective tissue conditions NEC | 19 | 0.62 | 0.90 | 1.23 | 26.4 | 0.50 | 0.73 | 1.02 | 0.76 | 0.76 | 0.52 | 17152
COVID19_JANSSEN | Musculoskeletal and connective tissue deformities of skull, face and buccal cavity | 3 | 0.28 | 0.68 | 1.21 | 5.8 | 0.26 | 0.59 | 1.18 | 0.54 | 0.54 | 0.21 | 86
COVID19_MODERNA | Musculoskeletal and connective tissue deformities of skull, face and buccal cavity | 12 | 0.46 | 0.75 | 1.09 | 17.5 | 0.44 | 0.70 | 1.06 | 0.53 | 0.53 | 0.32 | 77
COVID19_PFIZER/BIONTECH | Musculoskeletal and connective tissue deformities of skull, face and buccal cavity | 31 | 1.27 | 1.73 | 2.24 | 17.3 | 1.25 | 1.68 | 2.22 | 2.19 | 2.19 | 1.52 | 58
COVID19_UNKNOWN MFR | Musculoskeletal and connective tissue deformities of skull, face and buccal cavity | 1 | 0.41 | 1.32 | 2.65 | 0.1 | 0.40 | 1.32 | 5.24 | 7.82 | 7.82 | 1.50 | 88
COVID19_JANSSEN | Musculoskeletal and connective tissue disorders of face, neck and jaw congenital | 0 | 0.03 | 0.78 | 2.47 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Musculoskeletal and connective tissue disorders of face, neck and jaw congenital | 0 | 0.02 | 0.49 | 1.54 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Musculoskeletal and connective tissue disorders of face, neck and jaw congenital | 0 | 0.02 | 0.52 | 1.65 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Musculoskeletal and connective tissue disorders of face, neck and jaw congenital | 0 | 0.03 | 0.99 | 3.15 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Musculoskeletal and connective tissue disorders of limbs congenital | 0 | 0.01 | 0.35 | 1.15 | 1.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Musculoskeletal and connective tissue disorders of limbs congenital | 0 | 0.00 | 0.17 | 0.57 | 3.6 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Musculoskeletal and connective tissue disorders of limbs congenital | 1 | 0.06 | 0.40 | 0.99 | 2.9 | 0.15 | 0.51 | 1.29 | 0.14 | 0.14 | 0.03 | 29
COVID19_UNKNOWN MFR | Musculoskeletal and connective tissue disorders of limbs congenital | 0 | 0.02 | 0.96 | 3.18 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Musculoskeletal and connective tissue disorders of skull congenital | 0 | 0.00 | 0.38 | 1.42 | 0.9 |  |  |  |  |  |  | 
COVID19_MODERNA | Musculoskeletal and connective tissue disorders of skull congenital | 1 | 0.07 | 0.61 | 1.57 | 1.0 | 0.27 | 0.83 | 2.05 | 0.21 | 0.21 | 0.04 | 16
COVID19_PFIZER/BIONTECH | Musculoskeletal and connective tissue disorders of skull congenital | 1 | 0.06 | 0.52 | 1.36 | 1.6 | 0.23 | 0.70 | 1.73 | 0.26 | 0.26 | 0.05 | 16
COVID19_UNKNOWN MFR | Musculoskeletal and connective tissue disorders of skull congenital | 0 | 0.01 | 0.96 | 3.62 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Musculoskeletal and connective tissue disorders of trunk congenital (excl spine) | 1 | 0.34 | 1.87 | 4.44 | 0.1 | 0.42 | 1.40 | 7.00 | 46.31 | 46.32 | 3.16 | 0
COVID19_MODERNA | Musculoskeletal and connective tissue disorders of trunk congenital (excl spine) | 0 | 0.04 | 0.82 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Musculoskeletal and connective tissue disorders of trunk congenital (excl spine) | 0 | 0.04 | 0.84 | 2.50 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Musculoskeletal and connective tissue disorders of trunk congenital (excl spine) | 0 | 0.05 | 1.00 | 2.98 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Musculoskeletal and connective tissue infections and inflammations NEC | 0 | 0.07 | 0.43 | 1.06 | 2.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Musculoskeletal and connective tissue infections and inflammations NEC | 9 | 0.46 | 0.83 | 1.29 | 11.5 | 0.46 | 0.79 | 1.26 | 0.75 | 0.75 | 0.41 | 41
COVID19_PFIZER/BIONTECH | Musculoskeletal and connective tissue infections and inflammations NEC | 14 | 0.90 | 1.45 | 2.09 | 9.5 | 0.87 | 1.34 | 1.98 | 1.59 | 1.59 | 0.95 | 36
COVID19_UNKNOWN MFR | Musculoskeletal and connective tissue infections and inflammations NEC | 0 | 0.15 | 0.97 | 2.38 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Musculoskeletal and connective tissue pain and discomfort | 5494 | 1.26 | 1.29 | 1.32 | 4626.2 | 1.16 | 1.19 | 1.21 | 1.35 | 1.41 | 1.38 | 62816
COVID19_MODERNA | Musculoskeletal and connective tissue pain and discomfort | 18286 | 0.99 | 1.00 | 1.02 | 19835.1 | 0.91 | 0.92 | 0.93 | 1.24 | 1.28 | 1.26 | 50024
COVID19_PFIZER/BIONTECH | Musculoskeletal and connective tissue pain and discomfort | 13807 | 0.91 | 0.92 | 0.93 | 16307.0 | 0.84 | 0.85 | 0.86 | 1.04 | 1.04 | 1.02 | 54503
COVID19_UNKNOWN MFR | Musculoskeletal and connective tissue pain and discomfort | 117 | 0.98 | 1.15 | 1.33 | 110.7 | 0.90 | 1.05 | 1.22 | 1.18 | 1.21 | 1.03 | 68193
COVID19_JANSSEN | Musculoskeletal and soft tissue histopathology procedures | 4 | 0.20 | 0.51 | 0.94 | 10.3 | 0.22 | 0.46 | 0.86 | 0.37 | 0.37 | 0.16 | 166
COVID19_MODERNA | Musculoskeletal and soft tissue histopathology procedures | 10 | 0.22 | 0.39 | 0.61 | 31.7 | 0.21 | 0.35 | 0.55 | 0.21 | 0.21 | 0.12 | 160
COVID19_PFIZER/BIONTECH | Musculoskeletal and soft tissue histopathology procedures | 15 | 0.37 | 0.59 | 0.85 | 31.7 | 0.32 | 0.49 | 0.72 | 0.40 | 0.40 | 0.25 | 155
COVID19_UNKNOWN MFR | Musculoskeletal and soft tissue histopathology procedures | 0 | 0.02 | 0.77 | 2.51 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Musculoskeletal and soft tissue imaging procedures | 100 | 0.89 | 1.05 | 1.23 | 104.9 | 0.80 | 0.95 | 1.11 | 0.94 | 0.94 | 0.79 | 1641
COVID19_MODERNA | Musculoskeletal and soft tissue imaging procedures | 309 | 0.64 | 0.70 | 0.77 | 480.6 | 0.59 | 0.64 | 0.71 | 0.73 | 0.73 | 0.66 | 1432
COVID19_PFIZER/BIONTECH | Musculoskeletal and soft tissue imaging procedures | 328 | 0.83 | 0.91 | 1.00 | 394.4 | 0.76 | 0.83 | 0.91 | 0.95 | 0.95 | 0.86 | 1413
COVID19_UNKNOWN MFR | Musculoskeletal and soft tissue imaging procedures | 0 | 0.16 | 0.56 | 1.16 | 2.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Musculoskeletal and soft tissue tests NEC | 1 | 0.07 | 0.44 | 1.07 | 3.6 | 0.12 | 0.44 | 1.13 | 0.26 | 0.26 | 0.05 | 59
COVID19_MODERNA | Musculoskeletal and soft tissue tests NEC | 14 | 0.80 | 1.31 | 1.91 | 13.3 | 0.66 | 1.01 | 1.51 | 1.03 | 1.03 | 0.63 | 46
COVID19_PFIZER/BIONTECH | Musculoskeletal and soft tissue tests NEC | 5 | 0.23 | 0.54 | 0.95 | 12.2 | 0.24 | 0.47 | 0.84 | 0.37 | 0.37 | 0.17 | 55
COVID19_UNKNOWN MFR | Musculoskeletal and soft tissue tests NEC | 0 | 0.03 | 0.90 | 2.89 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Musculoskeletal disorders congenital NEC | 0 | 0.02 | 0.65 | 2.02 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Musculoskeletal disorders congenital NEC | 1 | 0.12 | 0.70 | 1.68 | 0.7 | 0.31 | 0.94 | 2.35 | 0.49 | 0.49 | 0.08 | 7
COVID19_PFIZER/BIONTECH | Musculoskeletal disorders congenital NEC | 0 | 0.01 | 0.36 | 1.13 | 1.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Musculoskeletal disorders congenital NEC | 0 | 0.04 | 0.99 | 3.08 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Mycobacteria identification and serology | 5 | 0.15 | 0.36 | 0.63 | 17.8 | 0.17 | 0.33 | 0.61 | 0.32 | 0.32 | 0.15 | 244
COVID19_MODERNA | Mycobacteria identification and serology | 24 | 0.37 | 0.53 | 0.72 | 49.6 | 0.36 | 0.50 | 0.68 | 0.36 | 0.36 | 0.25 | 225
COVID19_PFIZER/BIONTECH | Mycobacteria identification and serology | 27 | 0.44 | 0.62 | 0.83 | 48.9 | 0.41 | 0.56 | 0.76 | 0.50 | 0.50 | 0.36 | 222
COVID19_UNKNOWN MFR | Mycobacteria identification and serology | 0 | 0.02 | 0.69 | 2.26 | 0.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Mycoplasma infections | 0 | 0.00 | 0.31 | 1.14 | 1.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Mycoplasma infections | 1 | 0.05 | 0.42 | 1.07 | 1.9 | 0.21 | 0.65 | 1.60 | 0.08 | 0.08 | 0.02 | 41
COVID19_PFIZER/BIONTECH | Mycoplasma infections | 1 | 0.04 | 0.35 | 0.90 | 3.7 | 0.12 | 0.43 | 1.11 | 0.10 | 0.10 | 0.02 | 41
COVID19_UNKNOWN MFR | Mycoplasma infections | 0 | 0.01 | 0.95 | 3.51 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Mycoses fungoides | 0 | 0.06 | 0.77 | 2.15 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Mycoses fungoides | 0 | 0.04 | 0.48 | 1.32 | 1.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mycoses fungoides | 2 | 0.39 | 1.34 | 2.75 | 1.1 | 0.45 | 1.12 | 2.48 | 2.05 | 2.05 | 0.49 | 4
COVID19_UNKNOWN MFR | Mycoses fungoides | 0 | 0.08 | 0.99 | 2.76 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Myelitis (incl infective) | 15 | 0.52 | 0.82 | 1.18 | 20.7 | 0.48 | 0.73 | 1.07 | 0.77 | 0.77 | 0.50 | 301
COVID19_MODERNA | Myelitis (incl infective) | 28 | 0.33 | 0.47 | 0.61 | 66.8 | 0.32 | 0.43 | 0.58 | 0.33 | 0.33 | 0.24 | 288
COVID19_PFIZER/BIONTECH | Myelitis (incl infective) | 45 | 0.60 | 0.78 | 0.98 | 63.2 | 0.56 | 0.71 | 0.90 | 0.68 | 0.68 | 0.52 | 271
COVID19_UNKNOWN MFR | Myelitis (incl infective) | 1 | 0.31 | 1.24 | 2.68 | 0.5 | 0.34 | 1.01 | 2.57 | 2.18 | 2.19 | 0.42 | 315
COVID19_JANSSEN | Myelodysplastic syndromes | 0 | 0.01 | 0.55 | 1.90 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Myelodysplastic syndromes | 3 | 0.43 | 1.35 | 2.68 | 2.0 | 0.50 | 1.11 | 2.24 | 1.70 | 1.70 | 0.53 | 6
COVID19_PFIZER/BIONTECH | Myelodysplastic syndromes | 0 | 0.00 | 0.28 | 0.95 | 1.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myelodysplastic syndromes | 0 | 0.02 | 0.98 | 3.39 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Myeloproliferative disorders (excl leukaemias) | 1 | 0.28 | 1.40 | 3.22 | 0.3 | 0.36 | 1.11 | 2.97 | 3.09 | 3.09 | 0.51 | 5
COVID19_MODERNA | Myeloproliferative disorders (excl leukaemias) | 0 | 0.04 | 0.47 | 1.32 | 1.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myeloproliferative disorders (excl leukaemias) | 0 | 0.04 | 0.51 | 1.42 | 1.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myeloproliferative disorders (excl leukaemias) | 0 | 0.08 | 0.99 | 2.78 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Myocardial disorders NEC | 22 | 0.80 | 1.17 | 1.59 | 23.5 | 0.65 | 0.92 | 1.27 | 1.01 | 1.01 | 0.71 | 335
COVID19_MODERNA | Myocardial disorders NEC | 101 | 1.15 | 1.37 | 1.60 | 92.4 | 0.92 | 1.09 | 1.27 | 1.34 | 1.34 | 1.10 | 256
COVID19_PFIZER/BIONTECH | Myocardial disorders NEC | 140 | 1.93 | 2.23 | 2.55 | 79.8 | 1.50 | 1.73 | 1.98 | 2.64 | 2.64 | 2.21 | 217
COVID19_UNKNOWN MFR | Myocardial disorders NEC | 3 | 0.91 | 2.64 | 5.11 | 0.6 | 0.77 | 1.90 | 5.64 | 5.83 | 5.85 | 2.25 | 354
COVID19_JANSSEN | Myoneurogenic bladder disorders | 2 | 0.13 | 0.55 | 1.20 | 4.3 | 0.22 | 0.56 | 1.23 | 0.40 | 0.40 | 0.12 | 78
COVID19_MODERNA | Myoneurogenic bladder disorders | 12 | 0.42 | 0.71 | 1.07 | 18.5 | 0.42 | 0.66 | 1.01 | 0.60 | 0.60 | 0.36 | 68
COVID19_PFIZER/BIONTECH | Myoneurogenic bladder disorders | 16 | 0.69 | 1.09 | 1.57 | 16.1 | 0.65 | 0.97 | 1.41 | 1.02 | 1.02 | 0.65 | 64
COVID19_UNKNOWN MFR | Myoneurogenic bladder disorders | 1 | 0.30 | 2.18 | 5.50 | 0.1 | 0.41 | 1.34 | 5.65 | 8.71 | 8.72 | 1.66 | 79
COVID19_JANSSEN | Myopathies | 11 | 0.43 | 0.74 | 1.12 | 17.8 | 0.39 | 0.64 | 0.99 | 0.70 | 0.70 | 0.42 | 244
COVID19_MODERNA | Myopathies | 44 | 0.73 | 0.95 | 1.19 | 53.2 | 0.64 | 0.83 | 1.05 | 0.71 | 0.71 | 0.54 | 211
COVID19_PFIZER/BIONTECH | Myopathies | 48 | 0.85 | 1.09 | 1.36 | 51.3 | 0.73 | 0.93 | 1.17 | 0.95 | 0.95 | 0.73 | 207
COVID19_UNKNOWN MFR | Myopathies | 0 | 0.05 | 0.74 | 2.15 | 0.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Nail and nail bed conditions (excl infections and infestations) | 17 | 1.53 | 2.35 | 3.33 | 7.7 | 1.27 | 1.88 | 2.73 | 2.57 | 2.57 | 1.67 | 102
COVID19_MODERNA | Nail and nail bed conditions (excl infections and infestations) | 16 | 0.44 | 0.69 | 0.99 | 26.8 | 0.41 | 0.61 | 0.89 | 0.53 | 0.53 | 0.34 | 103
COVID19_PFIZER/BIONTECH | Nail and nail bed conditions (excl infections and infestations) | 22 | 0.72 | 1.05 | 1.44 | 24.2 | 0.63 | 0.90 | 1.24 | 0.93 | 0.93 | 0.63 | 97
COVID19_UNKNOWN MFR | Nail and nail bed conditions (excl infections and infestations) | 0 | 0.08 | 0.89 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Narcolepsy and associated conditions | 0 | 0.00 | 0.10 | 0.59 | 1.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Narcolepsy and associated conditions | 0 | 0.00 | 0.05 | 0.26 | 2.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Narcolepsy and associated conditions | 3 | 0.29 | 1.02 | 2.11 | 3.6 | 0.36 | 0.82 | 1.63 | 0.61 | 0.61 | 0.22 | 20
COVID19_UNKNOWN MFR | Narcolepsy and associated conditions | 0 | 0.00 | 0.83 | 4.69 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Narcolepsy and hypersomnia | 160 | 1.29 | 1.48 | 1.68 | 123.5 | 1.13 | 1.29 | 1.46 | 1.19 | 1.19 | 1.04 | 2075
COVID19_MODERNA | Narcolepsy and hypersomnia | 521 | 1.00 | 1.08 | 1.16 | 531.2 | 0.91 | 0.98 | 1.05 | 1.03 | 1.03 | 0.95 | 1714
COVID19_PFIZER/BIONTECH | Narcolepsy and hypersomnia | 429 | 0.99 | 1.07 | 1.16 | 449.5 | 0.88 | 0.95 | 1.03 | 0.97 | 0.97 | 0.89 | 1806
COVID19_UNKNOWN MFR | Narcolepsy and hypersomnia | 2 | 0.24 | 0.80 | 1.64 | 3.2 | 0.27 | 0.69 | 1.49 | 0.62 | 0.62 | 0.19 | 2233
COVID19_JANSSEN | Nasal congestion and inflammations | 220 | 1.18 | 1.33 | 1.48 | 195.5 | 1.00 | 1.12 | 1.25 | 1.36 | 1.36 | 1.21 | 2505
COVID19_MODERNA | Nasal congestion and inflammations | 735 | 1.11 | 1.18 | 1.25 | 742.1 | 0.93 | 0.99 | 1.05 | 1.25 | 1.25 | 1.17 | 1990
COVID19_PFIZER/BIONTECH | Nasal congestion and inflammations | 927 | 1.63 | 1.73 | 1.82 | 640.4 | 1.37 | 1.45 | 1.53 | 2.11 | 2.12 | 1.98 | 1798
COVID19_UNKNOWN MFR | Nasal congestion and inflammations | 10 | 1.18 | 2.02 | 3.04 | 4.4 | 1.07 | 1.79 | 2.86 | 2.53 | 2.55 | 1.51 | 2715
COVID19_JANSSEN | Nasal disorders NEC | 232 | 2.73 | 3.05 | 3.39 | 104.4 | 1.97 | 2.19 | 2.44 | 2.67 | 2.68 | 2.38 | 1343
COVID19_MODERNA | Nasal disorders NEC | 373 | 1.19 | 1.29 | 1.41 | 388.9 | 0.88 | 0.96 | 1.04 | 1.05 | 1.05 | 0.96 | 1202
COVID19_PFIZER/BIONTECH | Nasal disorders NEC | 490 | 1.82 | 1.96 | 2.11 | 341.0 | 1.33 | 1.43 | 1.54 | 1.85 | 1.85 | 1.69 | 1085
COVID19_UNKNOWN MFR | Nasal disorders NEC | 2 | 0.32 | 1.05 | 2.14 | 2.5 | 0.32 | 0.80 | 1.72 | 0.88 | 0.87 | 0.27 | 1573
COVID19_JANSSEN | Nasal therapeutic procedures | 2 | 0.44 | 1.76 | 3.80 | 1.0 | 0.46 | 1.15 | 2.56 | 1.72 | 1.72 | 0.50 | 18
COVID19_MODERNA | Nasal therapeutic procedures | 5 | 0.50 | 1.18 | 2.09 | 4.4 | 0.52 | 1.01 | 1.82 | 1.13 | 1.13 | 0.48 | 15
COVID19_PFIZER/BIONTECH | Nasal therapeutic procedures | 6 | 0.75 | 1.63 | 2.78 | 3.9 | 0.67 | 1.26 | 2.19 | 1.75 | 1.75 | 0.79 | 14
COVID19_UNKNOWN MFR | Nasal therapeutic procedures | 0 | 0.02 | 0.97 | 3.29 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Nausea and vomiting symptoms | 6985 | 1.60 | 1.63 | 1.67 | 4530.2 | 1.51 | 1.54 | 1.57 | 1.83 | 2.03 | 1.98 | 58799
COVID19_MODERNA | Nausea and vomiting symptoms | 18506 | 1.06 | 1.07 | 1.09 | 17911.5 | 1.02 | 1.03 | 1.05 | 1.33 | 1.38 | 1.36 | 47278
COVID19_PFIZER/BIONTECH | Nausea and vomiting symptoms | 16778 | 1.14 | 1.16 | 1.17 | 15158.8 | 1.09 | 1.11 | 1.12 | 1.40 | 1.47 | 1.44 | 49006
COVID19_UNKNOWN MFR | Nausea and vomiting symptoms | 142 | 1.25 | 1.44 | 1.64 | 101.5 | 1.21 | 1.39 | 1.59 | 1.49 | 1.58 | 1.36 | 65642
COVID19_JANSSEN | Necrosis NEC | 1 | 0.13 | 0.58 | 1.28 | 2.9 | 0.15 | 0.51 | 1.29 | 0.31 | 0.31 | 0.06 | 50
COVID19_MODERNA | Necrosis NEC | 2 | 0.11 | 0.37 | 0.74 | 8.0 | 0.13 | 0.35 | 0.79 | 0.14 | 0.14 | 0.04 | 49
COVID19_PFIZER/BIONTECH | Necrosis NEC | 5 | 0.30 | 0.66 | 1.14 | 8.4 | 0.32 | 0.64 | 1.14 | 0.45 | 0.45 | 0.21 | 46
COVID19_UNKNOWN MFR | Necrosis NEC | 0 | 0.11 | 0.95 | 2.49 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Neisseria infections | 0 | 0.00 | 0.01 | 0.05 | 13.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Neisseria infections | 1 | 0.00 | 0.06 | 0.16 | 13.8 | 0.01 | 0.10 | 0.38 | 0.01 | 0.01 | 0.00 | 312
COVID19_PFIZER/BIONTECH | Neisseria infections | 2 | 0.02 | 0.10 | 0.23 | 20.5 | 0.03 | 0.13 | 0.34 | 0.03 | 0.03 | 0.01 | 311
COVID19_UNKNOWN MFR | Neisseria infections | 0 | 0.00 | 0.25 | 1.44 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Nematode infections | 0 | 0.00 | 0.22 | 1.24 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Nematode infections | 1 | 0.04 | 0.58 | 1.66 | 1.3 | 0.25 | 0.77 | 1.90 | 0.38 | 0.38 | 0.07 | 9
COVID19_PFIZER/BIONTECH | Nematode infections | 1 | 0.05 | 0.67 | 1.90 | 1.6 | 0.23 | 0.70 | 1.72 | 0.46 | 0.46 | 0.08 | 9
COVID19_UNKNOWN MFR | Nematode infections | 0 | 0.00 | 0.92 | 5.15 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal disorders due to birth trauma (excl intracranial haemorrhages) | 0 | 0.00 | 0.51 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Neonatal disorders due to birth trauma (excl intracranial haemorrhages) | 0 | 0.00 | 0.22 | 1.05 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal disorders due to birth trauma (excl intracranial haemorrhages) | 0 | 0.00 | 0.25 | 1.18 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal disorders due to birth trauma (excl intracranial haemorrhages) | 0 | 0.00 | 0.98 | 4.70 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal gastrointestinal disorders | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Neonatal gastrointestinal disorders | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal gastrointestinal disorders | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal gastrointestinal disorders | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal hepatobiliary disorders | 0 | 0.00 | 0.06 | 0.34 | 1.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Neonatal hepatobiliary disorders | 0 | 0.00 | 0.03 | 0.20 | 2.3 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal hepatobiliary disorders | 0 | 0.00 | 0.02 | 0.14 | 3.3 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal hepatobiliary disorders | 0 | 0.00 | 0.69 | 4.01 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal hypoxic conditions | 1 | 0.07 | 0.36 | 0.85 | 7.1 | 0.05 | 0.24 | 0.70 | 0.07 | 0.07 | 0.01 | 224
COVID19_MODERNA | Neonatal hypoxic conditions | 3 | 0.14 | 0.41 | 0.79 | 11.1 | 0.15 | 0.35 | 0.71 | 0.05 | 0.05 | 0.02 | 222
COVID19_PFIZER/BIONTECH | Neonatal hypoxic conditions | 7 | 0.30 | 0.59 | 0.97 | 19.9 | 0.22 | 0.39 | 0.67 | 0.13 | 0.13 | 0.07 | 218
COVID19_UNKNOWN MFR | Neonatal hypoxic conditions | 0 | 0.06 | 0.89 | 2.57 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal metabolic and endocrine disorders | 0 | 0.01 | 0.78 | 2.74 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Neonatal metabolic and endocrine disorders | 0 | 0.01 | 0.48 | 1.70 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal metabolic and endocrine disorders | 0 | 0.01 | 0.52 | 1.83 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal metabolic and endocrine disorders | 0 | 0.01 | 0.99 | 3.52 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Neoplasms benign site unspecified NEC | 0 | 0.00 | 0.47 | 2.00 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Neoplasms benign site unspecified NEC | 0 | 0.00 | 0.19 | 0.82 | 1.6 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neoplasms benign site unspecified NEC | 0 | 0.00 | 0.22 | 0.92 | 1.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neoplasms benign site unspecified NEC | 0 | 0.00 | 0.97 | 4.10 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Neoplasms malignant site unspecified NEC | 2 | 0.08 | 0.31 | 0.66 | 10.2 | 0.09 | 0.28 | 0.64 | 0.19 | 0.19 | 0.06 | 166
COVID19_MODERNA | Neoplasms malignant site unspecified NEC | 13 | 0.42 | 0.69 | 1.02 | 20.9 | 0.41 | 0.64 | 0.96 | 0.28 | 0.28 | 0.18 | 155
COVID19_PFIZER/BIONTECH | Neoplasms malignant site unspecified NEC | 25 | 0.77 | 1.10 | 1.48 | 26.1 | 0.68 | 0.94 | 1.28 | 0.72 | 0.72 | 0.50 | 143
COVID19_UNKNOWN MFR | Neoplasms malignant site unspecified NEC | 0 | 0.03 | 0.78 | 2.43 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Neoplasms unspecified malignancy and site unspecified NEC | 0 | 0.00 | 0.19 | 0.85 | 1.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Neoplasms unspecified malignancy and site unspecified NEC | 1 | 0.03 | 0.32 | 0.87 | 5.4 | 0.07 | 0.32 | 0.86 | 0.11 | 0.11 | 0.02 | 30
COVID19_PFIZER/BIONTECH | Neoplasms unspecified malignancy and site unspecified NEC | 14 | 2.04 | 3.35 | 4.93 | 5.8 | 1.27 | 1.98 | 2.98 | 3.37 | 3.37 | 1.86 | 17
COVID19_UNKNOWN MFR | Neoplasms unspecified malignancy and site unspecified NEC | 0 | 0.00 | 0.90 | 4.01 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Nephritis NEC | 1 | 0.06 | 0.46 | 1.17 | 3.4 | 0.13 | 0.46 | 1.18 | 0.27 | 0.27 | 0.05 | 57
COVID19_MODERNA | Nephritis NEC | 4 | 0.18 | 0.48 | 0.89 | 9.0 | 0.24 | 0.51 | 0.97 | 0.25 | 0.25 | 0.11 | 54
COVID19_PFIZER/BIONTECH | Nephritis NEC | 2 | 0.07 | 0.28 | 0.61 | 9.2 | 0.11 | 0.31 | 0.70 | 0.15 | 0.15 | 0.05 | 56
COVID19_UNKNOWN MFR | Nephritis NEC | 0 | 0.01 | 0.89 | 3.27 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Nephropathies and tubular disorders NEC | 0 | 0.01 | 0.31 | 1.05 | 1.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Nephropathies and tubular disorders NEC | 3 | 0.19 | 0.60 | 1.20 | 6.2 | 0.25 | 0.56 | 1.12 | 0.33 | 0.33 | 0.12 | 31
COVID19_PFIZER/BIONTECH | Nephropathies and tubular disorders NEC | 10 | 1.04 | 1.87 | 2.90 | 5.9 | 0.87 | 1.44 | 2.28 | 1.71 | 1.71 | 0.92 | 24
COVID19_UNKNOWN MFR | Nephropathies and tubular disorders NEC | 0 | 0.01 | 0.94 | 3.23 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Nerve injuries NEC | 8 | 0.27 | 0.51 | 0.80 | 18.9 | 0.26 | 0.46 | 0.76 | 0.43 | 0.43 | 0.24 | 290
COVID19_MODERNA | Nerve injuries NEC | 25 | 0.28 | 0.39 | 0.53 | 70.8 | 0.26 | 0.37 | 0.50 | 0.31 | 0.31 | 0.22 | 273
COVID19_PFIZER/BIONTECH | Nerve injuries NEC | 38 | 0.51 | 0.68 | 0.86 | 61.7 | 0.48 | 0.62 | 0.80 | 0.60 | 0.60 | 0.45 | 260
COVID19_UNKNOWN MFR | Nerve injuries NEC | 0 | 0.10 | 0.78 | 2.02 | 0.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Nervous system cysts and polyps | 1 | 0.17 | 0.76 | 1.70 | 1.7 | 0.22 | 0.68 | 1.67 | 0.74 | 0.74 | 0.14 | 21
COVID19_MODERNA | Nervous system cysts and polyps | 5 | 0.57 | 1.26 | 2.16 | 3.4 | 0.61 | 1.19 | 2.15 | 1.00 | 1.00 | 0.43 | 17
COVID19_PFIZER/BIONTECH | Nervous system cysts and polyps | 2 | 0.19 | 0.60 | 1.21 | 4.2 | 0.23 | 0.58 | 1.26 | 0.41 | 0.41 | 0.12 | 20
COVID19_UNKNOWN MFR | Nervous system cysts and polyps | 0 | 0.11 | 0.97 | 2.55 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Nervous system disorders NEC | 28 | 0.62 | 0.87 | 1.15 | 41.0 | 0.50 | 0.69 | 0.92 | 0.63 | 0.63 | 0.46 | 691
COVID19_MODERNA | Nervous system disorders NEC | 33 | 0.27 | 0.36 | 0.47 | 104.1 | 0.25 | 0.33 | 0.43 | 0.16 | 0.16 | 0.12 | 686
COVID19_PFIZER/BIONTECH | Nervous system disorders NEC | 80 | 0.71 | 0.86 | 1.02 | 113.5 | 0.59 | 0.71 | 0.85 | 0.51 | 0.51 | 0.42 | 639
COVID19_UNKNOWN MFR | Nervous system disorders NEC | 0 | 0.03 | 0.54 | 1.65 | 0.8 |  |  |  |  |  |  | 
COVID19_JANSSEN | Nervous system neoplasms benign NEC | 0 | 0.00 | 0.53 | 1.97 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Nervous system neoplasms benign NEC | 2 | 0.25 | 1.08 | 2.37 | 0.8 | 0.51 | 1.28 | 2.96 | 1.13 | 1.13 | 0.30 | 6
COVID19_PFIZER/BIONTECH | Nervous system neoplasms benign NEC | 0 | 0.00 | 0.26 | 0.96 | 1.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nervous system neoplasms benign NEC | 0 | 0.01 | 0.98 | 3.66 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Nervous system neoplasms malignant NEC | 0 | 0.00 | 0.54 | 2.33 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Nervous system neoplasms malignant NEC | 0 | 0.00 | 0.24 | 1.03 | 1.1 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nervous system neoplasms malignant NEC | 0 | 0.00 | 0.27 | 1.15 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nervous system neoplasms malignant NEC | 0 | 0.00 | 0.98 | 4.23 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Nervous system neoplasms unspecified malignancy NEC | 5 | 0.87 | 1.88 | 3.22 | 1.9 | 0.83 | 1.64 | 3.11 | 2.21 | 2.21 | 1.00 | 35
COVID19_MODERNA | Nervous system neoplasms unspecified malignancy NEC | 4 | 0.27 | 0.62 | 1.11 | 7.5 | 0.28 | 0.59 | 1.11 | 0.38 | 0.38 | 0.16 | 36
COVID19_PFIZER/BIONTECH | Nervous system neoplasms unspecified malignancy NEC | 2 | 0.15 | 0.45 | 0.90 | 6.8 | 0.15 | 0.40 | 0.90 | 0.22 | 0.22 | 0.07 | 38
COVID19_UNKNOWN MFR | Nervous system neoplasms unspecified malignancy NEC | 0 | 0.14 | 0.97 | 2.43 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Nervous system therapeutic procedures NEC | 2 | 0.35 | 0.93 | 1.74 | 2.5 | 0.31 | 0.79 | 1.70 | 0.83 | 0.83 | 0.25 | 37
COVID19_MODERNA | Nervous system therapeutic procedures NEC | 6 | 0.47 | 0.91 | 1.47 | 7.5 | 0.43 | 0.80 | 1.38 | 0.62 | 0.62 | 0.30 | 33
COVID19_PFIZER/BIONTECH | Nervous system therapeutic procedures NEC | 3 | 0.25 | 0.60 | 1.07 | 7.3 | 0.22 | 0.50 | 1.00 | 0.34 | 0.34 | 0.13 | 36
COVID19_UNKNOWN MFR | Nervous system therapeutic procedures NEC | 1 | 0.43 | 1.35 | 2.68 | 0.1 | 0.43 | 1.50 | 9.07 | 18.10 | 18.12 | 3.42 | 38
COVID19_JANSSEN | Neurologic diagnostic procedures | 141 | 0.73 | 0.85 | 0.97 | 226.3 | 0.54 | 0.63 | 0.72 | 0.50 | 0.50 | 0.43 | 4345
COVID19_MODERNA | Neurologic diagnostic procedures | 342 | 0.53 | 0.57 | 0.63 | 737.9 | 0.43 | 0.46 | 0.51 | 0.28 | 0.28 | 0.25 | 4144
COVID19_PFIZER/BIONTECH | Neurologic diagnostic procedures | 474 | 0.80 | 0.87 | 0.93 | 717.6 | 0.61 | 0.66 | 0.71 | 0.48 | 0.48 | 0.44 | 4012
COVID19_UNKNOWN MFR | Neurologic diagnostic procedures | 9 | 1.07 | 1.96 | 3.06 | 5.3 | 0.84 | 1.42 | 2.28 | 1.38 | 1.39 | 0.80 | 4477
COVID19_JANSSEN | Neurologic visual problems NEC | 41 | 0.97 | 1.28 | 1.61 | 32.0 | 0.97 | 1.25 | 1.59 | 2.23 | 2.23 | 1.69 | 284
COVID19_MODERNA | Neurologic visual problems NEC | 84 | 0.74 | 0.89 | 1.05 | 93.7 | 0.75 | 0.89 | 1.06 | 1.18 | 1.18 | 0.96 | 241
COVID19_PFIZER/BIONTECH | Neurologic visual problems NEC | 128 | 1.28 | 1.48 | 1.71 | 85.1 | 1.28 | 1.48 | 1.71 | 2.66 | 2.66 | 2.21 | 197
COVID19_UNKNOWN MFR | Neurologic visual problems NEC | 1 | 0.29 | 1.19 | 2.60 | 0.6 | 0.33 | 0.98 | 2.47 | 2.12 | 2.12 | 0.41 | 324
COVID19_JANSSEN | Neurological and psychiatric procedural complications | 1 | 0.22 | 0.96 | 2.15 | 1.3 | 0.25 | 0.76 | 1.86 | 0.91 | 0.91 | 0.17 | 17
COVID19_MODERNA | Neurological and psychiatric procedural complications | 1 | 0.12 | 0.54 | 1.19 | 3.1 | 0.14 | 0.49 | 1.25 | 0.20 | 0.20 | 0.04 | 17
COVID19_PFIZER/BIONTECH | Neurological and psychiatric procedural complications | 2 | 0.23 | 0.76 | 1.53 | 3.3 | 0.26 | 0.67 | 1.45 | 0.51 | 0.51 | 0.15 | 16
COVID19_UNKNOWN MFR | Neurological and psychiatric procedural complications | 0 | 0.11 | 0.98 | 2.58 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Neurological disorders congenital NEC | 0 | 0.00 | 0.24 | 0.81 | 2.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Neurological disorders congenital NEC | 1 | 0.04 | 0.28 | 0.70 | 4.7 | 0.09 | 0.36 | 0.95 | 0.07 | 0.07 | 0.01 | 52
COVID19_PFIZER/BIONTECH | Neurological disorders congenital NEC | 7 | 0.54 | 1.11 | 1.84 | 6.1 | 0.58 | 1.05 | 1.76 | 0.62 | 0.62 | 0.32 | 46
COVID19_UNKNOWN MFR | Neurological disorders congenital NEC | 0 | 0.02 | 0.93 | 3.15 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Neurological signs and symptoms NEC | 6431 | 1.98 | 2.02 | 2.06 | 4069.9 | 1.55 | 1.58 | 1.61 | 2.03 | 2.25 | 2.20 | 48856
COVID19_MODERNA | Neurological signs and symptoms NEC | 14859 | 1.21 | 1.22 | 1.24 | 15234.1 | 0.96 | 0.98 | 0.99 | 1.25 | 1.28 | 1.26 | 40428
COVID19_PFIZER/BIONTECH | Neurological signs and symptoms NEC | 17265 | 1.65 | 1.67 | 1.69 | 13050.2 | 1.31 | 1.32 | 1.34 | 1.86 | 2.00 | 1.97 | 38022
COVID19_UNKNOWN MFR | Neurological signs and symptoms NEC | 102 | 1.22 | 1.44 | 1.68 | 87.7 | 0.98 | 1.15 | 1.35 | 1.27 | 1.31 | 1.10 | 55185
COVID19_JANSSEN | Neuromas | 0 | 0.01 | 0.74 | 2.53 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Neuromas | 0 | 0.01 | 0.43 | 1.48 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuromas | 2 | 0.45 | 1.82 | 3.95 | 0.6 | 0.54 | 1.39 | 3.41 | 4.09 | 4.09 | 0.79 | 2
COVID19_UNKNOWN MFR | Neuromas | 0 | 0.02 | 0.99 | 3.39 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Neuromuscular disorders NEC | 25 | 0.60 | 0.85 | 1.14 | 40.3 | 0.45 | 0.63 | 0.86 | 0.35 | 0.35 | 0.25 | 1104
COVID19_MODERNA | Neuromuscular disorders NEC | 50 | 0.44 | 0.56 | 0.70 | 99.9 | 0.40 | 0.51 | 0.63 | 0.16 | 0.16 | 0.12 | 1079
COVID19_PFIZER/BIONTECH | Neuromuscular disorders NEC | 56 | 0.52 | 0.65 | 0.80 | 113.7 | 0.40 | 0.50 | 0.62 | 0.21 | 0.21 | 0.17 | 1073
COVID19_UNKNOWN MFR | Neuromuscular disorders NEC | 1 | 0.23 | 1.15 | 2.62 | 1.0 | 0.28 | 0.84 | 2.08 | 0.61 | 0.61 | 0.12 | 1128
COVID19_JANSSEN | Neuromuscular junction dysfunction | 3 | 0.27 | 0.68 | 1.23 | 5.5 | 0.27 | 0.61 | 1.23 | 0.47 | 0.47 | 0.18 | 98
COVID19_MODERNA | Neuromuscular junction dysfunction | 22 | 0.72 | 1.04 | 1.41 | 22.5 | 0.68 | 0.96 | 1.33 | 0.95 | 0.95 | 0.64 | 79
COVID19_PFIZER/BIONTECH | Neuromuscular junction dysfunction | 22 | 0.79 | 1.14 | 1.54 | 19.9 | 0.76 | 1.07 | 1.48 | 1.14 | 1.14 | 0.77 | 79
COVID19_UNKNOWN MFR | Neuromuscular junction dysfunction | 0 | 0.18 | 0.93 | 2.16 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Neutropenias | 5 | 0.28 | 0.60 | 1.02 | 11.0 | 0.26 | 0.51 | 0.92 | 0.31 | 0.31 | 0.15 | 247
COVID19_MODERNA | Neutropenias | 19 | 0.52 | 0.78 | 1.08 | 26.0 | 0.51 | 0.74 | 1.04 | 0.28 | 0.28 | 0.19 | 233
COVID19_PFIZER/BIONTECH | Neutropenias | 30 | 0.79 | 1.09 | 1.43 | 31.3 | 0.70 | 0.95 | 1.26 | 0.55 | 0.55 | 0.40 | 222
COVID19_UNKNOWN MFR | Neutropenias | 0 | 0.12 | 0.87 | 2.18 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Newborn complications NEC | 0 | 0.00 | 0.10 | 0.47 | 2.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Newborn complications NEC | 1 | 0.02 | 0.17 | 0.46 | 9.7 | 0.03 | 0.17 | 0.54 | 0.09 | 0.09 | 0.02 | 39
COVID19_PFIZER/BIONTECH | Newborn complications NEC | 1 | 0.02 | 0.17 | 0.47 | 9.2 | 0.03 | 0.18 | 0.56 | 0.11 | 0.11 | 0.02 | 39
COVID19_UNKNOWN MFR | Newborn complications NEC | 0 | 0.00 | 0.83 | 3.89 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Newborn respiratory disorders NEC | 0 | 0.00 | 0.52 | 2.05 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Newborn respiratory disorders NEC | 0 | 0.00 | 0.22 | 0.89 | 1.6 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Newborn respiratory disorders NEC | 1 | 0.09 | 0.80 | 2.09 | 0.5 | 0.34 | 1.01 | 2.57 | 0.68 | 0.68 | 0.12 | 6
COVID19_UNKNOWN MFR | Newborn respiratory disorders NEC | 0 | 0.00 | 0.98 | 3.87 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Nocardia infections | 0 | 0.04 | 0.89 | 2.71 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Nocardia infections | 0 | 0.03 | 0.68 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nocardia infections | 0 | 0.03 | 0.71 | 2.16 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nocardia infections | 0 | 0.04 | 1.00 | 3.05 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Non-Hodgkin's lymphomas NEC | 0 | 0.01 | 0.35 | 1.22 | 1.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Non-Hodgkin's lymphomas NEC | 0 | 0.00 | 0.25 | 0.87 | 2.0 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Non-Hodgkin's lymphomas NEC | 2 | 0.20 | 0.81 | 1.75 | 2.1 | 0.35 | 0.87 | 1.88 | 0.59 | 0.59 | 0.17 | 14
COVID19_UNKNOWN MFR | Non-Hodgkin's lymphomas NEC | 0 | 0.01 | 0.95 | 3.30 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Non-mechanical ileus | 0 | 0.11 | 0.71 | 1.75 | 0.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Non-mechanical ileus | 1 | 0.17 | 0.67 | 1.43 | 2.3 | 0.18 | 0.58 | 1.44 | 0.28 | 0.28 | 0.05 | 12
COVID19_PFIZER/BIONTECH | Non-mechanical ileus | 2 | 0.31 | 0.93 | 1.84 | 2.5 | 0.32 | 0.79 | 1.71 | 0.74 | 0.74 | 0.21 | 11
COVID19_UNKNOWN MFR | Non-mechanical ileus | 0 | 0.15 | 0.99 | 2.44 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Non-occupational and unspecified environmental problems | 1 | 0.24 | 1.07 | 2.39 | 0.9 | 0.29 | 0.88 | 2.18 | 1.29 | 1.29 | 0.23 | 12
COVID19_MODERNA | Non-occupational and unspecified environmental problems | 6 | 0.68 | 1.41 | 2.35 | 3.8 | 0.69 | 1.29 | 2.25 | 2.91 | 2.91 | 1.17 | 7
COVID19_PFIZER/BIONTECH | Non-occupational and unspecified environmental problems | 5 | 0.66 | 1.45 | 2.51 | 3.0 | 0.66 | 1.29 | 2.33 | 2.56 | 2.56 | 1.00 | 8
COVID19_UNKNOWN MFR | Non-occupational and unspecified environmental problems | 0 | 0.11 | 0.99 | 2.60 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Non-occupational environmental exposures | 1 | 0.26 | 1.01 | 2.14 | 1.1 | 0.27 | 0.82 | 2.02 | 1.54 | 1.54 | 0.28 | 10
COVID19_MODERNA | Non-occupational environmental exposures | 5 | 0.61 | 1.31 | 2.23 | 3.1 | 0.65 | 1.27 | 2.31 | 2.83 | 2.83 | 1.05 | 6
COVID19_PFIZER/BIONTECH | Non-occupational environmental exposures | 1 | 0.15 | 0.59 | 1.25 | 2.9 | 0.15 | 0.51 | 1.30 | 0.41 | 0.41 | 0.07 | 10
COVID19_UNKNOWN MFR | Non-occupational environmental exposures | 0 | 0.16 | 0.99 | 2.40 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Non-site specific bone disorders congenital | 0 | 0.03 | 0.82 | 2.61 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Non-site specific bone disorders congenital | 0 | 0.02 | 0.56 | 1.76 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Non-site specific bone disorders congenital | 0 | 0.02 | 0.59 | 1.88 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Non-site specific bone disorders congenital | 0 | 0.03 | 1.00 | 3.15 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Non-site specific embolism and thrombosis | 514 | 7.16 | 7.71 | 8.27 | 111.8 | 4.25 | 4.58 | 4.92 | 6.92 | 7.01 | 6.42 | 1146
COVID19_MODERNA | Non-site specific embolism and thrombosis | 387 | 1.21 | 1.32 | 1.43 | 460.1 | 0.77 | 0.84 | 0.91 | 1.03 | 1.03 | 0.94 | 1273
COVID19_PFIZER/BIONTECH | Non-site specific embolism and thrombosis | 640 | 2.45 | 2.62 | 2.79 | 391.9 | 1.53 | 1.63 | 1.74 | 2.57 | 2.58 | 2.37 | 1020
COVID19_UNKNOWN MFR | Non-site specific embolism and thrombosis | 7 | 1.53 | 3.15 | 5.25 | 2.9 | 0.95 | 1.73 | 3.01 | 2.91 | 2.93 | 1.57 | 1653
COVID19_JANSSEN | Non-site specific gastrointestinal haemorrhages | 64 | 0.96 | 1.19 | 1.44 | 62.1 | 0.83 | 1.02 | 1.25 | 0.59 | 0.59 | 0.48 | 1678
COVID19_MODERNA | Non-site specific gastrointestinal haemorrhages | 171 | 0.88 | 1.00 | 1.14 | 178.2 | 0.84 | 0.96 | 1.08 | 0.37 | 0.37 | 0.32 | 1571
COVID19_PFIZER/BIONTECH | Non-site specific gastrointestinal haemorrhages | 243 | 1.28 | 1.42 | 1.58 | 204.6 | 1.06 | 1.18 | 1.31 | 0.66 | 0.66 | 0.59 | 1499
COVID19_UNKNOWN MFR | Non-site specific gastrointestinal haemorrhages | 5 | 1.09 | 2.50 | 4.39 | 1.7 | 0.88 | 1.76 | 3.41 | 1.98 | 1.99 | 0.95 | 1737
COVID19_JANSSEN | Non-site specific injuries NEC | 555 | 1.66 | 1.78 | 1.90 | 364.7 | 1.41 | 1.52 | 1.63 | 1.62 | 1.62 | 1.51 | 5305
COVID19_MODERNA | Non-site specific injuries NEC | 1215 | 1.00 | 1.05 | 1.10 | 1301.7 | 0.89 | 0.93 | 0.98 | 0.89 | 0.89 | 0.84 | 4645
COVID19_PFIZER/BIONTECH | Non-site specific injuries NEC | 1255 | 1.17 | 1.23 | 1.29 | 1162.2 | 1.03 | 1.08 | 1.13 | 1.12 | 1.12 | 1.06 | 4605
COVID19_UNKNOWN MFR | Non-site specific injuries NEC | 5 | 0.38 | 0.76 | 1.24 | 8.7 | 0.32 | 0.62 | 1.12 | 0.59 | 0.59 | 0.28 | 5855
COVID19_JANSSEN | Non-site specific muscle disorders congenital | 0 | 0.16 | 0.79 | 1.80 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Non-site specific muscle disorders congenital | 2 | 0.40 | 1.12 | 2.15 | 1.7 | 0.38 | 0.95 | 2.07 | 0.62 | 0.62 | 0.17 | 11
COVID19_PFIZER/BIONTECH | Non-site specific muscle disorders congenital | 1 | 0.24 | 0.81 | 1.66 | 1.8 | 0.22 | 0.67 | 1.66 | 0.34 | 0.34 | 0.06 | 12
COVID19_UNKNOWN MFR | Non-site specific muscle disorders congenital | 0 | 0.20 | 0.99 | 2.27 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Non-site specific necrosis and vascular insufficiency NEC | 26 | 1.84 | 2.60 | 3.47 | 10.4 | 1.59 | 2.21 | 3.01 | 2.77 | 2.77 | 1.95 | 145
COVID19_MODERNA | Non-site specific necrosis and vascular insufficiency NEC | 40 | 0.82 | 1.08 | 1.37 | 42.7 | 0.72 | 0.93 | 1.19 | 1.04 | 1.04 | 0.77 | 131
COVID19_PFIZER/BIONTECH | Non-site specific necrosis and vascular insufficiency NEC | 52 | 1.26 | 1.60 | 1.98 | 37.5 | 1.08 | 1.35 | 1.68 | 1.79 | 1.79 | 1.36 | 119
COVID19_UNKNOWN MFR | Non-site specific necrosis and vascular insufficiency NEC | 0 | 0.11 | 0.86 | 2.23 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Non-site specific procedural complications | 9 | 0.71 | 1.26 | 1.95 | 6.6 | 0.72 | 1.22 | 1.96 | 1.40 | 1.40 | 0.79 | 99
COVID19_MODERNA | Non-site specific procedural complications | 27 | 0.75 | 1.05 | 1.39 | 25.4 | 0.76 | 1.04 | 1.40 | 1.13 | 1.13 | 0.79 | 81
COVID19_PFIZER/BIONTECH | Non-site specific procedural complications | 20 | 0.61 | 0.90 | 1.23 | 22.5 | 0.61 | 0.88 | 1.24 | 0.93 | 0.93 | 0.62 | 88
COVID19_UNKNOWN MFR | Non-site specific procedural complications | 0 | 0.16 | 0.92 | 2.18 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Non-site specific vascular disorders NEC | 80 | 3.16 | 3.83 | 4.55 | 23.9 | 2.63 | 3.19 | 3.85 | 3.72 | 3.73 | 3.04 | 332
COVID19_MODERNA | Non-site specific vascular disorders NEC | 63 | 0.69 | 0.86 | 1.04 | 86.8 | 0.59 | 0.73 | 0.89 | 0.61 | 0.61 | 0.49 | 349
COVID19_PFIZER/BIONTECH | Non-site specific vascular disorders NEC | 81 | 1.02 | 1.23 | 1.46 | 78.9 | 0.85 | 1.02 | 1.22 | 1.00 | 1.00 | 0.82 | 331
COVID19_UNKNOWN MFR | Non-site specific vascular disorders NEC | 1 | 0.32 | 1.21 | 2.54 | 0.6 | 0.32 | 0.97 | 2.45 | 1.67 | 1.67 | 0.32 | 411
COVID19_JANSSEN | Non-small cell neoplasms malignant of the respiratory tract cell type specified | 0 | 0.00 | 0.13 | 0.70 | 1.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Non-small cell neoplasms malignant of the respiratory tract cell type specified | 2 | 0.12 | 0.64 | 1.48 | 4.3 | 0.22 | 0.57 | 1.24 | 0.40 | 0.40 | 0.12 | 17
COVID19_PFIZER/BIONTECH | Non-small cell neoplasms malignant of the respiratory tract cell type specified | 0 | 0.00 | 0.05 | 0.27 | 3.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Non-small cell neoplasms malignant of the respiratory tract cell type specified | 0 | 0.00 | 0.85 | 4.66 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Noninfectious myocarditis | 11 | 0.15 | 0.26 | 0.40 | 67.9 | 0.11 | 0.18 | 0.28 | 0.30 | 0.30 | 0.18 | 573
COVID19_MODERNA | Noninfectious myocarditis | 130 | 1.27 | 1.48 | 1.70 | 133.9 | 0.84 | 0.97 | 1.11 | 0.97 | 0.97 | 0.83 | 454
COVID19_PFIZER/BIONTECH | Noninfectious myocarditis | 268 | 2.80 | 3.10 | 3.42 | 131.2 | 1.83 | 2.02 | 2.23 | 3.47 | 3.48 | 3.03 | 316
COVID19_UNKNOWN MFR | Noninfectious myocarditis | 1 | 0.17 | 1.10 | 2.70 | 1.3 | 0.25 | 0.77 | 1.89 | 1.18 | 1.18 | 0.23 | 583
COVID19_JANSSEN | Noninfectious pericarditis | 17 | 0.45 | 0.70 | 0.99 | 37.5 | 0.32 | 0.47 | 0.68 | 0.67 | 0.67 | 0.45 | 390
COVID19_MODERNA | Noninfectious pericarditis | 94 | 1.18 | 1.41 | 1.66 | 95.3 | 0.83 | 0.98 | 1.16 | 1.02 | 1.02 | 0.84 | 313
COVID19_PFIZER/BIONTECH | Noninfectious pericarditis | 147 | 2.06 | 2.37 | 2.70 | 89.8 | 1.41 | 1.62 | 1.85 | 2.31 | 2.32 | 1.95 | 260
COVID19_UNKNOWN MFR | Noninfectious pericarditis | 2 | 0.54 | 2.27 | 4.98 | 0.8 | 0.50 | 1.26 | 2.87 | 3.40 | 3.40 | 1.06 | 405
COVID19_JANSSEN | Normal pregnancy, labour and delivery | 15 | 0.41 | 0.66 | 0.96 | 31.2 | 0.33 | 0.50 | 0.74 | 0.68 | 0.68 | 0.44 | 343
COVID19_MODERNA | Normal pregnancy, labour and delivery | 71 | 0.68 | 0.84 | 1.01 | 116.2 | 0.51 | 0.61 | 0.74 | 0.84 | 0.84 | 0.68 | 287
COVID19_PFIZER/BIONTECH | Normal pregnancy, labour and delivery | 72 | 0.78 | 0.95 | 1.15 | 103.3 | 0.57 | 0.70 | 0.84 | 1.03 | 1.03 | 0.83 | 286
COVID19_UNKNOWN MFR | Normal pregnancy, labour and delivery | 0 | 0.00 | 0.38 | 1.72 | 0.5 |  |  |  |  |  |  | 
COVID19_JANSSEN | Obsessive-compulsive disorders and symptoms | 1 | 0.14 | 0.65 | 1.49 | 2.3 | 0.18 | 0.59 | 1.46 | 0.15 | 0.15 | 0.03 | 101
COVID19_MODERNA | Obsessive-compulsive disorders and symptoms | 2 | 0.14 | 0.49 | 1.00 | 5.2 | 0.19 | 0.50 | 1.09 | 0.07 | 0.07 | 0.02 | 100
COVID19_PFIZER/BIONTECH | Obsessive-compulsive disorders and symptoms | 4 | 0.25 | 0.61 | 1.10 | 7.9 | 0.27 | 0.56 | 1.06 | 0.17 | 0.17 | 0.07 | 98
COVID19_UNKNOWN MFR | Obsessive-compulsive disorders and symptoms | 0 | 0.08 | 0.96 | 2.64 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Obstetric therapeutic procedures | 3 | 0.04 | 0.14 | 0.28 | 28.2 | 0.05 | 0.13 | 0.30 | 0.13 | 0.13 | 0.05 | 346
COVID19_MODERNA | Obstetric therapeutic procedures | 9 | 0.07 | 0.13 | 0.21 | 76.5 | 0.07 | 0.13 | 0.21 | 0.09 | 0.09 | 0.05 | 340
COVID19_PFIZER/BIONTECH | Obstetric therapeutic procedures | 17 | 0.16 | 0.24 | 0.35 | 80.0 | 0.15 | 0.23 | 0.33 | 0.21 | 0.21 | 0.14 | 332
COVID19_UNKNOWN MFR | Obstetric therapeutic procedures | 0 | 0.00 | 0.17 | 0.95 | 0.8 |  |  |  |  |  |  | 
COVID19_JANSSEN | Obstructive bile duct disorders (excl neoplasms) | 2 | 0.49 | 1.32 | 2.49 | 1.0 | 0.46 | 1.16 | 2.57 | 2.57 | 2.57 | 0.73 | 12
COVID19_MODERNA | Obstructive bile duct disorders (excl neoplasms) | 2 | 0.36 | 0.96 | 1.81 | 3.4 | 0.26 | 0.66 | 1.44 | 0.57 | 0.57 | 0.16 | 12
COVID19_PFIZER/BIONTECH | Obstructive bile duct disorders (excl neoplasms) | 4 | 0.60 | 1.32 | 2.27 | 3.2 | 0.51 | 1.05 | 1.98 | 1.64 | 1.64 | 0.62 | 10
COVID19_UNKNOWN MFR | Obstructive bile duct disorders (excl neoplasms) | 0 | 0.23 | 0.99 | 2.20 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Occupational exposures | 1 | 0.04 | 0.25 | 0.61 | 7.9 | 0.04 | 0.22 | 0.64 | 0.15 | 0.15 | 0.03 | 104
COVID19_MODERNA | Occupational exposures | 5 | 0.18 | 0.42 | 0.74 | 15.2 | 0.19 | 0.38 | 0.70 | 0.17 | 0.17 | 0.08 | 100
COVID19_PFIZER/BIONTECH | Occupational exposures | 27 | 1.17 | 1.65 | 2.20 | 19.0 | 0.99 | 1.35 | 1.82 | 1.42 | 1.42 | 0.98 | 78
COVID19_UNKNOWN MFR | Occupational exposures | 0 | 0.02 | 0.82 | 2.66 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ocular bleeding and vascular disorders NEC | 28 | 1.86 | 2.59 | 3.43 | 14.5 | 1.30 | 1.78 | 2.38 | 2.16 | 2.16 | 1.55 | 200
COVID19_MODERNA | Ocular bleeding and vascular disorders NEC | 71 | 1.34 | 1.64 | 1.98 | 62.4 | 0.92 | 1.13 | 1.36 | 1.54 | 1.54 | 1.21 | 157
COVID19_PFIZER/BIONTECH | Ocular bleeding and vascular disorders NEC | 91 | 2.11 | 2.52 | 2.97 | 51.5 | 1.45 | 1.72 | 2.04 | 2.72 | 2.72 | 2.18 | 137
COVID19_UNKNOWN MFR | Ocular bleeding and vascular disorders NEC | 1 | 0.30 | 1.49 | 3.42 | 0.4 | 0.36 | 1.08 | 2.85 | 3.03 | 3.03 | 0.58 | 227
COVID19_JANSSEN | Ocular cysts and polyps | 0 | 0.04 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Ocular cysts and polyps | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ocular cysts and polyps | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ocular cysts and polyps | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ocular disorders NEC | 505 | 1.22 | 1.31 | 1.41 | 389.8 | 1.20 | 1.29 | 1.39 | 1.50 | 1.51 | 1.40 | 5186
COVID19_MODERNA | Ocular disorders NEC | 1364 | 0.85 | 0.89 | 0.93 | 1554.8 | 0.84 | 0.88 | 0.92 | 1.07 | 1.07 | 1.02 | 4327
COVID19_PFIZER/BIONTECH | Ocular disorders NEC | 1603 | 1.18 | 1.23 | 1.28 | 1319.8 | 1.17 | 1.21 | 1.26 | 1.61 | 1.61 | 1.54 | 4088
COVID19_UNKNOWN MFR | Ocular disorders NEC | 8 | 0.57 | 0.95 | 1.41 | 8.9 | 0.51 | 0.88 | 1.44 | 0.97 | 0.97 | 0.54 | 5683
COVID19_JANSSEN | Ocular disorders congenital NEC | 1 | 0.11 | 0.93 | 2.42 | 1.4 | 0.24 | 0.74 | 1.82 | 0.81 | 0.81 | 0.15 | 19
COVID19_MODERNA | Ocular disorders congenital NEC | 2 | 0.17 | 0.74 | 1.64 | 3.4 | 0.26 | 0.67 | 1.45 | 0.38 | 0.38 | 0.11 | 18
COVID19_PFIZER/BIONTECH | Ocular disorders congenital NEC | 1 | 0.05 | 0.41 | 1.07 | 3.7 | 0.12 | 0.43 | 1.12 | 0.22 | 0.22 | 0.04 | 19
COVID19_UNKNOWN MFR | Ocular disorders congenital NEC | 0 | 0.00 | 0.94 | 3.67 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ocular infections, inflammations and associated manifestations | 199 | 0.90 | 1.01 | 1.13 | 208.5 | 0.85 | 0.95 | 1.07 | 1.04 | 1.04 | 0.92 | 2948
COVID19_MODERNA | Ocular infections, inflammations and associated manifestations | 688 | 0.82 | 0.87 | 0.93 | 852.3 | 0.76 | 0.81 | 0.86 | 0.95 | 0.95 | 0.89 | 2459
COVID19_PFIZER/BIONTECH | Ocular infections, inflammations and associated manifestations | 796 | 1.12 | 1.19 | 1.26 | 717.0 | 1.05 | 1.11 | 1.18 | 1.39 | 1.39 | 1.30 | 2351
COVID19_UNKNOWN MFR | Ocular infections, inflammations and associated manifestations | 2 | 0.32 | 0.71 | 1.22 | 5.0 | 0.20 | 0.51 | 1.12 | 0.44 | 0.44 | 0.14 | 3145
COVID19_JANSSEN | Ocular nerve and muscle disorders | 164 | 1.69 | 1.93 | 2.18 | 102.2 | 1.39 | 1.59 | 1.80 | 1.22 | 1.22 | 1.06 | 2083
COVID19_MODERNA | Ocular nerve and muscle disorders | 208 | 0.77 | 0.87 | 0.97 | 280.6 | 0.66 | 0.74 | 0.83 | 0.35 | 0.35 | 0.31 | 2039
COVID19_PFIZER/BIONTECH | Ocular nerve and muscle disorders | 229 | 0.83 | 0.93 | 1.03 | 297.9 | 0.69 | 0.77 | 0.86 | 0.46 | 0.46 | 0.41 | 2018
COVID19_UNKNOWN MFR | Ocular nerve and muscle disorders | 1 | 0.31 | 0.84 | 1.59 | 2.2 | 0.18 | 0.59 | 1.48 | 0.31 | 0.31 | 0.06 | 2246
COVID19_JANSSEN | Ocular sensation disorders | 201 | 1.33 | 1.50 | 1.68 | 149.1 | 1.19 | 1.34 | 1.50 | 1.59 | 1.60 | 1.41 | 1948
COVID19_MODERNA | Ocular sensation disorders | 497 | 0.91 | 0.99 | 1.06 | 539.5 | 0.86 | 0.92 | 0.99 | 1.02 | 1.02 | 0.94 | 1652
COVID19_PFIZER/BIONTECH | Ocular sensation disorders | 469 | 1.00 | 1.08 | 1.16 | 477.2 | 0.91 | 0.98 | 1.06 | 1.14 | 1.14 | 1.05 | 1680
COVID19_UNKNOWN MFR | Ocular sensation disorders | 3 | 0.34 | 1.02 | 2.00 | 3.2 | 0.39 | 0.87 | 1.74 | 0.96 | 0.96 | 0.37 | 2146
COVID19_JANSSEN | Oedema NEC | 95 | 0.62 | 0.74 | 0.86 | 148.7 | 0.54 | 0.64 | 0.76 | 0.63 | 0.63 | 0.53 | 2329
COVID19_MODERNA | Oedema NEC | 477 | 0.85 | 0.91 | 0.98 | 593.3 | 0.75 | 0.80 | 0.87 | 0.83 | 0.83 | 0.76 | 1947
COVID19_PFIZER/BIONTECH | Oedema NEC | 422 | 0.86 | 0.93 | 1.01 | 517.7 | 0.75 | 0.82 | 0.88 | 0.86 | 0.86 | 0.79 | 2002
COVID19_UNKNOWN MFR | Oedema NEC | 2 | 0.33 | 0.82 | 1.48 | 3.7 | 0.25 | 0.63 | 1.37 | 0.57 | 0.57 | 0.18 | 2422
COVID19_JANSSEN | Oesophageal disorders NEC | 1 | 0.19 | 0.88 | 1.97 | 1.2 | 0.25 | 0.78 | 1.91 | 0.77 | 0.77 | 0.14 | 20
COVID19_MODERNA | Oesophageal disorders NEC | 3 | 0.24 | 0.66 | 1.25 | 4.8 | 0.30 | 0.67 | 1.34 | 0.57 | 0.57 | 0.20 | 18
COVID19_PFIZER/BIONTECH | Oesophageal disorders NEC | 7 | 0.73 | 1.43 | 2.33 | 4.2 | 0.75 | 1.35 | 2.29 | 2.05 | 2.05 | 0.96 | 14
COVID19_UNKNOWN MFR | Oesophageal disorders NEC | 0 | 0.10 | 0.98 | 2.61 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal neoplasms malignant | 0 | 0.08 | 0.85 | 2.29 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal neoplasms malignant | 0 | 0.06 | 0.60 | 1.61 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal neoplasms malignant | 1 | 0.24 | 1.10 | 2.48 | 0.5 | 0.33 | 1.00 | 2.52 | 1.36 | 1.36 | 0.20 | 3
COVID19_UNKNOWN MFR | Oesophageal neoplasms malignant | 0 | 0.10 | 1.00 | 2.69 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal stenosis and obstruction | 1 | 0.33 | 1.30 | 2.78 | 0.4 | 0.35 | 1.08 | 2.82 | 3.09 | 3.09 | 0.51 | 5
COVID19_MODERNA | Oesophageal stenosis and obstruction | 2 | 0.39 | 1.20 | 2.37 | 1.9 | 0.37 | 0.91 | 1.98 | 1.70 | 1.70 | 0.41 | 4
COVID19_PFIZER/BIONTECH | Oesophageal stenosis and obstruction | 2 | 0.42 | 1.28 | 2.52 | 1.6 | 0.40 | 0.99 | 2.15 | 2.05 | 2.05 | 0.49 | 4
COVID19_UNKNOWN MFR | Oesophageal stenosis and obstruction | 0 | 0.15 | 1.00 | 2.45 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal therapeutic procedures | 0 | 0.00 | 0.33 | 1.68 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal therapeutic procedures | 0 | 0.00 | 0.12 | 0.59 | 1.6 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal therapeutic procedures | 0 | 0.00 | 0.13 | 0.67 | 1.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal therapeutic procedures | 0 | 0.00 | 0.95 | 4.88 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal ulcers and perforation | 2 | 0.44 | 1.44 | 2.90 | 0.9 | 0.48 | 1.21 | 2.72 | 2.57 | 2.57 | 0.73 | 12
COVID19_MODERNA | Oesophageal ulcers and perforation | 1 | 0.12 | 0.54 | 1.20 | 3.4 | 0.13 | 0.46 | 1.17 | 0.26 | 0.26 | 0.05 | 13
COVID19_PFIZER/BIONTECH | Oesophageal ulcers and perforation | 5 | 0.67 | 1.48 | 2.55 | 3.1 | 0.65 | 1.27 | 2.30 | 2.27 | 2.27 | 0.91 | 9
COVID19_UNKNOWN MFR | Oesophageal ulcers and perforation | 0 | 0.11 | 0.98 | 2.58 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal varices | 0 | 0.11 | 0.87 | 2.23 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal varices | 1 | 0.24 | 1.04 | 2.28 | 0.9 | 0.28 | 0.86 | 2.12 | 1.13 | 1.13 | 0.17 | 3
COVID19_PFIZER/BIONTECH | Oesophageal varices | 1 | 0.26 | 1.09 | 2.40 | 0.7 | 0.31 | 0.94 | 2.35 | 1.36 | 1.36 | 0.20 | 3
COVID19_UNKNOWN MFR | Oesophageal varices | 0 | 0.12 | 1.00 | 2.56 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Oesophagitis (excl infective) | 3 | 0.46 | 1.29 | 2.45 | 2.2 | 0.48 | 1.08 | 2.17 | 1.49 | 1.49 | 0.55 | 31
COVID19_MODERNA | Oesophagitis (excl infective) | 7 | 0.48 | 0.95 | 1.55 | 8.2 | 0.47 | 0.84 | 1.42 | 0.88 | 0.88 | 0.44 | 27
COVID19_PFIZER/BIONTECH | Oesophagitis (excl infective) | 12 | 0.97 | 1.62 | 2.42 | 7.4 | 0.90 | 1.43 | 2.18 | 2.23 | 2.23 | 1.24 | 22
COVID19_UNKNOWN MFR | Oesophagitis (excl infective) | 0 | 0.08 | 0.96 | 2.66 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Off label uses | 91 | 5.30 | 6.35 | 7.48 | 34.9 | 2.10 | 2.51 | 2.97 | 3.41 | 3.42 | 2.82 | 412
COVID19_MODERNA | Off label uses | 30 | 0.57 | 0.80 | 1.05 | 104.2 | 0.22 | 0.30 | 0.40 | 0.22 | 0.22 | 0.16 | 473
COVID19_PFIZER/BIONTECH | Off label uses | 260 | 6.13 | 6.81 | 7.52 | 98.9 | 2.34 | 2.59 | 2.87 | 4.38 | 4.39 | 3.79 | 243
COVID19_UNKNOWN MFR | Off label uses | 5 | 2.76 | 6.66 | 11.94 | 0.8 | 1.23 | 3.00 | 8.28 | 6.91 | 6.94 | 3.31 | 498
COVID19_JANSSEN | Olfactory nerve disorders | 186 | 1.95 | 2.21 | 2.49 | 123.1 | 1.33 | 1.50 | 1.69 | 2.14 | 2.15 | 1.89 | 1340
COVID19_MODERNA | Olfactory nerve disorders | 473 | 1.36 | 1.47 | 1.58 | 462.1 | 0.95 | 1.02 | 1.10 | 1.53 | 1.53 | 1.39 | 1053
COVID19_PFIZER/BIONTECH | Olfactory nerve disorders | 745 | 2.57 | 2.73 | 2.89 | 395.9 | 1.77 | 1.88 | 1.99 | 3.90 | 3.92 | 3.61 | 781
COVID19_UNKNOWN MFR | Olfactory nerve disorders | 0 | 0.00 | 0.20 | 0.78 | 1.9 |  |  |  |  |  |  | 
COVID19_JANSSEN | Oncologic complications and emergencies | 0 | 0.05 | 0.58 | 1.61 | 0.9 |  |  |  |  |  |  | 
COVID19_MODERNA | Oncologic complications and emergencies | 4 | 0.50 | 1.23 | 2.22 | 2.9 | 0.54 | 1.13 | 2.13 | 1.51 | 1.51 | 0.56 | 9
COVID19_PFIZER/BIONTECH | Oncologic complications and emergencies | 5 | 0.68 | 1.54 | 2.67 | 2.7 | 0.70 | 1.38 | 2.51 | 2.56 | 2.56 | 1.00 | 8
COVID19_UNKNOWN MFR | Oncologic complications and emergencies | 0 | 0.08 | 0.98 | 2.73 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ophthalmic function diagnostic procedures | 16 | 0.52 | 0.80 | 1.14 | 22.4 | 0.48 | 0.72 | 1.05 | 0.76 | 0.76 | 0.50 | 324
COVID19_MODERNA | Ophthalmic function diagnostic procedures | 38 | 0.43 | 0.56 | 0.72 | 75.9 | 0.39 | 0.51 | 0.66 | 0.43 | 0.43 | 0.32 | 302
COVID19_PFIZER/BIONTECH | Ophthalmic function diagnostic procedures | 79 | 1.01 | 1.23 | 1.46 | 71.1 | 0.91 | 1.10 | 1.32 | 1.24 | 1.24 | 1.00 | 261
COVID19_UNKNOWN MFR | Ophthalmic function diagnostic procedures | 0 | 0.12 | 0.78 | 1.92 | 0.5 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ophthalmic histopathology and imaging procedures | 7 | 0.44 | 0.88 | 1.45 | 9.3 | 0.42 | 0.76 | 1.28 | 0.76 | 0.76 | 0.40 | 143
COVID19_MODERNA | Ophthalmic histopathology and imaging procedures | 9 | 0.24 | 0.45 | 0.70 | 23.7 | 0.24 | 0.41 | 0.67 | 0.22 | 0.22 | 0.12 | 141
COVID19_PFIZER/BIONTECH | Ophthalmic histopathology and imaging procedures | 16 | 0.46 | 0.72 | 1.03 | 26.0 | 0.42 | 0.63 | 0.92 | 0.49 | 0.49 | 0.32 | 134
COVID19_UNKNOWN MFR | Ophthalmic histopathology and imaging procedures | 0 | 0.04 | 0.83 | 2.48 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Optic disc abnormalities NEC | 1 | 0.07 | 0.34 | 0.78 | 5.8 | 0.07 | 0.30 | 0.81 | 0.16 | 0.16 | 0.03 | 96
COVID19_MODERNA | Optic disc abnormalities NEC | 12 | 0.46 | 0.77 | 1.15 | 16.2 | 0.47 | 0.75 | 1.14 | 0.48 | 0.48 | 0.29 | 85
COVID19_PFIZER/BIONTECH | Optic disc abnormalities NEC | 6 | 0.20 | 0.42 | 0.71 | 16.8 | 0.22 | 0.41 | 0.71 | 0.27 | 0.27 | 0.14 | 91
COVID19_UNKNOWN MFR | Optic disc abnormalities NEC | 0 | 0.07 | 0.90 | 2.55 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Optic nerve and optic disc disorders congenital | 0 | 0.04 | 0.88 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Optic nerve and optic disc disorders congenital | 0 | 0.03 | 0.67 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Optic nerve and optic disc disorders congenital | 0 | 0.03 | 0.70 | 2.16 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optic nerve and optic disc disorders congenital | 0 | 0.04 | 1.00 | 3.06 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Optic nerve bleeding and vascular disorders | 3 | 0.42 | 1.18 | 2.24 | 2.2 | 0.48 | 1.07 | 2.14 | 1.29 | 1.29 | 0.48 | 36
COVID19_MODERNA | Optic nerve bleeding and vascular disorders | 5 | 0.28 | 0.63 | 1.10 | 8.8 | 0.31 | 0.61 | 1.10 | 0.50 | 0.50 | 0.23 | 34
COVID19_PFIZER/BIONTECH | Optic nerve bleeding and vascular disorders | 8 | 0.54 | 1.02 | 1.62 | 7.7 | 0.56 | 0.98 | 1.60 | 1.06 | 1.06 | 0.55 | 31
COVID19_UNKNOWN MFR | Optic nerve bleeding and vascular disorders | 0 | 0.08 | 0.95 | 2.61 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Optic nerve disorders NEC | 5 | 0.16 | 0.39 | 0.69 | 18.3 | 0.16 | 0.32 | 0.59 | 0.28 | 0.28 | 0.14 | 273
COVID19_MODERNA | Optic nerve disorders NEC | 18 | 0.34 | 0.52 | 0.74 | 41.7 | 0.31 | 0.45 | 0.64 | 0.24 | 0.24 | 0.16 | 260
COVID19_PFIZER/BIONTECH | Optic nerve disorders NEC | 29 | 0.57 | 0.79 | 1.04 | 46.6 | 0.46 | 0.63 | 0.84 | 0.48 | 0.48 | 0.35 | 249
COVID19_UNKNOWN MFR | Optic nerve disorders NEC | 0 | 0.01 | 0.66 | 2.30 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Oral dryness and saliva altered | 180 | 1.22 | 1.38 | 1.55 | 133.8 | 1.18 | 1.34 | 1.51 | 1.67 | 1.67 | 1.47 | 1665
COVID19_MODERNA | Oral dryness and saliva altered | 532 | 0.96 | 1.03 | 1.11 | 524.1 | 0.94 | 1.01 | 1.09 | 1.38 | 1.38 | 1.26 | 1313
COVID19_PFIZER/BIONTECH | Oral dryness and saliva altered | 588 | 1.26 | 1.35 | 1.44 | 446.4 | 1.23 | 1.31 | 1.41 | 1.92 | 1.92 | 1.77 | 1257
COVID19_UNKNOWN MFR | Oral dryness and saliva altered | 6 | 0.81 | 1.62 | 2.65 | 3.0 | 0.80 | 1.49 | 2.63 | 2.24 | 2.25 | 1.15 | 1839
COVID19_JANSSEN | Oral soft tissue disorders NEC | 48 | 0.68 | 0.87 | 1.07 | 56.4 | 0.67 | 0.85 | 1.06 | 0.91 | 0.91 | 0.71 | 816
COVID19_MODERNA | Oral soft tissue disorders NEC | 218 | 0.84 | 0.94 | 1.05 | 230.6 | 0.84 | 0.94 | 1.05 | 1.15 | 1.15 | 1.01 | 646
COVID19_PFIZER/BIONTECH | Oral soft tissue disorders NEC | 249 | 1.14 | 1.27 | 1.41 | 194.6 | 1.15 | 1.27 | 1.41 | 1.66 | 1.66 | 1.47 | 615
COVID19_UNKNOWN MFR | Oral soft tissue disorders NEC | 2 | 0.56 | 1.08 | 1.74 | 1.4 | 0.42 | 1.04 | 2.28 | 1.60 | 1.60 | 0.50 | 862
COVID19_JANSSEN | Oral soft tissue haemorrhages | 9 | 0.58 | 1.00 | 1.53 | 9.1 | 0.56 | 0.95 | 1.52 | 0.80 | 0.80 | 0.46 | 174
COVID19_MODERNA | Oral soft tissue haemorrhages | 35 | 0.73 | 0.98 | 1.25 | 37.2 | 0.71 | 0.93 | 1.21 | 0.80 | 0.80 | 0.59 | 148
COVID19_PFIZER/BIONTECH | Oral soft tissue haemorrhages | 42 | 0.99 | 1.29 | 1.62 | 32.9 | 0.97 | 1.25 | 1.59 | 1.22 | 1.22 | 0.91 | 141
COVID19_UNKNOWN MFR | Oral soft tissue haemorrhages | 0 | 0.24 | 0.93 | 1.97 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Oral soft tissue infections | 0 | 0.07 | 0.71 | 1.92 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Oral soft tissue infections | 2 | 0.29 | 0.99 | 2.01 | 2.2 | 0.34 | 0.85 | 1.83 | 0.97 | 0.97 | 0.26 | 7
COVID19_PFIZER/BIONTECH | Oral soft tissue infections | 1 | 0.16 | 0.75 | 1.70 | 1.7 | 0.22 | 0.69 | 1.69 | 0.51 | 0.51 | 0.09 | 8
COVID19_UNKNOWN MFR | Oral soft tissue infections | 0 | 0.10 | 0.99 | 2.68 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Oral soft tissue signs and symptoms | 490 | 0.87 | 0.94 | 1.01 | 665.2 | 0.68 | 0.74 | 0.79 | 0.89 | 0.89 | 0.82 | 8488
COVID19_MODERNA | Oral soft tissue signs and symptoms | 3047 | 1.31 | 1.35 | 1.40 | 2840.9 | 1.04 | 1.07 | 1.11 | 1.74 | 1.76 | 1.70 | 5931
COVID19_PFIZER/BIONTECH | Oral soft tissue signs and symptoms | 3816 | 2.01 | 2.06 | 2.12 | 2343.9 | 1.58 | 1.63 | 1.67 | 3.03 | 3.09 | 2.99 | 5162
COVID19_UNKNOWN MFR | Oral soft tissue signs and symptoms | 11 | 0.60 | 0.96 | 1.37 | 14.8 | 0.46 | 0.75 | 1.16 | 0.84 | 0.84 | 0.51 | 8967
COVID19_JANSSEN | Oral soft tissue swelling and oedema | 222 | 0.78 | 0.87 | 0.97 | 300.9 | 0.66 | 0.74 | 0.82 | 0.82 | 0.82 | 0.73 | 4176
COVID19_MODERNA | Oral soft tissue swelling and oedema | 1275 | 1.11 | 1.17 | 1.22 | 1275.5 | 0.95 | 1.00 | 1.05 | 1.39 | 1.39 | 1.32 | 3123
COVID19_PFIZER/BIONTECH | Oral soft tissue swelling and oedema | 1446 | 1.53 | 1.59 | 1.66 | 1060.3 | 1.31 | 1.36 | 1.42 | 2.01 | 2.02 | 1.91 | 2952
COVID19_UNKNOWN MFR | Oral soft tissue swelling and oedema | 5 | 0.51 | 0.93 | 1.44 | 6.8 | 0.38 | 0.75 | 1.34 | 0.78 | 0.78 | 0.37 | 4393
COVID19_JANSSEN | Orbit and globe therapeutic procedures | 0 | 0.07 | 0.87 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Orbit and globe therapeutic procedures | 1 | 0.23 | 1.17 | 2.70 | 0.7 | 0.31 | 0.93 | 2.32 | 1.70 | 1.70 | 0.23 | 2
COVID19_PFIZER/BIONTECH | Orbit and globe therapeutic procedures | 0 | 0.05 | 0.67 | 1.89 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orbit and globe therapeutic procedures | 0 | 0.08 | 1.00 | 2.81 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Orbital infections, inflammations and irritations | 1 | 0.27 | 1.23 | 2.76 | 0.7 | 0.31 | 0.93 | 2.31 | 1.93 | 1.93 | 0.34 | 8
COVID19_MODERNA | Orbital infections, inflammations and irritations | 1 | 0.15 | 0.70 | 1.56 | 2.3 | 0.18 | 0.58 | 1.44 | 0.42 | 0.42 | 0.07 | 8
COVID19_PFIZER/BIONTECH | Orbital infections, inflammations and irritations | 1 | 0.17 | 0.76 | 1.70 | 2.1 | 0.19 | 0.61 | 1.53 | 0.51 | 0.51 | 0.09 | 8
COVID19_UNKNOWN MFR | Orbital infections, inflammations and irritations | 0 | 0.10 | 0.99 | 2.64 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Orbital structural change, deposit and degeneration | 1 | 0.11 | 0.66 | 1.59 | 2.1 | 0.19 | 0.62 | 1.53 | 0.41 | 0.41 | 0.08 | 38
COVID19_MODERNA | Orbital structural change, deposit and degeneration | 11 | 0.80 | 1.40 | 2.12 | 7.5 | 0.81 | 1.31 | 2.04 | 1.33 | 1.33 | 0.74 | 28
COVID19_PFIZER/BIONTECH | Orbital structural change, deposit and degeneration | 9 | 0.68 | 1.26 | 1.98 | 7.0 | 0.69 | 1.16 | 1.86 | 1.23 | 1.23 | 0.66 | 30
COVID19_UNKNOWN MFR | Orbital structural change, deposit and degeneration | 0 | 0.04 | 0.95 | 2.96 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Orgasmic disorders and disturbances | 1 | 0.31 | 1.41 | 3.16 | 0.4 | 0.35 | 1.06 | 2.74 | 3.86 | 3.86 | 0.61 | 4
COVID19_MODERNA | Orgasmic disorders and disturbances | 2 | 0.41 | 1.34 | 2.72 | 1.4 | 0.41 | 1.03 | 2.24 | 2.26 | 2.26 | 0.50 | 3
COVID19_PFIZER/BIONTECH | Orgasmic disorders and disturbances | 0 | 0.06 | 0.59 | 1.57 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orgasmic disorders and disturbances | 0 | 0.10 | 1.00 | 2.65 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Orthopox viral infections | 0 | 0.00 | 0.02 | 0.11 | 4.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Orthopox viral infections | 0 | 0.00 | 0.01 | 0.05 | 10.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Orthopox viral infections | 0 | 0.00 | 0.01 | 0.05 | 10.7 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orthopox viral infections | 0 | 0.00 | 0.47 | 2.75 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Osteoarthropathies | 4 | 0.19 | 0.48 | 0.88 | 11.1 | 0.20 | 0.43 | 0.82 | 0.33 | 0.33 | 0.14 | 190
COVID19_MODERNA | Osteoarthropathies | 31 | 0.52 | 0.72 | 0.94 | 52.1 | 0.45 | 0.60 | 0.80 | 0.65 | 0.65 | 0.47 | 163
COVID19_PFIZER/BIONTECH | Osteoarthropathies | 38 | 0.80 | 1.06 | 1.35 | 43.3 | 0.67 | 0.87 | 1.13 | 1.00 | 1.00 | 0.74 | 156
COVID19_UNKNOWN MFR | Osteoarthropathies | 0 | 0.03 | 0.76 | 2.34 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian and fallopian tube cysts and neoplasms | 7 | 0.90 | 1.88 | 3.15 | 6.4 | 0.56 | 1.01 | 1.69 | 0.91 | 0.91 | 0.48 | 119
COVID19_MODERNA | Ovarian and fallopian tube cysts and neoplasms | 4 | 0.15 | 0.43 | 0.82 | 16.2 | 0.14 | 0.31 | 0.59 | 0.11 | 0.11 | 0.05 | 122
COVID19_PFIZER/BIONTECH | Ovarian and fallopian tube cysts and neoplasms | 9 | 0.46 | 0.87 | 1.39 | 18.5 | 0.31 | 0.52 | 0.83 | 0.32 | 0.32 | 0.18 | 117
COVID19_UNKNOWN MFR | Ovarian and fallopian tube cysts and neoplasms | 0 | 0.00 | 0.77 | 3.57 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian and fallopian tube disorders NEC | 3 | 0.31 | 1.10 | 2.27 | 3.5 | 0.37 | 0.83 | 1.66 | 0.81 | 0.81 | 0.31 | 57
COVID19_MODERNA | Ovarian and fallopian tube disorders NEC | 6 | 0.36 | 0.82 | 1.43 | 8.2 | 0.40 | 0.75 | 1.29 | 0.38 | 0.38 | 0.19 | 54
COVID19_PFIZER/BIONTECH | Ovarian and fallopian tube disorders NEC | 5 | 0.26 | 0.65 | 1.18 | 9.5 | 0.29 | 0.58 | 1.04 | 0.37 | 0.37 | 0.17 | 55
COVID19_UNKNOWN MFR | Ovarian and fallopian tube disorders NEC | 0 | 0.00 | 0.71 | 3.87 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian germ cell neoplasms malignant | 0 | 0.04 | 0.89 | 2.71 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Ovarian germ cell neoplasms malignant | 0 | 0.03 | 0.67 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian germ cell neoplasms malignant | 0 | 0.03 | 0.71 | 2.16 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian germ cell neoplasms malignant | 0 | 0.04 | 1.00 | 3.05 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian neoplasms benign | 0 | 0.04 | 0.88 | 2.73 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Ovarian neoplasms benign | 0 | 0.03 | 0.67 | 2.07 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian neoplasms benign | 0 | 0.03 | 0.70 | 2.16 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian neoplasms benign | 0 | 0.04 | 1.00 | 3.09 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian neoplasms malignant (excl germ cell) | 1 | 0.25 | 1.10 | 2.44 | 0.7 | 0.31 | 0.93 | 2.32 | 1.40 | 1.40 | 0.25 | 11
COVID19_MODERNA | Ovarian neoplasms malignant (excl germ cell) | 1 | 0.15 | 0.67 | 1.49 | 2.0 | 0.20 | 0.62 | 1.55 | 0.31 | 0.31 | 0.06 | 11
COVID19_PFIZER/BIONTECH | Ovarian neoplasms malignant (excl germ cell) | 2 | 0.28 | 0.92 | 1.86 | 2.1 | 0.34 | 0.86 | 1.85 | 0.82 | 0.82 | 0.23 | 10
COVID19_UNKNOWN MFR | Ovarian neoplasms malignant (excl germ cell) | 0 | 0.11 | 0.99 | 2.59 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian therapeutic procedures | 0 | 0.00 | 0.42 | 1.79 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Ovarian therapeutic procedures | 0 | 0.00 | 0.23 | 0.99 | 1.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian therapeutic procedures | 0 | 0.00 | 0.20 | 0.87 | 1.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian therapeutic procedures | 0 | 0.00 | 0.97 | 4.12 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Overdoses NEC | 13 | 0.87 | 1.45 | 2.16 | 14.7 | 0.56 | 0.87 | 1.31 | 0.73 | 0.73 | 0.46 | 276
COVID19_MODERNA | Overdoses NEC | 15 | 0.51 | 0.82 | 1.20 | 34.4 | 0.30 | 0.46 | 0.67 | 0.19 | 0.19 | 0.12 | 274
COVID19_PFIZER/BIONTECH | Overdoses NEC | 25 | 0.85 | 1.22 | 1.64 | 35.9 | 0.51 | 0.70 | 0.96 | 0.39 | 0.39 | 0.28 | 264
COVID19_UNKNOWN MFR | Overdoses NEC | 0 | 0.00 | 0.67 | 2.68 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pain and discomfort NEC | 9321 | 1.42 | 1.44 | 1.47 | 6927.0 | 1.32 | 1.35 | 1.37 | 1.68 | 1.91 | 1.87 | 85732
COVID19_MODERNA | Pain and discomfort NEC | 27801 | 1.05 | 1.06 | 1.07 | 27774.8 | 0.99 | 1.00 | 1.01 | 1.40 | 1.51 | 1.49 | 67252
COVID19_PFIZER/BIONTECH | Pain and discomfort NEC | 23012 | 1.04 | 1.05 | 1.06 | 23282.4 | 0.98 | 0.99 | 1.00 | 1.31 | 1.38 | 1.36 | 72041
COVID19_UNKNOWN MFR | Pain and discomfort NEC | 202 | 1.21 | 1.36 | 1.52 | 157.2 | 1.14 | 1.28 | 1.43 | 1.47 | 1.60 | 1.41 | 94851
COVID19_JANSSEN | Palate disorders congenital | 0 | 0.00 | 0.71 | 2.84 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Palate disorders congenital | 0 | 0.00 | 0.39 | 1.57 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Palate disorders congenital | 0 | 0.00 | 0.43 | 1.72 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Palate disorders congenital | 0 | 0.00 | 0.99 | 3.99 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatic disorders NEC | 1 | 0.25 | 0.88 | 1.84 | 1.5 | 0.24 | 0.73 | 1.80 | 0.62 | 0.62 | 0.12 | 25
COVID19_MODERNA | Pancreatic disorders NEC | 5 | 0.40 | 0.85 | 1.44 | 6.0 | 0.42 | 0.82 | 1.48 | 0.81 | 0.81 | 0.36 | 21
COVID19_PFIZER/BIONTECH | Pancreatic disorders NEC | 8 | 0.77 | 1.42 | 2.22 | 5.2 | 0.76 | 1.32 | 2.17 | 1.82 | 1.82 | 0.90 | 18
COVID19_UNKNOWN MFR | Pancreatic disorders NEC | 0 | 0.18 | 0.98 | 2.30 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatic neoplasms malignant (excl islet cell and carcinoid) | 0 | 0.17 | 0.80 | 1.81 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Pancreatic neoplasms malignant (excl islet cell and carcinoid) | 2 | 0.34 | 0.95 | 1.81 | 2.5 | 0.32 | 0.79 | 1.71 | 0.76 | 0.76 | 0.21 | 9
COVID19_PFIZER/BIONTECH | Pancreatic neoplasms malignant (excl islet cell and carcinoid) | 4 | 0.66 | 1.48 | 2.57 | 2.0 | 0.65 | 1.35 | 2.60 | 2.34 | 2.34 | 0.83 | 7
COVID19_UNKNOWN MFR | Pancreatic neoplasms malignant (excl islet cell and carcinoid) | 0 | 0.21 | 0.99 | 2.26 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatic therapeutic procedures | 0 | 0.05 | 0.94 | 2.83 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Pancreatic therapeutic procedures | 0 | 0.04 | 0.81 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pancreatic therapeutic procedures | 0 | 0.04 | 0.84 | 2.51 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatic therapeutic procedures | 0 | 0.05 | 1.00 | 3.00 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Panic attacks and disorders | 99 | 1.35 | 1.61 | 1.88 | 64.7 | 1.27 | 1.50 | 1.77 | 2.07 | 2.07 | 1.74 | 738
COVID19_MODERNA | Panic attacks and disorders | 193 | 0.78 | 0.88 | 0.99 | 227.3 | 0.75 | 0.85 | 0.95 | 1.02 | 1.02 | 0.89 | 644
COVID19_PFIZER/BIONTECH | Panic attacks and disorders | 271 | 1.27 | 1.41 | 1.56 | 200.9 | 1.21 | 1.34 | 1.48 | 1.96 | 1.96 | 1.74 | 566
COVID19_UNKNOWN MFR | Panic attacks and disorders | 0 | 0.03 | 0.46 | 1.35 | 1.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Panniculitides | 0 | 0.01 | 0.14 | 0.45 | 5.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Panniculitides | 17 | 0.68 | 1.05 | 1.49 | 16.6 | 0.67 | 0.99 | 1.43 | 0.78 | 0.78 | 0.50 | 74
COVID19_PFIZER/BIONTECH | Panniculitides | 10 | 0.36 | 0.65 | 1.00 | 17.3 | 0.37 | 0.60 | 0.95 | 0.51 | 0.51 | 0.29 | 81
COVID19_UNKNOWN MFR | Panniculitides | 0 | 0.04 | 0.87 | 2.69 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Papilloma viral infections | 0 | 0.00 | 0.01 | 0.06 | 7.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Papilloma viral infections | 0 | 0.00 | 0.01 | 0.03 | 13.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Papilloma viral infections | 1 | 0.00 | 0.06 | 0.18 | 28.0 | 0.00 | 0.04 | 0.17 | 0.02 | 0.02 | 0.00 | 190
COVID19_UNKNOWN MFR | Papilloma viral infections | 0 | 0.00 | 0.27 | 1.58 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Papulosquamous conditions | 6 | 0.26 | 0.52 | 0.85 | 14.8 | 0.24 | 0.45 | 0.79 | 0.44 | 0.44 | 0.22 | 209
COVID19_MODERNA | Papulosquamous conditions | 31 | 0.53 | 0.73 | 0.95 | 45.5 | 0.51 | 0.69 | 0.91 | 0.57 | 0.57 | 0.42 | 184
COVID19_PFIZER/BIONTECH | Papulosquamous conditions | 40 | 0.74 | 0.98 | 1.24 | 43.7 | 0.70 | 0.91 | 1.16 | 0.94 | 0.94 | 0.70 | 175
COVID19_UNKNOWN MFR | Papulosquamous conditions | 1 | 0.37 | 1.27 | 2.61 | 0.3 | 0.36 | 1.10 | 2.95 | 3.21 | 3.22 | 0.62 | 214
COVID19_JANSSEN | Paraesthesias and dysaesthesias | 2519 | 1.12 | 1.16 | 1.20 | 2205.3 | 1.11 | 1.14 | 1.18 | 1.48 | 1.52 | 1.46 | 26276
COVID19_MODERNA | Paraesthesias and dysaesthesias | 7357 | 0.85 | 0.86 | 0.88 | 8611.9 | 0.84 | 0.85 | 0.87 | 1.17 | 1.18 | 1.15 | 21438
COVID19_PFIZER/BIONTECH | Paraesthesias and dysaesthesias | 8555 | 1.17 | 1.19 | 1.21 | 7310.2 | 1.15 | 1.17 | 1.19 | 1.73 | 1.79 | 1.75 | 20240
COVID19_UNKNOWN MFR | Paraesthesias and dysaesthesias | 46 | 0.75 | 0.97 | 1.21 | 48.3 | 0.74 | 0.94 | 1.19 | 1.10 | 1.11 | 0.86 | 28749
COVID19_JANSSEN | Parainfluenzae viral infections | 0 | 0.03 | 0.67 | 2.02 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Parainfluenzae viral infections | 0 | 0.02 | 0.35 | 1.07 | 1.8 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parainfluenzae viral infections | 0 | 0.02 | 0.35 | 1.05 | 1.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parainfluenzae viral infections | 0 | 0.05 | 0.99 | 2.97 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Paralysis and paresis (excl cranial nerve) | 137 | 1.01 | 1.17 | 1.34 | 154.6 | 0.77 | 0.89 | 1.01 | 0.82 | 0.82 | 0.71 | 2567
COVID19_MODERNA | Paralysis and paresis (excl cranial nerve) | 365 | 0.76 | 0.83 | 0.90 | 505.2 | 0.66 | 0.72 | 0.79 | 0.53 | 0.53 | 0.48 | 2339
COVID19_PFIZER/BIONTECH | Paralysis and paresis (excl cranial nerve) | 413 | 0.98 | 1.06 | 1.15 | 476.3 | 0.80 | 0.87 | 0.94 | 0.74 | 0.74 | 0.68 | 2291
COVID19_UNKNOWN MFR | Paralysis and paresis (excl cranial nerve) | 5 | 0.63 | 1.46 | 2.58 | 4.1 | 0.55 | 1.07 | 1.93 | 1.27 | 1.28 | 0.61 | 2699
COVID19_JANSSEN | Paranasal sinus disorders (excl infections and neoplasms) | 88 | 1.21 | 1.46 | 1.72 | 61.5 | 1.18 | 1.41 | 1.67 | 1.76 | 1.76 | 1.47 | 771
COVID19_MODERNA | Paranasal sinus disorders (excl infections and neoplasms) | 231 | 0.84 | 0.94 | 1.05 | 250.6 | 0.83 | 0.92 | 1.02 | 1.25 | 1.25 | 1.10 | 628
COVID19_PFIZER/BIONTECH | Paranasal sinus disorders (excl infections and neoplasms) | 276 | 1.22 | 1.35 | 1.49 | 208.7 | 1.19 | 1.32 | 1.45 | 1.94 | 1.94 | 1.72 | 583
COVID19_UNKNOWN MFR | Paranasal sinus disorders (excl infections and neoplasms) | 1 | 0.22 | 0.87 | 1.87 | 1.5 | 0.24 | 0.73 | 1.80 | 0.80 | 0.80 | 0.15 | 858
COVID19_JANSSEN | Paranasal therapeutic procedures | 15 | 1.55 | 2.48 | 3.59 | 6.4 | 1.27 | 1.94 | 2.89 | 2.79 | 2.79 | 1.76 | 83
COVID19_MODERNA | Paranasal therapeutic procedures | 39 | 1.11 | 1.47 | 1.87 | 30.0 | 0.97 | 1.26 | 1.62 | 2.25 | 2.25 | 1.60 | 59
COVID19_PFIZER/BIONTECH | Paranasal therapeutic procedures | 35 | 1.22 | 1.64 | 2.12 | 23.9 | 1.06 | 1.40 | 1.82 | 2.27 | 2.27 | 1.61 | 63
COVID19_UNKNOWN MFR | Paranasal therapeutic procedures | 0 | 0.01 | 0.83 | 2.88 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Paraneoplastic syndromes NEC | 0 | 0.06 | 0.86 | 2.47 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Paraneoplastic syndromes NEC | 0 | 0.04 | 0.62 | 1.79 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Paraneoplastic syndromes NEC | 1 | 0.24 | 1.24 | 2.88 | 1.0 | 0.28 | 0.85 | 2.08 | 2.05 | 2.05 | 0.27 | 2
COVID19_UNKNOWN MFR | Paraneoplastic syndromes NEC | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Parasite identification and serology | 6 | 0.29 | 0.63 | 1.08 | 12.5 | 0.28 | 0.53 | 0.91 | 0.43 | 0.43 | 0.22 | 216
COVID19_MODERNA | Parasite identification and serology | 10 | 0.22 | 0.39 | 0.60 | 31.1 | 0.21 | 0.35 | 0.56 | 0.16 | 0.16 | 0.09 | 212
COVID19_PFIZER/BIONTECH | Parasite identification and serology | 10 | 0.21 | 0.37 | 0.58 | 34.1 | 0.19 | 0.32 | 0.51 | 0.19 | 0.19 | 0.11 | 212
COVID19_UNKNOWN MFR | Parasite identification and serology | 0 | 0.01 | 0.73 | 2.61 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Parasomnias | 76 | 1.31 | 1.60 | 1.91 | 48.9 | 1.26 | 1.52 | 1.82 | 1.73 | 1.73 | 1.42 | 679
COVID19_MODERNA | Parasomnias | 175 | 0.83 | 0.95 | 1.07 | 190.5 | 0.81 | 0.92 | 1.04 | 1.02 | 1.02 | 0.89 | 580
COVID19_PFIZER/BIONTECH | Parasomnias | 222 | 1.24 | 1.39 | 1.55 | 165.1 | 1.20 | 1.34 | 1.49 | 1.71 | 1.71 | 1.50 | 533
COVID19_UNKNOWN MFR | Parasomnias | 3 | 0.64 | 1.71 | 3.21 | 1.1 | 0.63 | 1.44 | 3.06 | 2.74 | 2.75 | 1.06 | 752
COVID19_JANSSEN | Parathyroid analyses | 0 | 0.06 | 0.45 | 1.15 | 1.9 |  |  |  |  |  |  | 
COVID19_MODERNA | Parathyroid analyses | 2 | 0.16 | 0.50 | 1.00 | 5.6 | 0.18 | 0.47 | 1.03 | 0.28 | 0.28 | 0.08 | 24
COVID19_PFIZER/BIONTECH | Parathyroid analyses | 9 | 0.85 | 1.54 | 2.39 | 5.4 | 0.83 | 1.40 | 2.26 | 2.17 | 2.17 | 1.10 | 17
COVID19_UNKNOWN MFR | Parathyroid analyses | 0 | 0.12 | 0.97 | 2.50 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Parenchymal lung disorders NEC | 35 | 0.84 | 1.13 | 1.45 | 33.4 | 0.78 | 1.03 | 1.34 | 0.86 | 0.86 | 0.65 | 627
COVID19_MODERNA | Parenchymal lung disorders NEC | 157 | 0.91 | 1.04 | 1.18 | 154.8 | 0.89 | 1.01 | 1.15 | 1.06 | 1.06 | 0.91 | 505
COVID19_PFIZER/BIONTECH | Parenchymal lung disorders NEC | 196 | 1.36 | 1.54 | 1.72 | 133.6 | 1.29 | 1.46 | 1.63 | 1.72 | 1.72 | 1.50 | 466
COVID19_UNKNOWN MFR | Parenchymal lung disorders NEC | 1 | 0.22 | 0.99 | 2.20 | 1.1 | 0.27 | 0.82 | 2.02 | 1.04 | 1.04 | 0.20 | 661
COVID19_JANSSEN | Parkinson's disease and parkinsonism | 21 | 1.64 | 2.40 | 3.29 | 8.7 | 1.45 | 2.09 | 2.94 | 2.59 | 2.60 | 1.76 | 125
COVID19_MODERNA | Parkinson's disease and parkinsonism | 31 | 0.69 | 0.94 | 1.23 | 38.2 | 0.60 | 0.81 | 1.07 | 0.92 | 0.92 | 0.66 | 115
COVID19_PFIZER/BIONTECH | Parkinson's disease and parkinsonism | 45 | 1.20 | 1.56 | 1.95 | 32.9 | 1.04 | 1.33 | 1.68 | 1.82 | 1.82 | 1.36 | 101
COVID19_UNKNOWN MFR | Parkinson's disease and parkinsonism | 0 | 0.12 | 0.88 | 2.23 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Partial complex seizures | 4 | 0.47 | 1.13 | 2.02 | 3.4 | 0.49 | 1.01 | 1.91 | 1.24 | 1.24 | 0.53 | 50
COVID19_MODERNA | Partial complex seizures | 8 | 0.42 | 0.80 | 1.27 | 10.1 | 0.46 | 0.79 | 1.30 | 0.59 | 0.59 | 0.31 | 46
COVID19_PFIZER/BIONTECH | Partial complex seizures | 10 | 0.57 | 1.00 | 1.52 | 10.1 | 0.58 | 0.95 | 1.50 | 0.93 | 0.93 | 0.52 | 44
COVID19_UNKNOWN MFR | Partial complex seizures | 0 | 0.11 | 0.95 | 2.49 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Partial simple seizures NEC | 1 | 0.32 | 1.27 | 2.73 | 0.4 | 0.36 | 1.09 | 2.88 | 2.57 | 2.57 | 0.44 | 6
COVID19_MODERNA | Partial simple seizures NEC | 1 | 0.21 | 0.82 | 1.77 | 1.1 | 0.27 | 0.82 | 2.01 | 0.57 | 0.57 | 0.10 | 6
COVID19_PFIZER/BIONTECH | Partial simple seizures NEC | 1 | 0.22 | 0.88 | 1.90 | 1.1 | 0.27 | 0.82 | 2.02 | 0.68 | 0.68 | 0.12 | 6
COVID19_UNKNOWN MFR | Partial simple seizures NEC | 0 | 0.14 | 0.99 | 2.47 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Parvoviral infections | 0 | 0.04 | 0.70 | 2.07 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Parvoviral infections | 0 | 0.02 | 0.39 | 1.14 | 1.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parvoviral infections | 0 | 0.02 | 0.38 | 1.13 | 1.7 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parvoviral infections | 0 | 0.06 | 0.99 | 2.92 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pathways and sources of exposure | 10 | 0.20 | 0.37 | 0.57 | 34.0 | 0.19 | 0.32 | 0.51 | 0.29 | 0.29 | 0.17 | 535
COVID19_MODERNA | Pathways and sources of exposure | 85 | 1.09 | 1.31 | 1.55 | 79.5 | 0.89 | 1.06 | 1.26 | 0.63 | 0.63 | 0.52 | 460
COVID19_PFIZER/BIONTECH | Pathways and sources of exposure | 27 | 0.27 | 0.38 | 0.50 | 88.2 | 0.23 | 0.32 | 0.43 | 0.21 | 0.21 | 0.15 | 518
COVID19_UNKNOWN MFR | Pathways and sources of exposure | 0 | 0.00 | 0.44 | 1.59 | 0.8 |  |  |  |  |  |  | 
COVID19_JANSSEN | Patient positioning | 1 | 0.31 | 1.34 | 2.98 | 0.4 | 0.35 | 1.05 | 2.72 | 3.09 | 3.09 | 0.51 | 5
COVID19_MODERNA | Patient positioning | 1 | 0.20 | 0.87 | 1.93 | 1.5 | 0.23 | 0.72 | 1.78 | 0.68 | 0.68 | 0.11 | 5
COVID19_PFIZER/BIONTECH | Patient positioning | 3 | 0.62 | 1.69 | 3.17 | 1.3 | 0.60 | 1.35 | 2.80 | 4.09 | 4.09 | 1.07 | 3
COVID19_UNKNOWN MFR | Patient positioning | 0 | 0.11 | 0.99 | 2.60 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pelvic fractures and dislocations | 0 | 0.06 | 0.69 | 1.88 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Pelvic fractures and dislocations | 5 | 0.69 | 1.54 | 2.67 | 3.2 | 0.64 | 1.24 | 2.24 | 2.12 | 2.12 | 0.83 | 8
COVID19_PFIZER/BIONTECH | Pelvic fractures and dislocations | 4 | 0.57 | 1.40 | 2.53 | 2.9 | 0.54 | 1.12 | 2.12 | 1.82 | 1.82 | 0.68 | 9
COVID19_UNKNOWN MFR | Pelvic fractures and dislocations | 0 | 0.09 | 0.98 | 2.69 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pelvic prolapse conditions | 0 | 0.00 | 0.69 | 2.58 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Pelvic prolapse conditions | 0 | 0.00 | 0.37 | 1.39 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pelvic prolapse conditions | 0 | 0.00 | 0.41 | 1.52 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pelvic prolapse conditions | 0 | 0.01 | 0.99 | 3.69 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pelvis and broad ligament disorders NEC | 6 | 0.93 | 2.01 | 3.43 | 2.8 | 0.83 | 1.56 | 2.77 | 2.81 | 2.81 | 1.35 | 33
COVID19_MODERNA | Pelvis and broad ligament disorders NEC | 12 | 0.68 | 1.16 | 1.73 | 11.9 | 0.61 | 0.97 | 1.48 | 1.51 | 1.51 | 0.85 | 27
COVID19_PFIZER/BIONTECH | Pelvis and broad ligament disorders NEC | 12 | 0.77 | 1.30 | 1.96 | 10.1 | 0.70 | 1.11 | 1.69 | 1.82 | 1.82 | 1.03 | 27
COVID19_UNKNOWN MFR | Pelvis and broad ligament disorders NEC | 0 | 0.02 | 0.93 | 3.06 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Penile and scrotal infections and inflammations | 0 | 0.10 | 0.81 | 2.09 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Penile and scrotal infections and inflammations | 1 | 0.20 | 0.87 | 1.93 | 0.7 | 0.32 | 0.95 | 2.38 | 0.68 | 0.68 | 0.11 | 5
COVID19_PFIZER/BIONTECH | Penile and scrotal infections and inflammations | 1 | 0.22 | 0.93 | 2.06 | 0.7 | 0.31 | 0.92 | 2.30 | 0.82 | 0.82 | 0.14 | 5
COVID19_UNKNOWN MFR | Penile and scrotal infections and inflammations | 0 | 0.12 | 0.99 | 2.58 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Penile disorders NEC (excl erection and ejaculation) | 5 | 0.67 | 1.41 | 2.37 | 3.0 | 0.66 | 1.30 | 2.35 | 1.68 | 1.68 | 0.77 | 46
COVID19_MODERNA | Penile disorders NEC (excl erection and ejaculation) | 6 | 0.40 | 0.80 | 1.31 | 8.2 | 0.40 | 0.75 | 1.29 | 0.45 | 0.45 | 0.22 | 45
COVID19_PFIZER/BIONTECH | Penile disorders NEC (excl erection and ejaculation) | 8 | 0.52 | 0.96 | 1.50 | 8.8 | 0.51 | 0.89 | 1.46 | 0.76 | 0.76 | 0.40 | 43
COVID19_UNKNOWN MFR | Penile disorders NEC (excl erection and ejaculation) | 0 | 0.20 | 0.97 | 2.21 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Peptic ulcers and perforation | 1 | 0.27 | 1.10 | 2.39 | 0.9 | 0.29 | 0.88 | 2.17 | 1.54 | 1.54 | 0.28 | 10
COVID19_MODERNA | Peptic ulcers and perforation | 5 | 0.60 | 1.31 | 2.24 | 3.1 | 0.65 | 1.26 | 2.29 | 2.83 | 2.83 | 1.05 | 6
COVID19_PFIZER/BIONTECH | Peptic ulcers and perforation | 1 | 0.15 | 0.61 | 1.32 | 2.6 | 0.17 | 0.54 | 1.36 | 0.41 | 0.41 | 0.07 | 10
COVID19_UNKNOWN MFR | Peptic ulcers and perforation | 0 | 0.13 | 0.99 | 2.50 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Perception disturbances NEC | 11 | 0.60 | 1.06 | 1.62 | 14.9 | 0.46 | 0.74 | 1.15 | 0.73 | 0.73 | 0.44 | 234
COVID19_MODERNA | Perception disturbances NEC | 39 | 0.84 | 1.11 | 1.42 | 47.4 | 0.63 | 0.82 | 1.05 | 0.64 | 0.64 | 0.48 | 206
COVID19_PFIZER/BIONTECH | Perception disturbances NEC | 77 | 1.94 | 2.37 | 2.83 | 45.4 | 1.37 | 1.65 | 1.98 | 1.88 | 1.88 | 1.50 | 168
COVID19_UNKNOWN MFR | Perception disturbances NEC | 0 | 0.00 | 0.57 | 2.51 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pericardial disorders NEC | 12 | 0.46 | 0.79 | 1.19 | 17.7 | 0.44 | 0.69 | 1.05 | 0.78 | 0.78 | 0.48 | 239
COVID19_MODERNA | Pericardial disorders NEC | 55 | 0.84 | 1.06 | 1.30 | 58.5 | 0.75 | 0.94 | 1.16 | 0.95 | 0.95 | 0.74 | 196
COVID19_PFIZER/BIONTECH | Pericardial disorders NEC | 79 | 1.39 | 1.68 | 2.00 | 53.4 | 1.20 | 1.45 | 1.74 | 1.88 | 1.88 | 1.50 | 172
COVID19_UNKNOWN MFR | Pericardial disorders NEC | 1 | 0.21 | 1.62 | 4.16 | 0.5 | 0.34 | 1.04 | 2.67 | 2.75 | 2.75 | 0.53 | 250
COVID19_JANSSEN | Peripheral T-cell lymphomas NEC | 0 | 0.07 | 0.95 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Peripheral T-cell lymphomas NEC | 1 | 0.30 | 1.57 | 3.64 | 0.3 | 0.37 | 1.12 | 3.03 | 10.19 | 10.19 | 0.69 | 0
COVID19_PFIZER/BIONTECH | Peripheral T-cell lymphomas NEC | 0 | 0.06 | 0.85 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral T-cell lymphomas NEC | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral aneurysms and dissections | 0 | 0.07 | 0.95 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Peripheral aneurysms and dissections | 1 | 0.30 | 1.57 | 3.64 | 0.3 | 0.37 | 1.13 | 3.09 | 10.19 | 10.19 | 0.69 | 0
COVID19_PFIZER/BIONTECH | Peripheral aneurysms and dissections | 0 | 0.06 | 0.85 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral aneurysms and dissections | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral embolism and thrombosis | 390 | 6.42 | 6.99 | 7.58 | 87.3 | 4.08 | 4.44 | 4.83 | 7.00 | 7.07 | 6.39 | 860
COVID19_MODERNA | Peripheral embolism and thrombosis | 327 | 1.13 | 1.24 | 1.35 | 379.5 | 0.79 | 0.86 | 0.94 | 1.20 | 1.20 | 1.08 | 923
COVID19_PFIZER/BIONTECH | Peripheral embolism and thrombosis | 467 | 2.02 | 2.19 | 2.36 | 314.1 | 1.37 | 1.48 | 1.60 | 2.44 | 2.45 | 2.22 | 783
COVID19_UNKNOWN MFR | Peripheral embolism and thrombosis | 9 | 2.65 | 5.00 | 7.96 | 2.2 | 1.49 | 2.75 | 5.33 | 4.99 | 5.03 | 2.89 | 1241
COVID19_JANSSEN | Peripheral nerve injuries | 3 | 0.27 | 0.86 | 1.71 | 3.9 | 0.35 | 0.77 | 1.54 | 0.91 | 0.91 | 0.34 | 51
COVID19_MODERNA | Peripheral nerve injuries | 6 | 0.24 | 0.52 | 0.89 | 12.3 | 0.28 | 0.53 | 0.93 | 0.42 | 0.42 | 0.21 | 48
COVID19_PFIZER/BIONTECH | Peripheral nerve injuries | 8 | 0.38 | 0.74 | 1.20 | 11.4 | 0.41 | 0.72 | 1.17 | 0.71 | 0.71 | 0.38 | 46
COVID19_UNKNOWN MFR | Peripheral nerve injuries | 1 | 0.31 | 2.36 | 6.02 | 0.1 | 0.42 | 1.41 | 7.23 | 12.98 | 12.99 | 2.47 | 53
COVID19_JANSSEN | Peripheral nerve therapeutic procedures | 0 | 0.00 | 0.38 | 1.45 | 0.8 |  |  |  |  |  |  | 
COVID19_MODERNA | Peripheral nerve therapeutic procedures | 3 | 0.27 | 0.86 | 1.72 | 4.1 | 0.34 | 0.75 | 1.50 | 0.78 | 0.78 | 0.27 | 13
COVID19_PFIZER/BIONTECH | Peripheral nerve therapeutic procedures | 0 | 0.00 | 0.15 | 0.59 | 2.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral nerve therapeutic procedures | 0 | 0.00 | 0.96 | 3.67 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral nervous system disorders congenital NEC | 0 | 0.00 | 0.16 | 0.94 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Peripheral nervous system disorders congenital NEC | 0 | 0.00 | 0.05 | 0.28 | 1.3 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peripheral nervous system disorders congenital NEC | 0 | 0.00 | 0.06 | 0.33 | 1.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral nervous system disorders congenital NEC | 0 | 0.00 | 0.89 | 5.12 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral nervous system histopathology procedures | 0 | 0.00 | 0.37 | 1.35 | 1.0 |  |  |  |  |  |  | 
COVID19_MODERNA | Peripheral nervous system histopathology procedures | 1 | 0.05 | 0.38 | 0.96 | 4.1 | 0.11 | 0.40 | 1.04 | 0.23 | 0.23 | 0.04 | 15
COVID19_PFIZER/BIONTECH | Peripheral nervous system histopathology procedures | 0 | 0.00 | 0.15 | 0.56 | 3.1 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral nervous system histopathology procedures | 0 | 0.01 | 0.96 | 3.53 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral neuropathies NEC | 31 | 0.31 | 0.43 | 0.57 | 88.0 | 0.27 | 0.36 | 0.48 | 0.37 | 0.37 | 0.27 | 1295
COVID19_MODERNA | Peripheral neuropathies NEC | 177 | 0.60 | 0.68 | 0.77 | 295.6 | 0.53 | 0.60 | 0.68 | 0.52 | 0.52 | 0.46 | 1149
COVID19_PFIZER/BIONTECH | Peripheral neuropathies NEC | 251 | 0.98 | 1.09 | 1.20 | 272.0 | 0.83 | 0.92 | 1.02 | 0.96 | 0.96 | 0.85 | 1075
COVID19_UNKNOWN MFR | Peripheral neuropathies NEC | 2 | 0.27 | 1.08 | 2.32 | 2.2 | 0.34 | 0.84 | 1.83 | 1.04 | 1.04 | 0.32 | 1324
COVID19_JANSSEN | Peripheral vascular disorders NEC | 829 | 1.29 | 1.36 | 1.44 | 746.7 | 1.05 | 1.11 | 1.17 | 1.34 | 1.34 | 1.26 | 9586
COVID19_MODERNA | Peripheral vascular disorders NEC | 2949 | 1.23 | 1.27 | 1.31 | 2841.5 | 1.01 | 1.04 | 1.07 | 1.34 | 1.35 | 1.30 | 7466
COVID19_PFIZER/BIONTECH | Peripheral vascular disorders NEC | 3655 | 1.79 | 1.84 | 1.89 | 2449.3 | 1.45 | 1.49 | 1.53 | 2.21 | 2.25 | 2.18 | 6760
COVID19_UNKNOWN MFR | Peripheral vascular disorders NEC | 8 | 0.39 | 0.69 | 1.06 | 15.9 | 0.31 | 0.54 | 0.88 | 0.53 | 0.52 | 0.29 | 10407
COVID19_JANSSEN | Peripheral vasoconstriction, necrosis and vascular insufficiency | 147 | 1.18 | 1.36 | 1.55 | 110.6 | 1.15 | 1.32 | 1.51 | 1.44 | 1.44 | 1.25 | 1575
COVID19_MODERNA | Peripheral vasoconstriction, necrosis and vascular insufficiency | 420 | 0.90 | 0.97 | 1.05 | 434.9 | 0.89 | 0.97 | 1.04 | 1.10 | 1.10 | 1.00 | 1302
COVID19_PFIZER/BIONTECH | Peripheral vasoconstriction, necrosis and vascular insufficiency | 442 | 1.11 | 1.20 | 1.29 | 376.3 | 1.08 | 1.17 | 1.27 | 1.41 | 1.42 | 1.29 | 1280
COVID19_UNKNOWN MFR | Peripheral vasoconstriction, necrosis and vascular insufficiency | 1 | 0.15 | 0.63 | 1.39 | 2.5 | 0.17 | 0.55 | 1.38 | 0.40 | 0.40 | 0.08 | 1721
COVID19_JANSSEN | Peritoneal and retroperitoneal disorders | 1 | 0.07 | 0.37 | 0.88 | 4.9 | 0.08 | 0.34 | 0.92 | 0.17 | 0.17 | 0.03 | 93
COVID19_MODERNA | Peritoneal and retroperitoneal disorders | 22 | 0.94 | 1.37 | 1.87 | 18.0 | 0.83 | 1.17 | 1.62 | 1.04 | 1.04 | 0.70 | 72
COVID19_PFIZER/BIONTECH | Peritoneal and retroperitoneal disorders | 21 | 0.97 | 1.43 | 1.96 | 17.0 | 0.83 | 1.18 | 1.65 | 1.18 | 1.18 | 0.78 | 73
COVID19_UNKNOWN MFR | Peritoneal and retroperitoneal disorders | 2 | 0.73 | 2.63 | 5.50 | 0.1 | 0.72 | 2.72 | 15.41 | 14.95 | 14.99 | 4.62 | 92
COVID19_JANSSEN | Peritoneal and retroperitoneal fibrosis and adhesions | 0 | 0.07 | 0.80 | 2.24 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Peritoneal and retroperitoneal fibrosis and adhesions | 1 | 0.19 | 0.94 | 2.16 | 1.1 | 0.27 | 0.82 | 2.02 | 0.85 | 0.85 | 0.14 | 4
COVID19_PFIZER/BIONTECH | Peritoneal and retroperitoneal fibrosis and adhesions | 3 | 0.68 | 1.91 | 3.66 | 1.1 | 0.65 | 1.48 | 3.20 | 6.14 | 6.14 | 1.37 | 2
COVID19_UNKNOWN MFR | Peritoneal and retroperitoneal fibrosis and adhesions | 0 | 0.08 | 0.99 | 2.77 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Peritoneal and retroperitoneal haemorrhages | 2 | 0.42 | 1.55 | 3.25 | 1.0 | 0.47 | 1.18 | 2.63 | 2.06 | 2.06 | 0.60 | 15
COVID19_MODERNA | Peritoneal and retroperitoneal haemorrhages | 10 | 1.11 | 1.97 | 3.04 | 5.2 | 0.96 | 1.59 | 2.53 | 4.85 | 4.85 | 2.16 | 7
COVID19_PFIZER/BIONTECH | Peritoneal and retroperitoneal haemorrhages | 4 | 0.43 | 1.08 | 1.98 | 4.1 | 0.44 | 0.91 | 1.71 | 1.26 | 1.26 | 0.49 | 13
COVID19_UNKNOWN MFR | Peritoneal and retroperitoneal haemorrhages | 0 | 0.05 | 0.98 | 2.92 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Peritoneal fluid and membrane function analyses | 0 | 0.07 | 0.91 | 2.57 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Peritoneal fluid and membrane function analyses | 1 | 0.26 | 1.34 | 3.10 | 0.6 | 0.33 | 0.98 | 2.48 | 3.40 | 3.40 | 0.33 | 1
COVID19_PFIZER/BIONTECH | Peritoneal fluid and membrane function analyses | 0 | 0.05 | 0.75 | 2.12 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peritoneal fluid and membrane function analyses | 0 | 0.07 | 1.00 | 2.84 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Persistent foetal circulation disorders | 0 | 0.00 | 0.45 | 2.18 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Persistent foetal circulation disorders | 0 | 0.00 | 0.18 | 0.87 | 1.1 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Persistent foetal circulation disorders | 0 | 0.00 | 0.20 | 0.98 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Persistent foetal circulation disorders | 0 | 0.00 | 0.97 | 4.72 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Personality disorders NEC | 0 | 0.01 | 0.42 | 1.43 | 1.0 |  |  |  |  |  |  | 
COVID19_MODERNA | Personality disorders NEC | 1 | 0.10 | 0.70 | 1.74 | 1.6 | 0.23 | 0.71 | 1.75 | 0.14 | 0.14 | 0.03 | 24
COVID19_PFIZER/BIONTECH | Personality disorders NEC | 1 | 0.08 | 0.54 | 1.36 | 2.7 | 0.16 | 0.54 | 1.35 | 0.17 | 0.17 | 0.03 | 24
COVID19_UNKNOWN MFR | Personality disorders NEC | 0 | 0.02 | 0.97 | 3.28 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Personality disorders with anxious behaviour (Cluster C) | 0 | 0.07 | 0.91 | 2.55 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Personality disorders with anxious behaviour (Cluster C) | 0 | 0.06 | 0.73 | 2.04 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Personality disorders with anxious behaviour (Cluster C) | 1 | 0.28 | 1.38 | 3.18 | 0.2 | 0.38 | 1.18 | 3.40 | 4.09 | 4.09 | 0.40 | 1
COVID19_UNKNOWN MFR | Personality disorders with anxious behaviour (Cluster C) | 0 | 0.08 | 1.00 | 2.80 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Personality disorders with dramatic behaviour (Cluster B) | 0 | 0.02 | 0.81 | 2.64 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Personality disorders with dramatic behaviour (Cluster B) | 0 | 0.02 | 0.54 | 1.75 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Personality disorders with dramatic behaviour (Cluster B) | 0 | 0.02 | 0.57 | 1.87 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Personality disorders with dramatic behaviour (Cluster B) | 0 | 0.03 | 1.00 | 3.23 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Personality disorders with eccentric behaviour (Cluster A) | 0 | 0.05 | 0.79 | 2.26 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Personality disorders with eccentric behaviour (Cluster A) | 0 | 0.03 | 0.50 | 1.43 | 1.1 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Personality disorders with eccentric behaviour (Cluster A) | 1 | 0.19 | 1.01 | 2.35 | 0.3 | 0.36 | 1.11 | 2.97 | 1.02 | 1.02 | 0.16 | 4
COVID19_UNKNOWN MFR | Personality disorders with eccentric behaviour (Cluster A) | 0 | 0.07 | 0.99 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pervasive developmental disorders NEC | 1 | 0.02 | 0.14 | 0.34 | 14.8 | 0.01 | 0.09 | 0.35 | 0.03 | 0.03 | 0.01 | 554
COVID19_MODERNA | Pervasive developmental disorders NEC | 2 | 0.06 | 0.22 | 0.47 | 11.6 | 0.08 | 0.25 | 0.58 | 0.01 | 0.01 | 0.00 | 553
COVID19_PFIZER/BIONTECH | Pervasive developmental disorders NEC | 2 | 0.03 | 0.10 | 0.21 | 36.1 | 0.02 | 0.06 | 0.18 | 0.02 | 0.02 | 0.01 | 553
COVID19_UNKNOWN MFR | Pervasive developmental disorders NEC | 0 | 0.02 | 0.67 | 2.18 | 0.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal and laryngeal neoplasms benign | 0 | 0.05 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Pharyngeal and laryngeal neoplasms benign | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pharyngeal and laryngeal neoplasms benign | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal and laryngeal neoplasms benign | 0 | 0.05 | 1.00 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal disorders (excl infections and neoplasms) | 251 | 0.79 | 0.88 | 0.98 | 345.2 | 0.66 | 0.73 | 0.81 | 0.88 | 0.88 | 0.79 | 4410
COVID19_MODERNA | Pharyngeal disorders (excl infections and neoplasms) | 1387 | 1.17 | 1.23 | 1.28 | 1371.7 | 0.97 | 1.01 | 1.06 | 1.44 | 1.44 | 1.37 | 3274
COVID19_PFIZER/BIONTECH | Pharyngeal disorders (excl infections and neoplasms) | 1690 | 1.69 | 1.76 | 1.83 | 1165.7 | 1.39 | 1.45 | 1.51 | 2.33 | 2.35 | 2.23 | 2971
COVID19_UNKNOWN MFR | Pharyngeal disorders (excl infections and neoplasms) | 6 | 0.52 | 0.98 | 1.56 | 7.4 | 0.43 | 0.80 | 1.39 | 0.89 | 0.89 | 0.45 | 4655
COVID19_JANSSEN | Pharyngeal therapeutic procedures | 0 | 0.07 | 0.95 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Pharyngeal therapeutic procedures | 1 | 0.30 | 1.57 | 3.64 | 0.3 | 0.36 | 1.11 | 3.00 | 10.19 | 10.19 | 0.69 | 0
COVID19_PFIZER/BIONTECH | Pharyngeal therapeutic procedures | 0 | 0.06 | 0.85 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal therapeutic procedures | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Phlebitis NEC | 6 | 0.83 | 1.75 | 2.94 | 3.6 | 0.72 | 1.34 | 2.34 | 1.93 | 1.93 | 0.95 | 48
COVID19_MODERNA | Phlebitis NEC | 15 | 0.75 | 1.19 | 1.71 | 14.7 | 0.65 | 0.99 | 1.45 | 1.31 | 1.31 | 0.79 | 39
COVID19_PFIZER/BIONTECH | Phlebitis NEC | 8 | 0.43 | 0.81 | 1.29 | 12.3 | 0.39 | 0.67 | 1.10 | 0.71 | 0.71 | 0.38 | 46
COVID19_UNKNOWN MFR | Phlebitis NEC | 0 | 0.08 | 0.95 | 2.65 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Phosphorus metabolism disorders | 0 | 0.05 | 0.66 | 1.87 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Phosphorus metabolism disorders | 5 | 0.79 | 1.79 | 3.12 | 2.7 | 0.70 | 1.36 | 2.48 | 3.40 | 3.40 | 1.20 | 5
COVID19_PFIZER/BIONTECH | Phosphorus metabolism disorders | 1 | 0.14 | 0.69 | 1.60 | 2.3 | 0.18 | 0.58 | 1.45 | 0.46 | 0.46 | 0.08 | 9
COVID19_UNKNOWN MFR | Phosphorus metabolism disorders | 0 | 0.07 | 0.99 | 2.81 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Photosensitivity and photodermatosis conditions | 28 | 1.31 | 1.84 | 2.44 | 17.6 | 1.10 | 1.50 | 2.01 | 1.82 | 1.83 | 1.31 | 237
COVID19_MODERNA | Photosensitivity and photodermatosis conditions | 37 | 0.54 | 0.72 | 0.93 | 54.0 | 0.53 | 0.69 | 0.89 | 0.55 | 0.55 | 0.41 | 228
COVID19_PFIZER/BIONTECH | Photosensitivity and photodermatosis conditions | 41 | 0.67 | 0.88 | 1.12 | 51.6 | 0.61 | 0.80 | 1.01 | 0.75 | 0.75 | 0.57 | 224
COVID19_UNKNOWN MFR | Photosensitivity and photodermatosis conditions | 0 | 0.00 | 0.59 | 2.26 | 0.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Phototherapies | 1 | 0.09 | 0.81 | 2.13 | 1.7 | 0.22 | 0.68 | 1.69 | 0.53 | 0.53 | 0.10 | 29
COVID19_MODERNA | Phototherapies | 0 | 0.00 | 0.11 | 0.45 | 3.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Phototherapies | 1 | 0.04 | 0.34 | 0.91 | 4.7 | 0.09 | 0.36 | 0.96 | 0.14 | 0.14 | 0.03 | 29
COVID19_UNKNOWN MFR | Phototherapies | 0 | 0.00 | 0.93 | 3.74 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Physical examination procedures and organ system status | 2267 | 2.09 | 2.16 | 2.24 | 1147.2 | 1.91 | 1.97 | 2.04 | 2.23 | 2.31 | 2.23 | 15676
COVID19_MODERNA | Physical examination procedures and organ system status | 4102 | 1.00 | 1.02 | 1.05 | 4258.8 | 0.94 | 0.96 | 0.99 | 1.01 | 1.01 | 0.98 | 13841
COVID19_PFIZER/BIONTECH | Physical examination procedures and organ system status | 4981 | 1.39 | 1.42 | 1.46 | 3759.6 | 1.29 | 1.33 | 1.36 | 1.57 | 1.60 | 1.55 | 12962
COVID19_UNKNOWN MFR | Physical examination procedures and organ system status | 49 | 1.42 | 1.81 | 2.23 | 27.2 | 1.36 | 1.72 | 2.16 | 1.88 | 1.94 | 1.52 | 17894
COVID19_JANSSEN | Pigmentation changes NEC | 1 | 0.08 | 0.48 | 1.15 | 3.4 | 0.13 | 0.46 | 1.18 | 0.27 | 0.27 | 0.05 | 58
COVID19_MODERNA | Pigmentation changes NEC | 7 | 0.43 | 0.87 | 1.42 | 8.2 | 0.47 | 0.84 | 1.42 | 0.46 | 0.46 | 0.24 | 52
COVID19_PFIZER/BIONTECH | Pigmentation changes NEC | 5 | 0.26 | 0.61 | 1.07 | 9.3 | 0.30 | 0.59 | 1.06 | 0.38 | 0.38 | 0.18 | 54
COVID19_UNKNOWN MFR | Pigmentation changes NEC | 0 | 0.04 | 0.92 | 2.80 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pilar disorders NEC | 27 | 1.83 | 2.58 | 3.44 | 14.2 | 1.27 | 1.75 | 2.36 | 2.23 | 2.23 | 1.59 | 187
COVID19_MODERNA | Pilar disorders NEC | 32 | 0.67 | 0.91 | 1.19 | 43.0 | 0.56 | 0.75 | 0.98 | 0.60 | 0.60 | 0.44 | 182
COVID19_PFIZER/BIONTECH | Pilar disorders NEC | 28 | 0.63 | 0.88 | 1.17 | 41.7 | 0.50 | 0.68 | 0.91 | 0.62 | 0.62 | 0.44 | 186
COVID19_UNKNOWN MFR | Pilar disorders NEC | 0 | 0.00 | 0.67 | 2.60 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pituitary analyses anterior | 88 | 0.95 | 1.14 | 1.35 | 83.3 | 0.88 | 1.05 | 1.24 | 1.24 | 1.24 | 1.03 | 1096
COVID19_MODERNA | Pituitary analyses anterior | 283 | 0.86 | 0.95 | 1.04 | 318.3 | 0.81 | 0.89 | 0.98 | 1.07 | 1.07 | 0.95 | 901
COVID19_PFIZER/BIONTECH | Pituitary analyses anterior | 295 | 1.04 | 1.15 | 1.26 | 276.1 | 0.97 | 1.07 | 1.17 | 1.36 | 1.36 | 1.22 | 889
COVID19_UNKNOWN MFR | Pituitary analyses anterior | 5 | 0.88 | 1.86 | 3.14 | 1.8 | 0.85 | 1.70 | 3.24 | 2.92 | 2.93 | 1.40 | 1179
COVID19_JANSSEN | Pituitary neoplasms | 0 | 0.00 | 0.70 | 2.85 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Pituitary neoplasms | 0 | 0.00 | 0.38 | 1.56 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pituitary neoplasms | 0 | 0.00 | 0.42 | 1.71 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pituitary neoplasms | 0 | 0.00 | 0.99 | 4.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Placental abnormalities (excl neoplasms) | 2 | 0.11 | 0.56 | 1.29 | 5.1 | 0.19 | 0.51 | 1.11 | 0.53 | 0.53 | 0.16 | 58
COVID19_MODERNA | Placental abnormalities (excl neoplasms) | 3 | 0.07 | 0.24 | 0.50 | 17.3 | 0.09 | 0.23 | 0.48 | 0.18 | 0.18 | 0.07 | 57
COVID19_PFIZER/BIONTECH | Placental abnormalities (excl neoplasms) | 3 | 0.08 | 0.26 | 0.54 | 15.8 | 0.10 | 0.25 | 0.52 | 0.22 | 0.22 | 0.08 | 57
COVID19_UNKNOWN MFR | Placental abnormalities (excl neoplasms) | 0 | 0.00 | 0.68 | 3.53 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Plasma cell myelomas | 0 | 0.00 | 0.28 | 1.08 | 1.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Plasma cell myelomas | 4 | 0.35 | 0.95 | 1.78 | 4.5 | 0.41 | 0.85 | 1.60 | 0.72 | 0.72 | 0.29 | 19
COVID19_PFIZER/BIONTECH | Plasma cell myelomas | 3 | 0.24 | 0.77 | 1.54 | 4.5 | 0.31 | 0.71 | 1.41 | 0.61 | 0.61 | 0.22 | 20
COVID19_UNKNOWN MFR | Plasma cell myelomas | 0 | 0.00 | 0.93 | 3.61 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Plasma cell neoplasms NEC | 0 | 0.00 | 0.42 | 1.57 | 0.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Plasma cell neoplasms NEC | 1 | 0.05 | 0.43 | 1.12 | 2.4 | 0.18 | 0.57 | 1.43 | 0.31 | 0.31 | 0.06 | 11
COVID19_PFIZER/BIONTECH | Plasma cell neoplasms NEC | 3 | 0.35 | 1.11 | 2.23 | 2.3 | 0.47 | 1.05 | 2.10 | 1.36 | 1.36 | 0.46 | 9
COVID19_UNKNOWN MFR | Plasma cell neoplasms NEC | 0 | 0.01 | 0.97 | 3.66 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Plasmodia infections | 1 | 0.12 | 1.76 | 5.03 | 0.5 | 0.34 | 1.02 | 2.62 | 1.54 | 1.54 | 0.28 | 10
COVID19_MODERNA | Plasmodia infections | 0 | 0.00 | 0.08 | 0.45 | 1.6 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Plasmodia infections | 0 | 0.00 | 0.08 | 0.45 | 1.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plasmodia infections | 0 | 0.00 | 0.91 | 5.08 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Platelet analyses | 427 | 2.60 | 2.82 | 3.05 | 182.3 | 2.15 | 2.33 | 2.52 | 2.11 | 2.12 | 1.95 | 3126
COVID19_MODERNA | Platelet analyses | 508 | 0.82 | 0.88 | 0.95 | 648.1 | 0.73 | 0.78 | 0.84 | 0.57 | 0.56 | 0.52 | 3045
COVID19_PFIZER/BIONTECH | Platelet analyses | 659 | 1.18 | 1.26 | 1.34 | 611.8 | 1.01 | 1.08 | 1.15 | 0.93 | 0.93 | 0.87 | 2894
COVID19_UNKNOWN MFR | Platelet analyses | 10 | 1.15 | 1.99 | 3.02 | 4.7 | 1.02 | 1.69 | 2.69 | 1.94 | 1.95 | 1.16 | 3543
COVID19_JANSSEN | Platelet disorders NEC | 4 | 0.86 | 2.04 | 3.63 | 1.2 | 0.81 | 1.73 | 3.68 | 3.25 | 3.25 | 1.32 | 19
COVID19_MODERNA | Platelet disorders NEC | 4 | 0.36 | 0.85 | 1.51 | 5.5 | 0.36 | 0.75 | 1.41 | 0.72 | 0.72 | 0.29 | 19
COVID19_PFIZER/BIONTECH | Platelet disorders NEC | 7 | 0.79 | 1.53 | 2.48 | 4.4 | 0.74 | 1.33 | 2.24 | 1.79 | 1.79 | 0.85 | 16
COVID19_UNKNOWN MFR | Platelet disorders NEC | 0 | 0.14 | 0.98 | 2.48 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pleural conditions NEC | 0 | 0.01 | 0.54 | 1.93 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Pleural conditions NEC | 4 | 0.47 | 1.25 | 2.34 | 3.5 | 0.48 | 0.99 | 1.87 | 1.13 | 1.13 | 0.44 | 12
COVID19_PFIZER/BIONTECH | Pleural conditions NEC | 4 | 0.55 | 1.46 | 2.72 | 3.1 | 0.52 | 1.07 | 2.02 | 1.36 | 1.36 | 0.53 | 12
COVID19_UNKNOWN MFR | Pleural conditions NEC | 0 | 0.01 | 0.97 | 3.50 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pleural infections and inflammations | 5 | 0.42 | 0.82 | 1.33 | 7.0 | 0.38 | 0.73 | 1.32 | 0.88 | 0.88 | 0.41 | 88
COVID19_MODERNA | Pleural infections and inflammations | 22 | 0.61 | 0.88 | 1.18 | 25.9 | 0.60 | 0.85 | 1.17 | 1.05 | 1.05 | 0.70 | 71
COVID19_PFIZER/BIONTECH | Pleural infections and inflammations | 29 | 0.92 | 1.26 | 1.65 | 22.4 | 0.92 | 1.25 | 1.66 | 1.86 | 1.86 | 1.28 | 64
COVID19_UNKNOWN MFR | Pleural infections and inflammations | 0 | 0.31 | 0.96 | 1.91 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pleural therapeutic procedures | 0 | 0.02 | 0.62 | 2.02 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Pleural therapeutic procedures | 0 | 0.01 | 0.30 | 0.98 | 1.8 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pleural therapeutic procedures | 3 | 0.53 | 1.61 | 3.16 | 1.3 | 0.60 | 1.36 | 2.82 | 2.46 | 2.46 | 0.74 | 5
COVID19_UNKNOWN MFR | Pleural therapeutic procedures | 0 | 0.03 | 0.99 | 3.22 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pneumocystis infections | 0 | 0.00 | 0.23 | 1.21 | 0.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Pneumocystis infections | 1 | 0.06 | 0.76 | 2.13 | 0.8 | 0.30 | 0.89 | 2.21 | 0.23 | 0.23 | 0.04 | 15
COVID19_PFIZER/BIONTECH | Pneumocystis infections | 0 | 0.00 | 0.10 | 0.54 | 1.7 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumocystis infections | 0 | 0.00 | 0.92 | 4.73 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pneumothorax and pleural effusions NEC | 23 | 0.84 | 1.22 | 1.65 | 25.1 | 0.64 | 0.91 | 1.24 | 0.81 | 0.81 | 0.57 | 438
COVID19_MODERNA | Pneumothorax and pleural effusions NEC | 104 | 1.04 | 1.24 | 1.44 | 112.7 | 0.78 | 0.92 | 1.08 | 0.99 | 0.99 | 0.82 | 357
COVID19_PFIZER/BIONTECH | Pneumothorax and pleural effusions NEC | 157 | 1.89 | 2.17 | 2.46 | 97.4 | 1.40 | 1.59 | 1.81 | 2.11 | 2.12 | 1.80 | 304
COVID19_UNKNOWN MFR | Pneumothorax and pleural effusions NEC | 1 | 0.25 | 1.24 | 2.84 | 0.7 | 0.31 | 0.92 | 2.30 | 1.50 | 1.50 | 0.29 | 460
COVID19_JANSSEN | Poisoning and toxicity | 3 | 0.27 | 0.80 | 1.57 | 4.6 | 0.31 | 0.69 | 1.39 | 0.48 | 0.48 | 0.18 | 97
COVID19_MODERNA | Poisoning and toxicity | 7 | 0.32 | 0.64 | 1.06 | 11.9 | 0.35 | 0.62 | 1.04 | 0.26 | 0.26 | 0.13 | 93
COVID19_PFIZER/BIONTECH | Poisoning and toxicity | 9 | 0.43 | 0.79 | 1.25 | 13.0 | 0.42 | 0.71 | 1.13 | 0.41 | 0.41 | 0.23 | 91
COVID19_UNKNOWN MFR | Poisoning and toxicity | 0 | 0.03 | 0.89 | 2.83 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Poliomyelitis viral infections | 0 | 0.00 | 0.13 | 0.74 | 0.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Poliomyelitis viral infections | 0 | 0.00 | 0.07 | 0.38 | 1.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Poliomyelitis viral infections | 0 | 0.00 | 0.06 | 0.35 | 1.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Poliomyelitis viral infections | 0 | 0.00 | 0.84 | 4.85 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Polycythaemia (excl rubra vera) | 2 | 0.53 | 1.67 | 3.32 | 0.7 | 0.51 | 1.31 | 3.07 | 4.41 | 4.41 | 1.18 | 7
COVID19_MODERNA | Polycythaemia (excl rubra vera) | 1 | 0.17 | 0.72 | 1.56 | 2.5 | 0.17 | 0.55 | 1.39 | 0.42 | 0.42 | 0.07 | 8
COVID19_PFIZER/BIONTECH | Polycythaemia (excl rubra vera) | 1 | 0.19 | 0.77 | 1.69 | 2.2 | 0.19 | 0.60 | 1.48 | 0.51 | 0.51 | 0.09 | 8
COVID19_UNKNOWN MFR | Polycythaemia (excl rubra vera) | 0 | 0.13 | 0.99 | 2.52 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Polyomavirus infections | 1 | 0.25 | 1.50 | 3.61 | 0.3 | 0.38 | 1.17 | 3.31 | 3.09 | 3.09 | 0.51 | 5
COVID19_MODERNA | Polyomavirus infections | 0 | 0.02 | 0.40 | 1.24 | 1.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Polyomavirus infections | 1 | 0.15 | 0.92 | 2.20 | 0.5 | 0.33 | 1.00 | 2.52 | 0.82 | 0.82 | 0.14 | 5
COVID19_UNKNOWN MFR | Polyomavirus infections | 0 | 0.04 | 0.99 | 3.07 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Posterior pituitary disorders | 0 | 0.01 | 0.30 | 0.96 | 2.0 |  |  |  |  |  |  | 
COVID19_MODERNA | Posterior pituitary disorders | 4 | 0.29 | 0.76 | 1.39 | 5.8 | 0.35 | 0.72 | 1.35 | 0.49 | 0.49 | 0.20 | 28
COVID19_PFIZER/BIONTECH | Posterior pituitary disorders | 7 | 0.59 | 1.20 | 1.98 | 5.8 | 0.61 | 1.09 | 1.84 | 1.15 | 1.15 | 0.57 | 25
COVID19_UNKNOWN MFR | Posterior pituitary disorders | 0 | 0.03 | 0.94 | 2.98 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Postpartum complications NEC | 1 | 0.23 | 1.30 | 3.10 | 0.7 | 0.31 | 0.92 | 2.30 | 1.93 | 1.93 | 0.34 | 8
COVID19_MODERNA | Postpartum complications NEC | 1 | 0.11 | 0.65 | 1.56 | 3.3 | 0.14 | 0.47 | 1.19 | 0.42 | 0.42 | 0.07 | 8
COVID19_PFIZER/BIONTECH | Postpartum complications NEC | 2 | 0.29 | 1.09 | 2.29 | 2.7 | 0.30 | 0.75 | 1.62 | 1.17 | 1.17 | 0.31 | 7
COVID19_UNKNOWN MFR | Postpartum complications NEC | 0 | 0.05 | 0.99 | 2.99 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Potassium imbalance | 14 | 0.69 | 1.12 | 1.64 | 12.7 | 0.69 | 1.05 | 1.57 | 1.03 | 1.03 | 0.66 | 209
COVID19_MODERNA | Potassium imbalance | 64 | 0.95 | 1.18 | 1.43 | 54.9 | 0.94 | 1.15 | 1.40 | 1.37 | 1.37 | 1.07 | 159
COVID19_PFIZER/BIONTECH | Potassium imbalance | 66 | 1.17 | 1.44 | 1.75 | 46.9 | 1.13 | 1.38 | 1.68 | 1.72 | 1.72 | 1.35 | 157
COVID19_UNKNOWN MFR | Potassium imbalance | 2 | 0.63 | 2.50 | 5.36 | 0.4 | 0.60 | 1.68 | 5.94 | 6.23 | 6.24 | 1.94 | 221
COVID19_JANSSEN | Precursor T-lymphoblastic lymphomas/leukaemias | 0 | 0.05 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Precursor T-lymphoblastic lymphomas/leukaemias | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Precursor T-lymphoblastic lymphomas/leukaemias | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Precursor T-lymphoblastic lymphomas/leukaemias | 0 | 0.05 | 1.00 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pregnancy complicated by maternal disorders | 0 | 0.00 | 0.06 | 0.29 | 3.0 |  |  |  |  |  |  | 
COVID19_MODERNA | Pregnancy complicated by maternal disorders | 2 | 0.04 | 0.21 | 0.47 | 15.5 | 0.05 | 0.18 | 0.44 | 0.15 | 0.15 | 0.05 | 46
COVID19_PFIZER/BIONTECH | Pregnancy complicated by maternal disorders | 5 | 0.22 | 0.54 | 0.97 | 13.7 | 0.21 | 0.42 | 0.77 | 0.48 | 0.48 | 0.22 | 43
COVID19_UNKNOWN MFR | Pregnancy complicated by maternal disorders | 0 | 0.00 | 0.72 | 3.85 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pregnancy related circumstances | 8 | 0.85 | 1.63 | 2.61 | 4.2 | 0.87 | 1.51 | 2.50 | 2.69 | 2.69 | 1.43 | 46
COVID19_MODERNA | Pregnancy related circumstances | 19 | 0.66 | 1.00 | 1.39 | 17.4 | 0.73 | 1.05 | 1.49 | 1.84 | 1.84 | 1.15 | 35
COVID19_PFIZER/BIONTECH | Pregnancy related circumstances | 20 | 0.82 | 1.22 | 1.69 | 15.2 | 0.86 | 1.24 | 1.75 | 2.41 | 2.41 | 1.52 | 34
COVID19_UNKNOWN MFR | Pregnancy related circumstances | 1 | 0.33 | 1.79 | 4.18 | 0.1 | 0.42 | 1.43 | 7.61 | 12.98 | 12.99 | 2.47 | 53
COVID19_JANSSEN | Primary immunodeficiency syndromes | 0 | 0.00 | 0.27 | 1.10 | 1.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Primary immunodeficiency syndromes | 2 | 0.17 | 0.76 | 1.70 | 2.7 | 0.30 | 0.75 | 1.62 | 0.31 | 0.31 | 0.09 | 22
COVID19_PFIZER/BIONTECH | Primary immunodeficiency syndromes | 0 | 0.00 | 0.12 | 0.50 | 2.9 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Primary immunodeficiency syndromes | 0 | 0.00 | 0.93 | 3.87 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Prion-associated disorders | 0 | 0.05 | 0.89 | 2.66 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Prion-associated disorders | 0 | 0.04 | 0.69 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prion-associated disorders | 0 | 0.04 | 0.72 | 2.15 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prion-associated disorders | 0 | 0.05 | 1.00 | 2.96 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Product administration errors and issues | 1146 | 0.71 | 0.75 | 0.79 | 2034.9 | 0.54 | 0.56 | 0.59 | 0.44 | 0.43 | 0.41 | 39915
COVID19_MODERNA | Product administration errors and issues | 7916 | 2.14 | 2.18 | 2.22 | 5271.3 | 1.47 | 1.50 | 1.53 | 0.81 | 0.80 | 0.78 | 33145
COVID19_PFIZER/BIONTECH | Product administration errors and issues | 3287 | 0.88 | 0.91 | 0.94 | 5092.1 | 0.63 | 0.65 | 0.66 | 0.36 | 0.34 | 0.33 | 37774
COVID19_UNKNOWN MFR | Product administration errors and issues | 36 | 0.74 | 0.99 | 1.26 | 48.6 | 0.56 | 0.74 | 0.96 | 0.60 | 0.59 | 0.44 | 41025
COVID19_JANSSEN | Product confusion errors and issues | 1 | 0.05 | 0.31 | 0.77 | 6.0 | 0.06 | 0.28 | 0.79 | 0.09 | 0.09 | 0.02 | 174
COVID19_MODERNA | Product confusion errors and issues | 44 | 1.76 | 2.29 | 2.88 | 23.4 | 1.39 | 1.78 | 2.26 | 1.14 | 1.14 | 0.86 | 131
COVID19_PFIZER/BIONTECH | Product confusion errors and issues | 2 | 0.04 | 0.16 | 0.34 | 21.0 | 0.03 | 0.13 | 0.33 | 0.05 | 0.05 | 0.02 | 173
COVID19_UNKNOWN MFR | Product confusion errors and issues | 0 | 0.03 | 0.84 | 2.68 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Product contamination and sterility issues | 2 | 0.33 | 1.24 | 2.63 | 1.5 | 0.40 | 0.99 | 2.16 | 1.07 | 1.07 | 0.32 | 29
COVID19_MODERNA | Product contamination and sterility issues | 4 | 0.37 | 0.94 | 1.73 | 4.6 | 0.41 | 0.84 | 1.58 | 0.50 | 0.50 | 0.21 | 27
COVID19_PFIZER/BIONTECH | Product contamination and sterility issues | 2 | 0.16 | 0.60 | 1.28 | 4.2 | 0.23 | 0.58 | 1.26 | 0.28 | 0.28 | 0.09 | 29
COVID19_UNKNOWN MFR | Product contamination and sterility issues | 0 | 0.04 | 0.96 | 3.00 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Product dispensing errors and issues | 13 | 1.79 | 2.90 | 4.23 | 3.4 | 1.72 | 2.84 | 4.78 | 3.72 | 3.72 | 2.24 | 54
COVID19_MODERNA | Product dispensing errors and issues | 15 | 0.87 | 1.37 | 1.96 | 10.9 | 0.84 | 1.27 | 1.87 | 0.98 | 0.98 | 0.61 | 52
COVID19_PFIZER/BIONTECH | Product dispensing errors and issues | 13 | 0.81 | 1.31 | 1.91 | 10.1 | 0.76 | 1.19 | 1.79 | 0.99 | 0.99 | 0.59 | 54
COVID19_UNKNOWN MFR | Product dispensing errors and issues | 0 | 0.18 | 0.97 | 2.27 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Product distribution and storage issues | 13 | 0.45 | 0.76 | 1.14 | 28.9 | 0.30 | 0.47 | 0.71 | 0.26 | 0.26 | 0.16 | 778
COVID19_MODERNA | Product distribution and storage issues | 614 | 24.88 | 26.63 | 28.42 | 49.5 | 11.56 | 12.36 | 13.20 | 11.78 | 11.83 | 10.28 | 177
COVID19_PFIZER/BIONTECH | Product distribution and storage issues | 41 | 1.74 | 2.29 | 2.91 | 41.1 | 0.76 | 0.99 | 1.26 | 0.22 | 0.22 | 0.17 | 750
COVID19_UNKNOWN MFR | Product distribution and storage issues | 0 | 0.00 | 0.29 | 1.59 | 0.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Product label issues | 4 | 0.86 | 2.26 | 4.18 | 1.4 | 0.76 | 1.61 | 3.27 | 1.99 | 1.99 | 0.83 | 31
COVID19_MODERNA | Product label issues | 1 | 0.06 | 0.39 | 0.95 | 3.3 | 0.14 | 0.47 | 1.20 | 0.10 | 0.10 | 0.02 | 34
COVID19_PFIZER/BIONTECH | Product label issues | 2 | 0.16 | 0.64 | 1.38 | 3.3 | 0.27 | 0.68 | 1.47 | 0.25 | 0.25 | 0.08 | 33
COVID19_UNKNOWN MFR | Product label issues | 0 | 0.02 | 0.96 | 3.17 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Product monitoring errors and issues | 0 | 0.00 | 0.08 | 0.35 | 3.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Product monitoring errors and issues | 3 | 0.11 | 0.37 | 0.76 | 8.8 | 0.18 | 0.42 | 0.86 | 0.15 | 0.15 | 0.06 | 68
COVID19_PFIZER/BIONTECH | Product monitoring errors and issues | 2 | 0.05 | 0.24 | 0.54 | 10.0 | 0.10 | 0.29 | 0.66 | 0.12 | 0.12 | 0.04 | 69
COVID19_UNKNOWN MFR | Product monitoring errors and issues | 0 | 0.00 | 0.76 | 3.45 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Product packaging issues | 6 | 0.52 | 1.16 | 2.01 | 6.1 | 0.50 | 0.93 | 1.60 | 0.95 | 0.95 | 0.47 | 98
COVID19_MODERNA | Product packaging issues | 6 | 0.29 | 0.65 | 1.13 | 11.1 | 0.31 | 0.58 | 1.01 | 0.21 | 0.21 | 0.10 | 98
COVID19_PFIZER/BIONTECH | Product packaging issues | 2 | 0.04 | 0.20 | 0.46 | 13.1 | 0.07 | 0.22 | 0.52 | 0.08 | 0.08 | 0.03 | 102
COVID19_UNKNOWN MFR | Product packaging issues | 0 | 0.00 | 0.66 | 3.15 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Product physical issues | 9 | 0.55 | 1.05 | 1.67 | 11.4 | 0.47 | 0.79 | 1.27 | 0.72 | 0.72 | 0.41 | 194
COVID19_MODERNA | Product physical issues | 11 | 0.25 | 0.45 | 0.69 | 30.9 | 0.24 | 0.38 | 0.60 | 0.20 | 0.19 | 0.12 | 192
COVID19_PFIZER/BIONTECH | Product physical issues | 18 | 0.52 | 0.80 | 1.13 | 28.7 | 0.44 | 0.64 | 0.91 | 0.40 | 0.40 | 0.27 | 185
COVID19_UNKNOWN MFR | Product physical issues | 0 | 0.00 | 0.60 | 2.70 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Product preparation errors and issues | 6 | 0.06 | 0.14 | 0.24 | 81.9 | 0.04 | 0.08 | 0.15 | 0.05 | 0.05 | 0.03 | 1794
COVID19_MODERNA | Product preparation errors and issues | 44 | 0.21 | 0.27 | 0.34 | 250.7 | 0.14 | 0.18 | 0.23 | 0.09 | 0.09 | 0.07 | 1756
COVID19_PFIZER/BIONTECH | Product preparation errors and issues | 580 | 3.91 | 4.19 | 4.48 | 236.3 | 2.28 | 2.44 | 2.61 | 1.95 | 1.95 | 1.80 | 1220
COVID19_UNKNOWN MFR | Product preparation errors and issues | 0 | 0.00 | 0.22 | 0.99 | 1.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Product prescribing errors and issues | 0 | 0.08 | 0.48 | 1.16 | 2.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Product prescribing errors and issues | 1 | 0.13 | 0.49 | 1.03 | 3.7 | 0.12 | 0.44 | 1.12 | 0.10 | 0.10 | 0.02 | 35
COVID19_PFIZER/BIONTECH | Product prescribing errors and issues | 2 | 0.19 | 0.57 | 1.12 | 4.5 | 0.21 | 0.55 | 1.20 | 0.24 | 0.24 | 0.07 | 34
COVID19_UNKNOWN MFR | Product prescribing errors and issues | 0 | 0.16 | 0.97 | 2.34 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Product quality issues NEC | 8 | 0.20 | 0.39 | 0.63 | 20.9 | 0.24 | 0.42 | 0.69 | 0.32 | 0.32 | 0.18 | 391
COVID19_MODERNA | Product quality issues NEC | 2 | 0.01 | 0.05 | 0.11 | 44.5 | 0.01 | 0.05 | 0.14 | 0.02 | 0.02 | 0.01 | 397
COVID19_PFIZER/BIONTECH | Product quality issues NEC | 8 | 0.08 | 0.16 | 0.26 | 48.4 | 0.10 | 0.19 | 0.31 | 0.08 | 0.08 | 0.05 | 391
COVID19_UNKNOWN MFR | Product quality issues NEC | 0 | 0.01 | 0.55 | 1.90 | 0.6 |  |  |  |  |  |  | 
COVID19_JANSSEN | Product selection errors and issues | 0 | 0.09 | 0.86 | 2.26 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Product selection errors and issues | 1 | 0.23 | 1.04 | 2.32 | 0.9 | 0.29 | 0.87 | 2.16 | 1.13 | 1.13 | 0.17 | 3
COVID19_PFIZER/BIONTECH | Product selection errors and issues | 2 | 0.47 | 1.55 | 3.13 | 0.8 | 0.49 | 1.24 | 2.82 | 4.09 | 4.09 | 0.79 | 2
COVID19_UNKNOWN MFR | Product selection errors and issues | 0 | 0.11 | 1.00 | 2.64 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Product storage errors and issues in the product use system | 151 | 0.10 | 0.11 | 0.13 | 1393.0 | 0.10 | 0.11 | 0.12 | 0.05 | 0.05 | 0.04 | 43777
COVID19_MODERNA | Product storage errors and issues in the product use system | 1238 | 0.54 | 0.56 | 0.59 | 2163.4 | 0.55 | 0.57 | 0.60 | 0.10 | 0.09 | 0.09 | 42690
COVID19_PFIZER/BIONTECH | Product storage errors and issues in the product use system | 135 | 0.06 | 0.07 | 0.08 | 1838.5 | 0.06 | 0.07 | 0.09 | 0.01 | 0.01 | 0.01 | 43793
COVID19_UNKNOWN MFR | Product storage errors and issues in the product use system | 1 | 0.01 | 0.05 | 0.14 | 33.2 | 0.00 | 0.03 | 0.14 | 0.02 | 0.02 | 0.00 | 43927
COVID19_JANSSEN | Product supply and availability issues | 1 | 0.03 | 0.37 | 1.04 | 8.3 | 0.04 | 0.20 | 0.61 | 0.11 | 0.11 | 0.02 | 139
COVID19_MODERNA | Product supply and availability issues | 1 | 0.01 | 0.17 | 0.48 | 19.6 | 0.01 | 0.06 | 0.26 | 0.02 | 0.02 | 0.01 | 139
COVID19_PFIZER/BIONTECH | Product supply and availability issues | 3 | 0.12 | 0.42 | 0.87 | 21.3 | 0.07 | 0.18 | 0.39 | 0.09 | 0.09 | 0.03 | 137
COVID19_UNKNOWN MFR | Product supply and availability issues | 0 | 0.00 | 0.55 | 2.96 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Product transcribing errors and communication issues | 0 | 0.06 | 0.95 | 2.73 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Product transcribing errors and communication issues | 0 | 0.06 | 0.83 | 2.39 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product transcribing errors and communication issues | 1 | 0.31 | 1.61 | 3.76 | 0.3 | 0.37 | 1.14 | 3.14 | 12.28 | 12.28 | 0.84 | 0
COVID19_UNKNOWN MFR | Product transcribing errors and communication issues | 0 | 0.07 | 1.00 | 2.88 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Prophylactic procedures NEC | 0 | 0.00 | 0.20 | 0.78 | 1.9 |  |  |  |  |  |  | 
COVID19_MODERNA | Prophylactic procedures NEC | 10 | 0.81 | 1.46 | 2.27 | 5.7 | 0.90 | 1.49 | 2.35 | 1.79 | 1.79 | 0.94 | 19
COVID19_PFIZER/BIONTECH | Prophylactic procedures NEC | 6 | 0.45 | 0.99 | 1.70 | 5.5 | 0.54 | 1.00 | 1.73 | 1.07 | 1.07 | 0.50 | 23
COVID19_UNKNOWN MFR | Prophylactic procedures NEC | 0 | 0.00 | 0.92 | 3.56 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Prostate and seminal vesicles infections and inflammations | 2 | 0.58 | 1.91 | 3.86 | 0.4 | 0.59 | 1.59 | 5.02 | 7.72 | 7.72 | 1.86 | 4
COVID19_MODERNA | Prostate and seminal vesicles infections and inflammations | 1 | 0.19 | 0.87 | 1.94 | 1.4 | 0.25 | 0.75 | 1.85 | 0.68 | 0.68 | 0.11 | 5
COVID19_PFIZER/BIONTECH | Prostate and seminal vesicles infections and inflammations | 1 | 0.21 | 0.93 | 2.08 | 1.2 | 0.26 | 0.79 | 1.93 | 0.82 | 0.82 | 0.14 | 5
COVID19_UNKNOWN MFR | Prostate and seminal vesicles infections and inflammations | 0 | 0.11 | 0.99 | 2.63 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Prostatic neoplasms and hypertrophy | 1 | 0.34 | 1.06 | 2.10 | 0.8 | 0.30 | 0.90 | 2.22 | 1.19 | 1.19 | 0.22 | 13
COVID19_MODERNA | Prostatic neoplasms and hypertrophy | 3 | 0.38 | 0.90 | 1.59 | 3.7 | 0.36 | 0.80 | 1.59 | 0.93 | 0.93 | 0.32 | 11
COVID19_PFIZER/BIONTECH | Prostatic neoplasms and hypertrophy | 2 | 0.31 | 0.83 | 1.54 | 3.1 | 0.28 | 0.70 | 1.51 | 0.68 | 0.68 | 0.19 | 12
COVID19_UNKNOWN MFR | Prostatic neoplasms and hypertrophy | 0 | 0.24 | 0.99 | 2.16 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Prostatic neoplasms malignant | 1 | 0.26 | 0.91 | 1.89 | 1.2 | 0.26 | 0.78 | 1.92 | 0.86 | 0.86 | 0.16 | 18
COVID19_MODERNA | Prostatic neoplasms malignant | 1 | 0.16 | 0.55 | 1.14 | 3.4 | 0.13 | 0.45 | 1.16 | 0.19 | 0.19 | 0.04 | 18
COVID19_PFIZER/BIONTECH | Prostatic neoplasms malignant | 7 | 0.85 | 1.62 | 2.59 | 3.5 | 0.84 | 1.52 | 2.59 | 2.39 | 2.39 | 1.09 | 12
COVID19_UNKNOWN MFR | Prostatic neoplasms malignant | 0 | 0.19 | 0.98 | 2.29 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Prostatic signs, symptoms and disorders NEC | 1 | 0.23 | 0.90 | 1.95 | 1.7 | 0.22 | 0.68 | 1.67 | 0.74 | 0.74 | 0.14 | 21
COVID19_MODERNA | Prostatic signs, symptoms and disorders NEC | 5 | 0.43 | 0.93 | 1.59 | 5.6 | 0.44 | 0.86 | 1.55 | 1.00 | 1.00 | 0.43 | 17
COVID19_PFIZER/BIONTECH | Prostatic signs, symptoms and disorders NEC | 5 | 0.49 | 1.07 | 1.83 | 5.1 | 0.47 | 0.92 | 1.65 | 1.20 | 1.20 | 0.52 | 17
COVID19_UNKNOWN MFR | Prostatic signs, symptoms and disorders NEC | 0 | 0.14 | 0.98 | 2.44 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Prostatic therapeutic procedures | 2 | 0.62 | 2.24 | 4.68 | 0.4 | 0.58 | 1.55 | 4.59 | 10.29 | 10.29 | 2.29 | 3
COVID19_MODERNA | Prostatic therapeutic procedures | 1 | 0.17 | 0.94 | 2.20 | 1.1 | 0.27 | 0.81 | 1.98 | 0.85 | 0.85 | 0.14 | 4
COVID19_PFIZER/BIONTECH | Prostatic therapeutic procedures | 0 | 0.03 | 0.52 | 1.52 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostatic therapeutic procedures | 0 | 0.06 | 0.99 | 2.91 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Protein analyses NEC | 143 | 0.64 | 0.74 | 0.84 | 253.7 | 0.49 | 0.57 | 0.65 | 0.49 | 0.48 | 0.42 | 4542
COVID19_MODERNA | Protein analyses NEC | 595 | 0.83 | 0.89 | 0.95 | 813.9 | 0.68 | 0.73 | 0.78 | 0.49 | 0.49 | 0.46 | 4090
COVID19_PFIZER/BIONTECH | Protein analyses NEC | 717 | 1.09 | 1.16 | 1.23 | 789.0 | 0.85 | 0.91 | 0.97 | 0.74 | 0.74 | 0.69 | 3968
COVID19_UNKNOWN MFR | Protein analyses NEC | 1 | 0.10 | 0.41 | 0.88 | 6.4 | 0.06 | 0.27 | 0.76 | 0.15 | 0.15 | 0.03 | 4684
COVID19_JANSSEN | Protein metabolism disorders NEC | 1 | 0.22 | 0.83 | 1.75 | 1.5 | 0.23 | 0.72 | 1.77 | 0.43 | 0.43 | 0.08 | 36
COVID19_MODERNA | Protein metabolism disorders NEC | 4 | 0.34 | 0.77 | 1.36 | 4.8 | 0.39 | 0.81 | 1.53 | 0.41 | 0.41 | 0.17 | 33
COVID19_PFIZER/BIONTECH | Protein metabolism disorders NEC | 1 | 0.11 | 0.40 | 0.84 | 4.9 | 0.09 | 0.35 | 0.92 | 0.11 | 0.11 | 0.02 | 36
COVID19_UNKNOWN MFR | Protein metabolism disorders NEC | 0 | 0.17 | 0.98 | 2.35 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pruritus NEC | 981 | 0.53 | 0.56 | 0.59 | 1785.1 | 0.52 | 0.55 | 0.58 | 0.57 | 0.56 | 0.53 | 26491
COVID19_MODERNA | Pruritus NEC | 9897 | 1.21 | 1.23 | 1.25 | 8198.8 | 1.19 | 1.21 | 1.23 | 1.91 | 1.98 | 1.94 | 17575
COVID19_PFIZER/BIONTECH | Pruritus NEC | 5812 | 0.87 | 0.89 | 0.91 | 6623.5 | 0.86 | 0.88 | 0.90 | 1.10 | 1.10 | 1.08 | 21660
COVID19_UNKNOWN MFR | Pruritus NEC | 32 | 0.59 | 0.79 | 1.01 | 42.2 | 0.57 | 0.76 | 1.00 | 0.80 | 0.80 | 0.59 | 27440
COVID19_JANSSEN | Pseudomonal infections | 1 | 0.23 | 1.00 | 2.21 | 0.8 | 0.30 | 0.90 | 2.24 | 0.91 | 0.91 | 0.17 | 17
COVID19_MODERNA | Pseudomonal infections | 1 | 0.10 | 0.45 | 0.98 | 3.7 | 0.12 | 0.43 | 1.11 | 0.20 | 0.20 | 0.04 | 17
COVID19_PFIZER/BIONTECH | Pseudomonal infections | 7 | 0.86 | 1.68 | 2.72 | 3.1 | 0.91 | 1.64 | 2.82 | 2.61 | 2.61 | 1.18 | 11
COVID19_UNKNOWN MFR | Pseudomonal infections | 0 | 0.12 | 0.98 | 2.53 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Psoriatic arthropathies | 2 | 0.16 | 0.63 | 1.37 | 4.3 | 0.22 | 0.57 | 1.24 | 0.61 | 0.61 | 0.19 | 51
COVID19_MODERNA | Psoriatic arthropathies | 7 | 0.37 | 0.75 | 1.24 | 11.2 | 0.36 | 0.65 | 1.10 | 0.52 | 0.52 | 0.27 | 46
COVID19_PFIZER/BIONTECH | Psoriatic arthropathies | 12 | 0.73 | 1.24 | 1.86 | 11.0 | 0.66 | 1.04 | 1.58 | 1.20 | 1.20 | 0.70 | 41
COVID19_UNKNOWN MFR | Psoriatic arthropathies | 1 | 0.31 | 2.15 | 5.37 | 0.1 | 0.42 | 1.41 | 7.03 | 13.23 | 13.24 | 2.51 | 52
COVID19_JANSSEN | Psoriatic conditions | 11 | 0.46 | 0.79 | 1.18 | 15.5 | 0.44 | 0.72 | 1.11 | 0.71 | 0.71 | 0.43 | 238
COVID19_MODERNA | Psoriatic conditions | 40 | 0.55 | 0.72 | 0.91 | 58.2 | 0.53 | 0.69 | 0.89 | 0.65 | 0.65 | 0.49 | 209
COVID19_PFIZER/BIONTECH | Psoriatic conditions | 49 | 0.79 | 1.02 | 1.26 | 50.7 | 0.76 | 0.96 | 1.20 | 1.00 | 1.00 | 0.77 | 200
COVID19_UNKNOWN MFR | Psoriatic conditions | 1 | 0.32 | 1.30 | 2.81 | 0.4 | 0.35 | 1.07 | 2.78 | 2.77 | 2.78 | 0.53 | 248
COVID19_JANSSEN | Psychiatric elimination disorders | 6 | 0.81 | 1.72 | 2.92 | 3.1 | 0.78 | 1.46 | 2.57 | 1.57 | 1.57 | 0.78 | 59
COVID19_MODERNA | Psychiatric elimination disorders | 9 | 0.57 | 1.06 | 1.66 | 8.9 | 0.57 | 0.96 | 1.55 | 0.55 | 0.55 | 0.30 | 56
COVID19_PFIZER/BIONTECH | Psychiatric elimination disorders | 3 | 0.14 | 0.40 | 0.78 | 9.4 | 0.17 | 0.40 | 0.81 | 0.20 | 0.20 | 0.08 | 62
COVID19_UNKNOWN MFR | Psychiatric elimination disorders | 0 | 0.05 | 0.94 | 2.83 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Psychiatric investigations | 0 | 0.00 | 0.18 | 0.66 | 2.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Psychiatric investigations | 4 | 0.21 | 0.57 | 1.07 | 8.2 | 0.26 | 0.55 | 1.04 | 0.20 | 0.20 | 0.08 | 69
COVID19_PFIZER/BIONTECH | Psychiatric investigations | 1 | 0.02 | 0.19 | 0.48 | 9.1 | 0.03 | 0.18 | 0.56 | 0.06 | 0.06 | 0.01 | 72
COVID19_UNKNOWN MFR | Psychiatric investigations | 0 | 0.01 | 0.90 | 3.30 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Psychiatric symptoms NEC | 8 | 0.55 | 1.02 | 1.61 | 9.4 | 0.48 | 0.84 | 1.37 | 0.33 | 0.33 | 0.18 | 379
COVID19_MODERNA | Psychiatric symptoms NEC | 19 | 0.65 | 0.98 | 1.35 | 21.4 | 0.60 | 0.88 | 1.24 | 0.18 | 0.18 | 0.12 | 368
COVID19_PFIZER/BIONTECH | Psychiatric symptoms NEC | 14 | 0.37 | 0.60 | 0.87 | 31.8 | 0.30 | 0.46 | 0.69 | 0.15 | 0.15 | 0.10 | 373
COVID19_UNKNOWN MFR | Psychiatric symptoms NEC | 0 | 0.14 | 0.90 | 2.19 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Psychiatric therapies | 0 | 0.08 | 0.75 | 1.97 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Psychiatric therapies | 1 | 0.17 | 0.75 | 1.67 | 1.4 | 0.24 | 0.75 | 1.83 | 0.49 | 0.49 | 0.08 | 7
COVID19_PFIZER/BIONTECH | Psychiatric therapies | 3 | 0.54 | 1.47 | 2.78 | 1.5 | 0.57 | 1.29 | 2.64 | 2.46 | 2.46 | 0.74 | 5
COVID19_UNKNOWN MFR | Psychiatric therapies | 0 | 0.11 | 0.99 | 2.62 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Psychotic disorder NEC | 7 | 0.51 | 1.04 | 1.73 | 7.4 | 0.51 | 0.91 | 1.54 | 1.09 | 1.09 | 0.57 | 99
COVID19_MODERNA | Psychotic disorder NEC | 28 | 0.99 | 1.38 | 1.83 | 21.1 | 0.93 | 1.27 | 1.70 | 1.22 | 1.22 | 0.85 | 78
COVID19_PFIZER/BIONTECH | Psychotic disorder NEC | 18 | 0.61 | 0.93 | 1.32 | 20.7 | 0.59 | 0.86 | 1.23 | 0.84 | 0.84 | 0.55 | 88
COVID19_UNKNOWN MFR | Psychotic disorder NEC | 0 | 0.01 | 0.79 | 2.84 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary and bronchial disorders congenital | 1 | 0.22 | 1.38 | 3.36 | 0.7 | 0.31 | 0.94 | 2.34 | 2.21 | 2.21 | 0.38 | 7
COVID19_MODERNA | Pulmonary and bronchial disorders congenital | 1 | 0.11 | 0.69 | 1.69 | 2.0 | 0.20 | 0.64 | 1.58 | 0.49 | 0.49 | 0.08 | 7
COVID19_PFIZER/BIONTECH | Pulmonary and bronchial disorders congenital | 0 | 0.01 | 0.35 | 1.12 | 1.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary and bronchial disorders congenital | 0 | 0.03 | 0.99 | 3.13 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary hypertensions | 11 | 1.68 | 2.93 | 4.47 | 4.0 | 1.27 | 2.10 | 3.37 | 2.88 | 2.88 | 1.68 | 59
COVID19_MODERNA | Pulmonary hypertensions | 18 | 0.84 | 1.28 | 1.80 | 18.2 | 0.66 | 0.97 | 1.38 | 1.18 | 1.18 | 0.75 | 52
COVID19_PFIZER/BIONTECH | Pulmonary hypertensions | 20 | 1.11 | 1.66 | 2.30 | 15.4 | 0.86 | 1.23 | 1.73 | 1.64 | 1.64 | 1.06 | 50
COVID19_UNKNOWN MFR | Pulmonary hypertensions | 1 | 0.31 | 2.15 | 5.39 | 0.1 | 0.41 | 1.34 | 5.75 | 9.97 | 9.98 | 1.90 | 69
COVID19_JANSSEN | Pulmonary oedemas | 37 | 1.06 | 1.41 | 1.81 | 34.8 | 0.80 | 1.05 | 1.35 | 1.00 | 1.00 | 0.76 | 569
COVID19_MODERNA | Pulmonary oedemas | 179 | 1.34 | 1.52 | 1.72 | 156.3 | 1.01 | 1.14 | 1.29 | 1.42 | 1.42 | 1.23 | 427
COVID19_PFIZER/BIONTECH | Pulmonary oedemas | 203 | 1.81 | 2.04 | 2.28 | 133.8 | 1.34 | 1.50 | 1.69 | 2.06 | 2.06 | 1.79 | 403
COVID19_UNKNOWN MFR | Pulmonary oedemas | 1 | 0.21 | 1.11 | 2.60 | 1.0 | 0.28 | 0.83 | 2.05 | 1.14 | 1.14 | 0.22 | 605
COVID19_JANSSEN | Pulmonary radiotherapies | 1 | 0.26 | 1.59 | 3.84 | 0.4 | 0.35 | 1.07 | 2.77 | 3.86 | 3.86 | 0.61 | 4
COVID19_MODERNA | Pulmonary radiotherapies | 4 | 0.94 | 2.42 | 4.45 | 1.6 | 0.74 | 1.55 | 3.07 | 13.58 | 13.58 | 2.16 | 1
COVID19_PFIZER/BIONTECH | Pulmonary radiotherapies | 0 | 0.02 | 0.47 | 1.48 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary radiotherapies | 0 | 0.04 | 0.99 | 3.11 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary thrombotic and embolic conditions | 385 | 3.62 | 3.95 | 4.28 | 116.4 | 3.01 | 3.27 | 3.56 | 4.31 | 4.34 | 3.95 | 1380
COVID19_MODERNA | Pulmonary thrombotic and embolic conditions | 587 | 1.13 | 1.21 | 1.29 | 524.5 | 1.04 | 1.12 | 1.20 | 1.69 | 1.70 | 1.56 | 1178
COVID19_PFIZER/BIONTECH | Pulmonary thrombotic and embolic conditions | 708 | 1.73 | 1.84 | 1.96 | 428.4 | 1.55 | 1.65 | 1.75 | 2.74 | 2.75 | 2.54 | 1057
COVID19_UNKNOWN MFR | Pulmonary thrombotic and embolic conditions | 19 | 4.11 | 6.26 | 8.77 | 3.0 | 3.55 | 5.69 | 8.46 | 7.49 | 7.63 | 5.20 | 1746
COVID19_JANSSEN | Pulmonary valvular disorders | 0 | 0.04 | 0.89 | 2.71 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary valvular disorders | 0 | 0.03 | 0.68 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary valvular disorders | 0 | 0.03 | 0.71 | 2.16 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary valvular disorders | 0 | 0.05 | 1.00 | 3.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pupil disorders | 27 | 0.60 | 0.84 | 1.10 | 32.8 | 0.60 | 0.82 | 1.10 | 0.90 | 0.90 | 0.65 | 464
COVID19_MODERNA | Pupil disorders | 68 | 0.61 | 0.75 | 0.90 | 94.6 | 0.59 | 0.72 | 0.87 | 0.55 | 0.55 | 0.44 | 423
COVID19_PFIZER/BIONTECH | Pupil disorders | 126 | 1.19 | 1.38 | 1.58 | 91.8 | 1.17 | 1.36 | 1.57 | 1.41 | 1.41 | 1.19 | 365
COVID19_UNKNOWN MFR | Pupil disorders | 1 | 0.39 | 1.08 | 2.04 | 0.7 | 0.31 | 0.94 | 2.35 | 1.40 | 1.40 | 0.27 | 490
COVID19_JANSSEN | Purine metabolism disorders congenital | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Purine metabolism disorders congenital | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Purine metabolism disorders congenital | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Purine metabolism disorders congenital | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Purpura and related conditions | 84 | 1.00 | 1.21 | 1.43 | 79.5 | 0.88 | 1.05 | 1.25 | 0.81 | 0.81 | 0.67 | 1603
COVID19_MODERNA | Purpura and related conditions | 195 | 0.76 | 0.86 | 0.96 | 243.5 | 0.71 | 0.80 | 0.90 | 0.44 | 0.44 | 0.39 | 1492
COVID19_PFIZER/BIONTECH | Purpura and related conditions | 234 | 0.95 | 1.06 | 1.18 | 249.7 | 0.84 | 0.94 | 1.04 | 0.66 | 0.66 | 0.59 | 1453
COVID19_UNKNOWN MFR | Purpura and related conditions | 4 | 0.70 | 1.48 | 2.50 | 2.0 | 0.66 | 1.36 | 2.62 | 1.64 | 1.64 | 0.72 | 1683
COVID19_JANSSEN | Purpuras (excl thrombocytopenic) | 1 | 0.32 | 1.76 | 4.14 | 0.1 | 0.40 | 1.30 | 4.98 | 15.44 | 15.44 | 1.51 | 1
COVID19_MODERNA | Purpuras (excl thrombocytopenic) | 0 | 0.04 | 0.70 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Purpuras (excl thrombocytopenic) | 0 | 0.04 | 0.73 | 2.15 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Purpuras (excl thrombocytopenic) | 0 | 0.06 | 1.00 | 2.95 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Pustular conditions | 1 | 0.21 | 0.95 | 2.12 | 1.1 | 0.26 | 0.80 | 1.97 | 0.97 | 0.97 | 0.18 | 16
COVID19_MODERNA | Pustular conditions | 0 | 0.03 | 0.28 | 0.75 | 3.6 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pustular conditions | 2 | 0.21 | 0.70 | 1.42 | 3.5 | 0.26 | 0.65 | 1.41 | 0.55 | 0.55 | 0.16 | 15
COVID19_UNKNOWN MFR | Pustular conditions | 0 | 0.11 | 0.98 | 2.60 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Rabies viral infections | 0 | 0.00 | 0.00 | 0.00 | 4.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Rabies viral infections | 0 | 0.00 | 0.00 | 0.00 | 4.6 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rabies viral infections | 0 | 0.00 | 0.00 | 0.00 | 8.1 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rabies viral infections | 0 | 0.00 | 0.10 | 0.08 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Radiation injuries | 8 | 0.76 | 1.36 | 2.10 | 5.2 | 0.76 | 1.32 | 2.17 | 1.87 | 1.87 | 1.01 | 66
COVID19_MODERNA | Radiation injuries | 12 | 0.40 | 0.65 | 0.95 | 20.2 | 0.39 | 0.61 | 0.94 | 0.66 | 0.66 | 0.39 | 62
COVID19_PFIZER/BIONTECH | Radiation injuries | 15 | 0.58 | 0.90 | 1.27 | 17.2 | 0.57 | 0.86 | 1.26 | 1.04 | 1.04 | 0.65 | 59
COVID19_UNKNOWN MFR | Radiation injuries | 0 | 0.26 | 0.96 | 2.02 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Radiotherapies site unspecified | 2 | 0.29 | 0.99 | 2.02 | 2.5 | 0.32 | 0.79 | 1.72 | 0.81 | 0.81 | 0.25 | 38
COVID19_MODERNA | Radiotherapies site unspecified | 3 | 0.19 | 0.54 | 1.02 | 7.3 | 0.22 | 0.50 | 1.00 | 0.28 | 0.28 | 0.10 | 37
COVID19_PFIZER/BIONTECH | Radiotherapies site unspecified | 2 | 0.13 | 0.43 | 0.88 | 7.5 | 0.14 | 0.37 | 0.83 | 0.22 | 0.22 | 0.07 | 38
COVID19_UNKNOWN MFR | Radiotherapies site unspecified | 0 | 0.09 | 0.96 | 2.61 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Rashes, eruptions and exanthems NEC | 1809 | 0.69 | 0.72 | 0.75 | 2984.6 | 0.58 | 0.61 | 0.63 | 0.57 | 0.55 | 0.53 | 48740
COVID19_MODERNA | Rashes, eruptions and exanthems NEC | 13935 | 1.27 | 1.29 | 1.30 | 12160.0 | 1.13 | 1.15 | 1.16 | 1.29 | 1.33 | 1.30 | 36614
COVID19_PFIZER/BIONTECH | Rashes, eruptions and exanthems NEC | 7514 | 0.81 | 0.83 | 0.85 | 10428.0 | 0.71 | 0.72 | 0.73 | 0.72 | 0.70 | 0.68 | 43035
COVID19_UNKNOWN MFR | Rashes, eruptions and exanthems NEC | 55 | 0.71 | 0.90 | 1.09 | 73.5 | 0.60 | 0.75 | 0.93 | 0.75 | 0.73 | 0.58 | 50494
COVID19_JANSSEN | Rate and rhythm disorders NEC | 334 | 0.92 | 1.01 | 1.10 | 423.6 | 0.72 | 0.79 | 0.86 | 0.94 | 0.94 | 0.85 | 5507
COVID19_MODERNA | Rate and rhythm disorders NEC | 1623 | 1.25 | 1.31 | 1.36 | 1564.0 | 1.00 | 1.04 | 1.08 | 1.31 | 1.31 | 1.25 | 4218
COVID19_PFIZER/BIONTECH | Rate and rhythm disorders NEC | 2068 | 1.83 | 1.90 | 1.97 | 1381.3 | 1.44 | 1.50 | 1.55 | 2.24 | 2.27 | 2.17 | 3773
COVID19_UNKNOWN MFR | Rate and rhythm disorders NEC | 11 | 0.82 | 1.41 | 2.11 | 9.3 | 0.68 | 1.10 | 1.71 | 1.30 | 1.30 | 0.79 | 5830
COVID19_JANSSEN | Rectal inflammations NEC | 1 | 0.30 | 1.10 | 2.32 | 0.6 | 0.32 | 0.96 | 2.40 | 1.40 | 1.40 | 0.25 | 11
COVID19_MODERNA | Rectal inflammations NEC | 2 | 0.30 | 0.87 | 1.69 | 2.3 | 0.33 | 0.82 | 1.76 | 0.68 | 0.68 | 0.19 | 10
COVID19_PFIZER/BIONTECH | Rectal inflammations NEC | 2 | 0.31 | 0.91 | 1.76 | 2.2 | 0.34 | 0.84 | 1.82 | 0.82 | 0.82 | 0.23 | 10
COVID19_UNKNOWN MFR | Rectal inflammations NEC | 0 | 0.17 | 0.99 | 2.36 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell abnormal findings NEC | 14 | 1.47 | 2.36 | 3.42 | 5.5 | 1.32 | 2.05 | 3.10 | 2.12 | 2.12 | 1.33 | 102
COVID19_MODERNA | Red blood cell abnormal findings NEC | 34 | 1.07 | 1.44 | 1.86 | 27.3 | 0.91 | 1.21 | 1.58 | 1.41 | 1.41 | 1.01 | 82
COVID19_PFIZER/BIONTECH | Red blood cell abnormal findings NEC | 25 | 0.89 | 1.26 | 1.69 | 23.1 | 0.76 | 1.05 | 1.43 | 1.12 | 1.13 | 0.78 | 91
COVID19_UNKNOWN MFR | Red blood cell abnormal findings NEC | 0 | 0.12 | 0.92 | 2.33 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell analyses | 167 | 1.19 | 1.36 | 1.53 | 143.3 | 1.02 | 1.16 | 1.31 | 0.96 | 0.96 | 0.84 | 2697
COVID19_MODERNA | Red blood cell analyses | 476 | 0.91 | 0.98 | 1.05 | 527.3 | 0.84 | 0.90 | 0.97 | 0.68 | 0.68 | 0.62 | 2388
COVID19_PFIZER/BIONTECH | Red blood cell analyses | 535 | 1.14 | 1.23 | 1.31 | 494.1 | 1.01 | 1.08 | 1.16 | 0.94 | 0.94 | 0.87 | 2329
COVID19_UNKNOWN MFR | Red blood cell analyses | 5 | 0.62 | 1.35 | 2.30 | 3.8 | 0.57 | 1.12 | 2.02 | 1.20 | 1.20 | 0.57 | 2859
COVID19_JANSSEN | Red cell membrane and enzyme abnormalities | 0 | 0.07 | 0.87 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Red cell membrane and enzyme abnormalities | 0 | 0.05 | 0.64 | 1.79 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red cell membrane and enzyme abnormalities | 1 | 0.25 | 1.23 | 2.83 | 0.4 | 0.35 | 1.07 | 2.78 | 2.05 | 2.05 | 0.27 | 2
COVID19_UNKNOWN MFR | Red cell membrane and enzyme abnormalities | 0 | 0.08 | 1.00 | 2.80 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Refractive and accommodative disorders | 5 | 0.59 | 1.38 | 2.45 | 3.8 | 0.57 | 1.12 | 2.02 | 1.35 | 1.35 | 0.63 | 57
COVID19_MODERNA | Refractive and accommodative disorders | 11 | 0.59 | 1.03 | 1.57 | 10.9 | 0.60 | 0.97 | 1.50 | 0.73 | 0.73 | 0.42 | 51
COVID19_PFIZER/BIONTECH | Refractive and accommodative disorders | 8 | 0.41 | 0.79 | 1.27 | 11.2 | 0.42 | 0.73 | 1.19 | 0.61 | 0.61 | 0.33 | 54
COVID19_UNKNOWN MFR | Refractive and accommodative disorders | 0 | 0.02 | 0.90 | 3.06 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Renal and urinary tract disorders congenital NEC | 0 | 0.05 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Renal and urinary tract disorders congenital NEC | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal and urinary tract disorders congenital NEC | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal and urinary tract disorders congenital NEC | 0 | 0.05 | 1.00 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Renal and urinary tract injuries NEC | 0 | 0.11 | 0.89 | 2.32 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Renal and urinary tract injuries NEC | 1 | 0.26 | 1.15 | 2.53 | 0.7 | 0.32 | 0.95 | 2.38 | 1.70 | 1.70 | 0.23 | 2
COVID19_PFIZER/BIONTECH | Renal and urinary tract injuries NEC | 1 | 0.28 | 1.20 | 2.64 | 0.5 | 0.34 | 1.02 | 2.59 | 2.05 | 2.05 | 0.27 | 2
COVID19_UNKNOWN MFR | Renal and urinary tract injuries NEC | 0 | 0.12 | 1.00 | 2.59 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Renal disorders NEC | 6 | 0.47 | 0.96 | 1.60 | 6.7 | 0.47 | 0.87 | 1.51 | 0.86 | 0.86 | 0.43 | 108
COVID19_MODERNA | Renal disorders NEC | 18 | 0.59 | 0.89 | 1.25 | 22.1 | 0.55 | 0.81 | 1.16 | 0.64 | 0.64 | 0.42 | 96
COVID19_PFIZER/BIONTECH | Renal disorders NEC | 29 | 1.05 | 1.45 | 1.91 | 21.3 | 0.96 | 1.30 | 1.74 | 1.40 | 1.40 | 0.98 | 85
COVID19_UNKNOWN MFR | Renal disorders NEC | 0 | 0.13 | 0.91 | 2.28 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Renal disorders congenital | 0 | 0.01 | 0.42 | 1.47 | 0.9 |  |  |  |  |  |  | 
COVID19_MODERNA | Renal disorders congenital | 2 | 0.22 | 0.88 | 1.92 | 1.9 | 0.36 | 0.91 | 1.97 | 0.57 | 0.57 | 0.16 | 12
COVID19_PFIZER/BIONTECH | Renal disorders congenital | 2 | 0.21 | 0.84 | 1.82 | 2.1 | 0.34 | 0.86 | 1.85 | 0.68 | 0.68 | 0.19 | 12
COVID19_UNKNOWN MFR | Renal disorders congenital | 0 | 0.01 | 0.96 | 3.34 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Renal failure and impairment | 46 | 0.84 | 1.09 | 1.36 | 58.3 | 0.62 | 0.79 | 0.99 | 0.65 | 0.65 | 0.51 | 1093
COVID19_MODERNA | Renal failure and impairment | 265 | 1.16 | 1.29 | 1.42 | 283.8 | 0.84 | 0.93 | 1.03 | 1.03 | 1.03 | 0.92 | 874
COVID19_PFIZER/BIONTECH | Renal failure and impairment | 424 | 2.24 | 2.43 | 2.63 | 242.1 | 1.61 | 1.74 | 1.89 | 2.43 | 2.43 | 2.20 | 715
COVID19_UNKNOWN MFR | Renal failure and impairment | 3 | 0.57 | 1.53 | 2.87 | 1.9 | 0.51 | 1.15 | 2.31 | 1.82 | 1.82 | 0.70 | 1136
COVID19_JANSSEN | Renal failure complications | 1 | 0.28 | 1.03 | 2.17 | 0.6 | 0.33 | 0.99 | 2.50 | 0.91 | 0.91 | 0.17 | 17
COVID19_MODERNA | Renal failure complications | 1 | 0.17 | 0.61 | 1.28 | 3.1 | 0.14 | 0.49 | 1.25 | 0.20 | 0.20 | 0.04 | 17
COVID19_PFIZER/BIONTECH | Renal failure complications | 5 | 0.67 | 1.43 | 2.42 | 3.0 | 0.66 | 1.30 | 2.35 | 1.57 | 1.57 | 0.66 | 13
COVID19_UNKNOWN MFR | Renal failure complications | 0 | 0.17 | 0.99 | 2.35 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Renal function analyses | 133 | 1.00 | 1.16 | 1.33 | 125.8 | 0.91 | 1.05 | 1.21 | 0.97 | 0.97 | 0.83 | 2126
COVID19_MODERNA | Renal function analyses | 427 | 0.83 | 0.90 | 0.97 | 499.6 | 0.79 | 0.85 | 0.92 | 0.79 | 0.79 | 0.72 | 1832
COVID19_PFIZER/BIONTECH | Renal function analyses | 573 | 1.29 | 1.39 | 1.48 | 444.9 | 1.20 | 1.29 | 1.38 | 1.39 | 1.39 | 1.29 | 1686
COVID19_UNKNOWN MFR | Renal function analyses | 5 | 0.62 | 1.37 | 2.35 | 3.4 | 0.61 | 1.19 | 2.14 | 1.53 | 1.53 | 0.73 | 2254
COVID19_JANSSEN | Renal hypertension and related conditions | 0 | 0.03 | 0.83 | 2.58 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Renal hypertension and related conditions | 0 | 0.02 | 0.57 | 1.77 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal hypertension and related conditions | 0 | 0.02 | 0.61 | 1.88 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal hypertension and related conditions | 0 | 0.04 | 1.00 | 3.08 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Renal lithiasis | 12 | 0.71 | 1.17 | 1.73 | 9.9 | 0.71 | 1.13 | 1.72 | 1.41 | 1.41 | 0.86 | 131
COVID19_MODERNA | Renal lithiasis | 39 | 0.87 | 1.15 | 1.46 | 34.2 | 0.86 | 1.12 | 1.43 | 1.27 | 1.27 | 0.94 | 104
COVID19_PFIZER/BIONTECH | Renal lithiasis | 43 | 1.06 | 1.38 | 1.73 | 31.3 | 1.04 | 1.33 | 1.69 | 1.76 | 1.76 | 1.30 | 100
COVID19_UNKNOWN MFR | Renal lithiasis | 0 | 0.14 | 0.88 | 2.13 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Renal neoplasms | 1 | 0.28 | 0.77 | 1.44 | 2.2 | 0.19 | 0.60 | 1.49 | 0.41 | 0.41 | 0.08 | 38
COVID19_MODERNA | Renal neoplasms | 11 | 0.70 | 1.15 | 1.69 | 9.3 | 0.68 | 1.10 | 1.70 | 1.33 | 1.33 | 0.74 | 28
COVID19_PFIZER/BIONTECH | Renal neoplasms | 13 | 0.90 | 1.43 | 2.06 | 8.2 | 0.90 | 1.41 | 2.12 | 2.05 | 2.05 | 1.17 | 26
COVID19_UNKNOWN MFR | Renal neoplasms | 0 | 0.30 | 0.98 | 1.98 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Renal neoplasms malignant | 0 | 0.02 | 0.69 | 2.23 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Renal neoplasms malignant | 0 | 0.01 | 0.37 | 1.20 | 1.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal neoplasms malignant | 1 | 0.14 | 0.91 | 2.23 | 1.0 | 0.28 | 0.84 | 2.08 | 0.82 | 0.82 | 0.14 | 5
COVID19_UNKNOWN MFR | Renal neoplasms malignant | 0 | 0.03 | 0.99 | 3.21 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Renal obstructive disorders | 4 | 0.82 | 2.00 | 3.60 | 1.1 | 0.85 | 1.85 | 4.21 | 2.94 | 2.94 | 1.20 | 21
COVID19_MODERNA | Renal obstructive disorders | 8 | 0.67 | 1.26 | 2.01 | 6.0 | 0.68 | 1.18 | 1.94 | 1.60 | 1.60 | 0.79 | 17
COVID19_PFIZER/BIONTECH | Renal obstructive disorders | 6 | 0.56 | 1.17 | 1.96 | 4.7 | 0.60 | 1.11 | 1.93 | 1.29 | 1.29 | 0.60 | 19
COVID19_UNKNOWN MFR | Renal obstructive disorders | 1 | 0.36 | 1.69 | 3.81 | 0.0 | 0.44 | 1.59 | 11.06 | 28.66 | 28.69 | 5.35 | 24
COVID19_JANSSEN | Renal structural abnormalities and trauma | 0 | 0.00 | 0.28 | 1.09 | 1.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Renal structural abnormalities and trauma | 0 | 0.00 | 0.18 | 0.67 | 2.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal structural abnormalities and trauma | 4 | 0.44 | 1.19 | 2.24 | 3.1 | 0.52 | 1.08 | 2.03 | 0.82 | 0.82 | 0.33 | 20
COVID19_UNKNOWN MFR | Renal structural abnormalities and trauma | 0 | 0.00 | 0.93 | 3.57 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Renal therapeutic procedures | 17 | 1.26 | 1.95 | 2.77 | 9.1 | 1.11 | 1.65 | 2.39 | 1.93 | 1.93 | 1.26 | 136
COVID19_MODERNA | Renal therapeutic procedures | 37 | 0.85 | 1.14 | 1.46 | 35.3 | 0.79 | 1.03 | 1.33 | 1.08 | 1.08 | 0.79 | 116
COVID19_PFIZER/BIONTECH | Renal therapeutic procedures | 32 | 0.83 | 1.14 | 1.48 | 31.0 | 0.76 | 1.01 | 1.34 | 1.08 | 1.08 | 0.78 | 121
COVID19_UNKNOWN MFR | Renal therapeutic procedures | 0 | 0.05 | 0.82 | 2.42 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Renal vascular and ischaemic conditions | 6 | 0.75 | 1.66 | 2.85 | 3.4 | 0.73 | 1.36 | 2.38 | 2.06 | 2.06 | 1.01 | 45
COVID19_MODERNA | Renal vascular and ischaemic conditions | 11 | 0.44 | 0.77 | 1.18 | 13.9 | 0.49 | 0.79 | 1.22 | 0.93 | 0.93 | 0.53 | 40
COVID19_PFIZER/BIONTECH | Renal vascular and ischaemic conditions | 21 | 1.17 | 1.74 | 2.40 | 11.7 | 1.14 | 1.63 | 2.28 | 2.87 | 2.87 | 1.79 | 30
COVID19_UNKNOWN MFR | Renal vascular and ischaemic conditions | 0 | 0.00 | 0.86 | 3.26 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Reproductive hormone analyses | 71 | 0.96 | 1.18 | 1.41 | 75.5 | 0.77 | 0.94 | 1.13 | 1.30 | 1.30 | 1.06 | 843
COVID19_MODERNA | Reproductive hormone analyses | 173 | 0.70 | 0.79 | 0.89 | 263.9 | 0.58 | 0.66 | 0.74 | 0.79 | 0.79 | 0.69 | 741
COVID19_PFIZER/BIONTECH | Reproductive hormone analyses | 239 | 1.09 | 1.22 | 1.35 | 239.3 | 0.90 | 1.00 | 1.11 | 1.45 | 1.45 | 1.28 | 675
COVID19_UNKNOWN MFR | Reproductive hormone analyses | 3 | 0.59 | 1.68 | 3.22 | 1.5 | 0.57 | 1.29 | 2.65 | 2.27 | 2.27 | 0.88 | 911
COVID19_JANSSEN | Reproductive neoplasms male benign NEC | 0 | 0.00 | 0.71 | 2.84 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Reproductive neoplasms male benign NEC | 0 | 0.00 | 0.40 | 1.58 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reproductive neoplasms male benign NEC | 0 | 0.00 | 0.43 | 1.73 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reproductive neoplasms male benign NEC | 0 | 0.00 | 0.99 | 3.95 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Reproductive neoplasms male unspecified malignancy | 0 | 0.07 | 0.87 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Reproductive neoplasms male unspecified malignancy | 0 | 0.05 | 0.64 | 1.79 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reproductive neoplasms male unspecified malignancy | 1 | 0.24 | 1.23 | 2.84 | 0.4 | 0.35 | 1.07 | 2.77 | 2.05 | 2.05 | 0.27 | 2
COVID19_UNKNOWN MFR | Reproductive neoplasms male unspecified malignancy | 0 | 0.08 | 1.00 | 2.81 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Reproductive organ and breast histopathology procedures | 10 | 0.62 | 1.14 | 1.78 | 17.0 | 0.37 | 0.61 | 0.96 | 0.68 | 0.68 | 0.40 | 228
COVID19_MODERNA | Reproductive organ and breast histopathology procedures | 14 | 0.34 | 0.56 | 0.82 | 37.9 | 0.25 | 0.39 | 0.58 | 0.21 | 0.21 | 0.14 | 224
COVID19_PFIZER/BIONTECH | Reproductive organ and breast histopathology procedures | 19 | 0.50 | 0.75 | 1.06 | 43.6 | 0.31 | 0.45 | 0.64 | 0.36 | 0.36 | 0.24 | 219
COVID19_UNKNOWN MFR | Reproductive organ and breast histopathology procedures | 0 | 0.00 | 0.48 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Reproductive organ and breast imaging procedures | 54 | 1.01 | 1.28 | 1.58 | 45.0 | 0.94 | 1.18 | 1.46 | 1.38 | 1.38 | 1.09 | 606
COVID19_MODERNA | Reproductive organ and breast imaging procedures | 181 | 0.88 | 1.00 | 1.12 | 190.4 | 0.84 | 0.95 | 1.07 | 1.28 | 1.28 | 1.11 | 479
COVID19_PFIZER/BIONTECH | Reproductive organ and breast imaging procedures | 204 | 1.20 | 1.35 | 1.51 | 160.2 | 1.13 | 1.27 | 1.42 | 1.83 | 1.83 | 1.60 | 456
COVID19_UNKNOWN MFR | Reproductive organ and breast imaging procedures | 2 | 0.42 | 1.44 | 2.95 | 1.1 | 0.46 | 1.14 | 2.53 | 2.09 | 2.09 | 0.65 | 658
COVID19_JANSSEN | Reproductive system and breast injuries | 0 | 0.12 | 0.82 | 2.06 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Reproductive system and breast injuries | 1 | 0.22 | 0.88 | 1.91 | 1.7 | 0.22 | 0.69 | 1.70 | 0.68 | 0.68 | 0.11 | 5
COVID19_PFIZER/BIONTECH | Reproductive system and breast injuries | 1 | 0.23 | 0.94 | 2.03 | 1.5 | 0.24 | 0.73 | 1.79 | 0.82 | 0.82 | 0.14 | 5
COVID19_UNKNOWN MFR | Reproductive system and breast injuries | 0 | 0.14 | 1.00 | 2.49 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Reproductive tract and breast procedural complications | 0 | 0.02 | 0.73 | 2.35 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Reproductive tract and breast procedural complications | 0 | 0.01 | 0.42 | 1.34 | 1.1 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reproductive tract and breast procedural complications | 3 | 0.70 | 2.13 | 4.18 | 1.3 | 0.61 | 1.38 | 2.87 | 6.14 | 6.14 | 1.37 | 2
COVID19_UNKNOWN MFR | Reproductive tract and breast procedural complications | 0 | 0.03 | 0.99 | 3.21 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Reproductive tract disorders NEC (excl neoplasms) | 8 | 0.96 | 1.84 | 2.96 | 4.5 | 0.83 | 1.45 | 2.39 | 2.29 | 2.29 | 1.23 | 54
COVID19_MODERNA | Reproductive tract disorders NEC (excl neoplasms) | 11 | 0.50 | 0.87 | 1.32 | 14.2 | 0.48 | 0.78 | 1.20 | 0.73 | 0.73 | 0.42 | 51
COVID19_PFIZER/BIONTECH | Reproductive tract disorders NEC (excl neoplasms) | 14 | 0.71 | 1.16 | 1.69 | 13.5 | 0.65 | 1.00 | 1.49 | 1.19 | 1.19 | 0.72 | 48
COVID19_UNKNOWN MFR | Reproductive tract disorders NEC (excl neoplasms) | 0 | 0.04 | 0.91 | 2.84 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Reproductive tract disorders congenital NEC | 0 | 0.04 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Reproductive tract disorders congenital NEC | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reproductive tract disorders congenital NEC | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reproductive tract disorders congenital NEC | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Reproductive tract infections and inflammations NEC | 0 | 0.05 | 0.94 | 2.84 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Reproductive tract infections and inflammations NEC | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reproductive tract infections and inflammations NEC | 0 | 0.04 | 0.83 | 2.51 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reproductive tract infections and inflammations NEC | 0 | 0.05 | 1.00 | 3.01 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Reproductive tract signs and symptoms NEC | 40 | 1.51 | 1.99 | 2.52 | 22.5 | 1.30 | 1.68 | 2.16 | 2.01 | 2.01 | 1.52 | 308
COVID19_MODERNA | Reproductive tract signs and symptoms NEC | 79 | 0.87 | 1.06 | 1.26 | 84.3 | 0.78 | 0.93 | 1.12 | 1.00 | 1.00 | 0.81 | 269
COVID19_PFIZER/BIONTECH | Reproductive tract signs and symptoms NEC | 68 | 0.85 | 1.04 | 1.26 | 74.9 | 0.74 | 0.90 | 1.10 | 0.99 | 0.99 | 0.80 | 280
COVID19_UNKNOWN MFR | Reproductive tract signs and symptoms NEC | 1 | 0.28 | 1.28 | 2.87 | 0.5 | 0.33 | 1.00 | 2.53 | 1.98 | 1.98 | 0.38 | 347
COVID19_JANSSEN | Respiratory and pulmonary function diagnostic procedures | 19 | 0.79 | 1.20 | 1.67 | 22.8 | 0.57 | 0.83 | 1.17 | 0.86 | 0.86 | 0.59 | 340
COVID19_MODERNA | Respiratory and pulmonary function diagnostic procedures | 40 | 0.54 | 0.71 | 0.91 | 73.1 | 0.43 | 0.56 | 0.71 | 0.43 | 0.43 | 0.32 | 319
COVID19_PFIZER/BIONTECH | Respiratory and pulmonary function diagnostic procedures | 44 | 0.67 | 0.87 | 1.09 | 69.4 | 0.50 | 0.64 | 0.81 | 0.57 | 0.57 | 0.44 | 315
COVID19_UNKNOWN MFR | Respiratory and pulmonary function diagnostic procedures | 0 | 0.01 | 0.56 | 1.88 | 0.6 |  |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory failures (excl neonatal) | 39 | 0.94 | 1.24 | 1.58 | 36.1 | 0.82 | 1.06 | 1.37 | 0.84 | 0.84 | 0.64 | 713
COVID19_MODERNA | Respiratory failures (excl neonatal) | 179 | 1.08 | 1.22 | 1.38 | 166.3 | 0.95 | 1.07 | 1.21 | 1.06 | 1.06 | 0.92 | 573
COVID19_PFIZER/BIONTECH | Respiratory failures (excl neonatal) | 226 | 1.58 | 1.77 | 1.96 | 146.3 | 1.37 | 1.53 | 1.71 | 1.76 | 1.76 | 1.54 | 526
COVID19_UNKNOWN MFR | Respiratory failures (excl neonatal) | 3 | 0.65 | 1.74 | 3.26 | 1.2 | 0.62 | 1.40 | 2.94 | 2.76 | 2.76 | 1.06 | 749
COVID19_JANSSEN | Respiratory signs and symptoms NEC | 63 | 1.18 | 1.46 | 1.77 | 43.9 | 1.14 | 1.40 | 1.71 | 1.65 | 1.65 | 1.33 | 590
COVID19_MODERNA | Respiratory signs and symptoms NEC | 133 | 0.74 | 0.85 | 0.98 | 159.1 | 0.72 | 0.84 | 0.96 | 0.87 | 0.87 | 0.74 | 520
COVID19_PFIZER/BIONTECH | Respiratory signs and symptoms NEC | 160 | 1.02 | 1.17 | 1.33 | 139.4 | 1.00 | 1.14 | 1.30 | 1.33 | 1.33 | 1.14 | 493
COVID19_UNKNOWN MFR | Respiratory signs and symptoms NEC | 3 | 0.66 | 1.52 | 2.67 | 1.0 | 0.66 | 1.52 | 3.35 | 3.18 | 3.18 | 1.23 | 650
COVID19_JANSSEN | Respiratory syncytial viral infections | 0 | 0.00 | 0.32 | 1.18 | 1.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Respiratory syncytial viral infections | 0 | 0.00 | 0.14 | 0.53 | 3.3 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory syncytial viral infections | 0 | 0.00 | 0.13 | 0.48 | 3.7 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory syncytial viral infections | 0 | 0.01 | 0.95 | 3.56 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory tract and pleural neoplasms benign NEC | 0 | 0.00 | 0.37 | 1.90 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Respiratory tract and pleural neoplasms benign NEC | 0 | 0.00 | 0.14 | 0.70 | 1.3 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory tract and pleural neoplasms benign NEC | 0 | 0.00 | 0.15 | 0.79 | 1.1 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory tract and pleural neoplasms benign NEC | 0 | 0.00 | 0.96 | 4.93 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory tract and pleural neoplasms malignancy unspecified NEC | 0 | 0.06 | 0.87 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Respiratory tract and pleural neoplasms malignancy unspecified NEC | 1 | 0.23 | 1.17 | 2.71 | 0.6 | 0.32 | 0.97 | 2.42 | 1.70 | 1.70 | 0.23 | 2
COVID19_PFIZER/BIONTECH | Respiratory tract and pleural neoplasms malignancy unspecified NEC | 0 | 0.05 | 0.67 | 1.89 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory tract and pleural neoplasms malignancy unspecified NEC | 0 | 0.07 | 1.00 | 2.82 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory tract and pleural neoplasms malignant cell type unspecified NEC | 1 | 0.24 | 0.73 | 1.41 | 2.3 | 0.18 | 0.58 | 1.46 | 0.37 | 0.37 | 0.07 | 42
COVID19_MODERNA | Respiratory tract and pleural neoplasms malignant cell type unspecified NEC | 6 | 0.45 | 0.86 | 1.38 | 7.2 | 0.44 | 0.82 | 1.42 | 0.55 | 0.55 | 0.27 | 37
COVID19_PFIZER/BIONTECH | Respiratory tract and pleural neoplasms malignant cell type unspecified NEC | 13 | 0.95 | 1.51 | 2.19 | 7.3 | 0.99 | 1.55 | 2.33 | 1.77 | 1.77 | 1.03 | 30
COVID19_UNKNOWN MFR | Respiratory tract and pleural neoplasms malignant cell type unspecified NEC | 0 | 0.26 | 0.97 | 2.06 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory tract and thoracic cavity procedural complications | 1 | 0.26 | 1.02 | 2.18 | 1.0 | 0.28 | 0.84 | 2.08 | 0.97 | 0.97 | 0.18 | 16
COVID19_MODERNA | Respiratory tract and thoracic cavity procedural complications | 1 | 0.16 | 0.62 | 1.33 | 3.1 | 0.14 | 0.48 | 1.23 | 0.21 | 0.21 | 0.04 | 16
COVID19_PFIZER/BIONTECH | Respiratory tract and thoracic cavity procedural complications | 3 | 0.40 | 1.05 | 1.93 | 3.0 | 0.41 | 0.91 | 1.82 | 0.88 | 0.88 | 0.31 | 14
COVID19_UNKNOWN MFR | Respiratory tract and thoracic cavity procedural complications | 0 | 0.16 | 0.99 | 2.41 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory tract and thoracic histopathology procedures | 1 | 0.05 | 0.28 | 0.65 | 7.8 | 0.04 | 0.22 | 0.65 | 0.11 | 0.11 | 0.02 | 141
COVID19_MODERNA | Respiratory tract and thoracic histopathology procedures | 16 | 0.48 | 0.76 | 1.08 | 27.0 | 0.41 | 0.61 | 0.88 | 0.43 | 0.43 | 0.28 | 126
COVID19_PFIZER/BIONTECH | Respiratory tract and thoracic histopathology procedures | 23 | 0.76 | 1.10 | 1.49 | 26.4 | 0.61 | 0.86 | 1.19 | 0.79 | 0.79 | 0.54 | 119
COVID19_UNKNOWN MFR | Respiratory tract and thoracic histopathology procedures | 0 | 0.05 | 0.85 | 2.49 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory tract and thoracic imaging procedures | 801 | 1.73 | 1.83 | 1.94 | 474.2 | 1.59 | 1.69 | 1.79 | 1.87 | 1.89 | 1.78 | 6599
COVID19_MODERNA | Respiratory tract and thoracic imaging procedures | 1920 | 0.98 | 1.01 | 1.05 | 2013.1 | 0.92 | 0.95 | 0.99 | 1.19 | 1.19 | 1.14 | 5480
COVID19_PFIZER/BIONTECH | Respiratory tract and thoracic imaging procedures | 2258 | 1.37 | 1.42 | 1.47 | 1698.8 | 1.28 | 1.33 | 1.38 | 1.80 | 1.81 | 1.74 | 5142
COVID19_UNKNOWN MFR | Respiratory tract and thoracic imaging procedures | 31 | 1.78 | 2.42 | 3.14 | 11.9 | 1.73 | 2.33 | 3.11 | 2.89 | 2.96 | 2.19 | 7369
COVID19_JANSSEN | Respiratory tract disorders NEC | 134 | 0.76 | 0.88 | 1.00 | 158.9 | 0.73 | 0.84 | 0.97 | 0.88 | 0.88 | 0.76 | 2346
COVID19_MODERNA | Respiratory tract disorders NEC | 538 | 0.82 | 0.89 | 0.95 | 624.4 | 0.80 | 0.86 | 0.92 | 0.94 | 0.94 | 0.87 | 1942
COVID19_PFIZER/BIONTECH | Respiratory tract disorders NEC | 695 | 1.24 | 1.32 | 1.40 | 543.6 | 1.20 | 1.28 | 1.36 | 1.59 | 1.60 | 1.48 | 1785
COVID19_UNKNOWN MFR | Respiratory tract disorders NEC | 7 | 0.80 | 1.39 | 2.12 | 3.8 | 0.81 | 1.45 | 2.46 | 1.95 | 1.96 | 1.05 | 2473
COVID19_JANSSEN | Respiratory tract disorders congenital NEC | 0 | 0.00 | 0.64 | 3.23 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Respiratory tract disorders congenital NEC | 0 | 0.00 | 0.33 | 1.63 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory tract disorders congenital NEC | 0 | 0.00 | 0.36 | 1.80 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory tract disorders congenital NEC | 0 | 0.00 | 0.99 | 4.97 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory tract small cell carcinomas | 1 | 0.33 | 1.65 | 3.79 | 0.1 | 0.42 | 1.48 | 8.69 | 15.44 | 15.44 | 1.51 | 1
COVID19_MODERNA | Respiratory tract small cell carcinomas | 0 | 0.06 | 0.73 | 2.03 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory tract small cell carcinomas | 1 | 0.28 | 1.38 | 3.15 | 0.4 | 0.35 | 1.05 | 2.72 | 4.09 | 4.09 | 0.40 | 1
COVID19_UNKNOWN MFR | Respiratory tract small cell carcinomas | 0 | 0.08 | 1.00 | 2.78 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory tract therapeutic procedures NEC | 52 | 1.15 | 1.47 | 1.81 | 40.8 | 0.99 | 1.25 | 1.56 | 1.05 | 1.05 | 0.83 | 767
COVID19_MODERNA | Respiratory tract therapeutic procedures NEC | 157 | 0.90 | 1.03 | 1.17 | 170.2 | 0.81 | 0.92 | 1.05 | 0.81 | 0.81 | 0.70 | 662
COVID19_PFIZER/BIONTECH | Respiratory tract therapeutic procedures NEC | 162 | 1.08 | 1.24 | 1.40 | 152.2 | 0.93 | 1.06 | 1.20 | 1.01 | 1.01 | 0.87 | 657
COVID19_UNKNOWN MFR | Respiratory tract therapeutic procedures NEC | 2 | 0.44 | 1.35 | 2.67 | 1.2 | 0.44 | 1.10 | 2.41 | 1.68 | 1.69 | 0.53 | 817
COVID19_JANSSEN | Reticuloendothelial disorders NEC | 0 | 0.06 | 0.95 | 2.73 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Reticuloendothelial disorders NEC | 0 | 0.06 | 0.83 | 2.39 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reticuloendothelial disorders NEC | 1 | 0.31 | 1.61 | 3.76 | 0.2 | 0.39 | 1.21 | 3.70 | 12.28 | 12.28 | 0.84 | 0
COVID19_UNKNOWN MFR | Reticuloendothelial disorders NEC | 0 | 0.07 | 1.00 | 2.88 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Retinal bleeding and vascular disorders (excl retinopathy) | 17 | 1.35 | 2.07 | 2.92 | 9.7 | 1.06 | 1.57 | 2.26 | 1.79 | 1.79 | 1.17 | 147
COVID19_MODERNA | Retinal bleeding and vascular disorders (excl retinopathy) | 33 | 0.80 | 1.09 | 1.41 | 40.2 | 0.61 | 0.82 | 1.07 | 0.86 | 0.86 | 0.62 | 131
COVID19_PFIZER/BIONTECH | Retinal bleeding and vascular disorders (excl retinopathy) | 60 | 1.79 | 2.24 | 2.73 | 34.9 | 1.34 | 1.66 | 2.04 | 2.36 | 2.36 | 1.81 | 104
COVID19_UNKNOWN MFR | Retinal bleeding and vascular disorders (excl retinopathy) | 1 | 0.33 | 1.50 | 3.35 | 0.3 | 0.38 | 1.16 | 3.28 | 4.22 | 4.22 | 0.81 | 163
COVID19_JANSSEN | Retinal disorders congenital | 1 | 0.32 | 1.73 | 4.05 | 0.1 | 0.40 | 1.31 | 5.21 | 15.44 | 15.44 | 1.51 | 1
COVID19_MODERNA | Retinal disorders congenital | 0 | 0.04 | 0.70 | 2.05 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinal disorders congenital | 0 | 0.05 | 0.73 | 2.14 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal disorders congenital | 0 | 0.06 | 1.00 | 2.91 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Retinal structural change, deposit and degeneration | 6 | 0.42 | 0.89 | 1.49 | 8.8 | 0.38 | 0.70 | 1.22 | 0.72 | 0.72 | 0.36 | 129
COVID19_MODERNA | Retinal structural change, deposit and degeneration | 19 | 0.58 | 0.88 | 1.22 | 25.5 | 0.52 | 0.75 | 1.06 | 0.56 | 0.56 | 0.37 | 116
COVID19_PFIZER/BIONTECH | Retinal structural change, deposit and degeneration | 26 | 0.88 | 1.24 | 1.66 | 25.6 | 0.72 | 1.00 | 1.35 | 0.98 | 0.98 | 0.68 | 109
COVID19_UNKNOWN MFR | Retinal structural change, deposit and degeneration | 0 | 0.08 | 0.87 | 2.40 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Retinal therapeutic procedures | 1 | 0.32 | 1.18 | 2.48 | 0.6 | 0.33 | 0.99 | 2.51 | 1.93 | 1.93 | 0.34 | 8
COVID19_MODERNA | Retinal therapeutic procedures | 1 | 0.20 | 0.74 | 1.56 | 2.0 | 0.20 | 0.63 | 1.56 | 0.42 | 0.42 | 0.07 | 8
COVID19_PFIZER/BIONTECH | Retinal therapeutic procedures | 2 | 0.36 | 1.06 | 2.06 | 1.8 | 0.37 | 0.93 | 2.01 | 1.17 | 1.17 | 0.31 | 7
COVID19_UNKNOWN MFR | Retinal therapeutic procedures | 0 | 0.18 | 0.99 | 2.36 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Retinal, choroid and vitreous infections and inflammations | 2 | 0.18 | 0.68 | 1.47 | 4.3 | 0.22 | 0.57 | 1.23 | 0.53 | 0.53 | 0.16 | 58
COVID19_MODERNA | Retinal, choroid and vitreous infections and inflammations | 2 | 0.07 | 0.28 | 0.61 | 10.5 | 0.09 | 0.27 | 0.63 | 0.12 | 0.12 | 0.04 | 58
COVID19_PFIZER/BIONTECH | Retinal, choroid and vitreous infections and inflammations | 7 | 0.39 | 0.79 | 1.31 | 11.3 | 0.36 | 0.65 | 1.09 | 0.54 | 0.54 | 0.28 | 53
COVID19_UNKNOWN MFR | Retinal, choroid and vitreous infections and inflammations | 0 | 0.03 | 0.91 | 2.95 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Retinopathies NEC | 1 | 0.11 | 0.60 | 1.43 | 2.8 | 0.16 | 0.52 | 1.32 | 0.44 | 0.44 | 0.08 | 35
COVID19_MODERNA | Retinopathies NEC | 3 | 0.18 | 0.51 | 0.99 | 6.8 | 0.23 | 0.52 | 1.05 | 0.31 | 0.31 | 0.11 | 33
COVID19_PFIZER/BIONTECH | Retinopathies NEC | 3 | 0.18 | 0.52 | 1.00 | 7.4 | 0.21 | 0.49 | 0.98 | 0.37 | 0.37 | 0.14 | 33
COVID19_UNKNOWN MFR | Retinopathies NEC | 0 | 0.05 | 0.95 | 2.81 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Retroviral infections | 1 | 0.19 | 0.99 | 2.28 | 1.3 | 0.25 | 0.77 | 1.91 | 0.97 | 0.97 | 0.18 | 16
COVID19_MODERNA | Retroviral infections | 0 | 0.03 | 0.35 | 0.98 | 2.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retroviral infections | 2 | 0.24 | 0.83 | 1.70 | 3.0 | 0.28 | 0.71 | 1.53 | 0.55 | 0.55 | 0.16 | 15
COVID19_UNKNOWN MFR | Retroviral infections | 0 | 0.07 | 0.98 | 2.77 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Rhabdomyosarcomas | 0 | 0.02 | 0.75 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Rhabdomyosarcomas | 0 | 0.01 | 0.45 | 1.49 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rhabdomyosarcomas | 0 | 0.01 | 0.48 | 1.62 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhabdomyosarcomas | 0 | 0.02 | 0.99 | 3.33 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Rheumatoid arthropathies | 17 | 0.42 | 0.65 | 0.92 | 33.2 | 0.36 | 0.53 | 0.76 | 0.47 | 0.47 | 0.31 | 562
COVID19_MODERNA | Rheumatoid arthropathies | 74 | 0.68 | 0.83 | 1.00 | 102.4 | 0.60 | 0.72 | 0.87 | 0.50 | 0.50 | 0.41 | 505
COVID19_PFIZER/BIONTECH | Rheumatoid arthropathies | 94 | 0.95 | 1.14 | 1.34 | 99.6 | 0.79 | 0.94 | 1.11 | 0.79 | 0.79 | 0.66 | 485
COVID19_UNKNOWN MFR | Rheumatoid arthropathies | 0 | 0.01 | 0.48 | 1.61 | 0.8 |  |  |  |  |  |  | 
COVID19_JANSSEN | Rhinoviral infections | 2 | 0.42 | 1.47 | 3.04 | 1.0 | 0.46 | 1.15 | 2.56 | 0.88 | 0.88 | 0.27 | 35
COVID19_MODERNA | Rhinoviral infections | 1 | 0.12 | 0.60 | 1.38 | 2.5 | 0.17 | 0.56 | 1.40 | 0.09 | 0.09 | 0.02 | 36
COVID19_PFIZER/BIONTECH | Rhinoviral infections | 1 | 0.10 | 0.52 | 1.21 | 3.5 | 0.13 | 0.45 | 1.16 | 0.11 | 0.11 | 0.02 | 36
COVID19_UNKNOWN MFR | Rhinoviral infections | 0 | 0.07 | 0.98 | 2.79 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Rickettsial infectious disorders NEC | 1 | 0.29 | 1.31 | 2.91 | 0.5 | 0.34 | 1.02 | 2.61 | 2.57 | 2.57 | 0.44 | 6
COVID19_MODERNA | Rickettsial infectious disorders NEC | 2 | 0.35 | 1.13 | 2.29 | 1.7 | 0.38 | 0.96 | 2.07 | 1.36 | 1.36 | 0.34 | 5
COVID19_PFIZER/BIONTECH | Rickettsial infectious disorders NEC | 0 | 0.06 | 0.51 | 1.35 | 1.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rickettsial infectious disorders NEC | 0 | 0.11 | 0.99 | 2.61 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Right ventricular failures | 6 | 1.11 | 2.34 | 3.94 | 1.9 | 1.00 | 1.93 | 3.67 | 3.43 | 3.43 | 1.63 | 27
COVID19_MODERNA | Right ventricular failures | 10 | 0.65 | 1.15 | 1.76 | 8.9 | 0.64 | 1.06 | 1.66 | 1.48 | 1.48 | 0.79 | 23
COVID19_PFIZER/BIONTECH | Right ventricular failures | 9 | 0.69 | 1.26 | 1.97 | 7.2 | 0.68 | 1.14 | 1.84 | 1.54 | 1.54 | 0.81 | 24
COVID19_UNKNOWN MFR | Right ventricular failures | 0 | 0.08 | 0.96 | 2.69 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Rosaceas | 2 | 0.37 | 0.84 | 1.45 | 3.1 | 0.28 | 0.70 | 1.51 | 0.58 | 0.58 | 0.18 | 53
COVID19_MODERNA | Rosaceas | 16 | 0.69 | 1.04 | 1.44 | 14.9 | 0.69 | 1.04 | 1.50 | 1.39 | 1.39 | 0.86 | 39
COVID19_PFIZER/BIONTECH | Rosaceas | 12 | 0.63 | 1.00 | 1.43 | 11.8 | 0.62 | 0.98 | 1.49 | 1.14 | 1.14 | 0.67 | 43
COVID19_UNKNOWN MFR | Rosaceas | 0 | 0.35 | 0.98 | 1.87 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Rotaviral infections | 0 | 0.00 | 0.01 | 0.03 | 32.8 |  |  |  |  |  |  | 
COVID19_MODERNA | Rotaviral infections | 0 | 0.00 | 0.01 | 0.03 | 28.8 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rotaviral infections | 0 | 0.00 | 0.00 | 0.01 | 61.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rotaviral infections | 0 | 0.00 | 0.16 | 0.85 | 0.9 |  |  |  |  |  |  | 
COVID19_JANSSEN | Rubella viral infections | 0 | 0.00 | 0.13 | 0.68 | 1.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Rubella viral infections | 1 | 0.03 | 0.46 | 1.31 | 1.7 | 0.22 | 0.68 | 1.67 | 0.10 | 0.10 | 0.02 | 33
COVID19_PFIZER/BIONTECH | Rubella viral infections | 0 | 0.00 | 0.05 | 0.28 | 2.9 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rubella viral infections | 0 | 0.00 | 0.81 | 4.44 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Rubeola viral infections | 1 | 0.02 | 0.22 | 0.59 | 11.0 | 0.02 | 0.14 | 0.48 | 0.05 | 0.05 | 0.01 | 326
COVID19_MODERNA | Rubeola viral infections | 1 | 0.01 | 0.11 | 0.30 | 16.5 | 0.01 | 0.08 | 0.32 | 0.01 | 0.01 | 0.00 | 326
COVID19_PFIZER/BIONTECH | Rubeola viral infections | 7 | 0.23 | 0.48 | 0.80 | 27.4 | 0.16 | 0.29 | 0.50 | 0.09 | 0.09 | 0.05 | 320
COVID19_UNKNOWN MFR | Rubeola viral infections | 0 | 0.00 | 0.62 | 2.84 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Salivary gland disorders NEC | 3 | 0.54 | 1.63 | 3.18 | 1.7 | 0.54 | 1.22 | 2.47 | 2.01 | 2.01 | 0.73 | 23
COVID19_MODERNA | Salivary gland disorders NEC | 2 | 0.11 | 0.43 | 0.91 | 5.9 | 0.17 | 0.45 | 0.99 | 0.28 | 0.28 | 0.08 | 24
COVID19_PFIZER/BIONTECH | Salivary gland disorders NEC | 9 | 0.92 | 1.70 | 2.67 | 5.2 | 0.85 | 1.45 | 2.33 | 2.17 | 2.17 | 1.10 | 17
COVID19_UNKNOWN MFR | Salivary gland disorders NEC | 0 | 0.03 | 0.96 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Salivary gland enlargements | 0 | 0.00 | 0.09 | 0.33 | 5.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Salivary gland enlargements | 12 | 0.37 | 0.64 | 0.96 | 19.3 | 0.40 | 0.64 | 0.98 | 0.42 | 0.42 | 0.25 | 97
COVID19_PFIZER/BIONTECH | Salivary gland enlargements | 23 | 0.90 | 1.30 | 1.77 | 18.6 | 0.84 | 1.19 | 1.63 | 1.10 | 1.10 | 0.74 | 86
COVID19_UNKNOWN MFR | Salivary gland enlargements | 1 | 0.28 | 2.22 | 5.70 | 0.2 | 0.40 | 1.29 | 4.72 | 6.37 | 6.38 | 1.22 | 108
COVID19_JANSSEN | Salivary gland infections and inflammations | 0 | 0.09 | 0.72 | 1.85 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Salivary gland infections and inflammations | 2 | 0.29 | 0.93 | 1.86 | 2.8 | 0.29 | 0.74 | 1.60 | 0.85 | 0.85 | 0.23 | 8
COVID19_PFIZER/BIONTECH | Salivary gland infections and inflammations | 2 | 0.32 | 1.01 | 2.02 | 2.6 | 0.31 | 0.78 | 1.69 | 1.02 | 1.02 | 0.28 | 8
COVID19_UNKNOWN MFR | Salivary gland infections and inflammations | 0 | 0.12 | 0.99 | 2.55 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Salivary gland neoplasms unspecified malignancy | 0 | 0.07 | 0.87 | 2.42 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Salivary gland neoplasms unspecified malignancy | 0 | 0.05 | 0.65 | 1.79 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Salivary gland neoplasms unspecified malignancy | 1 | 0.25 | 1.22 | 2.80 | 0.4 | 0.35 | 1.08 | 2.82 | 2.05 | 2.05 | 0.27 | 2
COVID19_UNKNOWN MFR | Salivary gland neoplasms unspecified malignancy | 0 | 0.08 | 1.00 | 2.77 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Salivary gland stenosis and obstruction | 0 | 0.07 | 0.95 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Salivary gland stenosis and obstruction | 1 | 0.30 | 1.57 | 3.64 | 0.4 | 0.35 | 1.06 | 2.77 | 10.19 | 10.19 | 0.69 | 0
COVID19_PFIZER/BIONTECH | Salivary gland stenosis and obstruction | 0 | 0.06 | 0.85 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Salivary gland stenosis and obstruction | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Salmonella infections | 0 | 0.00 | 0.10 | 0.54 | 1.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Salmonella infections | 0 | 0.00 | 0.07 | 0.37 | 2.3 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Salmonella infections | 0 | 0.00 | 0.05 | 0.26 | 3.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Salmonella infections | 0 | 0.00 | 0.81 | 4.34 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Scaly conditions | 0 | 0.10 | 0.73 | 1.85 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Scaly conditions | 2 | 0.30 | 0.93 | 1.85 | 2.7 | 0.30 | 0.76 | 1.64 | 0.85 | 0.85 | 0.23 | 8
COVID19_PFIZER/BIONTECH | Scaly conditions | 2 | 0.32 | 1.01 | 2.01 | 2.2 | 0.34 | 0.84 | 1.82 | 1.02 | 1.02 | 0.28 | 8
COVID19_UNKNOWN MFR | Scaly conditions | 0 | 0.13 | 0.99 | 2.51 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Schizoaffective and schizophreniform disorders | 0 | 0.00 | 0.57 | 2.36 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Schizoaffective and schizophreniform disorders | 1 | 0.10 | 0.91 | 2.43 | 0.7 | 0.31 | 0.93 | 2.31 | 0.85 | 0.85 | 0.14 | 4
COVID19_PFIZER/BIONTECH | Schizoaffective and schizophreniform disorders | 0 | 0.00 | 0.29 | 1.20 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Schizoaffective and schizophreniform disorders | 0 | 0.00 | 0.98 | 4.08 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Schizophrenia NEC | 1 | 0.11 | 1.14 | 3.08 | 1.0 | 0.28 | 0.84 | 2.08 | 0.86 | 0.86 | 0.16 | 18
COVID19_MODERNA | Schizophrenia NEC | 2 | 0.16 | 0.74 | 1.67 | 2.4 | 0.32 | 0.81 | 1.75 | 0.40 | 0.40 | 0.12 | 17
COVID19_PFIZER/BIONTECH | Schizophrenia NEC | 2 | 0.17 | 0.78 | 1.77 | 2.6 | 0.30 | 0.77 | 1.65 | 0.48 | 0.48 | 0.14 | 17
COVID19_UNKNOWN MFR | Schizophrenia NEC | 0 | 0.00 | 0.95 | 4.17 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Scleral infections, irritations and inflammations | 0 | 0.01 | 0.23 | 0.66 | 3.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Scleral infections, irritations and inflammations | 13 | 0.62 | 1.02 | 1.51 | 14.1 | 0.58 | 0.90 | 1.36 | 1.13 | 1.13 | 0.67 | 39
COVID19_PFIZER/BIONTECH | Scleral infections, irritations and inflammations | 13 | 0.69 | 1.13 | 1.67 | 12.8 | 0.63 | 0.98 | 1.47 | 1.36 | 1.36 | 0.81 | 39
COVID19_UNKNOWN MFR | Scleral infections, irritations and inflammations | 0 | 0.06 | 0.93 | 2.71 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Scleral structural change, deposit and degeneration | 0 | 0.20 | 0.81 | 1.77 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Scleral structural change, deposit and degeneration | 1 | 0.24 | 0.74 | 1.46 | 2.3 | 0.18 | 0.59 | 1.46 | 0.34 | 0.34 | 0.06 | 10
COVID19_PFIZER/BIONTECH | Scleral structural change, deposit and degeneration | 3 | 0.50 | 1.18 | 2.09 | 2.0 | 0.50 | 1.11 | 2.23 | 1.54 | 1.54 | 0.50 | 8
COVID19_UNKNOWN MFR | Scleral structural change, deposit and degeneration | 0 | 0.24 | 1.00 | 2.16 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Scrotal disorders NEC | 0 | 0.07 | 0.42 | 1.01 | 2.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Scrotal disorders NEC | 4 | 0.30 | 0.68 | 1.20 | 6.9 | 0.30 | 0.63 | 1.19 | 0.35 | 0.35 | 0.15 | 39
COVID19_PFIZER/BIONTECH | Scrotal disorders NEC | 10 | 0.77 | 1.34 | 2.03 | 7.3 | 0.74 | 1.23 | 1.93 | 1.24 | 1.24 | 0.69 | 33
COVID19_UNKNOWN MFR | Scrotal disorders NEC | 0 | 0.17 | 0.97 | 2.31 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Sebaceous gland disorders | 0 | 0.06 | 0.74 | 2.07 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Sebaceous gland disorders | 1 | 0.16 | 0.79 | 1.81 | 0.4 | 0.35 | 1.07 | 2.78 | 0.57 | 0.57 | 0.10 | 6
COVID19_PFIZER/BIONTECH | Sebaceous gland disorders | 2 | 0.36 | 1.24 | 2.55 | 0.7 | 0.51 | 1.31 | 3.06 | 1.64 | 1.64 | 0.41 | 5
COVID19_UNKNOWN MFR | Sebaceous gland disorders | 0 | 0.08 | 0.99 | 2.76 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Seizures and seizure disorders NEC | 430 | 1.19 | 1.29 | 1.40 | 412.1 | 0.96 | 1.04 | 1.13 | 0.76 | 0.76 | 0.70 | 8687
COVID19_MODERNA | Seizures and seizure disorders NEC | 775 | 0.81 | 0.86 | 0.91 | 1012.7 | 0.72 | 0.77 | 0.81 | 0.32 | 0.31 | 0.29 | 8342
COVID19_PFIZER/BIONTECH | Seizures and seizure disorders NEC | 983 | 1.00 | 1.06 | 1.11 | 1139.0 | 0.82 | 0.86 | 0.91 | 0.50 | 0.49 | 0.46 | 8134
COVID19_UNKNOWN MFR | Seizures and seizure disorders NEC | 9 | 0.67 | 1.18 | 1.81 | 9.4 | 0.55 | 0.92 | 1.48 | 0.68 | 0.68 | 0.39 | 9108
COVID19_JANSSEN | Sensory abnormalities NEC | 815 | 1.20 | 1.27 | 1.34 | 663.8 | 1.16 | 1.23 | 1.30 | 1.51 | 1.52 | 1.43 | 8321
COVID19_MODERNA | Sensory abnormalities NEC | 2311 | 0.89 | 0.92 | 0.95 | 2523.1 | 0.89 | 0.92 | 0.95 | 1.15 | 1.15 | 1.11 | 6825
COVID19_PFIZER/BIONTECH | Sensory abnormalities NEC | 2825 | 1.28 | 1.32 | 1.36 | 2176.7 | 1.26 | 1.30 | 1.34 | 1.83 | 1.85 | 1.78 | 6311
COVID19_UNKNOWN MFR | Sensory abnormalities NEC | 22 | 0.99 | 1.44 | 1.96 | 15.4 | 0.95 | 1.35 | 1.87 | 1.66 | 1.68 | 1.18 | 9114
COVID19_JANSSEN | Sepsis, bacteraemia, viraemia and fungaemia NEC | 33 | 0.59 | 0.80 | 1.03 | 52.2 | 0.48 | 0.64 | 0.84 | 0.48 | 0.48 | 0.36 | 1071
COVID19_MODERNA | Sepsis, bacteraemia, viraemia and fungaemia NEC | 169 | 0.96 | 1.09 | 1.24 | 191.5 | 0.78 | 0.88 | 1.00 | 0.61 | 0.61 | 0.53 | 935
COVID19_PFIZER/BIONTECH | Sepsis, bacteraemia, viraemia and fungaemia NEC | 227 | 1.38 | 1.54 | 1.71 | 184.3 | 1.10 | 1.23 | 1.37 | 1.06 | 1.06 | 0.94 | 877
COVID19_UNKNOWN MFR | Sepsis, bacteraemia, viraemia and fungaemia NEC | 1 | 0.19 | 0.90 | 2.03 | 1.6 | 0.23 | 0.71 | 1.75 | 0.62 | 0.62 | 0.12 | 1103
COVID19_JANSSEN | Serratia infections | 0 | 0.14 | 0.86 | 2.07 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Serratia infections | 1 | 0.25 | 0.96 | 2.02 | 1.2 | 0.26 | 0.78 | 1.92 | 0.85 | 0.85 | 0.14 | 4
COVID19_PFIZER/BIONTECH | Serratia infections | 2 | 0.46 | 1.35 | 2.63 | 1.0 | 0.46 | 1.17 | 2.59 | 2.73 | 2.73 | 0.61 | 3
COVID19_UNKNOWN MFR | Serratia infections | 0 | 0.17 | 1.00 | 2.39 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Sex chromosomal abnormalities | 0 | 0.07 | 0.95 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Sex chromosomal abnormalities | 1 | 0.30 | 1.57 | 3.64 | 0.3 | 0.38 | 1.17 | 3.31 | 10.19 | 10.19 | 0.69 | 0
COVID19_PFIZER/BIONTECH | Sex chromosomal abnormalities | 0 | 0.06 | 0.85 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sex chromosomal abnormalities | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Sexual desire disorders | 4 | 0.70 | 1.77 | 3.22 | 1.9 | 0.67 | 1.40 | 2.69 | 3.63 | 3.63 | 1.46 | 17
COVID19_MODERNA | Sexual desire disorders | 5 | 0.48 | 1.09 | 1.91 | 5.1 | 0.47 | 0.92 | 1.66 | 1.06 | 1.06 | 0.46 | 16
COVID19_PFIZER/BIONTECH | Sexual desire disorders | 3 | 0.25 | 0.73 | 1.40 | 4.9 | 0.30 | 0.67 | 1.33 | 0.68 | 0.68 | 0.25 | 18
COVID19_UNKNOWN MFR | Sexual desire disorders | 0 | 0.06 | 0.96 | 2.82 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Sexual dysfunction NEC | 0 | 0.07 | 0.95 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Sexual dysfunction NEC | 1 | 0.30 | 1.57 | 3.64 | 0.3 | 0.38 | 1.17 | 3.32 | 10.19 | 10.19 | 0.69 | 0
COVID19_PFIZER/BIONTECH | Sexual dysfunction NEC | 0 | 0.06 | 0.85 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sexual dysfunction NEC | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Sexual function and fertility disorders NEC | 1 | 0.02 | 0.28 | 0.77 | 7.1 | 0.05 | 0.24 | 0.69 | 0.18 | 0.18 | 0.04 | 84
COVID19_MODERNA | Sexual function and fertility disorders NEC | 1 | 0.01 | 0.13 | 0.37 | 12.7 | 0.02 | 0.12 | 0.41 | 0.04 | 0.04 | 0.01 | 84
COVID19_PFIZER/BIONTECH | Sexual function and fertility disorders NEC | 2 | 0.04 | 0.22 | 0.49 | 15.6 | 0.05 | 0.18 | 0.44 | 0.10 | 0.10 | 0.03 | 83
COVID19_UNKNOWN MFR | Sexual function and fertility disorders NEC | 0 | 0.00 | 0.71 | 3.43 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Sexuality issues | 0 | 0.01 | 0.58 | 2.00 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Sexuality issues | 1 | 0.09 | 0.67 | 1.69 | 1.4 | 0.24 | 0.75 | 1.84 | 0.49 | 0.49 | 0.08 | 7
COVID19_PFIZER/BIONTECH | Sexuality issues | 1 | 0.10 | 0.74 | 1.87 | 1.6 | 0.23 | 0.70 | 1.72 | 0.59 | 0.59 | 0.10 | 7
COVID19_UNKNOWN MFR | Sexuality issues | 0 | 0.01 | 0.98 | 3.42 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Shigella infections | 0 | 0.04 | 0.89 | 2.70 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Shigella infections | 0 | 0.03 | 0.68 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Shigella infections | 0 | 0.03 | 0.71 | 2.16 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Shigella infections | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Sickle cell trait and disorders | 1 | 0.19 | 0.87 | 1.97 | 1.7 | 0.22 | 0.69 | 1.69 | 0.77 | 0.77 | 0.14 | 20
COVID19_MODERNA | Sickle cell trait and disorders | 5 | 0.50 | 1.12 | 1.94 | 4.5 | 0.51 | 0.99 | 1.79 | 1.06 | 1.06 | 0.46 | 16
COVID19_PFIZER/BIONTECH | Sickle cell trait and disorders | 4 | 0.42 | 1.02 | 1.84 | 4.4 | 0.42 | 0.87 | 1.63 | 0.96 | 0.96 | 0.39 | 17
COVID19_UNKNOWN MFR | Sickle cell trait and disorders | 0 | 0.09 | 0.98 | 2.65 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Site specific embolism and thrombosis NEC | 0 | 0.09 | 0.85 | 2.28 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Site specific embolism and thrombosis NEC | 2 | 0.44 | 1.48 | 3.00 | 1.4 | 0.41 | 1.02 | 2.23 | 3.40 | 3.40 | 0.66 | 2
COVID19_PFIZER/BIONTECH | Site specific embolism and thrombosis NEC | 2 | 0.47 | 1.56 | 3.18 | 1.1 | 0.45 | 1.14 | 2.51 | 4.09 | 4.09 | 0.79 | 2
COVID19_UNKNOWN MFR | Site specific embolism and thrombosis NEC | 0 | 0.10 | 1.00 | 2.68 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Site specific injuries NEC | 223 | 1.72 | 1.92 | 2.14 | 145.0 | 1.37 | 1.53 | 1.70 | 1.77 | 1.77 | 1.58 | 1949
COVID19_MODERNA | Site specific injuries NEC | 393 | 0.93 | 1.01 | 1.10 | 465.4 | 0.78 | 0.84 | 0.92 | 0.75 | 0.75 | 0.68 | 1779
COVID19_PFIZER/BIONTECH | Site specific injuries NEC | 434 | 1.17 | 1.27 | 1.37 | 419.1 | 0.96 | 1.03 | 1.12 | 1.02 | 1.02 | 0.94 | 1738
COVID19_UNKNOWN MFR | Site specific injuries NEC | 5 | 0.73 | 1.53 | 2.56 | 3.0 | 0.65 | 1.28 | 2.32 | 1.59 | 1.59 | 0.76 | 2167
COVID19_JANSSEN | Site specific necrosis and vascular insufficiency NEC | 0 | 0.03 | 0.88 | 2.74 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Site specific necrosis and vascular insufficiency NEC | 0 | 0.03 | 0.66 | 2.07 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Site specific necrosis and vascular insufficiency NEC | 0 | 0.03 | 0.70 | 2.17 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Site specific necrosis and vascular insufficiency NEC | 0 | 0.04 | 1.00 | 3.10 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Site specific procedural complications NEC | 0 | 0.06 | 0.86 | 2.47 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Site specific procedural complications NEC | 2 | 0.49 | 1.73 | 3.58 | 0.9 | 0.49 | 1.24 | 2.81 | 6.79 | 6.79 | 0.91 | 1
COVID19_PFIZER/BIONTECH | Site specific procedural complications NEC | 0 | 0.05 | 0.66 | 1.89 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Site specific procedural complications NEC | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Site specific vascular disorders NEC | 547 | 1.39 | 1.49 | 1.59 | 413.7 | 1.23 | 1.32 | 1.41 | 1.37 | 1.38 | 1.28 | 6164
COVID19_MODERNA | Site specific vascular disorders NEC | 894 | 0.83 | 0.88 | 0.93 | 1104.4 | 0.77 | 0.81 | 0.86 | 0.52 | 0.52 | 0.49 | 5817
COVID19_PFIZER/BIONTECH | Site specific vascular disorders NEC | 1260 | 1.23 | 1.29 | 1.35 | 1098.8 | 1.09 | 1.15 | 1.20 | 0.95 | 0.95 | 0.90 | 5451
COVID19_UNKNOWN MFR | Site specific vascular disorders NEC | 8 | 0.62 | 1.09 | 1.68 | 8.1 | 0.55 | 0.95 | 1.55 | 0.82 | 0.82 | 0.46 | 6703
COVID19_JANSSEN | Skeletal and cardiac muscle analyses | 262 | 1.14 | 1.27 | 1.40 | 270.5 | 0.87 | 0.97 | 1.07 | 1.20 | 1.21 | 1.08 | 3361
COVID19_MODERNA | Skeletal and cardiac muscle analyses | 976 | 1.21 | 1.28 | 1.35 | 975.3 | 0.95 | 1.00 | 1.05 | 1.25 | 1.25 | 1.18 | 2647
COVID19_PFIZER/BIONTECH | Skeletal and cardiac muscle analyses | 1323 | 1.94 | 2.03 | 2.12 | 837.9 | 1.51 | 1.58 | 1.65 | 2.35 | 2.37 | 2.24 | 2300
COVID19_UNKNOWN MFR | Skeletal and cardiac muscle analyses | 7 | 0.68 | 1.34 | 2.18 | 6.3 | 0.57 | 1.02 | 1.72 | 1.33 | 1.33 | 0.71 | 3616
COVID19_JANSSEN | Skin and subcutaneous conditions NEC | 19 | 0.71 | 1.05 | 1.44 | 18.8 | 0.68 | 0.99 | 1.39 | 1.06 | 1.06 | 0.72 | 277
COVID19_MODERNA | Skin and subcutaneous conditions NEC | 80 | 0.97 | 1.18 | 1.40 | 69.8 | 0.94 | 1.14 | 1.36 | 1.26 | 1.26 | 1.01 | 216
COVID19_PFIZER/BIONTECH | Skin and subcutaneous conditions NEC | 44 | 0.59 | 0.76 | 0.95 | 61.7 | 0.56 | 0.72 | 0.91 | 0.72 | 0.72 | 0.55 | 252
COVID19_UNKNOWN MFR | Skin and subcutaneous conditions NEC | 2 | 0.58 | 1.44 | 2.61 | 0.5 | 0.57 | 1.52 | 4.37 | 4.68 | 4.69 | 1.46 | 294
COVID19_JANSSEN | Skin and subcutaneous tissue disorders congenital NEC | 2 | 0.35 | 1.27 | 2.67 | 1.5 | 0.41 | 1.01 | 2.21 | 1.10 | 1.10 | 0.33 | 28
COVID19_MODERNA | Skin and subcutaneous tissue disorders congenital NEC | 5 | 0.54 | 1.24 | 2.17 | 3.5 | 0.60 | 1.18 | 2.13 | 0.68 | 0.68 | 0.30 | 25
COVID19_PFIZER/BIONTECH | Skin and subcutaneous tissue disorders congenital NEC | 1 | 0.07 | 0.40 | 0.95 | 4.0 | 0.11 | 0.41 | 1.06 | 0.14 | 0.14 | 0.03 | 29
COVID19_UNKNOWN MFR | Skin and subcutaneous tissue disorders congenital NEC | 0 | 0.05 | 0.97 | 2.90 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin and subcutaneous tissue therapeutic procedures NEC | 3 | 0.51 | 1.18 | 2.07 | 2.0 | 0.50 | 1.11 | 2.23 | 1.65 | 1.65 | 0.61 | 28
COVID19_MODERNA | Skin and subcutaneous tissue therapeutic procedures NEC | 10 | 0.60 | 1.02 | 1.53 | 9.5 | 0.60 | 1.00 | 1.57 | 1.62 | 1.62 | 0.86 | 21
COVID19_PFIZER/BIONTECH | Skin and subcutaneous tissue therapeutic procedures NEC | 5 | 0.36 | 0.72 | 1.19 | 7.8 | 0.34 | 0.67 | 1.21 | 0.79 | 0.79 | 0.35 | 26
COVID19_UNKNOWN MFR | Skin and subcutaneous tissue therapeutic procedures NEC | 0 | 0.26 | 0.98 | 2.09 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin and subcutaneous tissue ulcerations | 5 | 0.24 | 0.49 | 0.81 | 16.4 | 0.18 | 0.36 | 0.65 | 0.27 | 0.27 | 0.13 | 282
COVID19_MODERNA | Skin and subcutaneous tissue ulcerations | 32 | 0.48 | 0.64 | 0.83 | 61.8 | 0.39 | 0.53 | 0.69 | 0.43 | 0.43 | 0.31 | 255
COVID19_PFIZER/BIONTECH | Skin and subcutaneous tissue ulcerations | 32 | 0.54 | 0.73 | 0.95 | 54.2 | 0.45 | 0.60 | 0.79 | 0.51 | 0.51 | 0.38 | 255
COVID19_UNKNOWN MFR | Skin and subcutaneous tissue ulcerations | 0 | 0.24 | 0.89 | 1.88 | 0.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin cysts and polyps | 0 | 0.10 | 0.68 | 1.69 | 0.8 |  |  |  |  |  |  | 
COVID19_MODERNA | Skin cysts and polyps | 2 | 0.26 | 0.79 | 1.56 | 2.8 | 0.29 | 0.74 | 1.60 | 0.45 | 0.45 | 0.13 | 15
COVID19_PFIZER/BIONTECH | Skin cysts and polyps | 3 | 0.40 | 1.06 | 1.97 | 2.9 | 0.42 | 0.93 | 1.86 | 0.88 | 0.88 | 0.31 | 14
COVID19_UNKNOWN MFR | Skin cysts and polyps | 0 | 0.14 | 0.99 | 2.46 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin dystrophies | 0 | 0.10 | 0.55 | 1.29 | 1.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Skin dystrophies | 5 | 0.46 | 0.98 | 1.65 | 5.8 | 0.43 | 0.84 | 1.51 | 0.77 | 0.77 | 0.34 | 22
COVID19_PFIZER/BIONTECH | Skin dystrophies | 6 | 0.58 | 1.17 | 1.91 | 5.1 | 0.57 | 1.05 | 1.83 | 1.17 | 1.17 | 0.55 | 21
COVID19_UNKNOWN MFR | Skin dystrophies | 0 | 0.18 | 0.98 | 2.30 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin grafts | 0 | 0.07 | 0.73 | 1.99 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Skin grafts | 1 | 0.16 | 0.74 | 1.67 | 1.0 | 0.28 | 0.85 | 2.09 | 0.49 | 0.49 | 0.08 | 7
COVID19_PFIZER/BIONTECH | Skin grafts | 0 | 0.04 | 0.45 | 1.24 | 1.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin grafts | 0 | 0.09 | 0.99 | 2.71 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin haemorrhages | 6 | 0.43 | 0.90 | 1.53 | 7.8 | 0.42 | 0.78 | 1.34 | 0.45 | 0.45 | 0.23 | 206
COVID19_MODERNA | Skin haemorrhages | 17 | 0.45 | 0.70 | 0.99 | 27.3 | 0.43 | 0.64 | 0.92 | 0.30 | 0.30 | 0.20 | 195
COVID19_PFIZER/BIONTECH | Skin haemorrhages | 12 | 0.32 | 0.53 | 0.80 | 27.7 | 0.29 | 0.46 | 0.70 | 0.25 | 0.25 | 0.15 | 200
COVID19_UNKNOWN MFR | Skin haemorrhages | 0 | 0.05 | 0.84 | 2.48 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin histopathology procedures | 10 | 0.19 | 0.33 | 0.51 | 36.6 | 0.18 | 0.30 | 0.48 | 0.25 | 0.25 | 0.15 | 614
COVID19_MODERNA | Skin histopathology procedures | 61 | 0.42 | 0.52 | 0.63 | 131.0 | 0.38 | 0.47 | 0.58 | 0.37 | 0.37 | 0.29 | 563
COVID19_PFIZER/BIONTECH | Skin histopathology procedures | 61 | 0.46 | 0.58 | 0.70 | 120.1 | 0.42 | 0.51 | 0.63 | 0.44 | 0.44 | 0.36 | 563
COVID19_UNKNOWN MFR | Skin histopathology procedures | 0 | 0.03 | 0.55 | 1.60 | 0.9 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin hyperplasias and hypertrophies | 2 | 0.20 | 0.82 | 1.78 | 3.3 | 0.26 | 0.67 | 1.45 | 0.55 | 0.55 | 0.17 | 56
COVID19_MODERNA | Skin hyperplasias and hypertrophies | 10 | 0.68 | 1.22 | 1.89 | 9.5 | 0.61 | 1.00 | 1.58 | 0.71 | 0.71 | 0.40 | 48
COVID19_PFIZER/BIONTECH | Skin hyperplasias and hypertrophies | 4 | 0.20 | 0.54 | 1.02 | 9.8 | 0.23 | 0.47 | 0.90 | 0.30 | 0.30 | 0.13 | 54
COVID19_UNKNOWN MFR | Skin hyperplasias and hypertrophies | 0 | 0.01 | 0.90 | 3.24 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin hypoplasias and atrophies | 1 | 0.07 | 0.53 | 1.36 | 2.6 | 0.17 | 0.55 | 1.37 | 0.26 | 0.26 | 0.05 | 60
COVID19_MODERNA | Skin hypoplasias and atrophies | 9 | 0.55 | 1.02 | 1.62 | 9.0 | 0.57 | 0.96 | 1.54 | 0.59 | 0.59 | 0.32 | 52
COVID19_PFIZER/BIONTECH | Skin hypoplasias and atrophies | 2 | 0.07 | 0.30 | 0.66 | 8.8 | 0.11 | 0.32 | 0.73 | 0.14 | 0.14 | 0.04 | 59
COVID19_UNKNOWN MFR | Skin hypoplasias and atrophies | 0 | 0.01 | 0.91 | 3.23 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin implants | 0 | 0.07 | 0.91 | 2.54 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Skin implants | 1 | 0.27 | 1.32 | 3.04 | 0.8 | 0.30 | 0.91 | 2.27 | 3.40 | 3.40 | 0.33 | 1
COVID19_PFIZER/BIONTECH | Skin implants | 0 | 0.06 | 0.76 | 2.11 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin implants | 0 | 0.08 | 1.00 | 2.78 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin injuries NEC | 428 | 1.67 | 1.81 | 1.96 | 268.5 | 1.47 | 1.59 | 1.72 | 1.63 | 1.64 | 1.51 | 4049
COVID19_MODERNA | Skin injuries NEC | 798 | 0.77 | 0.81 | 0.86 | 1127.2 | 0.67 | 0.71 | 0.75 | 0.74 | 0.74 | 0.69 | 3679
COVID19_PFIZER/BIONTECH | Skin injuries NEC | 650 | 0.74 | 0.79 | 0.84 | 950.8 | 0.64 | 0.68 | 0.73 | 0.70 | 0.69 | 0.65 | 3827
COVID19_UNKNOWN MFR | Skin injuries NEC | 8 | 0.69 | 1.27 | 2.00 | 6.7 | 0.63 | 1.09 | 1.78 | 1.23 | 1.23 | 0.69 | 4469
COVID19_JANSSEN | Skin injuries and mechanical dermatoses | 2 | 0.41 | 1.42 | 2.91 | 1.0 | 0.47 | 1.17 | 2.61 | 1.54 | 1.54 | 0.46 | 20
COVID19_MODERNA | Skin injuries and mechanical dermatoses | 3 | 0.22 | 0.63 | 1.20 | 6.1 | 0.25 | 0.57 | 1.13 | 0.54 | 0.54 | 0.19 | 19
COVID19_PFIZER/BIONTECH | Skin injuries and mechanical dermatoses | 11 | 1.24 | 2.14 | 3.24 | 5.1 | 1.07 | 1.73 | 2.71 | 4.09 | 4.09 | 2.03 | 11
COVID19_UNKNOWN MFR | Skin injuries and mechanical dermatoses | 0 | 0.08 | 0.97 | 2.72 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin lesion excisions | 0 | 0.01 | 0.35 | 1.16 | 1.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Skin lesion excisions | 0 | 0.00 | 0.17 | 0.55 | 3.8 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin lesion excisions | 2 | 0.14 | 0.58 | 1.24 | 5.1 | 0.19 | 0.51 | 1.11 | 0.28 | 0.28 | 0.09 | 29
COVID19_UNKNOWN MFR | Skin lesion excisions | 0 | 0.02 | 0.95 | 3.14 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin melanomas (excl ocular) | 0 | 0.02 | 0.42 | 1.24 | 1.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Skin melanomas (excl ocular) | 1 | 0.06 | 0.32 | 0.76 | 4.9 | 0.08 | 0.34 | 0.92 | 0.17 | 0.17 | 0.03 | 20
COVID19_PFIZER/BIONTECH | Skin melanomas (excl ocular) | 6 | 0.58 | 1.23 | 2.08 | 4.4 | 0.63 | 1.17 | 2.04 | 1.64 | 1.64 | 0.74 | 15
COVID19_UNKNOWN MFR | Skin melanomas (excl ocular) | 0 | 0.05 | 0.97 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin neoplasms benign | 2 | 0.08 | 0.34 | 0.75 | 10.4 | 0.09 | 0.27 | 0.63 | 0.19 | 0.19 | 0.06 | 161
COVID19_MODERNA | Skin neoplasms benign | 18 | 0.60 | 0.93 | 1.31 | 24.6 | 0.50 | 0.74 | 1.05 | 0.42 | 0.42 | 0.28 | 145
COVID19_PFIZER/BIONTECH | Skin neoplasms benign | 7 | 0.18 | 0.37 | 0.62 | 27.4 | 0.16 | 0.29 | 0.50 | 0.18 | 0.18 | 0.10 | 156
COVID19_UNKNOWN MFR | Skin neoplasms benign | 0 | 0.00 | 0.71 | 2.85 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin neoplasms malignant and unspecified (excl melanoma) | 0 | 0.11 | 0.48 | 1.05 | 2.8 |  |  |  |  |  |  | 
COVID19_MODERNA | Skin neoplasms malignant and unspecified (excl melanoma) | 3 | 0.23 | 0.54 | 0.96 | 8.9 | 0.18 | 0.42 | 0.85 | 0.21 | 0.21 | 0.08 | 49
COVID19_PFIZER/BIONTECH | Skin neoplasms malignant and unspecified (excl melanoma) | 8 | 0.54 | 0.97 | 1.50 | 9.0 | 0.50 | 0.87 | 1.42 | 0.74 | 0.74 | 0.40 | 44
COVID19_UNKNOWN MFR | Skin neoplasms malignant and unspecified (excl melanoma) | 0 | 0.23 | 0.97 | 2.13 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin preneoplastic conditions NEC | 1 | 0.25 | 1.38 | 3.26 | 0.6 | 0.33 | 0.98 | 2.47 | 1.54 | 1.54 | 0.28 | 10
COVID19_MODERNA | Skin preneoplastic conditions NEC | 1 | 0.15 | 0.84 | 1.97 | 1.9 | 0.20 | 0.64 | 1.59 | 0.34 | 0.34 | 0.06 | 10
COVID19_PFIZER/BIONTECH | Skin preneoplastic conditions NEC | 1 | 0.15 | 0.83 | 1.95 | 2.0 | 0.20 | 0.64 | 1.58 | 0.41 | 0.41 | 0.07 | 10
COVID19_UNKNOWN MFR | Skin preneoplastic conditions NEC | 0 | 0.06 | 0.99 | 2.92 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin procedural complications | 0 | 0.05 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Skin procedural complications | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin procedural complications | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin procedural complications | 0 | 0.05 | 1.00 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin structures and soft tissue infections | 20 | 0.38 | 0.57 | 0.78 | 50.8 | 0.28 | 0.41 | 0.58 | 0.34 | 0.34 | 0.23 | 910
COVID19_MODERNA | Skin structures and soft tissue infections | 102 | 0.63 | 0.74 | 0.87 | 190.1 | 0.46 | 0.54 | 0.63 | 0.42 | 0.42 | 0.35 | 828
COVID19_PFIZER/BIONTECH | Skin structures and soft tissue infections | 70 | 0.47 | 0.58 | 0.69 | 169.8 | 0.34 | 0.42 | 0.51 | 0.33 | 0.33 | 0.27 | 860
COVID19_UNKNOWN MFR | Skin structures and soft tissue infections | 1 | 0.18 | 1.03 | 2.46 | 1.3 | 0.25 | 0.77 | 1.89 | 0.74 | 0.74 | 0.14 | 929
COVID19_JANSSEN | Skin vascular conditions NEC | 0 | 0.02 | 0.44 | 1.37 | 1.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Skin vascular conditions NEC | 3 | 0.33 | 0.98 | 1.91 | 4.1 | 0.33 | 0.74 | 1.49 | 0.38 | 0.38 | 0.14 | 27
COVID19_PFIZER/BIONTECH | Skin vascular conditions NEC | 4 | 0.44 | 1.13 | 2.08 | 4.6 | 0.40 | 0.84 | 1.57 | 0.63 | 0.63 | 0.26 | 26
COVID19_UNKNOWN MFR | Skin vascular conditions NEC | 0 | 0.04 | 0.97 | 2.98 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin vasculitides | 7 | 0.48 | 0.94 | 1.53 | 9.0 | 0.43 | 0.78 | 1.31 | 0.70 | 0.70 | 0.37 | 154
COVID19_MODERNA | Skin vasculitides | 12 | 0.34 | 0.56 | 0.83 | 26.6 | 0.30 | 0.48 | 0.73 | 0.27 | 0.27 | 0.17 | 149
COVID19_PFIZER/BIONTECH | Skin vasculitides | 20 | 0.59 | 0.88 | 1.22 | 27.7 | 0.50 | 0.73 | 1.02 | 0.58 | 0.58 | 0.39 | 141
COVID19_UNKNOWN MFR | Skin vasculitides | 0 | 0.10 | 0.87 | 2.29 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skin vasomotor conditions | 8 | 0.34 | 0.65 | 1.04 | 14.2 | 0.34 | 0.59 | 0.97 | 0.41 | 0.41 | 0.23 | 301
COVID19_MODERNA | Skin vasomotor conditions | 66 | 1.08 | 1.34 | 1.62 | 49.3 | 1.07 | 1.31 | 1.60 | 0.92 | 0.92 | 0.73 | 243
COVID19_PFIZER/BIONTECH | Skin vasomotor conditions | 40 | 0.71 | 0.93 | 1.19 | 46.0 | 0.67 | 0.87 | 1.11 | 0.61 | 0.61 | 0.46 | 269
COVID19_UNKNOWN MFR | Skin vasomotor conditions | 0 | 0.05 | 0.78 | 2.24 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skull and brain therapeutic procedures | 11 | 1.52 | 2.61 | 3.94 | 3.8 | 1.31 | 2.16 | 3.50 | 2.74 | 2.74 | 1.60 | 62
COVID19_MODERNA | Skull and brain therapeutic procedures | 21 | 0.97 | 1.43 | 1.95 | 17.6 | 0.80 | 1.15 | 1.59 | 1.37 | 1.37 | 0.90 | 52
COVID19_PFIZER/BIONTECH | Skull and brain therapeutic procedures | 17 | 0.86 | 1.33 | 1.88 | 15.1 | 0.73 | 1.08 | 1.56 | 1.24 | 1.24 | 0.79 | 56
COVID19_UNKNOWN MFR | Skull and brain therapeutic procedures | 0 | 0.10 | 0.94 | 2.50 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Skull fractures, facial bone fractures and dislocations | 5 | 0.43 | 0.94 | 1.61 | 6.2 | 0.41 | 0.80 | 1.44 | 0.87 | 0.87 | 0.41 | 89
COVID19_MODERNA | Skull fractures, facial bone fractures and dislocations | 16 | 0.63 | 0.98 | 1.39 | 18.6 | 0.57 | 0.85 | 1.23 | 0.70 | 0.70 | 0.44 | 78
COVID19_PFIZER/BIONTECH | Skull fractures, facial bone fractures and dislocations | 24 | 1.05 | 1.50 | 2.02 | 17.6 | 0.93 | 1.30 | 1.77 | 1.40 | 1.40 | 0.95 | 70
COVID19_UNKNOWN MFR | Skull fractures, facial bone fractures and dislocations | 0 | 0.13 | 0.93 | 2.35 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Sleep disorders NEC | 714 | 1.87 | 2.00 | 2.12 | 402.4 | 1.66 | 1.77 | 1.88 | 2.17 | 2.19 | 2.05 | 5086
COVID19_MODERNA | Sleep disorders NEC | 1869 | 1.19 | 1.23 | 1.28 | 1636.2 | 1.10 | 1.14 | 1.19 | 1.61 | 1.62 | 1.55 | 3931
COVID19_PFIZER/BIONTECH | Sleep disorders NEC | 1277 | 0.98 | 1.02 | 1.07 | 1371.5 | 0.89 | 0.93 | 0.97 | 1.16 | 1.16 | 1.10 | 4523
COVID19_UNKNOWN MFR | Sleep disorders NEC | 10 | 0.67 | 1.18 | 1.82 | 9.2 | 0.62 | 1.03 | 1.62 | 1.19 | 1.19 | 0.71 | 5790
COVID19_JANSSEN | Sleep disturbances NEC | 5 | 0.64 | 1.40 | 2.42 | 3.3 | 0.62 | 1.22 | 2.20 | 1.35 | 1.35 | 0.63 | 57
COVID19_MODERNA | Sleep disturbances NEC | 13 | 0.67 | 1.10 | 1.62 | 11.4 | 0.69 | 1.08 | 1.63 | 0.90 | 0.90 | 0.54 | 49
COVID19_PFIZER/BIONTECH | Sleep disturbances NEC | 13 | 0.73 | 1.20 | 1.77 | 10.8 | 0.73 | 1.13 | 1.70 | 1.09 | 1.09 | 0.65 | 49
COVID19_UNKNOWN MFR | Sleep disturbances NEC | 0 | 0.11 | 0.95 | 2.48 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Small intestinal neoplasms malignant | 0 | 0.05 | 0.94 | 2.81 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Small intestinal neoplasms malignant | 0 | 0.04 | 0.82 | 2.43 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Small intestinal neoplasms malignant | 0 | 0.05 | 0.84 | 2.49 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Small intestinal neoplasms malignant | 0 | 0.05 | 1.00 | 2.97 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Small intestine therapeutic procedures | 1 | 0.15 | 1.02 | 2.55 | 1.0 | 0.28 | 0.84 | 2.08 | 0.47 | 0.47 | 0.09 | 33
COVID19_MODERNA | Small intestine therapeutic procedures | 3 | 0.28 | 0.88 | 1.73 | 3.8 | 0.35 | 0.78 | 1.56 | 0.33 | 0.33 | 0.12 | 31
COVID19_PFIZER/BIONTECH | Small intestine therapeutic procedures | 3 | 0.30 | 0.94 | 1.85 | 3.8 | 0.35 | 0.78 | 1.56 | 0.40 | 0.40 | 0.15 | 31
COVID19_UNKNOWN MFR | Small intestine therapeutic procedures | 0 | 0.02 | 0.97 | 3.24 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Social issues NEC | 14 | 0.40 | 0.65 | 0.94 | 26.2 | 0.36 | 0.55 | 0.82 | 0.51 | 0.51 | 0.33 | 422
COVID19_MODERNA | Social issues NEC | 46 | 0.50 | 0.65 | 0.81 | 78.0 | 0.47 | 0.60 | 0.75 | 0.40 | 0.40 | 0.31 | 390
COVID19_PFIZER/BIONTECH | Social issues NEC | 70 | 0.86 | 1.06 | 1.28 | 75.4 | 0.76 | 0.93 | 1.12 | 0.78 | 0.78 | 0.63 | 366
COVID19_UNKNOWN MFR | Social issues NEC | 0 | 0.04 | 0.66 | 1.92 | 0.6 |  |  |  |  |  |  | 
COVID19_JANSSEN | Sodium imbalance | 8 | 0.56 | 1.06 | 1.70 | 11.3 | 0.42 | 0.72 | 1.18 | 0.57 | 0.57 | 0.32 | 217
COVID19_MODERNA | Sodium imbalance | 45 | 0.96 | 1.25 | 1.56 | 55.2 | 0.64 | 0.81 | 1.03 | 0.85 | 0.85 | 0.65 | 180
COVID19_PFIZER/BIONTECH | Sodium imbalance | 93 | 2.56 | 3.06 | 3.59 | 46.1 | 1.65 | 1.96 | 2.31 | 2.88 | 2.89 | 2.31 | 132
COVID19_UNKNOWN MFR | Sodium imbalance | 3 | 1.06 | 3.04 | 5.84 | 0.4 | 0.91 | 2.82 | 11.19 | 9.30 | 9.32 | 3.58 | 222
COVID19_JANSSEN | Soft tissue disorders NEC | 67 | 0.85 | 1.04 | 1.25 | 64.1 | 0.85 | 1.04 | 1.26 | 1.24 | 1.24 | 1.01 | 834
COVID19_MODERNA | Soft tissue disorders NEC | 212 | 0.74 | 0.83 | 0.93 | 254.7 | 0.74 | 0.83 | 0.93 | 1.05 | 1.05 | 0.92 | 689
COVID19_PFIZER/BIONTECH | Soft tissue disorders NEC | 265 | 1.10 | 1.22 | 1.35 | 215.3 | 1.11 | 1.23 | 1.36 | 1.71 | 1.71 | 1.51 | 636
COVID19_UNKNOWN MFR | Soft tissue disorders NEC | 0 | 0.32 | 0.78 | 1.41 | 1.5 |  |  |  |  |  |  | 
COVID19_JANSSEN | Soft tissue neoplasms benign NEC | 0 | 0.04 | 0.40 | 1.09 | 2.0 |  |  |  |  |  |  | 
COVID19_MODERNA | Soft tissue neoplasms benign NEC | 1 | 0.06 | 0.27 | 0.60 | 7.5 | 0.04 | 0.23 | 0.67 | 0.09 | 0.09 | 0.02 | 37
COVID19_PFIZER/BIONTECH | Soft tissue neoplasms benign NEC | 4 | 0.27 | 0.66 | 1.20 | 6.9 | 0.30 | 0.63 | 1.18 | 0.48 | 0.48 | 0.20 | 34
COVID19_UNKNOWN MFR | Soft tissue neoplasms benign NEC | 0 | 0.09 | 0.96 | 2.59 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Soft tissue neoplasms malignant and unspecified NEC (excl sarcomas) | 0 | 0.05 | 0.90 | 2.64 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Soft tissue neoplasms malignant and unspecified NEC (excl sarcomas) | 0 | 0.04 | 0.70 | 2.05 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Soft tissue neoplasms malignant and unspecified NEC (excl sarcomas) | 0 | 0.04 | 0.73 | 2.14 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Soft tissue neoplasms malignant and unspecified NEC (excl sarcomas) | 0 | 0.06 | 1.00 | 2.93 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Soft tissue sarcomas histology unspecified | 0 | 0.04 | 0.77 | 2.29 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Soft tissue sarcomas histology unspecified | 0 | 0.03 | 0.47 | 1.41 | 1.1 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Soft tissue sarcomas histology unspecified | 0 | 0.03 | 0.51 | 1.52 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Soft tissue sarcomas histology unspecified | 0 | 0.05 | 0.99 | 2.96 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Soft tissue therapeutic procedures NEC | 0 | 0.03 | 0.83 | 2.60 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Soft tissue therapeutic procedures NEC | 0 | 0.02 | 0.56 | 1.77 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Soft tissue therapeutic procedures NEC | 0 | 0.02 | 0.60 | 1.88 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Soft tissue therapeutic procedures NEC | 0 | 0.04 | 1.00 | 3.12 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Somatic symptom disorders | 9 | 0.90 | 1.70 | 2.70 | 6.3 | 0.74 | 1.26 | 2.02 | 1.18 | 1.18 | 0.67 | 118
COVID19_MODERNA | Somatic symptom disorders | 9 | 0.34 | 0.64 | 1.02 | 15.0 | 0.37 | 0.62 | 1.00 | 0.26 | 0.26 | 0.15 | 118
COVID19_PFIZER/BIONTECH | Somatic symptom disorders | 10 | 0.37 | 0.66 | 1.03 | 17.8 | 0.36 | 0.59 | 0.93 | 0.35 | 0.35 | 0.20 | 117
COVID19_UNKNOWN MFR | Somatic symptom disorders | 0 | 0.00 | 0.78 | 3.12 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Special sense investigations NEC | 0 | 0.00 | 0.10 | 0.54 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Special sense investigations NEC | 0 | 0.00 | 0.03 | 0.16 | 1.8 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Special sense investigations NEC | 0 | 0.00 | 0.03 | 0.18 | 1.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Special sense investigations NEC | 0 | 0.00 | 0.82 | 4.46 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Speech and language abnormalities | 232 | 1.24 | 1.38 | 1.53 | 174.9 | 1.18 | 1.32 | 1.47 | 1.27 | 1.27 | 1.14 | 2823
COVID19_MODERNA | Speech and language abnormalities | 643 | 0.90 | 0.96 | 1.02 | 689.3 | 0.87 | 0.93 | 0.99 | 0.91 | 0.91 | 0.84 | 2412
COVID19_PFIZER/BIONTECH | Speech and language abnormalities | 723 | 1.15 | 1.23 | 1.30 | 614.0 | 1.11 | 1.18 | 1.25 | 1.27 | 1.27 | 1.18 | 2332
COVID19_UNKNOWN MFR | Speech and language abnormalities | 13 | 1.39 | 2.21 | 3.20 | 4.4 | 1.43 | 2.28 | 3.59 | 2.94 | 2.97 | 1.87 | 3042
COVID19_JANSSEN | Speech and language usage disturbances | 12 | 1.04 | 1.75 | 2.60 | 6.2 | 1.02 | 1.62 | 2.49 | 2.21 | 2.21 | 1.33 | 84
COVID19_MODERNA | Speech and language usage disturbances | 30 | 0.84 | 1.16 | 1.52 | 26.0 | 0.83 | 1.12 | 1.49 | 1.54 | 1.54 | 1.07 | 66
COVID19_PFIZER/BIONTECH | Speech and language usage disturbances | 34 | 1.13 | 1.53 | 1.98 | 22.3 | 1.10 | 1.46 | 1.90 | 2.25 | 2.25 | 1.58 | 62
COVID19_UNKNOWN MFR | Speech and language usage disturbances | 0 | 0.09 | 0.90 | 2.41 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Speech articulation and rhythm disturbances | 14 | 0.84 | 1.36 | 1.98 | 10.1 | 0.83 | 1.27 | 1.89 | 1.24 | 1.24 | 0.78 | 175
COVID19_MODERNA | Speech articulation and rhythm disturbances | 35 | 0.74 | 1.00 | 1.28 | 36.0 | 0.73 | 0.96 | 1.25 | 0.77 | 0.77 | 0.57 | 154
COVID19_PFIZER/BIONTECH | Speech articulation and rhythm disturbances | 47 | 1.11 | 1.43 | 1.79 | 33.2 | 1.08 | 1.37 | 1.73 | 1.36 | 1.36 | 1.03 | 142
COVID19_UNKNOWN MFR | Speech articulation and rhythm disturbances | 0 | 0.05 | 0.82 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Spermatogenesis and semen disorders | 1 | 0.30 | 1.24 | 2.71 | 1.0 | 0.28 | 0.85 | 2.11 | 2.21 | 2.21 | 0.38 | 7
COVID19_MODERNA | Spermatogenesis and semen disorders | 2 | 0.34 | 1.05 | 2.09 | 1.8 | 0.37 | 0.93 | 2.00 | 1.13 | 1.13 | 0.30 | 6
COVID19_PFIZER/BIONTECH | Spermatogenesis and semen disorders | 3 | 0.54 | 1.45 | 2.70 | 1.9 | 0.51 | 1.15 | 2.32 | 2.46 | 2.46 | 0.74 | 5
COVID19_UNKNOWN MFR | Spermatogenesis and semen disorders | 0 | 0.13 | 0.99 | 2.51 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Spinal cord and nerve root disorders NEC | 10 | 0.34 | 0.59 | 0.90 | 20.9 | 0.31 | 0.51 | 0.80 | 0.56 | 0.56 | 0.33 | 277
COVID19_MODERNA | Spinal cord and nerve root disorders NEC | 29 | 0.37 | 0.51 | 0.67 | 65.8 | 0.33 | 0.45 | 0.60 | 0.38 | 0.38 | 0.28 | 258
COVID19_PFIZER/BIONTECH | Spinal cord and nerve root disorders NEC | 42 | 0.59 | 0.78 | 0.98 | 62.1 | 0.53 | 0.68 | 0.87 | 0.70 | 0.70 | 0.53 | 245
COVID19_UNKNOWN MFR | Spinal cord and nerve root disorders NEC | 0 | 0.11 | 0.78 | 1.99 | 0.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Spinal cord injuries NEC | 2 | 0.38 | 1.24 | 2.49 | 1.6 | 0.40 | 0.99 | 2.14 | 2.06 | 2.06 | 0.60 | 15
COVID19_MODERNA | Spinal cord injuries NEC | 3 | 0.32 | 0.87 | 1.65 | 4.2 | 0.33 | 0.74 | 1.47 | 0.73 | 0.73 | 0.26 | 14
COVID19_PFIZER/BIONTECH | Spinal cord injuries NEC | 4 | 0.45 | 1.08 | 1.93 | 4.2 | 0.43 | 0.90 | 1.69 | 1.26 | 1.26 | 0.49 | 13
COVID19_UNKNOWN MFR | Spinal cord injuries NEC | 0 | 0.11 | 0.98 | 2.58 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Spinal fractures and dislocations | 3 | 0.38 | 1.00 | 1.84 | 2.7 | 0.43 | 0.96 | 1.91 | 0.83 | 0.83 | 0.31 | 56
COVID19_MODERNA | Spinal fractures and dislocations | 18 | 0.72 | 1.09 | 1.52 | 16.6 | 0.71 | 1.05 | 1.49 | 1.49 | 1.49 | 0.94 | 41
COVID19_PFIZER/BIONTECH | Spinal fractures and dislocations | 19 | 0.92 | 1.38 | 1.91 | 13.6 | 0.90 | 1.31 | 1.86 | 1.94 | 1.94 | 1.23 | 40
COVID19_UNKNOWN MFR | Spinal fractures and dislocations | 0 | 0.15 | 0.95 | 2.33 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Spine and neck deformities | 7 | 0.54 | 1.08 | 1.77 | 6.9 | 0.54 | 0.96 | 1.62 | 0.90 | 0.90 | 0.48 | 120
COVID19_MODERNA | Spine and neck deformities | 19 | 0.49 | 0.73 | 1.02 | 28.0 | 0.47 | 0.69 | 0.97 | 0.60 | 0.60 | 0.40 | 108
COVID19_PFIZER/BIONTECH | Spine and neck deformities | 26 | 0.80 | 1.14 | 1.52 | 24.6 | 0.75 | 1.03 | 1.40 | 1.05 | 1.05 | 0.73 | 101
COVID19_UNKNOWN MFR | Spine and neck deformities | 1 | 0.31 | 1.63 | 3.78 | 0.2 | 0.39 | 1.23 | 3.85 | 5.46 | 5.46 | 1.05 | 126
COVID19_JANSSEN | Spine and spinal cord therapeutic procedures | 2 | 0.32 | 0.92 | 1.76 | 2.5 | 0.31 | 0.79 | 1.70 | 0.67 | 0.67 | 0.21 | 46
COVID19_MODERNA | Spine and spinal cord therapeutic procedures | 7 | 0.37 | 0.71 | 1.13 | 11.6 | 0.35 | 0.63 | 1.06 | 0.58 | 0.58 | 0.30 | 41
COVID19_PFIZER/BIONTECH | Spine and spinal cord therapeutic procedures | 8 | 0.49 | 0.90 | 1.42 | 9.7 | 0.47 | 0.82 | 1.34 | 0.82 | 0.82 | 0.43 | 40
COVID19_UNKNOWN MFR | Spine and spinal cord therapeutic procedures | 0 | 0.19 | 0.97 | 2.25 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Spleen disorders | 19 | 1.14 | 1.72 | 2.40 | 12.1 | 1.00 | 1.45 | 2.05 | 1.86 | 1.86 | 1.25 | 158
COVID19_MODERNA | Spleen disorders | 36 | 0.78 | 1.04 | 1.33 | 38.1 | 0.71 | 0.94 | 1.21 | 0.87 | 0.87 | 0.64 | 141
COVID19_PFIZER/BIONTECH | Spleen disorders | 36 | 0.85 | 1.14 | 1.46 | 35.5 | 0.76 | 1.00 | 1.30 | 1.05 | 1.05 | 0.77 | 141
COVID19_UNKNOWN MFR | Spleen disorders | 0 | 0.06 | 0.82 | 2.34 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Spondyloarthropathies | 1 | 0.03 | 0.20 | 0.48 | 9.5 | 0.03 | 0.17 | 0.54 | 0.10 | 0.10 | 0.02 | 150
COVID19_MODERNA | Spondyloarthropathies | 13 | 0.32 | 0.53 | 0.78 | 26.6 | 0.33 | 0.51 | 0.77 | 0.32 | 0.32 | 0.20 | 138
COVID19_PFIZER/BIONTECH | Spondyloarthropathies | 23 | 0.65 | 0.94 | 1.28 | 26.8 | 0.61 | 0.85 | 1.17 | 0.74 | 0.74 | 0.51 | 128
COVID19_UNKNOWN MFR | Spondyloarthropathies | 1 | 0.28 | 1.72 | 4.16 | 0.2 | 0.38 | 1.18 | 3.38 | 4.59 | 4.59 | 0.88 | 150
COVID19_JANSSEN | Spotted fever disorders | 1 | 0.34 | 1.64 | 3.74 | 0.2 | 0.39 | 1.25 | 4.20 | 15.44 | 15.44 | 1.51 | 1
COVID19_MODERNA | Spotted fever disorders | 1 | 0.27 | 1.32 | 3.01 | 0.6 | 0.32 | 0.97 | 2.42 | 3.40 | 3.40 | 0.33 | 1
COVID19_PFIZER/BIONTECH | Spotted fever disorders | 0 | 0.07 | 0.76 | 2.11 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spotted fever disorders | 0 | 0.09 | 1.00 | 2.76 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Staphylococcal infections | 15 | 0.58 | 0.88 | 1.23 | 18.2 | 0.54 | 0.82 | 1.20 | 0.73 | 0.73 | 0.47 | 318
COVID19_MODERNA | Staphylococcal infections | 35 | 0.42 | 0.55 | 0.70 | 70.5 | 0.38 | 0.51 | 0.66 | 0.40 | 0.40 | 0.30 | 298
COVID19_PFIZER/BIONTECH | Staphylococcal infections | 50 | 0.67 | 0.85 | 1.04 | 62.2 | 0.64 | 0.80 | 1.00 | 0.72 | 0.72 | 0.56 | 283
COVID19_UNKNOWN MFR | Staphylococcal infections | 1 | 0.47 | 1.10 | 1.96 | 0.5 | 0.34 | 1.02 | 2.60 | 2.07 | 2.07 | 0.40 | 332
COVID19_JANSSEN | Stereotypies and automatisms | 8 | 0.39 | 0.70 | 1.08 | 12.9 | 0.37 | 0.64 | 1.06 | 0.38 | 0.38 | 0.21 | 327
COVID19_MODERNA | Stereotypies and automatisms | 25 | 0.49 | 0.69 | 0.92 | 37.7 | 0.48 | 0.67 | 0.91 | 0.27 | 0.27 | 0.19 | 310
COVID19_PFIZER/BIONTECH | Stereotypies and automatisms | 27 | 0.50 | 0.70 | 0.92 | 41.1 | 0.48 | 0.66 | 0.89 | 0.36 | 0.36 | 0.26 | 308
COVID19_UNKNOWN MFR | Stereotypies and automatisms | 0 | 0.23 | 0.90 | 1.93 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Stillbirth and foetal death | 3 | 0.09 | 0.32 | 0.65 | 13.7 | 0.12 | 0.29 | 0.59 | 0.28 | 0.28 | 0.11 | 164
COVID19_MODERNA | Stillbirth and foetal death | 20 | 0.41 | 0.61 | 0.85 | 43.5 | 0.33 | 0.48 | 0.67 | 0.46 | 0.46 | 0.31 | 147
COVID19_PFIZER/BIONTECH | Stillbirth and foetal death | 31 | 0.72 | 1.00 | 1.31 | 41.6 | 0.56 | 0.75 | 0.99 | 0.93 | 0.93 | 0.67 | 136
COVID19_UNKNOWN MFR | Stillbirth and foetal death | 0 | 0.00 | 0.54 | 2.57 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Stoma complications | 0 | 0.04 | 0.64 | 1.86 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Stoma complications | 3 | 0.32 | 0.93 | 1.80 | 3.3 | 0.39 | 0.86 | 1.72 | 1.02 | 1.02 | 0.35 | 10
COVID19_PFIZER/BIONTECH | Stoma complications | 7 | 1.12 | 2.25 | 3.69 | 2.6 | 1.00 | 1.82 | 3.21 | 4.78 | 4.78 | 1.91 | 6
COVID19_UNKNOWN MFR | Stoma complications | 0 | 0.06 | 0.98 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Stomatitis and ulceration | 68 | 0.92 | 1.13 | 1.37 | 61.0 | 0.90 | 1.10 | 1.34 | 1.18 | 1.18 | 0.96 | 888
COVID19_MODERNA | Stomatitis and ulceration | 262 | 0.97 | 1.07 | 1.18 | 248.2 | 0.95 | 1.05 | 1.16 | 1.28 | 1.28 | 1.14 | 694
COVID19_PFIZER/BIONTECH | Stomatitis and ulceration | 245 | 1.07 | 1.19 | 1.31 | 210.3 | 1.04 | 1.16 | 1.29 | 1.41 | 1.41 | 1.25 | 711
COVID19_UNKNOWN MFR | Stomatitis and ulceration | 2 | 0.41 | 1.16 | 2.22 | 1.5 | 0.41 | 1.01 | 2.21 | 1.44 | 1.44 | 0.45 | 954
COVID19_JANSSEN | Streptobacillus infections | 0 | 0.04 | 0.88 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Streptobacillus infections | 0 | 0.03 | 0.67 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Streptobacillus infections | 2 | 0.59 | 2.22 | 4.69 | 0.2 | 0.69 | 2.37 | 12.68 | 20.47 | 20.47 | 1.60 | 0
COVID19_UNKNOWN MFR | Streptobacillus infections | 0 | 0.04 | 1.00 | 3.07 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Streptococcal infections | 8 | 0.16 | 0.31 | 0.50 | 48.1 | 0.10 | 0.19 | 0.31 | 0.10 | 0.10 | 0.06 | 1191
COVID19_MODERNA | Streptococcal infections | 19 | 0.21 | 0.33 | 0.46 | 92.6 | 0.15 | 0.22 | 0.31 | 0.06 | 0.06 | 0.04 | 1180
COVID19_PFIZER/BIONTECH | Streptococcal infections | 34 | 0.36 | 0.49 | 0.63 | 125.8 | 0.21 | 0.28 | 0.36 | 0.12 | 0.12 | 0.09 | 1165
COVID19_UNKNOWN MFR | Streptococcal infections | 1 | 0.14 | 1.26 | 3.35 | 1.4 | 0.25 | 0.75 | 1.85 | 0.57 | 0.57 | 0.11 | 1198
COVID19_JANSSEN | Stress disorders | 1 | 0.15 | 0.66 | 1.47 | 2.5 | 0.17 | 0.56 | 1.41 | 0.45 | 0.45 | 0.09 | 34
COVID19_MODERNA | Stress disorders | 4 | 0.26 | 0.62 | 1.11 | 7.7 | 0.28 | 0.57 | 1.09 | 0.44 | 0.44 | 0.18 | 31
COVID19_PFIZER/BIONTECH | Stress disorders | 9 | 0.69 | 1.26 | 1.96 | 7.1 | 0.68 | 1.16 | 1.86 | 1.42 | 1.42 | 0.75 | 26
COVID19_UNKNOWN MFR | Stress disorders | 0 | 0.11 | 0.97 | 2.54 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Structural and obstructive urethral disorders (excl congenital) | 0 | 0.06 | 0.82 | 2.36 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Structural and obstructive urethral disorders (excl congenital) | 0 | 0.04 | 0.55 | 1.59 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Structural and obstructive urethral disorders (excl congenital) | 1 | 0.21 | 1.11 | 2.59 | 0.7 | 0.31 | 0.92 | 2.29 | 1.36 | 1.36 | 0.20 | 3
COVID19_UNKNOWN MFR | Structural and obstructive urethral disorders (excl congenital) | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Structural and other bile duct disorders | 1 | 0.27 | 1.07 | 2.28 | 0.8 | 0.30 | 0.90 | 2.24 | 1.19 | 1.19 | 0.22 | 13
COVID19_MODERNA | Structural and other bile duct disorders | 4 | 0.44 | 1.03 | 1.82 | 4.1 | 0.44 | 0.91 | 1.71 | 1.36 | 1.36 | 0.51 | 10
COVID19_PFIZER/BIONTECH | Structural and other bile duct disorders | 6 | 0.81 | 1.65 | 2.73 | 3.2 | 0.77 | 1.44 | 2.53 | 3.07 | 3.07 | 1.26 | 8
COVID19_UNKNOWN MFR | Structural and other bile duct disorders | 1 | 0.39 | 1.54 | 3.29 | 0.0 | 0.44 | 1.69 | 13.02 | 52.91 | 52.97 | 9.60 | 13
COVID19_JANSSEN | Structural brain disorders NEC | 37 | 1.62 | 2.16 | 2.76 | 19.4 | 1.37 | 1.79 | 2.32 | 1.67 | 1.67 | 1.26 | 342
COVID19_MODERNA | Structural brain disorders NEC | 53 | 0.68 | 0.86 | 1.06 | 71.1 | 0.60 | 0.75 | 0.93 | 0.55 | 0.55 | 0.43 | 326
COVID19_PFIZER/BIONTECH | Structural brain disorders NEC | 72 | 1.03 | 1.27 | 1.52 | 66.5 | 0.88 | 1.07 | 1.29 | 0.96 | 0.96 | 0.77 | 307
COVID19_UNKNOWN MFR | Structural brain disorders NEC | 2 | 0.56 | 1.83 | 3.70 | 0.5 | 0.55 | 1.45 | 3.76 | 3.65 | 3.66 | 1.14 | 377
COVID19_JANSSEN | Structural change, deposit and degeneration of eye NEC | 4 | 0.50 | 1.21 | 2.16 | 3.0 | 0.53 | 1.10 | 2.07 | 1.44 | 1.44 | 0.61 | 43
COVID19_MODERNA | Structural change, deposit and degeneration of eye NEC | 7 | 0.38 | 0.74 | 1.21 | 9.3 | 0.42 | 0.76 | 1.28 | 0.59 | 0.59 | 0.30 | 40
COVID19_PFIZER/BIONTECH | Structural change, deposit and degeneration of eye NEC | 10 | 0.61 | 1.07 | 1.64 | 8.8 | 0.65 | 1.07 | 1.68 | 1.11 | 1.11 | 0.62 | 37
COVID19_UNKNOWN MFR | Structural change, deposit and degeneration of eye NEC | 0 | 0.11 | 0.95 | 2.50 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Substance related and addictive disorders | 3 | 0.47 | 1.10 | 1.94 | 2.6 | 0.44 | 0.98 | 1.97 | 1.85 | 1.85 | 0.68 | 25
COVID19_MODERNA | Substance related and addictive disorders | 5 | 0.42 | 0.85 | 1.40 | 5.9 | 0.42 | 0.83 | 1.49 | 0.74 | 0.74 | 0.33 | 23
COVID19_PFIZER/BIONTECH | Substance related and addictive disorders | 4 | 0.35 | 0.76 | 1.29 | 6.0 | 0.34 | 0.70 | 1.31 | 0.68 | 0.68 | 0.28 | 24
COVID19_UNKNOWN MFR | Substance related and addictive disorders | 0 | 0.25 | 0.98 | 2.10 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Sugar intolerance (excl glucose intolerance) | 0 | 0.00 | 0.26 | 0.98 | 1.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Sugar intolerance (excl glucose intolerance) | 0 | 0.00 | 0.14 | 0.53 | 3.3 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sugar intolerance (excl glucose intolerance) | 0 | 0.00 | 0.11 | 0.41 | 4.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sugar intolerance (excl glucose intolerance) | 0 | 0.01 | 0.93 | 3.47 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Suicidal and self-injurious behaviour | 10 | 0.37 | 0.66 | 1.02 | 17.7 | 0.36 | 0.59 | 0.93 | 0.50 | 0.50 | 0.29 | 312
COVID19_MODERNA | Suicidal and self-injurious behaviour | 49 | 0.83 | 1.07 | 1.33 | 47.8 | 0.80 | 1.01 | 1.27 | 0.61 | 0.61 | 0.47 | 273
COVID19_PFIZER/BIONTECH | Suicidal and self-injurious behaviour | 50 | 0.85 | 1.09 | 1.35 | 50.8 | 0.77 | 0.98 | 1.22 | 0.75 | 0.75 | 0.58 | 272
COVID19_UNKNOWN MFR | Suicidal and self-injurious behaviour | 0 | 0.03 | 0.71 | 2.21 | 0.4 |  |  |  |  |  |  | 
COVID19_JANSSEN | Supraventricular arrhythmias | 115 | 1.21 | 1.42 | 1.65 | 105.6 | 0.93 | 1.08 | 1.26 | 1.05 | 1.05 | 0.90 | 1689
COVID19_MODERNA | Supraventricular arrhythmias | 557 | 1.37 | 1.47 | 1.58 | 499.9 | 1.04 | 1.11 | 1.19 | 1.52 | 1.52 | 1.40 | 1247
COVID19_PFIZER/BIONTECH | Supraventricular arrhythmias | 726 | 2.19 | 2.33 | 2.47 | 413.2 | 1.65 | 1.75 | 1.86 | 2.76 | 2.77 | 2.56 | 1078
COVID19_UNKNOWN MFR | Supraventricular arrhythmias | 1 | 0.20 | 0.71 | 1.48 | 3.0 | 0.15 | 0.50 | 1.27 | 0.38 | 0.38 | 0.07 | 1803
COVID19_JANSSEN | Synovial disorders | 8 | 0.64 | 1.17 | 1.84 | 6.8 | 0.62 | 1.08 | 1.78 | 0.89 | 0.89 | 0.49 | 139
COVID19_MODERNA | Synovial disorders | 13 | 0.36 | 0.58 | 0.85 | 24.0 | 0.36 | 0.56 | 0.85 | 0.33 | 0.33 | 0.20 | 134
COVID19_PFIZER/BIONTECH | Synovial disorders | 9 | 0.26 | 0.46 | 0.71 | 22.9 | 0.25 | 0.43 | 0.69 | 0.27 | 0.27 | 0.15 | 138
COVID19_UNKNOWN MFR | Synovial disorders | 1 | 0.38 | 1.37 | 2.87 | 0.2 | 0.39 | 1.25 | 4.12 | 4.71 | 4.72 | 0.90 | 146
COVID19_JANSSEN | Telangiectasia and related conditions | 2 | 0.50 | 1.35 | 2.54 | 1.0 | 0.47 | 1.19 | 2.66 | 2.57 | 2.57 | 0.73 | 12
COVID19_MODERNA | Telangiectasia and related conditions | 3 | 0.47 | 1.14 | 2.04 | 2.5 | 0.45 | 0.99 | 1.99 | 0.93 | 0.93 | 0.32 | 11
COVID19_PFIZER/BIONTECH | Telangiectasia and related conditions | 1 | 0.22 | 0.71 | 1.43 | 2.7 | 0.16 | 0.53 | 1.34 | 0.32 | 0.32 | 0.06 | 13
COVID19_UNKNOWN MFR | Telangiectasia and related conditions | 0 | 0.22 | 0.99 | 2.21 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Tendon disorders | 33 | 0.85 | 1.16 | 1.51 | 37.3 | 0.66 | 0.88 | 1.15 | 1.01 | 1.01 | 0.75 | 506
COVID19_MODERNA | Tendon disorders | 58 | 0.40 | 0.50 | 0.61 | 153.5 | 0.31 | 0.38 | 0.47 | 0.41 | 0.41 | 0.33 | 481
COVID19_PFIZER/BIONTECH | Tendon disorders | 71 | 0.60 | 0.73 | 0.88 | 128.0 | 0.46 | 0.56 | 0.68 | 0.62 | 0.62 | 0.50 | 468
COVID19_UNKNOWN MFR | Tendon disorders | 1 | 0.19 | 1.20 | 2.93 | 0.9 | 0.29 | 0.87 | 2.15 | 1.28 | 1.28 | 0.25 | 538
COVID19_JANSSEN | Tendon therapeutic procedures | 0 | 0.00 | 0.52 | 1.96 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Tendon therapeutic procedures | 0 | 0.00 | 0.23 | 0.85 | 1.8 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tendon therapeutic procedures | 0 | 0.00 | 0.25 | 0.95 | 1.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tendon therapeutic procedures | 0 | 0.01 | 0.98 | 3.69 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Testicular and epididymal disorders NEC | 24 | 1.42 | 2.03 | 2.72 | 13.0 | 1.21 | 1.69 | 2.31 | 3.37 | 3.37 | 2.33 | 110
COVID19_MODERNA | Testicular and epididymal disorders NEC | 27 | 0.78 | 1.09 | 1.44 | 29.5 | 0.66 | 0.90 | 1.22 | 0.86 | 0.86 | 0.60 | 107
COVID19_PFIZER/BIONTECH | Testicular and epididymal disorders NEC | 28 | 0.80 | 1.11 | 1.47 | 30.1 | 0.68 | 0.92 | 1.23 | 1.08 | 1.08 | 0.76 | 106
COVID19_UNKNOWN MFR | Testicular and epididymal disorders NEC | 0 | 0.21 | 0.92 | 2.04 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Testicular and epididymal infections and inflammations | 1 | 0.33 | 1.65 | 3.79 | 0.2 | 0.40 | 1.26 | 4.30 | 15.44 | 15.44 | 1.51 | 1
COVID19_MODERNA | Testicular and epididymal infections and inflammations | 0 | 0.06 | 0.73 | 2.03 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Testicular and epididymal infections and inflammations | 1 | 0.28 | 1.38 | 3.15 | 0.4 | 0.35 | 1.06 | 2.73 | 4.09 | 4.09 | 0.40 | 1
COVID19_UNKNOWN MFR | Testicular and epididymal infections and inflammations | 0 | 0.08 | 1.00 | 2.78 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Testicular and scrotal therapeutic procedures | 0 | 0.03 | 0.76 | 2.31 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Testicular and scrotal therapeutic procedures | 0 | 0.02 | 0.46 | 1.39 | 1.1 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Testicular and scrotal therapeutic procedures | 2 | 0.41 | 1.53 | 3.22 | 1.2 | 0.44 | 1.10 | 2.42 | 2.73 | 2.73 | 0.61 | 3
COVID19_UNKNOWN MFR | Testicular and scrotal therapeutic procedures | 0 | 0.05 | 0.99 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Testicular neoplasms malignant | 0 | 0.07 | 0.91 | 2.57 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Testicular neoplasms malignant | 0 | 0.05 | 0.72 | 2.04 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Testicular neoplasms malignant | 1 | 0.27 | 1.39 | 3.21 | 0.4 | 0.35 | 1.05 | 2.73 | 4.09 | 4.09 | 0.40 | 1
COVID19_UNKNOWN MFR | Testicular neoplasms malignant | 0 | 0.07 | 1.00 | 2.83 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Therapeutic and nontherapeutic responses | 924 | 1.03 | 1.08 | 1.14 | 1040.7 | 0.84 | 0.89 | 0.94 | 0.86 | 0.86 | 0.81 | 16570
COVID19_MODERNA | Therapeutic and nontherapeutic responses | 1725 | 0.68 | 0.70 | 0.73 | 2898.2 | 0.57 | 0.60 | 0.62 | 0.37 | 0.36 | 0.35 | 15769
COVID19_PFIZER/BIONTECH | Therapeutic and nontherapeutic responses | 3175 | 1.30 | 1.34 | 1.37 | 2868.2 | 1.08 | 1.11 | 1.14 | 0.91 | 0.91 | 0.88 | 14319
COVID19_UNKNOWN MFR | Therapeutic and nontherapeutic responses | 29 | 0.91 | 1.25 | 1.64 | 26.2 | 0.80 | 1.08 | 1.44 | 1.14 | 1.15 | 0.84 | 17465
COVID19_JANSSEN | Therapeutic bladder catheterisation | 8 | 0.84 | 1.51 | 2.35 | 4.6 | 0.81 | 1.42 | 2.34 | 1.30 | 1.30 | 0.71 | 95
COVID19_MODERNA | Therapeutic bladder catheterisation | 16 | 0.48 | 0.74 | 1.05 | 23.9 | 0.45 | 0.68 | 0.99 | 0.62 | 0.62 | 0.40 | 87
COVID19_PFIZER/BIONTECH | Therapeutic bladder catheterisation | 21 | 0.74 | 1.08 | 1.47 | 20.7 | 0.69 | 0.99 | 1.38 | 1.05 | 1.05 | 0.70 | 82
COVID19_UNKNOWN MFR | Therapeutic bladder catheterisation | 1 | 0.41 | 1.32 | 2.64 | 0.1 | 0.40 | 1.29 | 4.85 | 6.74 | 6.75 | 1.29 | 102
COVID19_JANSSEN | Therapeutic drug monitoring analyses | 5 | 0.40 | 0.85 | 1.42 | 7.0 | 0.38 | 0.73 | 1.32 | 0.73 | 0.73 | 0.34 | 106
COVID19_MODERNA | Therapeutic drug monitoring analyses | 20 | 0.63 | 0.92 | 1.27 | 24.6 | 0.56 | 0.81 | 1.14 | 0.75 | 0.75 | 0.50 | 91
COVID19_PFIZER/BIONTECH | Therapeutic drug monitoring analyses | 27 | 0.94 | 1.32 | 1.74 | 22.6 | 0.84 | 1.16 | 1.56 | 1.32 | 1.32 | 0.91 | 84
COVID19_UNKNOWN MFR | Therapeutic drug monitoring analyses | 3 | 0.90 | 2.23 | 4.05 | 0.2 | 1.19 | 5.64 | 21.04 | 19.11 | 19.17 | 7.31 | 108
COVID19_JANSSEN | Therapeutic procedures NEC | 470 | 1.31 | 1.41 | 1.52 | 391.0 | 1.11 | 1.20 | 1.29 | 1.12 | 1.13 | 1.04 | 6455
COVID19_MODERNA | Therapeutic procedures NEC | 1460 | 1.06 | 1.11 | 1.16 | 1428.3 | 0.98 | 1.02 | 1.07 | 0.91 | 0.91 | 0.86 | 5465
COVID19_PFIZER/BIONTECH | Therapeutic procedures NEC | 1444 | 1.21 | 1.27 | 1.32 | 1283.3 | 1.08 | 1.13 | 1.17 | 1.08 | 1.08 | 1.03 | 5481
COVID19_UNKNOWN MFR | Therapeutic procedures NEC | 17 | 1.17 | 1.79 | 2.51 | 10.1 | 1.03 | 1.52 | 2.19 | 1.69 | 1.71 | 1.14 | 6908
COVID19_JANSSEN | Thermal burns | 2 | 0.24 | 0.58 | 1.05 | 5.8 | 0.17 | 0.45 | 1.00 | 0.37 | 0.37 | 0.12 | 83
COVID19_MODERNA | Thermal burns | 25 | 0.79 | 1.10 | 1.46 | 22.7 | 0.77 | 1.07 | 1.46 | 1.42 | 1.42 | 0.96 | 60
COVID19_PFIZER/BIONTECH | Thermal burns | 24 | 0.85 | 1.21 | 1.61 | 19.6 | 0.84 | 1.18 | 1.61 | 1.61 | 1.61 | 1.08 | 61
COVID19_UNKNOWN MFR | Thermal burns | 0 | 0.29 | 0.96 | 1.95 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Thinking disturbances | 52 | 1.50 | 1.90 | 2.34 | 28.8 | 1.37 | 1.73 | 2.15 | 2.33 | 2.33 | 1.82 | 345
COVID19_MODERNA | Thinking disturbances | 87 | 0.69 | 0.83 | 0.98 | 113.9 | 0.64 | 0.76 | 0.91 | 0.95 | 0.95 | 0.78 | 310
COVID19_PFIZER/BIONTECH | Thinking disturbances | 120 | 1.16 | 1.36 | 1.56 | 96.2 | 1.06 | 1.24 | 1.43 | 1.77 | 1.77 | 1.48 | 277
COVID19_UNKNOWN MFR | Thinking disturbances | 2 | 0.54 | 1.41 | 2.61 | 0.7 | 0.52 | 1.34 | 3.17 | 3.48 | 3.49 | 1.09 | 395
COVID19_JANSSEN | Thoracic cage fractures and dislocations | 3 | 0.43 | 1.01 | 1.79 | 2.8 | 0.43 | 0.95 | 1.90 | 0.93 | 0.93 | 0.35 | 50
COVID19_MODERNA | Thoracic cage fractures and dislocations | 14 | 0.83 | 1.31 | 1.87 | 11.6 | 0.74 | 1.14 | 1.69 | 1.22 | 1.22 | 0.73 | 39
COVID19_PFIZER/BIONTECH | Thoracic cage fractures and dislocations | 15 | 0.93 | 1.44 | 2.05 | 10.7 | 0.85 | 1.29 | 1.89 | 1.62 | 1.62 | 0.98 | 38
COVID19_UNKNOWN MFR | Thoracic cage fractures and dislocations | 0 | 0.25 | 0.97 | 2.08 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Thoracic musculoskeletal disorders | 1 | 0.11 | 1.32 | 3.66 | 0.8 | 0.30 | 0.90 | 2.24 | 1.19 | 1.19 | 0.22 | 13
COVID19_MODERNA | Thoracic musculoskeletal disorders | 2 | 0.19 | 0.92 | 2.10 | 2.4 | 0.32 | 0.81 | 1.74 | 0.57 | 0.57 | 0.16 | 12
COVID19_PFIZER/BIONTECH | Thoracic musculoskeletal disorders | 0 | 0.00 | 0.10 | 0.49 | 2.1 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thoracic musculoskeletal disorders | 0 | 0.00 | 0.92 | 4.53 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Thrombocytopenias | 100 | 1.30 | 1.55 | 1.81 | 71.6 | 1.17 | 1.38 | 1.62 | 1.05 | 1.05 | 0.89 | 1466
COVID19_MODERNA | Thrombocytopenias | 181 | 0.76 | 0.86 | 0.96 | 212.3 | 0.75 | 0.85 | 0.96 | 0.44 | 0.44 | 0.39 | 1385
COVID19_PFIZER/BIONTECH | Thrombocytopenias | 243 | 1.06 | 1.18 | 1.31 | 222.4 | 0.98 | 1.09 | 1.21 | 0.75 | 0.75 | 0.67 | 1323
COVID19_UNKNOWN MFR | Thrombocytopenias | 3 | 0.52 | 1.40 | 2.63 | 1.9 | 0.51 | 1.14 | 2.30 | 1.32 | 1.32 | 0.51 | 1563
COVID19_JANSSEN | Thrombocytoses | 0 | 0.05 | 0.46 | 1.25 | 1.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Thrombocytoses | 3 | 0.26 | 0.72 | 1.36 | 4.8 | 0.30 | 0.68 | 1.35 | 0.27 | 0.27 | 0.10 | 38
COVID19_PFIZER/BIONTECH | Thrombocytoses | 5 | 0.46 | 1.02 | 1.76 | 5.6 | 0.44 | 0.86 | 1.55 | 0.57 | 0.57 | 0.26 | 36
COVID19_UNKNOWN MFR | Thrombocytoses | 0 | 0.09 | 0.97 | 2.63 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Thymus disorders | 0 | 0.03 | 0.79 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Thymus disorders | 0 | 0.02 | 0.50 | 1.55 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thymus disorders | 0 | 0.02 | 0.54 | 1.66 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thymus disorders | 0 | 0.04 | 0.99 | 3.08 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid analyses | 29 | 0.48 | 0.67 | 0.87 | 49.6 | 0.44 | 0.59 | 0.79 | 0.61 | 0.61 | 0.45 | 735
COVID19_MODERNA | Thyroid analyses | 134 | 0.70 | 0.81 | 0.93 | 179.4 | 0.65 | 0.75 | 0.86 | 0.72 | 0.72 | 0.62 | 630
COVID19_PFIZER/BIONTECH | Thyroid analyses | 173 | 1.05 | 1.19 | 1.34 | 160.9 | 0.94 | 1.07 | 1.21 | 1.20 | 1.20 | 1.04 | 591
COVID19_UNKNOWN MFR | Thyroid analyses | 2 | 0.44 | 1.38 | 2.75 | 1.1 | 0.45 | 1.13 | 2.50 | 1.81 | 1.81 | 0.56 | 762
COVID19_JANSSEN | Thyroid disorders NEC | 9 | 0.53 | 0.96 | 1.51 | 10.5 | 0.50 | 0.84 | 1.35 | 1.01 | 1.01 | 0.58 | 137
COVID19_MODERNA | Thyroid disorders NEC | 20 | 0.43 | 0.64 | 0.89 | 34.3 | 0.41 | 0.60 | 0.84 | 0.54 | 0.54 | 0.36 | 126
COVID19_PFIZER/BIONTECH | Thyroid disorders NEC | 37 | 0.94 | 1.25 | 1.60 | 32.2 | 0.86 | 1.13 | 1.45 | 1.39 | 1.39 | 1.02 | 109
COVID19_UNKNOWN MFR | Thyroid disorders NEC | 0 | 0.06 | 0.84 | 2.38 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid disorders congenital | 0 | 0.07 | 0.95 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Thyroid disorders congenital | 1 | 0.30 | 1.57 | 3.64 | 0.3 | 0.37 | 1.12 | 3.03 | 10.19 | 10.19 | 0.69 | 0
COVID19_PFIZER/BIONTECH | Thyroid disorders congenital | 0 | 0.06 | 0.85 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid disorders congenital | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid histopathology procedures | 0 | 0.11 | 0.76 | 1.89 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Thyroid histopathology procedures | 3 | 0.48 | 1.25 | 2.33 | 2.2 | 0.48 | 1.07 | 2.14 | 1.70 | 1.70 | 0.53 | 6
COVID19_PFIZER/BIONTECH | Thyroid histopathology procedures | 1 | 0.19 | 0.78 | 1.68 | 2.0 | 0.20 | 0.63 | 1.56 | 0.51 | 0.51 | 0.09 | 8
COVID19_UNKNOWN MFR | Thyroid histopathology procedures | 0 | 0.14 | 0.99 | 2.47 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid hyperfunction disorders | 1 | 0.04 | 0.22 | 0.54 | 8.4 | 0.03 | 0.20 | 0.61 | 0.13 | 0.13 | 0.02 | 121
COVID19_MODERNA | Thyroid hyperfunction disorders | 18 | 0.49 | 0.75 | 1.05 | 26.6 | 0.47 | 0.69 | 0.98 | 0.59 | 0.59 | 0.39 | 104
COVID19_PFIZER/BIONTECH | Thyroid hyperfunction disorders | 22 | 0.66 | 0.96 | 1.32 | 25.5 | 0.61 | 0.86 | 1.19 | 0.90 | 0.90 | 0.61 | 100
COVID19_UNKNOWN MFR | Thyroid hyperfunction disorders | 0 | 0.03 | 0.83 | 2.66 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid hypofunction disorders | 4 | 0.24 | 0.63 | 1.17 | 8.1 | 0.27 | 0.55 | 1.05 | 0.48 | 0.48 | 0.21 | 130
COVID19_MODERNA | Thyroid hypofunction disorders | 18 | 0.51 | 0.79 | 1.11 | 27.3 | 0.46 | 0.67 | 0.95 | 0.53 | 0.53 | 0.35 | 116
COVID19_PFIZER/BIONTECH | Thyroid hypofunction disorders | 15 | 0.45 | 0.72 | 1.04 | 25.9 | 0.39 | 0.60 | 0.87 | 0.52 | 0.52 | 0.33 | 119
COVID19_UNKNOWN MFR | Thyroid hypofunction disorders | 0 | 0.01 | 0.81 | 2.79 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid neoplasms | 0 | 0.13 | 0.83 | 2.04 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Thyroid neoplasms | 1 | 0.23 | 0.89 | 1.90 | 1.9 | 0.21 | 0.65 | 1.61 | 0.68 | 0.68 | 0.11 | 5
COVID19_PFIZER/BIONTECH | Thyroid neoplasms | 1 | 0.24 | 0.94 | 2.01 | 1.5 | 0.23 | 0.71 | 1.76 | 0.82 | 0.82 | 0.14 | 5
COVID19_UNKNOWN MFR | Thyroid neoplasms | 0 | 0.15 | 1.00 | 2.44 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid neoplasms benign | 0 | 0.03 | 0.88 | 2.76 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Thyroid neoplasms benign | 0 | 0.02 | 0.66 | 2.07 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroid neoplasms benign | 0 | 0.02 | 0.69 | 2.17 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid neoplasms benign | 0 | 0.04 | 1.00 | 3.14 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid neoplasms malignant | 0 | 0.04 | 0.67 | 1.93 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Thyroid neoplasms malignant | 1 | 0.13 | 0.67 | 1.56 | 1.4 | 0.24 | 0.75 | 1.84 | 0.42 | 0.42 | 0.07 | 8
COVID19_PFIZER/BIONTECH | Thyroid neoplasms malignant | 4 | 0.71 | 1.78 | 3.25 | 1.7 | 0.71 | 1.50 | 2.94 | 3.28 | 3.28 | 1.09 | 5
COVID19_UNKNOWN MFR | Thyroid neoplasms malignant | 0 | 0.06 | 0.99 | 2.87 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid radiotherapies | 0 | 0.03 | 0.88 | 2.75 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Thyroid radiotherapies | 0 | 0.02 | 0.66 | 2.07 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroid radiotherapies | 0 | 0.03 | 0.69 | 2.17 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid radiotherapies | 0 | 0.04 | 1.00 | 3.12 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid therapeutic procedures | 0 | 0.01 | 0.47 | 1.62 | 0.8 |  |  |  |  |  |  | 
COVID19_MODERNA | Thyroid therapeutic procedures | 1 | 0.09 | 0.61 | 1.54 | 1.7 | 0.22 | 0.69 | 1.69 | 0.34 | 0.34 | 0.06 | 10
COVID19_PFIZER/BIONTECH | Thyroid therapeutic procedures | 0 | 0.00 | 0.24 | 0.82 | 2.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid therapeutic procedures | 0 | 0.01 | 0.98 | 3.37 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Tic disorders | 2 | 0.20 | 0.51 | 0.93 | 7.5 | 0.13 | 0.37 | 0.83 | 0.11 | 0.11 | 0.03 | 286
COVID19_MODERNA | Tic disorders | 5 | 0.20 | 0.41 | 0.67 | 16.4 | 0.18 | 0.36 | 0.65 | 0.06 | 0.06 | 0.03 | 283
COVID19_PFIZER/BIONTECH | Tic disorders | 18 | 0.55 | 0.82 | 1.13 | 24.0 | 0.51 | 0.75 | 1.07 | 0.27 | 0.27 | 0.18 | 270
COVID19_UNKNOWN MFR | Tic disorders | 0 | 0.26 | 0.95 | 1.99 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Tinea infections | 2 | 0.26 | 0.84 | 1.68 | 2.7 | 0.30 | 0.76 | 1.65 | 0.81 | 0.81 | 0.25 | 38
COVID19_MODERNA | Tinea infections | 4 | 0.23 | 0.54 | 0.97 | 8.5 | 0.26 | 0.54 | 1.01 | 0.38 | 0.38 | 0.16 | 36
COVID19_PFIZER/BIONTECH | Tinea infections | 5 | 0.31 | 0.68 | 1.17 | 7.8 | 0.34 | 0.67 | 1.21 | 0.59 | 0.59 | 0.27 | 35
COVID19_UNKNOWN MFR | Tinea infections | 0 | 0.12 | 0.96 | 2.47 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Tissue enzyme analyses NEC | 60 | 0.84 | 1.05 | 1.28 | 66.3 | 0.73 | 0.90 | 1.11 | 0.84 | 0.84 | 0.68 | 1102
COVID19_MODERNA | Tissue enzyme analyses NEC | 195 | 0.80 | 0.90 | 1.01 | 239.8 | 0.72 | 0.81 | 0.91 | 0.69 | 0.68 | 0.60 | 967
COVID19_PFIZER/BIONTECH | Tissue enzyme analyses NEC | 233 | 1.08 | 1.20 | 1.34 | 220.3 | 0.95 | 1.06 | 1.17 | 1.03 | 1.03 | 0.91 | 929
COVID19_UNKNOWN MFR | Tissue enzyme analyses NEC | 1 | 0.20 | 0.84 | 1.83 | 1.7 | 0.22 | 0.68 | 1.68 | 0.59 | 0.59 | 0.11 | 1161
COVID19_JANSSEN | Tobacco use | 4 | 0.82 | 2.11 | 3.88 | 1.8 | 0.68 | 1.42 | 2.75 | 3.25 | 3.25 | 1.32 | 19
COVID19_MODERNA | Tobacco use | 4 | 0.31 | 0.81 | 1.50 | 6.3 | 0.32 | 0.67 | 1.27 | 0.72 | 0.72 | 0.29 | 19
COVID19_PFIZER/BIONTECH | Tobacco use | 6 | 0.59 | 1.27 | 2.17 | 5.5 | 0.54 | 1.00 | 1.74 | 1.45 | 1.45 | 0.66 | 17
COVID19_UNKNOWN MFR | Tobacco use | 1 | 0.34 | 2.10 | 5.10 | 0.0 | 0.43 | 1.58 | 10.84 | 31.27 | 31.30 | 5.82 | 22
COVID19_JANSSEN | Tongue disorders | 25 | 0.57 | 0.79 | 1.05 | 40.1 | 0.46 | 0.63 | 0.86 | 0.68 | 0.68 | 0.49 | 566
COVID19_MODERNA | Tongue disorders | 200 | 1.21 | 1.37 | 1.53 | 178.4 | 0.99 | 1.12 | 1.25 | 1.74 | 1.74 | 1.51 | 391
COVID19_PFIZER/BIONTECH | Tongue disorders | 222 | 1.66 | 1.85 | 2.06 | 144.9 | 1.36 | 1.52 | 1.70 | 2.46 | 2.47 | 2.14 | 369
COVID19_UNKNOWN MFR | Tongue disorders | 1 | 0.43 | 1.04 | 1.88 | 1.0 | 0.28 | 0.85 | 2.10 | 1.17 | 1.17 | 0.23 | 590
COVID19_JANSSEN | Tongue disorders congenital | 0 | 0.10 | 0.77 | 1.95 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Tongue disorders congenital | 2 | 0.33 | 1.05 | 2.10 | 1.1 | 0.46 | 1.14 | 2.52 | 1.13 | 1.13 | 0.30 | 6
COVID19_PFIZER/BIONTECH | Tongue disorders congenital | 1 | 0.20 | 0.82 | 1.79 | 1.3 | 0.25 | 0.77 | 1.90 | 0.59 | 0.59 | 0.10 | 7
COVID19_UNKNOWN MFR | Tongue disorders congenital | 0 | 0.13 | 0.99 | 2.52 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Tongue signs and symptoms | 229 | 0.82 | 0.92 | 1.02 | 308.8 | 0.67 | 0.74 | 0.83 | 0.86 | 0.86 | 0.77 | 4123
COVID19_MODERNA | Tongue signs and symptoms | 1444 | 1.26 | 1.32 | 1.38 | 1341.5 | 1.03 | 1.08 | 1.12 | 1.69 | 1.69 | 1.61 | 2908
COVID19_PFIZER/BIONTECH | Tongue signs and symptoms | 1747 | 1.87 | 1.95 | 2.02 | 1103.6 | 1.52 | 1.58 | 1.64 | 2.75 | 2.77 | 2.63 | 2605
COVID19_UNKNOWN MFR | Tongue signs and symptoms | 5 | 0.51 | 0.94 | 1.46 | 7.0 | 0.38 | 0.73 | 1.32 | 0.79 | 0.79 | 0.38 | 4347
COVID19_JANSSEN | Tongue therapeutic procedures | 0 | 0.02 | 0.80 | 2.67 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Tongue therapeutic procedures | 0 | 0.01 | 0.52 | 1.74 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tongue therapeutic procedures | 0 | 0.01 | 0.56 | 1.86 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue therapeutic procedures | 0 | 0.02 | 0.99 | 3.30 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Tonsillar therapeutic procedures | 0 | 0.00 | 0.27 | 1.06 | 1.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Tonsillar therapeutic procedures | 1 | 0.06 | 0.48 | 1.26 | 3.0 | 0.15 | 0.50 | 1.26 | 0.08 | 0.08 | 0.02 | 43
COVID19_PFIZER/BIONTECH | Tonsillar therapeutic procedures | 2 | 0.14 | 0.63 | 1.40 | 4.4 | 0.22 | 0.56 | 1.22 | 0.20 | 0.20 | 0.06 | 42
COVID19_UNKNOWN MFR | Tonsillar therapeutic procedures | 0 | 0.00 | 0.94 | 3.63 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Tooth missing | 1 | 0.20 | 0.95 | 2.14 | 1.5 | 0.24 | 0.73 | 1.80 | 0.81 | 0.81 | 0.15 | 19
COVID19_MODERNA | Tooth missing | 1 | 0.11 | 0.53 | 1.20 | 3.2 | 0.14 | 0.48 | 1.21 | 0.18 | 0.18 | 0.03 | 19
COVID19_PFIZER/BIONTECH | Tooth missing | 2 | 0.23 | 0.76 | 1.54 | 3.4 | 0.26 | 0.67 | 1.44 | 0.46 | 0.46 | 0.13 | 18
COVID19_UNKNOWN MFR | Tooth missing | 0 | 0.10 | 0.98 | 2.65 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Total fluid volume decreased | 213 | 1.77 | 1.99 | 2.22 | 121.5 | 1.55 | 1.74 | 1.94 | 1.82 | 1.83 | 1.62 | 1804
COVID19_MODERNA | Total fluid volume decreased | 443 | 0.96 | 1.04 | 1.12 | 467.7 | 0.88 | 0.95 | 1.02 | 0.96 | 0.96 | 0.87 | 1574
COVID19_PFIZER/BIONTECH | Total fluid volume decreased | 472 | 1.19 | 1.29 | 1.39 | 411.7 | 1.06 | 1.14 | 1.23 | 1.25 | 1.25 | 1.15 | 1545
COVID19_UNKNOWN MFR | Total fluid volume decreased | 8 | 1.19 | 2.21 | 3.48 | 3.0 | 1.08 | 1.91 | 3.27 | 2.74 | 2.76 | 1.53 | 2009
COVID19_JANSSEN | Total fluid volume increased | 28 | 1.78 | 2.48 | 3.28 | 12.4 | 1.49 | 2.04 | 2.74 | 2.26 | 2.26 | 1.62 | 191
COVID19_MODERNA | Total fluid volume increased | 49 | 0.77 | 0.98 | 1.22 | 61.3 | 0.63 | 0.80 | 1.00 | 0.98 | 0.98 | 0.75 | 170
COVID19_PFIZER/BIONTECH | Total fluid volume increased | 54 | 1.04 | 1.32 | 1.63 | 50.0 | 0.85 | 1.07 | 1.32 | 1.34 | 1.34 | 1.03 | 165
COVID19_UNKNOWN MFR | Total fluid volume increased | 0 | 0.11 | 0.84 | 2.15 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Toxicology laboratory analyses | 21 | 0.51 | 0.73 | 0.98 | 32.1 | 0.47 | 0.66 | 0.93 | 0.68 | 0.68 | 0.47 | 478
COVID19_MODERNA | Toxicology laboratory analyses | 75 | 0.70 | 0.85 | 1.01 | 91.7 | 0.68 | 0.82 | 0.98 | 0.60 | 0.60 | 0.49 | 424
COVID19_PFIZER/BIONTECH | Toxicology laboratory analyses | 85 | 0.83 | 1.00 | 1.18 | 88.3 | 0.80 | 0.96 | 1.14 | 0.84 | 0.84 | 0.69 | 414
COVID19_UNKNOWN MFR | Toxicology laboratory analyses | 0 | 0.30 | 0.86 | 1.66 | 0.7 |  |  |  |  |  |  | 
COVID19_JANSSEN | Toxoplasma infections | 0 | 0.01 | 0.52 | 1.81 | 0.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Toxoplasma infections | 0 | 0.00 | 0.22 | 0.78 | 2.3 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Toxoplasma infections | 2 | 0.25 | 1.01 | 2.21 | 2.1 | 0.34 | 0.86 | 1.85 | 1.02 | 1.02 | 0.28 | 8
COVID19_UNKNOWN MFR | Toxoplasma infections | 0 | 0.01 | 0.98 | 3.41 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Trace metal disorders NEC | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Trace metal disorders NEC | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Trace metal disorders NEC | 0 | 0.04 | 0.83 | 2.53 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trace metal disorders NEC | 0 | 0.05 | 1.00 | 3.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Tracheal disorders (excl infections and neoplasms) | 1 | 0.23 | 0.82 | 1.72 | 1.7 | 0.22 | 0.68 | 1.68 | 0.62 | 0.62 | 0.12 | 25
COVID19_MODERNA | Tracheal disorders (excl infections and neoplasms) | 5 | 0.42 | 0.89 | 1.51 | 5.4 | 0.45 | 0.88 | 1.58 | 0.81 | 0.81 | 0.36 | 21
COVID19_PFIZER/BIONTECH | Tracheal disorders (excl infections and neoplasms) | 6 | 0.55 | 1.10 | 1.81 | 5.2 | 0.56 | 1.04 | 1.81 | 1.23 | 1.23 | 0.57 | 20
COVID19_UNKNOWN MFR | Tracheal disorders (excl infections and neoplasms) | 0 | 0.18 | 0.98 | 2.31 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Tracheal therapeutic procedures | 60 | 1.16 | 1.45 | 1.77 | 43.4 | 1.09 | 1.35 | 1.66 | 1.17 | 1.17 | 0.94 | 789
COVID19_MODERNA | Tracheal therapeutic procedures | 183 | 0.92 | 1.04 | 1.17 | 186.2 | 0.87 | 0.98 | 1.11 | 0.93 | 0.93 | 0.81 | 666
COVID19_PFIZER/BIONTECH | Tracheal therapeutic procedures | 188 | 1.10 | 1.24 | 1.39 | 162.3 | 1.02 | 1.15 | 1.30 | 1.16 | 1.16 | 1.02 | 661
COVID19_UNKNOWN MFR | Tracheal therapeutic procedures | 7 | 1.53 | 2.96 | 4.77 | 1.2 | 1.56 | 3.50 | 8.01 | 5.72 | 5.76 | 3.08 | 842
COVID19_JANSSEN | Transfusion related complications | 0 | 0.00 | 0.70 | 3.26 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Transfusion related complications | 0 | 0.00 | 0.38 | 1.79 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transfusion related complications | 0 | 0.00 | 0.42 | 1.95 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transfusion related complications | 0 | 0.00 | 0.99 | 4.61 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Transient cerebrovascular events | 48 | 1.82 | 2.34 | 2.91 | 22.3 | 1.60 | 2.03 | 2.56 | 2.16 | 2.16 | 1.68 | 343
COVID19_MODERNA | Transient cerebrovascular events | 136 | 1.20 | 1.39 | 1.59 | 109.2 | 1.07 | 1.24 | 1.42 | 1.81 | 1.81 | 1.52 | 255
COVID19_PFIZER/BIONTECH | Transient cerebrovascular events | 128 | 1.37 | 1.59 | 1.83 | 89.6 | 1.22 | 1.41 | 1.63 | 1.99 | 1.99 | 1.67 | 263
COVID19_UNKNOWN MFR | Transient cerebrovascular events | 2 | 0.51 | 1.93 | 4.07 | 0.6 | 0.53 | 1.35 | 3.25 | 3.54 | 3.54 | 1.10 | 389
COVID19_JANSSEN | Transplant rejections | 0 | 0.00 | 0.17 | 0.76 | 1.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Transplant rejections | 1 | 0.03 | 0.29 | 0.80 | 5.4 | 0.07 | 0.31 | 0.86 | 0.12 | 0.12 | 0.02 | 29
COVID19_PFIZER/BIONTECH | Transplant rejections | 7 | 0.82 | 1.70 | 2.85 | 5.1 | 0.67 | 1.20 | 2.02 | 1.25 | 1.25 | 0.61 | 23
COVID19_UNKNOWN MFR | Transplant rejections | 0 | 0.00 | 0.89 | 4.00 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Transplantation complications | 0 | 0.14 | 0.75 | 1.78 | 0.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Transplantation complications | 1 | 0.20 | 0.74 | 1.54 | 2.0 | 0.20 | 0.63 | 1.57 | 0.34 | 0.34 | 0.06 | 10
COVID19_PFIZER/BIONTECH | Transplantation complications | 2 | 0.33 | 0.98 | 1.89 | 1.9 | 0.37 | 0.91 | 1.98 | 0.91 | 0.91 | 0.25 | 9
COVID19_UNKNOWN MFR | Transplantation complications | 0 | 0.18 | 0.99 | 2.35 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Trematode infections | 0 | 0.05 | 0.94 | 2.83 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Trematode infections | 0 | 0.04 | 0.81 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Trematode infections | 0 | 0.04 | 0.84 | 2.51 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trematode infections | 0 | 0.05 | 1.00 | 3.00 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Tremor (excl congenital) | 1368 | 2.00 | 2.09 | 2.19 | 722.1 | 1.81 | 1.89 | 1.98 | 2.18 | 2.22 | 2.12 | 9701
COVID19_MODERNA | Tremor (excl congenital) | 2769 | 1.00 | 1.03 | 1.06 | 2923.2 | 0.92 | 0.95 | 0.98 | 1.13 | 1.14 | 1.10 | 8300
COVID19_PFIZER/BIONTECH | Tremor (excl congenital) | 2472 | 1.06 | 1.10 | 1.13 | 2462.0 | 0.97 | 1.00 | 1.04 | 1.18 | 1.18 | 1.14 | 8597
COVID19_UNKNOWN MFR | Tremor (excl congenital) | 30 | 1.29 | 1.76 | 2.29 | 16.8 | 1.23 | 1.67 | 2.21 | 1.87 | 1.90 | 1.40 | 11039
COVID19_JANSSEN | Treponema infections | 1 | 0.31 | 1.16 | 2.45 | 1.0 | 0.28 | 0.83 | 2.06 | 1.72 | 1.72 | 0.30 | 9
COVID19_MODERNA | Treponema infections | 2 | 0.31 | 0.93 | 1.82 | 2.9 | 0.29 | 0.73 | 1.57 | 0.85 | 0.85 | 0.23 | 8
COVID19_PFIZER/BIONTECH | Treponema infections | 2 | 0.34 | 1.01 | 1.97 | 2.8 | 0.29 | 0.74 | 1.59 | 1.02 | 1.02 | 0.28 | 8
COVID19_UNKNOWN MFR | Treponema infections | 0 | 0.16 | 0.99 | 2.40 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Trichomonas infections | 2 | 0.42 | 1.69 | 3.67 | 0.9 | 0.48 | 1.22 | 2.75 | 3.43 | 3.43 | 0.95 | 9
COVID19_MODERNA | Trichomonas infections | 2 | 0.17 | 0.70 | 1.51 | 3.3 | 0.27 | 0.67 | 1.46 | 0.76 | 0.76 | 0.21 | 9
COVID19_PFIZER/BIONTECH | Trichomonas infections | 1 | 0.07 | 0.47 | 1.18 | 2.8 | 0.15 | 0.52 | 1.30 | 0.41 | 0.41 | 0.07 | 10
COVID19_UNKNOWN MFR | Trichomonas infections | 0 | 0.02 | 0.97 | 3.34 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Tricuspid valvular disorders | 5 | 0.76 | 1.72 | 2.98 | 3.2 | 0.63 | 1.24 | 2.24 | 1.58 | 1.58 | 0.73 | 49
COVID19_MODERNA | Tricuspid valvular disorders | 10 | 0.63 | 1.12 | 1.72 | 13.3 | 0.46 | 0.76 | 1.19 | 0.77 | 0.77 | 0.43 | 44
COVID19_PFIZER/BIONTECH | Tricuspid valvular disorders | 23 | 1.90 | 2.75 | 3.73 | 11.1 | 1.32 | 1.86 | 2.56 | 3.04 | 3.04 | 1.93 | 31
COVID19_UNKNOWN MFR | Tricuspid valvular disorders | 0 | 0.08 | 0.95 | 2.65 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Trigeminal disorders | 18 | 0.93 | 1.42 | 1.98 | 14.2 | 0.82 | 1.20 | 1.71 | 1.41 | 1.41 | 0.94 | 197
COVID19_MODERNA | Trigeminal disorders | 41 | 0.61 | 0.80 | 1.01 | 57.9 | 0.55 | 0.71 | 0.91 | 0.80 | 0.80 | 0.60 | 174
COVID19_PFIZER/BIONTECH | Trigeminal disorders | 51 | 0.92 | 1.17 | 1.45 | 49.2 | 0.81 | 1.02 | 1.28 | 1.27 | 1.27 | 0.98 | 164
COVID19_UNKNOWN MFR | Trigeminal disorders | 0 | 0.10 | 0.83 | 2.16 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Triglyceride analyses | 15 | 1.16 | 1.84 | 2.64 | 8.4 | 1.04 | 1.58 | 2.33 | 1.85 | 1.85 | 1.18 | 125
COVID19_MODERNA | Triglyceride analyses | 21 | 0.49 | 0.72 | 0.99 | 32.6 | 0.46 | 0.65 | 0.91 | 0.60 | 0.60 | 0.41 | 119
COVID19_PFIZER/BIONTECH | Triglyceride analyses | 37 | 1.06 | 1.41 | 1.81 | 28.7 | 0.95 | 1.25 | 1.62 | 1.47 | 1.47 | 1.07 | 103
COVID19_UNKNOWN MFR | Triglyceride analyses | 0 | 0.09 | 0.87 | 2.34 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Trophic disorders | 2 | 0.22 | 0.69 | 1.37 | 4.1 | 0.23 | 0.58 | 1.27 | 0.48 | 0.48 | 0.15 | 64
COVID19_MODERNA | Trophic disorders | 4 | 0.17 | 0.40 | 0.71 | 13.5 | 0.17 | 0.36 | 0.69 | 0.22 | 0.22 | 0.09 | 62
COVID19_PFIZER/BIONTECH | Trophic disorders | 5 | 0.24 | 0.52 | 0.88 | 12.3 | 0.23 | 0.46 | 0.84 | 0.34 | 0.34 | 0.16 | 61
COVID19_UNKNOWN MFR | Trophic disorders | 0 | 0.13 | 0.95 | 2.40 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Trunk deformities | 0 | 0.01 | 0.59 | 2.01 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Trunk deformities | 2 | 0.27 | 1.07 | 2.32 | 1.4 | 0.41 | 1.02 | 2.24 | 1.13 | 1.13 | 0.30 | 6
COVID19_PFIZER/BIONTECH | Trunk deformities | 1 | 0.11 | 0.75 | 1.87 | 1.3 | 0.25 | 0.77 | 1.90 | 0.59 | 0.59 | 0.10 | 7
COVID19_UNKNOWN MFR | Trunk deformities | 0 | 0.02 | 0.98 | 3.33 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Trypanosomal infections | 0 | 0.06 | 0.86 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Trypanosomal infections | 0 | 0.05 | 0.63 | 1.79 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Trypanosomal infections | 1 | 0.24 | 1.24 | 2.86 | 0.4 | 0.35 | 1.08 | 2.82 | 2.05 | 2.05 | 0.27 | 2
COVID19_UNKNOWN MFR | Trypanosomal infections | 0 | 0.07 | 1.00 | 2.84 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Tuberculous infections | 0 | 0.00 | 0.11 | 0.49 | 2.6 |  |  |  |  |  |  | 
COVID19_MODERNA | Tuberculous infections | 6 | 0.45 | 1.01 | 1.75 | 5.7 | 0.53 | 0.98 | 1.70 | 0.39 | 0.39 | 0.19 | 52
COVID19_PFIZER/BIONTECH | Tuberculous infections | 2 | 0.07 | 0.32 | 0.72 | 7.4 | 0.14 | 0.38 | 0.84 | 0.15 | 0.15 | 0.05 | 56
COVID19_UNKNOWN MFR | Tuberculous infections | 0 | 0.00 | 0.82 | 3.68 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Tympanic membrane disorders (excl infections) | 1 | 0.16 | 0.67 | 1.47 | 2.5 | 0.17 | 0.56 | 1.39 | 0.26 | 0.26 | 0.05 | 60
COVID19_MODERNA | Tympanic membrane disorders (excl infections) | 3 | 0.24 | 0.63 | 1.17 | 6.1 | 0.25 | 0.57 | 1.14 | 0.18 | 0.18 | 0.07 | 58
COVID19_PFIZER/BIONTECH | Tympanic membrane disorders (excl infections) | 5 | 0.37 | 0.80 | 1.37 | 7.3 | 0.36 | 0.71 | 1.27 | 0.37 | 0.37 | 0.17 | 56
COVID19_UNKNOWN MFR | Tympanic membrane disorders (excl infections) | 0 | 0.13 | 0.97 | 2.45 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Typhus infections | 0 | 0.00 | 0.53 | 2.33 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Typhus infections | 0 | 0.00 | 0.24 | 1.02 | 1.1 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Typhus infections | 0 | 0.00 | 0.26 | 1.14 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Typhus infections | 0 | 0.00 | 0.98 | 4.26 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ulcers NEC | 3 | 0.38 | 0.82 | 1.41 | 4.4 | 0.32 | 0.72 | 1.43 | 0.63 | 0.63 | 0.24 | 74
COVID19_MODERNA | Ulcers NEC | 14 | 0.54 | 0.84 | 1.20 | 17.3 | 0.52 | 0.81 | 1.20 | 0.76 | 0.76 | 0.46 | 63
COVID19_PFIZER/BIONTECH | Ulcers NEC | 17 | 0.72 | 1.08 | 1.50 | 15.5 | 0.71 | 1.06 | 1.52 | 1.16 | 1.16 | 0.74 | 60
COVID19_UNKNOWN MFR | Ulcers NEC | 0 | 0.31 | 0.97 | 1.92 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Umbilical cord complications | 0 | 0.02 | 0.54 | 1.73 | 0.7 |  |  |  |  |  |  | 
COVID19_MODERNA | Umbilical cord complications | 3 | 0.45 | 1.36 | 2.67 | 2.3 | 0.46 | 1.04 | 2.08 | 1.13 | 1.13 | 0.38 | 9
COVID19_PFIZER/BIONTECH | Umbilical cord complications | 1 | 0.11 | 0.68 | 1.67 | 2.4 | 0.18 | 0.57 | 1.42 | 0.37 | 0.37 | 0.07 | 11
COVID19_UNKNOWN MFR | Umbilical cord complications | 0 | 0.03 | 0.98 | 3.16 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Umbilical hernias | 0 | 0.00 | 0.52 | 1.98 | 0.5 |  |  |  |  |  |  | 
COVID19_MODERNA | Umbilical hernias | 3 | 0.36 | 1.15 | 2.30 | 1.7 | 0.53 | 1.20 | 2.42 | 1.02 | 1.02 | 0.35 | 10
COVID19_PFIZER/BIONTECH | Umbilical hernias | 1 | 0.07 | 0.60 | 1.56 | 1.7 | 0.22 | 0.69 | 1.70 | 0.34 | 0.34 | 0.06 | 12
COVID19_UNKNOWN MFR | Umbilical hernias | 0 | 0.01 | 0.97 | 3.68 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Underdoses NEC | 99 | 0.62 | 0.74 | 0.86 | 156.8 | 0.54 | 0.63 | 0.74 | 0.62 | 0.62 | 0.53 | 2454
COVID19_MODERNA | Underdoses NEC | 694 | 1.48 | 1.58 | 1.68 | 508.9 | 1.28 | 1.36 | 1.45 | 1.27 | 1.27 | 1.18 | 1859
COVID19_PFIZER/BIONTECH | Underdoses NEC | 434 | 1.02 | 1.10 | 1.19 | 455.4 | 0.88 | 0.95 | 1.03 | 0.84 | 0.84 | 0.77 | 2119
COVID19_UNKNOWN MFR | Underdoses NEC | 1 | 0.06 | 0.43 | 1.07 | 3.8 | 0.12 | 0.42 | 1.10 | 0.27 | 0.27 | 0.05 | 2552
COVID19_JANSSEN | Unintended pregnancies | 0 | 0.03 | 0.88 | 2.74 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Unintended pregnancies | 0 | 0.03 | 0.66 | 2.07 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Unintended pregnancies | 0 | 0.03 | 0.70 | 2.17 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Unintended pregnancies | 0 | 0.04 | 1.00 | 3.11 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Upper gastrointestinal neoplasms benign | 0 | 0.00 | 0.52 | 2.70 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Upper gastrointestinal neoplasms benign | 0 | 0.00 | 0.23 | 1.17 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Upper gastrointestinal neoplasms benign | 0 | 0.00 | 0.25 | 1.31 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Upper gastrointestinal neoplasms benign | 0 | 0.00 | 0.98 | 5.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Upper respiratory tract infections | 321 | 1.34 | 1.48 | 1.61 | 244.2 | 1.19 | 1.31 | 1.43 | 1.23 | 1.23 | 1.12 | 4043
COVID19_MODERNA | Upper respiratory tract infections | 601 | 0.75 | 0.80 | 0.85 | 801.2 | 0.70 | 0.75 | 0.80 | 0.54 | 0.54 | 0.50 | 3763
COVID19_PFIZER/BIONTECH | Upper respiratory tract infections | 781 | 1.06 | 1.13 | 1.20 | 762.4 | 0.97 | 1.02 | 1.09 | 0.89 | 0.89 | 0.84 | 3583
COVID19_UNKNOWN MFR | Upper respiratory tract infections | 6 | 0.54 | 1.07 | 1.74 | 6.1 | 0.50 | 0.93 | 1.61 | 0.95 | 0.95 | 0.48 | 4358
COVID19_JANSSEN | Upper respiratory tract neoplasms | 1 | 0.32 | 1.57 | 3.57 | 0.2 | 0.38 | 1.18 | 3.45 | 7.72 | 7.72 | 1.03 | 2
COVID19_MODERNA | Upper respiratory tract neoplasms | 1 | 0.24 | 1.16 | 2.66 | 0.9 | 0.28 | 0.86 | 2.12 | 1.70 | 1.70 | 0.23 | 2
COVID19_PFIZER/BIONTECH | Upper respiratory tract neoplasms | 0 | 0.06 | 0.68 | 1.88 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Upper respiratory tract neoplasms | 0 | 0.09 | 1.00 | 2.75 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Upper respiratory tract signs and symptoms | 1411 | 1.02 | 1.07 | 1.12 | 1595.4 | 0.85 | 0.88 | 0.92 | 1.04 | 1.05 | 1.00 | 20862
COVID19_MODERNA | Upper respiratory tract signs and symptoms | 6119 | 1.14 | 1.16 | 1.19 | 6317.1 | 0.95 | 0.97 | 0.99 | 1.29 | 1.30 | 1.27 | 16154
COVID19_PFIZER/BIONTECH | Upper respiratory tract signs and symptoms | 7682 | 1.69 | 1.73 | 1.76 | 5363.1 | 1.41 | 1.43 | 1.46 | 2.15 | 2.24 | 2.18 | 14591
COVID19_UNKNOWN MFR | Upper respiratory tract signs and symptoms | 40 | 1.01 | 1.32 | 1.66 | 35.4 | 0.85 | 1.11 | 1.42 | 1.24 | 1.25 | 0.96 | 22233
COVID19_JANSSEN | Ureteric disorders NEC | 2 | 0.47 | 1.51 | 3.02 | 0.7 | 0.52 | 1.32 | 3.09 | 3.09 | 3.09 | 0.86 | 10
COVID19_MODERNA | Ureteric disorders NEC | 2 | 0.27 | 0.85 | 1.71 | 2.7 | 0.30 | 0.75 | 1.62 | 0.68 | 0.68 | 0.19 | 10
COVID19_PFIZER/BIONTECH | Ureteric disorders NEC | 4 | 0.59 | 1.41 | 2.52 | 2.3 | 0.61 | 1.27 | 2.41 | 2.05 | 2.05 | 0.75 | 8
COVID19_UNKNOWN MFR | Ureteric disorders NEC | 0 | 0.12 | 0.99 | 2.56 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ureteric disorders congenital | 0 | 0.05 | 0.94 | 2.83 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Ureteric disorders congenital | 0 | 0.04 | 0.81 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ureteric disorders congenital | 0 | 0.04 | 0.84 | 2.51 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ureteric disorders congenital | 0 | 0.05 | 1.00 | 3.00 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ureteric therapeutic procedures | 1 | 0.32 | 1.25 | 2.68 | 0.2 | 0.38 | 1.19 | 3.48 | 2.57 | 2.57 | 0.44 | 6
COVID19_MODERNA | Ureteric therapeutic procedures | 2 | 0.37 | 1.12 | 2.19 | 1.7 | 0.39 | 0.96 | 2.09 | 1.36 | 1.36 | 0.34 | 5
COVID19_PFIZER/BIONTECH | Ureteric therapeutic procedures | 1 | 0.23 | 0.88 | 1.89 | 1.3 | 0.25 | 0.77 | 1.91 | 0.68 | 0.68 | 0.12 | 6
COVID19_UNKNOWN MFR | Ureteric therapeutic procedures | 0 | 0.16 | 0.99 | 2.43 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Urethral disorders NEC | 1 | 0.30 | 1.20 | 2.59 | 0.6 | 0.32 | 0.96 | 2.41 | 1.93 | 1.93 | 0.34 | 8
COVID19_MODERNA | Urethral disorders NEC | 3 | 0.48 | 1.25 | 2.33 | 2.3 | 0.47 | 1.05 | 2.11 | 1.70 | 1.70 | 0.53 | 6
COVID19_PFIZER/BIONTECH | Urethral disorders NEC | 3 | 0.52 | 1.35 | 2.52 | 2.1 | 0.49 | 1.10 | 2.21 | 2.05 | 2.05 | 0.64 | 6
COVID19_UNKNOWN MFR | Urethral disorders NEC | 0 | 0.14 | 0.99 | 2.47 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Urethral infections and inflammations | 0 | 0.05 | 0.94 | 2.84 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Urethral infections and inflammations | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urethral infections and inflammations | 0 | 0.04 | 0.83 | 2.51 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urethral infections and inflammations | 0 | 0.05 | 1.00 | 3.01 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Urethral therapeutic procedures | 0 | 0.07 | 0.95 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Urethral therapeutic procedures | 1 | 0.30 | 1.57 | 3.64 | 0.4 | 0.36 | 1.10 | 2.90 | 10.19 | 10.19 | 0.69 | 0
COVID19_PFIZER/BIONTECH | Urethral therapeutic procedures | 0 | 0.06 | 0.85 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urethral therapeutic procedures | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Urinalysis NEC | 336 | 1.36 | 1.49 | 1.63 | 242.2 | 1.26 | 1.38 | 1.51 | 1.25 | 1.25 | 1.14 | 4143
COVID19_MODERNA | Urinalysis NEC | 908 | 0.91 | 0.96 | 1.01 | 984.4 | 0.87 | 0.92 | 0.97 | 0.86 | 0.86 | 0.81 | 3571
COVID19_PFIZER/BIONTECH | Urinalysis NEC | 949 | 1.10 | 1.16 | 1.23 | 867.0 | 1.04 | 1.09 | 1.15 | 1.10 | 1.10 | 1.04 | 3530
COVID19_UNKNOWN MFR | Urinalysis NEC | 7 | 0.66 | 1.15 | 1.76 | 6.0 | 0.60 | 1.07 | 1.80 | 1.08 | 1.08 | 0.58 | 4472
COVID19_JANSSEN | Urinary abnormalities | 49 | 0.82 | 1.05 | 1.30 | 51.6 | 0.74 | 0.94 | 1.18 | 1.01 | 1.01 | 0.79 | 750
COVID19_MODERNA | Urinary abnormalities | 198 | 1.05 | 1.18 | 1.32 | 180.3 | 0.97 | 1.09 | 1.23 | 1.12 | 1.12 | 0.98 | 601
COVID19_PFIZER/BIONTECH | Urinary abnormalities | 133 | 0.77 | 0.89 | 1.02 | 163.7 | 0.70 | 0.81 | 0.93 | 0.82 | 0.82 | 0.70 | 666
COVID19_UNKNOWN MFR | Urinary abnormalities | 1 | 0.26 | 0.95 | 1.99 | 1.3 | 0.25 | 0.76 | 1.88 | 0.86 | 0.86 | 0.17 | 798
COVID19_JANSSEN | Urinary tract function analyses NEC | 5 | 0.38 | 0.80 | 1.35 | 7.2 | 0.37 | 0.71 | 1.29 | 0.43 | 0.43 | 0.21 | 178
COVID19_MODERNA | Urinary tract function analyses NEC | 23 | 0.62 | 0.90 | 1.21 | 27.7 | 0.59 | 0.83 | 1.14 | 0.49 | 0.49 | 0.34 | 160
COVID19_PFIZER/BIONTECH | Urinary tract function analyses NEC | 32 | 0.98 | 1.34 | 1.74 | 26.6 | 0.87 | 1.17 | 1.54 | 0.87 | 0.87 | 0.63 | 151
COVID19_UNKNOWN MFR | Urinary tract function analyses NEC | 0 | 0.17 | 0.92 | 2.18 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Urinary tract histopathology procedures | 0 | 0.00 | 0.14 | 0.47 | 4.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Urinary tract histopathology procedures | 9 | 0.35 | 0.65 | 1.02 | 16.5 | 0.34 | 0.57 | 0.92 | 0.39 | 0.39 | 0.22 | 79
COVID19_PFIZER/BIONTECH | Urinary tract histopathology procedures | 12 | 0.53 | 0.90 | 1.34 | 16.3 | 0.47 | 0.74 | 1.13 | 0.65 | 0.65 | 0.39 | 76
COVID19_UNKNOWN MFR | Urinary tract histopathology procedures | 0 | 0.02 | 0.86 | 2.92 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Urinary tract imaging procedures | 8 | 0.40 | 0.74 | 1.16 | 11.7 | 0.40 | 0.70 | 1.15 | 0.54 | 0.54 | 0.30 | 229
COVID19_MODERNA | Urinary tract imaging procedures | 46 | 0.80 | 1.03 | 1.28 | 46.6 | 0.77 | 0.98 | 1.23 | 0.82 | 0.82 | 0.62 | 191
COVID19_PFIZER/BIONTECH | Urinary tract imaging procedures | 35 | 0.66 | 0.88 | 1.13 | 42.2 | 0.63 | 0.83 | 1.08 | 0.71 | 0.71 | 0.53 | 202
COVID19_UNKNOWN MFR | Urinary tract imaging procedures | 1 | 0.36 | 1.31 | 2.76 | 0.3 | 0.37 | 1.13 | 3.11 | 2.92 | 2.92 | 0.56 | 236
COVID19_JANSSEN | Urinary tract infections | 64 | 0.95 | 1.18 | 1.43 | 61.0 | 0.85 | 1.04 | 1.27 | 0.89 | 0.88 | 0.72 | 1117
COVID19_MODERNA | Urinary tract infections | 260 | 0.97 | 1.07 | 1.19 | 262.4 | 0.89 | 0.99 | 1.09 | 0.96 | 0.96 | 0.85 | 921
COVID19_PFIZER/BIONTECH | Urinary tract infections | 307 | 1.32 | 1.45 | 1.59 | 233.7 | 1.19 | 1.31 | 1.44 | 1.44 | 1.44 | 1.29 | 874
COVID19_UNKNOWN MFR | Urinary tract infections | 3 | 0.54 | 1.46 | 2.74 | 1.7 | 0.54 | 1.20 | 2.44 | 1.75 | 1.75 | 0.68 | 1178
COVID19_JANSSEN | Urinary tract lithiasis (excl renal) | 1 | 0.29 | 1.25 | 2.76 | 0.4 | 0.35 | 1.06 | 2.75 | 2.21 | 2.21 | 0.38 | 7
COVID19_MODERNA | Urinary tract lithiasis (excl renal) | 1 | 0.18 | 0.76 | 1.67 | 2.5 | 0.17 | 0.56 | 1.40 | 0.49 | 0.49 | 0.08 | 7
COVID19_PFIZER/BIONTECH | Urinary tract lithiasis (excl renal) | 3 | 0.54 | 1.46 | 2.73 | 1.8 | 0.52 | 1.17 | 2.36 | 2.46 | 2.46 | 0.74 | 5
COVID19_UNKNOWN MFR | Urinary tract lithiasis (excl renal) | 0 | 0.12 | 0.99 | 2.56 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Urinary tract neoplasms malignant NEC | 0 | 0.07 | 0.95 | 2.72 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Urinary tract neoplasms malignant NEC | 1 | 0.30 | 1.57 | 3.64 | 0.3 | 0.38 | 1.17 | 3.31 | 10.19 | 10.19 | 0.69 | 0
COVID19_PFIZER/BIONTECH | Urinary tract neoplasms malignant NEC | 0 | 0.06 | 0.85 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary tract neoplasms malignant NEC | 0 | 0.07 | 1.00 | 2.86 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Urinary tract procedural complications | 0 | 0.05 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Urinary tract procedural complications | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary tract procedural complications | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary tract procedural complications | 0 | 0.05 | 1.00 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Urinary tract signs and symptoms NEC | 78 | 1.89 | 2.30 | 2.74 | 37.6 | 1.66 | 2.00 | 2.40 | 2.69 | 2.69 | 2.20 | 448
COVID19_MODERNA | Urinary tract signs and symptoms NEC | 150 | 1.00 | 1.15 | 1.31 | 146.2 | 0.89 | 1.02 | 1.17 | 1.36 | 1.36 | 1.16 | 376
COVID19_PFIZER/BIONTECH | Urinary tract signs and symptoms NEC | 139 | 1.08 | 1.25 | 1.43 | 125.2 | 0.96 | 1.10 | 1.27 | 1.47 | 1.47 | 1.25 | 387
COVID19_UNKNOWN MFR | Urinary tract signs and symptoms NEC | 0 | 0.08 | 0.65 | 1.70 | 0.8 |  |  |  |  |  |  | 
COVID19_JANSSEN | Urticarias | 830 | 0.66 | 0.70 | 0.74 | 1219.5 | 0.64 | 0.68 | 0.72 | 0.71 | 0.70 | 0.66 | 18050
COVID19_MODERNA | Urticarias | 5107 | 1.03 | 1.05 | 1.08 | 4961.2 | 1.01 | 1.03 | 1.05 | 1.26 | 1.27 | 1.24 | 13773
COVID19_PFIZER/BIONTECH | Urticarias | 3932 | 0.93 | 0.96 | 0.98 | 4211.8 | 0.91 | 0.93 | 0.96 | 1.08 | 1.08 | 1.05 | 14948
COVID19_UNKNOWN MFR | Urticarias | 22 | 0.64 | 0.88 | 1.15 | 27.1 | 0.57 | 0.81 | 1.12 | 0.80 | 0.80 | 0.56 | 18858
COVID19_JANSSEN | Uterine disorders NEC | 7 | 0.65 | 1.34 | 2.23 | 6.5 | 0.56 | 1.00 | 1.68 | 1.27 | 1.27 | 0.67 | 85
COVID19_MODERNA | Uterine disorders NEC | 9 | 0.27 | 0.51 | 0.81 | 22.1 | 0.26 | 0.44 | 0.71 | 0.37 | 0.37 | 0.21 | 83
COVID19_PFIZER/BIONTECH | Uterine disorders NEC | 27 | 1.14 | 1.61 | 2.15 | 20.6 | 0.92 | 1.26 | 1.69 | 1.70 | 1.70 | 1.17 | 65
COVID19_UNKNOWN MFR | Uterine disorders NEC | 1 | 0.29 | 2.44 | 6.34 | 0.1 | 0.40 | 1.31 | 5.07 | 7.56 | 7.57 | 1.45 | 91
COVID19_JANSSEN | Uterine infections and inflammations (excl cervix) | 0 | 0.10 | 0.86 | 2.24 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Uterine infections and inflammations (excl cervix) | 1 | 0.24 | 1.04 | 2.29 | 0.9 | 0.29 | 0.87 | 2.13 | 1.13 | 1.13 | 0.17 | 3
COVID19_PFIZER/BIONTECH | Uterine infections and inflammations (excl cervix) | 1 | 0.25 | 1.09 | 2.42 | 0.8 | 0.30 | 0.90 | 2.24 | 1.36 | 1.36 | 0.20 | 3
COVID19_UNKNOWN MFR | Uterine infections and inflammations (excl cervix) | 0 | 0.12 | 1.00 | 2.58 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Uterine neoplasms | 3 | 1.64 | 5.58 | 11.41 | 0.3 | 0.92 | 2.85 | 11.35 | 23.16 | 23.16 | 5.16 | 2
COVID19_MODERNA | Uterine neoplasms | 0 | 0.00 | 0.20 | 0.93 | 1.1 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine neoplasms | 0 | 0.00 | 0.23 | 1.05 | 1.0 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine neoplasms | 0 | 0.00 | 0.98 | 4.54 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Uterine neoplasms benign | 4 | 0.78 | 2.14 | 4.04 | 1.8 | 0.69 | 1.43 | 2.78 | 2.81 | 2.81 | 1.15 | 22
COVID19_MODERNA | Uterine neoplasms benign | 7 | 0.44 | 0.91 | 1.51 | 8.3 | 0.46 | 0.83 | 1.39 | 1.25 | 1.25 | 0.60 | 19
COVID19_PFIZER/BIONTECH | Uterine neoplasms benign | 7 | 0.54 | 1.11 | 1.86 | 6.8 | 0.54 | 0.97 | 1.63 | 1.51 | 1.51 | 0.73 | 19
COVID19_UNKNOWN MFR | Uterine neoplasms benign | 0 | 0.00 | 0.92 | 3.77 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Uterine neoplasms malignant NEC | 0 | 0.01 | 0.70 | 2.57 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Uterine neoplasms malignant NEC | 0 | 0.00 | 0.38 | 1.40 | 0.9 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine neoplasms malignant NEC | 0 | 0.00 | 0.41 | 1.53 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine neoplasms malignant NEC | 0 | 0.01 | 0.99 | 3.66 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Uterine structure and position disorders | 0 | 0.05 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Uterine structure and position disorders | 0 | 0.04 | 0.81 | 2.45 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine structure and position disorders | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine structure and position disorders | 0 | 0.05 | 1.00 | 3.02 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Uterine therapeutic procedures | 7 | 0.51 | 1.05 | 1.75 | 7.3 | 0.51 | 0.92 | 1.55 | 1.30 | 1.30 | 0.68 | 83
COVID19_MODERNA | Uterine therapeutic procedures | 25 | 0.65 | 0.94 | 1.26 | 29.8 | 0.60 | 0.84 | 1.14 | 1.31 | 1.31 | 0.89 | 65
COVID19_PFIZER/BIONTECH | Uterine therapeutic procedures | 30 | 0.93 | 1.29 | 1.70 | 25.7 | 0.84 | 1.14 | 1.51 | 2.05 | 2.05 | 1.42 | 60
COVID19_UNKNOWN MFR | Uterine therapeutic procedures | 0 | 0.00 | 0.79 | 2.99 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Uterine tone disorders | 4 | 0.53 | 1.26 | 2.25 | 2.9 | 0.54 | 1.12 | 2.11 | 2.06 | 2.06 | 0.86 | 30
COVID19_MODERNA | Uterine tone disorders | 14 | 0.74 | 1.19 | 1.72 | 11.6 | 0.74 | 1.14 | 1.69 | 2.38 | 2.38 | 1.34 | 20
COVID19_PFIZER/BIONTECH | Uterine tone disorders | 15 | 0.92 | 1.45 | 2.08 | 10.0 | 0.90 | 1.37 | 2.01 | 3.23 | 3.23 | 1.83 | 19
COVID19_UNKNOWN MFR | Uterine tone disorders | 0 | 0.12 | 0.97 | 2.48 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination related complications | 85 | 0.55 | 0.66 | 0.78 | 148.4 | 0.48 | 0.58 | 0.69 | 0.49 | 0.49 | 0.41 | 2682
COVID19_MODERNA | Vaccination related complications | 509 | 0.96 | 1.04 | 1.12 | 550.7 | 0.86 | 0.92 | 0.99 | 0.77 | 0.77 | 0.71 | 2258
COVID19_PFIZER/BIONTECH | Vaccination related complications | 211 | 0.43 | 0.49 | 0.54 | 495.7 | 0.38 | 0.43 | 0.48 | 0.34 | 0.34 | 0.30 | 2556
COVID19_UNKNOWN MFR | Vaccination related complications | 4 | 0.48 | 1.12 | 1.97 | 3.7 | 0.46 | 0.96 | 1.81 | 1.00 | 1.00 | 0.44 | 2763
COVID19_JANSSEN | Vaccination site reactions | 58 | 0.13 | 0.16 | 0.20 | 504.1 | 0.09 | 0.12 | 0.14 | 0.11 | 0.11 | 0.09 | 8388
COVID19_MODERNA | Vaccination site reactions | 1538 | 1.02 | 1.06 | 1.11 | 1940.0 | 0.76 | 0.79 | 0.83 | 0.76 | 0.75 | 0.72 | 6908
COVID19_PFIZER/BIONTECH | Vaccination site reactions | 2850 | 2.19 | 2.25 | 2.32 | 1704.5 | 1.62 | 1.67 | 1.72 | 2.09 | 2.11 | 2.03 | 5596
COVID19_UNKNOWN MFR | Vaccination site reactions | 0 | 0.02 | 0.15 | 0.38 | 9.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vaginal and vulval infections and inflammations | 0 | 0.12 | 0.90 | 2.29 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Vaginal and vulval infections and inflammations | 1 | 0.27 | 1.14 | 2.50 | 0.8 | 0.30 | 0.90 | 2.24 | 1.70 | 1.70 | 0.23 | 2
COVID19_PFIZER/BIONTECH | Vaginal and vulval infections and inflammations | 1 | 0.28 | 1.19 | 2.61 | 0.8 | 0.30 | 0.91 | 2.26 | 2.05 | 2.05 | 0.27 | 2
COVID19_UNKNOWN MFR | Vaginal and vulval infections and inflammations | 0 | 0.13 | 1.00 | 2.55 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vaginal neoplasms benign | 0 | 0.00 | 0.72 | 2.83 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Vaginal neoplasms benign | 0 | 0.00 | 0.41 | 1.61 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaginal neoplasms benign | 0 | 0.00 | 0.45 | 1.75 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaginal neoplasms benign | 0 | 0.00 | 0.99 | 3.87 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vaginal neoplasms malignant | 0 | 0.04 | 0.94 | 2.85 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Vaginal neoplasms malignant | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaginal neoplasms malignant | 0 | 0.04 | 0.83 | 2.52 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaginal neoplasms malignant | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vaginal therapeutic procedures | 1 | 0.34 | 1.87 | 4.44 | 0.1 | 0.42 | 1.40 | 7.00 | 46.31 | 46.32 | 3.16 | 0
COVID19_MODERNA | Vaginal therapeutic procedures | 0 | 0.04 | 0.82 | 2.44 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaginal therapeutic procedures | 0 | 0.04 | 0.84 | 2.50 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaginal therapeutic procedures | 0 | 0.05 | 1.00 | 2.98 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vagus nerve disorders | 1 | 0.34 | 0.89 | 1.63 | 1.7 | 0.22 | 0.67 | 1.66 | 0.55 | 0.55 | 0.10 | 28
COVID19_MODERNA | Vagus nerve disorders | 5 | 0.53 | 1.02 | 1.64 | 5.4 | 0.46 | 0.89 | 1.60 | 0.71 | 0.71 | 0.32 | 24
COVID19_PFIZER/BIONTECH | Vagus nerve disorders | 6 | 0.61 | 1.12 | 1.77 | 5.5 | 0.54 | 1.00 | 1.74 | 1.07 | 1.07 | 0.50 | 23
COVID19_UNKNOWN MFR | Vagus nerve disorders | 0 | 0.33 | 0.99 | 1.93 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Varicose veins NEC | 25 | 4.42 | 6.33 | 8.52 | 4.6 | 3.35 | 5.01 | 7.12 | 8.98 | 8.98 | 5.94 | 43
COVID19_MODERNA | Varicose veins NEC | 14 | 0.59 | 0.96 | 1.41 | 19.5 | 0.47 | 0.72 | 1.08 | 0.88 | 0.88 | 0.54 | 54
COVID19_PFIZER/BIONTECH | Varicose veins NEC | 12 | 0.57 | 0.97 | 1.46 | 16.3 | 0.47 | 0.74 | 1.13 | 0.88 | 0.88 | 0.52 | 56
COVID19_UNKNOWN MFR | Varicose veins NEC | 0 | 0.01 | 0.86 | 3.22 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vascular and lymphatic histopathology procedures | 3 | 0.52 | 1.63 | 3.23 | 1.7 | 0.54 | 1.20 | 2.43 | 1.54 | 1.54 | 0.57 | 30
COVID19_MODERNA | Vascular and lymphatic histopathology procedures | 6 | 0.37 | 0.81 | 1.39 | 8.9 | 0.37 | 0.70 | 1.21 | 0.76 | 0.76 | 0.36 | 27
COVID19_PFIZER/BIONTECH | Vascular and lymphatic histopathology procedures | 2 | 0.10 | 0.40 | 0.87 | 7.0 | 0.14 | 0.39 | 0.87 | 0.26 | 0.26 | 0.08 | 31
COVID19_UNKNOWN MFR | Vascular and lymphatic histopathology procedures | 0 | 0.01 | 0.93 | 3.24 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vascular anomalies congenital NEC | 2 | 0.27 | 1.11 | 2.43 | 2.1 | 0.35 | 0.86 | 1.87 | 1.14 | 1.14 | 0.34 | 27
COVID19_MODERNA | Vascular anomalies congenital NEC | 5 | 0.38 | 0.90 | 1.60 | 6.0 | 0.42 | 0.82 | 1.47 | 0.71 | 0.71 | 0.32 | 24
COVID19_PFIZER/BIONTECH | Vascular anomalies congenital NEC | 4 | 0.30 | 0.81 | 1.51 | 5.7 | 0.35 | 0.73 | 1.37 | 0.66 | 0.66 | 0.27 | 25
COVID19_UNKNOWN MFR | Vascular anomalies congenital NEC | 0 | 0.01 | 0.94 | 3.37 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vascular auscultatory investigations | 0 | 0.07 | 0.91 | 2.56 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Vascular auscultatory investigations | 1 | 0.26 | 1.33 | 3.07 | 0.4 | 0.36 | 1.08 | 2.83 | 3.40 | 3.40 | 0.33 | 1
COVID19_PFIZER/BIONTECH | Vascular auscultatory investigations | 0 | 0.06 | 0.75 | 2.12 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular auscultatory investigations | 0 | 0.08 | 1.00 | 2.81 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vascular complications associated with device | 1 | 0.28 | 1.40 | 3.20 | 0.4 | 0.35 | 1.05 | 2.70 | 3.09 | 3.09 | 0.51 | 5
COVID19_MODERNA | Vascular complications associated with device | 1 | 0.18 | 0.86 | 1.97 | 1.7 | 0.22 | 0.68 | 1.68 | 0.68 | 0.68 | 0.11 | 5
COVID19_PFIZER/BIONTECH | Vascular complications associated with device | 4 | 0.88 | 2.17 | 3.92 | 1.4 | 0.76 | 1.60 | 3.23 | 8.19 | 8.19 | 1.97 | 2
COVID19_UNKNOWN MFR | Vascular complications associated with device | 0 | 0.08 | 0.99 | 2.76 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vascular hypertensive disorders NEC | 350 | 1.77 | 1.93 | 2.10 | 238.7 | 1.34 | 1.46 | 1.59 | 1.73 | 1.74 | 1.58 | 3121
COVID19_MODERNA | Vascular hypertensive disorders NEC | 1119 | 1.32 | 1.38 | 1.45 | 1046.0 | 1.02 | 1.07 | 1.12 | 1.62 | 1.62 | 1.53 | 2352
COVID19_PFIZER/BIONTECH | Vascular hypertensive disorders NEC | 1414 | 2.04 | 2.13 | 2.23 | 863.4 | 1.57 | 1.64 | 1.71 | 2.81 | 2.84 | 2.68 | 2057
COVID19_UNKNOWN MFR | Vascular hypertensive disorders NEC | 10 | 1.07 | 1.86 | 2.83 | 5.8 | 0.88 | 1.46 | 2.31 | 1.99 | 2.00 | 1.18 | 3461
COVID19_JANSSEN | Vascular hypotensive disorders | 351 | 1.69 | 1.84 | 2.01 | 211.1 | 1.51 | 1.65 | 1.80 | 2.10 | 2.11 | 1.92 | 2583
COVID19_MODERNA | Vascular hypotensive disorders | 681 | 0.95 | 1.01 | 1.07 | 735.2 | 0.87 | 0.93 | 0.99 | 1.03 | 1.03 | 0.96 | 2253
COVID19_PFIZER/BIONTECH | Vascular hypotensive disorders | 859 | 1.37 | 1.45 | 1.53 | 652.6 | 1.24 | 1.31 | 1.39 | 1.69 | 1.70 | 1.59 | 2075
COVID19_UNKNOWN MFR | Vascular hypotensive disorders | 4 | 0.41 | 0.96 | 1.70 | 4.7 | 0.40 | 0.83 | 1.56 | 0.94 | 0.94 | 0.41 | 2930
COVID19_JANSSEN | Vascular imaging procedures NEC | 484 | 3.54 | 3.82 | 4.11 | 156.2 | 2.85 | 3.07 | 3.31 | 4.13 | 4.17 | 3.83 | 1810
COVID19_MODERNA | Vascular imaging procedures NEC | 609 | 1.00 | 1.07 | 1.14 | 682.2 | 0.84 | 0.89 | 0.95 | 1.23 | 1.23 | 1.14 | 1685
COVID19_PFIZER/BIONTECH | Vascular imaging procedures NEC | 762 | 1.54 | 1.64 | 1.74 | 561.2 | 1.28 | 1.36 | 1.44 | 2.04 | 2.04 | 1.90 | 1532
COVID19_UNKNOWN MFR | Vascular imaging procedures NEC | 11 | 1.53 | 2.61 | 3.92 | 3.9 | 1.29 | 2.13 | 3.43 | 3.31 | 3.34 | 2.03 | 2283
COVID19_JANSSEN | Vascular infections | 0 | 0.00 | 0.13 | 0.47 | 3.9 |  |  |  |  |  |  | 
COVID19_MODERNA | Vascular infections | 6 | 0.24 | 0.52 | 0.90 | 15.1 | 0.24 | 0.45 | 0.78 | 0.30 | 0.30 | 0.15 | 68
COVID19_PFIZER/BIONTECH | Vascular infections | 6 | 0.25 | 0.55 | 0.95 | 14.6 | 0.25 | 0.46 | 0.80 | 0.36 | 0.36 | 0.18 | 68
COVID19_UNKNOWN MFR | Vascular infections | 0 | 0.01 | 0.86 | 3.16 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vascular malformations and acquired anomalies | 1 | 0.34 | 1.64 | 3.74 | 0.1 | 0.41 | 1.35 | 5.99 | 15.44 | 15.44 | 1.51 | 1
COVID19_MODERNA | Vascular malformations and acquired anomalies | 1 | 0.27 | 1.32 | 3.01 | 0.7 | 0.31 | 0.95 | 2.36 | 3.40 | 3.40 | 0.33 | 1
COVID19_PFIZER/BIONTECH | Vascular malformations and acquired anomalies | 0 | 0.07 | 0.76 | 2.11 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular malformations and acquired anomalies | 0 | 0.09 | 1.00 | 2.76 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vascular pulmonary disorders NEC | 2 | 0.45 | 1.27 | 2.42 | 0.8 | 0.49 | 1.25 | 2.85 | 2.21 | 2.21 | 0.64 | 14
COVID19_MODERNA | Vascular pulmonary disorders NEC | 5 | 0.60 | 1.26 | 2.11 | 4.3 | 0.53 | 1.02 | 1.85 | 1.54 | 1.54 | 0.64 | 11
COVID19_PFIZER/BIONTECH | Vascular pulmonary disorders NEC | 5 | 0.62 | 1.30 | 2.18 | 3.9 | 0.56 | 1.10 | 1.98 | 1.86 | 1.86 | 0.77 | 11
COVID19_UNKNOWN MFR | Vascular pulmonary disorders NEC | 0 | 0.20 | 0.99 | 2.25 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vascular tests NEC (incl blood pressure) | 650 | 1.62 | 1.73 | 1.85 | 482.9 | 1.26 | 1.34 | 1.43 | 1.60 | 1.61 | 1.50 | 6273
COVID19_MODERNA | Vascular tests NEC (incl blood pressure) | 1968 | 1.21 | 1.26 | 1.31 | 2004.9 | 0.95 | 0.98 | 1.02 | 1.35 | 1.35 | 1.30 | 4955
COVID19_PFIZER/BIONTECH | Vascular tests NEC (incl blood pressure) | 2808 | 2.10 | 2.17 | 2.23 | 1670.9 | 1.63 | 1.68 | 1.73 | 2.79 | 2.84 | 2.72 | 4115
COVID19_UNKNOWN MFR | Vascular tests NEC (incl blood pressure) | 10 | 0.65 | 1.09 | 1.63 | 11.4 | 0.52 | 0.86 | 1.35 | 1.00 | 1.00 | 0.59 | 6913
COVID19_JANSSEN | Vascular therapeutic procedures NEC | 51 | 3.37 | 4.31 | 5.34 | 13.5 | 2.73 | 3.51 | 4.47 | 4.53 | 4.53 | 3.49 | 174
COVID19_MODERNA | Vascular therapeutic procedures NEC | 83 | 1.17 | 1.42 | 1.68 | 66.6 | 1.03 | 1.23 | 1.47 | 1.99 | 1.99 | 1.58 | 142
COVID19_PFIZER/BIONTECH | Vascular therapeutic procedures NEC | 67 | 1.18 | 1.45 | 1.76 | 53.4 | 1.01 | 1.23 | 1.50 | 1.74 | 1.74 | 1.37 | 158
COVID19_UNKNOWN MFR | Vascular therapeutic procedures NEC | 4 | 2.03 | 5.52 | 10.38 | 0.4 | 1.34 | 4.75 | 14.70 | 12.45 | 12.50 | 5.44 | 221
COVID19_JANSSEN | Vasculitides | 0 | 0.00 | 0.31 | 1.09 | 1.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Vasculitides | 2 | 0.14 | 0.59 | 1.29 | 5.6 | 0.18 | 0.47 | 1.03 | 0.24 | 0.24 | 0.07 | 28
COVID19_PFIZER/BIONTECH | Vasculitides | 3 | 0.25 | 0.78 | 1.55 | 5.9 | 0.26 | 0.58 | 1.16 | 0.46 | 0.46 | 0.17 | 27
COVID19_UNKNOWN MFR | Vasculitides | 0 | 0.01 | 0.94 | 3.30 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vasculitides NEC | 12 | 0.52 | 0.86 | 1.27 | 15.6 | 0.49 | 0.77 | 1.18 | 0.74 | 0.74 | 0.45 | 252
COVID19_MODERNA | Vasculitides NEC | 36 | 0.58 | 0.77 | 0.99 | 48.6 | 0.56 | 0.74 | 0.96 | 0.54 | 0.54 | 0.40 | 228
COVID19_PFIZER/BIONTECH | Vasculitides NEC | 21 | 0.34 | 0.50 | 0.68 | 46.5 | 0.33 | 0.47 | 0.65 | 0.35 | 0.35 | 0.24 | 243
COVID19_UNKNOWN MFR | Vasculitides NEC | 1 | 0.35 | 1.26 | 2.62 | 0.4 | 0.35 | 1.07 | 2.77 | 2.62 | 2.62 | 0.50 | 263
COVID19_JANSSEN | Vena caval embolism and thrombosis | 1 | 0.26 | 1.08 | 2.35 | 0.7 | 0.31 | 0.94 | 2.33 | 1.54 | 1.54 | 0.28 | 10
COVID19_MODERNA | Vena caval embolism and thrombosis | 6 | 0.76 | 1.56 | 2.60 | 3.1 | 0.78 | 1.46 | 2.57 | 4.08 | 4.08 | 1.51 | 5
COVID19_PFIZER/BIONTECH | Vena caval embolism and thrombosis | 3 | 0.40 | 1.07 | 2.00 | 2.5 | 0.45 | 1.00 | 2.01 | 1.54 | 1.54 | 0.50 | 8
COVID19_UNKNOWN MFR | Vena caval embolism and thrombosis | 0 | 0.13 | 0.99 | 2.51 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Venous disorders congenital | 0 | 0.13 | 0.85 | 2.11 | 0.3 |  |  |  |  |  |  | 
COVID19_MODERNA | Venous disorders congenital | 1 | 0.24 | 0.95 | 2.05 | 0.6 | 0.32 | 0.96 | 2.40 | 0.85 | 0.85 | 0.14 | 4
COVID19_PFIZER/BIONTECH | Venous disorders congenital | 1 | 0.25 | 1.01 | 2.17 | 0.7 | 0.31 | 0.93 | 2.30 | 1.02 | 1.02 | 0.16 | 4
COVID19_UNKNOWN MFR | Venous disorders congenital | 0 | 0.15 | 1.00 | 2.47 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Venous therapeutic procedures | 14 | 1.58 | 2.52 | 3.64 | 4.9 | 1.43 | 2.24 | 3.44 | 2.77 | 2.77 | 1.72 | 78
COVID19_MODERNA | Venous therapeutic procedures | 16 | 0.59 | 0.91 | 1.29 | 20.6 | 0.52 | 0.78 | 1.13 | 0.72 | 0.72 | 0.46 | 76
COVID19_PFIZER/BIONTECH | Venous therapeutic procedures | 17 | 0.72 | 1.10 | 1.54 | 17.9 | 0.63 | 0.93 | 1.34 | 0.93 | 0.93 | 0.60 | 75
COVID19_UNKNOWN MFR | Venous therapeutic procedures | 0 | 0.16 | 0.95 | 2.26 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | Ventricular arrhythmias and cardiac arrest | 79 | 1.12 | 1.36 | 1.62 | 73.4 | 0.89 | 1.07 | 1.28 | 0.97 | 0.97 | 0.80 | 1254
COVID19_MODERNA | Ventricular arrhythmias and cardiac arrest | 408 | 1.39 | 1.51 | 1.64 | 333.9 | 1.12 | 1.22 | 1.32 | 1.50 | 1.50 | 1.36 | 925
COVID19_PFIZER/BIONTECH | Ventricular arrhythmias and cardiac arrest | 499 | 2.03 | 2.19 | 2.35 | 285.7 | 1.62 | 1.74 | 1.87 | 2.45 | 2.46 | 2.24 | 834
COVID19_UNKNOWN MFR | Ventricular arrhythmias and cardiac arrest | 9 | 1.83 | 3.33 | 5.19 | 2.1 | 1.51 | 2.80 | 5.46 | 4.68 | 4.71 | 2.71 | 1324
COVID19_JANSSEN | Vertigos NEC | 0 | 0.11 | 0.89 | 2.32 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Vertigos NEC | 1 | 0.26 | 1.14 | 2.53 | 1.0 | 0.28 | 0.83 | 2.05 | 1.70 | 1.70 | 0.23 | 2
COVID19_PFIZER/BIONTECH | Vertigos NEC | 1 | 0.28 | 1.20 | 2.64 | 0.8 | 0.30 | 0.92 | 2.28 | 2.05 | 2.05 | 0.27 | 2
COVID19_UNKNOWN MFR | Vertigos NEC | 0 | 0.12 | 1.00 | 2.59 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vibrio infections | 1 | 0.31 | 1.81 | 4.32 | 0.1 | 0.41 | 1.33 | 5.56 | 15.44 | 15.44 | 1.51 | 1
COVID19_MODERNA | Vibrio infections | 0 | 0.03 | 0.68 | 2.06 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vibrio infections | 0 | 0.03 | 0.71 | 2.16 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vibrio infections | 0 | 0.05 | 1.00 | 3.03 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Viral infections NEC | 24 | 0.30 | 0.43 | 0.58 | 79.7 | 0.22 | 0.31 | 0.43 | 0.21 | 0.21 | 0.15 | 1728
COVID19_MODERNA | Viral infections NEC | 80 | 0.40 | 0.48 | 0.57 | 205.6 | 0.33 | 0.39 | 0.47 | 0.16 | 0.16 | 0.13 | 1672
COVID19_PFIZER/BIONTECH | Viral infections NEC | 122 | 0.59 | 0.69 | 0.80 | 231.2 | 0.46 | 0.53 | 0.61 | 0.31 | 0.31 | 0.26 | 1630
COVID19_UNKNOWN MFR | Viral infections NEC | 0 | 0.13 | 0.60 | 1.35 | 1.6 |  |  |  |  |  |  | 
COVID19_JANSSEN | Viral infections congenital | 0 | 0.03 | 0.83 | 2.60 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Viral infections congenital | 0 | 0.02 | 0.56 | 1.77 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral infections congenital | 0 | 0.02 | 0.60 | 1.88 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral infections congenital | 0 | 0.04 | 1.00 | 3.12 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Virus identification and serology | 1243 | 1.16 | 1.22 | 1.28 | 1509.9 | 0.79 | 0.82 | 0.86 | 0.88 | 0.88 | 0.84 | 21702
COVID19_MODERNA | Virus identification and serology | 3899 | 1.14 | 1.18 | 1.21 | 4841.5 | 0.78 | 0.81 | 0.83 | 0.70 | 0.69 | 0.67 | 19046
COVID19_PFIZER/BIONTECH | Virus identification and serology | 9585 | 3.03 | 3.08 | 3.13 | 4587.7 | 2.05 | 2.09 | 2.12 | 2.94 | 3.11 | 3.04 | 13360
COVID19_UNKNOWN MFR | Virus identification and serology | 31 | 0.87 | 1.19 | 1.55 | 37.1 | 0.62 | 0.83 | 1.10 | 0.93 | 0.93 | 0.69 | 22914
COVID19_JANSSEN | Visual colour distortions | 0 | 0.01 | 0.37 | 1.19 | 1.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Visual colour distortions | 8 | 0.61 | 1.19 | 1.91 | 5.9 | 0.69 | 1.20 | 1.97 | 1.70 | 1.70 | 0.83 | 16
COVID19_PFIZER/BIONTECH | Visual colour distortions | 7 | 0.65 | 1.33 | 2.19 | 4.5 | 0.72 | 1.29 | 2.18 | 1.69 | 1.69 | 0.81 | 17
COVID19_UNKNOWN MFR | Visual colour distortions | 0 | 0.03 | 0.96 | 3.12 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Visual disorders NEC | 688 | 1.97 | 2.10 | 2.23 | 368.3 | 1.75 | 1.86 | 1.98 | 2.44 | 2.47 | 2.31 | 4350
COVID19_MODERNA | Visual disorders NEC | 1181 | 0.91 | 0.96 | 1.00 | 1357.5 | 0.83 | 0.87 | 0.91 | 1.04 | 1.04 | 0.98 | 3857
COVID19_PFIZER/BIONTECH | Visual disorders NEC | 1411 | 1.27 | 1.33 | 1.39 | 1171.9 | 1.15 | 1.20 | 1.26 | 1.59 | 1.60 | 1.52 | 3627
COVID19_UNKNOWN MFR | Visual disorders NEC | 8 | 0.57 | 1.07 | 1.68 | 8.2 | 0.54 | 0.93 | 1.53 | 1.09 | 1.10 | 0.61 | 5030
COVID19_JANSSEN | Visual field disorders | 21 | 1.17 | 1.72 | 2.37 | 14.3 | 0.96 | 1.38 | 1.92 | 1.80 | 1.80 | 1.23 | 180
COVID19_MODERNA | Visual field disorders | 33 | 0.62 | 0.84 | 1.09 | 44.1 | 0.56 | 0.75 | 0.98 | 0.67 | 0.67 | 0.49 | 168
COVID19_PFIZER/BIONTECH | Visual field disorders | 30 | 0.61 | 0.85 | 1.11 | 41.0 | 0.54 | 0.73 | 0.97 | 0.72 | 0.72 | 0.52 | 171
COVID19_UNKNOWN MFR | Visual field disorders | 0 | 0.02 | 0.73 | 2.39 | 0.3 |  |  |  |  |  |  | 
COVID19_JANSSEN | Visual impairment and blindness (excl colour blindness) | 431 | 1.68 | 1.82 | 1.97 | 280.1 | 1.42 | 1.53 | 1.66 | 1.85 | 1.86 | 1.71 | 3605
COVID19_MODERNA | Visual impairment and blindness (excl colour blindness) | 731 | 0.84 | 0.89 | 0.95 | 925.5 | 0.74 | 0.79 | 0.84 | 0.75 | 0.75 | 0.70 | 3305
COVID19_PFIZER/BIONTECH | Visual impairment and blindness (excl colour blindness) | 925 | 1.21 | 1.27 | 1.34 | 839.5 | 1.04 | 1.10 | 1.16 | 1.22 | 1.22 | 1.15 | 3111
COVID19_UNKNOWN MFR | Visual impairment and blindness (excl colour blindness) | 9 | 0.85 | 1.53 | 2.39 | 6.3 | 0.74 | 1.25 | 2.02 | 1.54 | 1.54 | 0.89 | 4027
COVID19_JANSSEN | Visual pathway disorders | 1 | 0.18 | 0.73 | 1.59 | 1.9 | 0.21 | 0.65 | 1.60 | 0.53 | 0.53 | 0.10 | 29
COVID19_MODERNA | Visual pathway disorders | 3 | 0.25 | 0.66 | 1.23 | 5.0 | 0.29 | 0.66 | 1.31 | 0.38 | 0.38 | 0.14 | 27
COVID19_PFIZER/BIONTECH | Visual pathway disorders | 3 | 0.24 | 0.63 | 1.18 | 5.4 | 0.28 | 0.62 | 1.25 | 0.46 | 0.46 | 0.17 | 27
COVID19_UNKNOWN MFR | Visual pathway disorders | 0 | 0.13 | 0.97 | 2.47 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin analyses | 39 | 0.78 | 1.03 | 1.32 | 41.4 | 0.72 | 0.93 | 1.20 | 1.05 | 1.05 | 0.80 | 572
COVID19_MODERNA | Vitamin analyses | 116 | 0.69 | 0.81 | 0.94 | 154.9 | 0.64 | 0.75 | 0.87 | 0.80 | 0.80 | 0.67 | 495
COVID19_PFIZER/BIONTECH | Vitamin analyses | 140 | 0.98 | 1.13 | 1.29 | 136.7 | 0.89 | 1.02 | 1.17 | 1.22 | 1.22 | 1.04 | 471
COVID19_UNKNOWN MFR | Vitamin analyses | 2 | 0.45 | 1.48 | 2.99 | 1.0 | 0.47 | 1.19 | 2.66 | 2.26 | 2.26 | 0.70 | 609
COVID19_JANSSEN | Vitamin deficiencies NEC | 0 | 0.01 | 0.48 | 1.58 | 0.8 |  |  |  |  |  |  | 
COVID19_MODERNA | Vitamin deficiencies NEC | 1 | 0.09 | 0.56 | 1.36 | 2.8 | 0.15 | 0.52 | 1.30 | 0.17 | 0.17 | 0.03 | 20
COVID19_PFIZER/BIONTECH | Vitamin deficiencies NEC | 0 | 0.01 | 0.25 | 0.80 | 2.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin deficiencies NEC | 0 | 0.03 | 0.98 | 3.18 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vulval neoplasms malignant | 0 | 0.00 | 0.14 | 0.80 | 0.4 |  |  |  |  |  |  | 
COVID19_MODERNA | Vulval neoplasms malignant | 0 | 0.00 | 0.04 | 0.24 | 1.4 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulval neoplasms malignant | 0 | 0.00 | 0.05 | 0.28 | 1.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulval neoplasms malignant | 0 | 0.00 | 0.88 | 4.91 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vulvovaginal cysts and neoplasms | 1 | 0.30 | 1.53 | 3.51 | 0.3 | 0.37 | 1.14 | 3.15 | 5.15 | 5.15 | 0.77 | 3
COVID19_MODERNA | Vulvovaginal cysts and neoplasms | 2 | 0.44 | 1.52 | 3.13 | 1.5 | 0.40 | 0.99 | 2.16 | 3.40 | 3.40 | 0.66 | 2
COVID19_PFIZER/BIONTECH | Vulvovaginal cysts and neoplasms | 0 | 0.05 | 0.60 | 1.70 | 0.8 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulvovaginal cysts and neoplasms | 0 | 0.08 | 1.00 | 2.80 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Vulvovaginal disorders NEC | 80 | 1.75 | 2.13 | 2.53 | 41.6 | 1.55 | 1.87 | 2.23 | 2.80 | 2.80 | 2.30 | 441
COVID19_MODERNA | Vulvovaginal disorders NEC | 119 | 0.70 | 0.82 | 0.95 | 161.3 | 0.63 | 0.74 | 0.86 | 1.00 | 1.00 | 0.85 | 402
COVID19_PFIZER/BIONTECH | Vulvovaginal disorders NEC | 203 | 1.42 | 1.60 | 1.79 | 141.3 | 1.27 | 1.43 | 1.60 | 2.61 | 2.62 | 2.26 | 318
COVID19_UNKNOWN MFR | Vulvovaginal disorders NEC | 2 | 0.47 | 1.60 | 3.27 | 0.9 | 0.49 | 1.23 | 2.78 | 2.65 | 2.65 | 0.83 | 519
COVID19_JANSSEN | Vulvovaginal signs and symptoms | 15 | 0.85 | 1.34 | 1.93 | 11.6 | 0.80 | 1.21 | 1.77 | 1.44 | 1.44 | 0.92 | 161
COVID19_MODERNA | Vulvovaginal signs and symptoms | 42 | 0.73 | 0.96 | 1.21 | 46.7 | 0.69 | 0.89 | 1.14 | 1.06 | 1.06 | 0.80 | 134
COVID19_PFIZER/BIONTECH | Vulvovaginal signs and symptoms | 43 | 0.87 | 1.14 | 1.43 | 40.6 | 0.81 | 1.05 | 1.33 | 1.32 | 1.32 | 0.99 | 133
COVID19_UNKNOWN MFR | Vulvovaginal signs and symptoms | 0 | 0.12 | 0.87 | 2.20 | 0.2 |  |  |  |  |  |  | 
COVID19_JANSSEN | Waldenstrom's macroglobulinaemias | 0 | 0.04 | 0.94 | 2.86 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Waldenstrom's macroglobulinaemias | 0 | 0.04 | 0.81 | 2.46 | 0.2 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Waldenstrom's macroglobulinaemias | 0 | 0.04 | 0.83 | 2.53 | 0.2 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Waldenstrom's macroglobulinaemias | 0 | 0.05 | 1.00 | 3.04 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Water and electrolyte analyses NEC | 22 | 0.66 | 0.95 | 1.30 | 23.5 | 0.65 | 0.92 | 1.28 | 0.75 | 0.75 | 0.52 | 455
COVID19_MODERNA | Water and electrolyte analyses NEC | 79 | 0.74 | 0.90 | 1.07 | 88.9 | 0.74 | 0.89 | 1.06 | 0.67 | 0.67 | 0.55 | 398
COVID19_PFIZER/BIONTECH | Water and electrolyte analyses NEC | 93 | 0.98 | 1.17 | 1.37 | 81.6 | 0.95 | 1.13 | 1.33 | 0.99 | 0.99 | 0.82 | 384
COVID19_UNKNOWN MFR | Water and electrolyte analyses NEC | 2 | 0.54 | 1.58 | 3.07 | 0.6 | 0.55 | 1.42 | 3.62 | 2.90 | 2.90 | 0.90 | 475
COVID19_JANSSEN | Water soluble vitamin deficiencies | 2 | 0.19 | 0.88 | 1.98 | 2.9 | 0.29 | 0.73 | 1.58 | 0.75 | 0.75 | 0.23 | 41
COVID19_MODERNA | Water soluble vitamin deficiencies | 4 | 0.21 | 0.58 | 1.09 | 8.1 | 0.27 | 0.56 | 1.05 | 0.35 | 0.35 | 0.15 | 39
COVID19_PFIZER/BIONTECH | Water soluble vitamin deficiencies | 3 | 0.14 | 0.46 | 0.93 | 8.3 | 0.19 | 0.45 | 0.90 | 0.31 | 0.31 | 0.12 | 40
COVID19_UNKNOWN MFR | Water soluble vitamin deficiencies | 0 | 0.00 | 0.87 | 3.71 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | White blood cell abnormal findings NEC | 4 | 0.63 | 1.32 | 2.22 | 2.1 | 0.64 | 1.32 | 2.53 | 2.21 | 2.21 | 0.92 | 28
COVID19_MODERNA | White blood cell abnormal findings NEC | 9 | 0.66 | 1.13 | 1.71 | 7.7 | 0.64 | 1.08 | 1.73 | 1.33 | 1.33 | 0.70 | 23
COVID19_PFIZER/BIONTECH | White blood cell abnormal findings NEC | 7 | 0.55 | 1.01 | 1.57 | 7.0 | 0.53 | 0.94 | 1.59 | 1.15 | 1.15 | 0.57 | 25
COVID19_UNKNOWN MFR | White blood cell abnormal findings NEC | 0 | 0.29 | 0.98 | 2.01 | 0.1 |  |  |  |  |  |  | 
COVID19_JANSSEN | White blood cell analyses | 294 | 1.03 | 1.14 | 1.25 | 322.8 | 0.83 | 0.91 | 1.00 | 0.79 | 0.79 | 0.71 | 5768
COVID19_MODERNA | White blood cell analyses | 899 | 0.89 | 0.94 | 0.99 | 1148.0 | 0.74 | 0.78 | 0.83 | 0.59 | 0.59 | 0.55 | 5163
COVID19_PFIZER/BIONTECH | White blood cell analyses | 951 | 1.04 | 1.10 | 1.16 | 1069.9 | 0.84 | 0.89 | 0.94 | 0.76 | 0.76 | 0.72 | 5111
COVID19_UNKNOWN MFR | White blood cell analyses | 10 | 0.81 | 1.38 | 2.08 | 8.2 | 0.68 | 1.13 | 1.77 | 1.14 | 1.14 | 0.67 | 6052
COVID19_JANSSEN | Withdrawal and rebound effects | 1 | 0.27 | 1.04 | 2.23 | 0.9 | 0.29 | 0.88 | 2.17 | 1.54 | 1.54 | 0.28 | 10
COVID19_MODERNA | Withdrawal and rebound effects | 2 | 0.25 | 0.76 | 1.50 | 2.8 | 0.29 | 0.74 | 1.60 | 0.76 | 0.76 | 0.21 | 9
COVID19_PFIZER/BIONTECH | Withdrawal and rebound effects | 1 | 0.16 | 0.61 | 1.30 | 2.8 | 0.16 | 0.52 | 1.32 | 0.41 | 0.41 | 0.07 | 10
COVID19_UNKNOWN MFR | Withdrawal and rebound effects | 0 | 0.15 | 0.99 | 2.42 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Yersinia infections | 0 | 0.02 | 0.82 | 2.64 | 0.2 |  |  |  |  |  |  | 
COVID19_MODERNA | Yersinia infections | 0 | 0.02 | 0.54 | 1.75 | 0.7 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Yersinia infections | 0 | 0.02 | 0.58 | 1.87 | 0.6 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Yersinia infections | 0 | 0.03 | 1.00 | 3.22 | 0.0 |  |  |  |  |  |  | 
COVID19_JANSSEN | Zinc disorders | 0 | 0.03 | 0.88 | 2.76 | 0.1 |  |  |  |  |  |  | 
COVID19_MODERNA | Zinc disorders | 0 | 0.02 | 0.66 | 2.07 | 0.5 |  |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Zinc disorders | 0 | 0.03 | 0.69 | 2.17 | 0.4 |  |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Zinc disorders | 0 | 0.04 | 1.00 | 3.13 | 0.0 |  |  |  |  |  |  |